Citrus Sinensis ID: 045028
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1044 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.234 | 0.262 | 0.754 | 1e-129 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.267 | 0.339 | 0.649 | 1e-107 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.265 | 0.215 | 0.456 | 5e-68 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.258 | 0.420 | 0.447 | 1e-64 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.242 | 0.337 | 0.458 | 5e-63 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.25 | 0.378 | 0.437 | 3e-62 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.249 | 0.283 | 0.424 | 3e-61 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.248 | 0.511 | 0.458 | 4e-59 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.244 | 0.153 | 0.379 | 8e-58 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.244 | 0.157 | 0.403 | 9e-57 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 462 bits (1189), Expect = e-129, Method: Compositional matrix adjust.
Identities = 203/269 (75%), Positives = 230/269 (85%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLI 803
DV ECEIPW ++ + ERIGLGSYGEVY DWHGTEVAVK+FLDQDF G +L EFRSEV I
Sbjct: 658 DVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRI 717
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
M+R+RHPNVV F+GAVTRPPNLSIV EFLPRGSLYR+LHRP + +DERRR++MALD A G
Sbjct: 718 MRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMG 777
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923
MN LH TP IVHRDLK+PNLLVD NW VKV DFGLSR+KHNTFLSS+STAGT EWMAPE
Sbjct: 778 MNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPE 837
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
VLRNEPS+EKCDVYSFGVILWEL T++ PW GMNPMQVVGAVGFQ+RRL+IP LDP V
Sbjct: 838 VLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVG 897
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
II +CWQTDP +RP+F ++ LKPL +
Sbjct: 898 RIILECWQTDPNLRPSFAQLTEVLKPLNR 926
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 185/285 (64%), Positives = 222/285 (77%), Gaps = 6/285 (2%)
Query: 740 DVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRS 799
++G D + +IPW ++ + E+IG GS+G V+R +WHG++VAVK ++QDF E + EF
Sbjct: 536 ELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLR 595
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN--NQLDERRRLRMA 857
EV IMKR+RHPN+VLFMGAVT+PPNLSIV E+L RGSLYRLLH+ QLDERRRL MA
Sbjct: 596 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 655
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA 917
D A+GMNYLHN P IVHRDLKSPNLLVDK + VKVCDFGLSR+K +TFLSS+S AGT
Sbjct: 656 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 715
Query: 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977
EWMAPEVLR+EPS+EK DVYSFGVILWEL T+QQPWG +NP QVV AVGF+ +RL+IP N
Sbjct: 716 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 775
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRP 1022
L+P VA II CW +P RP+F IM L+PL K S VP P
Sbjct: 776 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK----SAVPPP 816
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 130/285 (45%), Positives = 182/285 (63%), Gaps = 8/285 (2%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E E+P EI +G RIG G YG+V+RG W GTEVAVK + + + + + R EV ++ +
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCK 902
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
+RHPN+VLFMGA T P + IV E+L RGSL +L + ++D RL++ D ARGM Y
Sbjct: 903 LRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTY 962
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
LH+ P+I+HRDLK+ NLLVD +W VKV DFGL+ +K +TF +++ GT W+APEVL
Sbjct: 963 LHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVLA 1020
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
E EK DVYS+ ++LWEL T P+ G N MQVV ++ + RL +P P A ++
Sbjct: 1021 EEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYAALM 1079
Query: 987 RKCWQTDPKMRPTFTEIMAALKPL----QKPITSSQVP-RPVPSV 1026
+CW+TDP RP+F EI+ ++ + QK S RP+P V
Sbjct: 1080 NRCWETDPTHRPSFPEILPIMEGMISEFQKEKKESIAQGRPIPYV 1124
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 124/277 (44%), Positives = 173/277 (62%), Gaps = 7/277 (2%)
Query: 734 NDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGES 793
ND ++ G D I +I +G RIG G+YGEVY G W G++VAVK+ +
Sbjct: 358 NDYTQIKDGKD-----IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENI 412
Query: 794 LEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR 853
L+EF E+ +MK +RHPNV+ F+G+ PP++ I E++PRGSLY +LH QL
Sbjct: 413 LKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLL 472
Query: 854 LRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913
++M +DAA+G+ YLHN TPVI+HRDLKS NLLVD+NW VKV DFGLS ++ ++ +
Sbjct: 473 IKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTA 530
Query: 914 AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD 973
GT W +PEVLR++ EK DVYSFG+ILWE T Q P+ G+ P QV+ AVG + R
Sbjct: 531 CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPP 590
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+P N P ++ C +P RPT + + L+ +
Sbjct: 591 VPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESI 627
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 5e-63, Method: Compositional matrix adjust.
Identities = 121/264 (45%), Positives = 164/264 (62%), Gaps = 11/264 (4%)
Query: 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKR--FL---DQDFFGESLEEFRSEVLIMKRVR 808
EI + RIG GS EV+ G W G VA+K+ L D+DF L E E IM ++R
Sbjct: 490 EIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDF----LNELAQEATIMSQLR 545
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPN+ F+G PP + IV E++P GSLYR+LH P+ LD R MALD A+GMNYLH
Sbjct: 546 HPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLH 605
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRSTAGTAEWMAPEVLR 926
C P+++HRDLKS NLLVD+++ VK+ DFGLS KH ++ + GT W APEVLR
Sbjct: 606 CCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPEVLR 665
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
N+P EK DV+SF ++LWE+ T + P+ GM Q+V +VG R +P + +I
Sbjct: 666 NDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFTRLI 725
Query: 987 RKCWQTDPKMRPTFTEIMAALKPL 1010
+CW DP+ RP+F EI+ L+ +
Sbjct: 726 TECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 115/263 (43%), Positives = 166/263 (63%), Gaps = 2/263 (0%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+I ++I +G RIG G++GEVY G W G++VAVK+ + L+EF E+ +MK +R
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPNV+ F+G+ P++ I E++PRGSLY +LH ++ RM +DAA+G+ YLH
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLH 504
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
TPVI+HRDLKS NLLVD+NW VKV DFGLS ++ ++ + GT W +PEVLR++
Sbjct: 505 GSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 562
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988
EK DVYSFG+ILWE T Q P+ G+ P QV+ AVG + R P P +++
Sbjct: 563 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKD 622
Query: 989 CWQTDPKMRPTFTEIMAALKPLQ 1011
C +P RPT + + L+ ++
Sbjct: 623 CLNENPSQRPTMEQCLEILESIE 645
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (606), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 112/264 (42%), Positives = 174/264 (65%), Gaps = 4/264 (1%)
Query: 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRF-LDQDFFGESLEEFRSEVLI 803
++ EI + E+ + ++G G++G VY+G W G+ VA+K+ +++D + LEEFR E+ I
Sbjct: 652 FSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
+ R+RHPN+VL M A T PPNL + E+LP GSLY LH +++ + ++A+ A+G
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQG 771
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923
MNYLH ++HRD+KS NLL+D++ VK+CDFGLS++K + ++S G+ WM+PE
Sbjct: 772 MNYLH--LSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSI-GSPIWMSPE 828
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
+L E EK DVY+FG+ILWEL T + P+ G++ +Q+ AV + R IP+ ++
Sbjct: 829 LLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLS 888
Query: 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007
+I+ CW DP RP+FTEI+ L
Sbjct: 889 HLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 230 bits (587), Expect = 4e-59, Method: Compositional matrix adjust.
Identities = 120/262 (45%), Positives = 161/262 (61%), Gaps = 3/262 (1%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
EI EEI E IG GS+G+VY+G VAVK Q+F +L FR EV +M ++
Sbjct: 18 EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIY 77
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPN+ LFMGA T P IV E +P+G+L LLH QL R+RMA DAA G+N+LH
Sbjct: 78 HPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDAALGINWLH 137
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS--RMKHNTFLSSRSTAGTAEWMAPEVLR 926
PV VHRD+KS NLLVD+N VK+CDFGLS + KH S GT +MAPEV+
Sbjct: 138 ESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEVMM 197
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV-GAVGFQHRRLDIPDNLDPAVADI 985
+ +E DVYSFG++LWE+ T ++P+ ++ AV +H R IP++ ++ +
Sbjct: 198 FKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDCLDSLRRL 257
Query: 986 IRKCWQTDPKMRPTFTEIMAAL 1007
I KCW +P RP+F EI++AL
Sbjct: 258 IEKCWDKEPISRPSFKEIISAL 279
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 8e-58, Method: Compositional matrix adjust.
Identities = 98/258 (37%), Positives = 164/258 (63%), Gaps = 3/258 (1%)
Query: 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
I ++EI +GE+IGLGSYG VYRG W +VA+K+F+ Q L R E+ +K++ H
Sbjct: 1394 INYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKKLHH 1453
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
PN++ +GA + PN+ IV E++ +G+L + +L+ +++++ ++ A+G++YLH+
Sbjct: 1454 PNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHS 1513
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
P I+HRD+K N+L+D+NW VK+ DFG +R+K + +R GT W APE++RN+
Sbjct: 1514 FDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPEIIRNDI 1571
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
DEK DV+SFG+++WE+ T ++P+ G N M++ + + R IP + A ++RKC
Sbjct: 1572 YDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAKLMRKC 1630
Query: 990 WQTDPKMRPTFTEIMAAL 1007
W RPT +++ L
Sbjct: 1631 WHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 104/258 (40%), Positives = 165/258 (63%), Gaps = 3/258 (1%)
Query: 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
I ++EI++G++IGLGSYG V+ G W G +VAVK+F+ Q L EFR+E+ + ++H
Sbjct: 1359 INYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKH 1418
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
N+V F+GA + PN+ IV E++ G+L +L P+ ++ +L++ AA G++YLH+
Sbjct: 1419 SNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHS 1478
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
P+IVHRD+K N+LVD+++ VK+ DFG +R+K + ++ + GT W APEV+R E
Sbjct: 1479 SNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPEVIRGEK 1536
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
EK DV+SFGV++WE+ T ++P+ N M+V + + R IP + A +I+KC
Sbjct: 1537 YCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEFAKLIKKC 1595
Query: 990 WQTDPKMRPTFTEIMAAL 1007
W RPT TE++ L
Sbjct: 1596 WHAKAHKRPTMTEVVQQL 1613
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1044 | ||||||
| 359491503 | 1033 | PREDICTED: uncharacterized protein LOC10 | 0.956 | 0.967 | 0.702 | 0.0 | |
| 224133208 | 979 | predicted protein [Populus trichocarpa] | 0.934 | 0.996 | 0.736 | 0.0 | |
| 147820054 | 1058 | hypothetical protein VITISV_002169 [Viti | 0.956 | 0.944 | 0.687 | 0.0 | |
| 356512978 | 1020 | PREDICTED: uncharacterized protein LOC10 | 0.953 | 0.975 | 0.719 | 0.0 | |
| 356512980 | 1016 | PREDICTED: uncharacterized protein LOC10 | 0.953 | 0.979 | 0.719 | 0.0 | |
| 356524668 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.951 | 0.972 | 0.709 | 0.0 | |
| 224121198 | 946 | predicted protein [Populus trichocarpa] | 0.900 | 0.993 | 0.711 | 0.0 | |
| 449439703 | 1011 | PREDICTED: uncharacterized protein LOC10 | 0.957 | 0.989 | 0.695 | 0.0 | |
| 356520645 | 1026 | PREDICTED: uncharacterized protein LOC10 | 0.973 | 0.990 | 0.687 | 0.0 | |
| 356529521 | 1022 | PREDICTED: uncharacterized protein LOC10 | 0.956 | 0.977 | 0.681 | 0.0 |
| >gi|359491503|ref|XP_003634285.1| PREDICTED: uncharacterized protein LOC100854850 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1390 bits (3599), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 747/1064 (70%), Positives = 834/1064 (78%), Gaps = 65/1064 (6%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGNNNSKSNELASLHNPEPNIN---KPTSGLSNWLN 57
MKN+LKKLHI+SN ++D EGSTS RG+ + L + P+ N KP SGLSNWLN
Sbjct: 1 MKNILKKLHIVSNQTEDVEGSTSSRGSKTHDGSSPDRLLHSRPHHNSEHKPFSGLSNWLN 60
Query: 58 SVVNRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEY 117
SV NR SPSPP SSNV R ER+EP+DS++ LDV + R DS S+NSRDPD+EEEY
Sbjct: 61 SVANRHSPSPPLSSNVTRV--ERSEPSDSMSSCGLDVVSDAVRRDSGSSNSRDPDIEEEY 118
Query: 118 QIQMALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGF 177
QIQ+ALELSA+EDPEAVQIEAVKQISLGSC PENTPAE+VAYRYWNYN+LSYDDKI+DGF
Sbjct: 119 QIQLALELSAREDPEAVQIEAVKQISLGSCAPENTPAEIVAYRYWNYNALSYDDKILDGF 178
Query: 178 YDLYGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSR 237
YDLYGI ESTS +MPSLVDLQGTP+S V WEAVLVNRAAD+NLLKLEQ+ L +AVKSR
Sbjct: 179 YDLYGILMESTSQKMPSLVDLQGTPLSDCVTWEAVLVNRAADANLLKLEQEALVMAVKSR 238
Query: 238 SHSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTI 297
S S FVG DLV+ LA LVA MGGPVGDP NMSRA +SLSYSLKATLGSMVLPLGSLTI
Sbjct: 239 SESPVFVGSDLVQRLAALVAANMGGPVGDPVNMSRAWQSLSYSLKATLGSMVLPLGSLTI 298
Query: 298 GLARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADPGTLI 357
GLARHRALLFKVLAD VGIPCRLVKGQQYTG DDVAMNFV+I+DGREYIVDLMADPGTLI
Sbjct: 299 GLARHRALLFKVLADSVGIPCRLVKGQQYTGSDDVAMNFVKIEDGREYIVDLMADPGTLI 358
Query: 358 PSDAVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRFRNSA 417
PSDA GSH+E DDS +SAS LSR+IDSS+ ASSSSGV + +
Sbjct: 359 PSDAAGSHIEYDDSIFSASTLSREIDSSYIASSSSGVVRPY-----------------LS 401
Query: 418 AVAGQSNETGKSNAFFNLTRTTEGEEELKMLPENKHPSDREKAFVRELPNKPNYPHAHAR 477
AV +S++ G+ A NL R + K + E+ +R LP++P++P+ H R
Sbjct: 402 AVGNESDDRGELTACANLPRPS------------KDSLNAEQTLLRALPSRPSHPYMHGR 449
Query: 478 SPSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYA 537
SPSWTEGVSSPA RMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIY
Sbjct: 450 SPSWTEGVSSPAVRRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYP 509
Query: 538 EQLDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLP----RPRAPSKATSF 593
E +D S VE +SPTE +D+N++ ++ K+QDD P FLPPLP +PR
Sbjct: 510 EHIDVSIVEAKSPTEDKDENEKRPVIRKIKDQDDLGPIGFLPPLPYHGMQPRVSPCVQPD 569
Query: 594 DQPEEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMVVAV 653
+P E LG + D GQ +S QSE P+KY K+VPVAAAAAAAA + + A
Sbjct: 570 LKPVEGLGFNNLLDFKEVTGQSVSSQSEVNPVKYVKNVPVAAAAAAAAVVASSMVV--AA 627
Query: 654 AKSNTDSNLELPVAAAATATAAAMVATTAAVGKQYEL-------------------SIRS 694
AKS D NLELPVAAAATA AA + T A GKQYE ++S
Sbjct: 628 AKSTADPNLELPVAAAATAAAAVVATTAAV-GKQYENLETGVHSPSGAAECFNQTDGMQS 686
Query: 695 DGDADSAGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVG-DDVAECEIPWE 753
GDAD AGYEP GSG REH+ G N EGER SDRSA DS+KSDV DDVA+CEIPW+
Sbjct: 687 GGDADGAGYEPH--GSGNREHDASGTNPEGERTSDRSA--DSTKSDVALDDVADCEIPWD 742
Query: 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
EI LGERIGLGSYGEVYRGDWHGTEVAVK+FLDQD GESL+EFRSEV IMKR+RHPNVV
Sbjct: 743 EIALGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDISGESLDEFRSEVRIMKRLRHPNVV 802
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
LFMGAVTR PNLSIV EFLPRGSLYRL+HRPNNQLDERRRLRMALDAARGMNYLHNCTPV
Sbjct: 803 LFMGAVTRVPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 862
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH+TFLSSRSTAGTAEWMAPEVLRNEPSDEK
Sbjct: 863 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTFLSSRSTAGTAEWMAPEVLRNEPSDEK 922
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
CDV+SFGVILWEL T+QQPWGGMNPMQVVGAVGFQHRRLDIPD++DP VADIIR+CW T+
Sbjct: 923 CDVFSFGVILWELSTLQQPWGGMNPMQVVGAVGFQHRRLDIPDDMDPVVADIIRRCWHTN 982
Query: 994 PKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVSSGRETGQISK 1037
PKMRPTF EIMA LKPLQKPITSSQVPRP ++SSG+E Q S+
Sbjct: 983 PKMRPTFAEIMATLKPLQKPITSSQVPRPSAAISSGQERVQPSR 1026
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133208|ref|XP_002321510.1| predicted protein [Populus trichocarpa] gi|222868506|gb|EEF05637.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1383 bits (3579), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 771/1047 (73%), Positives = 839/1047 (80%), Gaps = 71/1047 (6%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGN--NNSKSNELASLHNPEPNINKPTSGLSNWLNS 58
MKN LKKLHIM N S+DAEGS S RG+ N S + SLH+ NKP SGLSNWL+S
Sbjct: 1 MKNFLKKLHIMPNQSEDAEGSNSSRGHKSTNGSSPDNKSLHS-RSQENKPFSGLSNWLSS 59
Query: 59 VVNRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEYQ 118
V NRKSPSPPSSSNV R E+ E + DPD+EEEYQ
Sbjct: 60 VANRKSPSPPSSSNVTRG--EKVEQPE------------------------DPDIEEEYQ 93
Query: 119 IQMALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGFY 178
IQ+ALELSA EDPEAVQIEAVKQISLGSC PENTPAEV+AYRYWNYN+LSYDDK++DGFY
Sbjct: 94 IQLALELSASEDPEAVQIEAVKQISLGSCAPENTPAEVIAYRYWNYNALSYDDKVLDGFY 153
Query: 179 DLYGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSRS 238
DLYGI +EST+DRMP LVDLQGTPVS V WEAVLVNRAAD++LLKLEQK LE+ VKSRS
Sbjct: 154 DLYGIMTESTTDRMPPLVDLQGTPVSDGVTWEAVLVNRAADASLLKLEQKALEMTVKSRS 213
Query: 239 HSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIG 298
Q F+G LV LAVLV+DYMGG VGDP N+SRA RSLSYSLKATLGSMVLPLGSLTIG
Sbjct: 214 ECQIFIGSALVGRLAVLVSDYMGGSVGDPSNLSRAWRSLSYSLKATLGSMVLPLGSLTIG 273
Query: 299 LARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADPGTLIP 358
L RHRAL+FKVLAD VGIPCRLVKG YTG DDVAMNFV++DDGREYIVDL ADPGTLIP
Sbjct: 274 LPRHRALMFKVLADSVGIPCRLVKGHLYTGSDDVAMNFVKLDDGREYIVDLTADPGTLIP 333
Query: 359 SDAVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRFRNSAA 418
SDA GSH+E D++F+S+SPLSRDIDSSH ASSSSG SSFEEHSE GT +K+SR RN AA
Sbjct: 334 SDAAGSHIEYDETFFSSSPLSRDIDSSHIASSSSGHTSSFEEHSELGTLEKQSRLRNIAA 393
Query: 419 VAGQSNETGKSNAFFNLTRTTEGEEELKMLPENKHPSDREKAFVRELPNKPNYPHAHARS 478
V QS+ +S+ +LTR ++ +RELP +P YP+AHARS
Sbjct: 394 VGNQSDGRSESHEGASLTRPSK---------------------MRELPGRPIYPYAHARS 432
Query: 479 PSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYAE 538
PSWTEGVSSPAA RMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYAE
Sbjct: 433 PSWTEGVSSPAARRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYAE 492
Query: 539 QLDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRPRAPSKATSFDQPEE 598
QLD ST E +SPT + +KQ T + K+QDD PARFLPPLP R P KA+S P +
Sbjct: 493 QLDLSTAETKSPTVDKVDHKQRTEIRSVKDQDDLVPARFLPPLPPHRLPYKASSPGNPPD 552
Query: 599 DLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMVVAVAKSNT 658
QS + +G SE TP+KY K VPVAAAAAAAAA V +S +V A AKS T
Sbjct: 553 ------QSKPVEGSG------SEVTPVKYVKKVPVAAAAAAAAAVVASSMVVAA-AKSGT 599
Query: 659 DSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGYEPRDSGSGGREHNYL 718
DSNLELPVAAAATATAAA+VATTAAV KQYE RSDGDADSAGYEPR SG G
Sbjct: 600 DSNLELPVAAAATATAAAVVATTAAVNKQYEQGARSDGDADSAGYEPRGSGDKG------ 653
Query: 719 GANSEGERVSDRSASNDSSKSDVG-DDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGT 777
ANSEGER+SDRS NDSSKSD DDVAECEIPW+EI+LGERIGLGSYGEVYRGDWHGT
Sbjct: 654 -ANSEGERISDRSVGNDSSKSDAAMDDVAECEIPWDEISLGERIGLGSYGEVYRGDWHGT 712
Query: 778 EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837
EVAVKRFLDQD GESL EFRSEV IMKRVRHPNVVLFMGAVTR PNLSIV EFLPRGSL
Sbjct: 713 EVAVKRFLDQDITGESLAEFRSEVRIMKRVRHPNVVLFMGAVTRAPNLSIVTEFLPRGSL 772
Query: 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897
YRLLHRPNNQLDERRRLRMA DAARGMNYLHNCTP+IVHRDLKSPNLLVDKNWVVKVCDF
Sbjct: 773 YRLLHRPNNQLDERRRLRMAFDAARGMNYLHNCTPMIVHRDLKSPNLLVDKNWVVKVCDF 832
Query: 898 GLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN 957
GLSRMKH+TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWEL T+QQPWGGMN
Sbjct: 833 GLSRMKHSTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELSTLQQPWGGMN 892
Query: 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSS 1017
PMQVVGAVGFQHRRLDIP+++DP +ADIIR CW+TDPK+RPTF EIMAALKPLQKPIT
Sbjct: 893 PMQVVGAVGFQHRRLDIPNDMDPTIADIIRNCWKTDPKLRPTFAEIMAALKPLQKPITGP 952
Query: 1018 QVPRPVPSVSSGRETGQISKFLADSTG 1044
QVPRP S+ SGRE Q+ + D G
Sbjct: 953 QVPRPNASLRSGREKVQLFQEAEDQAG 979
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147820054|emb|CAN76042.1| hypothetical protein VITISV_002169 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1379 bits (3568), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 749/1089 (68%), Positives = 834/1089 (76%), Gaps = 90/1089 (8%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGNNNSKSNELASLHNPEPNIN---KPTSGLSNWLN 57
MKN+LKKLHI+SN ++D EGSTS RG+ + L + P+ N KP SGLSNWLN
Sbjct: 1 MKNILKKLHIVSNQTEDVEGSTSSRGSKTHDGSSPDRLLHSRPHHNSEHKPFSGLSNWLN 60
Query: 58 SVVNRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEY 117
SV NR SPSPP SSNV R ER+EP+DS++ LDV + R DS S+NSRDPDVEEEY
Sbjct: 61 SVANRHSPSPPLSSNVTRV--ERSEPSDSMSSCGLDVVSDAVRRDSGSSNSRDPDVEEEY 118
Query: 118 QIQMALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGF 177
QIQ+ALELSA+EDPEAVQIEAVKQISLGSC PENTPAE+VAYRYWNYN+LSYDDKI+DGF
Sbjct: 119 QIQLALELSAREDPEAVQIEAVKQISLGSCAPENTPAEIVAYRYWNYNALSYDDKILDGF 178
Query: 178 YDLYGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSR 237
YDLYGI ESTS +MPSLVDLQGTP+S V WEAVLVNRAAD+NLLKLEQ+ L +AVKSR
Sbjct: 179 YDLYGILMESTSQKMPSLVDLQGTPLSDCVTWEAVLVNRAADANLLKLEQEALVMAVKSR 238
Query: 238 SHSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTI 297
S S FVG DLV+ LA LVA MGGPVGDP NMSRA +SLSYSLKATLGSMVLPLGSLTI
Sbjct: 239 SESPVFVGSDLVQRLAALVAANMGGPVGDPVNMSRAWQSLSYSLKATLGSMVLPLGSLTI 298
Query: 298 GLARHRALLFK-------------------------VLADIVGIPCRLVKGQQYTGCDDV 332
GLARHRALLFK VLAD VGIPCRLVKGQQYTG DDV
Sbjct: 299 GLARHRALLFKYLLTNPLFGSIDGHFSLSLTLIIAQVLADSVGIPCRLVKGQQYTGSDDV 358
Query: 333 AMNFVRIDDGREYIVDLMADPGTLIPSDAVGSHVECDDSFYSASPLSRDIDSSHAASSSS 392
AMNFV+I+DGREYIVDLMADPGTLIPSDA GSH+E DDS +SAS LSR+IDSS+ ASSSS
Sbjct: 359 AMNFVKIEDGREYIVDLMADPGTLIPSDAAGSHIEYDDSIFSASTLSREIDSSYIASSSS 418
Query: 393 GVGSSFEEHSEFGTCDKRSRFRNSAAVAGQSNETGKSNAFFNLTRTTEGEEELKMLPENK 452
GV + +AV +S++ G+ A NL R + K
Sbjct: 419 GVVRPY-----------------LSAVGNESDDRGELTACANLPRPS------------K 449
Query: 453 HPSDREKAFVRELPNKPNYPHAHARSPSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQL 512
+ E+ +R LP++P++P+ H RSPSWTEGVSSPA RMKVKDVSQYMIDAAKENPQL
Sbjct: 450 DSFNAEQTLLRALPSRPSHPYMHGRSPSWTEGVSSPAVRRMKVKDVSQYMIDAAKENPQL 509
Query: 513 AQKLHDVLLESGVVAPPNLFTEIYAEQLDASTVEVRSPTETQDKNKQGTGSQERKNQDDP 572
AQKLHDVLLESGVVAPPNLFTEIY E +D S VE +SPTE +D+N++ ++ K+QDD
Sbjct: 510 AQKLHDVLLESGVVAPPNLFTEIYPEHIDVSIVEAKSPTEDKDENEKRPVIRKIKDQDDL 569
Query: 573 SPARFLPPLP----RPRAPSKATSFDQPEEDLGLSRQSDVMAAAGQPLSPQSEATPIKYR 628
P FLPPLP +PR +P E LG + D GQ +S QSE P+KY
Sbjct: 570 GPIGFLPPLPYHGMQPRVSPCVQPDLKPVEGLGFNNLLDFKEVTGQSVSSQSEVNPVKYV 629
Query: 629 KDVPVAAAAAAAAAAVVASSMVVAVAKSNTDSNLELPVAAAATATAAAMVATTAAVGKQY 688
K+VPVAAAAAAAA + + A AKS D NLELPVAAAATA AA + T A GKQY
Sbjct: 630 KNVPVAAAAAAAAVVASSMVV--AAAKSTADPNLELPVAAAATAAAAVVATTAAV-GKQY 686
Query: 689 EL-------------------SIRSDGDADSAGYEPRDSGSGGREHNYLGANSEGERVSD 729
E ++S GDAD AGYEP GSG REH+ G N EGER SD
Sbjct: 687 ENLETGVHSPSGAAECFNQTDGMQSGGDADGAGYEPH--GSGNREHDASGTNPEGERTSD 744
Query: 730 RSASNDSSKSDVG-DDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQD 788
RSA DS+KSDV DDVA+CEIPW+EI LGERIGLGSYGEVYRGDWHGTEVAVK+FLDQD
Sbjct: 745 RSA--DSTKSDVALDDVADCEIPWDEIALGERIGLGSYGEVYRGDWHGTEVAVKKFLDQD 802
Query: 789 FFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQL 848
GESL+EFRSEV IMKR+RHPNVVLFMGAVTR PNLSIV EFLPRGSLYRL+HRPNNQL
Sbjct: 803 ISGESLDEFRSEVRIMKRLRHPNVVLFMGAVTRVPNLSIVTEFLPRGSLYRLIHRPNNQL 862
Query: 849 DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908
DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH+TFL
Sbjct: 863 DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTFL 922
Query: 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ 968
SSRSTAGTAEWMAPEVLRNEPSDEKCDV+SFGVILWEL T+QQPWGGMNPMQVVGAVGFQ
Sbjct: 923 SSRSTAGTAEWMAPEVLRNEPSDEKCDVFSFGVILWELSTLQQPWGGMNPMQVVGAVGFQ 982
Query: 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVSS 1028
HRRLDIPD++DP VADIIR+CW T+PKMRPTF EIMA LKPLQKPITSSQVPRP S+SS
Sbjct: 983 HRRLDIPDDMDPVVADIIRRCWHTNPKMRPTFAEIMATLKPLQKPITSSQVPRPSASISS 1042
Query: 1029 GRETGQISK 1037
G+E Q S+
Sbjct: 1043 GQERVQPSR 1051
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512978|ref|XP_003525191.1| PREDICTED: uncharacterized protein LOC100778331 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1365 bits (3532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/1032 (71%), Positives = 830/1032 (80%), Gaps = 37/1032 (3%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGNNNSKSNELASLHNPEPNINKPTSGLSNWLNSVV 60
MKN+LKKLHIMSN S+DA+G+TS + N +S + ++ LSNWL+SV
Sbjct: 5 MKNILKKLHIMSNQSEDAQGATSSKSNKSSDGSSSST----------APKKLSNWLHSVS 54
Query: 61 NRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEYQIQ 120
NR+SPSPPS A ER EP+DSV+ LDV ++ R DSES+ SRDP+VEEEYQIQ
Sbjct: 55 NRQSPSPPSPI---LARGERMEPSDSVSSGGLDVVSDSARRDSESSTSRDPEVEEEYQIQ 111
Query: 121 MALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGFYDL 180
+ALELSAKEDPEAVQIEAVKQISLGSCDP+NTPAEVVAYRYWNYN+L YDDKI DGFYDL
Sbjct: 112 LALELSAKEDPEAVQIEAVKQISLGSCDPDNTPAEVVAYRYWNYNALGYDDKISDGFYDL 171
Query: 181 YGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSRSHS 240
YGI +ESTS RMPSLVDLQGTP S V WEAVLVNRAADS+LLKLEQ+ +E+AV SR
Sbjct: 172 YGILTESTSARMPSLVDLQGTPTSDDVTWEAVLVNRAADSSLLKLEQEAMEMAVNSRKDF 231
Query: 241 QAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIGLA 300
+ V DLV LA++VADYMGG V DPE+MSRA RSLSYSLKATLGSMVLPLGSLTIGLA
Sbjct: 232 EVLVDSDLVHKLAIIVADYMGGSVEDPESMSRAWRSLSYSLKATLGSMVLPLGSLTIGLA 291
Query: 301 RHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADPGTLIPSD 360
RHRALLFKVLAD +GIPCRLVKG QY G +DVAMNFV+ID GREYIVDLMA PGTLIPSD
Sbjct: 292 RHRALLFKVLADSLGIPCRLVKGLQYMGSNDVAMNFVKID-GREYIVDLMAAPGTLIPSD 350
Query: 361 AVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRFRNSAAVA 420
A GSH+E DDS + ASP SR++DSSH AS SSGVGSS EE S+ GT DK ++ +
Sbjct: 351 ATGSHIEFDDSSFVASPSSRELDSSHVASFSSGVGSSSEEASDSGTLDKDNKSKYFGYAG 410
Query: 421 GQSNETGKSNAFFNLTRTTEGEEELKMLP-ENKHPSDREKAFVRELPNKPNYPHAHARSP 479
+S+ +G T G+EELK E+K+ EK VR+ P++PNYP+ H RSP
Sbjct: 411 KESDVSG----------PTTGKEELKKPSNESKNTPYEEKIIVRDSPSRPNYPYMHGRSP 460
Query: 480 SWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYAEQ 539
SWTEG+SSPA RMKVKDVSQYMIDAAKENP LAQKLHDVLLESGVVAPPNLF+EIY Q
Sbjct: 461 SWTEGISSPAVRRMKVKDVSQYMIDAAKENPNLAQKLHDVLLESGVVAPPNLFSEIYHGQ 520
Query: 540 LDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRPRAPSKAT-------S 592
L T E PTE +D+NKQG+ +E K D+ PARFLPPLP R KAT
Sbjct: 521 LSTLT-EANFPTEQKDENKQGSVQRETKTDDNLVPARFLPPLPHYRVQRKATPSTSSHLE 579
Query: 593 FDQPEEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMVVA 652
+P + LG D AAGQ +S Q EAT +KY K++PVAAAAAAAAA V +S +V
Sbjct: 580 HSKPVDGLGTGLPLDSGEAAGQHISSQVEATQVKYGKNMPVAAAAAAAAAVVASSMVVAV 639
Query: 653 VAKSNTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGYEPRDSGSGG 712
KSN DSNLE+PVAAAATATAAA+VATTAAV KQYE RSDGDA+ AG E + SG G
Sbjct: 640 T-KSNADSNLEIPVAAAATATAAAVVATTAAVSKQYEQGSRSDGDAEGAGCESKGSGDG- 697
Query: 713 REHNYLGANSEGERVSDRSASNDSSKSDVG-DDVAECEIPWEEITLGERIGLGSYGEVYR 771
EHN LG NSEGER SDRS SNDS+KSD DDVAE +IPWEEI +GERIGLGSYGEVYR
Sbjct: 698 -EHNALGENSEGERKSDRSVSNDSTKSDSALDDVAEYDIPWEEIAVGERIGLGSYGEVYR 756
Query: 772 GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831
G+WHGTEVAVK+FL QD GE LEEF+SEV IMKR+RHPNVVLFMGAVTRPPNLSIV+EF
Sbjct: 757 GEWHGTEVAVKKFLYQDISGELLEEFKSEVQIMKRLRHPNVVLFMGAVTRPPNLSIVSEF 816
Query: 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891
LPRGSLYRL+HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV
Sbjct: 817 LPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 876
Query: 892 VKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ 951
VKVCDFGLSRMKH+TFLSSRSTAGTAEWMAPEVLRNE SDEKCDV+S+GVILWEL T+QQ
Sbjct: 877 VKVCDFGLSRMKHSTFLSSRSTAGTAEWMAPEVLRNELSDEKCDVFSYGVILWELSTLQQ 936
Query: 952 PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
PWGGMNPMQVVGAVGFQHRRLDIPDN+DPA+ADIIR+CWQTDPK+RPTF EIMAALKPLQ
Sbjct: 937 PWGGMNPMQVVGAVGFQHRRLDIPDNVDPAIADIIRQCWQTDPKLRPTFAEIMAALKPLQ 996
Query: 1012 KPITSSQVPRPV 1023
KPIT SQV RP+
Sbjct: 997 KPITVSQVHRPI 1008
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512980|ref|XP_003525192.1| PREDICTED: uncharacterized protein LOC100778331 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1364 bits (3531), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/1032 (71%), Positives = 830/1032 (80%), Gaps = 37/1032 (3%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGNNNSKSNELASLHNPEPNINKPTSGLSNWLNSVV 60
MKN+LKKLHIMSN S+DA+G+TS + N +S + ++ LSNWL+SV
Sbjct: 1 MKNILKKLHIMSNQSEDAQGATSSKSNKSSDGSSSST----------APKKLSNWLHSVS 50
Query: 61 NRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEYQIQ 120
NR+SPSPPS A ER EP+DSV+ LDV ++ R DSES+ SRDP+VEEEYQIQ
Sbjct: 51 NRQSPSPPSPI---LARGERMEPSDSVSSGGLDVVSDSARRDSESSTSRDPEVEEEYQIQ 107
Query: 121 MALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGFYDL 180
+ALELSAKEDPEAVQIEAVKQISLGSCDP+NTPAEVVAYRYWNYN+L YDDKI DGFYDL
Sbjct: 108 LALELSAKEDPEAVQIEAVKQISLGSCDPDNTPAEVVAYRYWNYNALGYDDKISDGFYDL 167
Query: 181 YGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSRSHS 240
YGI +ESTS RMPSLVDLQGTP S V WEAVLVNRAADS+LLKLEQ+ +E+AV SR
Sbjct: 168 YGILTESTSARMPSLVDLQGTPTSDDVTWEAVLVNRAADSSLLKLEQEAMEMAVNSRKDF 227
Query: 241 QAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIGLA 300
+ V DLV LA++VADYMGG V DPE+MSRA RSLSYSLKATLGSMVLPLGSLTIGLA
Sbjct: 228 EVLVDSDLVHKLAIIVADYMGGSVEDPESMSRAWRSLSYSLKATLGSMVLPLGSLTIGLA 287
Query: 301 RHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADPGTLIPSD 360
RHRALLFKVLAD +GIPCRLVKG QY G +DVAMNFV+ID GREYIVDLMA PGTLIPSD
Sbjct: 288 RHRALLFKVLADSLGIPCRLVKGLQYMGSNDVAMNFVKID-GREYIVDLMAAPGTLIPSD 346
Query: 361 AVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRFRNSAAVA 420
A GSH+E DDS + ASP SR++DSSH AS SSGVGSS EE S+ GT DK ++ +
Sbjct: 347 ATGSHIEFDDSSFVASPSSRELDSSHVASFSSGVGSSSEEASDSGTLDKDNKSKYFGYAG 406
Query: 421 GQSNETGKSNAFFNLTRTTEGEEELKMLP-ENKHPSDREKAFVRELPNKPNYPHAHARSP 479
+S+ +G T G+EELK E+K+ EK VR+ P++PNYP+ H RSP
Sbjct: 407 KESDVSG----------PTTGKEELKKPSNESKNTPYEEKIIVRDSPSRPNYPYMHGRSP 456
Query: 480 SWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYAEQ 539
SWTEG+SSPA RMKVKDVSQYMIDAAKENP LAQKLHDVLLESGVVAPPNLF+EIY Q
Sbjct: 457 SWTEGISSPAVRRMKVKDVSQYMIDAAKENPNLAQKLHDVLLESGVVAPPNLFSEIYHGQ 516
Query: 540 LDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRPRAPSKAT-------S 592
L T E PTE +D+NKQG+ +E K D+ PARFLPPLP R KAT
Sbjct: 517 LSTLT-EANFPTEQKDENKQGSVQRETKTDDNLVPARFLPPLPHYRVQRKATPSTSSHLE 575
Query: 593 FDQPEEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMVVA 652
+P + LG D AAGQ +S Q EAT +KY K++PVAAAAAAAAA V +S +V
Sbjct: 576 HSKPVDGLGTGLPLDSGEAAGQHISSQVEATQVKYGKNMPVAAAAAAAAAVVASSMVVAV 635
Query: 653 VAKSNTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGYEPRDSGSGG 712
KSN DSNLE+PVAAAATATAAA+VATTAAV KQYE RSDGDA+ AG E + SG G
Sbjct: 636 T-KSNADSNLEIPVAAAATATAAAVVATTAAVSKQYEQGSRSDGDAEGAGCESKGSGDG- 693
Query: 713 REHNYLGANSEGERVSDRSASNDSSKSDVG-DDVAECEIPWEEITLGERIGLGSYGEVYR 771
EHN LG NSEGER SDRS SNDS+KSD DDVAE +IPWEEI +GERIGLGSYGEVYR
Sbjct: 694 -EHNALGENSEGERKSDRSVSNDSTKSDSALDDVAEYDIPWEEIAVGERIGLGSYGEVYR 752
Query: 772 GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831
G+WHGTEVAVK+FL QD GE LEEF+SEV IMKR+RHPNVVLFMGAVTRPPNLSIV+EF
Sbjct: 753 GEWHGTEVAVKKFLYQDISGELLEEFKSEVQIMKRLRHPNVVLFMGAVTRPPNLSIVSEF 812
Query: 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891
LPRGSLYRL+HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV
Sbjct: 813 LPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 872
Query: 892 VKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ 951
VKVCDFGLSRMKH+TFLSSRSTAGTAEWMAPEVLRNE SDEKCDV+S+GVILWEL T+QQ
Sbjct: 873 VKVCDFGLSRMKHSTFLSSRSTAGTAEWMAPEVLRNELSDEKCDVFSYGVILWELSTLQQ 932
Query: 952 PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
PWGGMNPMQVVGAVGFQHRRLDIPDN+DPA+ADIIR+CWQTDPK+RPTF EIMAALKPLQ
Sbjct: 933 PWGGMNPMQVVGAVGFQHRRLDIPDNVDPAIADIIRQCWQTDPKLRPTFAEIMAALKPLQ 992
Query: 1012 KPITSSQVPRPV 1023
KPIT SQV RP+
Sbjct: 993 KPITVSQVHRPI 1004
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524668|ref|XP_003530950.1| PREDICTED: uncharacterized protein LOC100780884 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1338 bits (3464), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 731/1031 (70%), Positives = 824/1031 (79%), Gaps = 38/1031 (3%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGNNNSKSNELASLHNPEPNINKPTSGLSNWLNSVV 60
MKN+LKKLHIMSN S+DA+G+TS + N +S +S LSNWL+SV
Sbjct: 5 MKNILKKLHIMSNQSEDAQGATSSKSNKSSSDGSSSS---------TAPKKLSNWLHSVS 55
Query: 61 NRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEYQIQ 120
NR+SPSPPS N+ R E +P+DSV+ LDV ++ R DSES+ SRDP+VEEEYQIQ
Sbjct: 56 NRQSPSPPSP-NLARG--EIMDPSDSVSSGGLDVVSDSARRDSESSTSRDPEVEEEYQIQ 112
Query: 121 MALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGFYDL 180
+ALELSAKEDPEAVQIEAVKQISLGSCDP+NTPAEVVAYRYWNYN+L YDDKI DGFYDL
Sbjct: 113 LALELSAKEDPEAVQIEAVKQISLGSCDPDNTPAEVVAYRYWNYNALGYDDKISDGFYDL 172
Query: 181 YGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSRSHS 240
YGI +E+TS RMPSLVDLQGTP S V WEAVLVNRAADSNLLKLEQ+ +E+AV SR
Sbjct: 173 YGILTEATSARMPSLVDLQGTPTSDDVTWEAVLVNRAADSNLLKLEQEAMEMAVNSRKDF 232
Query: 241 QAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIGLA 300
+ + DLV LA++VA+YMGG V D E+M RA RSLSYSLKATLGSMVLPLGSLTIGLA
Sbjct: 233 EVVLDSDLVHKLAIVVAEYMGGSVEDHESMLRAWRSLSYSLKATLGSMVLPLGSLTIGLA 292
Query: 301 RHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADPGTLIPSD 360
RHRALLFKVLAD +GIPCRLVKG QY G +DVAMNFV+I+DGREYIVDLMA PGTLIPSD
Sbjct: 293 RHRALLFKVLADTLGIPCRLVKGLQYMGSNDVAMNFVKIEDGREYIVDLMAAPGTLIPSD 352
Query: 361 AVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRFRNSAAVA 420
A GSH+ECDDS + ASP SR++DS H AS SSGVGSS EE S+ GT DK ++ +
Sbjct: 353 ATGSHIECDDSSFVASPSSRELDS-HVASFSSGVGSSSEEASDSGTLDKDNKSKYFGYAR 411
Query: 421 GQSNETGKSNAFFNLTRTTEGEEELKMLPENKHPSD--REKAFVRELPNKPNYPHAHARS 478
+SN +G + G+EELK P N+ + EK ++E P + NYP+ H RS
Sbjct: 412 KESNVSGAAT----------GKEELKR-PSNESNNTPYEEKIILQESPIRSNYPYMHGRS 460
Query: 479 PSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYAE 538
PSWTEG+SSPA RMKVKDVSQYMIDAAKENP LAQKLHD+LLESGVVAPPNLF+EIY
Sbjct: 461 PSWTEGISSPAVRRMKVKDVSQYMIDAAKENPNLAQKLHDILLESGVVAPPNLFSEIYHG 520
Query: 539 QLDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRPRAPSKAT------- 591
QL T E PTE +D+NKQG+ QE K D+ PARFLPPLP R K T
Sbjct: 521 QLSTPT-EANFPTEQKDENKQGSVQQETKTDDNLVPARFLPPLPHHRVHRKVTPSSSSQL 579
Query: 592 SFDQPEEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMVV 651
+P E LG+ D AAGQ +S Q EAT +KY K++PVAAAAAAAAA V +S +V
Sbjct: 580 EHSKPVEGLGIGLPLDSGEAAGQHISSQVEATQVKYGKNMPVAAAAAAAAAVVASSMVVA 639
Query: 652 AVAKSNTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGYEPRDSGSG 711
KSN DSNLE+PVAAAATATAAA+VATTAAV KQYE S GD + AG EP+ SG G
Sbjct: 640 VT-KSNADSNLEIPVAAAATATAAAVVATTAAVSKQYEQGSWSGGDTEGAGCEPKCSGDG 698
Query: 712 GREHNYLGANSEGERVSDRSASNDSSKSDVG-DDVAECEIPWEEITLGERIGLGSYGEVY 770
EHN LG N+EGER SDRS SNDS+KSD DDVAE +IPW+EI +GERIGLGSYGEVY
Sbjct: 699 --EHNALGENTEGERKSDRSVSNDSTKSDSALDDVAEYDIPWDEIAVGERIGLGSYGEVY 756
Query: 771 RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830
RG+WHGTEVAVK+ L QD GE LEEF+SEV IMKR+RHPNVVLFMGAVTRPPNLSIV+E
Sbjct: 757 RGEWHGTEVAVKKLLYQDISGELLEEFKSEVQIMKRLRHPNVVLFMGAVTRPPNLSIVSE 816
Query: 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW 890
FLPRGSLYRL+HRPNNQLDERRRL+MALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW
Sbjct: 817 FLPRGSLYRLIHRPNNQLDERRRLQMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW 876
Query: 891 VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ 950
VVKVCDFGLSRMKH+TFLSSRSTAGTAEWMAPEVLRNE SDEKCDV+S+GVILWEL T+Q
Sbjct: 877 VVKVCDFGLSRMKHSTFLSSRSTAGTAEWMAPEVLRNELSDEKCDVFSYGVILWELSTLQ 936
Query: 951 QPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
QPWGGMNPMQVVGAVGFQHRRLDIPDN+DPA+ADIIR+CWQTDPK+RPTFTEIMAALKPL
Sbjct: 937 QPWGGMNPMQVVGAVGFQHRRLDIPDNVDPAIADIIRQCWQTDPKLRPTFTEIMAALKPL 996
Query: 1011 QKPITSSQVPR 1021
QKPIT+SQV R
Sbjct: 997 QKPITASQVHR 1007
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121198|ref|XP_002318523.1| predicted protein [Populus trichocarpa] gi|222859196|gb|EEE96743.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1318 bits (3412), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 736/1034 (71%), Positives = 807/1034 (78%), Gaps = 94/1034 (9%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGN--NNSKSNELASLHNPEPNINKPTSGLSNWLNS 58
MKN LKKLHIM N S DAEGS S RG+ +N S++ LH+ NKP SGLSNWL+S
Sbjct: 1 MKNFLKKLHIMPNQSQDAEGSNSSRGHKSSNESSSDNKFLHS-RLQENKPFSGLSNWLSS 59
Query: 59 VVNRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEYQ 118
V NRK + R DS S+ SRDPDVEEE+Q
Sbjct: 60 VANRK---------------------------------KGARRDSVSSTSRDPDVEEEFQ 86
Query: 119 IQMALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGFY 178
IQ+ALELSA+EDPEAVQIEAVKQISLGSC PE+T AE++AYRYWNYN+LSYDDK++DGFY
Sbjct: 87 IQLALELSAREDPEAVQIEAVKQISLGSCAPEHTLAELIAYRYWNYNALSYDDKVLDGFY 146
Query: 179 DLYGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSRS 238
DLYGI +ESTSD+MPSLVDLQ TPVSG V WEAVLVNRAAD+NLLKLE+K LE+AVKSRS
Sbjct: 147 DLYGIMTESTSDKMPSLVDLQATPVSGGVTWEAVLVNRAADANLLKLEKKALEIAVKSRS 206
Query: 239 HSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIG 298
SQ F+G LVR LAVLV+DYMGG VGDP N+SRA RSLSYSLKA LGSMVLPLGSLTIG
Sbjct: 207 ESQVFIGSALVRRLAVLVSDYMGGAVGDPSNLSRAWRSLSYSLKANLGSMVLPLGSLTIG 266
Query: 299 LARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADPGTLIP 358
L RHRAL+FKVLAD VGIPCRLVKG YTG DDVAMNFV+IDDGREYIVDL ADPGTLIP
Sbjct: 267 LPRHRALMFKVLADSVGIPCRLVKGHLYTGSDDVAMNFVKIDDGREYIVDLTADPGTLIP 326
Query: 359 SDAVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRFRNSAA 418
SDA GSH+E DDSF+S+SP SRDIDS ASSSSG S E +
Sbjct: 327 SDAAGSHIEYDDSFFSSSPFSRDIDSYRIASSSSGHTSDSHEGA---------------- 370
Query: 419 VAGQSNETGKSNAFFNLTRTTEGEEELKM-LPENKHPSDREKAFVRELPNKPNYPHAHAR 477
+LT+ ++GEEE + L + S EK VRELP +P YP AHAR
Sbjct: 371 ---------------SLTKLSKGEEESTISLNDFGKISIAEKVPVRELPGRPIYPSAHAR 415
Query: 478 SPSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYA 537
SPSWTEGVSSP+ RMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYA
Sbjct: 416 SPSWTEGVSSPSVRRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYA 475
Query: 538 EQLDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRPRAPSKATS-FDQP 596
EQL+AST E SPTE +D +KQ T + K+QDD PARF P LP P K++S +QP
Sbjct: 476 EQLNASTAEATSPTEGKDGHKQRTEIRYVKDQDDLVPARFFPLLPPNELPYKSSSPGNQP 535
Query: 597 EEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMVVAVAKS 656
E+ S SE TP+KY K+VP AAAAAAAAAVVASSMVVA AKS
Sbjct: 536 EQ------------------SKPSEFTPVKYVKNVP-VAAAAAAAAAVVASSMVVAAAKS 576
Query: 657 NTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGYEPRDSGSGGREHN 716
+TDSNLELPVAAAATATAAA++ATTAAV KQY RSDGDADSAGYEP SG G
Sbjct: 577 STDSNLELPVAAAATATAAAVMATTAAVNKQYVQGARSDGDADSAGYEPHGSGDKGS--- 633
Query: 717 YLGANSEGERVSDRSASNDSSKSDVG-DDVAECEIPWEEITLGERIGLGSYGEVYRGDWH 775
G +GER+SDR A N SKSD G DDVAECEIPWEEITLGERIGLGSYGEVYRGDWH
Sbjct: 634 --GGRGKGERISDRLAVNVRSKSDAGLDDVAECEIPWEEITLGERIGLGSYGEVYRGDWH 691
Query: 776 GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835
GTEVAVKRFLDQD GE+L EFRSEV IMKRVRHPNVVLFMGAVTR PNLSIV EF+PRG
Sbjct: 692 GTEVAVKRFLDQDITGEALAEFRSEVRIMKRVRHPNVVLFMGAVTRAPNLSIVTEFIPRG 751
Query: 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC 895
SLYRLLHRPNNQLD+RRRLRMALDAARGMNYLH+CTP+IVHRDLKSPNLLVDKNWVVKVC
Sbjct: 752 SLYRLLHRPNNQLDDRRRLRMALDAARGMNYLHSCTPMIVHRDLKSPNLLVDKNWVVKVC 811
Query: 896 DFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG 955
DFGLSR+K++TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWEL T+QQPWGG
Sbjct: 812 DFGLSRIKNSTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELSTLQQPWGG 871
Query: 956 MNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015
MNPMQVVGAVGFQHR LDIP+++DPA+ADIIRKCWQTDP++RPTF EIMAALK LQKPIT
Sbjct: 872 MNPMQVVGAVGFQHRSLDIPNDMDPAIADIIRKCWQTDPRLRPTFAEIMAALKLLQKPIT 931
Query: 1016 SSQVPRPVPSVSSG 1029
QVPRP + SG
Sbjct: 932 GPQVPRPNAPLRSG 945
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439703|ref|XP_004137625.1| PREDICTED: uncharacterized protein LOC101209024 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1318 bits (3410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/1055 (69%), Positives = 841/1055 (79%), Gaps = 55/1055 (5%)
Query: 1 MKNLLKKLHIMSN-PSDD-AEGSTSLRGNNN---SKSNELASLHNPE--PNINKPTSGLS 53
MKNLLKK HIMS+ SDD AEGSTS R N S ++L S P + +KP SG+S
Sbjct: 1 MKNLLKKFHIMSSGQSDDVAEGSTSSRSNKVMEVSSPDKLPSRSRPTHFSSEHKPFSGIS 60
Query: 54 NWLNSVVNRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDV 113
WLNSV NR+SPSPPSS++ A E EP+DSV S D A++T R DS S+NSRDPD+
Sbjct: 61 GWLNSVTNRRSPSPPSSADP--TAGEIMEPSDSV--SSRDAAMDTSRHDSGSSNSRDPDI 116
Query: 114 EEEYQIQMALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKI 173
EEEYQIQ+ALE+SA+EDPEA QIEAVKQISLGSCDP+NTPAEV+A+RYWNYNSLSYDDKI
Sbjct: 117 EEEYQIQLALEMSAREDPEAAQIEAVKQISLGSCDPDNTPAEVIAFRYWNYNSLSYDDKI 176
Query: 174 MDGFYDLYGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVA 233
+DGFYDLYG+ + STS+RMPSLVDLQG P+S SV WEAVL+N+AAD+NLLKLEQ LE+A
Sbjct: 177 LDGFYDLYGVFTRSTSERMPSLVDLQGAPMSDSVTWEAVLINKAADANLLKLEQTALEMA 236
Query: 234 VKSRSHSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLG 293
+K ++ S V LVR LA LV+D+MGGPVGDPE M R R+LSYSLKATLGSMVLPLG
Sbjct: 237 IKMQTESPISVNHYLVRKLAALVSDHMGGPVGDPEKMLRKWRNLSYSLKATLGSMVLPLG 296
Query: 294 SLTIGLARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADP 353
SLT+GLARHRALLFK LAD VGIPCRLVKG QYTG DDVAMNFV+IDDGREYIVDLMADP
Sbjct: 297 SLTVGLARHRALLFKFLADGVGIPCRLVKGPQYTGSDDVAMNFVKIDDGREYIVDLMADP 356
Query: 354 GTLIPSDAVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRF 413
G LIP+D GSHVE D S +SASP+SRD+DSS AASSSSGVGSS E +S+FG D++ +
Sbjct: 357 GALIPADVAGSHVEYDGSPFSASPVSRDVDSSQAASSSSGVGSSLEGNSDFGISDRKPKA 416
Query: 414 RNSAAVAGQSNETGKSNAFFNLTRTTEGEEELKMLPENKHPSDREKAFVRELPNKPNYPH 473
RN +A + E N +K PS R+ +K NYP
Sbjct: 417 RNLSA----TKEYDSPNI-------------------DKVPS-------RDFASKSNYPG 446
Query: 474 AHARSPSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFT 533
H RSPSWTEGVSSPA RMKVKDVSQYMIDAAKENP+LAQKLHDVLLESGVVAPPNLFT
Sbjct: 447 MHTRSPSWTEGVSSPAVRRMKVKDVSQYMIDAAKENPRLAQKLHDVLLESGVVAPPNLFT 506
Query: 534 EIYAEQLDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRPRAPSKATSF 593
E Y +Q+D VE +SPTE +D++++ G E +++DP + FLPPLP+PR S+A+
Sbjct: 507 EAYPDQIDV-IVESKSPTEDKDQSRKLPGICESADKNDPRLSNFLPPLPQPRLHSRASPT 565
Query: 594 DQPE---EDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMV 650
+ + L + D A GQP+ E TP+KY ++VPVAAAAAAAAA V +S +V
Sbjct: 566 HGQQLYIKPLEFNLSLDSREAGGQPIPLPFEVTPVKYGRNVPVAAAAAAAAAVVASSMVV 625
Query: 651 VAVAKSNTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGYEPRDSGS 710
A S D+NLE+PVAAAATATAAA+VATTAAV KQYE +AD+A YE R GS
Sbjct: 626 AAAKSS--DANLEIPVAAAATATAAAVVATTAAVNKQYE-----QVEADAALYELR--GS 676
Query: 711 GGREHNYLGANSEGERVSDRSASNDSSKSDVG-DDVAECEIPWEEITLGERIGLGSYGEV 769
G REH+ G NSEGER+SDRSA N+S+KSD+ DDVAECEIPWEEI+LGERIGLGSYGEV
Sbjct: 677 GDREHDACGDNSEGERISDRSAGNESTKSDITLDDVAECEIPWEEISLGERIGLGSYGEV 736
Query: 770 YRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829
YRGDWHGTEVAVKRFLDQD GESLEEF+SEV IMKR+RHPNVVLFMGAVTR P+LSIV
Sbjct: 737 YRGDWHGTEVAVKRFLDQDISGESLEEFKSEVRIMKRLRHPNVVLFMGAVTRAPHLSIVT 796
Query: 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN 889
EFLPRGSLYRL+HRPNNQLDER+RLRMALDAARGMNYLHNCTPV+VHRDLKSPNLLVDKN
Sbjct: 797 EFLPRGSLYRLIHRPNNQLDERKRLRMALDAARGMNYLHNCTPVVVHRDLKSPNLLVDKN 856
Query: 890 WVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM 949
WVVKVCDFGLS+MKH+TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYS+GVILWEL TM
Sbjct: 857 WVVKVCDFGLSKMKHSTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSYGVILWELSTM 916
Query: 950 QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009
QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA+ADIIRKCWQTDP++RP+F EIMAALKP
Sbjct: 917 QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAIADIIRKCWQTDPRLRPSFAEIMAALKP 976
Query: 1010 LQKPITSSQVPRPVPSVSSGRETGQISKFLADSTG 1044
LQKP++SSQVPRP SGR+ ++ + D +G
Sbjct: 977 LQKPLSSSQVPRPNAPAGSGRDKARLLQVTEDPSG 1011
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520645|ref|XP_003528971.1| PREDICTED: uncharacterized protein LOC100816332 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1310 bits (3389), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 722/1050 (68%), Positives = 830/1050 (79%), Gaps = 34/1050 (3%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGNNNSKSNELASLHNPEPNINKPTSGLSNWLNSVV 60
MKNLLKKLHIMSN S++ +GS S +GN ++ + +S + + +SGLS+WL+SV
Sbjct: 1 MKNLLKKLHIMSNRSENEQGSCSSKGNKSNLGSSSSSNKKVLGSKSPQSSGLSSWLHSVA 60
Query: 61 NRKSPSPPSSSNVKRAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVEEEYQIQ 120
NR+S PP S + +A ER EP+D+V+ D ++ RLDS S+ SRDP+VEEEYQIQ
Sbjct: 61 NRQSAGPPPS--LTQARGERMEPSDAVSSGGFDAVSDSARLDSGSSASRDPEVEEEYQIQ 118
Query: 121 MALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIMDGFYDL 180
+ALELSAKEDPEA QIEAVKQISLGSCDP TPAEVVAYRYWNYN+L YDDK +DGFYDL
Sbjct: 119 LALELSAKEDPEAAQIEAVKQISLGSCDPGYTPAEVVAYRYWNYNALGYDDKTLDGFYDL 178
Query: 181 YGIPSESTSDRMPSLVDLQ--GTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSRS 238
YG +EST RMPSLVDLQ GTP+SGS WEAVLVNRAADSNLLKL QK E+ KS
Sbjct: 179 YGSLTESTPARMPSLVDLQLQGTPISGSGTWEAVLVNRAADSNLLKLVQKAQELTDKSSP 238
Query: 239 HSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIG 298
+ + +LVR LA+ VADYMGGPVGDPE+M+RA RSLSYSLKATLGSMVLPLGSLTIG
Sbjct: 239 DFEVVIDSNLVRKLAIFVADYMGGPVGDPESMTRAWRSLSYSLKATLGSMVLPLGSLTIG 298
Query: 299 LARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADPGTLIP 358
LARHRALLFKVLAD +GIPCRLVKG QYTG DDVA+NFV+IDDGREYIVDLMADPGTLIP
Sbjct: 299 LARHRALLFKVLADSLGIPCRLVKGLQYTGSDDVAINFVKIDDGREYIVDLMADPGTLIP 358
Query: 359 SDAVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFGTCDKRSRFRNSAA 418
SDA GSH++ D+S Y ASP SRD+DSSH ASSSSGVGSS+EE S+ G DK +R ++
Sbjct: 359 SDATGSHIDYDESSYVASPSSRDLDSSHVASSSSGVGSSYEETSDLGMLDKGNRSKHFC- 417
Query: 419 VAGQSNETGKSNAFFNLTRTTEGEE-ELKMLPENKHPSDREKAFVRELPNKPNYPHAHAR 477
TGK ++++R + G E ++ L E K P + EK +E P +PN+PH HAR
Sbjct: 418 ------HTGKE---YDVSRPSTGNEGSMRPLNEFKSPYNVEKITGQEAPGRPNHPHVHAR 468
Query: 478 SPSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFTEIYA 537
SP WTEG+SSPA RMKVKDVS YMIDAAKENP LAQKLHDVLLESGVVAPPNLF+EIY
Sbjct: 469 SP-WTEGISSPAVRRMKVKDVSLYMIDAAKENPHLAQKLHDVLLESGVVAPPNLFSEIYD 527
Query: 538 EQLDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRPRAPSKAT-SFDQP 596
E+L +ST E TE +D++KQG+G QE + + SPA+ LPP P+A S + +P
Sbjct: 528 EELGSST-EANLLTEEKDEHKQGSGLQEAEIYGNLSPAQILPPRALPKASSSSQLEHSKP 586
Query: 597 EEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAAVVASSMVVAVAKS 656
E LG++ A GQ + Q +KY ++VPVAAAAAAAAA V +S +V AKS
Sbjct: 587 VEGLGINLPLHTREATGQHIPTQ-----VKYGQNVPVAAAAAAAAAVVASSMVVAV-AKS 640
Query: 657 NTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGYEPRDSGSGGREHN 716
+ DSN+ELPVAAAATATAAA+V + +QYE RSDGD DSAGY+ + SG G EH
Sbjct: 641 SIDSNIELPVAAAATATAAAVVTAAVS--RQYEQGSRSDGDTDSAGYDLKGSGDG--EHI 696
Query: 717 YLGANSEGERVSDRSA-SNDSSKSDVGDD---VAECEIPWEEITLGERIGLGSYGEVYRG 772
LGANSEG+R SDRS SNDS+KSD D VAE +IPWEEITLGERIGLGSYGEVY G
Sbjct: 697 ALGANSEGDRRSDRSVVSNDSTKSDSALDDHEVAEVDIPWEEITLGERIGLGSYGEVYHG 756
Query: 773 DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832
+WHGTE+AVKRFLDQD GESLEEF++EV IMKR+RHPNVVLFMGAVTRPPNLSIV EFL
Sbjct: 757 EWHGTEIAVKRFLDQDISGESLEEFKTEVRIMKRLRHPNVVLFMGAVTRPPNLSIVTEFL 816
Query: 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVV 892
PRGSLYRLLHRPN+QLDERRRL+MALD ARGMNYLHNCTPV+VHRDLKSPNLLVDKNWVV
Sbjct: 817 PRGSLYRLLHRPNSQLDERRRLKMALDTARGMNYLHNCTPVVVHRDLKSPNLLVDKNWVV 876
Query: 893 KVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQP 952
KVCDFGLSRMKH+TFLSSRSTAGTAEWMAPEVLRNEPS+EKCDVYSFGVILWEL T+QQP
Sbjct: 877 KVCDFGLSRMKHSTFLSSRSTAGTAEWMAPEVLRNEPSNEKCDVYSFGVILWELSTLQQP 936
Query: 953 WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
WGGMNPMQVVGAVGFQHRRLDIPD++DPA+ADIIRKCWQTDPK+RPTF EI+AALKPLQK
Sbjct: 937 WGGMNPMQVVGAVGFQHRRLDIPDDMDPAIADIIRKCWQTDPKLRPTFAEILAALKPLQK 996
Query: 1013 PITSSQVPRPVPSVSSGRETGQISKFLADS 1042
+ SQVPR PS S E Q + DS
Sbjct: 997 SVIGSQVPR--PSASGKHEKVQSLRVAEDS 1024
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529521|ref|XP_003533339.1| PREDICTED: uncharacterized protein LOC100788742 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1296 bits (3354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 724/1063 (68%), Positives = 833/1063 (78%), Gaps = 64/1063 (6%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLR---------GNNNSKSNELASLHNPEPNINKPTSG 51
MKNLLKKLHIMSN S++ +GS+S G+++S ++ +P+ + KP SG
Sbjct: 1 MKNLLKKLHIMSNQSENEQGSSSSSSKGGNKSNLGSSSSSKKKVVRSTSPQSSEQKPFSG 60
Query: 52 LSNWLNSVVNRKSPSPPSSSNVKRAAAERTEPADSVNVSC-LDVAL-ETKRLDSESNNSR 109
LS+WLNS+ ER EP+D+V+ LD ++ RLDS S+ SR
Sbjct: 61 LSSWLNSL-----------------RGERMEPSDAVSSGGGLDAVFSDSARLDSGSSGSR 103
Query: 110 DPDVEEEYQIQMALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSY 169
DP+VEEEYQIQ+ALELSAKEDPEAVQIEAVKQISLGSCDP TPAEVVAYRYWNYN+L Y
Sbjct: 104 DPEVEEEYQIQLALELSAKEDPEAVQIEAVKQISLGSCDPGYTPAEVVAYRYWNYNALGY 163
Query: 170 DDKIMDGFYDLYGIPSESTSDRMPSLVDLQ--GTPVSGSVMWEAVLVNRAADSNLLKLEQ 227
DDK +DGFYDLYG +EST RMPSLVDLQ GTP++GS WEAVLVNRAADSNLLKL Q
Sbjct: 164 DDKTLDGFYDLYGSLTESTPARMPSLVDLQLQGTPIAGSGTWEAVLVNRAADSNLLKLVQ 223
Query: 228 KVLEVAVKSRSHSQAFVGID--LVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATL 285
KV E+ KS S FV ID LVR LA+ VADYMGGPVGDPE+M+RA RSLSYSLKATL
Sbjct: 224 KVQELTGKS---SPDFVVIDSNLVRKLAIFVADYMGGPVGDPESMTRAWRSLSYSLKATL 280
Query: 286 GSMVLPLGSLTIGLARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREY 345
GSM+LPLGSLTIGLARHRALLFKVLAD +GIPCRLVKG QYTG +DVA+NFV+IDDGREY
Sbjct: 281 GSMILPLGSLTIGLARHRALLFKVLADSLGIPCRLVKGLQYTGSNDVAINFVKIDDGREY 340
Query: 346 IVDLMADPGTLIPSDAVGSHVECDDSFYSASPLSRDIDSSHAASSSSGVGSSFEEHSEFG 405
IVDLMADPGTLIPSDA GS ++ D+S Y ASP SRD+DSSH ASSSSGVGSS+EE S+ G
Sbjct: 341 IVDLMADPGTLIPSDATGSQIDYDESLYVASPSSRDLDSSHVASSSSGVGSSYEETSDLG 400
Query: 406 TCDKRSRFRNSAAVAGQSNETGKSNAFFNLTRTTEGEEE-LKMLPENKHPSDREKAFVRE 464
DK +R ++ + TGK ++++R++ G+EE ++ L E K P + EK +E
Sbjct: 401 MLDKGNRSKHFS-------HTGKE---YDVSRSSTGKEESMRPLNEFKSPYNVEKITGQE 450
Query: 465 LPNKPNYPHAHARSPSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESG 524
P +PN+PH HARSPSWTEG+SSPA RMKVKDVS YMIDAAKENP LAQKLHDVLLESG
Sbjct: 451 APGRPNHPHVHARSPSWTEGISSPAVRRMKVKDVSLYMIDAAKENPHLAQKLHDVLLESG 510
Query: 525 VVAPPNLFTEIYAEQLDASTVEVRSPTETQDKNKQGTGSQERKNQDDPSPARFLPPLPRP 584
VVAPPNLF+EIY E+L +ST E TE +D+++QG+G QE + + SPA+F PP P
Sbjct: 511 VVAPPNLFSEIYDEELSSST-EANLLTEEKDEHEQGSGRQEAEIDGNVSPAQFFPPRALP 569
Query: 585 RAPSKAT-SFDQPEEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDVPVAAAAAAAAAA 643
+A S + +P E LG++ AAGQ + Q +KY ++VPVAAAAAAAAA
Sbjct: 570 KASSSSQLEHLKPVEGLGINLPLHTGEAAGQQIPTQ-----VKYGQNVPVAAAAAAAAAV 624
Query: 644 VVASSMVVAVAKSNTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADSAGY 703
V +S +V AKS+ DSN+ELPVA AATATAAA+V + +QYE RSDGD DSAGY
Sbjct: 625 VASSMVVAV-AKSSIDSNIELPVAEAATATAAAVVTAAVS--RQYEQGSRSDGDTDSAGY 681
Query: 704 EPRDSGSGGREHNYLGANSEGERVSDRSA-SNDSSKSDVGDD---VAECEIPWEEITLGE 759
+ + SG G EH LGANSEG+R SDRS SNDS+KSD D VAE +IPWEEITLGE
Sbjct: 682 DLKGSGDG--EHIALGANSEGDRRSDRSVVSNDSTKSDSALDDHEVAEVDIPWEEITLGE 739
Query: 760 RIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819
RIGLGSYGEVYRG+WHGTE+AVKRFLDQD GESLEEF++EV IMKR+RHPNVVLFMGAV
Sbjct: 740 RIGLGSYGEVYRGEWHGTEIAVKRFLDQDISGESLEEFKTEVRIMKRLRHPNVVLFMGAV 799
Query: 820 TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDL 879
TRPPNLSIV EFLPRGSLYRLLHRPN+QLDERRRL+MALD ARGMNYLHNCTPV+VHRDL
Sbjct: 800 TRPPNLSIVTEFLPRGSLYRLLHRPNSQLDERRRLKMALDTARGMNYLHNCTPVVVHRDL 859
Query: 880 KSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSF 939
KSPNLLVDKNWVVKVCDFGLSRMKH+TFLSSRSTAGTAEWMAPEVLRNEPS+EKCDVYSF
Sbjct: 860 KSPNLLVDKNWVVKVCDFGLSRMKHSTFLSSRSTAGTAEWMAPEVLRNEPSNEKCDVYSF 919
Query: 940 GVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT 999
GVILWEL TMQQPWGGMNPMQVVGAVGFQHRRLDIPD++DP +ADIIRKCWQTDP +RPT
Sbjct: 920 GVILWELSTMQQPWGGMNPMQVVGAVGFQHRRLDIPDDMDPTIADIIRKCWQTDPNLRPT 979
Query: 1000 FTEIMAALKPLQKPITSSQVPRPVPSVSSGRETGQISKFLADS 1042
F EI+AALKPLQK + SQVPR PSVS E GQ + DS
Sbjct: 980 FAEILAALKPLQKSVIGSQVPR--PSVSGKHEKGQSLHVVEDS 1020
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1044 | ||||||
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.519 | 0.526 | 0.562 | 6.1e-291 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.301 | 0.317 | 0.712 | 5.7e-280 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.256 | 0.304 | 0.712 | 1.9e-179 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.257 | 0.288 | 0.717 | 1.4e-159 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.256 | 0.326 | 0.626 | 5e-125 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.254 | 0.344 | 0.571 | 4.4e-86 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.259 | 0.354 | 0.544 | 8.4e-85 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.256 | 0.364 | 0.542 | 9.4e-82 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.244 | 0.329 | 0.475 | 2.5e-81 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.244 | 0.315 | 0.460 | 6.6e-79 |
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1485 (527.8 bits), Expect = 6.1e-291, Sum P(2) = 6.1e-291
Identities = 325/578 (56%), Positives = 396/578 (68%)
Query: 1 MKNLLKKLHIMSNPSDDAEGSTSLRGNNNSKSNELASLHNPE------PNINKPTSGLSN 54
MKN LKKLHI N SD+AEGS S +N+ KS +++S +P P I KP SGLSN
Sbjct: 33 MKNFLKKLHISPNQSDEAEGSISTTKSNHHKSIDVSSSSSPRSHHSNSPEI-KPFSGLSN 91
Query: 55 WLXXXXXXXXXXXXXXXXXXXAAAERTEPADSVNVSCLDVALETKRLDSESNNSRDPDVE 114
WL AA D+V V+ ++ +D S+DP VE
Sbjct: 92 WLSSVGHRKIPSPPNSFNAKNRAATVD---DTVVVN------GSEHVDL---GSKDPAVE 139
Query: 115 EEYQIQMALELSAKEDPEAVQIEAVKQISLGSCDPENTPAEVVAYRYWNYNSLSYDDKIM 174
EE QIQ+ALELSA+EDPEA QIEA+KQ SLGSC PEN+PAE++AYRYWNYN L YDDKI+
Sbjct: 140 EENQIQLALELSAREDPEATQIEAIKQFSLGSCAPENSPAELIAYRYWNYNCLGYDDKIL 199
Query: 175 DGFYDLYGIPSESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAV 234
DGFYDLYG+ + S+++R+P L+DLQGTPVS V WEAVLVNR+ DSNLL+LEQ L++A
Sbjct: 200 DGFYDLYGVLNASSAERIPPLLDLQGTPVSDGVTWEAVLVNRSGDSNLLRLEQMALDIAA 259
Query: 235 KSRS-HSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLG 293
KSRS S FV +LVR LA+LV DYMGGPV PE+M RA RSLSYSLKATLGSMVLPLG
Sbjct: 260 KSRSVSSSGFVNSELVRKLAILVGDYMGGPVVHPESMLRAWRSLSYSLKATLGSMVLPLG 319
Query: 294 SLTIGLARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMADP 353
SLTIGLARHRALLFKVL D VG+PCR+VKGQQYTG +DVAMNF++ DDGREYIVDLM DP
Sbjct: 320 SLTIGLARHRALLFKVLCDSVGVPCRIVKGQQYTGSEDVAMNFIKADDGREYIVDLMGDP 379
Query: 354 GTLIPSDAVGSHVECDDSFYSASPLSRDIDXXXXXXXXXXXXXXXXXXXXXXTCDKRSRF 413
GTLIP+DA G ++ D+S YSASP D D T + RS
Sbjct: 380 GTLIPADAAGLQIDYDESAYSASP--GDNDSIHVASSSNGIESSYEENTEFRTGEHRSST 437
Query: 414 RNSAAVAGQSNETGKSNAFFNLTRTTEGEEELKMLPENKHPSDREKAFVRELPNKPNYPH 473
++S G+ N++G + E++K + EKA + L ++P +
Sbjct: 438 KSS----GERNQSGGGGDL--IVHPNISREDVK------NQKKVEKAPFQNLSSRPIHSF 485
Query: 474 AHARSPSWTEGVSSPAAHRMKVKDVSQYMIDAAKENPQLAQKLHDVLLESGVVAPPNLFT 533
H RSPSWTEGVSSPAA RMKVKDVSQYMIDAAKENP+LAQKLHDVLLESGVVAPPNLF+
Sbjct: 486 THMRSPSWTEGVSSPAAQRMKVKDVSQYMIDAAKENPRLAQKLHDVLLESGVVAPPNLFS 545
Query: 534 EIYAEQLDASTVEVRSPTETQ-DKNKQGTGSQERKNQD 570
E+Y +QL+A TVE ++ TE + ++ K +QE ++Q+
Sbjct: 546 EVYPQQLEA-TVESKNSTEAKKERGKDLETTQEGRHQN 582
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 5.7e-280, Sum P(3) = 5.7e-280
Identities = 235/330 (71%), Positives = 263/330 (79%)
Query: 686 KQYELSIRSDGDADSAGYEPRDSGSGGREHNYLGANSEGERVXXXXXXXXXXXXXVG-DD 744
+Q+EL S+GDA GSGG H G +S GER+ DD
Sbjct: 659 RQFELDSLSNGDA----------GSGGL-H---GVDSGGERISDRSIGNESSKSDAAIDD 704
Query: 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIM 804
VAECEI WEEIT+ ERIGLGSYGEVYRGDWHGT VAVK+F+DQD GE+LEEFRSEV +M
Sbjct: 705 VAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMM 764
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXXGM 864
+R+RHPN+VLFMGAVTRPPNLSIV EFLPRGSLYRL+HRPNNQ GM
Sbjct: 765 RRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAARGM 824
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV 924
NYLH+C PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK +T+LSS+STAGTAEWMAPEV
Sbjct: 825 NYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEV 884
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
LRNEP+DEKCDVYS+GVILWEL T+QQPWG MNPMQVVGAVGFQHRRLDIP+ +DP +AD
Sbjct: 885 LRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIAD 944
Query: 985 IIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014
IIRKCWQTDP++RP+F EIM +LK LQKPI
Sbjct: 945 IIRKCWQTDPRLRPSFGEIMDSLKQLQKPI 974
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 1.9e-179, Sum P(3) = 1.9e-179
Identities = 191/268 (71%), Positives = 227/268 (84%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLI 803
+ A+ EI WE++ +GERIG+GSYGEVYR +W+GTEVAVK+FLDQDF G++L +F+SE+ I
Sbjct: 598 EAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEI 657
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXXG 863
M R+RHPNVVLFMGAVTRPPN SI+ EFLPRGSLYRLLHRPN+Q G
Sbjct: 658 MLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKG 717
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923
MNYLH P +VHRDLKSPNLLVDKNWVVKVCDFGLSRMKH+T+LSS+STAGT EWMAPE
Sbjct: 718 MNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPE 777
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
VLRNEP++EKCDVYSFGVILWEL T + PW G+NPMQVVGAVGFQ+RRL+IPD++D VA
Sbjct: 778 VLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVA 837
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
IIR+CWQT+P +RP+FT++M +LK LQ
Sbjct: 838 QIIRECWQTEPHLRPSFTQLMQSLKRLQ 865
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1056 (376.8 bits), Expect = 1.4e-159, Sum P(2) = 1.4e-159
Identities = 193/269 (71%), Positives = 217/269 (80%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLI 803
DV ECEIPW ++ + ERIGLGSYGEVY DWHGTEVAVK+FLDQDF G +L EFRSEV I
Sbjct: 658 DVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRI 717
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXXG 863
M+R+RHPNVV F+GAVTRPPNLSIV EFLPRGSLYR+LHRP + G
Sbjct: 718 MRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMG 777
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923
MN LH TP IVHRDLK+PNLLVD NW VKV DFGLSR+KHNTFLSS+STAGT EWMAPE
Sbjct: 778 MNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPE 837
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
VLRNEPS+EKCDVYSFGVILWEL T++ PW GMNPMQVVGAVGFQ+RRL+IP LDP V
Sbjct: 838 VLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVG 897
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
II +CWQTDP +RP+F ++ LKPL +
Sbjct: 898 RIILECWQTDPNLRPSFAQLTEVLKPLNR 926
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 895 (320.1 bits), Expect = 5.0e-125, Sum P(2) = 5.0e-125
Identities = 171/273 (62%), Positives = 205/273 (75%)
Query: 742 GDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEV 801
GDD+ +IPW ++ + E+IG GS+G V+R +WHG++VAVK ++QDF E + EF EV
Sbjct: 541 GDDM---DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREV 597
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN--NQXXXXXXXXXXXX 859
IMKR+RHPN+VLFMGAVT+PPNLSIV E+L RGSLYRLLH+ Q
Sbjct: 598 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 657
Query: 860 XXXGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
GMNYLHN P IVHRDLKSPNLLVDK + VKVCDFGLSR+K +TFLSS+S AGT EW
Sbjct: 658 VAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979
MAPEVLR+EPS+EK DVYSFGVILWEL T+QQPWG +NP QVV AVGF+ +RL+IP NL+
Sbjct: 718 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 777
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
P VA II CW +P RP+F IM L+PL K
Sbjct: 778 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 810
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 4.4e-86, Sum P(2) = 4.4e-86
Identities = 152/266 (57%), Positives = 197/266 (74%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E EI W+++T+GE++G GS G VY G W G++VAVK F Q++ E +E F+ EVL+MKR
Sbjct: 486 EYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKR 545
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXXGMNY 866
+RHPNV+LFMGAVT P L IV+EFLPRGSL+RLL + ++ GMNY
Sbjct: 546 LRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIHMALDIARGMNY 605
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
LH+C+P I+HRDLKS NLLVDKNW VKV DFGLSR+KH T+L+S+S GT +WMAPEVLR
Sbjct: 606 LHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMAPEVLR 665
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
NE +DEK D+YSFGV+LWEL T + PW +N MQV+GAVGF +RL+IP ++DP ++
Sbjct: 666 NESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPRWISLM 725
Query: 987 RKCWQTDPKMRPTFTEIMAALKPLQK 1012
CW +D K+RPTF E+M L+ LQ+
Sbjct: 726 ESCWHSDTKLRPTFQELMDKLRDLQR 751
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 8.4e-85, Sum P(3) = 8.4e-85
Identities = 148/272 (54%), Positives = 194/272 (71%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLI 803
D + EI WE++T+GE+IG GS G VY G W G++VAVK F Q++ E + F+ EV +
Sbjct: 476 DCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSL 535
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXXG 863
MKR+RHPNV+LFMGAV P L IV EFLPRGSL+RLL R ++ G
Sbjct: 536 MKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARG 595
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923
MNYLH+C+P I+HRDLKS NLLVD+NW VKV DFGLSR+KH T+L++ GT +WMAPE
Sbjct: 596 MNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR-GTPQWMAPE 654
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
VLRNE +DEK DVYSFGV+LWEL T + PW +N MQV+GAVGF ++RL++P ++DP
Sbjct: 655 VLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWI 714
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015
++ CW ++P+ RP+F E+M L+ LQ+ T
Sbjct: 715 ALMESCWHSEPQCRPSFQELMDKLRELQRKYT 746
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 9.4e-82, Sum P(2) = 9.4e-82
Identities = 146/269 (54%), Positives = 192/269 (71%)
Query: 746 AECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMK 805
+ CEI WE++ LGE +G GS+ V+RG W+G++VA+K + D D+ +L E + E+ IMK
Sbjct: 459 SSCEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMK 518
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXXGMN 865
++RHPNV+LFMGAV +I+ E++PRGSL+++LH N GMN
Sbjct: 519 KLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMN 578
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
YLH P IVHRDLKS NLLVDKNW VKV DFGLS+ K+ TFLS++S GT +WMAPEVL
Sbjct: 579 YLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVL 638
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
R+EPS+EKCDV+SFGVILWEL T PW +N +QVVG VGF RRLD+P+ L+P +A I
Sbjct: 639 RSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASI 698
Query: 986 IRKCWQTDPKMRPTFTEIMAALKPL-QKP 1013
I+ CWQTDP RP+F E+++ + L +KP
Sbjct: 699 IQDCWQTDPAKRPSFEELISQMMSLFRKP 727
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
Identities = 125/263 (47%), Positives = 177/263 (67%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E +I + E+T+G R+G+G +GEV+RG W+GT+VA+K FL+QD E++E+F +E+ I+ R
Sbjct: 511 EWDIDFSELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILSR 570
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXX--GM 864
VRHPNVVLF+GA T+PP LS++ E++ GSLY L+H + G+
Sbjct: 571 VRHPNVVLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRGL 630
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV 924
+H IVHRDLKS N LVDK+W VK+CDFGLSR+ + + S+AGT EWMAPE+
Sbjct: 631 MCIHRMK--IVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPEL 688
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
+RN P EKCD++S GVI+WEL T+++PW G+ P +VV AV + RL+IPD P ++
Sbjct: 689 IRNRPFTEKCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPDG--P-LSK 745
Query: 985 IIRKCWQTDPKMRPTFTEIMAAL 1007
+I CW +P+ RP EI+ L
Sbjct: 746 LIADCW-AEPEERPNCEEILRGL 767
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 6.6e-79, Sum P(2) = 6.6e-79
Identities = 121/263 (46%), Positives = 176/263 (66%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E I + E+T+G R+G+G +GEV+RG W+GT+VA+K FL+QD E++E+F +E+ I+ R
Sbjct: 545 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 604
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQXXXXXXXXXXXXXXX--GM 864
+RHPNV+LF+GA T+PP LS++ E++ GSLY LLH + G+
Sbjct: 605 LRHPNVILFLGACTKPPRLSLITEYMEMGSLYYLLHLSGQKKRLSWRRKLKMLRDICRGL 664
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV 924
+H IVHRD+KS N L+ W VK+CDFGLSR+ T + +AGT EWMAPE+
Sbjct: 665 MCIHRMG--IVHRDIKSANCLLSNKWTVKICDFGLSRIMTGTTMRDTVSAGTPEWMAPEL 722
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
+RNEP EKCD++S GVI+WELCT+ +PW G+ P +VV A+ ++ RL+IP+ P +
Sbjct: 723 IRNEPFSEKCDIFSLGVIMWELCTLTRPWEGVPPERVVYAIAYEGARLEIPEG--P-LGK 779
Query: 985 IIRKCWQTDPKMRPTFTEIMAAL 1007
+I CW T+P+ RP+ EI++ L
Sbjct: 780 LIADCW-TEPEQRPSCNEILSRL 801
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 4.6.1 | 0.691 |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_XV0354 | hypothetical protein (979 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1044 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 2e-93 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-80 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-75 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-72 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-70 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-69 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-68 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-62 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-52 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-51 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-50 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-48 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-46 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-45 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-45 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-45 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-44 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-44 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-44 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-44 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-43 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-42 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-42 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-42 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-40 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-39 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-39 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-39 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-39 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-38 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-38 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-37 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-37 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-37 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-36 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-36 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-36 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-36 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-36 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-36 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-35 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-35 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-35 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-34 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-34 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-34 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-34 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-34 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-33 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-33 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-33 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-33 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-33 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-32 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-32 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-31 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-31 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-31 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-31 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-31 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-30 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-30 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-30 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-30 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-30 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-29 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-29 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-28 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-28 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-28 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-28 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-28 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-27 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-27 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-26 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-25 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-25 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-25 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-24 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-23 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-23 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-22 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-22 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-21 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-21 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-20 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-19 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.002 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 0.004 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 295 bits (757), Expect = 2e-93
Identities = 112/211 (53%), Positives = 137/211 (64%), Gaps = 11/211 (5%)
Query: 151 NTPAEVVAYRYWNYNSLSYDDKIMDGFYDLYGIPSES---TSDRMPSLVDLQGTPVSGSV 207
+ AE +++RYW Y LSYDDKI DGFYD+YG+ S R+PSL DLQ P G
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVP-PGDS 59
Query: 208 MWEAVLVNRAADSNLLKLEQKVLEVAVKSRSHSQAFVGIDLVRNLAVLVADYMGGPVGDP 267
+E VLV+R D L +LEQ + +++ A LV+ LA LV+D+MGGPV D
Sbjct: 60 SFEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAA-----LVQKLAGLVSDHMGGPVKDA 114
Query: 268 ENMSRASRSLSYSLKATLGSMVLPLGSLTIGLARHRALLFKVLADIVGIPCRLVKGQQYT 327
E+M + S LK G V+PLGSL IGL RHRALLFKVLAD +G+PCRLVKG +Y
Sbjct: 115 ESMLARWKECSNELKENSG--VVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYC 172
Query: 328 GCDDVAMNFVRIDDGREYIVDLMADPGTLIP 358
G DD A N V+ DDGREY+VDLM PGTLIP
Sbjct: 173 GSDDDASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 261 bits (670), Expect = 3e-80
Identities = 102/265 (38%), Positives = 150/265 (56%), Gaps = 19/265 (7%)
Query: 755 ITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+ LG+++G G++GEVY+G G T+VAVK L + E EEF E IMK++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPN+V +G T+ L IV E++P G L L + +L + L+MAL A+GM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE-----WMAPE 923
+ VHRDL + N LV +N VVK+ DFGLSR + WMAPE
Sbjct: 120 SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYED---DYYRKRGGGKLPIKWMAPE 174
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982
L++ K DV+SFGV+LWE+ T+ +QP+ GM+ +V+ + RL P+N +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDEL 233
Query: 983 ADIIRKCWQTDPKMRPTFTEIMAAL 1007
+++ +CW DP+ RPTF+E++ L
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 6e-75
Identities = 104/263 (39%), Positives = 148/263 (56%), Gaps = 16/263 (6%)
Query: 755 ITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+TLG+++G G++GEVY+G EVAVK L +D + +EEF E IM+++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPNVV +G T L IV E++ G L L + +L L AL ARGM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 869 --NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT-FLSSRSTAGTAEWMAPEVL 925
N +HRDL + N LV +N VVK+ DFGLSR ++ + R WMAPE L
Sbjct: 120 SKNF----IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 926 RNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
+ K DV+SFGV+LWE+ T+ +QP+ GM+ +V+ + RL P N P + D
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYD 234
Query: 985 IIRKCWQTDPKMRPTFTEIMAAL 1007
++ +CW DP+ RPTF+E++ L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 240 bits (616), Expect = 1e-72
Identities = 101/264 (38%), Positives = 148/264 (56%), Gaps = 17/264 (6%)
Query: 755 ITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+TLG+++G G++GEVY+G EVAVK L +D + +EEF E IM+++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYL 867
HPN+V +G T L IV E++P G L L + +L L AL ARGM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 868 H--NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-SSRSTAGTAEWMAPEV 924
N +HRDL + N LV +N VVK+ DFGLSR ++ + WMAPE
Sbjct: 120 ESKNF----IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
L+ K DV+SFGV+LWE+ T+ ++P+ GM+ +V+ + + RL P N P +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELY 234
Query: 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007
++ +CW DP+ RPTF+E++ L
Sbjct: 235 KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 1e-70
Identities = 80/258 (31%), Positives = 126/258 (48%), Gaps = 17/258 (6%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ E++G GS+G+VY T VA+K + + + E E+ I+K+++HPN+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L +V E+ G L+ LL + +L E + YLH+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
IVHRDLK N+L+D++ VK+ DFGL+R + GT E+MAPEVL + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKA 176
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD------NLDPAVADIIR 987
D++S GVIL+EL T + P+ G + + + F+ P ++ P D+IR
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLEL----FKKIGKPKPPFPPPEWDISPEAKDLIR 232
Query: 988 KCWQTDPKMRPTFTEIMA 1005
K DP+ R T E +
Sbjct: 233 KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 2e-69
Identities = 97/264 (36%), Positives = 143/264 (54%), Gaps = 26/264 (9%)
Query: 759 ERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+++G G++GEVY+G G TEVAVK L +D E ++F E +MK++ HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPN------NQLDERRRLRMALDAARGMN 865
+G T L +V E++ G L L RP + L + L A+ A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE---WMAP 922
YL + VHRDL + N LV ++ VVK+ DFGLSR R G WMAP
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLD 979
E L++ K DV+SFGV+LWE+ T+ P+ G++ +V+ + G+ RL P+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---RLPKPEYCP 233
Query: 980 PAVADIIRKCWQTDPKMRPTFTEI 1003
+ +++ CWQ DP+ RPTF+E+
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 6e-68
Identities = 91/262 (34%), Positives = 139/262 (53%), Gaps = 19/262 (7%)
Query: 755 ITLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
L ++G GS+G VY+ GT VAVK + + + R E+ I++R+ HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
V + A +L +V E+ G L+ L R L E ++AL RG+ YLH+
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRM--KHNTFLSSRSTAGTAEWMAPEVLR-NEP 929
I+HRDLK N+L+D+N VVK+ DFGL++ K ++ L++ GT +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF--VGTPWYMAPEVLLGGNG 175
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGG---MNPMQVVGAVGFQHRRLDIP----DNLDPAV 982
K DV+S GVIL+EL T + P+ G ++ +Q++ + L+ +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL--GPPLEFDEPKWSSGSEEA 233
Query: 983 ADIIRKCWQTDPKMRPTFTEIM 1004
D+I+KC DP RPT EI+
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 7e-66
Identities = 84/248 (33%), Positives = 121/248 (48%), Gaps = 40/248 (16%)
Query: 761 IGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818
+G G +G VY G +VA+K ++ LEE E+ I+K++ HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 819 VTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRD 878
+L +V E+ GSL LL +L E LR+ L G+ YLH+ I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRD 117
Query: 879 LKSPNLLVDK-NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDV 936
LK N+L+D N VK+ DFGLS++ + ++ GT +MAPEVL + EK D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 937 YSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKM 996
+S GVIL+EL P + D+IRK Q DP+
Sbjct: 178 WSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204
Query: 997 RPTFTEIM 1004
RP+ EI+
Sbjct: 205 RPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 5e-62
Identities = 94/259 (36%), Positives = 134/259 (51%), Gaps = 16/259 (6%)
Query: 754 EITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
E T GE +G GS+G VY G +AVK E LE E+ I+ ++HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 812 VVLFMGA-VTRPPN-LSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNY 866
+V + G+ N L+I E++ GSL LL + +L E R+ R L G+ Y
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQIL---EGLAY 116
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS--SRSTAGTAEWMAPEV 924
LH+ IVHRD+K N+LVD + VVK+ DFG ++ + + S GT WMAPEV
Sbjct: 117 LHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIPDNLDPAVA 983
+R E D++S G + E+ T + PW + NPM + +G +IP++L
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234
Query: 984 DIIRKCWQTDPKMRPTFTE 1002
D +RKC + DPK RPT E
Sbjct: 235 DFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 9e-52
Identities = 99/267 (37%), Positives = 145/267 (54%), Gaps = 11/267 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E+ +IT+ ++G G YGEVY G W + VAVK L +D +EEF E +MK
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM--EVEEFLKEAAVMKE 58
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMN 865
++HPN+V +G TR P I+ EF+ G+L L N Q ++ L MA + M
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEV 924
YL +HRDL + N LV +N +VKV DFGLSR M +T+ + +W APE
Sbjct: 119 YLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
L K DV++FGV+LWE+ T P+ G++ QV + + R++ P+ P V
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+++R CWQ +P RP+F EI A + +
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 5e-51
Identities = 98/280 (35%), Positives = 150/280 (53%), Gaps = 23/280 (8%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+P E+ITL +G GS+G VY G G T VA+K + E +E F +E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEA 60
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL--YRLLHRPNNQ-------LDERR 852
+MK +VV +G V+ +V E + +G L Y RP + ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 853 RLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912
++MA + A GM YL VHRDL + N +V ++ VK+ DFG++R + T +
Sbjct: 121 FIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 913 TAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQH 969
G WMAPE L++ K DV+SFGV+LWE+ T+ +QP+ G++ +V+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009
LD+P+N + +++R CWQ +PKMRPTF EI+++LK
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 7e-50
Identities = 93/263 (35%), Positives = 140/263 (53%), Gaps = 15/263 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
I +E+ LG IG G +G+V GD+ G +VAVK D + + F +E +M +R
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTLR 58
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYL 867
HPN+V +G V + L IV E++ +GSL L R + ++L ALD GM YL
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
VHRDL + N+LV ++ V KV DFGL++ S + +W APE LR
Sbjct: 119 E--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALRE 173
Query: 928 EPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVAD 984
+ K DV+SFG++LWE+ + + P+ + VV V G+ R++ P+ P V
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---RMEAPEGCPPEVYK 230
Query: 985 IIRKCWQTDPKMRPTFTEIMAAL 1007
+++ CW+ DP RPTF ++ L
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 91/258 (35%), Positives = 136/258 (52%), Gaps = 14/258 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EIP E + L ++G G +GEV+ G W+G T+VAVK S E F E IMK++
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNY 866
RH +V + + IV E++ +GSL L +L + + MA A GM Y
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG-TAEWMAPEVL 925
L + +HRDL + N+LV +N V K+ DFGL+R+ + ++R A +W APE
Sbjct: 119 LESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAV 982
K DV+SFG++L E+ T + P+ GM +V+ V G+ R+ P N +
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---RMPRPPNCPEEL 233
Query: 983 ADIIRKCWQTDPKMRPTF 1000
D++ +CW DP+ RPTF
Sbjct: 234 YDLMLQCWDKDPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 9e-48
Identities = 77/251 (30%), Positives = 135/251 (53%), Gaps = 12/251 (4%)
Query: 754 EITLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
LG+ IG G++G VY+G + G VA+K+ + E+L+ E+ ++K ++HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDER---RRLRMALDAARGMNYLH 868
+V ++G++ +L I+ E+ GSL +++ + E + L +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKK-FGPFPESLVAVYVYQVL---QGLAYLH 116
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
++HRD+K+ N+L K+ VVK+ DFG++ ++ S GT WMAPEV+
Sbjct: 117 EQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988
+ D++S G + EL T P+ +NPM + + Q +P+ + P + D + +
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQ 233
Query: 989 CWQTDPKMRPT 999
C+Q DP +RPT
Sbjct: 234 CFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 89/258 (34%), Positives = 138/258 (53%), Gaps = 16/258 (6%)
Query: 759 ERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMG 817
E+IG G++G+VY+G TEVAVK + +F E I+K+ HPN+V +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH--NCTPVIV 875
+ + IV E +P GSL L + N+L ++ L+M+LDAA GM YL NC +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC----I 115
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEK 933
HRDL + N LV +N V+K+ DFG+SR + + +W APE L +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 934 CDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVADIIRKCW 990
DV+S+G++LWE ++ P+ GM+ Q + G+ R+ P + ++ +CW
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY---RMPAPQLCPEEIYRLMLQCW 232
Query: 991 QTDPKMRPTFTEIMAALK 1008
DP+ RP+F+EI L+
Sbjct: 233 AYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 90/257 (35%), Positives = 134/257 (52%), Gaps = 16/257 (6%)
Query: 758 GERIGLGSYGEVYRG--DWHGTEVAVKR--FLDQDFFG-ESLEEFRSEVLIMKRVRHPNV 812
GE +G GS+G VY G G AVK D G E++++ E+ ++ +++HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRL--RMALDAARGMNYLHNC 870
V ++G NL I E +P GSL +LL + + + RL R L G+ YLH+
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLHDR 121
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS-SRSTAGTAEWMAPEVLRNE- 928
VHRD+K N+LVD N VVK+ DFG++ K S ++S G+ WMAPEV+ +
Sbjct: 122 N--TVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988
D++S G + E+ T + PW + + V +G IPD+L D I K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 989 CWQTDPKMRPTFTEIMA 1005
C Q DP +RPT E++
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 86/258 (33%), Positives = 137/258 (53%), Gaps = 20/258 (7%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+ E+IG G +GEVY+ H G EVA+K + E E+ +E+ I+K+ +HPN+
Sbjct: 3 EILEKIGKGGFGEVYKA-RHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNI 59
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
V + G+ + L IV EF GSL LL N L E + + + +G+ YLH+
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932
I+HRD+K+ N+L+ + VK+ DFGLS +T + + GT WMAPEV+ +P D
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-TMVGTPYWMAPEVINGKPYDY 176
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQV------VGAVGFQHRRLDIPDNLDPAVADII 986
K D++S G+ EL + P+ + PM+ G G ++ P+ D +
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-----PEKWSDEFKDFL 231
Query: 987 RKCWQTDPKMRPTFTEIM 1004
+KC Q +P+ RPT +++
Sbjct: 232 KKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 74/262 (28%), Positives = 135/262 (51%), Gaps = 20/262 (7%)
Query: 761 IGLGSYGEVY----RGDWHGTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNVVLF 815
IG GS+G+VY + D G +K +D E E+ +EV I+K++ HPN++ +
Sbjct: 8 IGKGSFGKVYLVRRKSD--GKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAARGMNYLHNCTP 872
+ L IV E+ G L + + + + E + L + + YLH+
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK- 123
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932
I+HRD+K N+ + N +VK+ DFG+S++ +T +++ GT +++PE+ +N+P +
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
K D++S G +L+ELCT++ P+ G N +++ + IP + +++ Q
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQK 241
Query: 993 DPKMRPTFTEIMAALKPLQKPI 1014
DP+ RP+ +I LQ P
Sbjct: 242 DPEERPSIAQI------LQSPF 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 85/257 (33%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
E P EE TL ++G G +GEV+ G W VA+K D ++F+ EV +KR+
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRL 59
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMNY 866
RH +++ + + I+ E + +GSL L P Q L + MA A GM Y
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
L +HRDL + N+LV ++ V KV DFGL+R+ S +W APE
Sbjct: 120 LEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVA 983
+ K DV+SFG++L+E+ T Q P+ GMN +V + G+ R+ P +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---RMPCPAKCPQEIY 234
Query: 984 DIIRKCWQTDPKMRPTF 1000
I+ +CW +P+ RP+F
Sbjct: 235 KIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-45
Identities = 76/278 (27%), Positives = 131/278 (47%), Gaps = 28/278 (10%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ +++G G +G+V + G +VAVK L+ + +F E+ I+
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEIL 60
Query: 805 KRVRHPNVVLFMGAVTRP--PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR 862
+ + H N+V + G +P +L ++ E+LP GSL L R +Q++ +R L + +
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEW 919
GM+YL + +HRDL + N+LV+ +VK+ DFGL+++ + + W
Sbjct: 121 GMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCT--------MQQPWGGMNPMQVVGAV-GFQHR 970
APE LR DV+SFGV L+EL T + + Q V
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 971 -----RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEI 1003
RL P + V D+++ CW+ +P+ RP+F ++
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 86/264 (32%), Positives = 137/264 (51%), Gaps = 18/264 (6%)
Query: 755 ITLGERIGLGSYGEVYRGDWHGT-----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
+T+ + IG G +GEV RG +VA+K + L+ F +E IM + H
Sbjct: 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDH 64
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
PN++ G VT+ + I+ E++ GSL + L + + + + M A GM YL
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG---TAEWMAPEVLR 926
VHRDL + N+LV+ N V KV DFGLSR ++ ++ +T G W APE +
Sbjct: 125 M--NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-EATYTTKGGKIPIRWTAPEAIA 181
Query: 927 NEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVA 983
DV+SFG+++WE+ + ++P+ M+ V+ AV G+ RL P + A+
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDCPSALY 238
Query: 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007
++ CWQ D RPTF++I++ L
Sbjct: 239 QLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 85/260 (32%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 754 EITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
E+T + +G G +G V+ G W G +VA+K + + E ++F E +M ++ HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSE--DDFIEEAKVMMKLSHPNL 61
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH-NCT 871
V G T+ + IV E++ G L L +L L M D M YL N
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
+HRDL + N LV ++ VVKV DFGL+R + + + SS+ T +W PEV
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 931 DEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVADIIR 987
K DV+SFGV++WE+ + + P+ + +VV +V G+ RL P V I+
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVYTIMY 235
Query: 988 KCWQTDPKMRPTFTEIMAAL 1007
CW P+ RP F ++++ L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 81/261 (31%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 759 ERIGLGSYGEVYRGDWHGT-----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+++G GS+G V RG+W + VAVK L D + +++F E IM + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNC 870
G V P L +V E P GSL L + L A+ A GM YL
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYLE-- 114
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR---MKHNTFLSSRSTAGTAEWMAPEVLRN 927
+ +HRDL + N+L+ + VK+ DFGL R + ++ W APE LR
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 928 EPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
DV+ FGV LWE+ T ++PW G++ Q++ + + RL+ P+ + +++
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234
Query: 987 RKCWQTDPKMRPTFTEIMAAL 1007
+CW +P RPTF + L
Sbjct: 235 LQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-44
Identities = 88/258 (34%), Positives = 127/258 (49%), Gaps = 14/258 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EI I L ++G G +GEV+ G W+ T VAVK ++F +E IMK++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNY 866
RHP ++ T + IV E + GSL L L + + MA A GM Y
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 867 L--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPE 923
L N +HRDL + N+LV +N + KV DFGL+R +K + + + +W APE
Sbjct: 119 LEAQN----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982
K DV+SFG++L E+ T + P+ GM +V+ V Q R+ P +
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 983 ADIIRKCWQTDPKMRPTF 1000
DI+ CW+ DP RPTF
Sbjct: 234 YDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 88/262 (33%), Positives = 134/262 (51%), Gaps = 12/262 (4%)
Query: 751 PWEEITLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P E+ L +RIG G+YG+VY+ D G VA+K + G+ E + E+ ++K R
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECR 58
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPN+V + G+ R L IV E+ GSL + L E + + + +G+ YLH
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL--- 925
+HRD+K N+L+ ++ VK+ DFG+S T +S GT WMAPEV
Sbjct: 119 ETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV---GAVGFQHRRLDIPDNLDPAV 982
R D KCD+++ G+ EL +Q P ++PM+ + F +L + P
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236
Query: 983 ADIIRKCWQTDPKMRPTFTEIM 1004
D I+KC DPK RPT T+++
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 89/268 (33%), Positives = 131/268 (48%), Gaps = 16/268 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE-----VAVKRFLDQDFFGESLEEFRSEVLI 803
EI E+ITLG IG G +G+VY+G + E VAVK E+F E I
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYI 60
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
M++ HP++V +G +T P + IV E P G L L LD + + +
Sbjct: 61 MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 864 MNYLH--NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWM 920
+ YL VHRD+ + N+LV VK+ DFGLSR ++ ++ + +WM
Sbjct: 120 LAYLESKRF----VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979
APE + DV+ FGV +WE+ + +P+ G+ V+G + RL +P N
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 234
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
P + ++ KCW DP RP FTE+ A L
Sbjct: 235 PTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 18/261 (6%)
Query: 757 LGERIGLGSYGEVYRG---DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
G +IG G++G+VY D G +AVK QD ++++E E+ +++ ++HPN+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ G + I E+ G+L LL LDE L G+ YLH+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHG-- 119
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRM--KHNTFLSSR--STAGTAEWMAPEVLRNEP 929
IVHRD+K N+ +D N V+K+ DFG + + T + S AGT +MAPEV+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 930 SDEK---CDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIPDNLD--PAVA 983
D++S G ++ E+ T ++PW + N Q++ VG H+ IPD+L P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-IPDSLQLSPEGK 238
Query: 984 DIIRKCWQTDPKMRPTFTEIM 1004
D + +C ++DPK RPT +E++
Sbjct: 239 DFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 86/258 (33%), Positives = 145/258 (56%), Gaps = 13/258 (5%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+++TLGE IG G +G V +G++ G +VAVK + D ++ F E +M ++ H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQA---FLEETAVMTKLHHKNL 61
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLHNCT 871
V +G + L IV E + +G+L L R + + L+ +LD A GM YL +
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--S 118
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSD 931
+VHRDL + N+LV ++ V KV DFGL+R+ +S+ +W APE L+++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKFS 175
Query: 932 EKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990
K DV+S+GV+LWE+ + + P+ M+ +V V + R++ P+ V ++ CW
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCW 234
Query: 991 QTDPKMRPTFTEIMAALK 1008
+T+PK RP+F ++ L+
Sbjct: 235 ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-42
Identities = 88/285 (30%), Positives = 150/285 (52%), Gaps = 30/285 (10%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE-------VAVKRFLDQDFFGESLEEFRSEV 801
E+P + +TLG+ +G G++G+V + + G + VAVK L D + L + SE+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLVSEM 66
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN------------ 846
+MK + +H N++ +G T+ L +V E+ G+L L RP
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 847 -QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905
L ++ + A ARGM +L + +HRDL + N+LV ++ V+K+ DFGL+R H+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 906 TFLSSRSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ-QPWGGMNPMQVV 962
++T G +WMAPE L + + DV+SFGV+LWE+ T+ P+ G+ P++ +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 243
Query: 963 GAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+ + R++ P N + ++R CW P RPTF +++ L
Sbjct: 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-41
Identities = 91/265 (34%), Positives = 141/265 (53%), Gaps = 25/265 (9%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+E+ L + IG G +G+V GD+ G +VAVK + D + + F +E +M ++RH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVK-CIKND---ATAQAFLAEASVMTQLRHSNL 61
Query: 813 VLFMGA-VTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLHNC 870
V +G V L IV E++ +GSL L R + L L+ +LD M YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WMAPEVLR 926
VHRDL + N+LV ++ V KV DFGL++ + ST T + W APE LR
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALR 172
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVA 983
+ K DV+SFG++LWE+ + + P+ + VV V G+ ++D PD P V
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVY 229
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALK 1008
D++++CW D RP+F ++ L+
Sbjct: 230 DVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 26/257 (10%)
Query: 759 ERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
E+IG G+ GEVY+ T EVA+K+ ++ E +E+LIMK +HPN+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L +V E++ GSL ++ + +++E + + + +G+ YLH+ VI H
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNVI-H 139
Query: 877 RDLKSPNLLVDKNWVVKVCDFG----LSRMKHNTFLSSRST-AGTAEWMAPEVLRNEPSD 931
RD+KS N+L+ K+ VK+ DFG L++ K S R++ GT WMAPEV++ +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP-----DNLDPAVADII 986
K D++S G++ E+ + P+ P++ + F IP + P D +
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPPLKNPEKWSPEFKDFL 250
Query: 987 RKCWQTDPKMRPTFTEI 1003
KC DP+ RP+ E+
Sbjct: 251 NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 95/279 (34%), Positives = 152/279 (54%), Gaps = 23/279 (8%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+ E+IT+ +G GS+G VY G G T VA+K + E +E F +E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEA 60
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH--RPNNQLDE-------RR 852
+MK +VV +G V++ ++ E + RG L L RP + + ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 853 RLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912
++MA + A GM YL+ VHRDL + N +V +++ VK+ DFG++R + T +
Sbjct: 121 MIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 913 TAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQH 969
G WM+PE L++ DV+SFGV+LWE+ T+ +QP+ GM+ QV+ V +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
LD PDN + +++R CWQ +PKMRP+F EI++++K
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-39
Identities = 92/264 (34%), Positives = 142/264 (53%), Gaps = 11/264 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EIP E + L +++G G +GEV+ G W+G T+VAVK S E F E IMK++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMNY 866
RH +V V+ P + IV E++ +GSL L + L + MA A GM Y
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG-TAEWMAPEVL 925
+ +HRDL+S N+LV V K+ DFGL+R+ + ++R A +W APE
Sbjct: 118 IERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
K DV+SFG++L EL T + P+ GMN +V+ V + R+ P + ++ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHE 234
Query: 985 IIRKCWQTDPKMRPTFTEIMAALK 1008
++ +CW+ DP+ RPTF + + L+
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 88/254 (34%), Positives = 135/254 (53%), Gaps = 11/254 (4%)
Query: 759 ERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMG 817
E +G G++GEV++G T VAVK +D E +F SE I+K+ HPN+V +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH--NCTPVIV 875
T+ + IV E +P G L + ++L ++ ++ ALDAA GM YL NC +
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA-EWMAPEVLRNEPSDEKC 934
HRDL + N LV +N V+K+ DFG+SR + + SS +W APE L +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 935 DVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
DV+S+G++LWE ++ P+ GM Q V + R+ P V ++++CW
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYK 234
Query: 994 PKMRPTFTEIMAAL 1007
P+ RP F+E+ L
Sbjct: 235 PENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 8e-39
Identities = 87/290 (30%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGD-WHG------TEVAVKRFLDQDFFGESLEEFRSEV 801
+ + I L +G G++G+V+ G+ +H VAVK L + ++ ++F E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREA 59
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR-------------PNNQL 848
++ +H N+V F G T +V E++ G L + L P +L
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 849 DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR------- 901
+ L++A+ A GM YL + VHRDL + N LV + VVK+ DFG+SR
Sbjct: 120 TLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 902 --MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNP 958
+ +T L R WM PE + + DV+SFGV+LWE+ T +QPW G++
Sbjct: 178 YRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230
Query: 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
+V+ + Q R L P V DI+ CW+ DP+ R +I L+
Sbjct: 231 EEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 74/257 (28%), Positives = 130/257 (50%), Gaps = 9/257 (3%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P E + E++G GSYG VY+ G VA+K E L+E E+ I+K+
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCD 56
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
P +V + G+ + +L IV E+ GS+ ++ N L E + +G+ YLH
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
+ +HRD+K+ N+L+++ K+ DFG+S +T + GT WMAPEV++
Sbjct: 117 SNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVADIIR 987
+ K D++S G+ E+ + P+ ++PM+ + + + L P+ P D ++
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234
Query: 988 KCWQTDPKMRPTFTEIM 1004
KC DP+ RP+ +++
Sbjct: 235 KCLVKDPEERPSAIQLL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 9e-39
Identities = 81/258 (31%), Positives = 126/258 (48%), Gaps = 9/258 (3%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
+++T + +G G +G V G W G +VA+K + S +EF E +M ++ H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEK 60
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT 871
+V G T+ + IV E++ G L L + + L M D GM YL +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--S 118
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
+HRDL + N LVD VKV DFGLSR + + + SS + W PEVL
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 931 DEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
K DV++FGV++WE+ ++ + P+ N + V V Q RL P V I+ C
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC 237
Query: 990 WQTDPKMRPTFTEIMAAL 1007
W + RPTF ++++++
Sbjct: 238 WHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 82/261 (31%), Positives = 127/261 (48%), Gaps = 25/261 (9%)
Query: 753 EEITLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP 810
E TL E IG GS+GEVY+ D VA+K +D + + +E+ + E+ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
+ + G+ + L I+ E+ GS LL +P LDE + + G+ YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGK-LDETYIAFILREVLLGLEYLHE- 116
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
+HRD+K+ N+L+ + VK+ DFG+S +T + GT WMAPEV++
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN----LD-----PA 981
DEK D++S G+ EL + P ++PM+V+ IP N L+
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEGNKFSKP 226
Query: 982 VADIIRKCWQTDPKMRPTFTE 1002
D + C DPK RP+ E
Sbjct: 227 FKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 4e-38
Identities = 99/279 (35%), Positives = 146/279 (52%), Gaps = 23/279 (8%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+ E+ITL +G GS+G VY G+ T VAVK + E +E F +E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEA 60
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH--RPNNQLDERR------- 852
+MK +VV +G V++ +V E + G L L RP + + R
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 853 RLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912
++MA + A GM YL+ VHRDL + N +V ++ VK+ DFG++R + T +
Sbjct: 121 MIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 913 TAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQH 969
G WMAPE L++ D++SFGV+LWE+ ++ +QP+ G++ QV+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 237
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
LD PDN V D++R CWQ +PKMRPTF EI+ LK
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 87/296 (29%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGD-------WHGTEVAVKRFLDQDFFGESLEEFRSEV 801
EIP + E +G G++G+VY+G+ T VA+K L ++ + +EFR E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNNQ------------ 847
+M ++HPN+V +G T+ ++ E+L G L+ L + P++
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 848 -LDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--- 901
LD L +A+ A GM YL H+ VHRDL + N LV + VK+ DFGLSR
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 902 ------MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWG 954
++ + L R WM PE + + D++SFGV+LWE+ + QP+
Sbjct: 176 SADYYRVQSKSLLPVR-------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
Query: 955 GMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
G + +V+ + + L P++ V ++ +CW P RP F +I L+
Sbjct: 229 GFSNQEVIEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 80/255 (31%), Positives = 128/255 (50%), Gaps = 17/255 (6%)
Query: 759 ERIGLGSYGEVYRGDW---HGTEVAVK-RFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+ +G G++G V +G + G EV V + L Q+ +EF E +M ++ HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
+G V + L +V E P G L + L + ++ +A A GM YL +
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH--F 116
Query: 875 VHRDLKSPN-LLVDKNWVVKVCDFGLSRM--KHNTFLSSRSTAGT--AEWMAPEVLRNEP 929
VHRDL + N LLV+++ K+ DFG+SR + + + TAG +W APE +
Sbjct: 117 VHRDLAARNVLLVNRHQA-KISDFGMSRALGAGSDYYRAT-TAGRWPLKWYAPECINYGK 174
Query: 930 SDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988
K DV+S+GV LWE + +P+G M +V+ + RL P+ + I+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLS 233
Query: 989 CWQTDPKMRPTFTEI 1003
CW+ P+ RPTF+E+
Sbjct: 234 CWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 82/258 (31%), Positives = 133/258 (51%), Gaps = 9/258 (3%)
Query: 753 EEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
E+TL + IG G +G V+ G W +VA+K + + E E+F E +M ++ HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSE--EDFIEEAQVMMKLSHPK 60
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT 871
+V G T + +V EF+ G L L + + L M LD GM YL +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
++HRDL + N LV +N VVKV DFG++R + + + SS T +W +PEV
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 931 DEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
K DV+SFGV++WE+ + + P+ + +VV + R P +V ++++ C
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK-PRLASQSVYELMQHC 237
Query: 990 WQTDPKMRPTFTEIMAAL 1007
W+ P+ RP+F+ ++ L
Sbjct: 238 WKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 84/257 (32%), Positives = 129/257 (50%), Gaps = 9/257 (3%)
Query: 754 EITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
E+T + +G G +G V+ G W +VA+K +++ E E+F E +M ++ HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSE--EDFIEEAKVMMKLSHPKL 61
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
V G T+ L IV EF+ G L L + +L + L M D GM YL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS- 120
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNEPSD 931
+HRDL + N LV VVKV DFG++R + + + SS +W PEV
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 932 EKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990
K DV+SFGV++WE+ T + P+ + +VV + RL P V +++ CW
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVMYSCW 238
Query: 991 QTDPKMRPTFTEIMAAL 1007
P+ RPTF E++ A+
Sbjct: 239 HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 9e-37
Identities = 84/256 (32%), Positives = 141/256 (55%), Gaps = 11/256 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
E+P E + L +++G G +GEV+ G ++G T+VA+K S E F +E +MK++
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNN-QLDERRRLRMALDAARGMNY 866
+HP +V VT+ P + I+ E++ GSL L P +L + + MA A GM +
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG-TAEWMAPEVL 925
+ +HRDL++ N+LV + K+ DFGL+R+ + ++R A +W APE +
Sbjct: 118 IERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
K DV+SFG++L E+ T + P+ GM +V+ + + R+ PDN + +
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYE 234
Query: 985 IIRKCWQTDPKMRPTF 1000
++R CW+ P+ RPTF
Sbjct: 235 LMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 90/264 (34%), Positives = 140/264 (53%), Gaps = 11/264 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EIP E + L ++G G +GEV+ G W+GT +VA+K E F E IMK++
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMNY 866
RH +V V+ P + IV EF+ +GSL L + + L + + MA A GM Y
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM-KHNTFLSSRSTAGTAEWMAPEVL 925
+ +HRDL++ N+LV N V K+ DFGL+R+ + N + + + +W APE
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
K DV+SFG++L EL T + P+ GM +V+ V + R+ P ++ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234
Query: 985 IIRKCWQTDPKMRPTFTEIMAALK 1008
+++ CW+ DP RPTF I + L+
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 21/265 (7%)
Query: 758 GERIGLGSYGEVYRG--DWHGTEVAVKRF--------LDQDFFGESLEEFRSEVLIMKRV 807
GE IG G+YG VY G +AVK+ + ++ RSE+ +K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
H N+V ++G T LSI E++P GS+ L + +E+ G+ YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL 124
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWMAPEVL 925
H+ I+HRDLK+ NLLVD + + K+ DFG+S+ + + + ++ + G+ WMAPEV+
Sbjct: 125 HSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 926 RNEPS--DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD----NLD 979
+ K D++S G ++ E+ ++PW + + +G + IP NL
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIM 1004
P D + C+ +P RPT E++
Sbjct: 243 PVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 83/267 (31%), Positives = 136/267 (50%), Gaps = 27/267 (10%)
Query: 756 TLGERIGLGSYGEVYRG-DWHGTEVAVKRFL----DQDFFGESLEEFRSEVLIMKRVRHP 810
T GE +G G+YG VY G G +AVK+ + + E+ + EV ++K ++H
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR--PNNQLDERRRLRMALDAARGMNYLH 868
N+V ++G +SI EF+P GS+ +L+R P + + + LD G+ YLH
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLH 119
Query: 869 -NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--------MKHNTFLSSRSTAGTAEW 919
NC +VHRD+K N+++ N ++K+ DFG +R H+ L +S GT W
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYW 174
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDN 977
MAPEV+ K D++S G ++E+ T + P M+ + + +G HR L +PD+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDS 233
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIM 1004
A D + C D RP+ +++
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 24/276 (8%)
Query: 755 ITLGERIGLGSYGEVYRG-----DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
+ LG+ +G G +G V G D +VAVK +EEF SE MK H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 810 PNVVLFMG------AVTRPPNLSIVAEFLPRGSLY------RLLHRPNNQLDERRRLRMA 857
PNV+ +G ++ + P ++ F+ G L+ RL P L + L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFM 119
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAG 915
+D A GM YL N +HRDL + N ++ ++ V V DFGLS+ ++ + R
Sbjct: 120 VDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDI 974
+W+A E L + K DV++FGV +WE+ T Q P+ G+ ++ + RL
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQ 236
Query: 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
P++ + D++ CW+ DPK RPTFT++ L+ +
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 91/264 (34%), Positives = 140/264 (53%), Gaps = 11/264 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EIP E + L ++G G +GEV+ G W+GT VA+K S E F E +MK++
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNY 866
RH +V V+ P + IV E++ +GSL L L + + MA A GM Y
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM-KHNTFLSSRSTAGTAEWMAPEVL 925
+ VHRDL++ N+LV +N V KV DFGL+R+ + N + + + +W APE
Sbjct: 118 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
K DV+SFG++L EL T + P+ GM +V+ V + R+ P ++ D
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 234
Query: 985 IIRKCWQTDPKMRPTFTEIMAALK 1008
++ +CW+ +P+ RPTF + A L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 82/257 (31%), Positives = 127/257 (49%), Gaps = 21/257 (8%)
Query: 761 IGLGSYGEVYRGDWHGTE-----VAVK---RFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
IG G +G VY G ++ AVK R D E +E+F E +IMK HPNV
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHPNV 58
Query: 813 VLFMGAVTRPPNLSIVA-EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT 871
+ +G +V ++ G L + + + + L A+GM YL +
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGT---AEWMAPEVLRN 927
VHRDL + N ++D+++ VKV DFGL+R + + S + G +WMA E L+
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 928 EPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
+ K DV+SFGV+LWEL T P+ ++ + + Q RRL P+ + +++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLYEVM 235
Query: 987 RKCWQTDPKMRPTFTEI 1003
CW P+MRPTF+E+
Sbjct: 236 LSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 25/265 (9%)
Query: 758 GERIGLGSYGEVY--RGDWHGTEVAVKRF-------LDQDFFGESLEEFRSEVLIMKRVR 808
G+++G G++ Y R GT +AVK+ +Q+ E +E R E+ +M R+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQE---EVVEALRKEIRLMARLN 61
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HP+++ +GA + ++ E++ GS+ LL + E + RG++YLH
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLH 120
Query: 869 NCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLSSRST-----AGTAEWMAP 922
I+HRD+K NLL+D +++ DFG + + + GT +MAP
Sbjct: 121 ENQ--IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG---MNPMQVVGAVGFQHRRLDIPDNLD 979
EVLR E CDV+S G ++ E+ T + PW N + ++ + IP++L
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIM 1004
P + D+ +C + P+ RP E++
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 86/267 (32%), Positives = 132/267 (49%), Gaps = 15/267 (5%)
Query: 755 ITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
+ + E IG G +GEV RG VA+K L + + +F SE IM + H
Sbjct: 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
PN++ G VT+ + I+ EF+ G+L L + + Q + + M A GM YL
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN-----TFLSSRSTAGTAEWMAPEV 924
VHRDL + N+LV+ N V KV DFGLSR + T+ SS W APE
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
+ DV+S+G+++WE+ + ++P+ M+ V+ A+ Q RL P + A+
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALH 241
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPL 1010
++ CWQ D RP F +I++ L +
Sbjct: 242 QLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 73/263 (27%), Positives = 128/263 (48%), Gaps = 14/263 (5%)
Query: 754 EITLGERIGLGSYGEVYRGDWH------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
E+ + +G G++G VY+G W VA+K + + ++ +E E +M V
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASV 66
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
HP+VV +G + + ++ + +P G L + + + + L + A+GM+YL
Sbjct: 67 DHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA--EWMAPEVL 925
+VHRDL + N+LV VK+ DFGL+++ + G +WMA E +
Sbjct: 126 EEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 926 RNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
+ K DV+S+GV +WEL T +P+ G+ +++ + + RL P V
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYM 242
Query: 985 IIRKCWQTDPKMRPTFTEIMAAL 1007
++ KCW D + RPTF E++
Sbjct: 243 VLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 84/256 (32%), Positives = 131/256 (51%), Gaps = 13/256 (5%)
Query: 759 ERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
ERIG G++GEV+ G T VAVK + + +F E I+K+ HPN+V +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
G T+ + IV E + G L +L + ++M +AA GM YL + +H
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE--SKHCIH 117
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WMAPEVLRNEPSDE 932
RDL + N LV + V+K+ DFG+SR + + + ST G + W APE L
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGGMKQIPVKWTAPEALNYGRYSS 175
Query: 933 KCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991
+ DV+SFG++LWE ++ P+ ++ Q A+ Q RL P+ AV ++ +CW+
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234
Query: 992 TDPKMRPTFTEIMAAL 1007
DP RP+F+ + L
Sbjct: 235 YDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 93/303 (30%), Positives = 137/303 (45%), Gaps = 61/303 (20%)
Query: 749 EIPWEEITLGERIGLGSYGEVY----------------RGDWHGTE--VAVKRFLDQDFF 790
E P + + E++G G +GEV+ D VAVK L D
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVK-VLRPDAS 59
Query: 791 GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR---PNNQ 847
+ E+F EV I+ R+ PN+ +G T P L ++ E++ G L + L + +
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 848 LDERRR-------LRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898
L + L MA A GM YL N VHRDL + N LV KN+ +K+ DFG
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADFG 175
Query: 899 LSR---------MKHNTFLSSRSTAGTAEWMAPE-VLRNEPSDEKCDVYSFGVILWELCT 948
+SR ++ L R WMA E VL + + K DV++FGV LWE+ T
Sbjct: 176 MSRNLYSSDYYRVQGRAPLPIR-------WMAWESVLLGKFT-TKSDVWAFGVTLWEILT 227
Query: 949 M--QQPWGGMNPMQVVGAVGFQHRR------LDIPDNLDPAVADIIRKCWQTDPKMRPTF 1000
+ +QP+ + QV+ G R L P N + +++ +CW+ D + RPTF
Sbjct: 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287
Query: 1001 TEI 1003
EI
Sbjct: 288 REI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 90/287 (31%), Positives = 149/287 (51%), Gaps = 32/287 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG---------TEVAVKRFLDQDFFGESLEEFRS 799
E+P + + LG+ +G G +G+V + G T+VAVK L D + L + S
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEKDLSDLIS 72
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSL---------------YRLLHR 843
E+ +MK + +H N++ +GA T+ L ++ E+ +G+L Y
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 844 PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903
P QL + + A ARGM YL + +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 904 HNTFLSSRSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQ 960
H+ ++T G +WMAPE L + + DV+SFGV+LWE+ T+ P+ G+ P++
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE 249
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+ + + R+D P N + ++R CW P RPTF +++ L
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 72/265 (27%), Positives = 126/265 (47%), Gaps = 29/265 (10%)
Query: 759 ERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFF-------GESLEEFR----SEVLIMKRV 807
E IG GS+G V + V+R D G E+ + SEV I++ +
Sbjct: 6 ETIGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL 56
Query: 808 RHPNVVLFMGAVTRPPN--LSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAAR 862
+HPN+V + + N L IV E+ G L +L+ + ++E R+
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 863 GMNYLHN---CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
+ HN ++HRDLK N+ +D N VK+ DFGL+++ + +++ GT +
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979
M+PE L + DEK D++S G +++ELC + P+ N +Q+ + + + IP
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYS 235
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIM 1004
+ ++I+ DP RP+ E++
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 23/262 (8%)
Query: 757 LGERIGLGSYGEVY---RGDWHGTEVAVKRF----LDQDFFGESLEEFRSEVLIMKRVRH 809
G+ +G G++G VY D G E+AVK+ + E + E+ ++K ++H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKE-VNALECEIQLLKNLQH 63
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSL--YRLLHRPNNQLDERRRLRMALDAARGMNYL 867
+V + G + LSI E++P GS+ + + R+ R L+ G+ YL
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE---GVEYL 120
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMK----HNTFLSSRSTAGTAEWMAP 922
H + +IVHRD+K N+L D VK+ DFG S R++ T + +S GT WM+P
Sbjct: 121 H--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGTPYWMSP 176
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982
EV+ E K DV+S G + E+ T + PW M + + Q +P ++ P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236
Query: 983 ADIIRKCWQTDPKMRPTFTEIM 1004
+ +R+ + + K RP+ E++
Sbjct: 237 RNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 88/285 (30%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 752 WEEITLGERIGLGSYGEVYRG----DWHGTEVAVKRFLDQDFFGES-LEEFRSEVLIMKR 806
WE+I + IG G++G+V R D A+K ++F E+ +F E+ ++ +
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEVLCK 58
Query: 807 V-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL---------------HRPNNQLDE 850
+ HPN++ +GA L I E+ P G+L L H + L
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 851 RRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910
++ L+ A D A GM YL +HRDL + N+LV +N K+ DFGLSR + +
Sbjct: 119 QQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEE---VYV 173
Query: 911 RSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ-QPWGGMNPMQVVGAVGF 967
+ T G WMA E L K DV+SFGV+LWE+ ++ P+ GM ++ +
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP- 232
Query: 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
Q R++ P N D V +++R+CW+ P RP F +I L + +
Sbjct: 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 6e-34
Identities = 89/272 (32%), Positives = 139/272 (51%), Gaps = 15/272 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH---GTEVAVK-RFLDQDFFGESLEEFRSEVLIM 804
EI IT + IG G +GEV+RG EVAV + L + + ++F SE IM
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGM 864
+ H N++ G VT+ I+ E++ G+L + L + + + + M A GM
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA---EWMA 921
YL + VHRDL + N+LV+ N KV DFGLSR+ + + +T+G W A
Sbjct: 121 KYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNL 978
PE + DV+SFG+++WE+ + ++P+ M+ +V+ A+ GF RL P +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDC 235
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
AV ++ +CWQ D RP F +I+ L L
Sbjct: 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 90/287 (31%), Positives = 142/287 (49%), Gaps = 42/287 (14%)
Query: 750 IPWEEITLGERIGLGSYGEVY----RGDWHGTEVAVKRFLD-------QDFFGESLEEFR 798
+ W +I + IG G++G+V + D + A+KR + +DF GE LE
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE-LE--- 59
Query: 799 SEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL---------------HR 843
++ K HPN++ +GA L + E+ P G+L L +
Sbjct: 60 ---VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116
Query: 844 PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903
+ L ++ L A D ARGM+YL +HRDL + N+LV +N+V K+ DFGLSR +
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQ 174
Query: 904 HNTFLSSRSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ-QPWGGMNPMQ 960
+ + T G WMA E L DV+S+GV+LWE+ ++ P+ GM +
Sbjct: 175 E---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+ + Q RL+ P N D V D++R+CW+ P RP+F +I+ +L
Sbjct: 232 LYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 80/263 (30%), Positives = 141/263 (53%), Gaps = 10/263 (3%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EIP E I L +++G G +GEV+ G ++ T+VAVK S++ F E +MK +
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNY 866
+H +V VT+ + I+ E++ +GSL L ++ + + + A GM Y
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG-TAEWMAPEVL 925
+ +HRDL++ N+LV ++ + K+ DFGL+R+ + ++R A +W APE +
Sbjct: 119 IERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
K DV+SFG++L+E+ T + P+ GM+ V+ A+ + R+ +N + D
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELYD 235
Query: 985 IIRKCWQTDPKMRPTFTEIMAAL 1007
I++ CW+ + RPTF + + L
Sbjct: 236 IMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-34
Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 31/268 (11%)
Query: 758 GERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGES--------LEEFRSEVLIMKRV 807
G IG GS+G VY G G +AVK+ ++ S L+ E+ ++K +
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQ-VELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNN--QLDE---RRRLRMALDAAR 862
+H N+V ++G+ +L+I E++P GS+ LL NN +E R +R L +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQIL---K 117
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTA-----GT 916
G+NYLHN I+HRD+K N+LVD +K+ DFG+S+ ++ N+ + + A G+
Sbjct: 118 GLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD 976
WMAPEV++ K D++S G ++ E+ T + P+ +Q + +G ++ +IP
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPS 234
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
N+ D + K ++ D RPT E++
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 86/295 (29%), Positives = 153/295 (51%), Gaps = 32/295 (10%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE---------VAVKRFLDQDFFGESLEEFRS 799
E P + + LG+ +G G +G+V R + +G + VAVK L + + L + S
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLIS 66
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR--------------- 843
E+ +MK + +H N++ +G T+ L ++ E+ +G+L L
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 844 PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903
P QL + + A ARGM YL + +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 904 HNTFLSSRSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQ 960
H+ +++ G +WMAPE L + + DV+SFG+++WE+ T+ P+ G+ P++
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015
+ + + R+D P N + ++R+CW P RPTF +++ AL + ++
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 87/274 (31%), Positives = 135/274 (49%), Gaps = 41/274 (14%)
Query: 752 WEEITLGERIGLGSYGEVYRGDWHGTEV--AVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
WE I GE +G G++G+VY+ T + A K + E LE+F E+ I+ +H
Sbjct: 7 WEII--GE-LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKH 61
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNY 866
PN+V A L I+ EF G+L ++ L E R R L+ +N+
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE---ALNF 118
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------RMKHNTFLSSRSTAGTAEWM 920
LH+ ++HRDLK+ N+L+ + VK+ DFG+S K +TF+ GT WM
Sbjct: 119 LHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWM 170
Query: 921 APEVL-----RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975
APEV+ ++ P D K D++S G+ L EL M+ P +NPM+V+ + + + P
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL----LKILKSEPP 226
Query: 976 DNLDPA-----VADIIRKCWQTDPKMRPTFTEIM 1004
P+ D ++ C DP RPT E++
Sbjct: 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 2e-33
Identities = 91/287 (31%), Positives = 148/287 (51%), Gaps = 32/287 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE---------VAVKRFLDQDFFGESLEEFRS 799
E+ +TLG+ +G G +G+V + G + VAVK L D + L + S
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLVS 66
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR--------------- 843
E+ +MK + +H N++ +GA T+ L ++ E+ +G+L L
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 844 PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903
P QL + + A ARGM YL + +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 904 HNTFLSSRSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQ 960
HN ++T G +WMAPE L + + DV+SFGV+LWE+ T+ P+ G+ P++
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 243
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+ + + R+D P N + I+R+CW P RPTF +++ L
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 87/287 (30%), Positives = 149/287 (51%), Gaps = 32/287 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE---------VAVKRFLDQDFFGESLEEFRS 799
E +++TLG+ +G G +G+V + G + VAVK L D + L + S
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVS 69
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSL---------------YRLLHR 843
E+ +MK + +H N++ +GA T+ L ++ E+ +G+L Y +
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 844 PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903
P+ Q+ + + ARGM YL + +HRDL + N+LV +N V+K+ DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 904 HNTFLSSRSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQ 960
+N ++T G +WMAPE L + + DV+SFGV++WE+ T+ P+ G+ P++
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 246
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+ + + R+D P N + ++R CW P RPTF +++ L
Sbjct: 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 78/288 (27%), Positives = 121/288 (42%), Gaps = 55/288 (19%)
Query: 758 GERIGLGSYGEVYRG-DWH-GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRV---- 807
G+ IG GS+ V + E A+K R L + E+ V I K V
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-------EKKVKYVKIEKEVLTRL 58
Query: 808 -RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR-RLRMA--LDAARG 863
HP ++ NL V E+ P G L + + + LDE+ R A L A
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLA--- 114
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--------- 914
+ YLH+ I+HRDLK N+L+DK+ +K+ DFG +++ +
Sbjct: 115 LEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 915 -----------GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVG 963
GTAE+++PE+L +P+ + D+++ G I++++ T + P+ G N
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-- 230
Query: 964 AVGFQ---HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
FQ P N P D+I K DP+ R E LK
Sbjct: 231 ---FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-33
Identities = 83/267 (31%), Positives = 143/267 (53%), Gaps = 17/267 (6%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EIP E + L +++G G +GEV+ ++ T+VAVK S+E F +E +MK +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNY 866
+H +V VT+ P + I+ EF+ +GSL L ++ + + + A GM +
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVL 925
+ +HRDL++ N+LV + V K+ DFGL+R ++ N + + +W APE +
Sbjct: 118 IEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 926 RNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLD-IPDNLDPA 981
K DV+SFG++L E+ T + P+ GM+ +V+ A+ G++ R + P+ L
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL--- 232
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALK 1008
+I+ +CW+ P+ RPTF I + L
Sbjct: 233 -YNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 79/263 (30%), Positives = 134/263 (50%), Gaps = 22/263 (8%)
Query: 751 PWEEITLGERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
P E T ERIG GS+GEVY+G D EV + +D + + +E+ + E+ ++ +
Sbjct: 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P + + G+ + L I+ E+L GS LL +P L+E + + +G++YLH
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPG-PLEETYIATILREILKGLDYLH- 118
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
+ +HRD+K+ N+L+ + VK+ DFG++ +T + + GT WMAPEV++
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV------- 982
D K D++S G+ EL + P ++PM+V+ IP N P +
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKP 228
Query: 983 -ADIIRKCWQTDPKMRPTFTEIM 1004
+ + C DP+ RPT E++
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 82/276 (29%), Positives = 134/276 (48%), Gaps = 33/276 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E P ++ G+ +G G++G+V +G +VAVK L E SE+
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSEL 89
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALD 859
IM + H N+V +GA T + ++ E+ G L L R L L +
Sbjct: 90 KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 860 AARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRSTAG 915
A+GM +L NC +HRDL + N+L+ +VK+CDFGL+R M + ++ +
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGM-------NPMQVVGAVGF 967
+WMAPE + N + DV+S+G++LWE+ ++ P+ GM ++ G+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGY 261
Query: 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEI 1003
R+ P++ + DI++ CW DP RPTF +I
Sbjct: 262 ---RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 32/261 (12%)
Query: 761 IGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRS-----------EVLIMKRVRH 809
+G GSYG VY+ VKR D F+ + S E+ I+ V H
Sbjct: 8 LGKGSYGSVYK---------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH 58
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN---NQLDERRRLRMALDAARGMNY 866
PN++ + A L IV E+ P G L + + + + E+ R+ + RG+
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
LH I+HRDLKS N+L+ N +VK+ D G+S++ ++ GT +MAPEV +
Sbjct: 119 LHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWK 174
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGG--MNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
P K D++S G +L+E+ T P+ M ++ G IP + +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYSQDLQN 231
Query: 985 IIRKCWQTDPKMRPTFTEIMA 1005
IR Q PK+RP +I+A
Sbjct: 232 FIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 13/265 (4%)
Query: 755 ITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
I + + IG G +GEV G VA+K L + + +F SE IM + H
Sbjct: 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKT-LKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
PN++ G VT+ + IV E++ GSL L + + Q + + M A GM YL +
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG---TAEWMAPEVLR 926
VHRDL + N+LV+ N V KV DFGLSR+ + ++ +T G W APE +
Sbjct: 125 MG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 927 NEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
DV+S+G+++WE+ + ++P+ M+ V+ A+ + RL P + A+ +
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQL 241
Query: 986 IRKCWQTDPKMRPTFTEIMAALKPL 1010
+ CWQ D RP F +I++ L L
Sbjct: 242 MLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 69/249 (27%), Positives = 119/249 (47%), Gaps = 16/249 (6%)
Query: 761 IGLGSYGEVYR------GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV- 813
+G GS+G+V G + +V K+ + + + +E +E I+ R+ HP +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVK 57
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L T L +V E+ P G L+ L + + E R A + + YLH+
Sbjct: 58 LHYAFQT-EEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLG-- 113
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
I++RDLK N+L+D + +K+ DFGL++ + + + GT E++APEVL + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
D +S GV+L+E+ T + P+ + ++ + L P+ L P D+I Q D
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQKD 231
Query: 994 PKMRPTFTE 1002
P R
Sbjct: 232 PTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 77/273 (28%), Positives = 132/273 (48%), Gaps = 25/273 (9%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGTE-------VAVKRFLDQDFFGESLEEFRSEVLIMK 805
+EIT +G G +GEV+ G E V VK EFR E+ + +
Sbjct: 8 QEITT---LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFR 63
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL---------HRPNNQLDERRRLRM 856
++ H NVV +G ++ E+ G L + L +P L ++++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LSTKQKVAL 122
Query: 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT-FLSSRSTAG 915
A GM++L N VHRDL + N LV VKV LS+ +N+ + R+
Sbjct: 123 CTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDI 974
W+APE ++ + K DV+SFGV++WE+ T + P+ G++ +V+ + L +
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
Query: 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
P+ + ++ +CW +PK RP+F+E+++AL
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 71/250 (28%), Positives = 134/250 (53%), Gaps = 7/250 (2%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
++IG GS+G++Y + +K + E + EV+++ +++HPN+V F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQL-DERRRLRMALDAARGMNYLHNCTPVIV 875
+ L IV E+ G L + ++R L E + L + + G+ ++H+ I+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--IL 123
Query: 876 HRDLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
HRD+KS N+ + KN V K+ DFG++R +++ + + GT +++PE+ +N P + K
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 935 DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994
D++S G +L+ELCT++ P+ G N Q+V + Q I N + +I + ++ P
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLFKVSP 242
Query: 995 KMRPTFTEIM 1004
+ RP+ T I+
Sbjct: 243 RDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 86/278 (30%), Positives = 128/278 (46%), Gaps = 43/278 (15%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPN 811
L E IG G+YG+VY+ H G VA+K D + EE + E I+++ HPN
Sbjct: 9 ELVEVIGEGTYGKVYKAR-HKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 812 VVLFMGAVT--RPPN----LSIVAEFLPRGSLYRL---LHRPNNQLDERRRLRMALDAAR 862
+ F GA PP L +V E GS+ L L + +L E + + R
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922
G+ YLH ++HRD+K N+L+ KN VK+ DFG+S +T + GT WMAP
Sbjct: 125 GLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 923 EVLRNEPS-----DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977
EV+ + D + DV+S G+ EL + P M+PM+ + F+ IP N
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK-----IPRN 233
Query: 978 LDPAVA----------DIIRKCWQTDPKMRPTFTEIMA 1005
P + D I +C + + RP E++
Sbjct: 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 86/289 (29%), Positives = 146/289 (50%), Gaps = 37/289 (12%)
Query: 755 ITLGERIGLGSYGEVYRG---DWHG----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
+ LG+ +G G +G+V + G T VAVK L ++ L + SE ++K+V
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQV 60
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL---------------HRPNNQLD--E 850
HP+V+ GA ++ L ++ E+ GSL L +R ++ LD +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 851 RRRLRM------ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--M 902
R L M A +RGM YL +VHRDL + N+LV + +K+ DFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQV 961
+ ++++ +WMA E L + + DV+SFGV+LWE+ T+ P+ G+ P ++
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 962 VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ + R++ P+N + +++ CW+ +P RPTF +I L+ +
Sbjct: 239 FNLLKTGY-RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-31
Identities = 75/309 (24%), Positives = 128/309 (41%), Gaps = 28/309 (9%)
Query: 756 TLGERIGLGSYGEVYRGDWHGTEVAVKRFL-DQDFFGESLEEFRSEVLIMKRVRHP-NVV 813
+ ++G GS+GEVY VA+K + + +E F E+ I+ + HP N+V
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRP--NNQLDERRRLRMALDAARGMNYLHNCT 871
+L +V E++ GSL LL + L E L + + YLH+
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 872 PVIVHRDLKSPNLLVDKN-WVVKVCDFGLSR------MKHNTFLSSRSTAGTAEWMAPEV 924
I+HRD+K N+L+D++ VVK+ DFGL++ + ++ GT +MAPEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 925 LR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG-----------FQHR 970
L + D++S G+ L+EL T P+ G
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 971 RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVSSGR 1030
P+ + A +D+++K DPK R + + ++ + S + + S
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAP 299
Query: 1031 ETGQISKFL 1039
+ L
Sbjct: 300 LRLSLPPSL 308
|
Length = 384 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 43/271 (15%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGE-SLEEFRSEVLIMKRVRHPNVVLFMG 817
I G+YG V+ + G A+K D + +++ +E I+ + + P VV
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GMNYLHN 869
+ NL +V E+LP G L LL + LDE D AR + YLH+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDE--------DVARIYIAEIVLALEYLHS 111
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTA-----GTAEWMA 921
I+HRDLK N+L+D N +K+ DFGLS++ + L+ GT +++A
Sbjct: 112 NG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH---RRLDIPD-- 976
PEV+ + + D +S G IL+E P+ G P ++ FQ+ +++ P+
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDV 224
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFT---EIM 1004
+ D+I K DP+ R EI
Sbjct: 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 87/269 (32%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 761 IGLGSYGEVYRG-----DWHGTE---VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+G G++GEVY G G+ VAVK L + + +EF E +M HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT-LRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ------LDERRRLRMALDAARGMNY 866
V +G I+ E + G L L + L + L + LD A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 867 LHNCTPVIVHRDLKSPNLLV-----DKNWVVKVCDFGLSR--MKHNTFLSSRSTAGTAEW 919
L +HRDL + N LV D + VVK+ DFGL+R K + + W
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978
MAPE L + + DV+SFGV++WE+ T+ QQP+ +N +V+ V RL P+N
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPENC 238
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+ ++ CW DP RPTF I L
Sbjct: 239 PDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 80/263 (30%), Positives = 131/263 (49%), Gaps = 22/263 (8%)
Query: 751 PWEEITLGERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
P E T ERIG GS+GEV++G D +V + +D + + +E+ + E+ ++ +
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P V + G+ + L I+ E+L GS LL DE + M + +G++YLH
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH- 118
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
+ +HRD+K+ N+L+ + VK+ DFG++ +T + + GT WMAPEV++
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA------ 983
D K D++S G+ EL + P M+PM+V+ IP N P +
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKP 228
Query: 984 --DIIRKCWQTDPKMRPTFTEIM 1004
+ I C DP RPT E++
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 29/280 (10%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMK 805
+I L +G G++G+V+ + H VAVK ++ + ++F+ E ++
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPN------------NQLDER 851
++H ++V F G T L +V E++ G L R L H P+ QL
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 852 RRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLS 909
+ L +A A GM YL + VHRDL + N LV + VVK+ DFG+SR ++T +
Sbjct: 123 QMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQ 968
T WM PE + + D++SFGV+LWE+ T +QPW ++ + + + Q
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
R L+ P P V I++ CWQ +P+ R +I + L+
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 81/292 (27%), Positives = 138/292 (47%), Gaps = 43/292 (14%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVL 802
E+P + E +G ++G++Y+G H VA+K D + + EF+ E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEAS 59
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPN--------------N 846
+M + HPN+V +G VT+ + ++ E+L +G L+ L P+ +
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 847 QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------ 900
LD L +A+ A GM YL + VH+DL + N+L+ + VK+ D GLS
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 901 ---RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ-QPWGGM 956
R++ + L R WM PE + D++SFGV+LWE+ + QP+ G
Sbjct: 178 DYYRVQPKSLLPIR-------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230
Query: 957 NPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
+ +V+ V + + L ++ P + ++ +CWQ P RP F +I L+
Sbjct: 231 SNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 90/282 (31%), Positives = 132/282 (46%), Gaps = 29/282 (10%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT-------EVAVKRFLDQDFFGESLEEFRSEV 801
E+P + ITL +G G++GEVY G + G +VAVK L + + +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKT-LPESCSEQDESDFLMEA 60
Query: 802 LIMKRVRHPNVVLFMG-AVTRPPNLSIVAEFLPRGSLYRLLH--RPN----NQLDERRRL 854
LIM + H N+V +G + R P I+ E + G L L RP + L + L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 855 RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD---KNWVVKVCDFGLSRMKHNTFLSSR 911
A D A+G YL +HRD+ + N L+ V K+ DFG++R + S
Sbjct: 120 FCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA--SYY 175
Query: 912 STAGTA----EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVG 966
G A +WM PE + K DV+SFGV+LWE+ ++ P+ G +V+ V
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV- 234
Query: 967 FQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
RLD P V I+ CWQ P+ RP F I+ ++
Sbjct: 235 TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 61/249 (24%), Positives = 121/249 (48%), Gaps = 6/249 (2%)
Query: 759 ERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+IG GS+G V++ A+K+ EE E ++ ++ ++ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMNYLHNCTPVIV 875
+ L+IV E+ G L++LL + L E + R + G+ +LH + I+
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKIL 123
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCD 935
HRD+KS NL +D VK+ D G++++ + + + GT +++PE+ ++P +EK D
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSD 183
Query: 936 VYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995
V++ GV+L+E CT + P+ N ++ + + + +A +I +C D +
Sbjct: 184 VWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQCLTKDYR 242
Query: 996 MRPTFTEIM 1004
RP +++
Sbjct: 243 QRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 85/277 (30%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 755 ITLGERIGLGSYGEVYRG-----DWHGTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVR 808
TLG +G G +G V D +VAVK L D F S +EEF E MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFD 59
Query: 809 HPNVVLFMG------AVTRPPNLSIVAEFLPRGSLY------RLLHRPNNQLDERRRLRM 856
HPNV+ +G A R P ++ F+ G L+ R+ P L + +R
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRF 118
Query: 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916
+D A GM YL + +HRDL + N ++++N V V DFGLS+ ++ + A
Sbjct: 119 MIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 917 --AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLD 973
+W+A E L + DV++FGV +WE+ T Q P+ G+ ++ + +R
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
PD L+ V +++ +CW +PK RP+F + L+ +
Sbjct: 237 PPDCLE-DVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 90/294 (30%), Positives = 135/294 (45%), Gaps = 41/294 (13%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E P I IG G++G V++ G T VAVK L ++ + +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREA 59
Query: 802 LIMKRVRHPNVVLFMG--AVTRPPNLSIVAEFLPRGSLYRLLHR---------------- 843
+M HPN+V +G AV +P + ++ E++ G L L
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 844 -----PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898
L +L +A A GM YL VHRDL + N LV +N VVK+ DFG
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFG 175
Query: 899 LSRMKHNT--FLSSRSTAGTAEWMAPE-VLRNEPSDEKCDVYSFGVILWELCTM-QQPWG 954
LSR ++ + +S + A WM PE + N + E DV+++GV+LWE+ + QP+
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYY 234
Query: 955 GMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
GM +V+ V L PDN + +++R CW P RP+F I L+
Sbjct: 235 GMAHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 24/257 (9%)
Query: 761 IGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVL----IMKRVRHPNVVL 814
+G GS G VY+ G A+K+ G+ EEFR ++L ++ P VV
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIH---VDGD--EEFRKQLLRELKTLRSCESPYVVK 63
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
GA + +SIV E++ GSL LL + ++ E +A +G++YLH I
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIARQILKGLDYLHT-KRHI 121
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
+HRD+K NLL++ VK+ DFG+S++ NT + GT +M+PE ++ E
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 935 DVYSFGVILWELCTMQQPW---GGMNPMQVVGAVGFQHRRLDIP----DNLDPAVADIIR 987
D++S G+ L E + P+ G + +++ A+ P + P D I
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----PPPSLPAEEFSPEFRDFIS 237
Query: 988 KCWQTDPKMRPTFTEIM 1004
C Q DPK RP+ E++
Sbjct: 238 ACLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/252 (23%), Positives = 123/252 (48%), Gaps = 6/252 (2%)
Query: 761 IGLGSYGE--VYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818
+G G++GE +YR + V K + + +E++I+ ++HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 819 VTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
L I E+ G+LY +++ + +E L ++Y+H I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 878 DLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVY 937
D+K+ N+ + K ++K+ DFG+S++ + + + + GT +M+PE+ + + K D++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 938 SFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR 997
+ G +L+EL T+++ + NP+ +V + Q + + ++ Q DP+ R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 998 PTFTEIMAALKP 1009
PT E++
Sbjct: 245 PTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 73/255 (28%), Positives = 134/255 (52%), Gaps = 6/255 (2%)
Query: 751 PWEEITLGERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
P E T E+IG GS+GEV++G D +V + +D + + +E+ + E+ ++ +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P V + G+ + L I+ E+L GS LL LDE + + + +G++YLH
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH- 118
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
+ +HRD+K+ N+L+ ++ VK+ DFG++ +T + + GT WMAPEV++
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
D K D++S G+ EL + P ++PM+V+ + ++ + N + + + C
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 236
Query: 990 WQTDPKMRPTFTEIM 1004
+P RPT E++
Sbjct: 237 LNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 84/265 (31%), Positives = 129/265 (48%), Gaps = 24/265 (9%)
Query: 757 LGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
L E IG+G+ VY + +VA+KR +D + S++E R EV M + HPNVV
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHR--PNNQLDER---RRLRMALDAARGMNYLHN 869
+ + L +V +L GSL ++ P LDE L+ L +G+ YLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHS 120
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM----KHNTFLSSRSTAGTAEWMAPEVL 925
+HRD+K+ N+L+ ++ VK+ DFG+S T ++ GT WMAPEV+
Sbjct: 121 NG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 926 RNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP---- 980
D K D++SFG+ EL T P+ PM+V+ + Q+ + D
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLETGADYKKYS 237
Query: 981 -AVADIIRKCWQTDPKMRPTFTEIM 1004
+ +I C Q DP RPT E++
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 17/270 (6%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
P E+ L +RIG G+YG+VY+ T E+A + + + GE + E+++MK +H
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKH 65
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
N+V + G+ R L I EF GSL + H L E + ++ + +G+ YLH+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL---R 926
+ HRD+K N+L+ N VK+ DFG+S T +S GT WMAPEV R
Sbjct: 125 KGKM--HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ---VVGAVGFQHRRLDIPDNLDPAVA 983
++ CD+++ G+ EL +Q P ++PM+ ++ FQ +L +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013
++ +PK RPT A K LQ P
Sbjct: 243 HFVKMALTKNPKKRPT------AEKLLQHP 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-30
Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 30/288 (10%)
Query: 750 IPWEEITLGERIGLGSYGEVYRGDWHGTE-------VAVKRFLDQDFFGESLEEFRSEVL 802
I +I L +G G++G+V+ + + VAVK D + ++F+ E
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAE 59
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRP-------------NNQ 847
++ ++H ++V F G L +V E++ G L + L H P +
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 848 LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT- 906
L + L +A A GM YL + VHRDL + N LV N +VK+ DFG+SR ++T
Sbjct: 120 LGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 907 -FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGA 964
+ T WM PE + + DV+SFGVILWE+ T +QPW ++ +V+
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 965 VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ Q R L+ P V DI+ CWQ +P+ R EI L L K
Sbjct: 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 88/276 (31%), Positives = 137/276 (49%), Gaps = 42/276 (15%)
Query: 761 IGLGSYGEVYRG----DWHGTEVAVKRFLD-------QDFFGESLEEFRSEVLIMKRVRH 809
IG G++G+V + D + A+KR + +DF GE LE ++ K H
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE-LE------VLCKLGHH 55
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL---------------HRPNNQLDERRRL 854
PN++ +GA L + E+ P G+L L + + L ++ L
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 855 RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914
A D ARGM+YL +HRDL + N+LV +N+V K+ DFGLSR + + + T
Sbjct: 116 HFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTM 170
Query: 915 G--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ-QPWGGMNPMQVVGAVGFQHRR 971
G WMA E L DV+S+GV+LWE+ ++ P+ GM ++ + Q R
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 229
Query: 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
L+ P N D V D++R+CW+ P RP+F +I+ +L
Sbjct: 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 60/292 (20%)
Query: 759 ERIGLGSYGEVYRGDWH---GTEVAVKRF-LDQD---FFGESLEEFRSEVLIMKRVRHPN 811
E++G G+YG VY+ G VA+K+ LD + +L E+ ++K ++HPN
Sbjct: 5 EKLGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELKHPN 59
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH-NC 870
+V + + L +V E+ L + L + L + RG+ Y H +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-APEVL 925
I+HRDLK N+L++++ V+K+ DFGL+R T E W APE+L
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 926 RNEPS-DEKCDVYSFGVILWELCTMQ--------------------QP----WGGMNPMQ 960
D++S G I E+ T + P W G+ +
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230
Query: 961 VVGAVGFQHRRLD----IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
+ D +P LDP D++ K Q +P R + ALK
Sbjct: 231 DYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRIS---AKEALK 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 21/271 (7%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRG-----DWHGTEVAVKRFLDQDFFGESLEE---FRSE 800
E+ + I + +G G +GE+ RG VA+ G S ++ F +E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA----GCSDKQRRGFLAE 56
Query: 801 VLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDA 860
L + + H N+V G +TR + IV E++ G+L L + QL + + M
Sbjct: 57 ALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL 116
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG-LSRMKHNTFLSSRSTAGTAEW 919
A GM YL VH+ L + +LV+ + V K+ F L K ++ S W
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPD 976
APE ++ DV+SFG+++WE+ + ++P+ M+ V+ AV GF RL P
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---RLPAPR 231
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
N + ++ CWQ + RP F++I + L
Sbjct: 232 NCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 77/261 (29%), Positives = 133/261 (50%), Gaps = 29/261 (11%)
Query: 759 ERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH---PNV 812
E IG G+YG VYRG H G VA+K ++ D + + + + EV ++ ++R PN+
Sbjct: 7 ELIGRGAYGAVYRG-KHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDER------RRLRMALDAARGMNY 866
+ G+ + P L I+ E+ GS+ R L + + E+ R + +AL Y
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAG-PIAEKYISVIIREVLVAL------KY 116
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST-AGTAEWMAPEVL 925
+H ++HRD+K+ N+LV VK+CDFG++ N S RST GT WMAPEV+
Sbjct: 117 IHKVG--VIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 926 RNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN-LDPAVA 983
D K D++S G+ ++E+ T P+ ++ + + + + + + DN +
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLR 232
Query: 984 DIIRKCWQTDPKMRPTFTEIM 1004
+ + C +PK R + E++
Sbjct: 233 EFVAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 73/253 (28%), Positives = 132/253 (52%), Gaps = 16/253 (6%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818
+G G++G V+ R V +K+ + + ++E ++K + HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 819 VTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
L IV E+ P G+L + R N+ LDE L + ++++H T +I+HR
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHR 125
Query: 878 DLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLSSRSTA----GTAEWMAPEVLRNEPSDE 932
DLK+ N+L+DK+ VVK+ DFG+S++ LSS+S A GT +++PE+ +P ++
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
K D+++ G +L+EL ++++ + N +V + I D P + +I
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 993 DPKMRPTFTEIMA 1005
DP RP ++IMA
Sbjct: 240 DPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 7e-29
Identities = 80/272 (29%), Positives = 130/272 (47%), Gaps = 21/272 (7%)
Query: 755 ITLGERIGLGSYGEVYRGDWHGTE----VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP 810
+ LG+ +G G +G V G + + VAVK +E+F SE + MK HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 811 NVVLFMGAVTRP------PNLSIVAEFLPRGSL--YRLLHRPNNQ---LDERRRLRMALD 859
NV+ +G + P+ ++ F+ G L + L R + L + ++ D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTA 917
A GM YL + +HRDL + N ++++N V V DFGLS+ +N + R
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPD 976
+W+A E L + K DV+SFGV +WE+ T Q P+ G+ ++ + +R PD
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
LD + ++ CW +PK RP+F + L+
Sbjct: 239 CLD-GLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 37/280 (13%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGT------EVAVKRFLDQDFFGESLEE---FRSEVLI 803
+ +TL + + G++G ++ G EV VK D S + E +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCL 61
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAE-FLPRGSLYRLLHRP------NNQ-LDERRRLR 855
+ + H N++ + V ++ G+L L + N Q L ++ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 856 MALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG 915
MA+ A GM+YLH ++H+D+ + N ++D+ VK+ D LSR + F G
Sbjct: 122 MAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLG 176
Query: 916 TAE-----WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GF 967
E WMA E L N+ DV+SFGV+LWEL T+ Q P+ ++P ++ + G+
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236
Query: 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
RL P N + ++ CW DP+ RP+F++++ L
Sbjct: 237 ---RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 72/267 (26%), Positives = 127/267 (47%), Gaps = 32/267 (11%)
Query: 756 TLGERIGLGSYGEVY--RGDWHGTEVAVKRF-LDQDFFGESLEEFR---SEVLIMKRVRH 809
LGE +G G+ G V G +AVK L+ + + E+ I+ +
Sbjct: 5 YLGE-LGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-----EAIQKQILRELDILHKCNS 58
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P +V F GA ++SI E++ GSL ++L ++ ER ++A+ +G+ YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
+I HRD+K N+LV+ +K+CDFG+S N+ +++ GT+ +MAPE ++
Sbjct: 119 KHKII-HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQGND 175
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGG-----MNPMQVVGAVGFQHRRLDIP------DNL 978
K D++S G+ L EL T + P+ +++ + ++ P
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI------VNEPPPRLPSGKF 229
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMA 1005
P D + C DP+ RP++ E++
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 84/277 (30%), Positives = 132/277 (47%), Gaps = 32/277 (11%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G G +G+V GD G +VAVK L + G + + + E+ I++ + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 815 FMGAVTRPPNLSI--VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ G T I + EFLP GSL L R N+++ +++L+ A+ +GM+YL +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--SR 128
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRM-----KHNTFLSSRSTAGTAEWMAPEVLRN 927
VHRDL + N+LV+ VK+ DFGL++ ++ T + W APE L
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--VFWYAPECLIQ 186
Query: 928 EPSDEKCDVYSFGVILWELCT--------------MQQPWGGMNPMQVVGAVGFQHRRLD 973
DV+SFGV L+EL T M P G + + V + +RL
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
P N V ++RKCW+ P R TF ++ + +
Sbjct: 247 RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 84/279 (30%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 761 IGLGSYGEVYR------GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G G++G V D G VAVK+ Q E L +F E+ I+K ++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 815 FMGAVTRP--PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ G NL +V E+LP GSL L + +LD R+ L A +GM YL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--SK 127
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWMAPEVLRNEP 929
VHRDL + N+LV+ VK+ DFGL+++ + W APE L
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNP----MQVVG------AVGF-------QHRRL 972
DV+SFGV+L+EL T +P M+++G + + + RL
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDK--SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL 245
Query: 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
P + I+++CW DP RP+F+E+ ++ ++
Sbjct: 246 PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 83/259 (32%), Positives = 129/259 (49%), Gaps = 16/259 (6%)
Query: 757 LGERIGLGSYGEVY---RGDWHGTEVAVKRF-LDQDFFGESLE--EFRSEVLIMKRVRHP 810
LG+ +G G++GEVY D G E+AVK+ D D S E E+ ++K +RH
Sbjct: 6 LGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 811 NVVLFMGAVTRPPN--LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+V + G + P LSI E++P GS+ L + L E R +G++YLH
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS---RSTAGTAEWMAPEVL 925
+ +IVHRD+K N+L D VK+ DFG S+ +S +S GT WM+PEV+
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
E K DV+S + E+ T + PW M + + Q + +PD + A D
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241
Query: 986 IRKCWQTDPKMRPTFTEIM 1004
+++ + + K RPT ++
Sbjct: 242 LKQIF-VEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 25/282 (8%)
Query: 752 WEEITLGERIGLGSYGEVYRGDWHGTEV-AVKRFLDQDFFGESLEEFRSEVLIMKRVRHP 810
WE I GE +G G++G+VY+ T V A + +D E LE++ E+ I+ HP
Sbjct: 7 WEII--GE-LGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHP 62
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRL---LHRPNNQLDERRRLRMALDAARGMNYL 867
N+V + A NL I+ EF G++ + L RP + R + L+A +NYL
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA---LNYL 119
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL-- 925
H I+HRDLK+ N+L + +K+ DFG+S T S GT WMAPEV+
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 926 ---RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG-FQHRRLDIPDNLDPA 981
++ P D K DV+S G+ L E+ ++ P +NPM+V+ + + L P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPV 1023
D ++KC + + R T T++ LQ P + +P+
Sbjct: 238 FKDFLKKCLEKNVDARWTTTQL------LQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 78/260 (30%), Positives = 127/260 (48%), Gaps = 12/260 (4%)
Query: 761 IGLGSYGEVYRGDW--HGTEVAVK---RFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+G G++G VY+G W G V + + L++ ++ EF E LIM + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+G V P + +V + +P G L +H + + + L + A+GM YL +V
Sbjct: 75 LG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LV 131
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA--EWMAPEVLRNEPSDEK 933
HRDL + N+LV VK+ DFGL+R+ + G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 934 CDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
DV+S+GV +WEL T +P+ G+ P + + + + RL P V ++ KCW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 993 DPKMRPTFTEIMAALKPLQK 1012
D RP F E+ A + +
Sbjct: 251 DADSRPKFKELAAEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 88/299 (29%), Positives = 139/299 (46%), Gaps = 46/299 (15%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE----------------VAVKRFLDQDFFGE 792
E P +++ L E++G G +GEV+ + G VAVK L D
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTKT 59
Query: 793 SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR--------- 843
+ +F E+ IM R+++PN++ +G L ++ E++ G L + L +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 844 PNN--QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
NN + L MA+ A GM YL + VHRDL + N LV ++ +K+ DFG+SR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 902 MKHNTFLSS-RSTAGTA----EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM--QQPWG 954
N + G A WMA E + DV++FGV LWE+ T+ +QP+
Sbjct: 178 ---NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
Query: 955 GMNPMQVVGAVG--FQHRRLDIPDNLDP----AVADIIRKCWQTDPKMRPTFTEIMAAL 1007
++ QV+ G F+++ I + P V ++ +CW D K RPTF +I L
Sbjct: 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 13/276 (4%)
Query: 752 WEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
WE I GE +G G++G+VY+ T + + E LE++ E+ I+ HP
Sbjct: 14 WEII--GE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT 871
+V +GA L I+ EF P G++ ++ + L E + + + YLH+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV-----LR 926
I+HRDLK+ N+L+ + +K+ DFG+S T S GT WMAPEV ++
Sbjct: 131 --IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG-FQHRRLDIPDNLDPAVADI 985
+ P D K D++S G+ L E+ ++ P +NPM+V+ + + L P D
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248
Query: 986 IRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPR 1021
++ P+ RP+ +++ P +TS++ R
Sbjct: 249 LKTALDKHPETRPSAAQLLE--HPFVSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 51/268 (19%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGTE--VAVKRF-------LDQDFFGESLEEFRSEVLI 803
++ + +G GS+G V G+ A+K L Q +E +E I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ------VEHVLNEKRI 54
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR- 862
++ +RHP +V G+ NL +V E++P G L+ L R+ R AR
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---------RKSGRFPEPVARF 105
Query: 863 -------GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTA 914
+ YLH+ IV+RDLK NLL+D + +K+ DFG + R+K T+ +
Sbjct: 106 YAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLC 159
Query: 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ-----VVGAVGFQH 969
GT E++APE++ ++ + D ++ G++++E+ P+ NP+Q + G V F
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF-- 217
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMR 997
P P D+IR Q D R
Sbjct: 218 -----PSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 83/280 (29%), Positives = 133/280 (47%), Gaps = 27/280 (9%)
Query: 755 ITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
I L +G G++G+V+ + + VAVK +D + ++F E ++ +
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTNL 64
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH------------RPNNQLDERRRLR 855
+H ++V F G L +V E++ G L + L +L + + L
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 856 MALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRST 913
+A A GM YL + VHRDL + N LV +N +VK+ DFG+SR ++T + T
Sbjct: 125 IAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 914 AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRL 972
WM PE + + DV+S GV+LWE+ T +QPW ++ +V+ + Q R L
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVL 241
Query: 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
P V D++ CWQ +P MR EI + L+ L K
Sbjct: 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 85/275 (30%), Positives = 130/275 (47%), Gaps = 34/275 (12%)
Query: 761 IGLGSYGEV--YR----GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G G +G+V Y D G VAVK L ++ ++ ++ E+ I+K + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 815 FMGAVTRP--PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ G + L ++ E++P GSL L P ++L+ + L A GM YLH +
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLH--SQ 126
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWMAPEVLRNEP 929
+HRDL + N+L+D + +VK+ DFGL++ H + W A E L+
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 930 SDEKCDVYSFGVILWELCT--------------MQQPWGGMNPMQVVGAVGFQHR--RLD 973
DV+SFGV L+EL T M P G M VV + R RL
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ--MTVVRLIELLERGMRLP 244
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
P N V +++ CW+T+ K RPTF ++ LK
Sbjct: 245 CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 89/304 (29%), Positives = 142/304 (46%), Gaps = 55/304 (18%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE------------------VAVKRFLDQDFF 790
E P + +T E++G G +GEV+ + G E VAVK L +D
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDAN 59
Query: 791 GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNNQL 848
+ +F E+ IM R++ PN++ + L ++ E++ G L + L H P
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 849 DERRR--------LRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900
++ + MA A GM YL + VHRDL + N LV KN+ +K+ DFG+S
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 901 RMKHNTF------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM--QQP 952
R N + + R+ WM+ E + DV++FGV LWE+ T+ +QP
Sbjct: 178 R---NLYSGDYYRIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233
Query: 953 WGGMNPMQVVGAVG-F---QHRRLDIPDNLDPA-----VADIIRKCWQTDPKMRPTFTEI 1003
+ ++ QV+ G F Q R++ +P PA + ++ CW+ + K RP+F EI
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLP---KPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
Query: 1004 MAAL 1007
A L
Sbjct: 291 HATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 71/264 (26%), Positives = 125/264 (47%), Gaps = 34/264 (12%)
Query: 760 RIGLGSYGEVYRGD--WHGTEVAVKRFLDQDFFGESLEEFRS----EVLIMKRVRHPNVV 813
+IG G + VY+ G VA+K+ F + R E+ ++K++ HPNV+
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKV---QIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAARGMNYLHNC 870
++ + L+IV E G L R++ Q + ER + + + ++H
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH-- 123
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA-----GTAEWMAPEVL 925
+ I+HRD+K N+ + VVK+ D GL R F SS++TA GT +M+PE +
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERI 178
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGG--MNPMQVVGAVGFQHRRLDIP----DNLD 979
+ K D++S G +L+E+ +Q P+ G MN + + + D P D+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EKCDYPPLPADHYS 234
Query: 980 PAVADIIRKCWQTDPKMRPTFTEI 1003
+ D++ +C DP+ RP + +
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 79/268 (29%), Positives = 131/268 (48%), Gaps = 29/268 (10%)
Query: 759 ERIGLGSYGEVYRGDWH---GTEVAVKR-FLDQDFFG-------ESLEEFRSEVLIMK-R 806
E +G G++G VY+ +A+K + FG +S+ + SEV I+K +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFL---PRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
+RHPN+V + L IV + + P G + L + E R + +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH-NTFLSSRSTAGTAEWMAP 922
+ YLH IVHRDL N+++ ++ V + DFGL++ K + L+S GT + P
Sbjct: 126 LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILYSCP 182
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN----PMQVVGAVGFQHRRLDIPDNL 978
E+++NEP EK DV++FG IL+++CT+Q P+ N ++V AV +P+ +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-----YEPLPEGM 237
Query: 979 -DPAVADIIRKCWQTDPKMRPTFTEIMA 1005
V D+I C D + RP ++ A
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 11/262 (4%)
Query: 751 PWEEITLGERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
P + L +R+G G+YG+VY+ + H E+A + + + G+ + E+ ++K +H
Sbjct: 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKH 65
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
N+V + G+ L I E+ GSL + H L E + + + +G+ YLH
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLH- 123
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL---R 926
+ +HRD+K N+L+ N VK+ DFG++ T +S GT WMAPEV +
Sbjct: 124 -SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ---VVGAVGFQHRRLDIPDNLDPAVA 983
N ++ CD+++ G+ EL +Q P ++PM+ ++ FQ +L
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242
Query: 984 DIIRKCWQTDPKMRPTFTEIMA 1005
+ ++ +PK RPT ++
Sbjct: 243 NFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 82/293 (27%), Positives = 137/293 (46%), Gaps = 45/293 (15%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE-------VAVKRFLDQDFFGESLEEFRSEV 801
EI + E +G +G+VY+G GT VA+K D+ G EEF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL-----HRPNNQLDERRRLRM 856
++ R++HPN+V +G VT+ LS++ + L+ L H D+ + ++
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 857 ALDA----------ARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR----- 901
L+ A GM +L + +VH+DL + N+LV VK+ D GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 902 ----MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ-QPWGGM 956
+ N+ L R WM+PE + D++S+GV+LWE+ + QP+ G
Sbjct: 178 DYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 957 NPMQVVGAVGFQHRR-LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
+ V+ + ++R+ L PD+ V ++ +CW P RP F +I + L+
Sbjct: 231 SNQDVIEMI--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 62/252 (24%), Positives = 132/252 (52%), Gaps = 12/252 (4%)
Query: 759 ERIGLGSYGE--VYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
++IG GS+G+ + + G + +K + EE R EV ++ ++HPN+V +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ----LDERRRLRMALDAARGMNYLHNCTP 872
+ NL IV ++ G LY+ + N Q E + L + + ++H+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQILDWFVQICLALKHVHDRK- 121
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932
I+HRD+KS N+ + K+ +K+ DFG++R+ ++T +R+ GT +++PE+ N P +
Sbjct: 122 -ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
K D+++ G +L+E+CT++ + N +V + + + + + +++ + ++
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKR 239
Query: 993 DPKMRPTFTEIM 1004
+P+ RP+ I+
Sbjct: 240 NPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 77/262 (29%), Positives = 131/262 (50%), Gaps = 20/262 (7%)
Query: 754 EITLGERIGLGSYGEVYRGDW--HGTE----VAVKRFLDQDFFG-ESLEEFRSEVLIMKR 806
E+ + +G G +G V++G W G VA+K QD G ++ +E +L M
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGS 65
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
+ H +V +G + +L +V + P GSL + + + LD +R L + A+GM Y
Sbjct: 66 LDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH----NTFLSSRSTAGTAEWMAP 922
L +VHR+L + N+L+ + +V++ DFG++ + + F S T +WMA
Sbjct: 125 LEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP--IKWMAL 180
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981
E + + DV+S+GV +WE+ + +P+ GM P +V + + RL P
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239
Query: 982 VADIIRKCWQTDPKMRPTFTEI 1003
V ++ KCW D +RPTF E+
Sbjct: 240 VYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 79/262 (30%), Positives = 127/262 (48%), Gaps = 22/262 (8%)
Query: 757 LGERIGLGSYGEVY---RGDWHGTEVAVKRFLDQDFFGESLEEFRS------EVLIMKRV 807
LG+ +G G++G VY D G E+AVK+ F ES E + E+ ++K +
Sbjct: 6 LGKLLGQGAFGRVYLCYDAD-TGRELAVKQV---QFDPESPETSKEVNALECEIQLLKNL 61
Query: 808 RHPNVVLFMGAVTRPP--NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMN 865
H +V + G + P LSI E +P GS+ L + L E + G++
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVS 120
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS---RSTAGTAEWMAP 922
YLH + +IVHRD+K N+L D VK+ DFG S+ LS +S GT WM+P
Sbjct: 121 YLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982
EV+ E K D++S G + E+ T + PW M + + Q +P ++
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238
Query: 983 ADIIRKCWQTDPKMRPTFTEIM 1004
D +++ + + K+RP+ E++
Sbjct: 239 RDFLKRIF-VEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 55/290 (18%)
Query: 759 ERIGLGSYGEVYR------GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+G G+YG V + G+ VA+K+F + + + + EV +++++RH N+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEI----VAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
V A R L +V E++ R +L LL L + + Y H+
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN- 120
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA------GTAEWMAPEVLR 926
I+HRD+K N+LV ++ V+K+CDFG +R L +R + T + APE+L
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLV 174
Query: 927 NEPS-DEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVGAVGFQH--------- 969
+ + + DV++ G I+ EL + + G + + +G + H
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234
Query: 970 -RRLDIPD-------------NLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ P+ + D ++ C + DPK R T E++
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 71/277 (25%), Positives = 110/277 (39%), Gaps = 44/277 (15%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+IG G+YG VY R G VA+K+ L + G R E+ ++K + HPN++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKL 63
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+ +L +V EF+ LY+L+ L E +G+ + H+ I+
Sbjct: 64 LDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWM-APEVLRNEPS- 930
HRDLK NLL++ V+K+ DFGL+R + T W APE+L +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT----RWYRAPELLLGDKGY 176
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMN--------------PMQVVGAVGFQHRR---LD 973
D++S G I EL + + + G + P V R
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 974 IPD-----------NLDPAVADIIRKCWQTDPKMRPT 999
P N P D++ + DP R T
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-25
Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 12/253 (4%)
Query: 761 IGLGSYGEVYRGDW--HGTEVAVK---RFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+G G++G VY+G W G +V + + L + ++ +E E +M V +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+G + + ++ + +P G L + + + + L + A+GMNYL +V
Sbjct: 75 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA--EWMAPEVLRNEPSDEK 933
HRDL + N+LV VK+ DFGL+++ + G +WMA E + + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 934 CDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
DV+S+GV +WEL T +P+ G+ P + ++ + RL P V I+ KCW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 993 DPKMRPTFTEIMA 1005
D RP F E++
Sbjct: 251 DADSRPKFRELII 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 87/340 (25%), Positives = 147/340 (43%), Gaps = 87/340 (25%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE-------VAVKRFLDQDFFGESLEEFR--- 798
E P + + LG+ +G G++G+V + G E VAVK + G + E++
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE----GATASEYKALM 58
Query: 799 SEVLIMKRV-RHPNVVLFMGAVTRPPN-LSIVAEFLPRGSLYRLL--------------- 841
+E+ I+ + H NVV +GA T+P L ++ E+ G+L L
Sbjct: 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKST 118
Query: 842 -------------------------------------HRPNNQLDERRRLRMALD----- 859
+ + DE + + L+
Sbjct: 119 RKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISY 178
Query: 860 ---AARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRS 912
ARGM +L C +HRDL + N+L+ +N VVK+CDFGL+R K ++
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 913 TAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQH-R 970
+WMAPE + ++ + DV+SFGV+LWE+ ++ P+ G+ + +
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-IDEEFCRRLKEGT 293
Query: 971 RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
R+ P+ P + I+ CW +P+ RPTF+E++ L L
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 89/295 (30%), Positives = 137/295 (46%), Gaps = 43/295 (14%)
Query: 736 SSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYR--GDWHGTEVAVKRFLDQDFFGES 793
S K+ + D + WE I E IG G+YG+V++ +G++ AVK D +
Sbjct: 4 SGKTIIFDSFPDPSDTWEII---ETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDI 57
Query: 794 LEEFRSEVLIMKRVR-HPNVVLFMGA-----VTRPPNLSIVAEFLPRGSLYRLLH---RP 844
EE +E I+K + HPNVV F G V L +V E GS+ L+ +
Sbjct: 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR 117
Query: 845 NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904
+++E + +A G+ +LH +HRD+K N+L+ VK+ DFG+S
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175
Query: 905 NTFLSSRSTAGTAEWMAPEVLRNEPS-----DEKCDVYSFGVILWELCTMQQPWGGMNPM 959
+T L ++ GT WMAPEV+ E D +CDV+S G+ EL P ++PM
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235
Query: 960 QVVGAVGFQHRRLDIPDNLDPAVA----------DIIRKCWQTDPKMRPTFTEIM 1004
+ + IP N P + D IRKC D + RPT ++++
Sbjct: 236 RAL---------FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 72/260 (27%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 761 IGLGSYGEVYRGDW--HGTEVAVK---RFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+G G++G VY+G W G V + + L ++ ++ +E E +M V P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+G + + +V + +P G L + +++ + L + A+GM+YL +V
Sbjct: 75 LG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA--EWMAPEVLRNEPSDEK 933
HRDL + N+LV VK+ DFGL+R+ + G +WMA E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 934 CDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
DV+S+GV +WEL T +P+ G+ P + + + + RL P V I+ KCW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 993 DPKMRPTFTEIMAALKPLQK 1012
D + RP F E++ + +
Sbjct: 251 DSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 76/269 (28%), Positives = 131/269 (48%), Gaps = 20/269 (7%)
Query: 749 EIPWEEITLGERI--GLGSYGEVYRGDWHGTEV--AVKRFLDQDFFGESLEEFRSEVLIM 804
E +E GER+ G G+YG VY T+V A+K ++D ++ E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALH 59
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRL-----RMALD 859
++H N+V ++G+ + I E +P GSL LL L + + + L+
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRMKHNTFLSSRSTAGTAE 918
G+ YLH+ IVHRD+K N+LV+ + VVK+ DFG S+ + + GT +
Sbjct: 120 ---GLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 919 WMAPEVLRNEPS--DEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIP 975
+MAPEV+ P D++S G + E+ T + P+ + P + VG +IP
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
++L + I +C++ DP R + +++
Sbjct: 235 ESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 88/274 (32%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 752 WEEITLGERIGLGSYGEVYR--GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-R 808
WE I E IG G+YG+VY+ G+ AVK D + EE +E I++ +
Sbjct: 24 WEII---ETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPN 77
Query: 809 HPNVVLFMGAVTRPPNLS-----IVAEFLPRGSLYRL---LHRPNNQLDERRRLRMALDA 860
HPNVV F G + L +V E GS+ L L +LDE + A
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWM 920
G+ +LHN I+HRD+K N+L+ VK+ DFG+S +T L ++ GT WM
Sbjct: 138 LLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195
Query: 921 APEVLRNEPS-----DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975
APEV+ E D +CDV+S G+ EL P M+P++ + F+ R P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPRNPPP 251
Query: 976 DNLDP-----AVADIIRKCWQTDPKMRPTFTEIM 1004
L P + I +C D + RP+ T ++
Sbjct: 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 79/271 (29%), Positives = 137/271 (50%), Gaps = 12/271 (4%)
Query: 751 PWEEITLGERIGLGSYGEVYRGD--WHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P ++ T E+IG G+ G V+ G EVA+K+ Q E +E+L+MK ++
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELK 74
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+PN+V F+ + L +V E+L GSL ++ +DE + + + + + +LH
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH 132
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST-AGTAEWMAPEVLRN 927
++HRD+KS N+L+ + VK+ DFG + S RST GT WMAPEV+
Sbjct: 133 --ANQVIHRDIKSDNVLLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAVADII 986
+ K D++S G++ E+ + P+ NP++ + + L P+ L P D +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249
Query: 987 RKCWQTDPKMRPTFTEIMA-ALKPLQKPITS 1016
+C + D + R + E++ L KP++S
Sbjct: 250 NRCLEMDVEKRGSAKELLQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 64/250 (25%), Positives = 123/250 (49%), Gaps = 11/250 (4%)
Query: 761 IGLGSYGEV----YRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+G GSYGEV +R D G + +K+ ++ + E ++ +++HPN+V +
Sbjct: 8 VGKGSYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 817 GAVTRPPN-LSIVAEFLPRGSLYRLLHRPNNQL-DERRRLRMALDAARGMNYLHNCTPVI 874
+ L IV F G LY L +L E + + + A + YLH I
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--KHI 123
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
+HRDLK+ N+ + + ++KV D G++R+ N + + GT +M+PE+ N+P + K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183
Query: 935 DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994
DV++ G ++E+ T++ + + +V + + + +P + P + ++I P
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSKRP 242
Query: 995 KMRPTFTEIM 1004
+ RP+ I+
Sbjct: 243 EKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 21/266 (7%)
Query: 755 ITLGERIGLGSYGEVYRGDWH---GTEVAVKRF-LDQDFFGESLEEFRSEV-LIMKRVRH 809
LGE IG G++G V + H GT +AVKR D + + ++ ++M+
Sbjct: 7 KDLGE-IGRGAFGTVNKM-LHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDC 62
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRG--SLYRLLH-RPNNQLDERRRLRMALDAARGMNY 866
P +V F GA+ R + I E + Y+ ++ + + E ++A+ + +NY
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL- 925
L I+HRD+K N+L+D+N +K+CDFG+S ++ +R AG +MAPE +
Sbjct: 123 LKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERID 180
Query: 926 --RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM--QVVGAVGFQHRRLDIPDNLD-- 979
+ D + DV+S G+ L+E+ T + P+ N + Q+ V L + +
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMA 1005
P+ + I C D RP + E++
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 19/259 (7%)
Query: 761 IGLGSYGEVYRGDWHGTE----VAVKRFLDQDFFGESL-EEFRSEVLIMKRVRHPNVVLF 815
+G G++G V +G + + VAVK L D +L +E E +M+++ +P +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL--HNCTPV 873
+G + + +V E G L + L + N + E+ + + GM YL N
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETN---- 115
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLS---RMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
VHRDL + N+L+ K+ DFGLS N + + +W APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 931 DEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
K DV+SFGV++WE + Q+P+ GM +V + R++ P P + D+++ C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLC 234
Query: 990 WQTDPKMRPTFTEIMAALK 1008
W RP F + L+
Sbjct: 235 WTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 76/258 (29%), Positives = 122/258 (47%), Gaps = 16/258 (6%)
Query: 758 GERIGLGSYGEV---YRGDWHGTEVAVKRF-LDQDFFGESLE--EFRSEVLIMKRVRHPN 811
G+ +G G++G V Y D G E+A K+ D + S E E+ ++K ++H
Sbjct: 7 GKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 812 VVLFMGAVTR--PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
+V + G + L+I E++P GS+ L + L E + GM+YLH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLH- 123
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS---RSTAGTAEWMAPEVLR 926
+ +IVHRD+K N+L D VK+ DFG S+ +S RS GT WM+PEV+
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
E K DV+S G + E+ T + PW M + + Q +P ++ D +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 987 RKCWQTDPKMRPTFTEIM 1004
C + + RP+ E++
Sbjct: 243 G-CIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 69/254 (27%), Positives = 117/254 (46%), Gaps = 33/254 (12%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEE-FRSEVLIMKRVRHPNVVLFMG 817
+G+G +G V + A+K + +E SE I++ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GMNYLHN 869
+ ++ E+ G L+ +L DE AR YLHN
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDE--------YTARFYIACVVLAFEYLHN 111
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA----GTAEWMAPEVL 925
I++RDLK NLL+D N VK+ DFG ++ L S GT E++APE++
Sbjct: 112 RG--IIYRDLKPENLLLDSNGYVKLVDFGFAKK-----LKSGQKTWTFCGTPEYVAPEII 164
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGG--MNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
N+ D D +S G++L+EL T + P+G +PM++ + + +L+ P+ +D A
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAK 224
Query: 984 DIIRKCWQTDPKMR 997
D+I++ + +P+ R
Sbjct: 225 DLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 71/270 (26%), Positives = 127/270 (47%), Gaps = 28/270 (10%)
Query: 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLF 815
++IG G + EVYR G VA+K+ D ++ + E+ ++K++ HPNV+ +
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAARGMNYLHNCTP 872
+ L+IV E G L R++ Q + E+ + + + ++H +
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SR 125
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA-----GTAEWMAPEVLRN 927
++HRD+K N+ + VVK+ D GL R F SS++TA GT +M+PE +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGG--MNPMQVVGAVGFQHRRLDIP----DNLDPA 981
+ K D++S G +L+E+ +Q P+ G MN + + + D P D+
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EQCDYPPLPSDHYSEE 236
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
+ ++ C DP+ RP T + K +
Sbjct: 237 LRQLVNMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 80/277 (28%), Positives = 139/277 (50%), Gaps = 24/277 (8%)
Query: 751 PWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P ++ T E+IG G+ G VY G EVA+K+ Q E +E+L+M+ +
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENK 74
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPN+V ++ + L +V E+L GSL ++ +DE + + + + + +LH
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH 132
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST-AGTAEWMAPEVLRN 927
+ ++HRD+KS N+L+ + VK+ DFG + S RST GT WMAPEV+
Sbjct: 133 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV------GAVGFQHRRLDIPDNLDPA 981
+ K D++S G++ E+ + P+ NP++ + G Q+ P+ L
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-----PEKLSAI 244
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPITS 1016
D + +C + D + R + E++ LK + KP++S
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLK-IAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-23
Identities = 84/312 (26%), Positives = 137/312 (43%), Gaps = 63/312 (20%)
Query: 749 EIPWEEITLGERIGLGSYGEVY--------------------RGDWHGTEVAVKRFLDQD 788
+ P + E++G G +GEV+ +G VAVK L D
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVK-ILRPD 57
Query: 789 FFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQL 848
+ +F EV I+ R++ PN++ +G L ++ E++ G L + L ++ L
Sbjct: 58 ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHL 115
Query: 849 DERRR--------------------LRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888
D++ L +AL A GM YL + VHRDL + N LV +
Sbjct: 116 DDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGE 173
Query: 889 NWVVKVCDFGLSRMKHNTFLSS-RSTAGTA----EWMAPEVLRNEPSDEKCDVYSFGVIL 943
N +K+ DFG+SR N + G A WMA E + DV++FGV L
Sbjct: 174 NLTIKIADFGMSR---NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230
Query: 944 WELCTM--QQPWGGMNPMQVVGAVG--FQHRRLDI----PDNLDPAVADIIRKCWQTDPK 995
WE+ + +QP+G + QV+ G F+ + + P + +++ +CW D +
Sbjct: 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290
Query: 996 MRPTFTEIMAAL 1007
RP+F++I A L
Sbjct: 291 ERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 56/157 (35%), Positives = 88/157 (56%), Gaps = 5/157 (3%)
Query: 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRSTA 914
+ ARGM +L + +HRDL + N+L+ +N VVK+CDFGL+R K ++ S
Sbjct: 180 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLD 973
+WMAPE + ++ + DV+SFGV+LWE+ ++ P+ G+ + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
P+N P + I+ CWQ DPK RPTF+ ++ L L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 58/251 (23%), Positives = 115/251 (45%), Gaps = 28/251 (11%)
Query: 769 VYRGDWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVV----LFMGAVTRPP 823
+Y+G ++ EV ++ F ++ +E+ ++R+ N++ + V P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT--PVIVHRDLKS 881
LS++ E+ RG L +L L + +L MA+D +G+ L+ T P +++L S
Sbjct: 96 RLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTS 151
Query: 882 PNLLVDKNWVVKVCDFGLSRM------KHNTFLSSRSTAGTAEWMAPEVLRN--EPSDEK 933
+ LV +N+ +K+ GL ++ K+ F+ S ++L + K
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFS---------YKMLNDIFSEYTIK 202
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
D+YS GV+LWE+ T + P+ + ++ + ++ L +P + + I+ C D
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262
Query: 994 PKMRPTFTEIM 1004
RP EI+
Sbjct: 263 SIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 42/275 (15%)
Query: 759 ERIGLGSYGEVYRGDWHG----TEVAVKRFLD------QDFFGESLEEFRSEVLIMKRVR 808
+ IG G +G+V G+ H V VK Q F + ++ +R +
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRE-------LN 53
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQL-----DERRRLRMALDAARG 863
HPNV+ +G +V EF P G L L R N + + RMA + A G
Sbjct: 54 HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL--SRMKHNTFLSSRSTAGTAEWMA 921
+ +LH +H DL N + + VK+ D+GL + + +++ A W+A
Sbjct: 113 LLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170
Query: 922 PEVLRNEPSD-------EKCDVYSFGVILWELCTM-QQPWGGMNPMQVVG-AVGFQHRRL 972
PE++ D +K +++S GV +WEL T QP+ ++ QV+ V Q +L
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230
Query: 973 DIPDNLDPAVAD----IIRKCWQTDPKMRPTFTEI 1003
P LD +D +++ CW DP+ RPT E+
Sbjct: 231 PKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 23/248 (9%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-PNVV 813
I G++G VY GD+ +V K + + ++E IM P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK---NQVTNVKAERAIMMIQGESPYVA 60
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ L +V E+L G L+ + L E + + G+ LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRG-- 117
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
I+HRD+K NLL+D+ +K+ DFGLSR L ++ GT +++APE + D+
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN----LDPAVADIIRKC 989
D +S G +++E P+ P V + RR++ P+ P D+I +
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 990 WQTDPKMR 997
DP R
Sbjct: 232 LCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 12/271 (4%)
Query: 751 PWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P ++ T E+IG G+ G VY G EVA+K+ Q E +E+L+M+ +
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENK 74
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+PN+V ++ + L +V E+L GSL ++ +DE + + + + +++LH
Sbjct: 75 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH 132
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST-AGTAEWMAPEVLRN 927
+ ++HRD+KS N+L+ + VK+ DFG + S RST GT WMAPEV+
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAVADII 986
+ K D++S G++ E+ + P+ NP++ + + L P+ L D +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249
Query: 987 RKCWQTDPKMRPTFTEIMA-ALKPLQKPITS 1016
+C + D R + E++ L KP++S
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 58/214 (27%), Positives = 117/214 (54%), Gaps = 4/214 (1%)
Query: 793 SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQL-DER 851
++E+ R E +++ +++HPN+V F + +L IV E+ G L + + +L E
Sbjct: 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED 100
Query: 852 RRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911
L+ + G+ ++H ++HRD+KS N+ + +N VK+ DFG +R+ + +
Sbjct: 101 TILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158
Query: 912 STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR 971
+ GT ++ PE+ N P + K D++S G IL+ELCT++ P+ + ++ V Q
Sbjct: 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQGSY 217
Query: 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+P + + +I++ ++ +P+ RP+ T I++
Sbjct: 218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 21/200 (10%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+IG G+YG+VY+ T VA+K+ ++ + G + R E+ +++++RHPN+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63
Query: 816 MGAVTRPPNLSI--VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
VT SI V E++ L LL P + E + G+ YLH+
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG-- 120
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG------TAEWMAPEVLRN 927
I+HRD+K N+L++ + V+K+ DFGL+R + R++A T + PE+L
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLAR-----PYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 928 EPS-DEKCDVYSFGVILWEL 946
+ D++S G IL EL
Sbjct: 176 ATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 74/285 (25%), Positives = 133/285 (46%), Gaps = 53/285 (18%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRS----EVLIMKRVRHPNVVL 814
+G GSYG V + G VA+K+FL+ E + + E+ ++K++RH N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLE----SEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
+ R L +V EF+ L L PN LDE R + RG+ + H+ I
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSHN--I 121
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT----AEWM-APEVLRNEP 929
+HRD+K N+LV ++ VVK+CDFG +R L++ T W APE+L +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 930 SDEK-CDVYSFGVILWELCTMQQPWGGMNP-------MQVVGAVGFQHRRL--------- 972
+ D+++ G ++ E+ T + + G + ++ +G + +H+ +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 973 -DIPD------------NLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+P+ L V D+ ++C + DP RP+ ++++
Sbjct: 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 80/295 (27%), Positives = 126/295 (42%), Gaps = 64/295 (21%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRS--EVL-IMKRVRHP 810
+ +++G G++G VY G VA+K+ + + F S EE + EV + K HP
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKK-MKKKF--YSWEECMNLREVKSLRKLNEHP 58
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL-HRPNNQLDERRRLRMALDAARGMNYLHN 869
N+V L V E++ G+LY+L+ R E + +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN-----TFLSSRSTAGTAEWM-APE 923
HRDLK NLLV VVK+ DFGL+R + ++S+R W APE
Sbjct: 118 HG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WYRAPE 168
Query: 924 V-LRNEPSDEKCDVYSFGVILWELCTM------------------------QQPWGGMNP 958
+ LR+ D+++ G I+ EL T+ +Q W P
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW----P 224
Query: 959 --MQVVGAVGF-----QHRRLD--IPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
++ +GF L IP N P D+I+ + DPK RPT ++ +
Sbjct: 225 EGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 11/250 (4%)
Query: 760 RIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFR-SEVLIMKRVRHPNVVLFM 816
+IG GS G V D G +VAVK+ D + E +EV+IM+ +HPN+V
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L +V EFL G+L ++ ++E + + L + +++LH ++H
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH--AQGVIH 138
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDV 936
RD+KS ++L+ + VK+ DFG +S GT WMAPEV+ P + D+
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 937 YSFGVILWELCTMQQPWGGMNPMQVVGAV-GFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995
+S G+++ E+ + P+ P+Q + + +L + P + + + DP
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA 258
Query: 996 MRPTFTEIMA 1005
R T E++
Sbjct: 259 QRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-22
Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 18/167 (10%)
Query: 854 LRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLS 909
L ARGM +L NC VHRDL + N+L+ + +VK+CDFGL+R M + ++S
Sbjct: 240 LSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH 969
ST +WMAPE + + DV+S+G++LWE+ ++ G P +V + +
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG---GTPYPGMIVDSTFYNK 352
Query: 970 ----RRLDIPDNLDPAVADIIRKCWQTDPKMRPTF---TEIMAALKP 1009
R+ PD+ V DI+ KCW ++P+ RP+F ++I+ +L P
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 79/264 (29%), Positives = 128/264 (48%), Gaps = 27/264 (10%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLI-----MKRVRHPN 811
E +G G+YG V R GT +AVKR S E+ R +L+ M+ V P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKR--LLMDLDISMRSVDCPY 61
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRG--SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
V F GA+ R ++ I E + Y+ ++ + E ++A+ + + YLH+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
VI HRD+K N+L+++N VK+CDFG+S ++ ++ AG +MAPE + E
Sbjct: 122 KLSVI-HRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPEL 179
Query: 930 S----DEKCDVYSFGVILWELCTMQQP---WGGMNPMQVVGAVGFQHRRLDIP-DNLDPA 981
+ D K DV+S G+ + EL T + P W P Q + V + +P + P
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWK--TPFQQLKQV-VEEPSPQLPAEKFSPE 236
Query: 982 VADIIRKCWQTDPKMRPTFTEIMA 1005
D + KC + + K RP + E++
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 47/152 (30%), Positives = 84/152 (55%), Gaps = 9/152 (5%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPP--NLSIVAEFLPRGSL---YRLLHRPNNQLDERRRL 854
E+ I K + P +V + GA ++ I E+ GSL Y+ + + ++ E+
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 855 RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914
++A +G++YLH + I+HRD+K N+L+ + VK+CDFG+S N+ + +
Sbjct: 109 KIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-- 164
Query: 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWEL 946
GT+ +MAPE ++ +P DV+S G+ L E+
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 12/256 (4%)
Query: 757 LGERIGLGSYGEVYR-GDWHGTEVAVKRFLDQDFFGE----SLEEFRSEVLIMKRVRHPN 811
L +R+G GS+G VY D + L + GE + E ++ ++ HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSL---YRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+V F + I+ E+ L L L E + + G++Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
I+HRDLK+ N+ + N ++K+ DFG+SR+ + + + GT +M+PE L+++
Sbjct: 124 --QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988
D K D++S G IL+E+C + + G N + VV + + +P+ + I++
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQS 239
Query: 989 CWQTDPKMRPTFTEIM 1004
DP +RP+ EI+
Sbjct: 240 MLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 5e-21
Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 757 LGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVL 814
L E +G G+YG+VY+G T ++A + +D G+ EE + E+ ++K+ H N+
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 815 FMGAVTR--PPNLS----IVAEFLPRGSLYRLL-HRPNNQLDERRRLRMALDAARGMNYL 867
+ GA + PP + +V EF GS+ L+ + N L E + + RG+++L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
H ++HRD+K N+L+ +N VK+ DFG+S T + GT WMAPEV+
Sbjct: 128 HQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 928 EPS-----DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982
+ + D K D++S G+ E+ P M+PM+ + IP N P +
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRL 236
Query: 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRP 1022
K W K +F E Q+P T + P
Sbjct: 237 KS---KKWS---KKFQSFIESCLVKNHSQRPTTEQLMKHP 270
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 41/274 (14%)
Query: 759 ERIGLGSYGEVYRGDW----------HGTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRV 807
E +G G++ +Y+G G EV+V L D F +M ++
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD--HRDSLAFFETASLMSQL 58
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
H ++V G R N+ +V E++ G L LHR N + +L +A A ++YL
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWV-------VKVCDFGLSRMKHNTFLSSRSTAGTAEWM 920
+ +VH ++ N+LV + + +K+ D G+ T LS W+
Sbjct: 118 EDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERIPWI 171
Query: 921 APEVLRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-----RLD 973
APE +RN + D +SFG L E+C G P+ + + + RL
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEIC-----SNGEEPLSTLSSSEKERFYQDQHRLP 226
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+PD +A++I +CW DP RP+F I+ L
Sbjct: 227 MPDC--AELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 61/291 (20%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEE-------FRSEVLIMKRVRH 809
+IG GSYG V+ R G VA+K+F+ ES ++ R E+ ++K+++H
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFV------ESEDDPVIKKIALR-EIRMLKQLKH 59
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH- 868
PN+V + R L +V E+ L L P + E ++ + +N+ H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHK 118
Query: 869 -NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL-- 925
NC +HRD+K N+L+ K +K+CDFG +R+ T + APE+L
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 926 ---RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-------QVVGAVGFQHRR---- 971
P DV++ G + EL T Q W G + + + +G + +H++
Sbjct: 175 DTQYGPP----VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230
Query: 972 ------LDIPD------------NLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
L IP+ N+ ++ C Q DP R + E++
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 7e-21
Identities = 71/270 (26%), Positives = 131/270 (48%), Gaps = 10/270 (3%)
Query: 751 PWEEITLGERIGLGSYGEVYRGD--WHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P ++ T E+IG G+ G VY G EVA+++ Q E +E+L+M+ +
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENK 75
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+PN+V ++ + L +V E+L GSL ++ +DE + + + + + +LH
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH 133
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
+ ++HRD+KS N+L+ + VK+ DFG + GT WMAPEV+ +
Sbjct: 134 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAVADIIR 987
K D++S G++ E+ + P+ NP++ + + L P+ L D +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 988 KCWQTDPKMRPTFTEIMA-ALKPLQKPITS 1016
+C D + R + E++ + KP++S
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 23/263 (8%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
++I E +G G+ G VY+ +H +AVK + D E ++ SE+ I+ +
Sbjct: 1 QDIQYQEILGHGNGGTVYKA-YHLLTRRILAVK-VIPLDITVELQKQIMSELEILYKCDS 58
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P ++ F GA +SI EF+ GSL P + L R+A+ +G+ YL +
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWS 113
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
I+HRD+K N+LV+ VK+CDFG+S N+ +++ GT +MAPE + E
Sbjct: 114 LK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQ 169
Query: 930 SDEKCDVYSFGVILWELCTMQQPW-------GGMNPMQVVGAVGFQHRRLDIPDNL-DPA 981
DV+S G+ EL + P+ G + P+Q++ + + + +P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-LPVGQFSEK 228
Query: 982 VADIIRKCWQTDPKMRPTFTEIM 1004
I +C + PK RP +M
Sbjct: 229 FVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-20
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 5/157 (3%)
Query: 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRSTA 914
+ A+GM +L + +HRDL + N+L+ +N VVK+CDFGL+R K ++
Sbjct: 185 SFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLD 973
+WMAPE + + + DV+SFGV+LWE+ ++ P+ G+ + + R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
PD P + + CW +P RPTF+E++ L L
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 75/262 (28%), Positives = 119/262 (45%), Gaps = 22/262 (8%)
Query: 757 LGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
LGE IG G+ G+VY R G +AVK+ E+ +++K P +V
Sbjct: 20 LGE-IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL---HNCT 871
G ++ I E L L +LL R + E +M + + ++YL H
Sbjct: 79 CYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG-- 135
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSD 931
++HRD+K N+L+D + VK+CDFG+S ++ +RS AG A +MAPE R +P D
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPE--RIDPPD 190
Query: 932 EK------CDVYSFGVILWELCTMQQPWGGMN-PMQVVGAV-GFQHRRLDIPDNLDPAVA 983
DV+S G+ L EL T Q P+ +V+ + + L + P
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250
Query: 984 DIIRKCWQTDPKMRPTFTEIMA 1005
+ C D + RP + E++
Sbjct: 251 SFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-20
Identities = 55/164 (33%), Positives = 87/164 (53%), Gaps = 13/164 (7%)
Query: 848 LDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905
LD L + A+GM++L NC +HRDL + N+L+ + K+CDFGL+R N
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 906 TFLSSRSTAGTA----EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQ 960
S+ G A +WMAPE + N + DV+S+G++LWE+ ++ P+ GM
Sbjct: 267 D--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ + R+ P+ + DI++ CW DP RPTF +I+
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 753 EEITLGER-IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMK 805
E++ R IG GS+G VY R VA+K+ + G E ++ EV ++
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQ 70
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMN 865
++RHPN + + G R +V E+ GS +L L E + A +G+
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH--NTFLSSRSTAGTAEWMAPE 923
YLH+ +HRD+K+ N+L+ + VK+ DFG + + N+F+ GT WMAPE
Sbjct: 130 YLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPE 181
Query: 924 VL--RNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980
V+ +E D K DV+S G+ EL + P MN M + + ++
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD 241
Query: 981 AVADIIRKCWQTDPKMRPTFTEIM 1004
+ + C Q P+ RP+ E++
Sbjct: 242 YFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 756 TLGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ RIG G++G V+ + G VA+K+ + G + E+ ++ +HP VV
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNC 870
+ +V E++P L +L L E + +RM L G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHAN 118
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA-GTAEWMAPEVLRNEP 929
I+HRDLK NLL+ + V+K+ DFGL+R+ S T + APE+L
Sbjct: 119 G--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 930 S-DEKCDVYSFGVILWEL 946
D D+++ G I EL
Sbjct: 177 KYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 68/252 (26%), Positives = 121/252 (48%), Gaps = 15/252 (5%)
Query: 761 IGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+G G++G V +G + +VA+K L + +E E IM ++ +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
G V L +V E G L + L +++ + + + GM YL VH
Sbjct: 62 G-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVH 118
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRM--KHNTFLSSRSTAGT--AEWMAPEVLRNEPSDE 932
RDL + N+L+ K+ DFGLS+ +++ +R +AG +W APE +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR-SAGKWPLKWYAPECINFRKFSS 177
Query: 933 KCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991
+ DV+S+G+ +WE + Q+P+ M +V+ + Q +RLD P P + +++ CW
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236
Query: 992 TDPKMRPTFTEI 1003
+ RP F ++
Sbjct: 237 YKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 4e-20
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 74/294 (25%)
Query: 761 IGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEE----FRSEVLIMKRVRHPNVV- 813
IG G+YG V D G +VA+K+ + F + L + R E+ +++ +RH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI--SNVF-DDLIDAKRILR-EIKLLRHLRHENIIG 63
Query: 814 LFMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRM--ALDAARGMN 865
L + RPP+ IV E + L++++ P D+ + + L RG+
Sbjct: 64 LL--DILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQIL---RGLK 117
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----MKHNTFLSS----RSTAGT 916
YLH+ ++HRDLK N+LV+ N +K+CDFGL+R FL+ R
Sbjct: 118 YLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR----- 170
Query: 917 AEWM-APEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVG---- 963
W APE+L + + D++S G I EL T + + G + ++V+G
Sbjct: 171 --WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 964 ----------AVGF-----QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPT 999
A + + + + P D++ K DPK R T
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-20
Identities = 47/128 (36%), Positives = 78/128 (60%), Gaps = 3/128 (2%)
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS--RSTAGTAEWMAPEVLRNEPSD 931
++HRD+KS N+L+ N +VK+ DFG S+M T R+ GT ++APE+ R +P
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991
+K D++S GV+L+EL T+++P+ G N M+ V R +P ++ P + +I+
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLS 282
Query: 992 TDPKMRPT 999
+DPK RP+
Sbjct: 283 SDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 759 ERIGLGSYGEVYRGDWH--GTEVAVKR---FLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
++IG G + EVYR VA+K+ F D ++ ++ E+ ++K++ HPNV+
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD--AKARQDCVKEIDLLKQLNHPNVI 65
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAARGMNYLHNC 870
++ + L+IV E G L +++ Q + ER + + + ++H
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH-- 123
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA-----GTAEWMAPEVL 925
+ ++HRD+K N+ + VVK+ D GL R F SS++TA GT +M+PE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERI 178
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGG--MNPMQVVGAVGFQHRRLDIP----DNLD 979
+ K D++S G +L+E+ +Q P+ G MN + + + D P ++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCDYPPLPTEHYS 234
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
+ +++ C DP RP + K +
Sbjct: 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 74/261 (28%), Positives = 111/261 (42%), Gaps = 32/261 (12%)
Query: 754 EITLGERIGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGESLEEFR---SEVLIMKRVR 808
+ + ++G G YG+V+ T VA+KR F L E R +E I+ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF--KLNEVRHVLTERDILTTTK 59
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR-RLRM-----ALDAAR 862
+V + A L + E++P G LL+ L E R M A+DA
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALH 118
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922
+ Y +HRDLK N L+D + +K+ DFGLS+ + S G+ ++MAP
Sbjct: 119 ELGY--------IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAP 167
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA- 981
EVLR + D D +S G +L+E P+ G P + + + L P DP
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227
Query: 982 -----VADIIRKCWQTDPKMR 997
D+I K DP R
Sbjct: 228 NLSDEAWDLITKLI-NDPSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-20
Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 19/229 (8%)
Query: 760 RIGLGSYGEV-YRGDWH-GTEVAVKRFLDQDFFGESLEEFR-SEVLIMKRVRHPNVVLFM 816
+IG GS G V + H G +VAVK+ D + E +EV+IM+ H NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L +V EFL G+L ++ + +++E + + L R ++YLHN ++H
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHN--QGVIH 141
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDV 936
RD+KS ++L+ + +K+ DFG +S GT WMAPEV+ P + D+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 937 YSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
+S G+++ E+ + P+ P+Q + RR I DNL P V D
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAM-------RR--IRDNLPPRVKDS 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-19
Identities = 66/243 (27%), Positives = 114/243 (46%), Gaps = 13/243 (5%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
IG GS+G+V G ++ +V K+ + + + R+ +++K ++HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVG 60
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
+ L V +++ G L+ L R L+ R R A + A + YLH+ I
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN--I 117
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
++RDLK N+L+D V + DFGL + ++ + GT E++APEVLR EP D
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 935 DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994
D + G +L+E+ P+ + Q+ H+ L +P A D++ D
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYD--NILHKPLQLPGGKTVAACDLLVGLLHKDQ 235
Query: 995 KMR 997
+ R
Sbjct: 236 RRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 71/240 (29%), Positives = 115/240 (47%), Gaps = 20/240 (8%)
Query: 738 KSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLE 795
+S D++ P L E +G G+YG+VY+G G A+K D + E
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEE 57
Query: 796 EFRSEVLIMKRV-RHPNVVLFMGAVTR--PP----NLSIVAEFLPRGSLYRLLHRPN-NQ 847
E + E+ ++K+ H N+ + GA + PP L +V EF GS+ L+ N
Sbjct: 58 EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA 117
Query: 848 LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907
L E + + RG+ +LH ++HRD+K N+L+ +N VK+ DFG+S T
Sbjct: 118 LKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 908 LSSRSTAGTAEWMAPEVLRNEPS-----DEKCDVYSFGVILWELCTMQQPWGGMNPMQVV 962
+ GT WMAPEV+ + + D + D++S G+ E+ P M+PM+ +
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 22/234 (9%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
E+ IM R P +V F GA N+ + EF+ GSL R+ + + ++A+
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILGKIAVA 111
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
G+ YL+N I+HRD+K N+LV+ +K+CDFG+S N+ + + GT+ +
Sbjct: 112 VVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTY 168
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW--------GGMNPMQVVGAVGFQHRR 971
M+PE ++ K DV+S G+ + EL + P+ G +PM G + +
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM---GILDLLQQI 225
Query: 972 LDIP------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQV 1019
+ P + + D + C DP RPT + + A+ P + + +S V
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ-LCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 760 RIGLGSYGEVYRG-DWHGTE-VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
RIG G+YG VYR D E VA+K+ +D + G + R E+ ++ +RHPN+V
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 817 GAVT--RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH-NCTPV 873
V ++ +V E+ + L LL E + + L RG+ YLH N
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN-EPSDE 932
I+HRDLK NLL+ +K+ DFGL+R T + APE+L
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 933 KCDVYSFGVILWEL 946
D+++ G IL EL
Sbjct: 189 AIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 60/240 (25%), Positives = 116/240 (48%), Gaps = 11/240 (4%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMG 817
+G G++G V+ R A+K + + + +E ++K V HP ++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
L ++ E++P G L+ L R + + L A + + YLH+ IV+R
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYR 125
Query: 878 DLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVY 937
DLK N+L+DK +K+ DFG ++ + + + GT E++APEV++++ ++ D +
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182
Query: 938 SFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR 997
+ G++++E+ P+ NP + + +L+ P +LD D+I+K D R
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKI-LAG-KLEFPRHLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 69/253 (27%), Positives = 115/253 (45%), Gaps = 29/253 (11%)
Query: 757 LGERIGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVV 813
+GE +G GS+G V GT A+K ++ + ++ E I+ + HP +V
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GMN 865
M + + + EF+ G L+ L R+ R D A+
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKFYHAELVLAFE 132
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEV 924
YLH+ I++RDLK NLL+D VKV DFG + ++ TF + GT E++APEV
Sbjct: 133 YLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLAPEV 186
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
++++ + D ++ GV+L+E P+ P ++ + RL P+ D D
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPNWFDGRARD 244
Query: 985 IIRKCWQTDPKMR 997
+++ QTD R
Sbjct: 245 LVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-19
Identities = 55/157 (35%), Positives = 92/157 (58%), Gaps = 13/157 (8%)
Query: 861 ARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRSTAGT 916
A GM +L NC VHRDL + N+L+ + +VK+CDFGL+R M+ + ++S ST
Sbjct: 249 ANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPM--QVVGAVGFQHRRLD 973
+WMAPE + N DV+SFG++LWE+ T+ P+ + PM Q A+ + R+
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL-PMNEQFYNAIK-RGYRMA 362
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
P + + +I++KCW+ ++RP F++++ + L
Sbjct: 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 6e-19
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 41/214 (19%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVK------RFLDQDFFGESLEEFRSEVLIMKRV 807
G+++G G+Y VY+ G VA+K R +D G + R E+ +++ +
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD--GINFTALR-EIKLLQEL 59
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQL---DERRRLRMALDAARGM 864
+HPN++ + N+++V EF+ L +++ + L D + + M L RG+
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGL 115
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--------MKHNTFLSSRSTAGT 916
YLH+ I+HRDLK NLL+ + V+K+ DFGL+R M H T
Sbjct: 116 EYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--------T 165
Query: 917 AEWMAPEVL---RNEPSDEKCDVYSFGVILWELC 947
+ APE+L R+ D++S G I EL
Sbjct: 166 RWYRAPELLFGARHYGV--GVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-19
Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 61/292 (20%)
Query: 760 RIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRHPNVV-L 814
IG G++GEV+ R G A+K D + R+E I+ P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKL 66
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMNYLH 868
+ + +L +V E++P G L LL R + E L +ALD+ + +
Sbjct: 67 YY-SFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGF-- 122
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS---------------------------- 900
+HRD+K N+L+D + +K+ DFGL
Sbjct: 123 ------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 901 -RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM 959
R + + ST GT +++APEVLR P +CD +S GVIL+E+ P+
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 960 QVVGAVGFQHRR-LDIPDNLDPAVA----DIIRKCWQTDPKMR-PTFTEIMA 1005
+ + + L P DP V+ D+I + DP+ R +F EI +
Sbjct: 237 ETYNKI-INWKESLRFPP--DPPVSPEAIDLICRLL-CDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 54/296 (18%)
Query: 758 GERIGLGSYGEVYRG-DWH-GTEVAVKRF---LDQDFFGESLEEFRSEVLIMKRVR---H 809
IG G+YG VY+ D + G VA+K+ L ++ G L R E+ ++K++ H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPLSTLR-EIALLKQLESFEH 60
Query: 810 PNVVLFMG-----AVTRPPNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARG 863
PN+V + R L++V E + + L L + P L + RG
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWM-AP 922
+++LH + IVHRDLK N+LV + VK+ DFGL+R+ +F + ++ W AP
Sbjct: 120 VDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAP 175
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ-------VVG------------ 963
EVL D++S G I EL + + G + V+G
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235
Query: 964 ----AVGFQHRR--LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013
+ R + D+++K +P R + A + LQ P
Sbjct: 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS------AFEALQHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-19
Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 22/273 (8%)
Query: 744 DVAEC---EIPWEEITLGERIGLGSYGEVYRG-DWHGTEV-AVKRFLDQDFFG----ESL 794
++AE E P + T IG GS+G VY D EV A+K+ + G E
Sbjct: 13 EIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKW 69
Query: 795 EEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRL 854
++ EV ++R++HPN + + G R +V E+ GS LL L E
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 128
Query: 855 RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914
+ A +G+ YLH+ ++HRD+K+ N+L+ + VK+ DFG + + + S
Sbjct: 129 AITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANSFV 182
Query: 915 GTAEWMAPEV---LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR 971
GT WMAPEV + D K DV+S G+ EL + P MN M + +
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 242
Query: 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ + + C Q P+ RPT E++
Sbjct: 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 42/263 (15%)
Query: 761 IGLGSYGEVY-----RGDWHGTEVAVK-----RFLDQDFFGESLEEFRSEVLIMKRVRH- 809
+G G+YG+V+ G G A+K + + ++ E R+E +++ VR
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQK---AKTAEHTRTERQVLEAVRRC 64
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERR----RLRMALDAARGM 864
P +V A L ++ +++ G L+ L R + E R + +ALD
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD----- 119
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS-----SRSTAGTAEW 919
+LH I++RD+K N+L+D V + DFGLS+ FL+ + S GT E+
Sbjct: 120 -HLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERAYSFCGTIEY 172
Query: 920 MAPEVLRNEPS--DEKCDVYSFGVILWELCTMQQPW---GGMNPMQVVGAVGFQHRRLDI 974
MAPEV+R D+ D +S GV+ +EL T P+ G N + + +
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-SRRILKSKPPF 231
Query: 975 PDNLDPAVADIIRKCWQTDPKMR 997
P + D I+K + DPK R
Sbjct: 232 PKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 53/164 (32%), Positives = 91/164 (55%), Gaps = 15/164 (9%)
Query: 848 LDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MK 903
LD LR + A+GM++L NC +HRD+ + N+L+ V K+CDFGL+R M
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGM---NPM 959
+ ++ + +WMAPE + + + DV+S+G++LWE+ ++ + P+ G+ +
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324
Query: 960 QVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEI 1003
+ G+Q R PD P + I++ CW +P RPTF++I
Sbjct: 325 YKMVKRGYQMSR---PDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 66/242 (27%), Positives = 117/242 (48%), Gaps = 10/242 (4%)
Query: 761 IGLGSYGEVY-----RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+G GS+G+V+ G G A+K + E I+ V HP +V
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
A L ++ +FL G L+ L + +E + +A + A +++LH+ I+
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG--II 120
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCD 935
+RDLK N+L+D+ +K+ DFGLS+ + + S GT E+MAPEV+ + D
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 180
Query: 936 VYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995
+SFGV+++E+ T P+ G + + + + +L +P L P ++R ++ +P
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMI--LKAKLGMPQFLSPEAQSLLRALFKRNPA 238
Query: 996 MR 997
R
Sbjct: 239 NR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 70/245 (28%), Positives = 110/245 (44%), Gaps = 13/245 (5%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMG 817
IG GS+G VY R + VA+K+ E ++ EV ++++RHPN + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
R +V E+ GS LL L E + A +G+ YLH+ ++HR
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHR 139
Query: 878 DLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV---LRNEPSDEKC 934
D+K+ N+L+ + +VK+ DFG + + + GT WMAPEV + D K
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 935 DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994
DV+S G+ EL + P MN M + + + + + C Q P
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 995 KMRPT 999
+ RPT
Sbjct: 256 QDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 84/314 (26%), Positives = 131/314 (41%), Gaps = 51/314 (16%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G G +GEV GD + +V K L E++ F E I+ P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ---ETVSFFEEERDILSISNSPWIPQ 65
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDER------RRLRMALDAARGMNYLH 868
A NL +V E+ P G L LL+R +Q DE L +A+ + M Y
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY-- 123
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLRN 927
VHRD+K N+L+D+ +K+ DFG + R+ N ++S+ GT +++APEVL
Sbjct: 124 ------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 928 EPSDEK------CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981
D K CD +S GVI +E+ + P+ + + R L P+ DP
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE--DPK 235
Query: 982 VADIIRKCWQ---TDPKMR---------PTFTEIMAALKPLQKPITSSQVPRPVPSVSSG 1029
V+ Q K R P F++I + +P VP++ S
Sbjct: 236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKI-----DWNN--IRNSLPPFVPTLKSD 288
Query: 1030 RETGQISKFLADST 1043
+T + +ST
Sbjct: 289 DDTSNFDEPEKNST 302
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 760 RIGLGSYGEV--YRGDWHGTEVAVKRFLDQDFFGESLEEFR-SEVLIMKRVRHPNVVLFM 816
+IG GS G V R G +VAVK D + E +EV+IM+ +H NVV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L ++ EFL G+L ++ + +L+E + + + + YLH + ++H
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--SQGVIH 140
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDV 936
RD+KS ++L+ + VK+ DFG +S GT WMAPEV+ P + D+
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 937 YSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP-------DNLDPAVADIIRKC 989
+S G+++ E+ + P+ +P+Q + R D P + P + D + +
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 990 WQTDPKMRPTFTEIMAALKPLQKPITSSQVP 1020
+P+ R T E++ LQ + VP
Sbjct: 255 LTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 60/258 (23%), Positives = 114/258 (44%), Gaps = 43/258 (16%)
Query: 761 IGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIM----------KRV--- 807
+G GS+G+V + GT+ + + +++ + +V++ KRV
Sbjct: 3 LGKGSFGKVLLAELKGTD---------ELY--AVKVLKKDVILQDDDVECTMTEKRVLAL 51
Query: 808 --RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMN 865
+HP + L V E++ G L + R + + DE R A + G+
Sbjct: 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQ 110
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------RMKHNTFLSSRSTAGTAEW 919
+LH I++RDLK N+L+D +K+ DFG+ + +TF GT ++
Sbjct: 111 FLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDY 162
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979
+APE+L +P D ++ GV+L+E+ Q P+ G + ++ ++ + P L
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLS 220
Query: 980 PAVADIIRKCWQTDPKMR 997
I++ +P+ R
Sbjct: 221 KEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 38/275 (13%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGTEV--AVKRF---LDQDFFGESLEEFRSEVLIMKRV 807
+EI + + +G G+YG VY+ T V A+K LD+ F + + E + I+ +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIME----LDILHKA 56
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNNQLDERRRLRMALDAARGMN 865
P +V F GA + + E++ GSL +L + E R+ +G+
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 866 YL---HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS-SRSTAGTAEWMA 921
+L HN I+HRD+K N+LV+ N VK+CDFG+S N S +++ G +MA
Sbjct: 117 FLKEEHN----IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMA 169
Query: 922 PEVLRNE-PSDE-----KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--- 972
PE +++ P+ + DV+S G+ + E+ + P+ P + + Q +
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDG 225
Query: 973 ---DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+P D + KC P RPT+ +++
Sbjct: 226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 75/259 (28%), Positives = 117/259 (45%), Gaps = 14/259 (5%)
Query: 753 EEITLG-ERIGLGSYGEVYRG-DWHGTE-VAVKRF-LDQDFFGESLEEFRSEVLIMKRVR 808
EEI +G IG GS+G VY + H E VAVK+ E ++ EV +++++
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPN + + G + +V E+ GS LL L E + A +G+ YLH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV---L 925
+ ++HRD+K+ N+L+ + VK+ DFG + + S GT WMAPEV +
Sbjct: 139 --SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAM 192
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
D K DV+S G+ EL + P MN M + + + +
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252
Query: 986 IRKCWQTDPKMRPTFTEIM 1004
+ C Q P+ RP E++
Sbjct: 253 VDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 23/160 (14%)
Query: 757 LGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVV 813
+ ++G G++GEVY+ G VA+K+ L + G + R E+ I+K+++HPNVV
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVV 70
Query: 814 -LFMGAVTRPPNLSIVAEFLPRGSLYR-----------LLHRPNNQLDERRRLRMALDAA 861
L AV RP RGS+Y LL P+ +L E + L
Sbjct: 71 PLIDMAVERPDKSKRK-----RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
G+NYLH I+HRD+K+ N+L+D ++K+ DFGL+R
Sbjct: 126 EGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 82/320 (25%), Positives = 126/320 (39%), Gaps = 51/320 (15%)
Query: 731 SASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFF 790
S+S+ SS S E+ RIG G+ G VY+ T + + + +
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTG---RLYALKVIY 108
Query: 791 GESLEEFRS----EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNN 846
G + R E+ I++ V HPNVV + ++ EF+ GSL
Sbjct: 109 GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIA- 165
Query: 847 QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906
DE+ +A G+ YLH IVHRD+K NLL++ VK+ DFG+SR+ T
Sbjct: 166 --DEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221
Query: 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKC-----DVYSFGVILWELCTMQQPWGGMNPMQV 961
S+ GT +M+PE + + + D++S GV + E + P+G
Sbjct: 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG------- 274
Query: 962 VGAVGFQ------------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009
VG Q + + P I C Q +P R + A++
Sbjct: 275 ---VGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWS------AMQL 325
Query: 1010 LQKPITSSQVPRPVPSVSSG 1029
LQ P + R P G
Sbjct: 326 LQHPF----ILRAQPGQGQG 341
|
Length = 353 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 72/258 (27%), Positives = 123/258 (47%), Gaps = 43/258 (16%)
Query: 761 IGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIM----------KRV--- 807
+G GS+G+V+ + GT FF +++ + +V++M KRV
Sbjct: 3 LGKGSFGKVFLAELKGT---------NQFF--AIKALKKDVVLMDDDVECTMVEKRVLSL 51
Query: 808 --RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGM 864
HP + NL V E+L G L + H + ++ D R A + G+
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWMAP 922
+LH + IV+RDLK N+L+D + +K+ DFG+ K N +++ GT +++AP
Sbjct: 110 QFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAP 165
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD---IPDNLD 979
E+L + + D +SFGV+L+E+ Q P+ G + ++ FQ R+D P L
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNPCYPRWLT 220
Query: 980 PAVADIIRKCWQTDPKMR 997
DI+ K + +P+ R
Sbjct: 221 REAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 33/253 (13%)
Query: 761 IGLGSYGEVYRGDWHGTEVAVKRFLDQDFFG------ESLEEFRSEVLIM-------KRV 807
IG GS+G+V K D F+ +++ + + + IM K V
Sbjct: 3 IGKGSFGKVLL---------AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
+HP +V + L V +++ G L+ L R + + R R A + A + YL
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYL 112
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRST-AGTAEWMAPEV 924
H+ I++RDLK N+L+D V + DFGL + ++H+ + ST GT E++APEV
Sbjct: 113 HSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KTTSTFCGTPEYLAPEV 167
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
LR +P D D + G +L+E+ P+ + ++ + ++ L + N+ +
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKPLRLKPNISVSARH 225
Query: 985 IIRKCWQTDPKMR 997
++ Q D R
Sbjct: 226 LLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 68/245 (27%), Positives = 105/245 (42%), Gaps = 16/245 (6%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFG-ESLEEFRSE---VLIMKRVRHPNVVL 814
+G G +G+V ++ T A+K D + +E E RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
++ V E+ G L +H + E R + A G+ YLH I
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--I 122
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR-ST-AGTAEWMAPEVLRNEPSDE 932
V+RDLK NLL+D VK+ DFGL K R ST GT E++APEVL
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
D + GV+++E+ + P+ G + +V ++ R P L I+R+ +
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY--PRFLSREAISIMRRLLRR 238
Query: 993 DPKMR 997
+P+ R
Sbjct: 239 NPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 13/254 (5%)
Query: 761 IGLGSYGEVYRGDWHGTEV--AVKRFLDQDFFGESLEE--FRSEVLIMKRVRHPNVVLFM 816
IG GS+G+V E AVK + + E+ +++K V+HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L V +++ G L+ L R L+ R R A + A + YLH+ IV+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN--IVY 119
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
RDLK N+L+D + + DFGL + ++HN ++ + GT E++APEVL +P D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 935 DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994
D + G +L+E+ P+ N ++ + ++ L + N+ + ++ Q D
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLEGLLQKDR 235
Query: 995 KMRPTFTEIMAALK 1008
R + +K
Sbjct: 236 TKRLGAKDDFMEIK 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818
+G G+YG V + T+ VA+K+F D + E E E+ +++ ++ N+V A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 819 VTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRD 878
R L +V E++ + L L PN E+ R + + +++ H IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKND--IVHRD 125
Query: 879 LKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMA------PEVLRNEPSDE 932
+K NLL+ N V+K+CDFG +R LS S A E++A PE+L P +
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARN-----LSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 933 KCDVYSFGVILWELCTMQ 950
D++S G IL EL Q
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 76/277 (27%), Positives = 113/277 (40%), Gaps = 48/277 (17%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E+IG G+YG VY R G VA+K+ L+ + G R E+ ++K + HPN+V
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRL 63
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+ V L +V EFL + P LD +G+ Y H + ++
Sbjct: 64 LDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVL 121
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-LSSRSTAGTAE----WM-APEVLRNEP 929
HRDLK NLL+D+ +K+ DFGL+R F + R T E W APE+L
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLAR----AFGVPVR--TYTHEVVTLWYRAPEILLGSR 175
Query: 930 S-DEKCDVYSFGVILWELCTMQQP-------------------------WGGMNPMQVVG 963
D++S G I E+ ++P W G+ +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234
Query: 964 AVGFQHRRLDIPD---NLDPAVADIIRKCWQTDPKMR 997
+ R D+ NLD D++ K DP R
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKR 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 7/200 (3%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLDERRRLRMAL 858
E I++ + HP +V + N+ +V + L G L Y L + +E+ + +
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQVKFWIC- 107
Query: 859 DAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE 918
+ + YLH+ I+HRD+K N+L+D+ V + DF ++ L++ ST+GT
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STSGTPG 164
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDN 977
+MAPEVL + D +S GV +E ++P+ G + Q + P
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
Query: 978 LDPAVADIIRKCWQTDPKMR 997
D I K + DP+ R
Sbjct: 225 WSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 21/254 (8%)
Query: 760 RIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFR-SEVLIMKRVRHPNVVLFM 816
+IG GS G V G VAVK+ D + E +EV+IM+ +H NVV
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L +V EFL G+L ++ + +++E + + L + ++ LH ++H
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLH--AQGVIH 139
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDV 936
RD+KS ++L+ + VK+ DFG +S GT WMAPE++ P + D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 937 YSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNL------DPAVADIIRKCW 990
+S G+++ E+ + P+ P++ + + R ++P L P++ + +
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI-----RDNLPPKLKNLHKVSPSLKGFLDRLL 254
Query: 991 QTDPKMRPTFTEIM 1004
DP R T E++
Sbjct: 255 VRDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 71/249 (28%), Positives = 121/249 (48%), Gaps = 25/249 (10%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGESLEEFRSE-VLIMKRV-----RHPNV 812
+G GS+G+V + GT A+K L +D LE+ E ++ +RV HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKA-LKKDVV---LEDDDVECTMVERRVLALAWEHPFL 58
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLHNCT 871
+L V E+L G L + H + + + DE R A + G+ +LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLH--K 114
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSD 931
I++RDLK N+L+DK+ +K+ DFG+ + N + + GT +++APE+L+ + +
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI---PDNLDPAVADIIRK 988
E D +SFGV+L+E+ Q P+ G + ++ F D P + D + K
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRPHFPRWISKEAKDCLSK 229
Query: 989 CWQTDPKMR 997
++ DP R
Sbjct: 230 LFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 55/294 (18%)
Query: 761 IGLGSYGEV--YRGDWHGTEVAVKRFLDQDFFGESLEE--FRSEVLIMKRVRHPNVVLFM 816
+G+G++G V R G VA+K+ + + F L + +R E+ ++K +RH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM-KPFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75
Query: 817 GAVTRP-PNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
P ++ V E L L+RLL RP L+++ RG+ Y+H+ +
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSAG--V 129
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMK--HNT-FLSSRSTAGTAEWMAPEV-LRNEPS 930
VHRDLK N+L+++N +K+CDFGL+R++ T ++S+R + APE+ L +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY------YRAPEIMLTWQKY 183
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMN---------------PMQVVGAVGFQH------ 969
D + D++S G I E+ + + G + P V+ + ++
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 970 ---RRLDIP-----DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKP 1013
+R +P N DP+ D++ K DP+ R + E +A L P P
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 84/355 (23%), Positives = 134/355 (37%), Gaps = 84/355 (23%)
Query: 761 IGLGSYGEV--YRGDWHGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMG 817
IG G++GEV + G A+K+ + E + R+E I+ +P VV
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR-----LRMALDAARGMNYLHNCTP 872
+ L ++ E+LP G + LL + + +E R +A+D+ + Y
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY------ 122
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLS-------------RMKHN-----------TFL 908
+HRD+K NLL+D +K+ DFGL + H
Sbjct: 123 --IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 909 SSR--------------STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWG 954
S R ST GT +++APEV +++CD +S GVI++E+ P+
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 955 GMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMR------------PTF 1000
NP + + L PD L P D+I++ + + R P F
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFF 299
Query: 1001 T--------EIMAALKPLQKPITSSQ-------VPRPVPSVSSGRETGQISKFLA 1040
E A + P K IT + + VP+ SK LA
Sbjct: 300 KGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSKDLA 354
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E+IG G+YG VY+G T VA+K+ L+ + G R E+ ++K ++HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCL 64
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+ + L ++ EFL L P Q +DA +YL+ I+
Sbjct: 65 QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY---------MDAELVKSYLYQILQGIL 115
Query: 876 --------HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
HRDLK NLL+D V+K+ DFGL+R T + APEVL
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 928 EPS-DEKCDVYSFGVILWELCT 948
P D++S G I E+ T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-16
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 10/219 (4%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTE---VAVKRFLDQDFFGE-SLEEFRSEVL 802
+ ++ +E+ +G GS+G V + + VA+KRF + ++ SE
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR 862
I+ + HP V G+ L +V EF+ G + L R N + A
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVL 142
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922
YL + IV+RDLK NLL+DK+ +K+ DFG +++ + + GT E++AP
Sbjct: 143 IFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAP 197
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV 961
E+L N + D ++ G+ ++E+ P+ P+ +
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 61/244 (25%), Positives = 114/244 (46%), Gaps = 16/244 (6%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+G G++G+V G ++ ++ K + +D ++ E R +++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR----VLQNTRHPFLT 58
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
A L V E+ G L+ L R +ER R A + + YLH+
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD-- 115
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
+V+RD+K NL++DK+ +K+ DFGL + + + ++ GT E++APEVL +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
D + GV+++E+ + P+ + ++ + + R P L P ++ + D
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSLLAGLLKKD 233
Query: 994 PKMR 997
PK R
Sbjct: 234 PKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 45/211 (21%)
Query: 761 IGLGSYGEVYRGD--WHGTEVAVKR---FLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
IG G+YG V G +VA+K+ F Q F +L E + I++R +H N++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKHENIIGI 68
Query: 816 MGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA-------- 861
+ + RPP+ IV E + LY+L+ + ++ D
Sbjct: 69 L-DIIRPPSFESFNDVYIVQELMET-DLYKLI----------KTQHLSNDHIQYFLYQIL 116
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM-----KHNTFLSSRSTAGT 916
RG+ Y+H+ ++HRDLK NLL++ N +K+CDFGL+R+ H FL+ T
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT--EYVAT 172
Query: 917 AEWMAPEVLRNEPSDEKC-DVYSFGVILWEL 946
+ APE++ N K D++S G IL E+
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-15
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+G G++G+V G ++ ++ K + +D +L E R ++K RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESR----VLKNTRHPFLT 58
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ L V E++ G L+ L R ++R R A + ++YLH+
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSGK-- 115
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
IV+RDLK NL++DK+ +K+ DFGL + + ++ GT E++APEVL +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 934 CDVYSFGVILWELCTMQQPW 953
D + GV+++E+ + P+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 761 IGLGSYGEVYRGDWHGTEVAVKRFLDQDFFG-------------ESLEEFRSEVLIMKRV 807
IG GS+G+V + KR LD + E +++K V
Sbjct: 3 IGKGSFGKV---------LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
+HP +V + L V +F+ G L+ L R + + R R A + A + YL
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYL 112
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
H+ IV+RDLK N+L+D V + DFGL + ++ + GT E++APEV+R
Sbjct: 113 HSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 928 EPSDEKCDVYSFGVILWEL 946
+P D D + G +L+E+
Sbjct: 171 QPYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 62/244 (25%), Positives = 114/244 (46%), Gaps = 15/244 (6%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKRFL-DQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+G G++G+V G ++ ++ K + +D +L E R +++ RHP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR----VLQNSRHPFLT 58
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ L V E+ G L+ L R ++R R A + ++YLH+ V
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV 117
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
V+RDLK NL++DK+ +K+ DFGL + + ++ GT E++APEVL +
Sbjct: 118 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
D + GV+++E+ + P+ + ++ + + R P L P ++ + D
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLLKKD 234
Query: 994 PKMR 997
PK R
Sbjct: 235 PKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 40/274 (14%)
Query: 759 ERIGLGSYGEVYRG----DWHGTEVAVKRF------LDQDFFGESLEEFRSEVLIMKRVR 808
+ IG G +G+V G + +V VK +Q F E + +RS ++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRS-------LQ 53
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH--RPNNQL--DERRRLRMALDAARGM 864
H N++ +G T +V EF P G L L R + D RMA + A G+
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGL 113
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH--NTFLSSRSTAGTAEWMAP 922
+LH +H DL N L+ + VK+ D+GLS K+ + +++ W+AP
Sbjct: 114 LHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
Query: 923 EVLRNEPSD-------EKCDVYSFGVILWELCTM-QQPWGGMNPMQVVG-AVGFQHRRLD 973
E++ + ++ +V+S GV +WEL + QP+ ++ QV+ V Q +L
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP 231
Query: 974 IPDNLDPAVAD----IIRKCWQTDPKMRPTFTEI 1003
P L ++D +++ CW P+ RP+ E+
Sbjct: 232 KP-RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 21/249 (8%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFF----GESLEEFRSEVLIMKRVRHPNVVL 814
+G G +GEV + G A K+ LD+ GE + +E I+++V +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVS 57
Query: 815 FMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
A +L +V + G L Y + + E R + A G+ +LH
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR-- 115
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932
IV+RDLK N+L+D + V++ D GL+ +K + R AGT +MAPEVL+ E D
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--AGTPGYMAPEVLQGEVYDF 173
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI----PDNLDPAVADIIRK 988
D ++ G L+E+ + P+ + V + R L++ PD P D+
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRK--EKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231
Query: 989 CWQTDPKMR 997
Q DP+ R
Sbjct: 232 LLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 28/207 (13%)
Query: 760 RIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVV--- 813
RI G+YG VYR T VA+K+ ++++ G + R E+ I+ +++HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVK 70
Query: 814 -LFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNNQLDERRRLRMALDAARGMNYLHNC 870
+ +G + + +V E++ L L+ + E + L + L G+ +LH+
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQL--LSGVAHLHD- 124
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----MKHNTFLSSRSTAGTAEWMAPEVL 925
I+HRDLK+ NLL++ ++K+CDFGL+R +K T T + APE+L
Sbjct: 125 -NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-----QLVVTLWYRAPELL 178
Query: 926 RNEPS-DEKCDVYSFGVILWELCTMQQ 951
D++S G I EL T +
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 68/295 (23%)
Query: 760 RIGLGSYGEVY--RGDWHGTEVAVKRFL-DQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+IG G++GEV+ R VA+K+ L + + G + R E+ I++ ++H NVV +
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 77
Query: 817 GAVTRPPN--------LSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMN 865
+V EF L LL N + ++ ++M L+ G+
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN---GLY 133
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG---------- 915
Y+H I+HRD+K+ N+L+ K+ ++K+ DFGL+R F S S
Sbjct: 134 YIH--RNKILHRDMKAANILITKDGILKLADFGLAR----AF--SLSKNSKPNRYTNRVV 185
Query: 916 TAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCT----MQ------------QPWGGMNP 958
T + PE+L E D++ G I+ E+ T MQ Q G + P
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245
Query: 959 MQVVGAVGFQ-HRRLDIPDNL-------------DPAVADIIRKCWQTDPKMRPT 999
G + +++++P DP D+I K DP R
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 5/200 (2%)
Query: 798 RSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMA 857
++E I++ V+HP +V + A L ++ E+L G L+ L R +++ ++
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA 917
+ + + +LH I++RDLK N+L+D VK+ DFGL + + + + GT
Sbjct: 108 -EISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977
E+MAPE+L + D +S G +++++ T P+ N + + + +L++P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI--LKGKLNLPPY 222
Query: 978 LDPAVADIIRKCWQTDPKMR 997
L P D+++K + +P R
Sbjct: 223 LTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 68/249 (27%), Positives = 121/249 (48%), Gaps = 25/249 (10%)
Query: 761 IGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRV-----RHPNVVL 814
+G GS+G+V + G E + L +D +++ ++ KRV +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+L V EFL G L + H + + D R A + G+ +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLH--SKG 116
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWMAPEVLRNEPSD 931
I++RDLK N+++D++ +K+ DFG+ K N F +R++ GT +++APE+L+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN---LDPAVADIIRK 988
D +SFGV+L+E+ Q P+ G + ++ F+ R+D P + DI+ K
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTPHYPRWITKESKDILEK 229
Query: 989 CWQTDPKMR 997
++ DP R
Sbjct: 230 LFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 69/258 (26%), Positives = 120/258 (46%), Gaps = 32/258 (12%)
Query: 761 IGLGSYGEVY---------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-P 810
+G G+YG+V+ G + +V K + Q ++ E R+E +++ +R P
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK--AKTTEHTRTERQVLEHIRQSP 65
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
+V A L ++ +++ G L+ L + + E+ + + + +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS-SRSTAGTAEWMAPEVLRNEP 929
I++RD+K N+L+D N V + DFGLS+ H + + S GT E+MAP+++R
Sbjct: 125 G--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 930 S--DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRL-----DIPDNLD 979
D+ D +S GV+++EL T G +P V G Q RR+ P +
Sbjct: 183 GGHDKAVDWWSMGVLMYELLT------GASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236
Query: 980 PAVADIIRKCWQTDPKMR 997
DII++ DPK R
Sbjct: 237 ALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRF--------LDQDFFGESLEEFRSEVLIMKRVRHP 810
IG G++GEV R A+K D FF E E IM
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE-------ERDIMAHANSE 103
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDER------RRLRMALDAARGM 864
+V A L +V E++P G L L+ N + E+ + +ALDA M
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPE 923
+ +HRD+K N+L+DK+ +K+ DFG +M N + + GT ++++PE
Sbjct: 162 GF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 924 VLRNEPSD----EKCDVYSFGVILWELCTMQQPW 953
VL+++ D +CD +S GV L+E+ P+
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 8/198 (4%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E+IG G+YG V++ T VA+KR LD D G R E+ ++K ++H N+V
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL 64
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+ L++V E+ + L + N +D +G+ + H+ ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VL 121
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP-SDEKC 934
HRDLK NLL++KN +K+ DFGL+R + T + P+VL
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 181
Query: 935 DVYSFGVILWELCTMQQP 952
D++S G I EL +P
Sbjct: 182 DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-14
Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 39/261 (14%)
Query: 761 IGLGSYGEVY---------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-P 810
+G G+YG+V+ G + +V K L Q +++E R+E +++ VR P
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK--AKTVEHTRTERNVLEHVRQSP 65
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
+V A L ++ +++ G ++ L++ +N ++ R + + +LH
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLHKL 124
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR-----STAGTAEWMAPEVL 925
IV+RD+K N+L+D V + DFGLS+ FLS S GT E+MAPE++
Sbjct: 125 G--IVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYMAPEII 178
Query: 926 RNEPSDEKC-DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRL-----DIPD 976
R + K D +S G++++EL T G +P + G Q RR+ P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLT------GASPFTLEGERNTQSEVSRRILKCDPPFPS 232
Query: 977 NLDPAVADIIRKCWQTDPKMR 997
+ P D++ K + DPK R
Sbjct: 233 FIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRFLDQD--FFGESLEEFRSEVLIMKRV-----RHPN 811
+G GS+G+V + GT+ A+K L +D + +E ++ KRV + P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVEC----TMVEKRVLALPGKPPF 62
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
+ L V E++ G L Y + + + E + A + A G+ +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
+ I++RDLK N+++D +K+ DFG+ + ++R+ GT +++APE++ +P
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 931 DEKCDVYSFGVILWELCTMQQPWGG 955
+ D ++FGV+L+E+ Q P+ G
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 3/148 (2%)
Query: 799 SEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMAL 858
+E +++ RHP + + L V E+ G L+ L R ++R R A
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA- 102
Query: 859 DAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE 918
+ + YLH+C +V+RDLK NL++DK+ +K+ DFGL + + + ++ GT E
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWEL 946
++APEVL + D + GV+++E+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 20/251 (7%)
Query: 761 IGLGSYGEVY-----RGD-WHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
IG GSY +V + + + +V K ++ D E ++ ++E + ++ HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 59
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L V E++ G L + R +E R A + + +NYLH
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG-- 116
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
I++RDLK N+L+D +K+ D+G+ + ++ + GT ++APE+LR E
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 934 CDVYSFGVILWELCTMQQPW----GGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVADII 986
D ++ GV+++E+ + P+ NP Q FQ +++ IP +L A ++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 987 RKCWQTDPKMR 997
+ DPK R
Sbjct: 237 KSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 757 LGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+G+ + + T VAVK+ E L+ + E++ ++++HPN++ ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLL--HRPNNQLDERRRLRMAL---DAARGMNYLHNCT 871
+ L +V+ + GS LL H P L E L +A D ++Y+H+
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPE---LAIAFILKDVLNALDYIHSKG 121
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDF--GLSRMKHN-----TFLSSRSTAGTAEWMAPEV 924
+HR +K+ ++L+ + V + +S +KH +S+ W++PEV
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 925 LRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMNPMQ 960
L+ +EK D+YS G+ EL P+ M Q
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 7/205 (3%)
Query: 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
E++G GSY VY+G +G VA+K Q+ G R E ++K ++H N+VL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLH 69
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L++V E++ + P E +L + RG++Y+H I+H
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ--RYILH 126
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC-D 935
RDLK NLL+ +K+ DFGL+R K + + T + P+VL C D
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 936 VYSFGVILWELCTMQQPWGGMNPMQ 960
++ G I E+ + GM +Q
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 41/133 (30%), Positives = 73/133 (54%), Gaps = 4/133 (3%)
Query: 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881
+L +V +++ G L+ L + ++R + +A + + +LH IV+RDLK
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--IVYRDLKP 124
Query: 882 PNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK-CDVYSFG 940
N+L+D + +CDFGLS+ ++ + GT E++APEVL +E K D +S G
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 941 VILWELCTMQQPW 953
V+++E+C P+
Sbjct: 185 VLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNVVLFMG 817
IG GS+G+V + T+ A+K S + +E ++ +V P +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
+ P L +V F+ G L+ L R + D R + + LH +++R
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFN--VIYR 117
Query: 878 DLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVY 937
DLK N+L+D + +CDFGL ++ + + GT E++APE+L + D +
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 938 SFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR 997
+ GV+L+E+ T P+ N ++ + L PD D D++ DP R
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
Query: 998 ------------PTFTEI------MAALKPLQKPITSSQV 1019
P F+++ M ++P KP SS +
Sbjct: 236 LGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAI 275
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP--RGSLYRLLHRPNNQLDERRRLRMA 857
E ++++ V HP+V+ + +V LP LY L + + L + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAG 915
G+ YLH I+HRD+K+ N+ ++ V + D G ++ FL AG
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAG 218
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWEL 946
T E APEVL + + K D++S G++L+E+
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 28/205 (13%)
Query: 760 RIGLGSYGEVYRGD--WHGTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVR-HPNVVL 814
+IG G++ EV + G A+K + + F +SLE+ + E+ ++R+ HPN++
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKC-MKKHF--KSLEQVNNLREIQALRRLSPHPNILR 62
Query: 815 FMGAVTRPPN--LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ + L++V E L +LY L+ L E+R + ++++H
Sbjct: 63 LIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFG-----LSRMKHNTFLSSRSTAGTAEWM-APEVLR 926
I HRD+K N+L+ + ++K+ DFG S+ + ++S+R W APE L
Sbjct: 121 -IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-------WYRAPECLL 171
Query: 927 NEPS-DEKCDVYSFGVILWELCTMQ 950
+ K D+++ G + +E+ ++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 66/256 (25%), Positives = 108/256 (42%), Gaps = 22/256 (8%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMG 817
I G+YG VY R A+K+ Q+ +++ E I+ +P VV
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
+ +L +V E++ G LL + R+ A + + YLHN IVHR
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLHNYG--IVHR 125
Query: 878 DLKSPNLLVDKNWVVKVCDFGLSRM---------------KHNTFLSSRSTAGTAEWMAP 922
DLK NLL+ +K+ DFGLS++ K + GT E++AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV-GFQHRRLDIPDNLDPA 981
EV+ + + D ++ G+IL+E P+ G P ++ G V + + L
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPAD 245
Query: 982 VADIIRKCWQTDPKMR 997
D+I + + +P R
Sbjct: 246 AQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-13
Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 58/289 (20%)
Query: 761 IGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEE----FRSEVLIMKRVRHPNVVL 814
+G G+YG+V T +VA+K+ L + F +S +R E+ ++K + H NV+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKK-LSRPF--QSAIHAKRTYR-ELRLLKHMDHENVIG 78
Query: 815 FMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+ T +L +V + L ++ +L + + RG+ Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH 135
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWMAPEVLR 926
+ I+HRDLK N+ V+++ +K+ DFGL+R T T + APE++
Sbjct: 136 SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIML 188
Query: 927 NEPS-DEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVG--------------A 964
N ++ D++S G I+ EL T + + G + M +VG A
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 965 VGF-----QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ Q + D + +P D++ K DP R T E +A
Sbjct: 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 76/300 (25%), Positives = 123/300 (41%), Gaps = 63/300 (21%)
Query: 756 TLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFR--SEVLIMKRVRHPN 811
+ E IG GSYG V D H G +VA+K+ D F + R E+ +++ +RHP+
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 812 VVLFMGAVTRPPN------LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMN 865
+V + + PP+ + +V E L L++++ + N+ L R +
Sbjct: 61 IVE-IKHIMLPPSRREFKDIYVVFE-LMESDLHQVI-KANDDLTPEHHQFFLYQLLRALK 117
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
Y+H T + HRDLK N+L + + +K+CDFGL+R+ N T W
Sbjct: 118 YIH--TANVFHRDLKPKNILANADCKLKICDFGLARVAFN------DTPTAIFWTDYVAT 169
Query: 926 RNEPSDEKC-----------DVYSFGVILWELCTMQQPWGGMN---------------PM 959
R + E C D++S G I E+ T + + G N
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 960 QVVGAVGFQHRR---------LDIP-----DNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ + V + R +P N DP ++ + DPK RPT E +A
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 48/247 (19%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR----PNNQLDERRRLR 855
E+ ++ P +V F GA +SI E + GSL ++L + P N L +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----K 103
Query: 856 MALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG 915
+++ RG+ YL I+HRD+K N+LV+ +K+CDFG+S ++ + S G
Sbjct: 104 ISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVG 160
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQP--------WGGMNPMQVV-GAVG 966
T +M+PE L+ + D++S G+ L E+ + P M V G
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK 220
Query: 967 FQHRRLDI--PDN---------LD----------------PAVADIIRKCWQTDPKMRPT 999
HR + PD+ LD D + KC + +PK R
Sbjct: 221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD 280
Query: 1000 FTEIMAA 1006
E+
Sbjct: 281 LKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 38/269 (14%)
Query: 759 ERIGLGSYGEVYRG---------DWHGTEVAVKRFLDQDF--FGESLEEFRSEVLIMKRV 807
E +G G++ ++++G + H TEV +K LD+ + ES E S +M ++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLK-VLDKSHRNYSESFFEAAS---MMSQL 56
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
H ++VL G +V E++ GSL L + N ++ +L +A A +++L
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL 116
Query: 868 HNCTPVIVHRDLKSPNLLVDKNW--------VVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
+ + H ++ + N+L+ + +K+ D G+S T L W
Sbjct: 117 EDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPW 170
Query: 920 MAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGA---VGFQHRRLDIP 975
+ PE + N + D +SFG LWE+ + GG P+ + + + F R +P
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS-----GGDKPLSALDSQKKLQFYEDRHQLP 225
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+A++I +C +P RP+F I+
Sbjct: 226 APKWTELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 40/230 (17%)
Query: 755 ITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFR------------SE 800
I G +G G+YG+V + G VA+K+ + + ++ + E
Sbjct: 11 IQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE 70
Query: 801 VLIMKRVRHPNVVLFMGAV---TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMA 857
+ IM ++H N+ MG V +++V + + L +++ R +L E + +
Sbjct: 71 LKIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDR-KIRLTESQVKCIL 125
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF----LSSRST 913
L G+N LH +HRDL N+ ++ + K+ DFGL+R LS T
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 914 AGTAEWMAPEV-----------LRNEPSDEKCDVYSFGVILWELCTMQQP 952
E M +V + E D++S G I EL T +P
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKP 232
|
Length = 335 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 40/272 (14%)
Query: 759 ERIGLGSYGEVYRG----------DWHGTEVAVK---RFLDQDFFGESLEEFRSEVLIMK 805
E +G G+ ++Y G D + E +K + LD SL F + + M+
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASM-MR 59
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMN 865
+V H ++VL G R +V EF+ G L +HR ++ L + ++A A ++
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWV-------VKVCDFGLSRMKHNTFLSSRSTAGTAE 918
YL + +VH ++ + N+L+ + + +K+ D G+ T LS +
Sbjct: 120 YLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVLSRQECVERIP 173
Query: 919 WMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQ---VVGAVGF--QHRRL 972
W+APE + + + D +SFG LWE+C + G P++ + F L
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAEKERFYEGQCML 228
Query: 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
P + +AD++ C DP RP F IM
Sbjct: 229 VTPSCKE--LADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 19/196 (9%)
Query: 761 IGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEE--FRSEVLIMKRVRHPNVVLFM 816
IG G+ G V G VA+K+ L + F + + +R E+++MK V H N++ +
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKK-LSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLL 81
Query: 817 GAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
T +L +V E + +L +++ LD R + G+ +LH+
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSA 137
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 138 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGY 194
Query: 931 DEKCDVYSFGVILWEL 946
E D++S G I+ E+
Sbjct: 195 KENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 73/254 (28%), Positives = 108/254 (42%), Gaps = 29/254 (11%)
Query: 776 GTEVAVKRFLDQDFFGESL-EEFRSEVLIMKRVRHPNVV-LFMGAVTRPPNLSIVAEFLP 833
G EVA+K E FR E + R+ HPN+V L P L V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV-- 891
+L +L + L R+ L + HN IVHRDLK N++V + V
Sbjct: 63 GRTLREVL-AADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRP 119
Query: 892 -VKVCDFGLSRMKHNTFLSSRSTA-------GTAEWMAPEVLRNEPSDEKCDVYSFGVIL 943
KV DFG+ + + +T GT + APE LR EP D+Y++G+I
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 944 WELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA-----DIIRKCWQTDPKMR- 997
E T Q+ G + +++ +Q +L P +A ++RK DP+ R
Sbjct: 180 LECLTGQRVVQGASVAEIL----YQQLSPV-DVSLPPWIAGHPLGQVLRKALNKDPRQRA 234
Query: 998 ---PTFTEIMAALK 1008
P E AL+
Sbjct: 235 ASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 7/193 (3%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+++G G+Y VY+G T+ VA+K + G R EV ++K ++H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ +L++V E+L + L + L N ++ RG+NY H ++H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLH 127
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCD 935
RDLK NLL+++ +K+ DFGL+R K + + T + P++L + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 936 VYSFGVILWELCT 948
++ G I +E+ T
Sbjct: 188 MWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-12
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 9/162 (5%)
Query: 797 FRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRM 856
F E IM P VV A L +V E++P G L L+ N + E+
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY 147
Query: 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAG 915
+ ++ +H+ ++HRD+K N+L+DK+ +K+ DFG +M + + G
Sbjct: 148 TAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 916 TAEWMAPEVLRNEPSD----EKCDVYSFGVILWELCTMQQPW 953
T ++++PEVL+++ D +CD +S GV L+E+ P+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-12
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 44/283 (15%)
Query: 761 IGLGSYGEV--YRGDWHGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMG 817
IG G++GEV + G A+K D E + R+E I+ VV
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
+ NL ++ EFLP G + LL + + +E + +A + ++ +H +HR
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHR 125
Query: 878 DLKSPNLLVDKNWVVKVCDFGL------------------------------SRMKHNTF 907
D+K NLL+D VK+ DFGL S+ K T+
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185
Query: 908 LSSR-----STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV 962
+R ST GT +++APEV ++ CD +S GVI++E+ P+ P +
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 963 GAVGFQHRRLDIPDNL---DPAVADIIRKCWQTDPKMRPTFTE 1002
V L P + + A I+R C + + ++ E
Sbjct: 246 KKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE 288
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 761 IGLGSYGEV--YRGDWHGTEVAVKRFLDQDFFGESLEEF-RSEVLIMKRVRHPNVVLFMG 817
IG G++GEV R A+K + S F E IM P VV
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDER------RRLRMALDAARGMNYLHNCT 871
A L +V E++P G L L+ N + E+ + +ALDA M +
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIHSMGF----- 163
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
+HRD+K N+L+DK+ +K+ DFG +M + + GT ++++PEVL+++
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 931 D----EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979
D +CD +S GV L+E+ P+ + + + L PD+ D
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 52/202 (25%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 761 IGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSE-VLIMKRV-----RHPNVV 813
+G GS+G+V + GT E+ + L +D +++ E ++ KRV + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVV---IQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L V E++ G L + + + E + A + A G+ +LH +
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH--SKG 121
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
I++RDLK N+++D +K+ DFG+ + +++++ GT +++APE++ +P +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 934 CDVYSFGVILWELCTMQQPWGG 955
D ++FGV+L+E+ Q P+ G
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-12
Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 54/286 (18%)
Query: 761 IGLGSYGEVYRGDWHGTEV--AVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNVVLFMG 817
IG+G++GEV T A+K D + ++E I+ + VV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
+ NL V +++P G + LL R ++ R +A + + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMG--FIHR 125
Query: 878 DLKSPNLLVDKNWVVKVCDFGLS------------------------------------- 900
D+K N+L+D++ +K+ DFGL
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 901 ------RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWG 954
R + + + S GT ++APEVL + CD +S GVIL+E+ Q P+
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
Query: 955 GMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRK-CWQTDPKMR 997
P + V L IP L +D+I + C + R
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC--CGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-12
Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 41/238 (17%)
Query: 761 IGLGSYGEV--YRGDWHGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMG 817
IG G++GEV + G A+K D E + R+E I+ VV
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
+ NL ++ EFLP G + LL + + +E + +A + ++ +H +HR
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHR 125
Query: 878 DLKSPNLLVDKNWVVKVCDFGL------------------------------SRMKHNTF 907
D+K NLL+D VK+ DFGL S+ K T+
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185
Query: 908 LSSR-----STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ 960
+R ST GT +++APEV ++ CD +S GVI++E+ P+ P +
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 18/250 (7%)
Query: 761 IGLGSYGEVYRGDWHGTEVA-----VKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVL 814
IG GSY +V + T +K+ L D E ++ ++E + + HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--DEDIDWVQTEKHVFETASNHPFLVG 60
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
L V EF+ G L + R +E R A + + +N+LH I
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERG--I 117
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
++RDLK N+L+D +K+ D+G+ + ++ + GT ++APE+LR E
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 935 DVYSFGVILWELCTMQQPWG--GM--NPMQVVGAVGFQ---HRRLDIPDNLDPAVADIIR 987
D ++ GV+++E+ + P+ GM NP Q FQ +++ IP +L + +++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 988 KCWQTDPKMR 997
DPK R
Sbjct: 238 GFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 52/211 (24%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E+IG G+YG VY R G VA+K+ LD + G R E+ ++K + HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKL 64
Query: 816 MGAVTRPPNLSIVAEFLP--------------------RGSLYRLLHRPNNQLDERRRLR 855
+ + L +V EFL + L++LL
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ------------- 111
Query: 856 MALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG 915
G+ + H + ++HRDLK NLL++ +K+ DFGL+R +
Sbjct: 112 -------GLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWEL 946
T + APE+L C YS V +W L
Sbjct: 163 TLWYRAPEILLG------CKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 22/254 (8%)
Query: 761 IGLGSYGEVYRGDWHGT-------EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+G G +GEV T ++ KR + + ++ E R I+ +V +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR----ILAKVHSRFIV 56
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSL-YRL--LHRPNNQLDERRRLRMALDAARGMNYLHNC 870
A +L +V + G L Y + + N E R G+ +LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
I++RDLK N+L+D + V++ D GL+ + ++ AGT +MAPE+L+ E
Sbjct: 117 R--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD----IPDNLDPAVADII 986
D D ++ GV L+E+ + P+ + V + R L+ PD PA
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARG--EKVENKELKQRILNDSVTYPDKFSPASKSFC 232
Query: 987 RKCWQTDPKMRPTF 1000
DP+ R F
Sbjct: 233 EALLAKDPEKRLGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 46/153 (30%), Positives = 80/153 (52%), Gaps = 4/153 (2%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
E+ ++ P +V F GA +SI E + GSL ++L + ++ E ++++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIA 111
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
RG+ YL I+HRD+K N+LV+ +K+CDFG+S ++ + S GT +
Sbjct: 112 VLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSY 168
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQP 952
M+PE L+ + D++S G+ L EL + P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 761 IGLGSYGEVYRGDW------HGTEVAVKRFLD--QDFFGESLEEFRSEVLIMKRVRHPNV 812
IG G++G V W G VA+K+ + Q+ FR E+ ++ +H NV
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLVS-CKRVFR-ELKMLCFFKHDNV 61
Query: 813 VLFMGA--VTRPPNLSIVAEF-----LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMN 865
+ A + +PP++ E L + L++++ P + ++ RG+
Sbjct: 62 ---LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLK 117
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE-----WM 920
YLH + I+HRD+K NLLV+ N V+K+CDFGL+R++ S T E +
Sbjct: 118 YLH--SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE----PDESKHMTQEVVTQYYR 171
Query: 921 APEVLRNEPS-DEKCDVYSFGVILWEL 946
APE+L D++S G I EL
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 761 IGLGSYGEVYRG---DWHGTEVAVKRFLDQ-DFFGESLEEFRSEVLIMKRVR---HPNVV 813
IG G+YG+V++ G VA+KR Q G L R EV +++ + HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 814 LFMGAVT-----RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
T R L++V E + + L P + M RG+++LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
+ +VHRDLK N+LV + +K+ DFGL+R+ + S T + APEVL
Sbjct: 128 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQS 184
Query: 929 PSDEKCDVYSFGVILWEL 946
D++S G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 761 IGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSE-VLIMKRV-----RHPNVV 813
+G GS+G+V + GT EV + L +D L++ + + KR+ +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI---LQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L V E++ G L + R + + DE R A + + +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLH--RHG 116
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
+++RDLK N+L+D K+ DFG+ + +++ + GT +++APE+L+
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176
Query: 934 CDVYSFGVILWELCTMQQPWGGMN 957
D ++ GV+++E+ Q P+ N
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 735 DSSKSDVGDDVAECEIPWEEITLGERIGL--GSYGEVYRGDWHGTEVAVKRFL----DQD 788
D S S++ + CEI +++ L G +G+V T+ K F+
Sbjct: 3 DKSLSELVQFLKNCEIV-------KKLKLIDGKFGKVSVLKHKPTQ---KLFVQKIIKAK 52
Query: 789 FFGESLEEFRSEV-LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ 847
F +E V +MK +PN + +VT ++ +++ G L+ LL + +
Sbjct: 53 NFNA-IEPM---VHQLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGK 105
Query: 848 LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKHNT 906
L E ++ +N LH I+H D+K N+L D + +CD+GL ++
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-- 161
Query: 907 FLSSRSTA-GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQP 952
+ S GT ++ +PE ++ D D ++ GV+ +EL T + P
Sbjct: 162 ---TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/249 (24%), Positives = 112/249 (44%), Gaps = 18/249 (7%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVV 813
IG GSY +V + +V K + D E ++ ++E + ++ +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD---EDIDWVQTEKHVFEQASSNPFLV 59
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L +V E++ G L + R +E R A + +N+LH
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE--RG 116
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
I++RDLK N+L+D + +K+ D+G+ + ++ + GT ++APE+LR E
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 934 CDVYSFGVILWELCTMQQPWGGM--NPMQVVGAVGFQ---HRRLDIPDNLDPAVADIIRK 988
D ++ GV+++E+ + P+ + NP FQ + + IP L + +++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236
Query: 989 CWQTDPKMR 997
DPK R
Sbjct: 237 FLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 51/202 (25%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 761 IGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSE-VLIMKRV-----RHPNVV 813
+G GS+G+V + GT E+ + L +D +++ E ++ KRV + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVV---IQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L V E++ G L + + + E + + A + + G+ +LH
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHR--RG 121
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
I++RDLK N+++D +K+ DFG+ + +++R+ GT +++APE++ +P +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 934 CDVYSFGVILWELCTMQQPWGG 955
D +++GV+L+E+ Q P+ G
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 759 ERIGLGSYGEVYRG-DWHGTE-VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E+IG G+YG VY+ D E +A+K+ L+Q+ G R E+ ++K ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRL 66
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
V L +V E+L + P+ + R RG+ Y H + ++
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVL 124
Query: 876 HRDLKSPNLLVDK-NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEK 933
HRDLK NLL+D+ +K+ DFGL+R + T + APE+L
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184
Query: 934 CDVYSFGVILWELCTMQQP 952
D++S G I E+ Q+P
Sbjct: 185 VDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 7/193 (3%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+++G G+Y V++G TE VA+K + G R EV ++K ++H N+V
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L++V E+L L + L N + RG++Y H I+H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILH 126
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCD 935
RDLK NLL+++ +K+ DFGL+R K + + T + P+VL D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 936 VYSFGVILWELCT 948
++ G IL+E+ T
Sbjct: 187 MWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-11
Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 697 DADSAGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEI---PWE 753
D D YE ++ + N + +RS +N++ + + + + + +I P +
Sbjct: 7 DEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNK 66
Query: 754 EITLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRS-EVLIMKRVRHP 810
LG IG GS+G VY T +VA+K+ L QD ++++ E+LIMK + H
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QD------PQYKNRELLIMKNLNHI 119
Query: 811 NVVL-----FMGAVTRPPN---LSIVAEFLPRGSLYRLLH--RPNNQLDERRRLRMALDA 860
N++ + + L++V EF+P+ + H R N+ L +
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLSSRSTAGTAE- 918
R + Y+H + I HRDLK NLL+D N +K+CDFG ++ N RS +
Sbjct: 180 CRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQRSVSYICSR 234
Query: 919 -WMAPEVLRNEPS-DEKCDVYSFGVILWEL 946
+ APE++ + D++S G I+ E+
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E++G G+Y VY+G T VA+K LD + G R E+ +MK ++H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIR-EISLMKELKHENIVRL 63
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA----------RGMN 865
+ L +V E++ L + + + +R ALD +G+
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYM--------DTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR---MKHNTFLSSRSTAGTAEWMAP 922
+ H ++HRDLK NLL++K +K+ DFGL+R + NTF + T + AP
Sbjct: 115 FCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLWYRAP 169
Query: 923 EVLRNEPS-DEKCDVYSFGVILWELCT 948
+VL + D++S G I+ E+ T
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 761 IGLGSYGEVYRG-DWH-GTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMG 817
IG G+YG+VY+ D G VA+K+ LD + G + R E+ I++++ H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNLKE 73
Query: 818 AVT----------RPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGM 864
VT +V E++ L LL E + ++ L+ G+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLE---GL 129
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG---TAEWMA 921
NY H +HRD+K N+L++ +K+ DFGL+R+ ++ SR T +
Sbjct: 130 NYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE--ESRPYTNKVITLWYRP 185
Query: 922 PEVLRNE----PSDEKCDVYSFGVILWELCT 948
PE+L E P+ DV+S G IL EL T
Sbjct: 186 PELLLGEERYGPA---IDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 761 IGLGSYGEVYRG-DWH-GTEVAVKRFLDQ-DFFGESLEEFRSEVLIMKRVR---HPNVVL 814
IG+G+YG VY+ D H G VA+K Q + G L R EV ++KR+ HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIVR 66
Query: 815 FMGAVT-----RPPNLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNY 866
M R +++V E + + L L + P + + L RG+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDF 123
Query: 867 LH-NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
LH NC IVHRDLK N+LV VK+ DFGL+R+ ++ ++ T + APEVL
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRAPEVL 179
Query: 926 RNEPSDEKCDVYSFGVILWEL 946
D++S G I E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 791 GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLD 849
GE + E+L ++V P +V A +L +V + G L Y + + L+
Sbjct: 36 GEKMALLEKEIL--EKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE 93
Query: 850 ERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFL 908
R + + G+ +LH+ IV+RD+K N+L+D ++ D GL+ +K +
Sbjct: 94 MERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI 151
Query: 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG---------MNPM 959
+ R AGT +MAPE+L+ EP D ++ G ++E+ + P+ +
Sbjct: 152 TQR--AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209
Query: 960 QVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR 997
+ V F+H N DI R P+ R
Sbjct: 210 TLEDEVKFEH------QNFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 67/279 (24%), Positives = 124/279 (44%), Gaps = 51/279 (18%)
Query: 759 ERIGLGSYGEVYRGDWH----GTEVAVKRFL------DQDFFGESLEEFRSEVLIMKRVR 808
+ IG G +G+V + + V VK +Q+ F + + +R ++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI-------LQ 53
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL-----HRPNNQLDERRRLRMALDAARG 863
HPN++ +G +V E+ G L L HR N+QL +R MA + A G
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAG 111
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL--SRMKHNTFLSSRSTAGTAEWMA 921
+ ++H +H DL N + + VKV D+G+ SR K + + W+A
Sbjct: 112 VTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169
Query: 922 PEVL-----------RNEPSDEKCDVYSFGVILWELC-TMQQPWGGMNPMQVVGAVGFQH 969
PE++ + +PS+ V++ GV LWEL QP+ ++ +V+ V +
Sbjct: 170 PELVGEFHGGLITAEQTKPSN----VWALGVTLWELFENAAQPYSHLSDREVLNHV-IKD 224
Query: 970 RRLDIPD-NLDPAVAD----IIRKCWQTDPKMRPTFTEI 1003
+++ + L+ ++ +++ CW + P+ R T E+
Sbjct: 225 QQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 4/153 (2%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
E+ ++ P +V F GA +SI E + GSL ++L + ++ E+ ++++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIA 111
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
+G+ YL I+HRD+K N+LV+ +K+CDFG+S ++ + S GT +
Sbjct: 112 VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSY 168
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQP 952
M+PE L+ + D++S G+ L E+ + P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
E++G G+Y V++G TE VA+K + G R EV ++K ++H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
V +L++V E+L + L + + N + RG+ Y H ++H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLH 127
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCD 935
RDLK NLL+++ +K+ DFGL+R K + + T + P+VL + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 936 VYSFGVILWELCT 948
++ G I +E+ +
Sbjct: 188 MWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 63/245 (25%), Positives = 111/245 (45%), Gaps = 17/245 (6%)
Query: 761 IGLGSYGEVY------RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVV 813
+G GS+G+V G + +V K + QD + +E +E I+ R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPFLT 59
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLHNCTP 872
P L V EF+ G L + H + + + DE R A + + +LH+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHD--K 115
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932
I++RDLK N+L+D K+ DFG+ + ++ + GT +++APE+L+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
D ++ GV+L+E+ P+ N + A+ + + P L DI++
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWLSQDAVDILKAFMTK 233
Query: 993 DPKMR 997
+P MR
Sbjct: 234 NPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 52/240 (21%)
Query: 798 RSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRM 856
+E I+ + HP + + L +V ++ P G L+RLL R P L E
Sbjct: 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE------ 102
Query: 857 ALDAAR--------GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-------- 900
+ AR + YLH IV+RDLK N+L+ ++ + + DF LS
Sbjct: 103 --EVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158
Query: 901 -----------RMKHNTFLS----------SRSTAGTAEWMAPEVLRNEPSDEKCDVYSF 939
R N+ S S S GT E++APEV+ + D ++
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218
Query: 940 GVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNL-DPAVA-DIIRKCWQTDPKMR 997
G++L+E+ P+ G N + + + + P + + A D+IRK DP R
Sbjct: 219 GILLYEMLYGTTPFKGSNRDETFSNI--LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 22/199 (11%)
Query: 761 IGLGSYGEV--YRGDWHGTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVLFM 816
IG G+YG V + +VA+K+ + F ++ R+ E+ +++ + H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDHENVIA-I 69
Query: 817 GAVTRPPN------LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
+ PP+ + IV E L L++++ R + L + RG+ Y+H+
Sbjct: 70 KDIMPPPHREAFNDVYIVYE-LMDTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
++HRDLK NLL++ N +K+CDFGL+R T + APE+L N
Sbjct: 128 N--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN--C 183
Query: 931 DE---KCDVYSFGVILWEL 946
E DV+S G I EL
Sbjct: 184 SEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-10
Identities = 36/133 (27%), Positives = 72/133 (54%), Gaps = 3/133 (2%)
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSD 931
++HRDLKS N+ + ++K+ DFG S+ ++ + S GT ++APE+ +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991
+K D++S GVIL+EL T+ +P+ G + +++ V + P + + ++
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLS 308
Query: 992 TDPKMRPTFTEIM 1004
+P +RPT +++
Sbjct: 309 KNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 761 IGLGSYGEV----YRGDWHGTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVR-HPNVV 813
+G G+YG V VA+K+ + F + + R+ E+ +++ R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI--TNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 814 -LFMGAVTRPPNLSIVA--EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
L+ + P N + + E L L++++ R L + G+ Y+H+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR------MKHNTFLSSRSTAGTAEWMAPEV 924
++HRDLK NLLV+ + +K+CDFGL+R ++ F++ T + APE+
Sbjct: 125 N--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA--TRWYRAPEI 180
Query: 925 -LRNEPSDEKCDVYSFGVILWEL 946
L + + DV+S G IL EL
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 51/178 (28%), Positives = 89/178 (50%), Gaps = 15/178 (8%)
Query: 776 GTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS------IV 828
G VAVK+ L + F ++ + E++++K V H N++ + T +L +V
Sbjct: 46 GINVAVKK-LSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888
E + +L +++H +LD R + G+ +LH+ I+HRDLK N++V
Sbjct: 105 MELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS 158
Query: 889 NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWEL 946
+ +K+ DFGL+R F+ + T + APEV+ E D++S G I+ EL
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 799 SEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLDERRRLRMA 857
+E I+++V VV A L +V + G L + + + N DE R + A
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGT 916
+ G+ LH IV+RDLK N+L+D +++ D GL+ + + R GT
Sbjct: 109 AEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR--VGT 164
Query: 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW 953
+MAPEV++NE D + G +++E+ + P+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 67/286 (23%)
Query: 761 IGLGSYGEV---YRGDWHGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFM 816
IG G++GEV + D G A+K L + F + L ++E ++ P VV
Sbjct: 9 IGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMA-----LDAARGMNYLHNCT 871
+ L ++ EFLP G L +L + + ++ R MA ++A + +
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF----- 122
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLS------------------------------- 900
+HRD+K N+L+D+ +K+ DFGLS
Sbjct: 123 ---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 901 -----------RMKHNTFLSSR-----STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILW 944
+ + T+ +R ST GT +++APE+ + ++CD +S G I++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 945 ELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN--LDPAVADIIRK 988
E P+ N + + L PD+ L D+IR+
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 33/208 (15%)
Query: 759 ERIGLGSYGEV--YRGDWHGTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVL 814
E IG G+YG V G +VA+K+ F R+ E+ I++ +H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA--FDVPTLAKRTLRELKILRHFKHDNIIA 68
Query: 815 FMGAVTRPPNLSIVAEF--------LPRGSLYRLLHRPNNQLDERRRLRMAL-DAARGMN 865
+ RPP A+F L L+ ++H ++Q +R L RG+
Sbjct: 69 IR-DILRPP----GADFKDVYVVMDLMESDLHHIIH--SDQPLTEEHIRYFLYQLLRGLK 121
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR------MKHNTFLSSRSTAGTAEW 919
Y+H+ ++HRDLK NLLV+++ +++ DFG++R +H F++ T +
Sbjct: 122 YIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRWY 177
Query: 920 MAPEVLRNEPS-DEKCDVYSFGVILWEL 946
APE+L + P D++S G I E+
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 791 GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLD 849
GES+ +E I+++V VV A L +V + G L + + H +
Sbjct: 43 GESMA--LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE 100
Query: 850 ERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFL 908
E R + A + G+ LH IV+RDLK N+L+D + +++ D GL+ + +
Sbjct: 101 EGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158
Query: 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW 953
R GT +MAPEV++NE D ++ G +L+E+ Q P+
Sbjct: 159 KGR--VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 6/166 (3%)
Query: 791 GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLD 849
GES+ +E I+++V VV A L +V + G L + + + N +
Sbjct: 43 GESMA--LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE 100
Query: 850 ERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909
E R L A + G+ LH V+RDLK N+L+D +++ D GL+ +K S
Sbjct: 101 EERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGES 157
Query: 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG 955
R GT +MAPEVL N+ D + G +++E+ Q P+ G
Sbjct: 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMNYLHNCTPVIVHR 877
NL +V ++ G L LL + ++L E + +A+D+ ++Y VHR
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--------VHR 126
Query: 878 DLKSPNLLVDKNWVVKVCDFG--LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE--- 932
D+K N+L+D N +++ DFG L M+ T SS + GT ++++PE+L+ +
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGKGKY 185
Query: 933 --KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP---DNLDPAVADIIR 987
+CD +S GV ++E+ + P+ + ++ G + R P ++ D+IR
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245
Query: 988 K 988
+
Sbjct: 246 R 246
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 7/201 (3%)
Query: 759 ERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
E++G GSY VY+G +G VA+K + G R E ++K ++H N+VL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLH 69
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVH 876
+ L+ V E++ ++ P RL M RG+ Y+H I+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHG--QHILH 126
Query: 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCD 935
RDLK NLL+ +K+ DFGL+R K + S T + P+VL D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 936 VYSFGVILWELCTMQQPWGGM 956
++ G I E+ Q + G+
Sbjct: 187 IWGAGCIFIEMLQGQPAFPGV 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRR 853
E+++MK V H N++ + T +L IV E + +L +++ +LD R
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERM 128
Query: 854 LRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913
+ G+ +LH+ I+HRDLK N++V + +K+ DFGL+R +F+ +
Sbjct: 129 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 914 AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWEL 946
T + APEV+ E D++S G I+ E+
Sbjct: 187 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-10
Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 44/178 (24%)
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH-------------NTFLS 909
+ Y+H + ++HRDLK N+L+ V + D+G + K
Sbjct: 125 TIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 910 SRST-----AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG--------- 955
S T GT ++MAPE L P+ E D+Y+ GVIL+++ T+ P+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 956 ---MNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR-PTFTEIMAALKP 1009
++P++V +R +IP P ++ I K DP R + E+ L+P
Sbjct: 243 DVILSPIEVA-----PYR--EIP----PFLSQIAMKALAVDPAERYSSVQELKQDLEP 289
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-10
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 25/201 (12%)
Query: 761 IGLGSYGEV-YRGDWH-GTEVAVKR----FLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G G+YG V D G +VA+K+ F + F + E R ++K ++H NV+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMKHENVIG 78
Query: 815 FMGAVTRPPNLSIVAEF---LP-RGS-LYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
+ T +L +F +P G+ L +L+ + +L E R + +G+ Y+H
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWM-APEVLRN- 927
I+HRDLK NL V+++ +K+ DFGL+R + T W APEV+ N
Sbjct: 137 AG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVT----RWYRAPEVILNW 190
Query: 928 EPSDEKCDVYSFGVILWELCT 948
+ D++S G I+ E+ T
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E+IG G+YG+VY R G VA+K+ L+ D G R E+ +++ + ++
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVR 65
Query: 816 MGAVTR------PPNLSIVAEFLPRG------SLYRLLHRPNNQLDERRRLRMALDAARG 863
+ V P+L +V E+L S R RP L + +G
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP---LPAKTIKSFMYQLLKG 122
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922
+ + H ++HRDLK NLLVDK ++K+ D GL R S T + AP
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 923 EVLRNEPS-DEKCDVYSFGVILWELCTMQ 950
EVL D++S G I E+ Q
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+++G GSY VY+G T VA+K + G R E ++K ++H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR-RLRMALDAARGMNYLHNCTPVIV 875
+ L++V E+L L + + L RL + RG+ Y H ++
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFL-FQLLRGLAYCHQ--RRVL 125
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMK 903
HRDLK NLL+ + +K+ DFGL+R K
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 761 IGLGSYGEVYRGDWH----GTEVAVKRF--LDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
IG G+YG VY+ G E A+K+F + + G S R E+ +++ ++H NVV
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVVS 66
Query: 815 FMGAVTRPPNLSI-----VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA-------- 861
+ + S+ AE L++++ R+ R+++ +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH----DLWQIIK------FHRQAKRVSIPPSMVKSLLWQ 116
Query: 862 --RGMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSRMKHN---TFLSSRS 912
G++YLH + ++HRDLK N+LV + VVK+ D GL+R+ +
Sbjct: 117 ILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 913 TAGTAEWMAPEVLRNEPSDEKC-DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR 971
T + APE+L K D+++ G I EL T++ + G ++ + FQ +
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG-REAKIKKSNPFQRDQ 233
Query: 972 LD 973
L+
Sbjct: 234 LE 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR 862
+M +V H ++ G R +V EF+ G L L + ++ ++ +A A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWV-------VKVCDFGLSRMKHNTFLSSRSTAG 915
++YL + +VH ++ + N+L+ + + +K+ D G+S T LS
Sbjct: 129 ALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TALSREERVE 182
Query: 916 TAEWMAPEVLRNEPS-DEKCDVYSFGVILWELC-TMQQPWGGMNPMQVVGAVGFQHRRLD 973
W+APE + S D +SFG L E+C + P P + F ++
Sbjct: 183 RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KERFYEKKHR 239
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
+P+ +A +I +C +P RP+F I+ L
Sbjct: 240 LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRR 853
E+++MK V H N++ + T +L +V E + +L +++ +LD R
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERM 121
Query: 854 LRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913
+ G+ +LH+ I+HRDLK N++V + +K+ DFGL+R +F+ +
Sbjct: 122 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179
Query: 914 AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWEL 946
T + APEV+ E D++S G I+ E+
Sbjct: 180 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 68/295 (23%)
Query: 761 IGLGSYGEV---YRGDWHGTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNVVLFM 816
+G+G++GEV + D H A+K +D + + ++E I+ + VV
Sbjct: 9 LGIGAFGEVCLACKVDTHAL-YAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR-----LRMALDAARGMNYLHNCT 871
+ NL V +++P G + LL R + R L +A+++ M +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF----- 122
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLS---RMKHNT---------------------- 906
+HRD+K N+L+D + +K+ DFGL R HN+
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 907 -----------FLSSRST-----------AGTAEWMAPEVLRNEPSDEKCDVYSFGVILW 944
L R+T GT ++APEVL + + CD +S GVIL+
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 945 ELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN--LDPAVADIIRK-CWQTDPKM 996
E+ Q P+ P + V L IP L P D+I K C + ++
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL 294
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 53/265 (20%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFF----GESLEEFRSEVLIMKRVRH---PN 811
IG G +GEVY R G A+K LD+ GE+L +E +++ V P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPF 58
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT 871
+V A P L + + + G L+ L + + E+ A + G+ ++HN
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGL----SRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
+V+RDLK N+L+D++ V++ D GL S+ K ++ GT +MAPEVL+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQK 169
Query: 928 EPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD------------- 973
+ D D +S G +L++L P+ QH+ D
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFR-------------QHKTKDKHEIDRMTLTVNV 216
Query: 974 -IPDNLDPAVADIIRKCWQTDPKMR 997
+PD+ P + ++ Q D R
Sbjct: 217 ELPDSFSPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFF----GESLEEFRSEVLIMKRVRH---PN 811
IG G +GEVY R G A+K LD+ GE+L +E +++ V P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPF 58
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT 871
+V A P LS + + + G L+ L + + E A + G+ ++HN
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN-- 115
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGL----SRMKHNTFLSSRSTAGTAEWMAPEVL-R 926
+V+RDLK N+L+D++ V++ D GL S+ K ++ GT +MAPEVL +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQK 169
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPW 953
D D +S G +L++L P+
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 65/285 (22%)
Query: 761 IGLGSYGEV--YRGDWHGTEVAVKRFLDQD-FFGESLEEFRSEVLIMKRVRHPNVVLFMG 817
+G+G++GEV R A+K +D + ++E I+ + VV
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR-----LRMALDAARGMNYLHNCTP 872
+ NL V +++P G + LL R ++ R L A+++ M +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF------ 122
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGL--------------------------------- 899
+HRD+K N+L+D++ +K+ DFGL
Sbjct: 123 --IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 900 ------SRMKHNTFLSSR--------STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWE 945
R+K ++R S GT ++APEVL + CD +S GVIL+E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 946 LCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRK 988
+ Q P+ P++ V L IP L P +D+I K
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK 285
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 776 GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835
GT V V+ ++ E L+ ++EV++ RHPN++ T L +++ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 836 SLYRLL--HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVK 893
S LL + P + E + A RG+NYLH +HR++K+ ++L+ + +V
Sbjct: 85 SANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVS 141
Query: 894 VCDFGLSRM--------KHNTF--LSSRSTAGTAEWMAPEVLRNEPS--DEKCDVYSFGV 941
+ GLS + K ST+ W++PE+LR + + K D+YS G+
Sbjct: 142 LS--GLSHLYSLVRNGQKAKVVYDFPQFSTS-VLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 942 ILWELCTMQQPWGGMNPMQVV 962
EL T + P+ M Q++
Sbjct: 199 TACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 27/164 (16%)
Query: 799 SEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR--GSLYRLLHRPNNQLDERRR--- 853
+E I++ + HP+++ G T LPR LY L +R
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYN---KFTCLILPRYKTDLY-------CYLAAKRNIAI 181
Query: 854 ---LRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS----RMKHNT 906
L + R + YLH I+HRD+K+ N+ ++ V + DFG + + N
Sbjct: 182 CDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ 950
+ AGT APE+L +P D++S G++L+E+ T
Sbjct: 240 YYG---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-09
Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 38/274 (13%)
Query: 764 GSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821
G G Y+G +G + VK D + S+ SE+ M +++HPN+V +G
Sbjct: 701 GKKGASYKGKSIKNGMQFVVKEINDVN----SIPS--SEIADMGKLQHPNIVKLIGLCRS 754
Query: 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH-NCTPVIVHRDLK 880
++ E++ +L +L L RR ++A+ A+ + +LH C+P +V +L
Sbjct: 755 EKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 881 SPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFG 940
+++D + L + S+A ++APE + EK D+Y FG
Sbjct: 811 PEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFG 865
Query: 941 VILWELCTMQQP----WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA------------- 983
+IL EL T + P +G + + LD+ +DP++
Sbjct: 866 LILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW--IDPSIRGDVSVNQNEIVEV 923
Query: 984 -DIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016
++ C TDP RP +++ L+ + +S
Sbjct: 924 MNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEE--FRSEVLIM 804
E+P +L +++G G+YG V G +VA+K+ L + F E + +R E+ ++
Sbjct: 12 ELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKK-LSRPFQSEIFAKRAYR-ELTLL 68
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEF---LP--RGSLYRLLHRPNNQLDERRRLRMALD 859
K ++H NV+ + T + +F +P + L +++ P L E + +
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQ 125
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
G+ Y+H+ I+HRDLK NL V+++ +K+ DFGL+R T W
Sbjct: 126 MLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT----RW 179
Query: 920 M-APEVLRN-EPSDEKCDVYSFGVILWELCT 948
APEV+ N ++ D++S G I+ E+ T
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 9e-09
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 47/211 (22%)
Query: 759 ERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEE---FRSEVLIMKRVR-HPNV 812
+++G G+YG V++ VA+K+ D F + + FR E++ ++ + HPN+
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFR-EIMFLQELGDHPNI 69
Query: 813 VLFMGAVTRPPN---LSIVAEFLPRGSLYRLLH---RPNNQLDERRRLRM--ALDAARGM 864
V + V + N + +V E++ LH R N D +R M L A +
Sbjct: 70 VKLL-NVIKAENDKDIYLVFEYMETD-----LHAVIRANILEDVHKRYIMYQLLKA---L 120
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA------- 917
Y+H + ++HRDLK N+L++ + VK+ DFGL+R +
Sbjct: 121 KYIH--SGNVIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTDYVA 174
Query: 918 -EWM-APEVLRNEPSDEKCDVYSFGVILWEL 946
W APE+L Y+ GV +W +
Sbjct: 175 TRWYRAPEILLGSTR------YTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 1e-08
Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 54/241 (22%)
Query: 759 ERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRS-----------EVLIMKRV 807
++IG G +GEV+ VK Q+FF +R EV +M+ +
Sbjct: 19 KKIGNGRFGEVF---------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69
Query: 808 RHPNVVLFMGAVTRPPN--LSIVAEFLPRGSLYRLL---HRPNNQLDERRRLRMALDAAR 862
+H N+V ++ N L I+ EF G L R + ++ +++E + +
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 863 GMNYLHNCT-----PVIVHRDLKSPNLLVDKNW-----------------VVKVCDFGLS 900
+ Y HN ++HRDLK N+ + + K+ DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 901 RMKHNTFLSS--RSTAGTAEWMAPEVLRNEPS--DEKCDVYSFGVILWELCTMQQPWGGM 956
+ N + S S GT + +PE+L +E D+K D+++ G I++ELC+ + P+
Sbjct: 190 K---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
Query: 957 N 957
N
Sbjct: 247 N 247
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 45/181 (24%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMNYLHNCTPVIVHR 877
NL +V ++ G L LL + ++L E + +A+D+ + Y VHR
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--------VHR 126
Query: 878 DLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE---- 932
D+K N+L+DKN +++ DFG R+ + + S GT ++++PE+L+ +
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186
Query: 933 -KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA----DIIR 987
+CD +S GV ++E+ + P+ + ++ G + P + V+ D+IR
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD-VTDVSEEAKDLIR 245
Query: 988 K 988
+
Sbjct: 246 R 246
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 48/203 (23%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 779 VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV-----LFMGAVTRPPNLSIVAEF-- 831
VAVK+ + D +S++ E+ I++R+ H N+V L ++ + E
Sbjct: 33 VAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90
Query: 832 ------LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLL 885
L +L + L E RG+ Y+H+ ++HRDLK N+
Sbjct: 91 VYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVF 146
Query: 886 VD-KNWVVKVCDFGLSRM-----KHNTFLSSRSTAGTAEWMAPEVLRNEPSD--EKCDVY 937
++ ++ V+K+ DFGL+R+ H +LS T + +P +L + P++ + D++
Sbjct: 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKWYRSPRLLLS-PNNYTKAIDMW 203
Query: 938 SFGVILWELCTMQQPWGGMNPMQ 960
+ G I E+ T + + G + ++
Sbjct: 204 AAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 6/164 (3%)
Query: 791 GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLD 849
GE++ +E I+++V VV A L +V + G L + + + N D
Sbjct: 43 GEAMA--LNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD 100
Query: 850 ERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909
E+R + A + G+ L IV+RDLK N+L+D +++ D GL+ ++ +
Sbjct: 101 EQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGET 157
Query: 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW 953
R GT +MAPEV+ NE D + G +++E+ Q P+
Sbjct: 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 41/167 (24%), Positives = 80/167 (47%), Gaps = 22/167 (13%)
Query: 825 LSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMNYLHNCTPVIVHRD 878
L +V ++ G L LL + ++L E + +A+ + ++Y VHRD
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--------VHRD 127
Query: 879 LKSPNLLVDKNWVVKVCDFG--LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-----D 931
+K N+L+D N +++ DFG L + T SS + GT ++++PE+L+
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYG 186
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978
+CD +S GV ++E+ + P+ + ++ G + R P ++
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 27/202 (13%)
Query: 761 IGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFG--ESLEEFRSEVLIMKRVRHPNVVLFM 816
+G G+YG V G VAVK+ L + F + +R E+ ++K ++H NV+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD---------AARGMNYL 867
T +L EF +Y + H L+ + + D RG+ Y+
Sbjct: 83 DVFTPARSLE---EF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 136
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
H+ I+HRDLK NL V+++ +K+ DFGL+R +T T + APE++ N
Sbjct: 137 HSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLN 191
Query: 928 -EPSDEKCDVYSFGVILWELCT 948
++ D++S G I+ EL T
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 23/198 (11%)
Query: 761 IGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRS---EVLIMKRVRHPNVVLF 815
+G G+YG V +VAVK+ L + F +SL R E+ ++K ++H NV+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKK-LSRPF--QSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLR------MALDAARGMNYLHN 869
+ T P SI F + L+ N + + ++L + RG+ Y+H+
Sbjct: 80 LDVFT--PATSI-ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN-E 928
I+HRDLK N+ V+++ +++ DFGL+R + T + APE++ N
Sbjct: 137 AG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM---TGYVATRWYRAPEIMLNWM 191
Query: 929 PSDEKCDVYSFGVILWEL 946
++ D++S G I+ EL
Sbjct: 192 HYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 6/156 (3%)
Query: 753 EEITLGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESL-EEFRSEVLIMKRVRH 809
EE + + I G++G+VY R + AVK D +++ + ++E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P +V ++ N+ +V E+L G + LLH DE ++ + A ++YLH
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR 122
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905
I+HRDLK N+L+ +K+ DFGLS++ N
Sbjct: 123 HG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 20/200 (10%)
Query: 776 GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835
G V V+R + E + + E+ + K HPN+V + L +V F+ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 836 SLYRLLHRPNNQLDERRRLRMA---LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVV 892
S L+ + +D L +A + ++Y+H+ VHR +K+ ++L+ +
Sbjct: 85 SAKDLI--CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDG-- 138
Query: 893 KVCDFGL----SRMKHNTFLS-----SRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGV 941
KV GL S + H L + + W++PEVL+ + D K D+YS G+
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198
Query: 942 ILWELCTMQQPWGGMNPMQV 961
EL P+ M Q+
Sbjct: 199 TACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 58/285 (20%)
Query: 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQ-DFFGESLEEFRSEVLIMKRVRHPNVV--- 813
G ++G G+YG VY+ + L Q + G S+ R E+ +++ ++HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQ 64
Query: 814 -LFMGAVTRP---------PNLSIVAEF------------LPRGSLYRLLHRPNNQLDER 851
+F+ R +L + +F LPRG + LL++
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 116
Query: 852 RRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSRMKHNTF 907
LD G++YLH ++HRDLK N+LV + VK+ D G +R+ ++
Sbjct: 117 -----ILD---GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 908 --LSSRSTAGTAEWM-APEVLRNEPSDEKC-DVYSFGVILWELCTMQQPWGGMNPMQVVG 963
L+ W APE+L K D+++ G I EL T +P +
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKT 225
Query: 964 AVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
+ + H +LD N+ AD K W+ D K P + +M +
Sbjct: 226 SNPYHHDQLDRIFNVMGFPAD---KDWE-DIKKMPEHSTLMKDFR 266
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 22/234 (9%)
Query: 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQ-DFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
G ++G G+YG VY+ + + L Q + G S+ R E+ +++ ++HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQ 64
Query: 817 GAVTRPPNLSIVAEF-LPRGSLYRLL--HRPNN------QLDERRRLRMALDAARGMNYL 867
+ + F L+ ++ HR + QL + G++YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 868 HNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWM- 920
H ++HRDLK N+LV + VK+ D G +R+ ++ L+ W
Sbjct: 125 H--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 921 APEVLRNEPSDEKC-DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD 973
APE+L K D+++ G I EL T +P + + F H +LD
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPFHHDQLD 235
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 35/118 (29%), Positives = 53/118 (44%), Gaps = 14/118 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+P + + LG +G G++G V HG +VAVK L + SE+
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVK-MLKSTARSSEKQALMSEL 91
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-----LDERRR 853
IM + H N+V +GA T+ + I+ E+ G L LHR + LD+ R
Sbjct: 92 KIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRD 149
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 17/154 (11%)
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP--RGSLYRLLHRPNNQLDERRRLRMA 857
E +++R+ HP V+ + R + LP R LY L L + +A
Sbjct: 210 EARLLRRLSHPAVLALLD--VRVVG-GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST---- 913
++Y+H I+HRD+K+ N+LV+ + + DFG + S ST
Sbjct: 267 RQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR----GSWSTPFHY 320
Query: 914 --AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWE 945
AGT + APEVL +P D++S G++++E
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 764 GSYGEVY----RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819
GS GEV+ GD +V VK G++ E+ I+K + H ++ + A
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTG----GKTPG---REIDILKTISHRAIINLIHAY 155
Query: 820 TRPPNLSIVAEFLP--RGSLYRLLHR----PNNQLDE-RRRLRMALDAARGMNYLHNCTP 872
S V +P + L+ + R P Q +RRL AL YLH
Sbjct: 156 R---WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEAL------AYLHG--R 204
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLS--RMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
I+HRD+K+ N+ +D+ + DFG + H +GT E +PE+L +P
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264
Query: 931 DEKCDVYSFGVILWEL 946
K D++S G++L+E+
Sbjct: 265 CAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 33/124 (26%), Positives = 53/124 (42%), Gaps = 9/124 (7%)
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
IV RDL N+L+D +++ F + S A + APEV E
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---SCDGEAVENMYCAPEVGGISEETEA 162
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
CD +S G IL+EL T G ++ + H L+IP+ + ++++ Q +
Sbjct: 163 CDWWSLGAILFELLT------GKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFN 216
Query: 994 PKMR 997
P R
Sbjct: 217 PTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 26/156 (16%)
Query: 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDF----FGESLEEFR--SEVLIMKRVRHPN 811
+ I G+ E+Y GD+ G + +K + + + E + R E IM R R
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60
Query: 812 V----VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
V V F+ P N IV E++ L L++ + E ++ + R + L
Sbjct: 61 VNVPAVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELE-----LSREIGRLVGKL 111
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVC--DFGLSR 901
H+ I+H DL + N+++ K+ DFGL+
Sbjct: 112 HSAG--IIHGDLTTSNMILSGG---KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 20/66 (30%), Positives = 24/66 (36%), Gaps = 2/66 (3%)
Query: 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC-D 896
LD L L AA + L V+VH DL NLLVD V D
Sbjct: 132 ALRRLVAAELLDRLAELWERLLAAL-LALLPALPLVLVHGDLHPGNLLVDPGGRVTGVID 190
Query: 897 FGLSRM 902
F + +
Sbjct: 191 FEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.004
Identities = 34/147 (23%), Positives = 51/147 (34%), Gaps = 22/147 (14%)
Query: 572 PSPARFLPPLPRPRAPSKATSFDQPEEDLGLSRQSDVMAAAGQPLSPQSEATPIKYRKDV 631
A +P P RA + + P + V AAG L+P++ A R +
Sbjct: 374 ARVAGAVPA-PGARAAAAVGASAVPA-------VTAVTGAAGAALAPKAAAAAAATRAEA 425
Query: 632 PVAAAAAAAAAAVVASSMVV-----------AVAKSNTDSNLELPVAAAATATAAAMVAT 680
P AA A A A + A A S D P A + +A+A A A
Sbjct: 426 PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAP 485
Query: 681 TAAVGKQYELSIRSDGDADSAGYEPRD 707
A +E + R+ + + D
Sbjct: 486 PDA---AFEPAPRAAAPSAATPAAVPD 509
|
Length = 830 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1044 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 98.21 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 98.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.74 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.6 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.52 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.36 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.26 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.11 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.51 | |
| PF04473 | 153 | DUF553: Transglutaminase-like domain; InterPro: IP | 96.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.43 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.34 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.27 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.17 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.15 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.99 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.9 | |
| COG1305 | 319 | Transglutaminase-like enzymes, putative cysteine p | 95.74 | |
| PLN02236 | 344 | choline kinase | 95.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.09 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.93 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.84 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.83 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.32 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-62 Score=512.25 Aligned_cols=199 Identities=55% Similarity=0.843 Sum_probs=186.4
Q ss_pred CccchheeeeccccCccCCCcCCCceeeccCCCC----ccccCCCCCcccccCCCCCCCceeeEEEEecccChhHHHHHH
Q 045028 152 TPAEVVAYRYWNYNSLSYDDKIMDGFYDLYGIPS----ESTSDRMPSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQ 227 (1044)
Q Consensus 152 ~~~~~~~~~~w~~~~lsy~d~i~dGFY~i~g~~~----~~~~~~~psl~~L~~~~~~~~~~~EvilVdr~~D~~L~~l~~ 227 (1044)
+++|++|||||++|+|+|+||||||||||||++. ..+.+|||||++|++++ .+.+++|||||||.+|++|++|++
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~-~~~~~~EvIlVDr~~D~~L~~L~~ 79 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVP-PDDSSREVILVDRRRDPSLKELEQ 79 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCC-CCCCCeeEEEEccccCHHHHHHHH
Confidence 5799999999999999999999999999999974 35779999999999999 777899999999999999999999
Q ss_pred HHHHHHhhccCcccccchHHHHHHHHHHHHHhcCCCCCCcchhhhhHHHHHHHHHHhhCCceeecccccceecchhHHHH
Q 045028 228 KVLEVAVKSRSHSQAFVGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIGLARHRALLF 307 (1044)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~v~~la~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~~~v~plG~l~~g~c~~~Allf 307 (1044)
+|++++..+. .+..+++++||++||++|||++.+++.+...|.+++..||+ +++|+|||+|++|+||||||||
T Consensus 80 ~a~~~~~~~~-----~~~~~~v~~LA~lVa~~MGG~~~~~~~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLF 152 (204)
T PF14381_consen 80 RAHELSKGLS-----TNTKELVQKLAKLVADRMGGPVSDAEDMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLF 152 (204)
T ss_pred HHHHHHhccc-----cCHHHHHHHHHHHHHHHhCCCCCcchhhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHH
Confidence 9999983221 24789999999999999999999999899999998888888 8999999999999999999999
Q ss_pred HHHHHHhCCceEEeecccccCC-CCceeEEEEeCCCceEEEeccCCCCcccC
Q 045028 308 KVLADIVGIPCRLVKGQQYTGC-DDVAMNFVRIDDGREYIVDLMADPGTLIP 358 (1044)
Q Consensus 308 k~lad~~gl~~~lv~G~~~~~~-~~~~~~~v~~~~~~~y~vDl~~~pg~l~~ 358 (1044)
|+|||+|||||+||||+|||++ ++.+||+|++.|++|||||||++||+|+|
T Consensus 153 KvLAD~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 153 KVLADRIGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred HHHHHhcCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 9999999999999999999999 89999999999999999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=450.01 Aligned_cols=382 Identities=20% Similarity=0.291 Sum_probs=286.7
Q ss_pred hhhhhhhhhccCCCCCCcchhhhhhHHHHHHHHHHHhhhcccccccccCCCCCCC-C--CCCCCCCCC---CCCCCCCCC
Q 045028 646 ASSMVVAVAKSNTDSNLELPVAAAATATAAAMVATTAAVGKQYELSIRSDGDADS-A--GYEPRDSGS---GGREHNYLG 719 (1044)
Q Consensus 646 ass~~~aac~sn~~s~~~~pvAaa~a~~AAa~aaa~aav~~~~~~s~~s~sds~S-~--~~~p~~S~s---gs~~~s~~~ 719 (1044)
.-+..|.+|..|+|.+|...+++.|+.++..++......+..............+ . ...|..+.. .........
T Consensus 256 qqGlkCs~Cg~n~H~~c~~~va~~CG~s~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (694)
T KOG0694|consen 256 QQGLKCSTCGRNVHNRCVENLAPNCGGSRTFSPEILEEIGTSPRAQSELKPKLPSVEKLFDPPQLSPRPGPPSSPASLVS 335 (694)
T ss_pred ccCeeehhhhccccHHHHHhcccCCCCchhhhhhhhhhcccCCCCccccCCCCcchhhcccCccccCCCCCCCCcccccC
Confidence 3467899999999999999999999999999999888765332211111110000 0 000100000 000000000
Q ss_pred CCCCCCccccCCCCCCCCCCCCCCCccccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHH
Q 045028 720 ANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEE 796 (1044)
Q Consensus 720 ~sSsg~r~Sd~sss~~ss~S~~~~~~~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~ 796 (1044)
..+.... ......................+..++|.++++||+|.||+|+++.. +++.||||++++..+. .+.++.
T Consensus 336 p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~ 414 (694)
T KOG0694|consen 336 PIQESTA-PEFPQPTFENSGPPEFPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVES 414 (694)
T ss_pred CcccccC-CCCCCccccCCCcccCCCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHH
Confidence 0000000 00000000011111111112467789999999999999999999977 5678999999887654 567889
Q ss_pred HHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEE
Q 045028 797 FRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875 (1044)
Q Consensus 797 ~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IV 875 (1044)
++.|..|+...+ ||+++.++.+|+..+++|+||||+.||++..+++ ...|++..+..|+.+|+.||.|||++| ||
T Consensus 415 ~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~--II 490 (694)
T KOG0694|consen 415 LMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENG--II 490 (694)
T ss_pred HHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcC--ce
Confidence 999999999886 9999999999999999999999999999555544 478999999999999999999999999 99
Q ss_pred EecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 045028 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG 955 (1044)
Q Consensus 876 HRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~ 955 (1044)
|||||.+|||||.+|++||+|||+++..........++||||.|||||++.+..|+..+|||+|||+|||||.|+.||.+
T Consensus 491 YRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 491 YRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred eeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999999776566678899999999999999999999999999999999999999999999
Q ss_pred CChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHh-------ccccCCCCCCCCCCCC
Q 045028 956 MNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT-----FTEIMAAL-------KPLQKPITSSQVPRPV 1023 (1044)
Q Consensus 956 ~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPT-----a~ELLe~L-------k~L~k~l~~~~~p~~~ 1023 (1044)
.++++++..| ......+|.+++.|+.++++++|+++|++|.. +.+|.+|- ..|..+ .-.||.+
T Consensus 571 ddEee~FdsI--~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r---~i~PPf~ 645 (694)
T KOG0694|consen 571 DDEEEVFDSI--VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNR---RIKPPFV 645 (694)
T ss_pred CCHHHHHHHH--hcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhc---cCCCCCC
Confidence 9999999999 57788899999999999999999999999974 57777662 223333 2334445
Q ss_pred CCCCCCCCccchhh
Q 045028 1024 PSVSSGRETGQISK 1037 (1044)
Q Consensus 1024 ps~s~~~~~~~i~~ 1037 (1044)
|.-..++..+-+++
T Consensus 646 P~i~~~~D~snFd~ 659 (694)
T KOG0694|consen 646 PTIKGPEDVSNFDE 659 (694)
T ss_pred cccCChhhhcccch
Confidence 55544444444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=421.06 Aligned_cols=281 Identities=25% Similarity=0.398 Sum_probs=242.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.+..++|+++++||+|+||+||.++. +++.||+|++++..... ..+..++.|..||.+++||+||.++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34568999999999999999999865 68899999998765543 4678899999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|||+||+.||+|+.+|++ ...|++..++.++.+|+.||.|||++| ||||||||+|||||.+|+|+|+|||+++....
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999999987 678999999999999999999999999 99999999999999999999999999997666
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
......++|||+.|||||++.+.+|+..+||||||++||||++|.+||.+.+..+++++|... .....|..++.+.+++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~-k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG-KLPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-cCCCCCccCCHHHHHH
Confidence 666677899999999999999999999999999999999999999999999999999998532 2355566699999999
Q ss_pred HHHhhhcCCCCCC----CHHHHHHHh-------ccccCCCCCCCCCCCCCCCCCCCCccchh
Q 045028 986 IRKCWQTDPKMRP----TFTEIMAAL-------KPLQKPITSSQVPRPVPSVSSGRETGQIS 1036 (1044)
Q Consensus 986 I~rcL~kDPekRP----Ta~ELLe~L-------k~L~k~l~~~~~p~~~ps~s~~~~~~~i~ 1036 (1044)
|+++|.+||++|. ++.+|.+|- +.+..+ .-.||..|..........++
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k---~l~PpF~P~~~~~~~~~~Fd 315 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAK---KLSPPFKPNVTGLEDTSNFD 315 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhc---CCCCCeecCCCCcccccccc
Confidence 9999999999995 677777662 222222 33335555555555554444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=434.75 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=236.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+|+.++.||+|||.+||.+++ +|..||+|++.+..+. ..+.+.+.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999976 7999999999765443 456788999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+|..++|..++++ ++.++|.+++.++.||+.||.|||+++ |||||||..||||+.+.+|||+|||+|.........
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999985 789999999999999999999999999 999999999999999999999999999998877778
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
..+.||||-|+|||++....++..+||||+||+||.||+|++||+..+..+.+..| ....+.+|..++.++++||.+|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I--k~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI--KLNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH--HhcCcccccccCHHHHHHHHHH
Confidence 88999999999999999999999999999999999999999999999999999999 5677889999999999999999
Q ss_pred hhcCCCCCCCHHHHHHHhc
Q 045028 990 WQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~Lk 1008 (1044)
|++||.+|||+++||.|-.
T Consensus 253 L~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred hcCCcccCCCHHHHhcCHh
Confidence 9999999999999997643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=416.83 Aligned_cols=283 Identities=48% Similarity=0.795 Sum_probs=255.7
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEECCcE-EEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTE-VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~-VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
....+.+.++++.+.+.||.|+||+||++.|.|+. ||+|++..........+.|.+|+.+|.+++|||||+|++++..+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34556777888899999999999999999999999 99999988776666678999999999999999999999999988
Q ss_pred C-CceEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEeccc
Q 045028 823 P-NLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGL 899 (1044)
Q Consensus 823 ~-~l~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGL 899 (1044)
. .+.|||||+++|+|.+++.+ ....++...++.++.||+.||.|||++++ ||||||||+||||+.++ ++||+|||+
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCcc
Confidence 7 79999999999999999988 47899999999999999999999999996 99999999999999998 999999999
Q ss_pred cccccCCcccccCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLR--NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~--g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
++.............||+.|||||++. ...|+.++||||||++||||+||+.||.+....+....+.....++.+|..
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 987766543444478999999999999 568999999999999999999999999999998888888888999999999
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCCCCCCCCCCC
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVS 1027 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~~p~~~ps~s 1027 (1044)
+++.+..||.+||..||.+||++.+|+..|+.+..............+..
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~~~~~~~ 320 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPEDSADSDS 320 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccccccccc
Confidence 99999999999999999999999999999999988777666555544433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=404.58 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=228.5
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC-
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN- 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~- 824 (1044)
..+...+++.++.||+|..|+||++++ +++.+|+|.+ ..+......+++.+|+++++..+||+||.+|+.|..++.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 346667899999999999999999988 5888999998 444455667889999999999999999999999999995
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++|+||||+||+|.++++. .+++++...-.++.++++||.|||+ ++ ||||||||+||||+..|.|||||||.+...
T Consensus 153 isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 9999999999999999987 3779999999999999999999995 88 999999999999999999999999999877
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHhhhccccccCCCCCC-
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM-----NPMQVVGAVGFQHRRLDIPDN- 977 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~-----~~~eil~~I~~~~~~~~ip~~- 977 (1044)
.+. ...+++||..|||||.+.+..|+.++||||||+.|+||.+|+.||... +..+++..|. ....+.+|..
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~ 306 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGE 306 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCccc
Confidence 665 567899999999999999999999999999999999999999999874 6677777775 4466777876
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++++++++|..||++||.+||++.|+++|-
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 999999999999999999999999999883
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=393.92 Aligned_cols=249 Identities=26% Similarity=0.457 Sum_probs=229.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
...++|++++.||.|+||+|.+++. +|..||+|++.+..+. -++++.+.+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4567899999999999999999976 6888999999876543 467889999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
|||||++||.|+.++++ .++|++..++.++.||+.||+|||+++ |+||||||+|||||.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999999987 578999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
..+.||||.|+|||+++..+|+.++|||+||+++|||+.|++||...++.+++++| ....+.+|..+++++++||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCHHHHHHH
Confidence 56789999999999999999999999999999999999999999999999999999 5677889999999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 045028 987 RKCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
.++|+.|-++|. ...+|..|
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccC
Confidence 999999999992 44555554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=409.97 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=219.0
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchh-----hHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGE-----SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~-----~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
..+.|.+.+.||+|+||.|-+|.. +|+.||||++.+...... ....+.+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 457799999999999999999965 799999999987654432 1234679999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC---CeEEEEecccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN---WVVKVCDFGLS 900 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d---g~VKLiDFGLA 900 (1044)
..||||||++||+|++++-. ++.+.+.....+++|++.||.|||++| |+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999987 567888899999999999999999999 9999999999999866 78999999999
Q ss_pred ccccCCcccccCCCCCCCccCcccccCCCC---CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhcccccc--CCC
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLRNEPS---DEKCDVYSFGVILWELCTMQQPWGGMNPMQ-VVGAVGFQHRR--LDI 974 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~---s~kSDIWSLG~LLyELLTGk~PF~~~~~~e-il~~I~~~~~~--~~i 974 (1044)
+..+.. ....++||||.|.|||++.+..+ ..++|||||||+||-+|+|++||.+..... +.++|...... ...
T Consensus 327 K~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 988744 45678999999999999987653 348899999999999999999998865555 66666432222 234
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+..++.+.++||++||..||++|||+.|+|+|-+
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 4679999999999999999999999999998854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=409.23 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=230.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~ 824 (1044)
.....+|.+++.||.|+|++|++|+. +++.||||++.+.-+. +..++.+.+|..+|.+| .||.|+++|..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34567999999999999999999976 6889999998665443 34567788999999999 79999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+|+||+++|+|.++|++ -+.|++..++.++.||+.||+|||++| ||||||||+|||||.+|++||+|||.|+...
T Consensus 149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999998 478999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCcc-----------c--ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc
Q 045028 905 NTFL-----------S--SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR 971 (1044)
Q Consensus 905 ~~~~-----------~--~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~ 971 (1044)
.... . ..+++||..|.+||+|.....+..+|||+||||||.|+.|.+||.+.++.-++++| ....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHhc
Confidence 2211 1 25689999999999999999999999999999999999999999999999999998 5678
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 ~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+.+|..+++.+++||+++|..||.+|+|+.+|.+|.
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 899999999999999999999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=398.36 Aligned_cols=252 Identities=28% Similarity=0.493 Sum_probs=227.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
..+|.+.+.||+|+||+||+|++ ++..||||.+.+..+..+.++.+..|+.+|+.++|||||.+++++...+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 5789999999988878888899999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC------CeEEEEeccccccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN------WVVKVCDFGLSRMK 903 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d------g~VKLiDFGLA~~~ 903 (1044)
|||.||+|.++|++ .+.+++..++.++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999988 458999999999999999999999999 9999999999999864 56999999999987
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC-CCCCCCCHHH
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL-DIPDNLDPAV 982 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~-~ip~~ip~EL 982 (1044)
... ....+.||+|.|||||++..+.|+.|+|+||+|+|||+|++|+.||...+..+++..+....... .++..++...
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 643 45678999999999999999999999999999999999999999999999999998776554433 3445677778
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+|+...|..++..|.+..+.+.+-
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhh
Confidence 8999999999999999888877553
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=407.63 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=226.3
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.+..++|++++.||+|+||.||+|+. +|..||+|++++.... ..++..++.|..+|....+|.||++|..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999965 7899999999877544 56788999999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
||||||++||++..+|.+ ...|++.+++.++.+++.||..||+.| ||||||||+|+|||..|+|||+||||+.....
T Consensus 217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999999987 678999999999999999999999999 99999999999999999999999999852100
Q ss_pred -----------------------Ccc------------------------cccCCCCCCCccCcccccCCCCCchhHHHH
Q 045028 906 -----------------------TFL------------------------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYS 938 (1044)
Q Consensus 906 -----------------------~~~------------------------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWS 938 (1044)
... ...+.+|||.|||||++.+.+|+..+||||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 013466999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC--CCCHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 045028 939 FGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMRP---TFTEIMAA 1006 (1044)
Q Consensus 939 LG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~--~ip~ELkdLI~rcL~kDPekRP---Ta~ELLe~ 1006 (1044)
|||||||||.|.+||.+.++.+.+.+|..-...+.+|. .+++++++||.+||. ||++|. .+.||.+|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999999999966555566664 578999999999999 999996 58888876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=392.82 Aligned_cols=259 Identities=25% Similarity=0.475 Sum_probs=229.5
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEe-eeecCCC-
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMG-AVTRPPN- 824 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~-~~~~~~~- 824 (1044)
.-...+|+|.++||+|.||+||++.. +|..+|.|.+..........+.+..|+.+|++|+|||||++++ .|..++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 34567899999999999999999865 8999999999877777788888999999999999999999998 4555555
Q ss_pred ceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCC--CcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 825 LSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCT--PVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G--~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
++||||||.+|+|...|+. ..+.+++..+|.++.|++.||.+||..- +-|+||||||.||||+.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999999864 4678999999999999999999999832 3399999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC-CCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP-DNL 978 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip-~~i 978 (1044)
++..........+.+|||+||+||.+.+.+|+.++|||||||++|||+.-++||.+.+-.++..+|.. .....+| +.+
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q-gd~~~~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ-GDYPPLPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc-CCCCCCcHHHh
Confidence 99887777777889999999999999999999999999999999999999999999999999888853 3334466 788
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+.++..||..|+..||+.||+...++..+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 999999999999999999998655555544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=395.51 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=228.6
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc---hhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF---GESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~---~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~ 823 (1044)
.....|.+++.||+|+||+|+++.+ ++..||+|++...... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999976 6899999976554221 123456779999999999 999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA~~ 902 (1044)
.+||||||+.||+|++++.+ ..++.+..+..++.||+.|++|||++| |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999998 788999999999999999999999999 9999999999999999 9999999999987
Q ss_pred ccCCcccccCCCCCCCccCcccccCCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCC-C
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEP-SD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNL-D 979 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~-~s-~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~i-p 979 (1044)
.........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+...++..+ ....+.+|..+ +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLS 248 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCC
Confidence 743445677899999999999999987 75 7999999999999999999999999988888886 67788999999 9
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+++++||.+||..||.+|+|+.+|++|=+
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 99999999999999999999999996543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=404.77 Aligned_cols=250 Identities=30% Similarity=0.483 Sum_probs=231.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeecc-CcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQ-DFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~-~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.-|++++.||+|+-|.|.+|++ +|+..|||++.+. .........+.+||.||+.+.||||+++|++|....++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4589999999999999999987 8999999998765 455556677999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||++||.|++++.+ .+.+++..+.+++.||+.|+.|||..+ |+||||||+|+||+..++|||+|||+|...... ..
T Consensus 92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 99999999999987 577899999999999999999999999 999999999999999999999999999865443 45
Q ss_pred ccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
..+.||.|.|.+||++.|.+| +.++||||+|+|||.||+|++||.+.+...++.++ ..+.+.+|.++++++++||.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHH
Confidence 677899999999999999997 67999999999999999999999999999999998 677899999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHhc
Q 045028 989 CWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~Lk 1008 (1044)
||..||.+|.|++||++|..
T Consensus 246 ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HhccCccccccHHHHhhCch
Confidence 99999999999999999853
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=377.89 Aligned_cols=281 Identities=26% Similarity=0.383 Sum_probs=238.5
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEECC--cEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~g--~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
...+..+.|++++.||+|.-|+||+++..+ ..+|+|++.+.... .+.+.++..|.+||..+.||+++.+|..|+.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 345667889999999999999999999865 78999999876554 345667888999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
..+++||||+||+|..++++ ..+.|++..++.|+.+++.||+|||..| ||||||||+||||.++|+|.|+||.++..
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999999987 4678999999999999999999999999 99999999999999999999999998742
Q ss_pred c-------c-----------------------C-----C---------------------cccccCCCCCCCccCccccc
Q 045028 903 K-------H-----------------------N-----T---------------------FLSSRSTAGTAEWMAPEVLR 926 (1044)
Q Consensus 903 ~-------~-----------------------~-----~---------------------~~~~~s~~GTp~Y~APEvL~ 926 (1044)
. . . . .....+++||-+|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 0 0 0 0 01124567999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCC----HHH
Q 045028 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT----FTE 1002 (1044)
Q Consensus 927 g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPT----a~E 1002 (1044)
|...+.++|||+|||+|||||.|..||.+.+..+.+..|..+...+.--..++..+++||+++|.+||.+|.. +.|
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 9999999999999999999999999999999999999986555554444578899999999999999999987 889
Q ss_pred HHHH--hccccCCCCCCCCCCCCCCCCCC
Q 045028 1003 IMAA--LKPLQKPITSSQVPRPVPSVSSG 1029 (1044)
Q Consensus 1003 LLe~--Lk~L~k~l~~~~~p~~~ps~s~~ 1029 (1044)
|.+| ++.+.=.+..-..||.+|.+.+.
T Consensus 389 IK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 389 IKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred hhcCccccCCChhheeccCCCcCCCcccc
Confidence 9887 34443334444556666665554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=376.33 Aligned_cols=263 Identities=32% Similarity=0.576 Sum_probs=218.5
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAV 819 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~ 819 (1044)
++++.++|+++++||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 567889999999999999999999964 24579999886432 233456789999999999 899999999987
Q ss_pred ecCC-CceEEEEecCCCcHHHHhcCCC-----------------------------------------------------
Q 045028 820 TRPP-NLSIVAEFLPRGSLYRLLHRPN----------------------------------------------------- 845 (1044)
Q Consensus 820 ~~~~-~l~LVmEy~~GGsL~dlLkr~~----------------------------------------------------- 845 (1044)
...+ .+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 5899999999999999987521
Q ss_pred --------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--cccccCCCC
Q 045028 846 --------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAG 915 (1044)
Q Consensus 846 --------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~~~~~s~~G 915 (1044)
..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 24778888999999999999999999 999999999999999999999999999754221 122233456
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 916 Tp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
++.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+............+..+++++.+||.+||..||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 788999999999999999999999999999997 9999988654443333333344556678899999999999999999
Q ss_pred CCCCCHHHHHHHhccccCC
Q 045028 995 KMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 995 ekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.+|||+.+|++.|+.+.+.
T Consensus 319 ~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 319 KERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=390.08 Aligned_cols=267 Identities=40% Similarity=0.682 Sum_probs=236.6
Q ss_pred CCccccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 743 DDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 743 ~~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
.....|+|+.+++.++..||+|.||+||+|+|.|. ||||++.......++++.|++|+.+|++-+|.||+-|.|++..+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34578999999999999999999999999999985 99999998888888999999999999999999999999999987
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.. .||+-+|+|-+|+.+++.....|...+.+.|+.||++|+.|||.++ |||||||..|||+.++++|||+|||++..
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceee
Confidence 77 9999999999999999988889999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCc--ccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc---ccCCC
Q 045028 903 KHNTF--LSSRSTAGTAEWMAPEVLRN---EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH---RRLDI 974 (1044)
Q Consensus 903 ~~~~~--~~~~s~~GTp~Y~APEvL~g---~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~---~~~~i 974 (1044)
...-. .......|...|||||+++. .+|++.+|||||||++|||++|.+||...+.++++..+.... +....
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 44321 12334457889999999964 458899999999999999999999999877777777665442 22334
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
-..++.++++|+..||.+++++||.+.+||..|..+.+.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 467888999999999999999999999999988888775
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=373.41 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=217.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+.|+.+.++|+|+||+||+|++ +|+.||||++....-.+...+-.++||++|++++|+|+|.++++|.....+++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5688999999999999999976 78999999998776555555668999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
||+. ++.+.+.+....++...+..++.|++.|+.|||+++ +|||||||+||||+.+|.+||||||+|+....+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9966 566667777788999999999999999999999999 9999999999999999999999999999877666666
Q ss_pred cCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-------------------c
Q 045028 911 RSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-------------------R 970 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-------------------~ 970 (1044)
...+.|.+|+|||.+.| ..|+..+|||++||++.||++|.+.|.+....+.+..|...- .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 67789999999999988 679999999999999999999999999988776655542111 1
Q ss_pred cCCCC----------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 RLDIP----------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ~~~ip----------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+++.| +.++.-+.+|++.||..||++|++.++++.|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 2345568899999999999999999999976
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=395.58 Aligned_cols=248 Identities=30% Similarity=0.526 Sum_probs=232.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|.+.+.||+|.||+||+|+. +.+.||+|.+.+.....+.++.+.+|++|++.++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5799999999999999999976 56789999999888888889999999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.| +|+.++.. ...++++.+..++.+++.||.|||+.+ |+|||+||.|||++..|.+|+||||+++.........
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9987 99999987 678999999999999999999999999 9999999999999999999999999999877766666
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....|||.|||||.+.+++|+..+|+||||||+|||++|++||......++...| .......|..++..+.+++..+|
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I--~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI--LKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH--hcCCCCCcccccHHHHHHHHHHh
Confidence 7778999999999999999999999999999999999999999999988988888 45566777899999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
.+||.+|.|..+++.|
T Consensus 236 ~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGH 251 (808)
T ss_pred hcChhhcccHHHHhcC
Confidence 9999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=378.27 Aligned_cols=257 Identities=33% Similarity=0.550 Sum_probs=220.5
Q ss_pred CCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC--CceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP--NLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~--~l~LV 828 (1044)
.++..++.||+|+||+||++.+. |...|||.+..... ...+.+.+|+.+|.+++|||||++++...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46888999999999999999874 68999998876532 22677999999999999999999999755444 59999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEeccccccccC--
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRMKHN-- 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~~~~-- 905 (1044)
|||+.+|+|.+++.+.+..+++..++.+..||++||.|||++| ||||||||+||||+. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999986558999999999999999999999999 999999999999999 79999999999986552
Q ss_pred -CcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhccccccCCCCCCCCHHH
Q 045028 906 -TFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGG-MNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 906 -~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~-~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.........||+.|||||++.+ .....++|||||||++.||+||.+||.. ....+.+..+......+.+|..+++++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1222445789999999999995 3344599999999999999999999998 455555566655555668999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+++|.+||.+||++|||+.++|+|..-....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999997654443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=372.31 Aligned_cols=249 Identities=25% Similarity=0.431 Sum_probs=221.0
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++.+.||+|+||.||++++ +++.||||++...... ....+.+.+|+.++++++||||+++++++..++.+++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 457899999999999999999987 5788999998754322 2345678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+.|++|.+++.+ ...+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999999976 457889999999999999999999999 999999999999999999999999999765432
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
.....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+. .....+|..++.++++||.
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHHH
Confidence 234579999999999999999999999999999999999999999988877777763 3456778889999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHHh
Q 045028 988 KCWQTDPKMRPT-----FTEIMAAL 1007 (1044)
Q Consensus 988 rcL~kDPekRPT-----a~ELLe~L 1007 (1044)
+||++||.+|++ +.+|++|-
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 999999999986 79999873
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=389.07 Aligned_cols=263 Identities=37% Similarity=0.652 Sum_probs=237.5
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEECCc-EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~-~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
...+++..+.+++++.||+|.||.||+|+++++ .||+|.++.... ..+.|.+|+++|++|+|+|||++++++..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 346778888899999999999999999999887 899999876543 2356889999999999999999999999988
Q ss_pred CceEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.+||||||+..|+|.++++. .+..+...+.+.|+.||++|++||++++ +|||||...||||+.+..+||+|||+|+.
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999999997 5778999999999999999999999999 99999999999999999999999999996
Q ss_pred ccCCccc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 903 KHNTFLS-SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 903 ~~~~~~~-~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..+..+. .....-...|.|||.+....++.++||||||++||||+| |+.||.+....+.++.+. ...++.-|+.||+
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPD 431 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCH
Confidence 5554443 333334568999999999999999999999999999998 899999999999999885 5678889999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
++.+|+..||+.+|++|||+..+...|+++...
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 999999999999999999999999999988764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=364.50 Aligned_cols=247 Identities=23% Similarity=0.408 Sum_probs=219.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||+||++.+ +++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4799999999999999999987 4889999998654322 234567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 99999999999976 457899999999999999999999999 999999999999999999999999998765332
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+. .....++..+++.+++||.+|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHHH
Confidence 234579999999999999999999999999999999999999999988888777763 345667888999999999999
Q ss_pred hhcCCCCCCC-----HHHHHHHh
Q 045028 990 WQTDPKMRPT-----FTEIMAAL 1007 (1044)
Q Consensus 990 L~kDPekRPT-----a~ELLe~L 1007 (1044)
|..||.+||+ +.++++|-
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCc
Confidence 9999999995 99999884
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=387.38 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=217.7
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCC-Cc
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPP-NL 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~-~l 825 (1044)
+..++|.++++||.|+||.||+|+. +|..||||.+++.-.. .+...-.+|++-|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4457899999999999999999976 6888999998776543 33334567999999999 999999999999888 89
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|+||||| ..+|+++++.+++.|++..++.|+.||++||+|+|.+| ++||||||+|||+.....|||+|||+|+....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 9999999 56999999999999999999999999999999999999 99999999999999999999999999986543
Q ss_pred CcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-------------
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------- 971 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------- 971 (1044)
.. .....+.|.+|+|||+|.. ..|+.+.|||++|||++|+++-++.|.+.++.+.+.+|+..-+.
T Consensus 163 kp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 32 2334678999999999865 45899999999999999999999999999988877766432211
Q ss_pred ----CCCC-----------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 972 ----LDIP-----------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 972 ----~~ip-----------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+.+| ...+.++.+||.+||.+||.+|||+.++|++--
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 1111 246789999999999999999999999999853
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=371.00 Aligned_cols=243 Identities=25% Similarity=0.424 Sum_probs=214.2
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
+.||+|+||.||++++ +|+.||||++..... .......+.+|+.++++++||||+++++++...+.+++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 678999999875432 2334566788999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG 915 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~G 915 (1044)
+|.+++.+ ...+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99999876 467899999999999999999999999 999999999999999999999999998754333333445679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCC
Q 045028 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995 (1044)
Q Consensus 916 Tp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPe 995 (1044)
|+.|+|||++.+..++.++|||||||+||||++|+.||...+.......+. .....+|..+++++.+||.+||.+||+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999888777776663 345677889999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 045028 996 MRP-----TFTEIMAA 1006 (1044)
Q Consensus 996 kRP-----Ta~ELLe~ 1006 (1044)
+|| ++.++++|
T Consensus 236 ~R~~~~~~~~~~ll~h 251 (323)
T cd05571 236 QRLGGGPEDAKEIMEH 251 (323)
T ss_pred HcCCCCCCCHHHHHcC
Confidence 999 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=379.37 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=220.8
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCce
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLS 826 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~ 826 (1044)
..+.|+.+++||+|+||.||++++ +|+.||+|++..............+||.||++|+||||+++.++.... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346799999999999999999987 688899999988776677777888999999999999999999998876 6799
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||||||+. +|..++....-.|++.++..|++||+.||+|||.+| |+|||||.+|||||.+|.+||+|||+|++....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999966 899999988889999999999999999999999999 999999999999999999999999999965443
Q ss_pred c-ccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--------CCC-
Q 045028 907 F-LSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--------DIP- 975 (1044)
Q Consensus 907 ~-~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--------~ip- 975 (1044)
. ......+-|.+|++||.|.|.. |+.++|+||+||||.||+.|++.|++.++.+.+..|......+ .+|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 2345567899999999999875 9999999999999999999999999999888777663222110 111
Q ss_pred ------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 976 ------------------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 976 ------------------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..++....+|+..||..||.+|.|+.+.|++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 2467888999999999999999999999864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=370.56 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=218.6
Q ss_pred CCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||+||++++. ++.||||++....... .....+..|+.++..++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999884 8899999987654322 44567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-- 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-- 907 (1044)
||+.+++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999874 67999999999999999999999999 9999999999999999999999999997544332
Q ss_pred ---------------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 045028 908 ---------------------------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ 960 (1044)
Q Consensus 908 ---------------------------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e 960 (1044)
.......||+.|+|||++.+..++.++|||||||+||+|++|+.||...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12334569999999999999999999999999999999999999999988777
Q ss_pred HHhhhccccccCCCCC--CCCHHHHHHHHHhhhcCCCCCCC-HHHHHHHh
Q 045028 961 VVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMRPT-FTEIMAAL 1007 (1044)
Q Consensus 961 il~~I~~~~~~~~ip~--~ip~ELkdLI~rcL~kDPekRPT-a~ELLe~L 1007 (1044)
....+........+|. .+++++.+||.+||. ||.+||+ +.++++|.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 7766654223334443 369999999999997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=357.65 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=220.8
Q ss_pred CCCCeeEE--eEecccCcEEEEEEEECCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeec----CC
Q 045028 751 PWEEITLG--ERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PP 823 (1044)
Q Consensus 751 ~~e~y~I~--r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~----~~ 823 (1044)
..++++.. ..||+|++|.||+|+++|+.||||.+....... ...+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 33444444 679999999999999999999999987654322 235678899999999999999999999876 34
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.+++||||+.+|+|.+++.+ ...+++...+.++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 68999999999999999976 45789999999999999999999984 7 88999999999999999999999999875
Q ss_pred ccCCcccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
.... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+.....+..++..+++
T Consensus 173 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (283)
T PHA02988 173 LSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL 249 (283)
T ss_pred hccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence 4332 224568999999999976 67899999999999999999999999998888888777655666777778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
+++++|.+||+.||++|||+.++++.|+.+.
T Consensus 250 ~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 250 EIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=384.58 Aligned_cols=250 Identities=28% Similarity=0.499 Sum_probs=226.7
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+...|....+||+|+-|.||.++. +++.||||++....... .+-+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 456799999999999999999976 67889999987665433 34588999999999999999999999888999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||++||+|-+.+.. ..+++.++..|+.++++||+|||.+| |+|||||.+|||++.+|.|||+|||++........
T Consensus 349 MEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999999986 56999999999999999999999999 99999999999999999999999999988777766
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELkdLI~ 987 (1044)
...+.+|||+|||||++....|+.++||||||++++||+-|++||-..++...+..|.. ....+..++.+++++++++.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 77888999999999999999999999999999999999999999998888776666643 33456778999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||..|+.+|+++.|||+|
T Consensus 505 ~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcchhcCCCHHHHhcC
Confidence 9999999999999999987
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=362.90 Aligned_cols=244 Identities=24% Similarity=0.400 Sum_probs=213.2
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
+.||+|+||.||+++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999976 678999999875432 2334566788999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG 915 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~G 915 (1044)
+|..++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..............|
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 99998876 457899999999999999999999999 999999999999999999999999998753333233345679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCC
Q 045028 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995 (1044)
Q Consensus 916 Tp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPe 995 (1044)
|+.|+|||++.+..++.++|||||||+||+|++|+.||...+.......+. .....+|..++++++++|.+||.+||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999888777776663 344567888999999999999999999
Q ss_pred CCC-----CHHHHHHHh
Q 045028 996 MRP-----TFTEIMAAL 1007 (1044)
Q Consensus 996 kRP-----Ta~ELLe~L 1007 (1044)
+|+ ++.++++|-
T Consensus 236 ~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 236 QRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HhCCCCCCCHHHHHcCC
Confidence 998 899998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=364.69 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=216.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.++..++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3699999999999999999987 5789999998754322 234567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 99999999999976 457899999999999999999999999 99999999999999999999999999975443 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC------CCCHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD------NLDPAVA 983 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~------~ip~ELk 983 (1044)
.....||+.|+|||++.+..++.++|||||||+||||++|..||...+..+....+.........|. .++.++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 3456799999999999999999999999999999999999999998888777665543222222222 5689999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++|.+||..+|.+||++.++++|-
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCc
Confidence 999999999999999999999883
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=366.82 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=213.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||+||++++ +++.||||++...... ......+..|+.++..++||||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999977 5789999998754322 334567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-- 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-- 907 (1044)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999976 467999999999999999999999999 9999999999999999999999999987432110
Q ss_pred ---------------------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 045028 908 ---------------------------------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWG 954 (1044)
Q Consensus 908 ---------------------------------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~ 954 (1044)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00124579999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhccccccCCCCC--CCCHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 045028 955 GMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPK---MRPTFTEIMAA 1006 (1044)
Q Consensus 955 ~~~~~eil~~I~~~~~~~~ip~--~ip~ELkdLI~rcL~kDPe---kRPTa~ELLe~ 1006 (1044)
+.+..+.+..+........+|. .++++++++|.+|+. +|. .||++.||++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9888888777754334444554 478999999999764 444 46899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=368.46 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=222.0
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC---CcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~---g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
...+..++|++.+.||+|+||.||+|.+. +..||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34567789999999999999999999763 25799998865432 234456788999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+++||||+.||+|.+++.+ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999999999976 457899999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.... .....||+.|+|||++.+..++.++|||||||+||||++|.+||...+....+..+. .....+|..+++++
T Consensus 181 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~ 255 (340)
T PTZ00426 181 VDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNC 255 (340)
T ss_pred cCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHH
Confidence 5332 234679999999999999989999999999999999999999999988877777764 34456788899999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 045028 983 ADIIRKCWQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 983 kdLI~rcL~kDPekRP-----Ta~ELLe~L 1007 (1044)
+++|.+||+.||.+|+ ++.++++|-
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 9999999999999995 899999883
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.54 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=234.1
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
....+..++|..+++||+|+||+|.+++. +++.||+|++++..+. ...+.....|-++|+..+||++..+-..|+..
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 34567789999999999999999999976 6889999999876554 45667788899999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+++||||.+||.|+.++.+ .+.|++...+.+..+|+.||.|||+.+ ||+||||.+|+|+|.+|+|||+|||+++.
T Consensus 241 drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred ceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchh
Confidence 999999999999999999987 678999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.........++||||.|+|||++....|+.++|||.+|++||||++|++||...+...++..| ....+.+|..+++++
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--l~ed~kFPr~ls~eA 395 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--LMEDLKFPRTLSPEA 395 (516)
T ss_pred cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH--HhhhccCCccCCHHH
Confidence 666666778999999999999999999999999999999999999999999999988888887 456788999999999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHHH
Q 045028 983 ADIIRKCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 983 kdLI~rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
+.|+..+|.+||.+|. ++.||.+|
T Consensus 396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 9999999999999994 57788776
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=353.13 Aligned_cols=254 Identities=25% Similarity=0.447 Sum_probs=231.1
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchh-hHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGE-SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~-~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
....++|++++.||+|.||.||+++. ++-.||+|++.+..+... ...++++|++|...|+||||+++|++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 45678999999999999999999987 456799999987665433 345789999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
|+++||..+|+|+..++. ...++++.....++.|++.||.|||.++ ||||||||+|+|++..|.+||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999999984 3577999999999999999999999999 9999999999999999999999999986543
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+..| ...++.+|..++.++++
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTISGGAAD 251 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccChhHHH
Confidence 44567899999999999999999999999999999999999999999999988999888 45677888999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+|.+||.++|.+|.+..|+++|-.
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHH
Confidence 999999999999999999998854
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=360.57 Aligned_cols=248 Identities=22% Similarity=0.367 Sum_probs=215.1
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCC-CCeeEEEeeeecCCCceEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRH-PNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrH-PNIVkl~~~~~~~~~l~LVm 829 (1044)
+|++++.||+|+||.||+|++ +++.||||++..... .....+.+..|+.++..+.| ++|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999987 457899999875432 23445678889999999976 56888999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||++||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999999876 456899999999999999999999999 999999999999999999999999998753322233
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+. .....+|..+++++.++|.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999988888877774 345667888999999999999
Q ss_pred hhcCCCCCCCH-----HHHHHH
Q 045028 990 WQTDPKMRPTF-----TEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa-----~ELLe~ 1006 (1044)
|.+||.+|++. .++++|
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999976 777776
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=368.66 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=215.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||+||++++ +++.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 5789999998764322 344566889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL- 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~- 908 (1044)
||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.++|+|||+++.......
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999999876 456999999999999999999999999 99999999999999999999999999864321100
Q ss_pred -------------------------------------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCC
Q 045028 909 -------------------------------------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ 951 (1044)
Q Consensus 909 -------------------------------------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~ 951 (1044)
.....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 1123469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHhhhccccccCCCCC--CCCHHHHHHHHHhhhcCCCCCCC---HHHHHHHh
Q 045028 952 PWGGMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMRPT---FTEIMAAL 1007 (1044)
Q Consensus 952 PF~~~~~~eil~~I~~~~~~~~ip~--~ip~ELkdLI~rcL~kDPekRPT---a~ELLe~L 1007 (1044)
||...+..+....+........++. .+++++++||.+||. +|.+|++ +.++++|-
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999888777766644333444443 478999999999996 9999997 99999873
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=363.52 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=213.7
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
+.||+|+||.||+++. +++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 578999999875432 2344567888999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAG 915 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~G 915 (1044)
+|..++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99998876 457899999999999999999999999 999999999999999999999999998753332223345679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCC
Q 045028 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995 (1044)
Q Consensus 916 Tp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPe 995 (1044)
|+.|+|||++.+..++.++|||||||+||+|++|+.||...+..+....+. .....+|..+++++.+||.+||.+||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 999999999999999999999999999999999999999888777776653 345567889999999999999999999
Q ss_pred CCC-----CHHHHHHHh
Q 045028 996 MRP-----TFTEIMAAL 1007 (1044)
Q Consensus 996 kRP-----Ta~ELLe~L 1007 (1044)
+|+ ++.++++|-
T Consensus 236 ~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 236 KRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HcCCCCCCCHHHHhcCC
Confidence 997 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=351.13 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=208.7
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||+|+||+||++++ +++.||||++............+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999987 46789999987665444556678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc-cc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-LS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-~~ 909 (1044)
|+.++.|..+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9998776655443 567899999999999999999999999 9999999999999999999999999997653321 12
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------------cC
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-----------------RL 972 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-----------------~~ 972 (1044)
.....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+..... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 2345689999999999998999999999999999999999999988665443322111000 00
Q ss_pred -------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 -------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 -------------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.....++.++++||++||++||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1112478899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.44 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=214.2
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHH---HhCCCCCeeEEEeeeecCCCceEE
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIM---KRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~IL---k~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
|++.+.||+|+||.||++.+ +++.||||++...... ....+.+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999987 5788999998754322 23455677777665 456799999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.|++|..++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999998865 57999999999999999999999999 99999999999999999999999999875433333
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+....+. .....+|..+++++.++|.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH
Confidence 3455679999999999999999999999999999999999999999988887777663 33456788899999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHHh
Q 045028 989 CWQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRP-----Ta~ELLe~L 1007 (1044)
||.+||.+|| ++.+++++-
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhCC
Confidence 9999999999 688888873
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.69 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=209.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.++||.|+||.||+|+. +++.||+|++..... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46899999999999999999976 578899998865432 223346778999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+ +|.+++......+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 899988776667899999999999999999999999 999999999999999999999999999765443333
Q ss_pred ccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------------c
Q 045028 910 SRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-----------------R 971 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-----------------~ 971 (1044)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+..... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 445578999999999876 5589999999999999999999999988776554433311000 0
Q ss_pred C-----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 L-----------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ~-----------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. .....++.++++||.+||.+||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 1123568899999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=361.18 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=211.9
Q ss_pred ecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 761 IGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 761 LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
||+|+||+||++++ +++.||+|++..... .......+.+|+.++++++||||+++++++...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999987 577899999865432 234456788899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCC
Q 045028 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA 917 (1044)
Q Consensus 838 ~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp 917 (1044)
.+++.+ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999976 457899999999999999999999999 99999999999999999999999999975433333344567999
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 045028 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR 997 (1044)
Q Consensus 918 ~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekR 997 (1044)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+. .....++..++++++++|.+||..||.+|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999999999999999999999999999999988887777663 44567788999999999999999999999
Q ss_pred C---CHHHHHHH
Q 045028 998 P---TFTEIMAA 1006 (1044)
Q Consensus 998 P---Ta~ELLe~ 1006 (1044)
| ++.+++.|
T Consensus 236 ~~~~~~~e~l~h 247 (312)
T cd05585 236 LGYNGAQEIKNH 247 (312)
T ss_pred CCCCCHHHHHcC
Confidence 7 57888876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.90 Aligned_cols=257 Identities=27% Similarity=0.479 Sum_probs=220.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
+..++|++.+.||+|+||.||++.+ .+..||+|.++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4567899999999999999999975 25679999886543 23345678899999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999876668999999999999999999999999 9999999999999999999999999876532
Q ss_pred CCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 905 NTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 905 ~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
... .......++..|+|||.+.+..++.++|||||||++||+++ |..||......+....+.. ......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHH
Confidence 221 11122345678999999999999999999999999999775 9999999888777766642 23455678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.+++.+||..+|.+||++.+|++.|..+
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=372.01 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=219.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch------------hhHHHHHHHHHHHHhCCCCCeeE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG------------ESLEEFRSEVLIMKRVRHPNVVL 814 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~------------~~~~~~~~EI~ILk~LrHPNIVk 814 (1044)
....++|++++.||+|.||.|-++++ +++.||||++.+..... ...+.+++||.||+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44568999999999999999999987 68899999986554322 12468999999999999999999
Q ss_pred EEeeeecC--CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeE
Q 045028 815 FMGAVTRP--PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVV 892 (1044)
Q Consensus 815 l~~~~~~~--~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~V 892 (1044)
++++..+. +.+|||+|||..|.+.+.-.. ...+++.+++.|+.+++.||+|||.+| ||||||||+|+||+.+|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcE
Confidence 99998775 469999999999887654332 223899999999999999999999999 9999999999999999999
Q ss_pred EEEecccccccc-----CCcccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh
Q 045028 893 KVCDFGLSRMKH-----NTFLSSRSTAGTAEWMAPEVLRNEP----SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVG 963 (1044)
Q Consensus 893 KLiDFGLA~~~~-----~~~~~~~s~~GTp~Y~APEvL~g~~----~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~ 963 (1044)
||+|||.+.... ..........|||.|+|||.+.+.. .+.+.||||||++||.|+.|+.||.+....+++.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 999999987542 1222233478999999999997732 3678999999999999999999999999999999
Q ss_pred hhccccccCCCCCC--CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 964 AVGFQHRRLDIPDN--LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 964 ~I~~~~~~~~ip~~--ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+|. +..+.+|.. +.+++++||.+||.+||++|.++.+|..|.+-...
T Consensus 330 KIv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 994 556666654 79999999999999999999999999988764443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=367.96 Aligned_cols=251 Identities=26% Similarity=0.359 Sum_probs=211.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.|++++.||+|+||+||++++ +++.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 589999999999999999987 5788999998765432 3456778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc---
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--- 907 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--- 907 (1044)
|++||+|.+++.+ ...+++..+..++.||+.||.|||+.| |+||||||+||||+.++++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999976 456899999999999999999999999 9999999999999999999999999975321000
Q ss_pred --------------------------------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 045028 908 --------------------------------------------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVIL 943 (1044)
Q Consensus 908 --------------------------------------------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LL 943 (1044)
......+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhccccccCCCCC--CCCHHHHHHHHHhh--hcCCCCCCCHHHHHHHh
Q 045028 944 WELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRKCW--QTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 944 yELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~--~ip~ELkdLI~rcL--~kDPekRPTa~ELLe~L 1007 (1044)
|||++|..||...+..+....+........++. .+++++++||.+|+ ..++..|+++.++++|-
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 999999999998877666655543333344443 58999999999955 45555699999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=347.81 Aligned_cols=271 Identities=24% Similarity=0.341 Sum_probs=226.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|...++||+|+||.||+|++ +|+.||||+++..+..+.......+||+.|+.++|+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4788899999999999999987 68999999998776655545567899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|++ .+|...|+.....++..++..|+.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+++.........
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 995 5999999998899999999999999999999999999 9999999999999999999999999999887766555
Q ss_pred cCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--C--------------
Q 045028 911 RSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--D-------------- 973 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~-------------- 973 (1044)
...+-|.+|+|||.+.|.. |+..+||||.|||+.||+-|.+-|.+.+..+.+..|...-..+ +
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 5557899999999998865 8999999999999999999999999988777665542211110 0
Q ss_pred ----------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCCCCCCCCCC
Q 045028 974 ----------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSV 1026 (1044)
Q Consensus 974 ----------ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~~p~~~ps~ 1026 (1044)
+-...+.++.+|+.+||..||.+|+|+.|++++=---..+........|.|+.
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 11234667899999999999999999999998633222233333333344443
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=360.90 Aligned_cols=245 Identities=25% Similarity=0.413 Sum_probs=213.2
Q ss_pred EeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 758 GERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++.||+|+||.||+++. .++.||||++...... ......+..|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999875 4678999998754322 2234567889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.|++|.+++.+ ...+.+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999999976 456788899999999999999999999 9999999999999999999999999987543333334
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+....+. .....+|..+++++.++|.+||
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHc
Confidence 45679999999999999989999999999999999999999999888777776663 3456778889999999999999
Q ss_pred hcCCCCCC-----CHHHHHHHh
Q 045028 991 QTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 991 ~kDPekRP-----Ta~ELLe~L 1007 (1044)
++||++|| ++.++++|-
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhcCC
Confidence 99999999 899998873
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.65 Aligned_cols=257 Identities=32% Similarity=0.597 Sum_probs=220.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECC-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+..++|++.+.||+|+||.||++...+ ..|++|.+.... .......+.+|+.++.+++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 456789999999999999999997632 469999876443 234456789999999999999999999999998
Q ss_pred CCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD 887 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd 887 (1044)
+..+++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 99999999999999999987531 45788999999999999999999999 99999999999999
Q ss_pred CCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 045028 888 KNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGA 964 (1044)
Q Consensus 888 ~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~ 964 (1044)
.++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||+||||++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999987543221 22234457889999999998889999999999999999998 9999999888887776
Q ss_pred hccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 965 VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 965 I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+. .......+..+++++.+|+.+||..||.+||++.+|+++|+.+
T Consensus 239 i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 64 3334456788999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.17 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=211.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.|++.+.||+|+||+||++.+ +++.||+|.+....... .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 388999999999999999976 68899999886544322 233457889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+.+|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-T 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-e
Confidence 99999999887643 346899999999999999999999999 9999999999999999999999999997643221 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc--cccccCCCCCCCCHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG--FQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~--~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
.....||+.|+|||++.+..++.++|||||||+||+|++|+.||...+.......+. .......++..++.++.+||.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 234579999999999999999999999999999999999999998765432222111 123345567789999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHH
Q 045028 988 KCWQTDPKMRPT-----FTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPT-----a~ELLe~ 1006 (1044)
+||.+||.+||+ +.++++|
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcC
Confidence 999999999997 8999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=367.99 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=213.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|+++++||+|+||+||+++. +++.||||++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999976 678999999865432 2345667889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL- 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~- 908 (1044)
||++||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999999976 467899999999999999999999999 99999999999999999999999999863211000
Q ss_pred ----------------------------------------------cccCCCCCCCccCcccccCCCCCchhHHHHHHHH
Q 045028 909 ----------------------------------------------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVI 942 (1044)
Q Consensus 909 ----------------------------------------------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~L 942 (1044)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0013569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHhhhccccccCCCCC--CCCHHHHHHHHHhhhcCCCCC---CCHHHHHHHh
Q 045028 943 LWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMR---PTFTEIMAAL 1007 (1044)
Q Consensus 943 LyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~--~ip~ELkdLI~rcL~kDPekR---PTa~ELLe~L 1007 (1044)
||||++|.+||...+..+.+..+........+|. .++.++++||.+||. +|.+| +++.++++|-
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 9999999999998887777666643334444554 578999999999997 67665 5999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=362.03 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=216.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||+||++++ +++.||||++..... .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999976 678999999876543 2334567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc-c
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-L 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-~ 908 (1044)
||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999886678999999999999999999999999 9999999999999999999999999997643322 1
Q ss_pred cccCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCH
Q 045028 909 SSRSTAGTAEWMAPEVLR------NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDP 980 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~------g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ 980 (1044)
......||+.|+|||++. +..++.++|||||||+||+|++|+.||...+..+.+..+........+| ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223457999999999987 4567889999999999999999999999888777776664443334444 35789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++.+||.+||. +|.+|||+.++++|
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 99999999998 99999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=361.98 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=212.8
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
+.||+|+||+||++++ +++.||+|++...... ......+..|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 6789999998754322 234566788999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
+|..++.+ ...+++..++.++.||+.||.|||+ .| |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 99998876 4578999999999999999999997 78 99999999999999999999999999875333222334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||+||+|++|..||...+..+....+. .....+|..+++++.+||.+||.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999888777776663 44566788899999999999999999
Q ss_pred CCCC-----CHHHHHHHh
Q 045028 995 KMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 995 ekRP-----Ta~ELLe~L 1007 (1044)
.+|+ ++.++++|-
T Consensus 236 ~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 236 KQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HHhCCCCCCCHHHHhcCC
Confidence 9996 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.44 Aligned_cols=243 Identities=25% Similarity=0.387 Sum_probs=211.7
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +++.||||++..... .......+..|+.++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999987 578899999875432 223456677888888876 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 999999876 457899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+++..+. .....++..++.+++++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999998888877773 44556778899999999999999999
Q ss_pred CCCCCH------HHHHHH
Q 045028 995 KMRPTF------TEIMAA 1006 (1044)
Q Consensus 995 ekRPTa------~ELLe~ 1006 (1044)
.+||++ .++++|
T Consensus 236 ~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 236 TMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHCCCCCCCCCHHHHHcC
Confidence 999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=357.67 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=214.8
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVm 829 (1044)
+|++++.||+|+||+||++++ +++.||||++.+... .......+..|..++..+ .|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999987 467899999875432 223445567788888877 4899999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999999876 356899999999999999999999999 999999999999999999999999999754333333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+. .....+|..++.++.++|.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999988888877774 345567888999999999999
Q ss_pred hhcCCCCCCCH-----HHHHHH
Q 045028 990 WQTDPKMRPTF-----TEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa-----~ELLe~ 1006 (1044)
|++||.+|++. .++++|
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhcC
Confidence 99999999974 677765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=348.83 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=211.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC------------------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH------------------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~------------------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN 811 (1044)
++.++|++.++||+|+||.||+|.+. +..||+|.+.... .......+.+|+.++.+++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 45678999999999999999999742 3369999876543 2344567899999999999999
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCC------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCc
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN------------------NQLDERRRLRMALDAARGMNYLHNCTPV 873 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~------------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~ 873 (1044)
|+++++++...+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999986421 24677889999999999999999999
Q ss_pred EEEecCCCCcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--C
Q 045028 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT--M 949 (1044)
Q Consensus 874 IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT--G 949 (1044)
|+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999997543221 12233456789999999998889999999999999999986 5
Q ss_pred CCCCCCCChHHHHhhhcc------ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 950 QQPWGGMNPMQVVGAVGF------QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 950 k~PF~~~~~~eil~~I~~------~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..||......+....+.. .......+..++..+.+||.+||..||.+|||+.+|.+.|+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 778888776655543321 11122345678899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=360.93 Aligned_cols=243 Identities=27% Similarity=0.416 Sum_probs=212.7
Q ss_pred eEecccCcEEEEEEEE-----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecC
Q 045028 759 ERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 759 r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
+.||+|+||.||+++. .|+.||+|++............+..|+.++++++||||+++++++..++.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999998864 57889999987654433444567889999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCC
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~ 913 (1044)
+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 9999999976 456899999999999999999999999 9999999999999999999999999987654443334456
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcC
Q 045028 914 AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993 (1044)
Q Consensus 914 ~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kD 993 (1044)
.||+.|+|||++.+..++.++|||||||+||+|++|+.||...+..+....+. .....+|..+++++.+||.+||++|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 79999999999999889999999999999999999999999888877777663 3445678889999999999999999
Q ss_pred CCCCCC-----HHHHHHH
Q 045028 994 PKMRPT-----FTEIMAA 1006 (1044)
Q Consensus 994 PekRPT-----a~ELLe~ 1006 (1044)
|.+||+ +.+++++
T Consensus 237 P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 237 PANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HhHcCCCCCCCHHHHhCC
Confidence 999999 5667655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=354.36 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=207.7
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
....++|+++++||+|+||+||++++ +++.||||++.... .......+.+|+.+++.++|+||+++++++...+.++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34467899999999999999999987 57899999986443 2334567899999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.+++|... ....+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 149 lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 149 VLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999999998653 23567788899999999999999999 999999999999999999999999999865443
Q ss_pred cccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HhhhccccccCCCCCCC
Q 045028 907 FLSSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV---VGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~ei---l~~I~~~~~~~~ip~~i 978 (1044)
........||..|+|||++.. ...+.++|||||||+||||++|+.||......+. ...+. .......+..+
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 300 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATA 300 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCcc
Confidence 333345679999999999853 2345689999999999999999999975433222 22221 23345566788
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+.++++||.+||..||++|||+.|+++|-.
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 999999999999999999999999999844
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=357.81 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=212.5
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||.||+|++ +++.||||++..... .......+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999987 467899999875432 233455677889998866 799999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.+ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 999999876 457899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+. .....+|..++.++.++|.+||.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 9999999999999999999999999999999999999999998888887774 34456777899999999999999999
Q ss_pred CCCC-------CHHHHHHHh
Q 045028 995 KMRP-------TFTEIMAAL 1007 (1044)
Q Consensus 995 ekRP-------Ta~ELLe~L 1007 (1044)
++|+ ++.++++|-
T Consensus 236 ~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 236 NKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHcCCCCCCCCCHHHHhcCC
Confidence 9999 889998873
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.79 Aligned_cols=243 Identities=26% Similarity=0.427 Sum_probs=208.5
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||.||++++ +++.||||+++.... .....+.+..|..++..+ +||||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 467899999875432 223345566677777654 799999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999999876 457899999999999999999999999 99999999999999999999999999975433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+. .....+|..++.++.++|.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988888777763 34556788899999999999999999
Q ss_pred CCCCCHH-HHHHH
Q 045028 995 KMRPTFT-EIMAA 1006 (1044)
Q Consensus 995 ekRPTa~-ELLe~ 1006 (1044)
.+||++. ++++|
T Consensus 236 ~~R~~~~~~l~~h 248 (316)
T cd05592 236 TKRLGVDGDIRQH 248 (316)
T ss_pred HHcCCChHHHHcC
Confidence 9999865 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=364.88 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=211.9
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.|+++++||+|+||+||+++. +++.||||++..... .......+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 589999999999999999987 578899999875432 23456678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC----
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT---- 906 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~---- 906 (1044)
|++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999976 356899999999999999999999999 999999999999999999999999997522100
Q ss_pred -------------------------------------------cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 045028 907 -------------------------------------------FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVIL 943 (1044)
Q Consensus 907 -------------------------------------------~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LL 943 (1044)
.......+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 045028 944 WELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRPT---FTEIMAA 1006 (1044)
Q Consensus 944 yELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ELkdLI~rcL~kDPekRPT---a~ELLe~ 1006 (1044)
|||++|++||...++.+....+........+| ..+++++.++|.+|+ .+|.+|++ +.++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999888777666654333334444 468999999999987 59999987 9999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.35 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=212.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
+..++|++++.||+|+||.||++++ ++..+|+|.+.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4567999999999999999999987 47789999876532 23445678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999999976 45689999999999999999999985 6 999999999999999999999999998754332
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-------------------
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF------------------- 967 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~------------------- 967 (1044)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...+..++...+..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 23345799999999999999999999999999999999999999977655443222110
Q ss_pred --------------------------ccccCCC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 968 --------------------------QHRRLDI-PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 968 --------------------------~~~~~~i-p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
....... ...+++++++||.+||.+||++|||+.+|++|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0001111 1246889999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.54 Aligned_cols=257 Identities=30% Similarity=0.562 Sum_probs=220.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
|.+..++|+++++||+|+||.||++.. +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 356778999999999999999999986 45779999876433 23567899999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++|||+.+++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999998753 456889999999999999999999999 99999999999999999999999999976543
Q ss_pred Cccc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 906 TFLS-SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 906 ~~~~-~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.. ......+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 2211 122345678999999998889999999999999999998 9999998877776666542 234445567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++|.+||..+|++||++.++++.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=365.72 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=212.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+|+++++||+|+||+||++++ +++.||||++.+.... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3699999999999999999986 5788999998654322 234567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC---
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--- 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--- 906 (1044)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999976 456889999999999999999999999 999999999999999999999999997422100
Q ss_pred ----------------------------------------cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHH
Q 045028 907 ----------------------------------------FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWEL 946 (1044)
Q Consensus 907 ----------------------------------------~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyEL 946 (1044)
.......+||+.|+|||++.+..++.++|||||||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0011235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 045028 947 CTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRP---TFTEIMAA 1006 (1044)
Q Consensus 947 LTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ELkdLI~rcL~kDPekRP---Ta~ELLe~ 1006 (1044)
++|+.||.+.+..+....+........++ ..+++++.++|.+|+ .+|.+|+ ++.++++|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999988777666554333333333 468999999999977 5999999 99999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=349.70 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=204.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.++||+|+||+||+++. +++.||||++..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 578899999865432 222345778999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+. ++|.+++.+....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9995 6888888776677899999999999999999999999 999999999999999999999999998754433333
Q ss_pred ccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccc-----------------
Q 045028 910 SRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHR----------------- 970 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~----------------- 970 (1044)
.....||+.|+|||++.+. .++.++|||||||+||+|++|..||.+.... +.+..+.....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 3456789999999998764 5788999999999999999999999875432 22221110000
Q ss_pred --cC--CCC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 --RL--DIP---------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 --~~--~ip---------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.. ..+ ..++.++++||.+||++||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 000 1245788999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=374.95 Aligned_cols=252 Identities=23% Similarity=0.430 Sum_probs=233.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC-ceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN-LSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~-l~LV 828 (1044)
.+.|..++.+|+|+||.++++++ .++.|++|.+.-............+|+.++++++|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46899999999999999998765 57789999998777777777788999999999999999999999998888 9999
Q ss_pred EEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|+||+||+|.+.|.+.+ ..|+++.++.|+.||+.|+.|||++. |+|||||+.|||++.++.|||.|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999998754 78999999999999999999999988 9999999999999999999999999999988877
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
....+..|||.||.||++.+.+|+.++|||||||++|||++-+++|...+...+..+|.... -..+|...+.+++.+|+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence 67788899999999999999999999999999999999999999999999999998885333 56788999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
.||.++|..||++.+||.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999987
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=363.09 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=219.7
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
...+..++|++.+.||+|+||.||++++ +++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3445678999999999999999999987 5788999998654322 233455788999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||++||+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999999875 46889999999999999999999999 999999999999999999999999999765
Q ss_pred cCCc-ccccCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC--
Q 045028 904 HNTF-LSSRSTAGTAEWMAPEVLRNE----PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD-- 976 (1044)
Q Consensus 904 ~~~~-~~~~s~~GTp~Y~APEvL~g~----~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~-- 976 (1044)
.... ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||...+....+..+........+|.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 4322 123456799999999998754 378899999999999999999999999888777777754444455555
Q ss_pred CCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 045028 977 NLDPAVADIIRKCWQTDPKM--RPTFTEIMAAL 1007 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPek--RPTa~ELLe~L 1007 (1044)
.++.++++||.+||..+|.+ |+++.++++|-
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 57999999999999999988 99999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=364.79 Aligned_cols=263 Identities=28% Similarity=0.511 Sum_probs=219.8
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~ 817 (1044)
..+.++.++|++++.||+|+||.||++.+. +..||||.+..... ......+.+|+.+++.+ +|+||+++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 456678889999999999999999998752 24799999875432 23456788999999999 8999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCC----------------------------------------------------
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------------------------------------------- 845 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------------------------------------------- 845 (1044)
++...+.+++||||+.+|+|.+++.+..
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999999999999885421
Q ss_pred -----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 846 -----------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 846 -----------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 24788889999999999999999999 99999999999999999999999999875432211
Q ss_pred --cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 909 --SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 909 --~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
......++..|+|||++.+..++.++|||||||+||+|++ |+.||.....................+..+++++.++
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 1222335678999999998899999999999999999997 9999988665544444433444555677789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
|.+||+.||.+|||+.++++.|+++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=354.42 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=208.7
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||.||++++ +|+.||+|+++..... ......+..|+.++..+ +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999987 5778999998754321 23445667788888755 799999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999999876 457899999999999999999999999 99999999999999999999999999874332222334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+. .....+|..++.+++++|.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888887777663 34456778899999999999999999
Q ss_pred CCCCCH-HHHHHH
Q 045028 995 KMRPTF-TEIMAA 1006 (1044)
Q Consensus 995 ekRPTa-~ELLe~ 1006 (1044)
++||++ .++++|
T Consensus 236 ~~R~~~~~~~~~h 248 (316)
T cd05620 236 TRRLGVVGNIRGH 248 (316)
T ss_pred HHcCCChHHHHcC
Confidence 999997 466655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=362.16 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=224.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+|++.+.||+|+||.|-++.. .|+.||||.+++..+.. ..+-.+++||+||..|+||||+.+|++|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4799999999999999999965 68999999988766543 45667999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||..+|.|++++.+ .+.+++..++.++.||+.|+.|||.++ ++|||||.+|||+|.++++||+|||++...... ..
T Consensus 133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 99999999999987 578999999999999999999999999 999999999999999999999999999876543 34
Q ss_pred ccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
..++||.|.|.+||+++|.+| ++.+|-||||++||.|+.|.+||.+.+-..++.+|.... +.-| .-|..+.-||+.
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga--YrEP-~~PSdA~gLIRw 285 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA--YREP-ETPSDASGLIRW 285 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc--ccCC-CCCchHHHHHHH
Confidence 578999999999999999998 578999999999999999999999999998888885433 3333 335578899999
Q ss_pred hhhcCCCCCCCHHHHHHHhcc
Q 045028 989 CWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
||-.||++|.|+.+|..|.+-
T Consensus 286 mLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred HHhcCcccchhHHHHhhhhee
Confidence 999999999999999999763
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=353.83 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=227.7
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
...+.|++.+.||+|.|+.||++.+ +|+.+|+|++....+.....+.+.+|+.|.+.|+|||||++.+.+..+...||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3457899999999999999998855 78999999987777766778899999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc---CCCeEEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD---KNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd---~dg~VKLiDFGLA~~~~ 904 (1044)
|||++.|++|..-|-+ +..+++..+-.++.||+++|.|+|.+| |||||+||+|+|+- ..--+||+|||++....
T Consensus 88 vFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999876654 266889999999999999999999999 99999999999995 34579999999998877
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCC--CCCCCCHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD--IPDNLDPAV 982 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~--ip~~ip~EL 982 (1044)
.......+.|||.|||||+++..+|+..+|||+.|+|||-||.|++||++.+...+++.|......+. .++++++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 44566778999999999999999999999999999999999999999999999999999865544333 456899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
++||++||..||.+|.|+.|.|+|-+
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCch
Confidence 99999999999999999999988743
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=363.05 Aligned_cols=262 Identities=29% Similarity=0.504 Sum_probs=217.1
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~ 817 (1044)
..+.++.++|+++++||+|+||.||+|++ ++..||||+++.... ....+.+.+|+.++..+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 35667788999999999999999999864 345799998864432 23446788999999999 7999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCC----------------------------------------------------
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------------------------------------------- 845 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------------------------------------------- 845 (1044)
++...+..++||||++||+|.+++.+..
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986422
Q ss_pred ----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 846 ----------------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 846 ----------------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceec
Confidence 24678889999999999999999999 999999999999999999999999999754
Q ss_pred cCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 904 HNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 904 ~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... ......++..|+|||++.+..++.++|||||||+||||++ |..||.................+...+...+.
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS 344 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCH
Confidence 33221 1222345678999999999999999999999999999998 89999876544333333333334555677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++++||.+||..||++||++.+|++.|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=351.26 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=201.7
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-----Cce
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-----NLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-----~l~ 826 (1044)
+|++.++||+|+||.||++.+ +++.||||++............+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999986 5789999988654333334456889999999999999999999875432 489
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+. ++|.+++.+ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 689998876 456899999999999999999999999 999999999999999999999999999754221
Q ss_pred c---ccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc--------------
Q 045028 907 F---LSSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-------------- 967 (1044)
Q Consensus 907 ~---~~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-------------- 967 (1044)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 12234579999999999876 5688999999999999999999999987654332211100
Q ss_pred ------------ccccC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 968 ------------QHRRL---DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 968 ------------~~~~~---~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..... .....+++++.++|.+||..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0113567889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=337.97 Aligned_cols=256 Identities=32% Similarity=0.593 Sum_probs=222.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
....+|+++++||.|+||.||++.+ .++.+++|.+.... ......+..|+.+++.++||||+++++++.....+++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3456799999999999999999987 46779999876543 22345688999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|||+++++|.+++.+. ...+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999999763 456899999999999999999999999 9999999999999999999999999997654433
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.......++..|++||.+.+..++.++||||||+++|+|++ |+.||...+..+.+..+. ...+...+..+++++.++|
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHH
Confidence 33334456778999999998889999999999999999998 899999888777777665 3345566788999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccc
Q 045028 987 RKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.+||..||.+|||+.+|++.|+.+
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.72 Aligned_cols=257 Identities=36% Similarity=0.656 Sum_probs=221.3
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
++...+|.+.++||+|+||.||++.+ .++.|++|++.... .....+.+|+.++++++|+||+++++++...+.++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45667899999999999999999976 47889999876442 33567889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++|||+.+++|.+++... ...+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999998753 356899999999999999999999999 99999999999999999999999999876543
Q ss_pred Cccc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 906 TFLS-SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 906 ~~~~-~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+. .......+..++.++.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 3211 122234668999999999999999999999999999998 999999887777666653 2335567788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
++|.+||..+|++||++.++++.|+.+.
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 9999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.62 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=204.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE---CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC---CCCCeeEEEeeee-----c
Q 045028 753 EEITLGERIGLGSYGEVYRGDW---HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV---RHPNVVLFMGAVT-----R 821 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~---~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L---rHPNIVkl~~~~~-----~ 821 (1044)
.+|++++.||+|+||+||++++ +++.||+|.+............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3699999999999999999976 357799998875543333344566788877766 6999999999875 3
Q ss_pred CCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 5898888653 356899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc---------
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR--------- 971 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~--------- 971 (1044)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 765433 2234567899999999999989999999999999999999999999988776655544211100
Q ss_pred ----------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 ----------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ----------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+...++..+++||.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 01123578889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=354.43 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=209.1
Q ss_pred CeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCc
Q 045028 754 EITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l 825 (1044)
+|++++.||+|+||+||+++. +++.||+|++.+.... ....+.+..|+.+++.++ ||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 589999999999999999875 5788999998754322 233456888999999995 99999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999876 456899999999999999999999999 99999999999999999999999999875432
Q ss_pred C-cccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhccccccCCCCCCCC
Q 045028 906 T-FLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMN----PMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 906 ~-~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~----~~eil~~I~~~~~~~~ip~~ip 979 (1044)
. ........||+.|+|||++.+.. ++.++|||||||+||||++|+.||.... .......+ ......++..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 2 22233467999999999998764 7889999999999999999999996532 22233333 233456778899
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 045028 980 PAVADIIRKCWQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRP-----Ta~ELLe~L 1007 (1044)
++++++|.+||..||++|| ++.++++|-
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 9999999999999999999 788998873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.81 Aligned_cols=252 Identities=29% Similarity=0.503 Sum_probs=218.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch---hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG---ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~---~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
+.|++.+.||+|+||.||++.. +++.|++|.+....... .....+.+|+.++++++||||+++++++..+..+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999976 67899999886543222 234678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+.| |+|+||+|+|||++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999999876 356889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccc---cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 908 LSS---RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 908 ~~~---~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+........++..++.++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23457889999999999999999999999999999999999998877766665555555566788889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+|.+||.++|.+|||+.+++++.
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.31 Aligned_cols=256 Identities=30% Similarity=0.583 Sum_probs=218.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+.+++|++.+.||+|+||+||+|.+ .+..+++|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4567899999999999999999974 45679999886533 2344567889999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCC----------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP----------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD 887 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~----------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd 887 (1044)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 999999999999999998532 235788999999999999999999999 99999999999999
Q ss_pred CCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 045028 888 KNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGA 964 (1044)
Q Consensus 888 ~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~ 964 (1044)
.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997543221 12233446778999999998889999999999999999998 9999988877666665
Q ss_pred hccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 965 VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 965 I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
+. .......+..++++++++|.+||..||.+||++.+|+++|+.
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 54 333455678899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.30 Aligned_cols=250 Identities=34% Similarity=0.582 Sum_probs=215.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.++|++.+.||+|+||.||++++. +..+|+|.+..... ....+.+|+.++++++||||+++++++.....+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 467999999999999999999885 45799998764432 23568889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-c
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-S 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~ 909 (1044)
|+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999999999765567899999999999999999999999 99999999999999999999999999875432221 1
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.. ..+...+...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHH
Confidence 222345668999999998889999999999999999999 8999998887777777643 23445567788999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||..+|++||++.++++.|
T Consensus 237 c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.19 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=220.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|.+.+.||+|+||.||++.+ +++.|++|.+............+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588999999999999999977 678899999876555556677899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 832 LPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
+.|++|.+++... ...+++..++.++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999999764 467899999999999999999999999 9999999999999999999999999987654443333
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+. ......++..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 44578999999999999989999999999999999999999999888766666553 23334456678999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
+.+|++||++.+++++
T Consensus 238 ~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 238 TKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.27 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=219.3
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
..+-...++|++.++||.|.-++||+|+. .+..||||++....... .++.+.+|+..|+.++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34555678999999999999999999977 67899999987655443 3889999999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.+|+||.||.+|++.++++.. ...+++..+..+++++++||.|||++| .||||||+.||||+.+|.|||+|||.+-.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeee
Confidence 999999999999999999863 456999999999999999999999999 99999999999999999999999998753
Q ss_pred ccCCc---ccc-cCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-----
Q 045028 903 KHNTF---LSS-RSTAGTAEWMAPEVLR--NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----- 971 (1044)
Q Consensus 903 ~~~~~---~~~-~s~~GTp~Y~APEvL~--g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~----- 971 (1044)
..... ... .++.||++|||||++. ..+|+.|+||||||++..||.+|+.||...-+.+++..-......
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 32221 111 5678999999999963 456999999999999999999999999999888876543222211
Q ss_pred ---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 ---LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ---~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+....++..++.+|..||.+||.+|||+.++++|
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11112466789999999999999999999999987
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=352.80 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=211.7
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +++.||||++.+... .......+..|+.+++.+ +||||+++++++...+.+++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 467899999875432 223456678899999888 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999999876 457999999999999999999999999 99999999999999999999999999875333323334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+|..++.++.+||.+||.+||
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888877777663 34456778899999999999999999
Q ss_pred CCCCCH-----HHHHHH
Q 045028 995 KMRPTF-----TEIMAA 1006 (1044)
Q Consensus 995 ekRPTa-----~ELLe~ 1006 (1044)
.+||++ .+++++
T Consensus 236 ~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 236 EKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 999999 999876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=359.57 Aligned_cols=250 Identities=27% Similarity=0.394 Sum_probs=213.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||+||++.. +++.||||++..... .......+..|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999977 578899999875432 2344567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-- 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-- 907 (1044)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999976 456899999999999999999999999 9999999999999999999999999986432110
Q ss_pred ---------------------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 045028 908 ---------------------------------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWG 954 (1044)
Q Consensus 908 ---------------------------------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~ 954 (1044)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 01124579999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhccccccCCCCC--CCCHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 045028 955 GMNPMQVVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMRP---TFTEIMAA 1006 (1044)
Q Consensus 955 ~~~~~eil~~I~~~~~~~~ip~--~ip~ELkdLI~rcL~kDPekRP---Ta~ELLe~ 1006 (1044)
..+..+.+..+........+|. .++++++++|.+|+. ||.+|+ ++.++++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9888887777654334444554 378999999999874 999998 47888887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=354.03 Aligned_cols=243 Identities=27% Similarity=0.418 Sum_probs=207.2
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHH-HHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVL-IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~-ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +|+.||||++...... ......+..|.. +++.++||||+++++++...+.+++||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999987 6889999998654322 223344555554 56789999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999999876 467899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||+||+|++|..||...+..++...+. .....++..+++++.++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999988888777763 33455677889999999999999999
Q ss_pred CCCCCH----HHHHHH
Q 045028 995 KMRPTF----TEIMAA 1006 (1044)
Q Consensus 995 ekRPTa----~ELLe~ 1006 (1044)
.+||++ .++++|
T Consensus 236 ~~R~~~~~~~~~il~~ 251 (323)
T cd05575 236 TKRLGAKDDFLEIKNH 251 (323)
T ss_pred HhCCCCCCCHHHHHcC
Confidence 999987 466654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.66 Aligned_cols=257 Identities=23% Similarity=0.431 Sum_probs=216.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||.||++++ +++.||||.+..... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999976 688999998765332 2344567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988753 2456899999999999999999999999 999999999999999999999999998765433
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN--PMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~--~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+.........+..++..+++
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 332334568899999999998889999999999999999999999997643 234444443222222233467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
+|.+||..+|++||++.++++.|+++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.21 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=217.3
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+..++|++.+.||+|+||.||++++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 345567899999999999999999987 577899999865332 22334567889999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999999975 46899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCc-ccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC--C
Q 045028 905 NTF-LSSRSTAGTAEWMAPEVLRNEP----SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD--N 977 (1044)
Q Consensus 905 ~~~-~~~~s~~GTp~Y~APEvL~g~~----~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~--~ 977 (1044)
... ......+||+.|+|||++.+.. ++.++|||||||+||+|++|+.||...+....+..+........+|. .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 322 1234567999999999997653 67899999999999999999999999888777777754444555554 5
Q ss_pred CCHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 045028 978 LDPAVADIIRKCWQTDPKM--RPTFTEIMAAL 1007 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPek--RPTa~ELLe~L 1007 (1044)
++..++++|.+||..++.+ |+++.++++|-
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 6999999999999855544 88999999983
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.96 Aligned_cols=256 Identities=32% Similarity=0.566 Sum_probs=219.6
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
..++|++.+.||+|+||+||+|.+. ...||||.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3468999999999999999999873 3469999876433 334456788999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+++|||+.+++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999999876668999999999999999999999999 99999999999999999999999999986542
Q ss_pred Cc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 906 TF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 906 ~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.. .......++..|++||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 11 11222345678999999999889999999999999999998 999998877777666664 223445567789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.+++.+||+.+|++||++.+++++|..+
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.88 Aligned_cols=256 Identities=31% Similarity=0.596 Sum_probs=218.9
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+++..++|+++++||+|+||.||++.. +++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+.++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 356788999999999999999999987 568899998865443 2356889999999999999999999874 46799
Q ss_pred EEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++|||+.+++|.+++.+ ....+++..++.++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999999865 3457899999999999999999999999 99999999999999999999999999876542
Q ss_pred C-cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 906 T-FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 906 ~-~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
. ........++..|++||++.+..++.++||||||+++|+|++ |++||.+.+..+....+. .......+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 2 222223446778999999998889999999999999999999 999999887777666553 2334456778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++|.+||..+|++|||++++++.|+++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=373.47 Aligned_cols=251 Identities=37% Similarity=0.691 Sum_probs=229.7
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
...|+|+++.+.-++-||.|+.|.||+|+..++.||||+++.. -..+|+-|++|+||||+.|.++|.....
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 3468999999999999999999999999999999999976432 1347889999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++||||||..|-|...++. ++.+.......|..+|+.|+.|||.++ |||||||.-||||+.+..|||+|||-++...
T Consensus 187 yCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhh
Confidence 9999999999999999987 677888899999999999999999999 9999999999999999999999999998655
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.- .+.-+++||..|||||++++.+.++|+||||||++|||||||..||.+.+...++.-+..+...+.+|..+|..|+=
T Consensus 264 ~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 264 DK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence 44 34567899999999999999999999999999999999999999999988887777776666778899999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
||++||.-.|..||++.+|+.||+
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999999999996
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.74 Aligned_cols=248 Identities=21% Similarity=0.368 Sum_probs=214.1
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVm 829 (1044)
+|++.+.||+|+||+||++++ +++.||||++.+... .......+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478999999999999999987 578899999875432 2234556778899998886 578888999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999999999876 456999999999999999999999999 999999999999999999999999998754333333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999988887777764 345567888999999999999
Q ss_pred hhcCCCCCCC-----HHHHHHH
Q 045028 990 WQTDPKMRPT-----FTEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPT-----a~ELLe~ 1006 (1044)
|.++|.+|++ ..++++|
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcC
Confidence 9999999997 4566665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.00 Aligned_cols=243 Identities=25% Similarity=0.405 Sum_probs=208.1
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +++.||||++...... ......+..|..++..+ +||||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 4678999998754321 23345566788888764 899999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999999976 456899999999999999999999999 99999999999999999999999999875333222334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....++..++.+++++|.+||.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccCH
Confidence 99999999999999999999999999999999999999999888877777643 3345677899999999999999999
Q ss_pred CCCCCHH-HHHHH
Q 045028 995 KMRPTFT-EIMAA 1006 (1044)
Q Consensus 995 ekRPTa~-ELLe~ 1006 (1044)
.+||++. ++++|
T Consensus 236 ~~R~~~~~~l~~h 248 (316)
T cd05619 236 ERRLGVKGDIRQH 248 (316)
T ss_pred hhcCCChHHHHcC
Confidence 9999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.75 Aligned_cols=259 Identities=27% Similarity=0.516 Sum_probs=218.3
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCc----EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGT----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~----~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
...+|++.+.||+|+||.||+|.+ ++. .||+|.+.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-ST 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CC
Confidence 456899999999999999999976 333 38999876432 23445678899999999999999999998876 45
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.++++||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccccc
Confidence 78999999999999999876677899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 905 NTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 905 ~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.... ......++..|++||++.+..++.++|||||||+||||++ |..||.+....++...+ ........+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHH
Confidence 3221 1122334678999999999999999999999999999997 99999887766654433 234455567788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
+.++|.+||..+|.+||++.+++.+|..+.+..
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=332.46 Aligned_cols=256 Identities=34% Similarity=0.571 Sum_probs=219.2
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
++..++|++.+.||+|+||.||++.+ .++.||+|.+..... ....+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 46678899999999999999999986 456799998865432 24568889999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+|||+.+++|.+++... ...+++..+..++.|++.||.|||+.| |+||||||+|||++.++.++|+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999763 357899999999999999999999999 999999999999999999999999999765432
Q ss_pred ccc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 FLS-SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~-~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
... ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+....+. .......+..++..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHH
Confidence 111 111223457999999999999999999999999999999 999999888777666653 23344566778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++.+||..+|.+||++.+|++.|+.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=354.55 Aligned_cols=239 Identities=26% Similarity=0.410 Sum_probs=203.0
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHH-HHHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEV-LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI-~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +++.||+|++...... ......+..|. .+++.++||||+++++++...+.+++||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999987 5678999998754322 12223344444 456788999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|.+++.+ ...+.+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 999999976 456888899999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|++||...+..+.+..+. .....++..++.++.++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999988888777663 33455667899999999999999999
Q ss_pred CCCCCHHH
Q 045028 995 KMRPTFTE 1002 (1044)
Q Consensus 995 ekRPTa~E 1002 (1044)
.+|+++.+
T Consensus 236 ~~R~~~~~ 243 (325)
T cd05602 236 TKRLGAKD 243 (325)
T ss_pred HHCCCCCC
Confidence 99998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.95 Aligned_cols=243 Identities=24% Similarity=0.399 Sum_probs=206.6
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||.||++++ +++.||||+++..... ......+..|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999987 5788999998764332 23456688899999998 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 999998876 467999999999999999999999999 99999999999999999999999999875332223344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHhhhccccccCCCCCCCCHHHHHH
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN--------PMQ-VVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~--------~~e-il~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+ ....+ ......+|..++.++.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999999999996321 111 22223 334566788899999999
Q ss_pred HHHhhhcCCCCCCC------HHHHHHH
Q 045028 986 IRKCWQTDPKMRPT------FTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPT------a~ELLe~ 1006 (1044)
|.+||.+||.+|++ +.++++|
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999987 7888877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=334.05 Aligned_cols=251 Identities=32% Similarity=0.571 Sum_probs=215.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEECCc-EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~g~-~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.++|++++.||+|+||+||++++.+. .+|+|.+..... ..+.+.+|+.++++++||||+++++++.....+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 46799999999999999999987554 599998765432 23568899999999999999999999998889999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-c
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-S 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~ 909 (1044)
|+.+++|.+++......+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999999875567899999999999999999999999 99999999999999999999999999875433221 1
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....++..|++||.+.+..++.++|||||||++|+|++ |..||...+..+....+.. ..+...+...+.++++++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 122345678999999998889999999999999999998 9999988887776666643 33445566788999999999
Q ss_pred hhhcCCCCCCCHHHHHHHhc
Q 045028 989 CWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~Lk 1008 (1044)
||..+|.+|||+.+|++.|+
T Consensus 237 cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HcCCCcccCCCHHHHHHhhC
Confidence 99999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=369.29 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=220.2
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC---
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP--- 823 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~--- 823 (1044)
+...++|++.+.||+|+||+||++++ +++.||||++............+.+|+.++..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999976 6889999998776655666677899999999999999999988775432
Q ss_pred -----CceEEEEecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEE
Q 045028 824 -----NLSIVAEFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC 895 (1044)
Q Consensus 824 -----~l~LVmEy~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLi 895 (1044)
.+++||||+.+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEE
Confidence 268999999999999998642 357899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCC
Q 045028 896 DFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD 973 (1044)
Q Consensus 896 DFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ 973 (1044)
|||+++..... .......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+++..+.. .....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~ 264 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDP 264 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCC
Confidence 99999754322 1223456799999999999999999999999999999999999999998888777766543 23345
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++..+++++.++|.+||..||.+||++.+++++
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 778899999999999999999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=358.44 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=217.7
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
...+..++|++.+.||+|+||.||++++ +++.||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3456678999999999999999999987 5788999998653322 233456788999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||++||+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999999999975 45889999999999999999999999 999999999999999999999999999765
Q ss_pred cCCc-ccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--C
Q 045028 904 HNTF-LSSRSTAGTAEWMAPEVLRNEP----SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--D 976 (1044)
Q Consensus 904 ~~~~-~~~~s~~GTp~Y~APEvL~g~~----~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~ 976 (1044)
.... ......+||+.|+|||++.+.. ++.++|||||||+||||++|..||...+....+..+........+| .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 4322 2234567999999999997643 7889999999999999999999999988877777775444444444 3
Q ss_pred CCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHhc
Q 045028 977 NLDPAVADIIRKCWQTDPKM--RPTFTEIMAALK 1008 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPek--RPTa~ELLe~Lk 1008 (1044)
.++.+++++|.+||..++.+ |+++.+|++|..
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 68999999999999844443 789999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.84 Aligned_cols=255 Identities=33% Similarity=0.551 Sum_probs=217.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
..++|.+.+.||+|+||.||+|.+. +..||||.+..... ......+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4567999999999999999999752 36799998865432 334568999999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg 890 (1044)
..++||||+++++|.+++... ...+++..+..++.||+.+|.|||++| |+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~ 159 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDL 159 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCC
Confidence 999999999999999999653 245788999999999999999999999 99999999999999999
Q ss_pred eEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhcc
Q 045028 891 VVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGF 967 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~ 967 (1044)
.++|+|||++....... .......+++.|+|||++.+..++.++|||||||+||+|++ |..||...+..+....+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~- 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT- 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 99999999987543221 12233456788999999999999999999999999999998 999999888777777664
Q ss_pred ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 968 ~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
.......+..++.+++++|.+||..||++||++.|+++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 333344567889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=331.47 Aligned_cols=252 Identities=34% Similarity=0.629 Sum_probs=217.1
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee-cCCCceE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT-RPPNLSI 827 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~-~~~~l~L 827 (1044)
.+..++|++.+.||+|+||.||++...|..+++|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 3556789999999999999999999999999999875432 3456889999999999999999998754 5567999
Q ss_pred EEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+|||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999999987643 35889999999999999999999999 999999999999999999999999998754332
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.. ......+..+++.+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence 1 23345678999999999899999999999999999997 9999998877776666532 33455677899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
|.+||..+|++|||+.++++.|+.+
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.97 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=212.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||+||+++. +++.||+|++.+... .......+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 578899999875332 2234566888999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL- 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~- 908 (1044)
||+.|++|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999876677999999999999999999999999 99999999999999999999999999865433221
Q ss_pred cccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC---CCCCH
Q 045028 909 SSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP---DNLDP 980 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip---~~ip~ 980 (1044)
......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+.+..+........++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223469999999999973 447889999999999999999999999888777776665444334444 34789
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 045028 981 AVADIIRKCWQTDPKM--RPTFTEIMAAL 1007 (1044)
Q Consensus 981 ELkdLI~rcL~kDPek--RPTa~ELLe~L 1007 (1044)
+++++|.+||..++++ |+++.++++|-
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 9999999998664444 78999999983
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=349.21 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=209.2
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
+..++|++.++||+|+||.||++.+ ++..+|+|++.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4567899999999999999999987 47789999876542 23445678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||||+.+++|.+++.+ ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999999976 4568899999999999999999997 47 999999999999999999999999998754322
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc--------------------
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG-------------------- 966 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~-------------------- 966 (1044)
......||..|+|||++.+..++.++|||||||++|+|++|+.||......++...+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2234578999999999999899999999999999999999999997655433321110
Q ss_pred -----------------------cccccCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 967 -----------------------FQHRRLDIP-DNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 967 -----------------------~~~~~~~ip-~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.......++ ..++.++++||.+||++||++|||+.|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 000111111 23678999999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=336.42 Aligned_cols=256 Identities=35% Similarity=0.584 Sum_probs=215.4
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
++..++|++.+.||+|+||.||++.+. +..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456678999999999999999998753 35699998754322 2344568899999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCC---------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeE
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPN---------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVV 892 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~---------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~V 892 (1044)
....++||||+.+++|.+++.+.. ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCE
Confidence 899999999999999999986522 23577889999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhcccc
Q 045028 893 KVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQH 969 (1044)
Q Consensus 893 KLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~ 969 (1044)
+|+|||++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EG 237 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 9999999875432211 1122345788999999999889999999999999999999 789999887776666553 33
Q ss_pred ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 970 ~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.....+..++..++++|.+||+.+|++|||+.|+++.|+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 345667788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=338.78 Aligned_cols=259 Identities=32% Similarity=0.545 Sum_probs=220.9
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+.+.+|.+.+.||+|+||+||++.. ++..+|+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4567899999999999999999874 23458899876443 33456789999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCC------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPN------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg 890 (1044)
+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999986422 35899999999999999999999999 99999999999999999
Q ss_pred eEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhcc
Q 045028 891 VVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGF 967 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~ 967 (1044)
.++|+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987543221 11223446778999999999999999999999999999998 9999998887777766643
Q ss_pred ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 968 ~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
......+..++.++.+|+.+||..||.+|||+.++++.|+++.+.
T Consensus 238 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 -GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 333455677899999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=332.49 Aligned_cols=253 Identities=32% Similarity=0.544 Sum_probs=215.3
Q ss_pred eeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC-----
Q 045028 755 ITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN----- 824 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~----- 824 (1044)
|++++.||+|+||.||+|... +..||+|+++...........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678999999999999999762 3679999987655555566789999999999999999999998765443
Q ss_pred -ceEEEEecCCCcHHHHhcCC-----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 825 -LSIVAEFLPRGSLYRLLHRP-----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 825 -l~LVmEy~~GGsL~dlLkr~-----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
.+++|||+.+++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999887432 246899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCC
Q 045028 899 LSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 899 LA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip 975 (1044)
+++...... .......++..|++||.+.+..++.++|||||||++|||++ |..||.+....+.+..+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 987543221 11122335678999999998889999999999999999999 899998888777776664 33455677
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
..++.++.++|.+||+.||.+|||+.+++++|+++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.67 Aligned_cols=253 Identities=36% Similarity=0.651 Sum_probs=220.8
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.+..++|++.+.||.|+||.||++...|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 34567899999999999999999999999999999865542 456789999999999999999999999988999999
Q ss_pred EEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999997643 36899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ......+..+++++.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHH
Confidence 12345667999999998889999999999999999997 9999988877776665532 234456778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccc
Q 045028 987 RKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.+||..+|++|||+.++++.|+.+
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.47 Aligned_cols=243 Identities=28% Similarity=0.425 Sum_probs=206.0
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHH-HHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVL-IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~-ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +++.||+|++.+.... ......+..|+. +++.++||||+++++++...+.+++||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 5788999998654322 222344555554 67889999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.+ ...+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999988875 467889999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....++...+.++.++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988777777663 34567778899999999999999999
Q ss_pred CCCCCH----HHHHHH
Q 045028 995 KMRPTF----TEIMAA 1006 (1044)
Q Consensus 995 ekRPTa----~ELLe~ 1006 (1044)
.+|+++ .+++++
T Consensus 236 ~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 236 RRRLGAKADFLEIKNH 251 (321)
T ss_pred hhcCCCCCCHHHHhCC
Confidence 999875 355544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.74 Aligned_cols=262 Identities=30% Similarity=0.568 Sum_probs=217.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAV 819 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~ 819 (1044)
|+++.++|++.+.||+|+||.||+|... ++.||+|++.... .......+.+|+.+++++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 6778889999999999999999998642 3679999886543 233456688899999999 799999999987
Q ss_pred ecC-CCceEEEEecCCCcHHHHhcCCC-----------------------------------------------------
Q 045028 820 TRP-PNLSIVAEFLPRGSLYRLLHRPN----------------------------------------------------- 845 (1044)
Q Consensus 820 ~~~-~~l~LVmEy~~GGsL~dlLkr~~----------------------------------------------------- 845 (1044)
... ..++++|||+.+++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 654 56889999999999999985421
Q ss_pred -------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--cccccCCCCC
Q 045028 846 -------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGT 916 (1044)
Q Consensus 846 -------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~~~~~s~~GT 916 (1044)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... ........++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 26788999999999999999999999 999999999999999999999999999754321 1122334567
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCC
Q 045028 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995 (1044)
Q Consensus 917 p~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPe 995 (1044)
..|+|||++.+..++.++|||||||+||||++ |..||.+....+.+............+..+++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 99999876544443333333345556778899999999999999999
Q ss_pred CCCCHHHHHHHhccccC
Q 045028 996 MRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 996 kRPTa~ELLe~Lk~L~k 1012 (1044)
+||++.+|+++|+.+..
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=327.22 Aligned_cols=246 Identities=36% Similarity=0.627 Sum_probs=217.4
Q ss_pred eEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecC
Q 045028 759 ERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
+.||+|+||.||++.+. +..|++|.+....... ....+.+|+.+++.++|+||+++++++.....+++||||+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999875 7789999887654322 46789999999999999999999999999999999999999
Q ss_pred CCcHHHHhcCC--------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 834 RGSLYRLLHRP--------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 834 GGsL~dlLkr~--------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999875 478999999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 906 TF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 906 ~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ......+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 22344567889999999998889999999999999999999 6999999888877777653 44567788899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.+++.+||..+|.+||++.+++++|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=333.40 Aligned_cols=257 Identities=36% Similarity=0.581 Sum_probs=220.2
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
+++..++|++.+.||+|+||.||++... +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 3566789999999999999999998763 2579999875443 2234457889999999999999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCC---------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRP---------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~---------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~ 891 (1044)
.....++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 999999999999999999998642 124678899999999999999999999 999999999999999999
Q ss_pred EEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccc
Q 045028 892 VKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQ 968 (1044)
Q Consensus 892 VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~ 968 (1044)
+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence 9999999987543321 12234457889999999988889999999999999999998 999999888777776665 4
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 969 ~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.....+|..++.++.++|.+||..+|++|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 4456678889999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.48 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=213.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||+||++++ +++.||+|++.+... .......+..|+.++..++|+||+++++++...+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 567899999865322 2233456788999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL- 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~- 908 (1044)
||+.||+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999875678899999999999999999999999 99999999999999999999999999875543222
Q ss_pred cccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC---CCCH
Q 045028 909 SSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD---NLDP 980 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~---~ip~ 980 (1044)
......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+.+..+.....+..+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2234579999999999976 4578899999999999999999999998888777777654444444443 4689
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 045028 981 AVADIIRKCWQTDPKM--RPTFTEIMAA 1006 (1044)
Q Consensus 981 ELkdLI~rcL~kDPek--RPTa~ELLe~ 1006 (1044)
+++++|.+||...+.+ |+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999999876554 4689999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=351.88 Aligned_cols=243 Identities=24% Similarity=0.401 Sum_probs=205.7
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +++.||+|++...... ......+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999987 5778999998765322 34456688899988877 799999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999988866 457899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHhhhccccccCCCCCCCCHHHHHH
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN--------PMQ-VVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~--------~~e-il~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ... ....+ ......+|..++.++.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999999999995311 111 22222 344567888999999999
Q ss_pred HHHhhhcCCCCCCC------HHHHHHH
Q 045028 986 IRKCWQTDPKMRPT------FTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPT------a~ELLe~ 1006 (1044)
|.+||.+||.+||+ +.++++|
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999998 5788877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.38 Aligned_cols=247 Identities=27% Similarity=0.506 Sum_probs=211.8
Q ss_pred EecccCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCC
Q 045028 760 RIGLGSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 760 ~LGkG~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
+||+|+||.||+|.+ ++..+|+|++..........+.+.+|+.+++.+.||||+++++++. .+..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999864 4678999988755544455678999999999999999999999875 45689999999999
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc---cccC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL---SSRS 912 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~---~~~s 912 (1044)
+|.+++.+ ...+++..++.++.|++.||.|||++| |+||||||.|||++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999976 356899999999999999999999999 99999999999999999999999999875433211 1122
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhh
Q 045028 913 TAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991 (1044)
Q Consensus 913 ~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~ 991 (1044)
..++..|+|||.+.+..++.++|||||||++|||++ |..||...+..++...+. .......|..++++++++|.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 234678999999988889999999999999999998 999999888777777664 334566788899999999999999
Q ss_pred cCCCCCCCHHHHHHHhcccc
Q 045028 992 TDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 992 kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.||.+||++.+|.+.|+++.
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 237 YGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred cCchhCcCHHHHHHHHhccc
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.30 Aligned_cols=253 Identities=30% Similarity=0.533 Sum_probs=211.5
Q ss_pred eeEEeEecccCcEEEEEEEECC--c--EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------CC
Q 045028 755 ITLGERIGLGSYGEVYRGDWHG--T--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------PN 824 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g--~--~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~~ 824 (1044)
|.+++.||+|+||.||+|.+.. . .+|+|.++...........+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999998743 2 589998876544455667889999999999999999999876432 24
Q ss_pred ceEEEEecCCCcHHHHhcC-----CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 825 LSIVAEFLPRGSLYRLLHR-----PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr-----~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
.+++|||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999988742 2345889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCC
Q 045028 900 SRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 900 A~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~ 976 (1044)
++....... ......+++.|++||++.+..++.++|||||||++|+|++ |+.||......++...+.. ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-GNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 986543211 1223346778999999999999999999999999999999 8999988777777666542 33445667
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.++..++++|.+||..||++|||+.+|++.|+.+
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 8899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=342.89 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=208.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|.+.++||+|+||+||+++. +++.||+|.+..... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46899999999999999999976 577899998865432 222345778999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+ +|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99975 888888766667899999999999999999999999 999999999999999999999999999765443333
Q ss_pred ccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------------c
Q 045028 910 SRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-----------------R 971 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-----------------~ 971 (1044)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+..... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 344568999999999865 4578999999999999999999999988766544333211000 0
Q ss_pred C-----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 L-----------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 ~-----------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
. .....+++++++||.+||..||.+|||+.|+++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0 11235788999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.78 Aligned_cols=249 Identities=25% Similarity=0.455 Sum_probs=216.7
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||++.+ +++.+++|.+..... ....+.+.+|+.+++.++|+||+++++.+...+.++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 589999999999999999976 578899998864432 34556788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 832 LPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
+++++|.+++.. ....+++..++.++.||+.||.|||++| |+|+||||+|||++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999998865 3456899999999999999999999999 9999999999999999999999999987654443334
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..++++|.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999887776666553 23334467788999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
..||++||++.+|+..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=341.89 Aligned_cols=263 Identities=32% Similarity=0.565 Sum_probs=222.2
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEE
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFM 816 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~ 816 (1044)
.+++..++|.+++.||+|+||.||++++. ...+|+|.+.... .......+..|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 45677789999999999999999998752 2469999886542 234456788899999999 799999999
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
+++...+.+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 99999999999999999999999997532 34788999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCccc--ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTFLS--SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~~~--~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~ 958 (1044)
+|||++.++.+||+|||++......... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999998754322111 112234568999999999889999999999999999998 8999988777
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.++...+. .......+..++.++++||.+||..+|++|||+.++++.|+.+...
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 66666553 3344567788999999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.53 Aligned_cols=249 Identities=33% Similarity=0.522 Sum_probs=209.7
Q ss_pred eeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|++++.||+|+||+||+++.. ++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 889999999999999999984 567999999887655555555567999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccC
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s 912 (1044)
.+++|.+++.+ ...+++..++.++.||+.||.+||+++ |+|+||||+|||++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999983 577899999999999999999999999 999999999999999999999999998754333334456
Q ss_pred CCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhccccc--cCCCCCCCCHHHHHHH
Q 045028 913 TAGTAEWMAPEVLR-NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGFQHR--RLDIPDNLDPAVADII 986 (1044)
Q Consensus 913 ~~GTp~Y~APEvL~-g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~~~~--~~~ip~~ip~ELkdLI 986 (1044)
..++..|+|||++. +..++.++||||||+++|+|++|..||...... ........... ..........++.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 77899999999998 888999999999999999999999999987332 22222211111 1111122348999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 045028 987 RKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+||+.||++||++.+++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.72 Aligned_cols=243 Identities=27% Similarity=0.400 Sum_probs=206.0
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHH-HHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVL-IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~-ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||++++ +|+.||+|++...... ......+..|.. +++.++||||+++++++...+.+++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 5889999998654321 223344555655 46778999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 999998875 467899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
||+.|+|||++.+..++.++|||||||+||+|++|..||...+..+++..+. .....++..++.++.++|.+||.++|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCCHHHHHHHHHHhccCH
Confidence 9999999999999999999999999999999999999999988888777764 33445566789999999999999999
Q ss_pred CCCCCHH----HHHHH
Q 045028 995 KMRPTFT----EIMAA 1006 (1044)
Q Consensus 995 ekRPTa~----ELLe~ 1006 (1044)
.+||++. ++++|
T Consensus 236 ~~R~~~~~~~~~i~~h 251 (325)
T cd05604 236 QRRLGAKEDFLEIQEH 251 (325)
T ss_pred HhcCCCCCCHHHHhcC
Confidence 9999775 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.88 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=215.2
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-CCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-PNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-~~l~LVmE 830 (1044)
+|++++.||+|+||.||++.+ +++.|++|.+..........+.+.+|+.++++++|+|++++++.+... ..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999976 577899999876555455567789999999999999999999987644 45899999
Q ss_pred ecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+++++|.+++... ...+++.+++.++.|++.+|.+||+.| |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999998763 456899999999999999999999999 999999999999999999999999998765443333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .......+..+++++.++|.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHH
Confidence 445678999999999999999999999999999999999999998877666555443 2223356678899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 045028 990 WQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~ 1006 (1044)
|..+|++|||+.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 238 LSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hccCcccCCCHHHHhcC
Confidence 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.54 Aligned_cols=250 Identities=32% Similarity=0.583 Sum_probs=214.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
..+|++.+.||+|+||.||++++. +..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 457999999999999999999874 45799998765432 23457889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc-
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS- 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~- 909 (1044)
|++|++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999875567899999999999999999999999 999999999999999999999999998754432211
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....++..|+|||.+.+..++.++||||||++||+|++ |+.||......+....+. ...+...+..++.++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHH
Confidence 111223457999999999899999999999999999999 899998887777766654 233456677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||..+|++|||+.++++.|
T Consensus 237 cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HhcCChhhCcCHHHHHHHh
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=359.48 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=224.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~L 827 (1044)
.+.|++.+.||+|.||+||+++. +|+.+|+|.+.+..... ...+.+.+|+.+|+++. |||||.+++.|.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45799999999999999999976 58899999997765433 34678999999999998 9999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC----CCeEEEEeccccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK----NWVVKVCDFGLSRMK 903 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~----dg~VKLiDFGLA~~~ 903 (1044)
|||++.||.|++.+.+. .+++..+..++.|++.++.|||+.| |+||||||+|+|+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999875 3999999999999999999999999 999999999999963 358999999999987
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCCHH
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLDPA 981 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip~E 981 (1044)
.. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.......+......+ ..++.++..
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 66 455677899999999999999999999999999999999999999999999888888776554433 334678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++++|.+||..||.+|+|+.++|+|-
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCc
Confidence 99999999999999999999999963
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.23 Aligned_cols=256 Identities=34% Similarity=0.592 Sum_probs=219.7
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
++..++|++.++||+|+||.||++.. +++.++||.+..... ....+.+|+.++++++|+||+++++++......++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 46778999999999999999999976 456799998875442 34568899999999999999999999998899999
Q ss_pred EEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||||+.+++|.+++... ...+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999764 357899999999999999999999999 999999999999999999999999998754422
Q ss_pred c-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 F-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
. .......++..|++||.+.+..++.++||||||+++|+|++ |+.||.+.+.......+.. ......+..++.++.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 1 11122335678999999999889999999999999999998 9999988887777766642 2344556778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++.+||..+|.+||++.++++.|+.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=364.98 Aligned_cols=249 Identities=21% Similarity=0.353 Sum_probs=214.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--C-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--H-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
..|.+.+.||+|+||.||++.. + ++.|++|.+.... ......+.+|+.+++.++||||+++++++...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3599999999999999999976 3 5678888764332 234456788999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||++||+|.+++.+ ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999998754 2456899999999999999999999999 999999999999999999999999999865432
Q ss_pred c--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 F--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+++..+... ....++..++.++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHH
Confidence 2 1234567999999999999999999999999999999999999999988887777766432 233466788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+|.+||.+||++||++.+++.+
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999999764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.42 Aligned_cols=256 Identities=34% Similarity=0.600 Sum_probs=217.7
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
|++..++|++.++||+|+||.||++.. .+..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 356778999999999999999999986 456799998875443 2356889999999999999999999875 46689
Q ss_pred EEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999998763 356899999999999999999999999 99999999999999999999999999975433
Q ss_pred Ccc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 906 TFL-SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 906 ~~~-~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+. .......+..++.+++
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 221 1122335668999999998889999999999999999999 899998888777776664 2344566778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+|+.+||.++|.+|||+.++.+.|+++
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=336.36 Aligned_cols=249 Identities=38% Similarity=0.672 Sum_probs=211.6
Q ss_pred eeEEeEecccCcEEEEEEEEC------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 755 ITLGERIGLGSYGEVYRGDWH------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+++.+.||.|.||.||+|.+. +..|+||.+... ......+.+.+|++++++++||||+++++++...+.+++|
T Consensus 1 ~~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 1 IKLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred CEEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccc
Confidence 367899999999999999887 678999998543 2344577899999999999999999999999988889999
Q ss_pred EEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC--
Q 045028 829 AEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN-- 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~-- 905 (1044)
|||+.+|+|.+++... ...+++..++.++.||+.||.|||+++ |+|++|+++|||++.++.+||+|||++.....
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 9999999999999875 678999999999999999999999999 99999999999999999999999999976521
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+ ....+...+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHH
Confidence 1122333456778999999999889999999999999999999 78999999888888777 455667778889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+|.+||..||.+|||+.+|++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=360.60 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=230.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.-|.+.+.||+|.|..|-++++ +|..||||++.+..+..-....+.+|+..|+.++|||||++|++......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588999999999999999987 89999999999888777777789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE-cCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV-DKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL-d~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
.-++|+|+++|-++...+.+..+.+|+.||+.|+.|||+.. +|||||||+||+| .+-|.|||+|||++..... ...
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-G~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-GKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCC-cch
Confidence 99999999999999999999999999999999999999999 9999999999976 4679999999999976543 345
Q ss_pred ccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s-~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
..+.||...|-|||++.|..|+ +++||||||+|||.|++|++||+..+..+.+-.| ..-.+.+|.+++.+.++||..
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLIQS 252 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHHHH
Confidence 6788999999999999999986 6899999999999999999999999999888887 456788999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||..||.+|.+.++|..+-
T Consensus 253 MLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred HHhcCchhhccHHHHhccc
Confidence 9999999999999998763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=377.27 Aligned_cols=259 Identities=25% Similarity=0.452 Sum_probs=217.8
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEee-eec
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGA-VTR 821 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~-~~~ 821 (1044)
....+..-+++|.+.|-+|||+.||++... |..||+|++... .+..+..+++||.+|+.|. |+|||.|++. ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 455667778999999999999999999873 379999998766 4677889999999999997 9999999993 221
Q ss_pred ------CCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEE
Q 045028 822 ------PPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKV 894 (1044)
Q Consensus 822 ------~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKL 894 (1044)
...++|+||||.||.|.+++.++ ...|++.++++|++++++|+.+||.+.++|||||||-|||||+.+|++||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 12488999999999999999853 45599999999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCcccc---------cCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 045028 895 CDFGLSRMKHNTFLSS---------RSTAGTAEWMAPEVL---RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV 962 (1044)
Q Consensus 895 iDFGLA~~~~~~~~~~---------~s~~GTp~Y~APEvL---~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil 962 (1044)
||||.++......... -...-|+.|++||++ .+.+.++|+|||+|||+||-||....||++.....
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-- 265 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-- 265 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence 9999987433221110 112369999999998 67889999999999999999999999998764432
Q ss_pred hhhccccccCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 963 GAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 963 ~~I~~~~~~~~ip~--~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
| .+..+.+|. .++..+++||..||+.||.+||++-+++.++..+..
T Consensus 266 --I--lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 --I--LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred --E--EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 2 344555554 789999999999999999999999999999887664
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=338.77 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=205.0
Q ss_pred ecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 761 IGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 761 LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
||+|+||+||++.+ +++.||+|.+....... ...+.+..|+.+++.++|+||+++++++.....+++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999976 57899999986543322 2345678899999999999999999999999999999999999999
Q ss_pred HHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 838 YRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 838 ~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 888743 3457899999999999999999999999 99999999999999999999999999876544333334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----QVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~----eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +....+ ......++..+++++.+++.+||
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999865432 222222 22345567789999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 045028 991 QTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRP-----Ta~ELLe~ 1006 (1044)
+.||++|| +++++++|
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 78999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=333.46 Aligned_cols=252 Identities=29% Similarity=0.499 Sum_probs=209.4
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..++|++++.||+|+||.||++++ +++.||+|++.... ......+.+|+.++++++||||+++++++...+.+++|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 456899999999999999999986 67889999886543 23345688899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.+++|.+++.+ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 85 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999999875 457899999999999999999999999 99999999999999999999999999976543332
Q ss_pred cccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc---ccCCCCCCCCHHH
Q 045028 909 SSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH---RRLDIPDNLDPAV 982 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~---~~~~ip~~ip~EL 982 (1044)
......|++.|+|||.+. ...++.++|||||||++|+|++|+.||....+.+....+.... .....+..++.++
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 334456899999999985 3447789999999999999999999997665444332221111 1112224578899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.++|.+||..+|++|||+++|+++|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.44 Aligned_cols=258 Identities=32% Similarity=0.586 Sum_probs=217.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--Cc--EEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~--~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~ 826 (1044)
+++|++.+.||+|+||.||++... +. .+++|.++... .....+.+.+|+.++.++ +||||+++++++...+.++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 578999999999999999999763 33 46888765322 233456788999999999 6999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe
Q 045028 827 IVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~ 891 (1044)
++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999986522 35888999999999999999999999 999999999999999999
Q ss_pred EEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccc
Q 045028 892 VKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHR 970 (1044)
Q Consensus 892 VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~ 970 (1044)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||......+....+.. ..
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 235 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CC
Confidence 999999998643221 11122233557999999999999999999999999999997 9999998888777766642 33
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 971 RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 971 ~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
....+..++.++++||.+||..+|.+|||+.++++.|+.+....
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 45567789999999999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=358.27 Aligned_cols=264 Identities=31% Similarity=0.527 Sum_probs=220.3
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~ 817 (1044)
..+.++.++|.++++||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 356677889999999999999999999762 2369999886543 2344567899999999996 999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCC----------------------------------------------------
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------------------------------------------- 845 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------------------------------------------- 845 (1044)
++...+.+||||||+++|+|.+++.+..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999876421
Q ss_pred -------------------------------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCC
Q 045028 846 -------------------------------------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSP 882 (1044)
Q Consensus 846 -------------------------------------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPe 882 (1044)
..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~ 266 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR 266 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence 24677888999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 045028 883 NLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPM 959 (1044)
Q Consensus 883 NILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~ 959 (1044)
|||++.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||+||+|++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999987543221 12233457788999999999999999999999999999997 99999876544
Q ss_pred HHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 960 QVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 960 eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
...........+...+..++.++.++|.+||..||++|||+.+|.+.|+.+.+
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 43333322334556677899999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.31 Aligned_cols=261 Identities=31% Similarity=0.601 Sum_probs=221.8
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEee
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGA 818 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~ 818 (1044)
.+++..++|++.+.||+|+||.||++.+. ...+|+|.+.... .......+.+|+.+++++ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45677789999999999999999999763 2569999876543 234456788999999999 79999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCc
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPN 883 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeN 883 (1044)
+...+.++++|||+.+++|..++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999998642 356899999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 045028 884 LLVDKNWVVKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQ 960 (1044)
Q Consensus 884 ILLd~dg~VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~e 960 (1044)
||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999986543211 1222335678999999999999999999999999999997 999999888777
Q ss_pred HHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 961 il~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
....+. .......+..++.++.+|+.+||..||++|||+.+++++|+.+.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 666554 33445667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.83 Aligned_cols=256 Identities=24% Similarity=0.478 Sum_probs=216.6
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||.||++.. +|+.|++|.++..... ......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 5889999988654332 334677899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||+++++|..++.. ....+++..++.++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998864 2456899999999999999999999999 999999999999999999999999998755433
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhccccccCCCCC-CCCHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN--PMQVVGAVGFQHRRLDIPD-NLDPAVA 983 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~--~~eil~~I~~~~~~~~ip~-~ip~ELk 983 (1044)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+....+.. ......+. .++.++.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHH
Confidence 333344568999999999999889999999999999999999999996543 2233333321 22233444 7888999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
++|.+||..+|++|||+.+|++.|+++.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.01 Aligned_cols=259 Identities=33% Similarity=0.537 Sum_probs=220.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+...+|.+.+.||+|+||.||++++. +..+++|.+.... ......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45678999999999999999999752 3458888875433 23346788999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD 887 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd 887 (1044)
+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 9999999999999999998653 234889999999999999999999999 99999999999999
Q ss_pred CCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 045028 888 KNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGA 964 (1044)
Q Consensus 888 ~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~ 964 (1044)
.++.++|+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987543321 12233457889999999999999999999999999999998 9999988887776665
Q ss_pred hccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 965 VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 965 I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+. .......+..++..+.+++.+||..+|++|||+.++++.|+++.+.
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 53 3334445667899999999999999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.22 Aligned_cols=246 Identities=33% Similarity=0.591 Sum_probs=208.9
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCc
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGS 836 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGs 836 (1044)
+.||+|+||.||++.+ +++.+|+|.+... ........+.+|++++++++||||+++++++......++||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999976 6888999987543 233445678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc--cCCC
Q 045028 837 LYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS--RSTA 914 (1044)
Q Consensus 837 L~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~--~s~~ 914 (1044)
|.+++.+....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99999775667899999999999999999999999 9999999999999999999999999987543221110 1112
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcC
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kD 993 (1044)
++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. .......+..++.++.+++.+||..+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999999889999999999999999997 899998777665555443 23345667788999999999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 045028 994 PKMRPTFTEIMAALK 1008 (1044)
Q Consensus 994 PekRPTa~ELLe~Lk 1008 (1044)
|++|||+.++++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.17 Aligned_cols=251 Identities=22% Similarity=0.409 Sum_probs=220.5
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++++.||.|+||.||.++. +++.+++|.+............+.+|+.++++++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999888765 678899999876665566667889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 832 LPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
+.+++|.+++.+. ...+++..+..++.|++.+|.|||+.| |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 456899999999999999999999999 9999999999999999999999999987654443334
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.... ....+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHc
Confidence 45678999999999998888999999999999999999999999888777776664322 33345778999999999999
Q ss_pred hcCCCCCCCHHHHHHHh
Q 045028 991 QTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~L 1007 (1044)
.++|.+||++.++++++
T Consensus 238 ~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 238 QQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCcccCCCHHHHhhCc
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.87 Aligned_cols=257 Identities=24% Similarity=0.453 Sum_probs=215.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||.||++.+ +++.++||.+..... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5799999999999999999985 688999998765432 2334567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998864 2456899999999999999999999999 999999999999999999999999998765443
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP--MQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~--~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+... .+....+.........+..+++++++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 3333345789999999999998899999999999999999999999976543 23333332222222233468899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
+|.+||..||++|||+.+|++.++++.
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.35 Aligned_cols=253 Identities=26% Similarity=0.313 Sum_probs=214.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CCCceE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PPNLSI 827 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~~l~L 827 (1044)
.++|+.+.+|++|+||.||+|++ +++.||+|+++...-...-.-...+||.+|.+++|||||.+-.+... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46899999999999999999987 57789999987554222222346789999999999999999887654 457999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|||||+. +|..++......|...++..++.|++.||+|||.+. |+|||||++|+|++..|.+||+|||+|+..+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999965 899999987789999999999999999999999999 9999999999999999999999999999888776
Q ss_pred ccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc---------------
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR--------------- 971 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~--------------- 971 (1044)
......+-|.+|+|||.+.|.. |+.++|+||+|||+.||+++++.|.+..+.+.+.+|...-..
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 5566677899999999998876 899999999999999999999999998877766655211110
Q ss_pred --C------------CCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 --L------------DIPDN-LDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 --~------------~ip~~-ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
. .++.. ++....+|++.+|..||.+|.|+.|.|+|=
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 0 11111 557788999999999999999999999873
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=348.13 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=213.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.++||+|+||+||++++ .++.||+|++.+.... ......+..|+.++..++|+||+++++++...+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999987 4678999998653322 233455888999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC-cc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT-FL 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~-~~ 908 (1044)
||+.+|+|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999876677999999999999999999999999 999999999999999999999999998754322 12
Q ss_pred cccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC---CCCCH
Q 045028 909 SSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP---DNLDP 980 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip---~~ip~ 980 (1044)
.....+||+.|+|||++. ...++.++|||||||+||||++|+.||...+..+.+..+.....+..+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3457889999999999999999999999988888877775544444444 35799
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 045028 981 AVADIIRKCWQTDPKM--RPTFTEIMAA 1006 (1044)
Q Consensus 981 ELkdLI~rcL~kDPek--RPTa~ELLe~ 1006 (1044)
++++||.+||..++.+ |+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999665544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=359.77 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=196.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC------CCeeEEEeeeec
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH------PNVVLFMGAVTR 821 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH------PNIVkl~~~~~~ 821 (1044)
+..++|+++++||+|+||+||++.+ .++.||||++.... .....+..|+.+++.++| .+|++++++|..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3457899999999999999999976 57789999986432 223345667777777654 458889998876
Q ss_pred C-CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCC---------
Q 045028 822 P-PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNW--------- 890 (1044)
Q Consensus 822 ~-~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg--------- 890 (1044)
+ ..++||||++ |++|.+++.+ ...+++..++.++.||+.||.|||. .| ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccc
Confidence 5 4688999988 7788888876 3579999999999999999999997 59 99999999999998765
Q ss_pred -------eEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh
Q 045028 891 -------VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVG 963 (1044)
Q Consensus 891 -------~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~ 963 (1044)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||+||||++|++||.+.+..+.+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 599999998864322 2345689999999999999999999999999999999999999998877654433
Q ss_pred hhccccccC-------------------------C-CC--------------CCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 045028 964 AVGFQHRRL-------------------------D-IP--------------DNLDPAVADIIRKCWQTDPKMRPTFTEI 1003 (1044)
Q Consensus 964 ~I~~~~~~~-------------------------~-ip--------------~~ip~ELkdLI~rcL~kDPekRPTa~EL 1003 (1044)
.+......+ . .+ ...++.+.+||.+||.+||.+|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 221110000 0 00 0124567899999999999999999999
Q ss_pred HHHh
Q 045028 1004 MAAL 1007 (1044)
Q Consensus 1004 Le~L 1007 (1044)
|+|-
T Consensus 436 L~Hp 439 (467)
T PTZ00284 436 TTHP 439 (467)
T ss_pred hcCc
Confidence 9874
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.38 Aligned_cols=248 Identities=24% Similarity=0.313 Sum_probs=204.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------C
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------P 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~ 823 (1044)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999976 578899999876544444556788999999999999999999987543 3
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+|+||||+.+ +|..++.. .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 47999999965 67777753 4788999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------- 970 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------- 970 (1044)
.... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+.....
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 4322 22345789999999999999999999999999999999999999988776554443321100
Q ss_pred -------c--------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 -------R--------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 -------~--------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+ .......+.++++||.+||..||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00111235678999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=362.65 Aligned_cols=249 Identities=29% Similarity=0.507 Sum_probs=223.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
..|+..+.||+|.||.||+|.+ +++.||+|++.-.. ....++.+.+|+.+|..++++||.++|+.+.....+|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4688889999999999999977 67889999876443 34556788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
||.||++.++++. +..+.+..+..++.+++.||.|||.++ .+|||||+.|||+..+|.|||+|||.+..........
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999999987 455588888889999999999999999 9999999999999999999999999998877777777
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
.+++|||.|||||++++..|+.++||||||++.+||.+|.+||....+...+..|. +...+.+...+++.++++|..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999988876665553 44455555689999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
.+||+.||++.++|+|
T Consensus 248 ~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKH 263 (467)
T ss_pred hcCcccCcCHHHHhhh
Confidence 9999999999999987
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=336.06 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=216.9
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+...+|++.++||+|+||.||+|.+. ++.||||++.... .......+..|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 34467899999999999999999763 3679999886443 233446688999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD 887 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd 887 (1044)
...++++||+.+++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 9999999999999999998521 235788889999999999999999999 99999999999999
Q ss_pred CCCeEEEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 045028 888 KNWVVKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGA 964 (1044)
Q Consensus 888 ~dg~VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~ 964 (1044)
.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999875432221 1233446789999999988889999999999999999998 8899998888777777
Q ss_pred hccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 965 VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 965 I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
+.. .....++..++.++.+|+.+||+.+|.+||++.+|++.|+.
T Consensus 239 i~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 643 33345678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.63 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=211.3
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchh-hHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGE-SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~-~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.|++.++||+|+||+||++.+ +++.||||++........ ....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999986 578999999865433222 23457789999999999999999999999899999999
Q ss_pred ecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+.+++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999888653 356899999999999999999999999 9999999999999999999999999987643221 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc--cccccCCCCCCCCHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG--FQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~--~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+. .......++..++..+.+||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 234578999999999999889999999999999999999999998765533222221 123344566779999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHH
Q 045028 988 KCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
+||..||.+|| ++.++++|
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 89999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.49 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=203.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++.+.||+|+||.||++.+ +|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999976 5789999998765444445567889999999999999999999986543
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999965 56666643 4788999999999999999999999 999999999999999999999999999754
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc---------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ--------------- 968 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~--------------- 968 (1044)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 322 2233457899999999999999999999999999999999999999876644322211000
Q ss_pred -----cccC--------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 969 -----HRRL--------------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 969 -----~~~~--------------------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.... ......++++++||.+||..||++|||+.|+++|-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0000 011234678999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.17 Aligned_cols=253 Identities=29% Similarity=0.502 Sum_probs=215.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
.+.+.|+++++||+|+||.||+++. +++.+++|.+.... ......+.+|+.+++.++||||+++++.+..++.+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3457899999999999999999987 47889999886543 3456678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+.+++|..++.+....+++..++.++.||+.+|.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99999999999988765677999999999999999999999999 9999999999999999999999999987544333
Q ss_pred ccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHH
Q 045028 908 LSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPA 981 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~E 981 (1044)
.......+++.|+|||++. ...++.++|||||||++|+|++|.+||...+..+....+.... .....+..++.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 3334556889999999985 3446789999999999999999999998877665554443221 233445678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+.++|.+||..+|++||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.90 Aligned_cols=255 Identities=33% Similarity=0.552 Sum_probs=217.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
..+|++.+.||+|+||.||+|.+. +..+|+|.+.... .......+.+|+.++++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457999999999999999999762 2369999876432 2345567899999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999876667899999999999999999999999 999999999999999999999999998764332
Q ss_pred ccc---ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 907 FLS---SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 907 ~~~---~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
... .....++..|++||.+.+..++.++|+|||||++|++++ |..||......+....+... .+...+..+++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAAL 238 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHH
Confidence 111 112223568999999999889999999999999999886 99999988777666665432 3445566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++++.+||+++|.+||++.++++.|+.+
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.47 Aligned_cols=256 Identities=34% Similarity=0.589 Sum_probs=216.2
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
.+..++|++.++||+|+||.||++++. ...||+|.+..... ..+.+.+|+.++++++||||+++++.+. ....++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 456678999999999999999999874 35799998875432 2356889999999999999999998874 466899
Q ss_pred EEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||||+.+++|.+++.+. ...+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999763 346889999999999999999999999 999999999999999999999999999754432
Q ss_pred cc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 FL-SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~-~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.. ......++..|++||++.+..++.++|||||||++|+|++ |+.||......+....+.. ......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHH
Confidence 21 1123346678999999998889999999999999999999 8999988877776665532 2334456678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
+|.+||+++|.+||++.++++.|+.++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.01 Aligned_cols=243 Identities=23% Similarity=0.394 Sum_probs=206.1
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||+||+++. +++.||+|++...... ......+.+|+.++.++ +||||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999986 5688999998765332 34456788999999888 599999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|..++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 999998875 457999999999999999999999999 99999999999999999999999999875333333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHH-HHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN------PMQ-VVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~------~~e-il~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
||+.|+|||++.+..++.++|||||||+||+|++|..||.... ..+ ....+ ......+|..++..+.++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~ 235 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIRIPRFLSVKASHVLK 235 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999996421 122 22223 33456678889999999999
Q ss_pred HhhhcCCCCCCC------HHHHHHH
Q 045028 988 KCWQTDPKMRPT------FTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPT------a~ELLe~ 1006 (1044)
+||.+||.+|++ +.++++|
T Consensus 236 ~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 236 GFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999997 5688776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.24 Aligned_cols=255 Identities=35% Similarity=0.611 Sum_probs=215.2
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECC-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
++..++|++.+.||+|+||.||++.+.+ ..+++|.+..... ..+.+.+|+.++++++|+||+++++++. .+..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4556789999999999999999998754 5799998764432 2356888999999999999999998875 466899
Q ss_pred EEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+|||+.+++|.+++.+. ...+++..+..++.||+.||.|||+.| |+|+||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999999763 345889999999999999999999999 999999999999999999999999999754332
Q ss_pred cc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 FL-SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~-~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.. ......++..|++||.+.+..++.++||||||+++|+|++ |+.||.+....+....+. .......+..++..+++
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHH
Confidence 21 1122346678999999998889999999999999999999 999999887777666653 23344566788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+|.+||.+||.+||++.++++.|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.36 Aligned_cols=256 Identities=32% Similarity=0.533 Sum_probs=214.4
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
++..++|++.+.||+|+||.||++.+. +..|++|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345678999999999999999999874 3568888765432 23334568889999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCC------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---eE
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPN------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW---VV 892 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg---~V 892 (1044)
....++||||+.|++|.+++.+.. ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 899999999999999999987632 25899999999999999999999999 99999999999998654 69
Q ss_pred EEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhcccc
Q 045028 893 KVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQH 969 (1044)
Q Consensus 893 KLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~ 969 (1044)
||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+. ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 9999999976532211 1112234568999999998889999999999999999997 999999877776665553 33
Q ss_pred ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 970 ~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.....+..++.++.+++.+||+.+|++||++.+++++|.
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 455667889999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.83 Aligned_cols=251 Identities=33% Similarity=0.563 Sum_probs=214.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.+.||.|+||.||++.+ +++.+++|.+..... ...+.+.+|+.++++++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 46899999999999999999987 567899999875532 25577899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999876578999999999999999999999999 999999999999999999999999998765443323
Q ss_pred ccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc---ccCCCCCCCCHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNE---PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH---RRLDIPDNLDPAVA 983 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~---~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~---~~~~ip~~ip~ELk 983 (1044)
.....++..|++||.+.+. .++.++|+||||+++|+|++|..||......+....+.... .....+..++.+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3445789999999999877 78899999999999999999999998877655444332221 11223345678899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++|.+||..+|.+|||+.+|+.+
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.90 Aligned_cols=257 Identities=33% Similarity=0.541 Sum_probs=214.9
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECC------------------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHG------------------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g------------------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN 811 (1044)
+...+|+++++||+|+||.||++.+.. ..||+|.+..... ......+.+|+.++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCC
Confidence 345789999999999999999987632 4589998765432 345677899999999999999
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCC----------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN----------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~----------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
|+++++++..++..+++|||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp 158 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLAT 158 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccch
Confidence 9999999999999999999999999999987633 26899999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCC
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT--MQQPWGGMN 957 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT--Gk~PF~~~~ 957 (1044)
+|||++.++.++|+|||++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999987543221 22234456789999999998889999999999999999998 788998777
Q ss_pred hHHHHhhhccc------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 958 PMQVVGAVGFQ------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 958 ~~eil~~I~~~------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
..+.+..+... ......+..++.++.++|.+||+.||.+|||+.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 66665544322 11233456678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.10 Aligned_cols=263 Identities=31% Similarity=0.561 Sum_probs=223.0
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE---------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEE
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW---------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFM 816 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~---------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~ 816 (1044)
.+++..++|++.+.||+|+||.||++++ .+..||+|.+... ........+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3567788999999999999999999964 2346999987643 2234556789999999999 799999999
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
+++......++||||+.+++|.+++.+.. ..++...++.++.||+.||.|||++| |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999987531 35788889999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~ 958 (1044)
+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||++||+|++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999976543221 1222345678999999999889999999999999999998 8899988887
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.++...+. .......+..++.+++++|.+||..+|.+|||+.++++.|+++...
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 77777664 3334556778899999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=340.05 Aligned_cols=264 Identities=31% Similarity=0.588 Sum_probs=223.0
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEE
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFM 816 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~ 816 (1044)
.+.+..++|.++++||+|+||.||+++.. ...+|+|.+.... .......+..|+.+++++ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 45677889999999999999999998752 3468999876543 244566788999999999 599999999
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
+++...+.++++|||+.+++|.+++... ...+++..+..++.||+.||.|||++| |+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 9999989999999999999999998652 235888999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCccc--ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTFLS--SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~~~--~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~ 958 (1044)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999755432111 122234567999999999889999999999999999999 8999988887
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.+.+..+. .......+..++.+++++|.+||..+|++|||+.++++.|+.+....
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 EELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 77776654 23345667788999999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.65 Aligned_cols=262 Identities=36% Similarity=0.568 Sum_probs=218.3
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
|++..++|++.++||+|+||.||+|... +..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566789999999999999999998643 34799998764432 233446788999999999999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCC---------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRP---------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~---------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~ 891 (1044)
.....++||||+.+|+|.+++.+. ...++...+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 999999999999999999999642 133466788899999999999999999 999999999999999999
Q ss_pred EEEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccc
Q 045028 892 VKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQ 968 (1044)
Q Consensus 892 VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~ 968 (1044)
++|+|||+++....... ......++..|++||.+.+..++.++|||||||++|||++ |..||.+....+....+. .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999875432211 1122345778999999999889999999999999999998 789999888777666553 2
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 969 ~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
......+..++++++++|.+||+.||.+|||+.++++.|++...+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 334456677889999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.05 Aligned_cols=261 Identities=30% Similarity=0.528 Sum_probs=219.3
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEee
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGA 818 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~ 818 (1044)
.+.+..++|.+.+.||+|+||.||++.+ .+..+|+|.++.... ....+.+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4567778999999999999999999864 234699998765432 33456789999999999 79999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
+...+.++++|||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999997533 34899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCC
Q 045028 898 GLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDI 974 (1044)
Q Consensus 898 GLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~i 974 (1044)
|++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..............
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 9987543221 11223346788999999999999999999999999999998 99999887665544443333334455
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+..+++++.+++.+||.++|++|||+.++++.|+++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 677899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.00 Aligned_cols=260 Identities=28% Similarity=0.520 Sum_probs=218.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCc----EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGT----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~----~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+..++|++.++||+|+||+||+|++ ++. .||+|.+.... .......+.+|+.+++.+.||||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 3457899999999999999999976 343 48999876443 23445678899999999999999999998875 5
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..+++|||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 578999999999999999876677999999999999999999999999 999999999999999999999999999755
Q ss_pred cCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 904 HNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 904 ~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... ......+++.|++||.+.+..++.++|||||||+||||++ |..||.......+...+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCH
Confidence 32211 1122335678999999999999999999999999999998 999998877666555443 3334455677899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
++.++|.+||..||++||++.++++.|..+....
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 9999999999999999999999999998886653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.97 Aligned_cols=250 Identities=27% Similarity=0.482 Sum_probs=217.3
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CCCceEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PPNLSIVA 829 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~~l~LVm 829 (1044)
+|++.+.||.|+||.||++.+ +++.|++|++..........+.+..|+.+++.++||||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 589999999999999999976 67889999987666556666788999999999999999999997754 34589999
Q ss_pred EecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHH-----hCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 830 EFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLH-----NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLH-----s~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
||+.+++|.+++.+. ...+++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998653 467899999999999999999999 888 9999999999999999999999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.............|++.|++||++.+..++.++|+||||+++|+|++|+.||...+..+....+. ......++..++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence 66544332344578999999999999889999999999999999999999999887666666553 23334567788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+.+++.+||..+|.+||++.+|+++
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.50 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=216.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+.+.+|.+.++||+|+||.||++.. .+..+++|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567899999999999999999863 34578888776433 34456799999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCC--------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPN--------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~--------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~ 888 (1044)
...+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 99999999999999999987532 35789999999999999999999999 999999999999999
Q ss_pred CCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 045028 889 NWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAV 965 (1044)
Q Consensus 889 dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I 965 (1044)
++.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999999987543221 11223345788999999999999999999999999999998 99999887777666655
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 966 GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 966 ~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
. .......+..+++.+.++|.+||..||.+||++.+|++.|+
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 3 33345667789999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=332.97 Aligned_cols=256 Identities=31% Similarity=0.559 Sum_probs=216.4
Q ss_pred CeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 754 EITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+|++.+.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4889999999999999999763 2458888776443 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC-----------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCc
Q 045028 827 IVAEFLPRGSLYRLLHRP-----------------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPN 883 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-----------------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeN 883 (1044)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999987642 134788999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 045028 884 LLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQ 960 (1044)
Q Consensus 884 ILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~e 960 (1044)
||++.++.+||+|||+++...... .......++..|++||++.+..++.++||||||+++|+|++ |..||.+..+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987543221 11223446778999999998889999999999999999998 999999888777
Q ss_pred HHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 961 il~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+...+. .......+..++.++.++|.+||+.+|.+||++.++++.|+++..+
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 666553 2234556778899999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.29 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=206.8
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-----Cce
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-----NLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-----~l~ 826 (1044)
+|+++++||+|+||+||++.+ +++.||||++............+.+|+.+++.++||||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999986 6889999988654333344567889999999999999999999998776 789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 578887765 467999999999999999999999999 999999999999999999999999999754322
Q ss_pred c-ccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc----------------
Q 045028 907 F-LSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---------------- 968 (1044)
Q Consensus 907 ~-~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~---------------- 968 (1044)
. .......+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1 1223346899999999998754 789999999999999999999999887765544433110
Q ss_pred -------cc-------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 969 -------HR-------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 969 -------~~-------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.. ...+...+++++.+||.+||..||.+|||+.|+++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00 0123345688999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.98 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=200.8
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC---CCCCeeEEEeeeecC-----C
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV---RHPNVVLFMGAVTRP-----P 823 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L---rHPNIVkl~~~~~~~-----~ 823 (1044)
+|++.+.||+|+||+||++++ +++.||+|.+............+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999987 578899998875433222233456677777665 699999999987642 3
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.++++|||+.+ +|.+++.+. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999975 888888653 345899999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc---------c--
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR---------R-- 971 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~---------~-- 971 (1044)
..... ......||..|+|||++.+..++.++|||||||++|+|++|++||.+....+.+..+..... .
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54322 22345689999999999998999999999999999999999999987766554433311000 0
Q ss_pred --------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 --------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 --------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......++.++++||.+||++||.+|||+.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01123578889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.15 Aligned_cols=262 Identities=31% Similarity=0.544 Sum_probs=215.3
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAV 819 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~ 819 (1044)
|.++.++|++++.||+|+||.||+|.+ .++.||||+++... .......+.+|+.++.++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 567888999999999999999999963 45789999986543 233456788999999999 689999999977
Q ss_pred ecC-CCceEEEEecCCCcHHHHhcCCC-----------------------------------------------------
Q 045028 820 TRP-PNLSIVAEFLPRGSLYRLLHRPN----------------------------------------------------- 845 (1044)
Q Consensus 820 ~~~-~~l~LVmEy~~GGsL~dlLkr~~----------------------------------------------------- 845 (1044)
... ..++++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46899999999999999986421
Q ss_pred -------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--ccc
Q 045028 846 -------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--LSS 910 (1044)
Q Consensus 846 -------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~~~ 910 (1044)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 23677888899999999999999999 9999999999999999999999999987542221 112
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
....++..|+|||++.+..++.++||||||+++|+|++ |..||......+..............+..+++++.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 23345678999999999899999999999999999997 99999876543333333233445566777889999999999
Q ss_pred hhcCCCCCCCHHHHHHHhccccC
Q 045028 990 WQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
|..+|.+|||+.+|+++|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.72 Aligned_cols=260 Identities=32% Similarity=0.633 Sum_probs=216.9
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcE--EEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTE--VAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~--VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~ 823 (1044)
.+.+++|++.+.||+|+||.||+|.+ ++.. +++|.+... ........+.+|+.++.++ +||||+++++++...+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 35678999999999999999999986 3443 567765432 2234456788999999999 8999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~ 888 (1044)
.+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecC
Confidence 9999999999999999986532 35789999999999999999999999 999999999999999
Q ss_pred CCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhcc
Q 045028 889 NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGF 967 (1044)
Q Consensus 889 dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~ 967 (1044)
++.+||+|||++..... ........++..|+|||++.+..++.++|||||||+||+|++ |..||...+..+....+.
T Consensus 160 ~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~- 237 (303)
T cd05088 160 NYVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 237 (303)
T ss_pred CCcEEeCccccCcccch-hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-
Confidence 99999999999864321 111222334678999999998889999999999999999998 999998887777666553
Q ss_pred ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 968 ~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.......+..+++++.+||.+||..+|++||++.++++.|+.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2234456667899999999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=325.57 Aligned_cols=256 Identities=31% Similarity=0.580 Sum_probs=217.6
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
|++..++|++.++||+|+||.||++.+ .+..+++|.+.... ...+.+.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 456788999999999999999999986 45679999876432 345678899999999999999999999887 7789
Q ss_pred EEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++|||+.+++|.+++.+. ...+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999999763 456888999999999999999999999 99999999999999999999999999875432
Q ss_pred Cc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 906 TF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 906 ~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.. .......++..|++||++.+..++.++|+|||||++|++++ |+.||...+..+....+. .......+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 21 11222345678999999998889999999999999999998 999999887766666553 2334455678899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+++.+||.++|++||++.++++.|+++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=329.93 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=205.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||.|+||.||+++. +++.||||.+............+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 589999999999999999987 578899998865543334456788899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 832 LPRGSLYRLLHRP--NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 832 ~~GGsL~dlLkr~--~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
+. ++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 5888888653 357899999999999999999999999 999999999999999999999999998755433333
Q ss_pred ccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc--------------------
Q 045028 910 SRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-------------------- 968 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-------------------- 968 (1044)
.....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+....+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3344678999999998764 4788999999999999999999999876543322211000
Q ss_pred -------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 969 -------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 969 -------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.........++++++++|.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001124578999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.49 Aligned_cols=250 Identities=24% Similarity=0.468 Sum_probs=219.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||+++. +++.|++|.+............+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999876 678999999876544455566889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 832 LPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
+.+++|.+++... ...+++..++.++.|++.+|.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999998753 346889999999999999999999999 9999999999999999999999999997654433333
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+. .......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHh
Confidence 34568899999999999889999999999999999999999998887777766653 23344567788999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
+.+|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 238 KRNPRDRPSVNSILEK 253 (256)
T ss_pred hCChhhCcCHHHHhhC
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=357.11 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=199.8
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-----
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP----- 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~----- 822 (1044)
....+|+++++||+|+||+||+|.+ +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3457899999999999999999977 67889999875432 2345799999999999999998876432
Q ss_pred ---CCceEEEEecCCCcHHHHhc---CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEE
Q 045028 823 ---PNLSIVAEFLPRGSLYRLLH---RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVC 895 (1044)
Q Consensus 823 ---~~l~LVmEy~~GGsL~dlLk---r~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLi 895 (1044)
..+++||||+++ +|.+++. +....+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 236789999975 6766654 23567999999999999999999999999 99999999999999664 79999
Q ss_pred eccccccccCCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-----
Q 045028 896 DFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH----- 969 (1044)
Q Consensus 896 DFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~----- 969 (1044)
|||+++...... ......||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+..+.+..+....
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999998654322 22345789999999998764 68999999999999999999999998876654443332100
Q ss_pred ----------------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 ----------------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 ----------------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....+|...++++++||.+||.+||.+|||+.|+++|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0112345678899999999999999999999999987
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.32 Aligned_cols=257 Identities=32% Similarity=0.537 Sum_probs=217.9
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC--Cc---EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH--GT---EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~--g~---~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
+...+|+..+.||+|+||.||++... ++ .+++|.+.... .......+..|+.++++++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34567999999999999999999763 33 68999875432 23445678899999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.++||||+.+++|.+++......+++..+..++.|++.||.|||+.| |+|+||||+|||++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999999876678999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCcccc---cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 905 NTFLSS---RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 905 ~~~~~~---~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
...... .....+..|++||++.+..++.++|||||||++|||++ |+.||...+..+....+.. ......+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 237 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPS 237 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCH
Confidence 321111 11223457999999998889999999999999999997 9999988877777766642 334455667899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++.+++.+||..+|++||++.++++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.63 Aligned_cols=251 Identities=31% Similarity=0.510 Sum_probs=216.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.+.||.|+||.||++.+ ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++.....+++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 46799999999999999999987 57889999886442 344567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+++++|.+++.+....+++..++.++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999876677999999999999999999999999 999999999999999999999999998765444333
Q ss_pred ccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHHHH
Q 045028 910 SRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVA 983 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~ELk 983 (1044)
.....|++.|++||.+. +..++.++|||||||++|+|++|+.||...+..+....+.... .....+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 44567899999999985 3446779999999999999999999999887766555553222 23345667899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++|.+||..+|.+||++.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcC
Confidence 99999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=332.47 Aligned_cols=247 Identities=26% Similarity=0.463 Sum_probs=217.8
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||.||++.+ +++.||+|.+...... ....+.+.+|+++++++.||||+++++++...+.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999987 5789999998654332 244567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.| |+|+||+|.||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999773 67899999999999999999999999 999999999999999999999999998765433
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.....|++.|++||.+.+..++.++||||||+++|+|++|..||...+..+....+. .....++..++..++++|.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHH
Confidence 334578999999999988888999999999999999999999998887666666553 445567788899999999999
Q ss_pred hhcCCCCCC-----CHHHHHHHh
Q 045028 990 WQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 990 L~kDPekRP-----Ta~ELLe~L 1007 (1044)
|..||.+|+ ++.|+++|-
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcCc
Confidence 999999999 889998763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=326.93 Aligned_cols=255 Identities=33% Similarity=0.582 Sum_probs=216.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--C---cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--G---TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g---~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
..+|++.+.||+|+||.||+|.+. + ..||||.+... ........+..|+.+++.++||||+++++++......+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 356999999999999999999763 3 35999987643 23445678999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.+++|.+++......+++..++.++.|++.||.|||++| ++|+||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999999876677899999999999999999999999 999999999999999999999999998754322
Q ss_pred ccc---c--cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 907 FLS---S--RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 907 ~~~---~--~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
... . .....+..|++||.+.+..++.++|||||||++|||++ |..||...+..+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCH
Confidence 111 1 11112457999999999999999999999999999886 999999888777776663 2334455678899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
++.+++.+||.++|.+||++.+++..|+.+
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=331.17 Aligned_cols=251 Identities=30% Similarity=0.477 Sum_probs=212.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
-|++.++||+|+||.||++.+ ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 478899999999999999987 45678888875433 34556788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+.+++|..++.+....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999999988765667999999999999999999999999 99999999999999999999999999876543333334
Q ss_pred CCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCCCCCCCCHHHHHH
Q 045028 912 STAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ip~~ip~ELkdL 985 (1044)
...++..|+|||++. +..++.++|||||||++|+|++|++||...+..+....+... ......+..++.+++++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 457899999999984 445678999999999999999999999887766655544322 22334566788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
|.+||..||.+||++.+++++-.
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCC
Confidence 99999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=326.63 Aligned_cols=259 Identities=33% Similarity=0.573 Sum_probs=218.6
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECC-----cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g-----~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
+..++|.+.++||+|+||.||+|.+.. ..|+||...... .....+.+.+|+.+++++.||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 455689999999999999999997632 358889775432 23455678999999999999999999998875 56
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.++||||+.+++|.+++.+....+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecc
Confidence 78999999999999999876667899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCcc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 905 NTFL-SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 905 ~~~~-~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. .......+..++.++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTL 237 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHH
Confidence 3211 1222334568999999988889999999999999999986 999998887776665553 334556778899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.++|.+||..+|.+|||+.++++.|+.+...
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.10 Aligned_cols=247 Identities=26% Similarity=0.493 Sum_probs=209.1
Q ss_pred EecccCcEEEEEEEEC----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCC
Q 045028 760 RIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 760 ~LGkG~FGtVykak~~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999998763 4469999876542 2344567899999999999999999999875 45789999999999
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc---ccC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS---SRS 912 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~---~~s 912 (1044)
+|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......... ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999999766678999999999999999999999999 999999999999999999999999998754322111 111
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhh
Q 045028 913 TAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991 (1044)
Q Consensus 913 ~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~ 991 (1044)
..++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...+...+..+++++.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 223578999999998889999999999999999996 999999888777666553 334566778899999999999999
Q ss_pred cCCCCCCCHHHHHHHhcccc
Q 045028 992 TDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 992 kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.+|++||++.+|++.|+.++
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CChhhCcCHHHHHHHHhhhc
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=347.78 Aligned_cols=241 Identities=25% Similarity=0.438 Sum_probs=203.5
Q ss_pred ecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC---CCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 761 IGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV---RHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 761 LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L---rHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
||+|+||+||++++ +++.||||++.+.... ......+..|..++..+ +||||+++++++.....+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999977 5789999998654322 22334455677777665 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999876 467899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC-CCCCHHHHHHHHHhhhc
Q 045028 915 GTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP-DNLDPAVADIIRKCWQT 992 (1044)
Q Consensus 915 GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip-~~ip~ELkdLI~rcL~k 992 (1044)
||+.|+|||++.+. .++.++|||||||+||+|++|+.||...+..+.+..+.... ..++ ..++++++++|.+||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCC
Confidence 99999999999765 47899999999999999999999999988887777764332 3344 35789999999999999
Q ss_pred CCCCCC----CHHHHHHH
Q 045028 993 DPKMRP----TFTEIMAA 1006 (1044)
Q Consensus 993 DPekRP----Ta~ELLe~ 1006 (1044)
||.+|| ++.++++|
T Consensus 236 ~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 236 NPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CHHHCCCCCCCHHHHhcC
Confidence 999998 68888876
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=328.45 Aligned_cols=250 Identities=29% Similarity=0.456 Sum_probs=209.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRP------ 822 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~------ 822 (1044)
.+.|++.+.||+|+||.||++.+ .++.||+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45789999999999999999977 57889999886543 2345688899999998 699999999998653
Q ss_pred CCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..++++|||+.+++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 3589999999999999998863 456899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCcccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~ 976 (1044)
.............|++.|+|||++. +..++.++|||||||++|+|++|..||...........+.....+...+.
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 6543333344567999999999986 34578899999999999999999999987665554444433333333445
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.++.++.+||.+||..+|.+|||+.++++|
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 688999999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=323.51 Aligned_cols=249 Identities=29% Similarity=0.538 Sum_probs=215.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.++||.|+||.||++.+. ++.+++|.+.... ..+.+.+|+.+++.++||||+++++++.....+++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 468999999999999999999874 6889999876432 2577999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+++|.+++......+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999999999876678999999999999999999999999 999999999999999999999999998865544333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....|+..|++||++.+..++.++||||||+++|+|++|+.||......+....+.. .......+..++.++.++|.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 3445688999999999999999999999999999999999999987766554433321 122334456788999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||..||.+|||+.+++++
T Consensus 236 ~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 236 CLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHhcChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=333.90 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=208.6
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..++|++.++||.|+||.||++++ +++.||+|.+..... ......+.+|+.+++.++||||+++++++..++.+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 357899999999999999999977 578899998864432 22334577899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+. ++|..++.+....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99996 5899888776677899999999999999999999999 99999999999999999999999999976543333
Q ss_pred cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-----------------c
Q 045028 909 SSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-----------------R 970 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-----------------~ 970 (1044)
......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+.... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 33445678999999998764 47889999999999999999999998877654433221100 0
Q ss_pred cCCC-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 RLDI-----------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ~~~i-----------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...+ ...+++++++||.+||..||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111 13578899999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=329.85 Aligned_cols=256 Identities=32% Similarity=0.522 Sum_probs=216.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+..++|++.+.||+|+||.||++.+ ++..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4567899999999999999999976 35679999876433 234456788999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCC---------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRP---------------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~---------------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
..+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 9999999999999999998642 124788889999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~ 958 (1044)
+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987533221 11222345667999999999899999999999999999997 8899988887
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
.+....+.. ......+..++.++.++|.+||..+|.+|||+.|+++.|++
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 777766542 33344567889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.41 Aligned_cols=257 Identities=28% Similarity=0.526 Sum_probs=214.8
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCc----EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGT----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~----~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..++|++.+.||+|+||+||+|.+ +++ .+++|.+.... .......+..|+.++.++.||||+++++++. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 456899999999999999999987 444 46777664321 2234456788888999999999999999875 456
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.++++||+.+|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 78999999999999999876678999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 905 NTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 905 ~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
... .......++..|++||.+.+..++.++|||||||++|||++ |..||.+.........+ ........+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCCHH
Confidence 221 12223456778999999998889999999999999999998 99999887766554444 244455566678889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+.+++.+||..||.+|||+.|+++.|..+.+
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.43 Aligned_cols=251 Identities=30% Similarity=0.502 Sum_probs=209.0
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..++|++.++||+|+||.||++.+ +++.||+|.++... ......+.+|+.+++.++||||+++++.+...+.+++|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 346899999999999999999987 57889999886543 23345678899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.| |+|+||||+|||++.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999999876 457899999999999999999999999 99999999999999999999999999875543333
Q ss_pred cccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC---CCCCCCCHHH
Q 045028 909 SSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL---DIPDNLDPAV 982 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~---~ip~~ip~EL 982 (1044)
......|+..|+|||++. ...++.++|||||||++|+|++|..||....+.............. .....++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 334567999999999984 4557889999999999999999999997765544333221111111 1112467889
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.++|.+||..+|++||++.+|++|
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=323.38 Aligned_cols=247 Identities=30% Similarity=0.533 Sum_probs=209.4
Q ss_pred eEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecC
Q 045028 759 ERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
++||+|+||.||+|.+. +..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++. .+..++||||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 47999999999999762 257999988755433 34567889999999999999999999876 456899999999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc---c
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS---S 910 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~---~ 910 (1044)
+++|.+++.+. ..+++..++.++.|++.+|.|||..+ |+|+||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999999874 47899999999999999999999999 999999999999999999999999998755332211 1
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..++..++++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 11223567999999999899999999999999999998 999998888777666654 3345567788999999999999
Q ss_pred hhcCCCCCCCHHHHHHHhcccc
Q 045028 990 WQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
|..+|++||++.++++.|+.+.
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.93 Aligned_cols=251 Identities=33% Similarity=0.594 Sum_probs=215.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
..+|++.+.||.|+||.||++.+. +..+++|.+...... ...+.+|++++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 457999999999999999999874 788999987654332 3468889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-c
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-S 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~ 909 (1044)
|+.+++|.+++......+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999999999875567899999999999999999999999 99999999999999999999999999875433211 1
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.. ..+...+...+.++.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCCCCCHHHHHHHHH
Confidence 122335678999999998889999999999999999998 9999988877777766532 23444566688999999999
Q ss_pred hhhcCCCCCCCHHHHHHHhc
Q 045028 989 CWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~Lk 1008 (1044)
||..+|++|||+.++++.|.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HcccChhhCCCHHHHHHhhC
Confidence 99999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=352.49 Aligned_cols=262 Identities=31% Similarity=0.534 Sum_probs=220.5
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEECC-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEee
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGA 818 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~ 818 (1044)
.++++.++|.++++||+|+||.||++++.+ ..||||++.... .......+.+|+.+|.++. ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 477888899999999999999999998643 579999987543 2334457889999999997 9999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCCC-----------------------------------------------------
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRPN----------------------------------------------------- 845 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~~----------------------------------------------------- 845 (1044)
+...+.+++||||+.+|+|.+++.+..
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986531
Q ss_pred --------------------------------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 846 --------------------------------------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 846 --------------------------------------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
..+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp 267 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAA 267 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCc
Confidence 13567778899999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~ 958 (1044)
+|||++.++.+||+|||+++..... ........++..|++||.+.+..++.++|||||||+||||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999999754321 112233467889999999999889999999999999999998 8999987665
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.+..........+...|..++.++.+||.+||..+|.+||++.+|++.|+++.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 55444433334455677789999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=327.32 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=207.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||+|+||.||++++ +++.||+|++..........+.+.+|+.++++++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999987 57899999886544333334567889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|++++.|..++.. ...+++..++.++.||+.+|.|||+.+ |+||||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9999888887765 456899999999999999999999999 9999999999999999999999999998655443233
Q ss_pred cCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-------------------
Q 045028 911 RSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------------- 970 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------------- 970 (1044)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+.....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34568899999999876 4578899999999999999999999987765443332210000
Q ss_pred cCC----------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 RLD----------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ~~~----------ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
... ....++..+.+||.+||..+|++||++.+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 013467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=332.21 Aligned_cols=257 Identities=30% Similarity=0.513 Sum_probs=211.7
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECC----------------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCee
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHG----------------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g----------------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIV 813 (1044)
++..+|++.++||+|+||.||++++.+ ..||+|.+... ........+.+|++++++++|+||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456789999999999999999986532 24899987643 2344456789999999999999999
Q ss_pred EEEeeeecCCCceEEEEecCCCcHHHHhcCCC-----------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCC
Q 045028 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN-----------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSP 882 (1044)
Q Consensus 814 kl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~-----------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPe 882 (1044)
++++++...+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR 158 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence 99999999999999999999999999986421 24688899999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCh
Q 045028 883 NLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT--MQQPWGGMNP 958 (1044)
Q Consensus 883 NILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT--Gk~PF~~~~~ 958 (1044)
|||++.++.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999987543221 11223345778999999998889999999999999999988 6789988776
Q ss_pred HHHHhhhcc------ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 959 MQVVGAVGF------QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 959 ~eil~~I~~------~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
.+....+.. .......+..+++.+.+||.+||..||++||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 665544321 111233456688999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.05 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=204.3
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||++++ +|+.|++|.+............+.+|+.+++.++||||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 489999999999999999987 688999999876543334445678899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+. ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 4788887765677999999999999999999999999 99999999999999999999999999876543333333
Q ss_pred CCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHhhhcccc---------------c---c
Q 045028 912 STAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWG-GMNPMQVVGAVGFQH---------------R---R 971 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~-~~~~~eil~~I~~~~---------------~---~ 971 (1044)
...+++.|+|||++.+.. ++.++|||||||++|+|++|..||. +.+..+.+..+.... . .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987754 6899999999999999999988854 333333222211000 0 0
Q ss_pred ---------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 ---------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ---------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......++++++++|.+||..||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 01123578899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.63 Aligned_cols=260 Identities=26% Similarity=0.455 Sum_probs=219.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec-C
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-P 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-~ 822 (1044)
+..++|++.+.||+|+||.||+|.+. +..|++|.+... ........+.+|+.+++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 45678999999999999999999874 467889987543 334556778999999999999999999998655 5
Q ss_pred CCceEEEEecCCCcHHHHhcCCC-------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEE
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPN-------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC 895 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~-------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLi 895 (1044)
...++++||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEEC
Confidence 67999999999999999987532 45899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccC
Q 045028 896 DFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRL 972 (1044)
Q Consensus 896 DFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~ 972 (1044)
|||+++....... ......++..|+|||++.+..++.++|||||||++|++++ |++||...+..++...+.. ....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~ 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRL 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCC
Confidence 9999975432211 1122345678999999999889999999999999999999 9999998887776665532 2334
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
..+..+++++.+++.+||..||++|||+.++++.|+.+.+.
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 45567899999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.08 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=214.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||.||++.. +++.||+|.+....... .....+..|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999987 47899999987654432 35567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc-
Q 045028 830 EFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF- 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~- 907 (1044)
||+.|++|.+++.+. ...+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998763 467899999999999999999999999 9999999999999999999999999986432110
Q ss_pred ----------------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 045028 908 ----------------------------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM 959 (1044)
Q Consensus 908 ----------------------------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~ 959 (1044)
.......||..|+|||++.+..++.++||||||+++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 1112346899999999999998999999999999999999999999988877
Q ss_pred HHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 045028 960 QVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT----FTEIMAA 1006 (1044)
Q Consensus 960 eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPT----a~ELLe~ 1006 (1044)
..+..+............++.+++++|.+||..||++||+ +.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 6666554333333333347999999999999999999999 8999886
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=350.94 Aligned_cols=246 Identities=20% Similarity=0.253 Sum_probs=199.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
+...+|+++++||+|+||.||++.+ +++.||+|... ...+.+|+.++++++||||++++++|......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4557899999999999999999987 57889999643 2346789999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC-
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT- 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~- 906 (1044)
|||++. ++|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 161 v~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999995 688888866 356899999999999999999999999 999999999999999999999999999753222
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHhhhcc------------
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVGAVGF------------ 967 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~-------~eil~~I~~------------ 967 (1044)
........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...+..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1223346799999999999999999999999999999999999988754221 011100000
Q ss_pred --------------c-c-ccCCC-----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 968 --------------Q-H-RRLDI-----PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 968 --------------~-~-~~~~i-----p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
. . ..... ...++.++.+||.+||++||.+|||+.|+|+|-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0 0 00000 013567899999999999999999999999753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=342.18 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=203.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999976 5788999998765444455567888999999999999999999886543
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+.+ +|.+.+.. .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999965 67666643 5888999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc--------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-------------- 969 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-------------- 969 (1044)
.... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+....
T Consensus 170 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 4332 2234578999999999999999999999999999999999999998766543322211000
Q ss_pred --------c------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 --------R------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 --------~------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. ....+...+.++++||.+||..||.+|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 001112345678999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.74 Aligned_cols=257 Identities=30% Similarity=0.510 Sum_probs=211.2
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC------------------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH------------------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~------------------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN 811 (1044)
++.++|++.++||+|+||.||++++. +..+|+|.+.... .......+.+|+.+++.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999998542 2358999876442 2344567899999999999999
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCC----------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN----------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~----------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
|+++++++...+..++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++| |+|+||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLAT 158 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCh
Confidence 9999999999999999999999999999987532 24677889999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCC
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT--MQQPWGGMN 957 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT--Gk~PF~~~~ 957 (1044)
+|||++.++.++|+|||++....... .......++..|++||++.+..++.++|||||||++|||++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999999987543221 11222345678999999988889999999999999999998 788998777
Q ss_pred hHHHHhhhcc------ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 958 PMQVVGAVGF------QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 958 ~~eil~~I~~------~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
..+....... .......+..+++.+.+||.+||..||.+||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6665443211 111233456788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.34 Aligned_cols=246 Identities=35% Similarity=0.612 Sum_probs=209.8
Q ss_pred eEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 759 ERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 759 r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
++||+|+||.||++.. +++.+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||+.+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4689999999999976 56789999876443 233345688999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc-ccCCCCC
Q 045028 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS-SRSTAGT 916 (1044)
Q Consensus 838 ~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~-~~s~~GT 916 (1044)
.+++......+++..++.++.|++.+|.|||+.| ++||||||+||+++.++.+||+|||++......... .....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9999775667899999999999999999999999 999999999999999999999999998754322111 1222346
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCC
Q 045028 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995 (1044)
Q Consensus 917 p~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPe 995 (1044)
..|+|||++.+..++.++||||||+++|++++ |..||...........+. ...+...+..++..+.+++.+||..+|+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999998889999999999999999998 999998887776666554 3334566778999999999999999999
Q ss_pred CCCCHHHHHHHhc
Q 045028 996 MRPTFTEIMAALK 1008 (1044)
Q Consensus 996 kRPTa~ELLe~Lk 1008 (1044)
+||++.++++.|.
T Consensus 237 ~Rp~~~~l~~~l~ 249 (250)
T cd05085 237 NRPKFSELQKELA 249 (250)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.86 Aligned_cols=246 Identities=35% Similarity=0.615 Sum_probs=211.0
Q ss_pred eEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 759 ERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
++||+|+||.||++.+. ++.|++|.+...... .....+.+|+.+++++.|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 47999999999999875 788999987655432 4556789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc--ccCCCC
Q 045028 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS--SRSTAG 915 (1044)
Q Consensus 838 ~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~--~~s~~G 915 (1044)
.+++.+....+++..++.++.+++.+|.|||+++ |+||||||+|||++.++.++|+|||++......... .....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999775567899999999999999999999999 999999999999999999999999998754421111 112234
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 916 Tp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.. ......+..++.++.++|.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998889999999999999999999 8999988777666655532 23455677889999999999999999
Q ss_pred CCCCCHHHHHHHhc
Q 045028 995 KMRPTFTEIMAALK 1008 (1044)
Q Consensus 995 ekRPTa~ELLe~Lk 1008 (1044)
.+|||+.|+++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=360.78 Aligned_cols=269 Identities=35% Similarity=0.628 Sum_probs=240.6
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEEC---C--cE-EEEEEeec-cCcchhhHHHHHHHHHHHHhCCCCCeeEEEe
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWH---G--TE-VAVKRFLD-QDFFGESLEEFRSEVLIMKRVRHPNVVLFMG 817 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~---g--~~-VAVK~l~~-~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~ 817 (1044)
...|++.-++..+.++||+|+||.||+|+.. + .. ||+|..+. ......+..++.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3467888889999999999999999999762 2 13 89998875 3356778899999999999999999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
+......++||||+|.||+|.+++++....++..+...++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999999997668999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCccccc-CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCC
Q 045028 898 GLSRMKHNTFLSSR-STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 898 GLA~~~~~~~~~~~-s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip 975 (1044)
|+++... .+.... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....++..++.....+...|
T Consensus 307 GLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 307 GLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred ccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 9987554 222222 2235678999999999999999999999999999998 888999999999999997788889999
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
...+.++..++.+||..+|++||++.++.+.|+.+.+....
T Consensus 386 ~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 386 SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999999999998887654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=326.77 Aligned_cols=248 Identities=31% Similarity=0.505 Sum_probs=215.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||.|+||.||++.+ +++.|++|.+.... .......+.+|+.+++.++|+||+++++++..+..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4689999999999999999987 57889999886543 23445678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.+++|.+++... .+++..++.++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999863 7899999999999999999999999 9999999999999999999999999998765443334
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCC-CCHHHHHHHHHh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN-LDPAVADIIRKC 989 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~-ip~ELkdLI~rc 989 (1044)
....|++.|++||.+.+..++.++||||||+++|+|++|..||...+..+....+.. .....++.. ++.++.++|.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHHHH
Confidence 456789999999999998899999999999999999999999988776665554432 223334444 889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 045028 990 WQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~ 1006 (1044)
|..+|++|||+.+++++
T Consensus 235 l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 235 LNKDPKERPSAKELLKH 251 (274)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 99999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.78 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=212.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
..+|++.+.||+|+||.||++.+ +++.|++|.+...... ....+.+|+.+++.++|+||+++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 46899999999999999999976 6788999988754432 3466889999999999999999999999989999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.|++|.+++.+ ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++.++|+|||++.........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999999865 45889999999999999999999999 999999999999999999999999998754433222
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++......+.. .......+..++..+.++|.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 3345789999999999998899999999999999999999999988766544333221 222334566788999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||.++|++||++.+++++
T Consensus 253 ~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 253 CLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HCcCCcccCcCHHHHhhC
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.82 Aligned_cols=250 Identities=31% Similarity=0.508 Sum_probs=211.6
Q ss_pred CeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCc----chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDF----FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~----~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+|++++.||+|+||+||++.. +++.+|+|.+..... .......+.+|+.+++.++|+||+++++++...+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 488999999999999999976 678899998764322 123345688999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC---
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN--- 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~--- 905 (1044)
|||+.|++|.+++.+. ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999763 56889999999999999999999999 99999999999999999999999999875321
Q ss_pred ---CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCCCCCCCCHH
Q 045028 906 ---TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLDIPDNLDPA 981 (1044)
Q Consensus 906 ---~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ip~~ip~E 981 (1044)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+... .....++..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 111123456899999999999988999999999999999999999999876655444333222 2334567789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+.++|.+||.++|.+||++.+++++
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.44 Aligned_cols=246 Identities=32% Similarity=0.587 Sum_probs=212.7
Q ss_pred eEecccCcEEEEEEEEC---Cc--EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecC
Q 045028 759 ERIGLGSYGEVYRGDWH---GT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~---g~--~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
++||+|+||.||++.+. ++ .||||.+...... ...+.+.+|+.++++++||||+++++++.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 46899999999999763 22 5899988765543 556789999999999999999999999988 88999999999
Q ss_pred CCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc---cc
Q 045028 834 RGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF---LS 909 (1044)
Q Consensus 834 GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~---~~ 909 (1044)
+++|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997744 57899999999999999999999999 9999999999999999999999999987643321 11
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....++..|++||++.+..++.++|||||||++|+|++ |+.||...+..+....+.........+..++..+.+++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 223457788999999999999999999999999999998 9999988888877776654455556677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHHhc
Q 045028 989 CWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~Lk 1008 (1044)
||..+|++||++.++++.|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.55 Aligned_cols=250 Identities=31% Similarity=0.547 Sum_probs=207.0
Q ss_pred eEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee-cCCCceEEEEec
Q 045028 759 ERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT-RPPNLSIVAEFL 832 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~-~~~~l~LVmEy~ 832 (1044)
+.||+|+||.||+|.+. +..+|+|.+.... .......+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999752 3469999875322 2344567889999999999999999999765 455689999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc----c
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF----L 908 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~----~ 908 (1044)
.+++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999875566788888999999999999999999 9999999999999999999999999987543211 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+. .......+..++..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 1123346778999999998889999999999999999999 567787777766665543 33345556778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccccC
Q 045028 988 KCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+||..+|++||++.++++.|+++..
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.22 Aligned_cols=249 Identities=31% Similarity=0.543 Sum_probs=212.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-------hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-------ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-------~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
+|.+.+.||+|+||.||+|.+ .++.+|+|.+....... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 377889999999999999976 57889999886543221 234568899999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.+++|||+++++|.+++.+ ...+++..+..++.|++.||.|||++| |+||||+|+|||++.++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999976 356889999999999999999999999 9999999999999999999999999987554
Q ss_pred CCc------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 905 NTF------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 905 ~~~------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+. ......++..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCccc
Confidence 211 11123458899999999999889999999999999999999999998876655544442 23345667789
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+.+++++|.+||++||.+||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 9999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=330.26 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=197.8
Q ss_pred ecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 761 IGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 761 LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
||+|+||+||+++. +|+.||+|.+....... .....+..|++++++++||||+++++++.....+++||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999976 58899999986543322 1233456799999999999999999999999999999999999999
Q ss_pred HHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCC
Q 045028 838 YRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916 (1044)
Q Consensus 838 ~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GT 916 (1044)
.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 9888653 346889999999999999999999999 9999999999999999999999999987654322 22345689
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhc
Q 045028 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP----MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992 (1044)
Q Consensus 917 p~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~----~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~k 992 (1044)
..|+|||++.+..++.++|||||||++|+|++|+.||..... .++........ .......+++++++||.+||.+
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-VKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-cccccccCCHHHHHHHHHHhcc
Confidence 999999999998899999999999999999999999976433 22222221111 1112246899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 045028 993 DPKMRPTFTEIMAA 1006 (1044)
Q Consensus 993 DPekRPTa~ELLe~ 1006 (1044)
||.+||++.|++++
T Consensus 237 ~P~~R~~~~~~~~~ 250 (277)
T cd05607 237 KPEDRLGSREKNDD 250 (277)
T ss_pred CHhhCCCCccchhh
Confidence 99999999665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.62 Aligned_cols=254 Identities=31% Similarity=0.478 Sum_probs=208.7
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeee-----
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVT----- 820 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~----- 820 (1044)
....++|++.+.||+|+||.||++++ +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34578999999999999999999976 57889999875432 2234578899999999 6999999999873
Q ss_pred cCCCceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
..+.+++||||++|++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 34568999999999999998753 3456889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCcccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-cc
Q 045028 898 GLSRMKHNTFLSSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RR 971 (1044)
Q Consensus 898 GLA~~~~~~~~~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~ 971 (1044)
|++..............|++.|+|||++.. ..++.++|||||||++|+|++|+.||........+..+.... ..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 998765433333344568999999999853 447889999999999999999999998776554443332211 12
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 ~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
...+..++.++.+||.+||..||++|||+.|+++++
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 334566788999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=346.26 Aligned_cols=284 Identities=22% Similarity=0.394 Sum_probs=241.2
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECC--cEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g--~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~ 824 (1044)
.+...+|.++.+||+|+||.|.++...| ..||||++++..+. ...++..+.|.++|... +-|+++.++.+|+..+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5666789999999999999999998865 45999998876543 45566677788888766 47899999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||+.||+|.-+|++ -.++.+..+..++.+|+-||-|||++| ||+||||.+|||++.+|+|||+|||+++...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999999987 567889999999999999999999999 9999999999999999999999999999777
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.......++||||.|+|||++..++|+..+||||+|++|||||.|++||.+.++.++++.|. .....+|..++.|+.+
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAVA 579 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHHH
Confidence 67778889999999999999999999999999999999999999999999999999999994 5567889999999999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHHHhccccC-----CCCCCCCC-CCCCCCCCCCCccchhhhh
Q 045028 985 IIRKCWQTDPKMRPT-----FTEIMAALKPLQK-----PITSSQVP-RPVPSVSSGRETGQISKFL 1039 (1044)
Q Consensus 985 LI~rcL~kDPekRPT-----a~ELLe~Lk~L~k-----~l~~~~~p-~~~ps~s~~~~~~~i~~~~ 1039 (1044)
+++..|.+.|.+|.. -.+|.+| .+++ ++.....+ |..|.....+.+..++++.
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H--~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~F 643 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREH--PFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFF 643 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhC--cchhhccHHHHhhccCCCCCCCccccCCchhhhhHHH
Confidence 999999999999953 2344433 1221 23334444 3445555667777776654
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.01 Aligned_cols=250 Identities=25% Similarity=0.294 Sum_probs=210.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.|++.+.||+|+||+||++.+ +++.||+|.+....... .....+.+|+.++++++|+||+.+++.+..++.++++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 378889999999999999987 57889999986554332 223457789999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-S 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-c
Confidence 99999999888653 346999999999999999999999999 9999999999999999999999999986543221 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc--ccccCCCCCCCCHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF--QHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~--~~~~~~ip~~ip~ELkdLI~ 987 (1044)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.. ......++..++.++.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 2345789999999999998999999999999999999999999987765443332211 22234556778999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHH
Q 045028 988 KCWQTDPKMRPT-----FTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPT-----a~ELLe~ 1006 (1044)
+||.+||.+||+ +.+++++
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcC
Confidence 999999999999 7888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.77 Aligned_cols=255 Identities=29% Similarity=0.520 Sum_probs=216.8
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
..++|++++.||+|+||.||+++.. .+.+++|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4478999999999999999999852 3569999875433 1234567899999999999999999999999989
Q ss_pred CceEEEEecCCCcHHHHhcCCC--------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEE
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPN--------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC 895 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~--------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLi 895 (1044)
..++||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ |+||||||+|||++.++.++|+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence 9999999999999999997632 15899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCC-cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCC
Q 045028 896 DFGLSRMKHNT-FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLD 973 (1044)
Q Consensus 896 DFGLA~~~~~~-~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ 973 (1044)
|||++...... ........++..|++||.+.+..++.++||||||+++|+|++ |..||...........+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 99998643221 222233456778999999988888999999999999999998 8899988777777766654444455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.+..++..+.++|.+||..+|.+|||+.++++.|.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 66789999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.06 Aligned_cols=259 Identities=28% Similarity=0.544 Sum_probs=221.2
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCc----EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGT----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~----~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+...+|++.+.||+|+||.||++.+ +|. .+|+|.+..... ......+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 4457899999999999999999976 232 588997654432 3455678899999999999999999999887 7
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 899999999999999999876677999999999999999999999999 999999999999999999999999999754
Q ss_pred cCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 904 HNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 904 ~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... ......++..|++||.+.+..++.++|+|||||++||+++ |+.||.+....++...+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCH
Confidence 42211 1112224568999999988889999999999999999998 999999988777776664 3445566777889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.+.+++.+||..+|.+||++.++++.|+.+.+.
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.61 Aligned_cols=263 Identities=32% Similarity=0.570 Sum_probs=222.0
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEE
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLF 815 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl 815 (1044)
..+++...+|++++.||+|+||.||++++. +..||+|.+... ........+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 456677778999999999999999999752 236899977643 3344567889999999999 79999999
Q ss_pred EeeeecCCCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC
Q 045028 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK 880 (1044)
Q Consensus 816 ~~~~~~~~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK 880 (1044)
++++...+.++++|||+.+++|.+++.+. ...++...++.++.||+.||.|||++| |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 99999999999999999999999998752 234788889999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 045028 881 SPNLLVDKNWVVKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957 (1044)
Q Consensus 881 PeNILLd~dg~VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~ 957 (1044)
|+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||+||||++ |..||.+.+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875443221 1122334567999999999999999999999999999998 899999888
Q ss_pred hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 958 ~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
..+....+. .......+..++.++.++|.+||+.+|++|||+.+++++|+.+..
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 777766653 334455677889999999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=340.01 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=202.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------C
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------P 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~ 823 (1044)
.++|++++.||+|+||+||++.+ +++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36899999999999999999976 577899998865433334456678899999999999999999887543 3
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.++++++++ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999988 7899888864 56999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------ 970 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------ 970 (1044)
... .....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..+.....
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 432 234578999999999977 4688999999999999999999999987665443333211000
Q ss_pred ---------cC--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 ---------RL--------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ---------~~--------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.. ......++.+.+||.+||..||.+|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0112456778999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.07 Aligned_cols=255 Identities=31% Similarity=0.530 Sum_probs=206.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PP 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~ 823 (1044)
..+|++.+.||+|+||.||++.. .+..||+|.+.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 35799999999999999999874 46789999876543 3445678999999999999999999997654 34
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+++++|.+++.+....+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 689999999999999999875667899999999999999999999999 999999999999999999999999999854
Q ss_pred cCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---------------Hhhh
Q 045028 904 HNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV---------------VGAV 965 (1044)
Q Consensus 904 ~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~ei---------------l~~I 965 (1044)
..... ......++..|+|||++.+..++.++|||||||++|||++|..++........ +..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32211 11122344569999999998899999999999999999998776543221100 0011
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 966 GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 966 ~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.........+..++.++.+||.+||..+|++|||+.+|++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 112223445667899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.04 Aligned_cols=248 Identities=33% Similarity=0.620 Sum_probs=213.3
Q ss_pred CCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
..++|++.+.||+|+||.||++...++.||+|.+.... ....+.+|+.++++++||||+++++++..+ ..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 45679999999999999999999999999999875432 235688999999999999999999998754 5799999
Q ss_pred ecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+.+++|.+++... ...+++..++.++.|++.||.|||+.| ++||||||+|||++.++.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999999764 346899999999999999999999999 999999999999999999999999998754322
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
......+..|++||.+.+..++.++|+|||||++|+|++ |++||...+..+....+.. ......+..++.++.++|.+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHH
Confidence 122334678999999998889999999999999999997 9999998887776665532 33445567789999999999
Q ss_pred hhhcCCCCCCCHHHHHHHhcc
Q 045028 989 CWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
||..+|++||++.++++.|+.
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.22 Aligned_cols=249 Identities=26% Similarity=0.450 Sum_probs=216.4
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||++.. +++.+++|.+............+.+|+.++++++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999876 678899999876655555677899999999999999999999999988999999999
Q ss_pred cCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEeccccccccCCccc
Q 045028 832 LPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 832 ~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA~~~~~~~~~ 909 (1044)
+++++|.+++.+. ...+++..++.++.|++.+|.|||++| |+|+||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 9999999999764 345899999999999999999999999 9999999999999855 468999999998654332 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.. .....++..++++++++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHH
Confidence 2335688999999999998889999999999999999999999988777666655532 233456778899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 045028 990 WQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~ 1006 (1044)
|..+|.+|||+.+++++
T Consensus 237 l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 237 LNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCChhhCCCHHHHhhC
Confidence 99999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.55 Aligned_cols=248 Identities=32% Similarity=0.618 Sum_probs=206.9
Q ss_pred eEecccCcEEEEEEEEC--Cc--EEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEEecC
Q 045028 759 ERIGLGSYGEVYRGDWH--GT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~--g~--~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
+.||+|+||.||++.+. +. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.++++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999873 33 4678876532 2234456788999999999 79999999999999999999999999
Q ss_pred CCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 834 RGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 834 GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
+++|.+++.... ..+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCC
Confidence 999999986522 24789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 899 LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 899 LA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.. ......+..
T Consensus 158 l~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLN 235 (270)
T ss_pred Cccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCc
Confidence 98632211 11122234567999999998889999999999999999997 9999988877776666532 234456677
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
++.++.+++.+||..+|.+|||+.++++.|+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 8999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.72 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=204.8
Q ss_pred eeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCce
Q 045028 755 ITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLS 826 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~ 826 (1044)
|++.+.||+|+||+||++.+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 49999999999999988653 46789999886543 223456788999999999999999999987653 3589
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
++|||+.+++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999976 45999999999999999999999999 999999999999999999999999998754332
Q ss_pred cc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHH------------hhhcccc
Q 045028 907 FL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM--QVV------------GAVGFQH 969 (1044)
Q Consensus 907 ~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~--eil------------~~I~~~~ 969 (1044)
.. ......++..|++||++.+..++.++||||||+++|+|++|..||...... +.. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 11 112234567799999999888999999999999999999999998653211 110 0011112
Q ss_pred ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 970 ~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.....+..++.++.+++.+||..+|++|||+.++++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 233456778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.41 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=208.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.++||+|+||.||++.+ ++..+|+|.+... ........+.+|++++++++||||+++++++..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4799999999999999999987 4677889887543 233445678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|++|++|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+|+||||+|||++.++.+||+|||++...... .
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCccccccc--c
Confidence 99999999999763 678999999999999999999997 58 999999999999999999999999998754332 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc--------------------
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-------------------- 969 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-------------------- 969 (1044)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 234678999999999998889999999999999999999999997655443332221110
Q ss_pred ---------------ccCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 970 ---------------RRLDIP-DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 970 ---------------~~~~ip-~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.....| ..++.+++++|.+||..+|++|||+.+++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 011111 236789999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.41 Aligned_cols=250 Identities=28% Similarity=0.486 Sum_probs=215.1
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
...+|++.+.||.|+||.||++.+ +++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 346799999999999999999975 688999998865432 2346688999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.+++|..++.+ ..+++..++.++.|++.+|.|||+.| |+|+||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 95 MEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999999999875 46899999999999999999999999 99999999999999999999999999875443332
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELkdLI~ 987 (1044)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. .......+..+++.+.++|.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence 33345689999999999998899999999999999999999999988776554443321 22234456778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||..||.+||++.+|+++
T Consensus 251 ~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHhhcChhhCCCHHHHhhC
Confidence 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.97 Aligned_cols=249 Identities=39% Similarity=0.694 Sum_probs=213.6
Q ss_pred eeEEeEecccCcEEEEEEEECC------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 755 ITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+++.+.||.|+||.||++.+.. ..+|+|.+.... .......+..|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 4678899999999999998753 779999885443 222567889999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCC-CcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~-Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|||+++++|.+++...... +++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999764444 999999999999999999999999 9999999999999999999999999997654331
Q ss_pred ccc-cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 908 LSS-RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~-~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
... ....+++.|++||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.. ......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHH
Confidence 111 12337789999999988889999999999999999998 8999988877777766643 34455677799999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHh
Q 045028 986 IRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+.+||..+|++|||+.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=382.53 Aligned_cols=285 Identities=25% Similarity=0.350 Sum_probs=245.5
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
..+...++|.|+++||+|+||.|.++++ +++.||+|++.+-... ......|..|..+|..-+.+=|+.++..|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4566789999999999999999999987 5788999998764332 234456888999999888999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++|+||||++||+|..++.+.. .+++.+++.|+.+|+.||.-||+.| +|||||||+|||||..|+|||+|||.+-..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhc
Confidence 9999999999999999999866 8999999999999999999999999 999999999999999999999999988765
Q ss_pred c-CCcccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--
Q 045028 904 H-NTFLSSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP-- 975 (1044)
Q Consensus 904 ~-~~~~~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip-- 975 (1044)
. +......+.+|||.|++||+++. ..|+..+|||||||++|||++|..||+...-.+.+.+|......+.||
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE 305 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc
Confidence 5 45555677889999999999952 458899999999999999999999999999999999998887788888
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCC---HHHHHHHhccccCCCC--CCCCCCCCCCCCCCCCccch
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPT---FTEIMAALKPLQKPIT--SSQVPRPVPSVSSGRETGQI 1035 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPT---a~ELLe~Lk~L~k~l~--~~~~p~~~ps~s~~~~~~~i 1035 (1044)
..++.++++||.+++. +|+.|.. +++|..|..-.-..|. ....||-+|.++.+.-+..|
T Consensus 306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence 5689999999999885 7899987 9999988644333332 24566777777776666666
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.54 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=208.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeec-----
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTR----- 821 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~----- 821 (1044)
...+.|++.+.||.|+||.||++++ .++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3557899999999999999999987 57889999875432 3345688899999998 69999999998853
Q ss_pred -CCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 822 -PPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 822 -~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
...++++|||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence 35689999999999999998753 355888999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI 974 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i 974 (1044)
+..............|++.|+|||.+. +..++.++|||||||++|+|++|..||....+......+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence 875543333344567899999999986 345788999999999999999999999876655444433222222223
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...++.++.++|.+||..||.+|||+.||+++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 44688999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.53 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=210.4
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||.|+||.||++.+ +|+.|++|++............+.+|+.++++++||||+++++++.....+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999986 578999999876654445556789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-cc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-SS 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~~ 910 (1044)
+ +++|.+++......+++..++.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999776677999999999999999999999999 99999999999999999999999999876543321 12
Q ss_pred cCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc------------------
Q 045028 911 RSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------------ 971 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------------ 971 (1044)
....|+..|+|||++.+.. ++.++|||||||++|+|++|.+||.+......+..+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 3456899999999987654 688999999999999999999888876654443332111000
Q ss_pred ----------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 ----------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 ----------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
......++.++.++|.+||..+|.+|||++++++|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 011135678999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.69 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=211.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec-----CCCc
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-----PPNL 825 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-----~~~l 825 (1044)
..|..++.||+|+||.|+.+.+ +|+.||||.+...-......++..+|+++|+.++|+||+.+++++.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3566689999999999999876 68899999887554445667889999999999999999999999876 2459
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|+|+|+| +.+|...|+. +..+++..+..+++||+.||.|+|+.+ |+||||||.|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 7799999987 455999999999999999999999999 99999999999999999999999999987643
Q ss_pred C--cccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc--------------
Q 045028 906 T--FLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-------------- 968 (1044)
Q Consensus 906 ~--~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-------------- 968 (1044)
. .......+.|.+|+|||++.. ..|+...||||+||||.||++|++.|.+.+..+.+..|...
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 122244568999999999854 55999999999999999999999999987755444333111
Q ss_pred ----------cccCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccC
Q 045028 969 ----------HRRLD-----IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQK 1012 (1044)
Q Consensus 969 ----------~~~~~-----ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k 1012 (1044)
..... +-++.++.+.+|+.+||..||.+|+|++|.|+| |..+.+
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 11111 124788999999999999999999999999987 444444
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.14 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=209.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.|++.+.||+|+||+||++.+ +++.||||.+....... .....+..|+.++++++|++|+.+++.+...+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 378899999999999999977 57899999886543322 233457789999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+.|++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99999999988642 346899999999999999999999999 9999999999999999999999999987543221 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... +....+. ......++..+++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 23457899999999999999999999999999999999999999865432 1122211 1223346678899999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHHh
Q 045028 987 RKCWQTDPKMRPT-----FTEIMAAL 1007 (1044)
Q Consensus 987 ~rcL~kDPekRPT-----a~ELLe~L 1007 (1044)
.+||+.||.+||| +.|+++|-
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcCh
Confidence 9999999999999 89999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.00 Aligned_cols=246 Identities=28% Similarity=0.425 Sum_probs=204.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.++||+|+||.||++.+ +++.||+|.+.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4689999999999999999976 67889999886542 23445678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+++++|..+. .+++..+..++.|++.||.|||+.| |+|+||||+|||++.++.++|+|||++...... ..
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999996552 4678889999999999999999999 999999999999999999999999999755432 23
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHhhhccccccCCCCCCCCHHHH
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~-------~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
....||..|+|||++.+..++.++|+|||||++|+|++|+.||..... .+....+............++++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 345789999999999999999999999999999999999999965322 1222222111111112345788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
++|.+||..+|.+||++.+++++..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcc
Confidence 9999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=369.77 Aligned_cols=265 Identities=33% Similarity=0.580 Sum_probs=232.9
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEE
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~ 816 (1044)
.....+++..+.+..+.||+|+||+||+|+.. .+.||||.+++... .....+|++|++++..++|||||+++
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 34456788899999999999999999999753 35699999876652 34567899999999999999999999
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCc
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRP-------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPN 883 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~-------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeN 883 (1044)
|.+...+.++||||||..|||.+||..+ ...++..+.+.|+.||+.|+.||-++. +|||||-..|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRN 633 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRN 633 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhh
Confidence 9999999999999999999999999642 123888999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEEeccccccccCCc-cc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 045028 884 LLVDKNWVVKVCDFGLSRMKHNTF-LS-SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQ 960 (1044)
Q Consensus 884 ILLd~dg~VKLiDFGLA~~~~~~~-~~-~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~e 960 (1044)
+||+++..|||+|||+++...... +. .....-..+||+||.+....++.++||||+||+|||+++ |+.||.+....+
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 999999999999999998654332 22 223345679999999999999999999999999999997 899999999999
Q ss_pred HHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 961 il~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+++.+.... .+..|+.+|.++.+|+..||+.+|.+||++.||-..|+...+
T Consensus 714 VIe~i~~g~-lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 VIECIRAGQ-LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHcCC-cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 999997444 488999999999999999999999999999999999987655
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.24 Aligned_cols=249 Identities=34% Similarity=0.565 Sum_probs=214.9
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc---chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF---FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~---~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+|+..+.||+|+||+||+|.. +++.|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477889999999999999977 578999998865432 234556789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+++++|.+++.+ ...+++..++.++.||+.||.|||+.| |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999976 346889999999999999999999999 9999999999999999999999999987654332
Q ss_pred cccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
......|+..|++||.+.... ++.++|+||||+++|+|++|+.||......+....+........++..++++++++|.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 234466899999999998776 8899999999999999999999998877655555544334455677789999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||..+|.+||++.+++++
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhhcCcccCcCHHHHhcC
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.04 Aligned_cols=249 Identities=29% Similarity=0.497 Sum_probs=210.7
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc---chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCce
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF---FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~---~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~ 826 (1044)
+|++.+.||+|+||.||++.. +++.|++|.+..... .......+.+|+.++++++||||+++++++... ..++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999976 578899998865432 123456788999999999999999999988753 5688
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
++|||+++++|.+++.+ ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999999976 345899999999999999999999999 999999999999999999999999998754321
Q ss_pred c---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 907 F---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 907 ~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
. .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+.............++..+++.++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 1 1112345889999999999988999999999999999999999999887766655555444455667788899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++| +||..+|++||++.|+++|
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcC
Confidence 999 6777899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.04 Aligned_cols=250 Identities=29% Similarity=0.498 Sum_probs=210.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc---chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCc
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF---FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNL 825 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~---~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l 825 (1044)
.+|++.+.||+|+||.||++.+ ++..|+||.+..... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999986 578899998754321 123456789999999999999999999988764 458
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+++|||+++++|.+++.+. ..+++..++.++.|++.+|.|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999998763 45889999999999999999999999 99999999999999999999999999875432
Q ss_pred Cc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 906 TF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 906 ~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.........|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 11 112234588999999999988899999999999999999999999987766555555543444555677888999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.++|.+||. +|.+||++++|+++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhcC
Confidence 999999995 89999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.65 Aligned_cols=251 Identities=32% Similarity=0.515 Sum_probs=209.1
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCC----
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPP---- 823 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~---- 823 (1044)
..++|++.+.||+|+||.||++.+ +++.+++|++.... ...+.+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 457899999999999999999987 56789999876543 2345688999999999 6999999999987644
Q ss_pred --CceEEEEecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 824 --NLSIVAEFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 824 --~l~LVmEy~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
.+++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998652 467899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccC
Q 045028 899 LSRMKHNTFLSSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRL 972 (1044)
Q Consensus 899 LA~~~~~~~~~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~ 972 (1044)
++..............|+..|+|||++.. ..++.++|||||||+||+|++|+.||...........+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765444333445678999999999854 346778999999999999999999998766555444443221 122
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+..++.++++||.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 3334578899999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.60 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=213.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
..+|++.+.||+|+||.||++.. +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+.+++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46899999999999999999976 688999998865443 23356888999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999865 46889999999999999999999999 999999999999999999999999998765433333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....+++.|++||.+.+..++.++|+|||||++|+|++|..||...+.......+.. .......+..++..++++|.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 3445789999999999998899999999999999999999999987665443332221 122334567788999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||..+|++||++.+++++
T Consensus 252 ~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 252 CLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.46 Aligned_cols=256 Identities=29% Similarity=0.532 Sum_probs=212.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PP 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~ 823 (1044)
.++|++.+.||+|+||.||++++. +..+|||.+...... .....+.+|+.+++.+.|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 467899999999999999999863 568999998755432 345679999999999999999999999877 55
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..+++|||+++++|.+++.+....+++..++.++.||+.||.|||++| |+|+||||+|||++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 799999999999999999876667999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------HHhhh
Q 045028 904 HNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ---------------VVGAV 965 (1044)
Q Consensus 904 ~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e---------------il~~I 965 (1044)
..... ......++..|++||.+.+..++.++|||||||++|||++|..||....... +...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 42211 1112345667999999998889999999999999999999999986532211 11111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 966 GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 966 ~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
........+..++.++.+|+.+||..+|.+|||+.+|++.|+.+.
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 -KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred -HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 123344456678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.44 Aligned_cols=251 Identities=31% Similarity=0.482 Sum_probs=211.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++++.||.|+||+||++.. ++..+++|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4799999999999999999976 67789999886544333 56789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 831 FLPRGSLYRLLHRP--NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 831 y~~GGsL~dlLkr~--~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|+.+++|.+++... ...+++..+..++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999999763 256899999999999999999999999 99999999999999999999999999875443221
Q ss_pred ----cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCC---CCCC
Q 045028 909 ----SSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIP---DNLD 979 (1044)
Q Consensus 909 ----~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip---~~ip 979 (1044)
......|+..|++||++... .++.++|+|||||++|+|++|+.||...+..+.+..+.... ...... ..++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 12345689999999999877 78899999999999999999999998877665554432221 111111 3678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+++.++|.+||.+||++||++.+|++|
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 999999999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.05 Aligned_cols=249 Identities=33% Similarity=0.572 Sum_probs=211.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||++.. +++.|++|.+............+.+|+.++++++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 589999999999999999976 678899999877665445678899999999999999999999999998999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc-
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS- 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~- 910 (1044)
+.+++|.+++.+ ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999976 355889999999999999999999999 9999999999999999999999999987654332211
Q ss_pred ---cCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccccCCCCCCC--CHH
Q 045028 911 ---RSTAGTAEWMAPEVLRNEP---SDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLDIPDNL--DPA 981 (1044)
Q Consensus 911 ---~s~~GTp~Y~APEvL~g~~---~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~~~~ip~~i--p~E 981 (1044)
....++..|++||++.+.. ++.++||||||+++|+|++|+.||...... .....+. ......+|... ++.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCHH
Confidence 2356889999999998776 788999999999999999999999765332 3332332 23344455544 899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+.++|.+||+.+|.+|||+.+++.+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.53 Aligned_cols=253 Identities=28% Similarity=0.490 Sum_probs=208.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
+..+.+.....||+|+||.||++++ ++..|++|.+.... ......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445555667899999999999976 46779999876543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCC--cHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQL--DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~L--se~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~~~ 904 (1044)
||||+.+++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999998644445 88889999999999999999999 999999999999976 6799999999987554
Q ss_pred CCcccccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhccccccCCCCCCCCHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEP--SDEKCDVYSFGVILWELCTMQQPWGGMNPMQ-VVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~--~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e-il~~I~~~~~~~~ip~~ip~E 981 (1044)
..........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .............++..++++
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 3333333456899999999986643 7889999999999999999999997654322 222222223345677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++++|.+||..+|.+|||+.++++|
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=344.32 Aligned_cols=244 Identities=21% Similarity=0.282 Sum_probs=198.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
...|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|+.+|++++|+|||++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999987 467899996322 23568999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-- 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-- 907 (1044)
|++. ++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9995 6888888765567999999999999999999999999 9999999999999999999999999997543221
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHhhhcccccc-CCC----
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN--------PMQVVGAVGFQHRR-LDI---- 974 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~--------~~eil~~I~~~~~~-~~i---- 974 (1044)
.......||+.|+|||++.+..++.++|||||||+||||++|..++.... ..++...+...... ..+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 12234579999999999999999999999999999999999876543321 12222222110000 000
Q ss_pred ---------------------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 975 ---------------------------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 975 ---------------------------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...++.++.+||.+||+.||.+|||+.|+|+|
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01356789999999999999999999999987
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.49 Aligned_cols=250 Identities=27% Similarity=0.523 Sum_probs=221.7
Q ss_pred CeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||.|+||.||++.+. ++.|++|++............+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999885 88999999877665556667889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 832 LPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 832 ~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
+++++|.+++.+. ...+++..++.++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999764 378999999999999999999999999 99999999999999999999999999976554433
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
......|++.|++||.+.+..++.++|+|+||+++|+|++|+.||...+..+...... ......++..++.++.++|.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3444578999999999999889999999999999999999999998887777666653 233455677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||..+|++|||+.+++++
T Consensus 238 ~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 238 LLQKDPEERPSIAQILQS 255 (258)
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=339.33 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=195.7
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
...+|++++.||+|+||.||+|++. ++.||+|+.... ....|+.++++++||||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999884 568999974332 234689999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+. ++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence 99995 5888888776678999999999999999999999999 999999999999999999999999998753322 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChH----------HHHhhhcc-ccccCCCC-
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW-GGMNPM----------QVVGAVGF-QHRRLDIP- 975 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF-~~~~~~----------eil~~I~~-~~~~~~ip- 975 (1044)
......||+.|+|||++.+..++.++|||||||+||||+++..++ ...... .+...+.. ......++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 223456999999999999999999999999999999999865544 321110 11111100 00000011
Q ss_pred -----------------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 976 -----------------------------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 976 -----------------------------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..++.++.+||.+||+.||.+|||+.|+|+|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1456678889999999999999999999987
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.91 Aligned_cols=250 Identities=25% Similarity=0.454 Sum_probs=210.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++++.||+|+||.||++++ .++.||+|.+... ........+.+|+.++++++||||+++++.+...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4789999999999999999987 4889999987643 233445678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC--CCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 831 FLPRGSLYRLLHRP--NNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 831 y~~GGsL~dlLkr~--~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|+++++|..++... ...+++..+..++.||+.||.|||. ++ |+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998763 2478999999999999999999996 58 999999999999999999999999998754332
Q ss_pred ccccCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc--cccccCCCCCCCC
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEP------SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG--FQHRRLDIPDNLD 979 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~------~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~--~~~~~~~ip~~ip 979 (1044)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+. .......++..++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 223456888999999986543 4789999999999999999999997765544333221 1233455677799
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.++.++|.+||..+|.+||++.+++.+-
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 9999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=339.43 Aligned_cols=248 Identities=22% Similarity=0.296 Sum_probs=201.8
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
+...+|++++.||+|+||.||++... +..|++|.+... ..+.+|+.+|+.++||||+++++++.....+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34568999999999999999998753 467899977543 2356799999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+++||++. ++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.++|+|||+++....
T Consensus 162 ~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999995 688888854 567999999999999999999999999 99999999999999999999999999875433
Q ss_pred Cc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhcc-------------
Q 045028 906 TF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGF------------- 967 (1044)
Q Consensus 906 ~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~------------- 967 (1044)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... ..+..+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 2233567999999999999999999999999999999999999999765421 11111100
Q ss_pred --------------ccccCCCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 968 --------------QHRRLDIP-----DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 968 --------------~~~~~~ip-----~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.......+ ..++.+++++|.+||..||++|||+.|++.|-.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 00001111 235678999999999999999999999998843
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.77 Aligned_cols=287 Identities=22% Similarity=0.333 Sum_probs=241.2
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeec
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTR 821 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~ 821 (1044)
..+.+...+|.++++||+|+|.+|.++++ +.+.||+|++++..++ .+.++.+..|..+..+. +||++|.++.+|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45567788999999999999999999876 5788999999877655 45678888899998877 59999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+..+++|.||++||+|.-++++ .++++++.++.+..+|+.||.|||+.| ||+||||.+|||++..|++||+|+|+++
T Consensus 323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhh
Confidence 9999999999999999999987 678999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC-------CChHHHHhhhccccccCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG-------MNPMQVVGAVGFQHRRLDI 974 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~-------~~~~eil~~I~~~~~~~~i 974 (1044)
..-.+.....++||||.|+|||+++|..|+..+|||+||++|+||+.|+.||.- .+.++.+.++. ..+.+.+
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-lekqiri 478 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-LEKQIRI 478 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-hhhcccc
Confidence 776677778899999999999999999999999999999999999999999952 33444444443 5677889
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCC------CHHHHHHHhc-cccC--CCC-CCCCCCCCCCCCCCCCccchh
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRP------TFTEIMAALK-PLQK--PIT-SSQVPRPVPSVSSGRETGQIS 1036 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRP------Ta~ELLe~Lk-~L~k--~l~-~~~~p~~~ps~s~~~~~~~i~ 1036 (1044)
|..++-.+..+++..|.+||.+|. .+.++..|-. .... -+. ..-.||..|..+.+...+.++
T Consensus 479 prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd 550 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFD 550 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccc
Confidence 999999999999999999999984 3555554411 0000 001 134566677777777776665
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.01 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=207.6
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.++||+|+||.||++.+ .++.||+|++..........+.+.+|+++++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4799999999999999999987 47889999876544333345668899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.++.|..+... ...+++..++.++.||+.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999999887765 345899999999999999999999999 9999999999999999999999999987654433333
Q ss_pred cCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc------------------
Q 045028 911 RSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------------ 971 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------------ 971 (1044)
....++..|+|||++.+. .++.++||||||+++|+|++|++||......+....+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345688999999998764 4788999999999999999999999876544332222110000
Q ss_pred -----------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 -----------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 -----------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......++..+.+++.+||..+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 01124578899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.22 Aligned_cols=255 Identities=30% Similarity=0.510 Sum_probs=208.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CC
Q 045028 753 EEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PN 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~ 824 (1044)
.-|++++.||+|+||.||++++ .+..||+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3578999999999999999874 46789999876442 234456799999999999999999999988775 56
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.++||||++|++|.+++.+....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||+++...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999999775567899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHhhhcc
Q 045028 905 NTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP--------------MQVVGAVGF 967 (1044)
Q Consensus 905 ~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~--------------~eil~~I~~ 967 (1044)
.... ......++..|+|||++.+..++.++|||||||++|+|+++..|+..... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 3211 12234567789999999988899999999999999999998766432110 000111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 968 ~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.......+..++.++.+||.+||+.+|++|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2234455677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.34 Aligned_cols=250 Identities=30% Similarity=0.513 Sum_probs=215.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
..|+..++||.|+||.||++.+ .++.||+|.+..... ......+.+|+.++++++||||+++++++.....+++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999986 578899998765432 3445778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.|++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999875 46889999999999999999999999 9999999999999999999999999997654433333
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....++..|+|||++.+..++.++|+|||||++|||++|..||...........+. ......++..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 34568889999999998889999999999999999999999998877666554442 22344556678899999999999
Q ss_pred hcCCCCCCCHHHHHHHhc
Q 045028 991 QTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~Lk 1008 (1044)
..+|++||++.+++++-.
T Consensus 238 ~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 238 NKDPSFRPTAKELLKHKF 255 (277)
T ss_pred ccCcccCcCHHHHHhChH
Confidence 999999999999998843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.17 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=207.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc---hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF---GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~---~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+|++.+.||+|+||.||+|.+ +++.|+||.+...... ......+..|+.+++.++|+||+++++++...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999986 5789999998765443 22344577899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+ +++|.+++.+....+++..++.++.||+.||.|||++| |+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 89999999875447999999999999999999999999 99999999999999999999999999986554433
Q ss_pred cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------------
Q 045028 909 SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR----------------- 970 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~----------------- 970 (1044)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+....+.+..+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334457889999999865 4578999999999999999999888887665444333211000
Q ss_pred ---------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 ---------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ---------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.......++.++.++|.+||.++|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 001123457889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=333.00 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=200.6
Q ss_pred EEeEeccc--CcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 757 LGERIGLG--SYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 757 I~r~LGkG--~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
++++||+| +|++||++.. +|+.||+|++............+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7889999876 6789999998765544555667888999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc---
Q 045028 833 PRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL--- 908 (1044)
Q Consensus 833 ~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~--- 908 (1044)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999999753 345899999999999999999999999 99999999999999999999999986543211110
Q ss_pred ----cccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc------------
Q 045028 909 ----SSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------ 970 (1044)
Q Consensus 909 ----~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------ 970 (1044)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122356778999999976 4588999999999999999999999986544332221110000
Q ss_pred --------------------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 971 --------------------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 971 --------------------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.......+++++++||.+||+.||++|||+.++++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0011224578899999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.92 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=208.6
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||+|+||.||++.+ +++.|++|++..........+.+.+|+.++++++|+||+++++++...+.++++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3699999999999999999987 57889999887654444455778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-c
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-S 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~ 909 (1044)
|+.++.|..++.+ ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9998777666554 456899999999999999999999999 99999999999999999999999999876544332 2
Q ss_pred ccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc--------------cc----
Q 045028 910 SRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ--------------HR---- 970 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~--------------~~---- 970 (1044)
.....++..|+|||++.+. .++.++||||||++||+|++|++||.+....+.+..+... ..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345688999999999888 7899999999999999999999999876544332221100 00
Q ss_pred ------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 ------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...++..++.++++||++||..+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 001234568999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=336.91 Aligned_cols=256 Identities=27% Similarity=0.353 Sum_probs=215.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC-eeEEEeeeecCC-----
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN-VVLFMGAVTRPP----- 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN-IVkl~~~~~~~~----- 823 (1044)
.+.|..+++||+|+||+||+|+. +|+.||+|++....-.+.......+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688889999999999999976 7899999998765432334456789999999999999 999999998877
Q ss_pred -CceEEEEecCCCcHHHHhcCCC---CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 824 -NLSIVAEFLPRGSLYRLLHRPN---NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 824 -~l~LVmEy~~GGsL~dlLkr~~---~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
.+++||||+ ..+|..++.... ..++...++.++.||+.||+|||+++ |+||||||.||||+..|.+||+|||+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 799999999 459999998755 46888999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC------
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL------ 972 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~------ 972 (1044)
|+....+.......++|.+|+|||++.|. .|+...||||+|||++||+++++.|.+..+.+.+..|...-..+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99766555555667899999999999988 58999999999999999999999999988877666553211111
Q ss_pred ----------CCC------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccc
Q 045028 973 ----------DIP------------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPL 1010 (1044)
Q Consensus 973 ----------~ip------------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L 1010 (1044)
.++ ...++...+++.+||+.+|.+|.++..+++| +..+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111 1233578999999999999999999999988 5444
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.94 Aligned_cols=250 Identities=28% Similarity=0.521 Sum_probs=214.7
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||++.+ +|..+|+|.+..........+.+.+|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 589999999999999999987 578899999866544344556788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEeccccccccCCccc
Q 045028 832 LPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 832 ~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~~~~~~~~ 909 (1044)
+.+++|.+++.+. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++ .+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999999998763 346899999999999999999999999 99999999999999886 5699999998765543333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+. .......+..++.+++++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 334568999999999998889999999999999999999999998877666665543 2233345567889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 045028 990 WQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~ 1006 (1044)
|..+|++|||+.+++++
T Consensus 238 l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 238 FKVSPRDRPSITSILKR 254 (257)
T ss_pred hccChhhCcCHHHHhhC
Confidence 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.58 Aligned_cols=261 Identities=35% Similarity=0.555 Sum_probs=209.5
Q ss_pred CCCCeeEEeEecccCcEEEEEEEECC-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC-ceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN-LSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~-l~LV 828 (1044)
..++|.-.+.||+|+||.||+|...+ +.||||++....... ..+|.+|+.++.+++|||+|+++|||.+.+. .+||
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 45788888999999999999999865 899999876554321 4559999999999999999999999999884 9999
Q ss_pred EEecCCCcHHHHhcCCCC-CCcHHHHHHHHHHHHHHHHHHHhCC-CcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 829 AEFLPRGSLYRLLHRPNN-QLDERRRLRMALDAARGMNYLHNCT-PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~-~Lse~~il~Ia~QIa~AL~yLHs~G-~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||+.+|+|.+++..... .++|..+++|+.+++.||+|||... ++|||||||++|||||.+++.||+|||+++.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999988655 8999999999999999999999855 47999999999999999999999999999655431
Q ss_pred cccccCC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhh---hccccc-----cCCC
Q 045028 907 FLSSRST-AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN---PMQVVGA---VGFQHR-----RLDI 974 (1044)
Q Consensus 907 ~~~~~s~-~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---~~eil~~---I~~~~~-----~~~i 974 (1044)
....... .||..|++||++.....+.++||||||++|+||++|+.+..... ...+..+ ...... ...+
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 1111222 79999999999999889999999999999999999998876432 1112221 111111 1111
Q ss_pred C-CCCC--HH---HHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 975 P-DNLD--PA---VADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 975 p-~~ip--~E---LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
. ...+ .+ +..+..+|++.+|.+||++.++++.|+.+...
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 1 2233 22 56788999999999999999999999766554
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.18 Aligned_cols=249 Identities=29% Similarity=0.511 Sum_probs=213.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+.|++.+.||+|+||.||+|.+ ++..||+|.+..... ....+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4577888999999999999976 577899998764432 3345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.+++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999999864 56899999999999999999999999 9999999999999999999999999987654433333
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....|+..|++||++.+..++.++|+|||||++|+|++|+.||...........+. ......++..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 34568899999999999989999999999999999999999998766655544432 22334455678899999999999
Q ss_pred hcCCCCCCCHHHHHHHh
Q 045028 991 QTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~L 1007 (1044)
..+|++||++.+++++-
T Consensus 238 ~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 238 NKDPRFRPTAKELLKHK 254 (277)
T ss_pred cCCcccCcCHHHHHHhH
Confidence 99999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.69 Aligned_cols=250 Identities=36% Similarity=0.582 Sum_probs=218.2
Q ss_pred CeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCceEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLSIVA 829 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~LVm 829 (1044)
+|++.+.||+|+||.||++... ++.|++|++..........+.+.+|+.++++++||||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4889999999999999999874 88899999876655456678899999999999999999999999888 7899999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL- 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~- 908 (1044)
||+.+++|.+++.+.. .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998743 8999999999999999999999999 99999999999999999999999999886654432
Q ss_pred -cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 909 -SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 909 -~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
......++..|++||.+.+...+.++||||||+++|+|++|..||.... .......+........++..++.+++++|
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334568999999999998889999999999999999999999998765 33333344333455667888899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 045028 987 RKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+||..+|.+||++.+++++
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.82 Aligned_cols=248 Identities=28% Similarity=0.495 Sum_probs=211.2
Q ss_pred CCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||.|+||.||++.+. ++.+++|.+..... ......+.+|++++++++||||+++++++...+.++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 46889999999999999999884 78899998866432 3445678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+.+++|.+++.+....+++..+..++.|++.+|.|||+ .+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999998755789999999999999999999999 99 99999999999999999999999999875433221
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHhhhccccccCCCCCC-CCHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN-----PMQVVGAVGFQHRRLDIPDN-LDPAVA 983 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-----~~eil~~I~~~~~~~~ip~~-ip~ELk 983 (1044)
....++..|++||.+.+..++.++||||||+++|+|++|+.||.... ..+....+. .......+.. ++.+++
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 12678899999999999999999999999999999999999997642 223333332 2233344444 899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++|.+||..+|++|||+.+++.+
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhC
Confidence 99999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=352.22 Aligned_cols=247 Identities=27% Similarity=0.334 Sum_probs=208.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-C-----CCeeEEEeeeecCCC
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-H-----PNVVLFMGAVTRPPN 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-H-----PNIVkl~~~~~~~~~ 824 (1044)
-+|.|++.||+|+||+|.+|.+ +++.||||+++... ....+-..|+.||..|+ | -|||+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3899999999999999999976 67899999987654 44455677999999997 3 389999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC--CeEEEEeccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN--WVVKVCDFGLSR 901 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d--g~VKLiDFGLA~ 901 (1044)
+|||+|.+ +.+|+++++.+ ...++...++.|+.||+.+|.+||+.+ |||+|||||||||..- ..|||+|||.++
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999999 66999999874 466999999999999999999999999 9999999999999743 489999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc------------
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH------------ 969 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~------------ 969 (1044)
....... +.+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.++.+.+..|....
T Consensus 340 ~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 340 FESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred ccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 7655432 5677899999999999999999999999999999999999999988776555441100
Q ss_pred --------------------------------------ccCCCC-----------CCCCHHHHHHHHHhhhcCCCCCCCH
Q 045028 970 --------------------------------------RRLDIP-----------DNLDPAVADIIRKCWQTDPKMRPTF 1000 (1044)
Q Consensus 970 --------------------------------------~~~~ip-----------~~ip~ELkdLI~rcL~kDPekRPTa 1000 (1044)
.....| ..-...+.++|++||.+||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 000011 0123568999999999999999999
Q ss_pred HHHHHHhc
Q 045028 1001 TEIMAALK 1008 (1044)
Q Consensus 1001 ~ELLe~Lk 1008 (1044)
.+.|+|-.
T Consensus 497 ~qal~Hpf 504 (586)
T KOG0667|consen 497 AQALNHPF 504 (586)
T ss_pred HHHhcCcc
Confidence 99999854
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.06 Aligned_cols=249 Identities=31% Similarity=0.582 Sum_probs=219.4
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||++.+ .++.|++|.+............+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999976 578899999987765556677899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+.+++|.+++.+. ..+++..++.++.|++.+|.|||+.| |+||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999764 67899999999999999999999999 99999999999999999999999999987655444344
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhh
Q 045028 912 STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~ 991 (1044)
...++..|++||.+.+..++.++|||+||+++|+|++|..||............. ......++..++.++.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHh
Confidence 5678999999999988888999999999999999999999998776655444443 334456778899999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 045028 992 TDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 992 kDPekRPTa~ELLe~ 1006 (1044)
.+|++|||+.+++.+
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=352.77 Aligned_cols=283 Identities=21% Similarity=0.345 Sum_probs=247.1
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECCcE--EEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE--VAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g~~--VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
++...+++++..||-|+||.|-+++.+++. +|+|++++..+ ..++.+.+..|..||..++.|+||++|..|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 456678999999999999999999887766 89999876543 346677899999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
||+||-|-||.|+..+.. +..|++..+..++..+++|++|||.+| ||+|||||+|+|++.+|-+||.|||+|+....
T Consensus 496 YmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999999987 578999999999999999999999999 99999999999999999999999999998775
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
. ....++||||+|.|||++.+..++.++|.|+||+++||||+|.+||.+.++...+..|......+.+|..++....+|
T Consensus 573 g-~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 G-RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred C-CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 5 356789999999999999999999999999999999999999999999999999999988888899999999999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHHHhcc-------ccCCCCCCCCCCCCCCCCCCCCccch
Q 045028 986 IRKCWQTDPKMRPT-----FTEIMAALKP-------LQKPITSSQVPRPVPSVSSGRETGQI 1035 (1044)
Q Consensus 986 I~rcL~kDPekRPT-----a~ELLe~Lk~-------L~k~l~~~~~p~~~ps~s~~~~~~~i 1035 (1044)
|++++..+|.+|.. +.+|.+|-+- |......++..|++.++-+.+.-+.+
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF 713 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence 99999999999964 8889888543 33343344444444444444444433
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.93 Aligned_cols=247 Identities=33% Similarity=0.581 Sum_probs=212.6
Q ss_pred CeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.+.||+|+||.||++.+. ++.+++|++..... .....+.+|+.+++.++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 5889999999999999999874 78899999866543 3556789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+++++|.+++......+++..+..++.|++.+|.+||..| ++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999875568999999999999999999999999 99999999999999999999999999876554322 34
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHHHHHHHHh
Q 045028 912 STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRKC 989 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ELkdLI~rc 989 (1044)
...++..|++||.+.+..++.++|+||||++||+|++|..||...+.......... ......+ ..++.++.++|.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 56689999999999988899999999999999999999999988755554444322 2222222 33489999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 045028 990 WQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~ 1006 (1044)
|..||++|||+.+++++
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.31 Aligned_cols=251 Identities=32% Similarity=0.480 Sum_probs=208.2
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecC-----
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRP----- 822 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~----- 822 (1044)
..++|++.+.||+|+||.||++.. +++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 457899999999999999999977 57889999886542 2235677899999999 799999999988653
Q ss_pred CCceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
+.+++||||++|++|.++++. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998863 3467899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEP-----SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLD 973 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~-----~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ 973 (1044)
+..............|+..|++||++.... ++.++|||||||++|+|++|++||......+.+..+... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 876544333334456899999999986432 578999999999999999999999887765555444221 12233
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+..++.++.++|.+||.++|++||++.+|++|
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 455677899999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=320.89 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=205.8
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++++.||.|+||.||++++ +++.|+||.+............+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 489999999999999999987 578899998865543334446788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 832 LPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
+. ++|..++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 96 5888887653 467899999999999999999999999 9999999999999999999999999987554332223
Q ss_pred cCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-------------------
Q 045028 911 RSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------------- 970 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------------- 970 (1044)
....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3345788999999987654 58899999999999999999999987665443322211000
Q ss_pred --------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 --------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 --------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.......++++++++|.+||..||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 001123578899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=318.53 Aligned_cols=247 Identities=34% Similarity=0.559 Sum_probs=207.8
Q ss_pred eEecccCcEEEEEEEECC--------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 759 ERIGLGSYGEVYRGDWHG--------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~g--------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+.||+|+||.||++++.. ..+++|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997632 568999875432 22345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-----eEEEEeccc
Q 045028 831 FLPRGSLYRLLHRP------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-----VVKVCDFGL 899 (1044)
Q Consensus 831 y~~GGsL~dlLkr~------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-----~VKLiDFGL 899 (1044)
|+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .++|+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999998642 244788999999999999999999999 99999999999999877 899999999
Q ss_pred cccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCC
Q 045028 900 SRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 900 A~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~ 976 (1044)
+....... .......++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+. .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 236 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPE 236 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCcc
Confidence 87543221 11223346788999999999899999999999999999998 999998877777666553 334556677
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
.++..+.++|.+||..+|.+||++.+|++.|++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 889999999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.83 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=211.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..++|++.+.||+|+||+||++.+. ++.||+|++.... .......+.+|+++++.++||||+++++++...+.+++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 4568999999999999999999874 8889999876543 233456789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|||+++++|.+++.+ ...+++..+..++.+++.+|.|||+ ++ |+||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999999876 4568999999999999999999997 58 999999999999999999999999998654222
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHhhhccccccCCCCC
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-----------QVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-----------eil~~I~~~~~~~~ip~ 976 (1044)
......|+..|++||++.+..++.++|||||||++|+|++|..||...... +....+.. .....++.
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 235 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPS 235 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCc
Confidence 123457899999999998888999999999999999999999999865542 22222221 12223333
Q ss_pred -CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 977 -NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 977 -~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.++.++.+||.+||.+||.+|||+.|++++..-+.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 37889999999999999999999999998855433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.16 Aligned_cols=253 Identities=30% Similarity=0.520 Sum_probs=211.2
Q ss_pred eeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 755 ITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
|++.+.||+|+||.||++.+ +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 67889999999999999975 3578999998766555556677899999999999999999999876432
Q ss_pred CceEEEEecCCCcHHHHhcC-----CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 824 NLSIVAEFLPRGSLYRLLHR-----PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr-----~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
..+++++|+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 24788999999999888642 1235788999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCC
Q 045028 899 LSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 899 LA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip 975 (1044)
+++...... .......+++.|++||.+.+..++.++|||||||++|+|++ |++||.+.+..+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 987543221 12223345678999999999999999999999999999999 899998887776666554 23344555
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.10 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=215.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||+|+||.||++.+ +++.|+||++...... .....+.+|+.++.+++|+||+++++++...+.+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 3689999999999999999977 4788999988665432 445678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|+++++|.+++.+. ..+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999763 678999999999999999999999 99 999999999999999999999999998865444333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhccccccCCCCCC-CCHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN---PMQVVGAVGFQHRRLDIPDN-LDPAVADI 985 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---~~eil~~I~~~~~~~~ip~~-ip~ELkdL 985 (1044)
.....++..|+|||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+. ......++.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 334568899999999999989999999999999999999999998763 344444443 3334445555 89999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||..+|++||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.83 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=220.3
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc------hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeec
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF------GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTR 821 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~------~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~ 821 (1044)
....|.-.+.||+|..++|.++.+ +|+.+|+|++...... ...++...+|+.||+++ .||+|+.+.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345688888999999999998855 7889999988644322 23356678899999998 59999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+..+++|||.++.|.|+|++.. .-.+++...++++.||++|++|||..+ ||||||||+|||++++.+|||+|||+++
T Consensus 95 ~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999999976 567999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRN------EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip 975 (1044)
..... ......||||.|+|||.+.. .+|+..+|+|++|+|||.|+.|.+||+.....-+++.|......+.-|
T Consensus 172 ~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 76544 34566899999999999853 357889999999999999999999999988887888876555554444
Q ss_pred --CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 976 --DNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 976 --~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
..++.+.++||.+||+.||++|.|++|+|+|-
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 56889999999999999999999999999884
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.90 Aligned_cols=260 Identities=30% Similarity=0.554 Sum_probs=216.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCc----EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGT----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~----~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+..++|++.+.||+|+||.||++.+ ++. .+|+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-P 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-C
Confidence 3456899999999999999999976 444 47888775432 23334568899999999999999999998865 4
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..++++||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 578999999999999999876667899999999999999999999999 999999999999999999999999999754
Q ss_pred cCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 904 HNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 904 ~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... ......++..|++||++.+..++.++|||||||++|||++ |..||.+....+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTI 238 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 32211 1223345778999999999999999999999999999997 999998876655554443 3344555677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.+.+++.+||..+|++||++.++++.|+.+.+..
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 9999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.45 Aligned_cols=255 Identities=27% Similarity=0.344 Sum_probs=208.4
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCce
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLS 826 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~ 826 (1044)
..++|++.+.||+|+||.||++.+ +|+.||+|.+............+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999987 588999999875443333334567799999999999999999998765 4689
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.+ +|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999965 888888775677999999999999999999999999 999999999999999999999999999765443
Q ss_pred cccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc---------------
Q 045028 907 FLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR--------------- 970 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~--------------- 970 (1044)
........+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222333446888999999876 4578999999999999999999999998877665544321100
Q ss_pred --cCCCC-----------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 971 --RLDIP-----------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 971 --~~~ip-----------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
...++ ..+++++.++|.+||..||++|||+.++++|-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00111 235888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.15 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=213.8
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+|++.+.||.|+||.||++++ +++.|++|++....... ...+.+.+|++++++++||||+++++++.....+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 489999999999999999987 48899999987654332 456789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.|++|.+++.+. ..+++..+..++.||+.+|.|||+++ |+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999763 57899999999999999999999999 9999999999999999999999999987654332 22
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP---MQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~---~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
....|+..|++||.+.+..++.++|+||||+++|+|++|..||...+. .+..... ......++..++.++.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHH
Confidence 345688999999999988899999999999999999999999987763 3333332 22556677889999999999
Q ss_pred HhhhcCCCCCCCH--HHHHHH
Q 045028 988 KCWQTDPKMRPTF--TEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa--~ELLe~ 1006 (1044)
+||..||.+||++ .|++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHccCChhHcCCccHHHHhcC
Confidence 9999999999999 777653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=366.50 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=209.9
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-- 822 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-- 822 (1044)
..+...++|+++++||+|+||+||++++ .+..||+|++............+..|+.+++.|+|||||+++++|...
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3455678999999999999999999987 567899999876665556667899999999999999999999988543
Q ss_pred CCceEEEEecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCC-----CcEEEecCCCCcEEEcC------
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCT-----PVIVHRDLKSPNLLVDK------ 888 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G-----~~IVHRDIKPeNILLd~------ 888 (1044)
..+||||||+.+++|.++|... ...+++..++.|+.||+.||.|||..+ ..||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 4689999999999999998752 356999999999999999999999843 23999999999999964
Q ss_pred -----------CCeEEEEeccccccccCCcccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 045028 889 -----------NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWGG 955 (1044)
Q Consensus 889 -----------dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~~ 955 (1044)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|..||..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3459999999997654322 2334579999999999965 4578999999999999999999999987
Q ss_pred CChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 956 MNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 956 ~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+....+......... .....++.++.+||.+||..+|.+||++.++|.+
T Consensus 246 ~~~~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNFSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcHHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 6544333222111111 1124578999999999999999999999999964
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.83 Aligned_cols=250 Identities=29% Similarity=0.537 Sum_probs=209.8
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc----hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF----GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~----~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
+|+..+.||+|+||.||+++. +++.||+|++...... ......+++|+.++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478899999999999999976 6889999988643311 1235678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~~~~~ 906 (1044)
||||+.|++|.+++.+ ...+++..++.++.||+.||.|||++| |+|+||||+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999976 457899999999999999999999999 99999999999998775 6999999998754432
Q ss_pred cc----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhccccccCCCCCCCC
Q 045028 907 FL----SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 907 ~~----~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~~~~~~~ip~~ip 979 (1044)
.. ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .....+........++..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 122346889999999999888999999999999999999999999754432 22222222334556777889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+++.++|.+||..+|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 999999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.02 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=209.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||.||++.+ .++.|++|.+...... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4799999999999999999987 5678999988655332 234567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC---
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--- 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--- 906 (1044)
||+.|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999999976 356899999999999999999999999 999999999999999999999999988631100
Q ss_pred ------------cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-CC
Q 045028 907 ------------FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR-LD 973 (1044)
Q Consensus 907 ------------~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~-~~ 973 (1044)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 00112245788999999999888999999999999999999999999988877776665332221 22
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCH---HHHHHH
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTF---TEIMAA 1006 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa---~ELLe~ 1006 (1044)
....++.++.++|.+||+++|++||++ .+++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 233688999999999999999999984 555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.22 Aligned_cols=242 Identities=27% Similarity=0.449 Sum_probs=211.7
Q ss_pred ecccCcEEEEEEEEC--CcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 761 IGLGSYGEVYRGDWH--GTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 761 LGkG~FGtVykak~~--g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
||.|+||.||+++.. ++.+++|++...... ....+.+.+|+.+++.++||||+++++++.+...++++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999885 889999998765433 23456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCC
Q 045028 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA 917 (1044)
Q Consensus 838 ~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp 917 (1044)
.+++.+ ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 999976 356899999999999999999999999 9999999999999999999999999987654432 233457899
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCC
Q 045028 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN--PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPK 995 (1044)
Q Consensus 918 ~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~--~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPe 995 (1044)
.|++||.+.+..++.++|+||||+++|+|++|..||.... ..+....+........+|..++++++++|.+||..+|.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998776 55666665444566777888899999999999999999
Q ss_pred CCCC-----HHHHHHH
Q 045028 996 MRPT-----FTEIMAA 1006 (1044)
Q Consensus 996 kRPT-----a~ELLe~ 1006 (1044)
+||+ +.|+++|
T Consensus 237 ~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 237 ERLGNLKGGIKDIKKH 252 (262)
T ss_pred hCcCCcccCHHHHhcC
Confidence 9999 8999885
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.67 Aligned_cols=250 Identities=32% Similarity=0.547 Sum_probs=207.9
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc--------hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF--------GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~--------~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+|.+.+.||.|+||.||+|.. +++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999975 6788999987542211 122456888999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999774 57899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCcc--cccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC----
Q 045028 904 HNTFL--SSRSTAGTAEWMAPEVLRNEP--SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP---- 975 (1044)
Q Consensus 904 ~~~~~--~~~s~~GTp~Y~APEvL~g~~--~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip---- 975 (1044)
..... ......|+..|++||.+.+.. ++.++|+||||+++|+|++|..||......+....+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 33211 123345889999999987754 7889999999999999999999997766554444332222223333
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..++.+++++|.+||.++|.+||++.++++|
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3568999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.06 Aligned_cols=239 Identities=24% Similarity=0.434 Sum_probs=195.5
Q ss_pred eEecccCcEEEEEEEEC--------------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 759 ERIGLGSYGEVYRGDWH--------------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~--------------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
+.||+|+||.||+|++. ...+++|.+.... ......+..|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46899999999999752 2247888765432 2334567889999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe-------EEEEec
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV-------VKVCDF 897 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~-------VKLiDF 897 (1044)
.++||||+++++|..++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999998776677999999999999999999999999 999999999999986654 899999
Q ss_pred cccccccCCcccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHhhhccccccCCCC
Q 045028 898 GLSRMKHNTFLSSRSTAGTAEWMAPEVLR-NEPSDEKCDVYSFGVILWELC-TMQQPWGGMNPMQVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 898 GLA~~~~~~~~~~~s~~GTp~Y~APEvL~-g~~~s~kSDIWSLG~LLyELL-TGk~PF~~~~~~eil~~I~~~~~~~~ip 975 (1044)
|++..... .....++..|+|||.+. +..++.++|||||||+||+|+ .|..||......+..... .......
T Consensus 157 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~ 229 (262)
T cd05077 157 GIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLV 229 (262)
T ss_pred CCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCC
Confidence 99864432 22345788999999987 466889999999999999998 588888776544433211 1222333
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
...++++.+||.+||..||.+||++.+|+++|+
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 445688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=322.62 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=208.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~LV 828 (1044)
++|++.+.||.|+||.||+|.+ +++.+++|.++...........+.+|+.++++++||||+++++++... ..+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5799999999999999999987 478899999876544333344567899999999999999999998877 789999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.+ +|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++........
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 999975 999998776667999999999999999999999999 99999999999999999999999999886554433
Q ss_pred cccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc------------------
Q 045028 909 SSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH------------------ 969 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~------------------ 969 (1044)
......+++.|+|||.+.+.. ++.++||||||+++|+|++|.+||......+....+....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 333456789999999987654 6889999999999999999999998776554443321100
Q ss_pred -----------ccCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 -----------RRLDIPDN-LDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 -----------~~~~ip~~-ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....++.. +++.+.++|.+||+.+|++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 01112333 68889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.78 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=202.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.+.||+|+||.||++.. +++.||||.+..... ......+.+|+.++++++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999976 578899999865432 122344678999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+ +|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99975 899998876668899999999999999999999999 999999999999999999999999998754333222
Q ss_pred ccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccc-------------------
Q 045028 910 SRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQ------------------- 968 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~------------------- 968 (1044)
.....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.... ..+....+...
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 233457889999999876 457899999999999999999999997654 22221111000
Q ss_pred cccC---------CCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 969 HRRL---------DIPDNLD--PAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 969 ~~~~---------~ip~~ip--~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.... .....++ .++.++|.+||..+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0001234 788999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.11 Aligned_cols=251 Identities=31% Similarity=0.505 Sum_probs=213.6
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccC---cchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCc
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQD---FFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNL 825 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~---~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l 825 (1044)
.+|++.+.||+|+||.||++.+ +++.|++|.+.... ........+++|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999976 57889999875321 2234556789999999999999999999998764 358
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+++|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 899999999999999876 345889999999999999999999999 99999999999999999999999999975432
Q ss_pred Cc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 906 TF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 906 ~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
.. .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......+...++........+|..+++++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 21 112235689999999999998899999999999999999999999988776666666554555667889999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.++|.+||. +|.+||++.+++.|.
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhcCC
Confidence 999999999 579999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.53 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=187.6
Q ss_pred EeEecccCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CCCceEEEEe
Q 045028 758 GERIGLGSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PPNLSIVAEF 831 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~~l~LVmEy 831 (1044)
+++||+|+||+||+|++ .++.||+|.+..... ...+.+|+.++++++||||+++++++.. ...++++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 46899999999999985 356799998865432 2346789999999999999999998854 3458999999
Q ss_pred cCCCcHHHHhcCC--------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE----cCCCeEEEEeccc
Q 045028 832 LPRGSLYRLLHRP--------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGL 899 (1044)
Q Consensus 832 ~~GGsL~dlLkr~--------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL----d~dg~VKLiDFGL 899 (1044)
+. ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +..+.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 95 5888877531 235899999999999999999999999 9999999999999 4567999999999
Q ss_pred cccccCCc---ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHhhhc
Q 045028 900 SRMKHNTF---LSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPM---------QVVGAVG 966 (1044)
Q Consensus 900 A~~~~~~~---~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---------eil~~I~ 966 (1044)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...... +.+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 97654322 122345789999999999874 5899999999999999999999999754321 1111100
Q ss_pred cc-c-------------------------ccC----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 967 FQ-H-------------------------RRL----------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 967 ~~-~-------------------------~~~----------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.. . ... ......+.++.+||.+||+.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 000 0011235678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.63 Aligned_cols=239 Identities=23% Similarity=0.426 Sum_probs=198.8
Q ss_pred eEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 759 ERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
+.||+|+||+||++.+. ...+++|.+.... ....+.+..|+.+++.+.||||+++++++......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46999999999999763 2247777764332 233457888999999999999999999999989999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe--------EEEEeccccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV--------VKVCDFGLSR 901 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~--------VKLiDFGLA~ 901 (1044)
||+.+|+|..++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++|||++.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999876667899999999999999999999999 999999999999987654 7999999886
Q ss_pred cccCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++| .+||...+........ .....+|...+
T Consensus 157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (258)
T cd05078 157 TVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAPKW 229 (258)
T ss_pred ccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCCCc
Confidence 5432 223568889999999987 4578999999999999999999 5677665554433322 23456677788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.++.+||.+||+.||++|||+.+|++.|+
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.89 Aligned_cols=246 Identities=27% Similarity=0.463 Sum_probs=196.8
Q ss_pred eEecccCcEEEEEEEE-C---CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW-H---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~-~---g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
++||+|+||+||+|.. . ...+++|.+.... .......+.+|+.+++.++|+||+++++.+.....+++||||+.+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 3699999999999965 2 3468888765432 233345688899999999999999999999999999999999999
Q ss_pred CcHHHHhcCCC----CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--c
Q 045028 835 GSLYRLLHRPN----NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--L 908 (1044)
Q Consensus 835 GsL~dlLkr~~----~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~ 908 (1044)
|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999987632 23467888899999999999999999 9999999999999999999999999986532221 1
Q ss_pred cccCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccc----cCCCCC
Q 045028 909 SSRSTAGTAEWMAPEVLRN-------EPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHR----RLDIPD 976 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g-------~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~----~~~ip~ 976 (1044)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+.+..+..... ...++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 1233446778999999743 456789999999999999999 7889988776665554432221 223445
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.+++.+.+++..|| .||++|||+.++++.|.
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 78899999999999 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.85 Aligned_cols=248 Identities=29% Similarity=0.530 Sum_probs=214.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+-|++.++||.|+||.||++.+ ++..||||++..... ......+.+|+.++.+++||||+++++++..++.+++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3478899999999999999976 578899998754332 3345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.+++|.+++.. ..+++..+..++.|++.+|.|||+.| |+|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 9999999999875 46899999999999999999999999 9999999999999999999999999987554333233
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
....++..|++||.+.+...+.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 34568899999999998888999999999999999999999998877666555543 23344566778999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
..+|.+||++.++++|
T Consensus 238 ~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 238 NKEPSFRPTAKELLKH 253 (277)
T ss_pred cCChhhCcCHHHHHhC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.30 Aligned_cols=248 Identities=29% Similarity=0.516 Sum_probs=198.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHH-HHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLI-MKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~I-Lk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++.+.||+|+||.||++.+ +|+.||+|++......... ..+..|+.+ ++.++||||+++++++..++.++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4799999999999999999987 5889999998765433332 344456554 66678999999999999999999999
Q ss_pred EecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 830 EFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
||++ ++|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 578777653 345789999999999999999999997 8 99999999999999999999999999875433
Q ss_pred CcccccCCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccCCCC-CCCC
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRN----EPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIP-DNLD 979 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~~ip-~~ip 979 (1044)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+.+..+. ......++ ..++
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 21 1223468899999999865 456889999999999999999999997532 223332322 22223333 4578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.++.++|.+||..+|.+||++.+++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.88 Aligned_cols=237 Identities=25% Similarity=0.466 Sum_probs=195.7
Q ss_pred eEecccCcEEEEEEEECCc------------EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 759 ERIGLGSYGEVYRGDWHGT------------EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~g~------------~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+.||+|+||.||++.+... .+++|.+..... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 4699999999999987433 377776654331 15678899999999999999999999887 7889
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-------eEEEEeccc
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-------VVKVCDFGL 899 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-------~VKLiDFGL 899 (1044)
+||||+.+++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999875557899999999999999999999999 99999999999999887 899999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNE--PSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~--~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~ 976 (1044)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+...... .....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCCC
Confidence 875433 2234567889999999877 78999999999999999999 588887765444433332 1122222
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.....+.++|.+||..+|.+|||+.++++.|+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 23378999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.44 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=223.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEECC--cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~g--~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+-|.|+..||.|+||.||++.... -..|-|++.... .+.++.+.-||+||..+.||+||++++.|..++.+||+.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4568899999999999999997753 335567654433 567788999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|||.||-...++-.-+..+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+-....+...
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 999999999988877889999999999999999999999999 999999999999999999999999998776666666
Q ss_pred ccCCCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHH
Q 045028 910 SRSTAGTAEWMAPEVL-----RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL-----~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELk 983 (1044)
..+++|||+|||||+. ...+|+.++||||||++|.||..+.+|-...++..++.+|.. ....+..|...+..+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 7789999999999986 567899999999999999999999999999999988877743 3345566788899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+++++||.+||..||++.+|++|-
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhCc
Confidence 999999999999999999999874
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.77 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=211.0
Q ss_pred CeeEEeEecccCcEEEEEEEEC---CcEEEEEEeeccC--------cchhhHHHHHHHHHHHHh-CCCCCeeEEEeeeec
Q 045028 754 EITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQD--------FFGESLEEFRSEVLIMKR-VRHPNVVLFMGAVTR 821 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~---g~~VAVK~l~~~~--------~~~~~~~~~~~EI~ILk~-LrHPNIVkl~~~~~~ 821 (1044)
+|++.+.||+|+||.||++.+. ++.+|+|.+.... ........+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4888999999999999999874 4779999875332 122345567788888865 789999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
.+..+++|||+.|++|.+++.. ....+++..++.++.|++.+|.|||+ .+ |+|+||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 35678999999999999999999996 67 999999999999999999999999
Q ss_pred cccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 898 GLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 898 GLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
|++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9997654432 234456899999999999888999999999999999999999999887766665555322222222236
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
+++++.++|.+||..||++||++.|+.+++++
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 78999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.00 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=202.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCC-----
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPN----- 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~----- 824 (1044)
++|++.+.||+|+||.||++.+ +++.||||.+............+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999987 5788999987654333333456888999999995 6999999999877665
Q ss_pred ceEEEEecCCCcHHHHhcCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEeccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRP----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGL 899 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGL 899 (1044)
+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 788887542 245899999999999999999999999 999999999999998 89999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc--------
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-------- 970 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-------- 970 (1044)
+..............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8754333222233457889999998865 4578999999999999999999999988765544433211000
Q ss_pred --------------c----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 --------------R----LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 --------------~----~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. ......++.++.++|.+||..||.+||++.+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00113578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.17 Aligned_cols=248 Identities=29% Similarity=0.504 Sum_probs=217.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.++||+|+||.||++++ +++.+++|.+............+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 589999999999999999976 577899999876655555567788899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 832 LPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 832 ~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
+++++|.+++.+ ....+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999998865 2356899999999999999999999999 999999999999999999999999999765544
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+. .......+..++.+++++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2334568999999999999989999999999999999999999999888766655553 233344566789999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||..+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 236 MLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HcCCCcccCCCHHHHhcC
Confidence 999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=366.95 Aligned_cols=260 Identities=34% Similarity=0.616 Sum_probs=228.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC---Cc----EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH---GT----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~---g~----~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
.+..+..++.+.||+|.||.||.|... |. .||||.+.... .......|.+|..+|..++|||||+++|++-+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 466788999999999999999999762 32 48888775432 34567889999999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCC------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEE
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRP------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC 895 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLi 895 (1044)
....+|++|||.||+|..+|+.. ...++....+.++.+|++|+.||++++ +|||||...|+||+....|||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence 99999999999999999999986 677999999999999999999999999 9999999999999999999999
Q ss_pred eccccccccC-CcccccCC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccC
Q 045028 896 DFGLSRMKHN-TFLSSRST-AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRL 972 (1044)
Q Consensus 896 DFGLA~~~~~-~~~~~~s~-~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~ 972 (1044)
|||+|+.... .++..... .-...|||||.+....++.++||||||++|||+++ |..||...+..+++..+... .++
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-gRL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-GRL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-Ccc
Confidence 9999994433 23322222 23458999999999999999999999999999998 79999999999988866544 499
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+.|..||..+.+||..||+.+|++||++..|++.+..+..
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 9999999999999999999999999999999999888765
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.58 Aligned_cols=269 Identities=23% Similarity=0.318 Sum_probs=211.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++.+.||+|+||.||++.+ +++.||||++............+.+|+.++++++||||++++++|....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999986 6889999988654433445567788999999999999999999886443
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..|+||||+. ++|.+.+.. .++...+..++.||+.||.|||.+| |+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 4799999995 488888764 2889999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------- 970 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------- 970 (1044)
..... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 169 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 44322 2345688999999999999999999999999999999999999987664333222210000
Q ss_pred -------cC--------------CC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCCCCCC
Q 045028 971 -------RL--------------DI-------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRP 1022 (1044)
Q Consensus 971 -------~~--------------~i-------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~~p~~ 1022 (1044)
+. .+ +...+.+++++|.+||..||.+|||+.|+|++-. +...+.......+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~-~~~~~~~~~~~~~ 326 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY-INVWYDPSEVEAP 326 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh-HhhccCCccCCCC
Confidence 00 00 1234667899999999999999999999998732 2233334444444
Q ss_pred CCCCCC
Q 045028 1023 VPSVSS 1028 (1044)
Q Consensus 1023 ~ps~s~ 1028 (1044)
.|..++
T Consensus 327 ~~~~~~ 332 (353)
T cd07850 327 PPAPYD 332 (353)
T ss_pred CCCccc
Confidence 444444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.86 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=196.7
Q ss_pred eEecccCcEEEEEEEEC----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||+|+||.||+|.+. +..+++|.+..... ......+.+|+.++++++||||+++++++.+...+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999753 34689998765442 23334688899999999999999999999998999999999999
Q ss_pred CcHHHHhcCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--c
Q 045028 835 GSLYRLLHRP----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--L 908 (1044)
Q Consensus 835 GsL~dlLkr~----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~ 908 (1044)
++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++...... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999998642 234567788889999999999999999 9999999999999999999999999987543322 1
Q ss_pred cccCCCCCCCccCcccccCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccc-ccc---CCCCC
Q 045028 909 SSRSTAGTAEWMAPEVLRNE-------PSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQ-HRR---LDIPD 976 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~-------~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~-~~~---~~ip~ 976 (1044)
......++..|+|||++.+. .++.++||||||+++|||++ |..||......+........ ... ..+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 12234578899999998643 35789999999999999996 99999877666544332111 111 22233
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.+++.+.+++.+|| .+|++|||+.+|++.|.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 57789999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.73 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=204.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||+|+||.||++++ +++.|++|.+............+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999986 57889999886554333445678889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEeccccccccCCcc
Q 045028 831 FLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 831 y~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 996 5788777553 334688899999999999999999999 999999999999985 56899999999975543322
Q ss_pred cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------------
Q 045028 909 SSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR----------------- 970 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~----------------- 970 (1044)
......+++.|++||++.+. .++.++|||||||++|+|++|.+||......+.+..+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 23344678999999998764 578999999999999999999999987665544433211000
Q ss_pred ----c------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 ----R------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ----~------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. ......+++++.++|.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00124578899999999999999999999999975
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=351.16 Aligned_cols=244 Identities=29% Similarity=0.516 Sum_probs=213.8
Q ss_pred eEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCc
Q 045028 759 ERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGS 836 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGs 836 (1044)
-+||+|+||+||-|++. ....|||.+...+ .+..+-+..||.+.++|+|.|||+++|.+..++.+-|.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 36999999999999874 4568888775443 3455678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCC--cHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-CCCeEEEEeccccccccCCcccccCC
Q 045028 837 LYRLLHRPNNQL--DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKHNTFLSSRST 913 (1044)
Q Consensus 837 L~dlLkr~~~~L--se~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-~dg~VKLiDFGLA~~~~~~~~~~~s~ 913 (1044)
|.++++..-+++ .+..+-.+.+||++||.|||++. |||||||-+||||+ ..|.+||.|||-++....-.....++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999998866666 88889999999999999999999 99999999999996 57999999999999877777778899
Q ss_pred CCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 914 AGTAEWMAPEVLRNE--PSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 914 ~GTp~Y~APEvL~g~--~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
.||..|||||++... +|+.++|||||||++.||.||++||.... +.....++..-..-+.+|..++.+++++|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999999999654 48999999999999999999999998754 333444554455567889999999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
.+||.+||++.++|+.
T Consensus 817 epd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcccCccHHHhccC
Confidence 9999999999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=347.48 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=229.7
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
....|.+.+.||+|.|+.|.++++ ++..||||++.+.......+..+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456799999999999999999987 789999999998888877777899999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.+|.+++++.++ .++.+..+..++.|++.+++|||+++ |||||||.+||||+.+.++||+|||++.... ...
T Consensus 134 ~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFD-YGL 209 (596)
T ss_pred EEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeec-ccc
Confidence 9999999999999985 45666999999999999999999999 9999999999999999999999999998766 445
Q ss_pred cccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
...++||++.|.|||++.+..| ++.+|+|+||++||-|++|.+||.+.+..++...+. ...+.+|..++.+..++|+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--RGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--eeeecccceeechhHHHHH
Confidence 6788999999999999999886 679999999999999999999999988877777663 4556677788899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhc
Q 045028 988 KCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
++|.++|.+|+++++|+++-+
T Consensus 288 k~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred HhhccCccccCCHHHhhhhcc
Confidence 999999999999999998854
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.03 Aligned_cols=252 Identities=30% Similarity=0.516 Sum_probs=215.4
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..+.|++.+.||+|+||.||++.+. ++.|++|++..... ....+.+|+.+++.++|+||+++++.+......+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567999999999999999999884 88899999875542 456788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
+||++|++|.+++......+++..++.++.|++.+|.|||+.| |+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999875458999999999999999999999999 99999999999999999999999998865443322
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-cCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-~~~ip~~ip~ELkdLI~ 987 (1044)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+..... ....+..++.+++++|.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 33345688999999999988899999999999999999999999988776655544432211 22233448899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHh
Q 045028 988 KCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~L 1007 (1044)
+||+.+|.+||++.+++++.
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHhccChhhCcCHHHHhhCh
Confidence 99999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=324.97 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=210.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+.|.....||+|+||.||++.. ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4566677899999999999976 57889999875433 2345668899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..........
T Consensus 100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999999998865 46899999999999999999999999 9999999999999999999999999987544333333
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCCCCCCCCHHHHHHHHHh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ip~~ip~ELkdLI~rc 989 (1044)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+... .........++..++++|.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 4456899999999999888999999999999999999999999887766555443211 122223346788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 045028 990 WQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~ 1006 (1044)
|..||.+|||+.+++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.74 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=205.0
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|++.++||.|+||.||++++ +|+.||||++..... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 589999999999999999987 578899998875432 22345677899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCC--CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 832 LPRGSLYRLLHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~--~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8888876533 56899999999999999999999999 999999999999999999999999998754433222
Q ss_pred ccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc----------------ccC
Q 045028 910 SRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH----------------RRL 972 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~----------------~~~ 972 (1044)
.....++..|++||++.+. .++.++|||+|||++|+|++|+.||.+.+..+....+.... ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3345678899999998764 46889999999999999999999998876555443321100 000
Q ss_pred -----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 -----------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 -----------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+...++.+++++|.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1123467889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.19 Aligned_cols=247 Identities=26% Similarity=0.517 Sum_probs=208.9
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC---CCCeeEEEeeeecCCCceEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR---HPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~~~~~l~LV 828 (1044)
.|++.+.||+|+||.||+|.+ +++.|++|.+.... .......+.+|+.+++.++ ||||+++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 478899999999999999987 57889999876432 2344567889999999996 99999999999998999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.|++|.+++.. ..+++..++.++.|++.+|.|||+.| |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999999876 47899999999999999999999999 99999999999999999999999999876554433
Q ss_pred cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC-CCCHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD-NLDPAVADII 986 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~-~ip~ELkdLI 986 (1044)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+... ....++. .++.++.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3444578999999999875 44688999999999999999999999887665554433221 2223333 3788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 045028 987 RKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+||..||++||++.+++++
T Consensus 236 ~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 236 AACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.88 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=216.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LV 828 (1044)
++|++.+.||+|+||.||++.. +++.|++|++...... ......+.+|+.++++++ ||||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 6889999988664332 234467888999999998 99999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc-
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF- 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~- 907 (1044)
|||+.+++|.+++.+ ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999999987 347999999999999999999999999 9999999999999999999999999987543322
Q ss_pred -------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc
Q 045028 908 -------------------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ 968 (1044)
Q Consensus 908 -------------------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~ 968 (1044)
.......|+..|++||++.+..++.++|+||||+++|++++|..||........+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 12233457899999999998889999999999999999999999999887666655553
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 045028 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTF----TEIMAA 1006 (1044)
Q Consensus 969 ~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa----~ELLe~ 1006 (1044)
.....++..+++.+.++|.+||..+|.+||++ .++++|
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 44566778889999999999999999999999 888875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.27 Aligned_cols=238 Identities=22% Similarity=0.411 Sum_probs=195.8
Q ss_pred EecccCcEEEEEEEEC--------------------------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCee
Q 045028 760 RIGLGSYGEVYRGDWH--------------------------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813 (1044)
Q Consensus 760 ~LGkG~FGtVykak~~--------------------------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIV 813 (1044)
+||+|+||.||+|.+. ...|++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6999999999998641 1347888775432 23345688899999999999999
Q ss_pred EEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---
Q 045028 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW--- 890 (1044)
Q Consensus 814 kl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg--- 890 (1044)
++++++......++||||+++++|..++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999776678899999999999999999999999 99999999999997643
Q ss_pred ----eEEEEeccccccccCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHhh
Q 045028 891 ----VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELC-TMQQPWGGMNPMQVVGA 964 (1044)
Q Consensus 891 ----~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELL-TGk~PF~~~~~~eil~~ 964 (1044)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987543221 23457888999999876 55889999999999999985 79999987766554333
Q ss_pred hccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 965 VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 965 I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+ .....++....+++.++|.+||..+|++|||+.+|+++|.
T Consensus 234 ~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 Y---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 2 1233455566788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.34 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=211.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.+.||.|+||.||++.. +++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47899999999999999999975 678899998754332 23466888999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+++++|.+++.+ ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999999975 45789999999999999999999999 999999999999999999999999988755433333
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....|++.|++||.+.+..++.++|+||||+++|++++|+.||...+..+....+.. .......+..++..++++|.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 3445688999999999888899999999999999999999999987665544332211 112233445678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||..+|++||++.+++.|
T Consensus 252 ~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 252 CLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.00 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=200.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||+|+||.||+|.. +++.|++|++..... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999976 588999999865432 2223356789999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+. ++|.+++......+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 995 6777776654566888889999999999999999999 9999999999999999999999999987644333333
Q ss_pred cCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhcc-----------------cccc
Q 045028 911 RSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGF-----------------QHRR 971 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~-----------------~~~~ 971 (1044)
....+++.|+|||.+.+. .++.++|||||||+||+|++|..||...... +.+..+.. ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 445679999999998764 4788999999999999999999999765432 11111100 0000
Q ss_pred C----CCC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 L----DIP---------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ~----~ip---------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. ..+ ...+.++.+++.+||..||.+|||+.+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 000 0125789999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.15 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=214.1
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC--
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-- 823 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-- 823 (1044)
..+..++|+|.+.||+|||+-||+++. ++..||+|++.... .+..+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 446778999999999999999999985 78889999998776 466788999999999999999999988764433
Q ss_pred ---CceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 824 ---NLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 824 ---~l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
..||++.|...|+|.+.+.+ .+..+++.+++.|+.+|++||.+||+..++++||||||.|||+...+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 49999999999999999875 456899999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcc---------cccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh
Q 045028 898 GLSRMKHNTFL---------SSRSTAGTAEWMAPEVLRN---EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV 965 (1044)
Q Consensus 898 GLA~~~~~~~~---------~~~s~~GTp~Y~APEvL~g---~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I 965 (1044)
|.++...-.-. .......|..|+|||.+.- ...++++|||||||+||+|+.|..||...-...---..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99875321110 0112236889999999964 45688999999999999999999999642221111111
Q ss_pred ccccccCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 966 GFQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 966 ~~~~~~~~ip--~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
...+..+.+| .-++..+.+||+.||+.||.+||++.+++.+++++.
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1123333344 348999999999999999999999999999998764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.10 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=199.6
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecC--CCceEEE
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRP--PNLSIVA 829 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~--~~l~LVm 829 (1044)
|++.++||+|+||.||++.. +++.||+|+++........ ....+|+.++.++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 68899999999999999976 6788999988654322222 23456888888885 99999999999887 8899999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++. +.+||+|||++........
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99975 788888765567999999999999999999999999 999999999999999 9999999999976543322
Q ss_pred ccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc----------------cccC
Q 045028 910 SRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ----------------HRRL 972 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~----------------~~~~ 972 (1044)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 223468899999998754 45788999999999999999999999887765543332110 0011
Q ss_pred CC-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 DI-----------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ~i-----------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+ ...++.++.++|.+||.++|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11 13568899999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.62 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=212.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
..|.....||+|+||.||++.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3455667899999999999976 588999999865432 234568889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+++++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..........
T Consensus 99 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 9999999998865 56899999999999999999999999 9999999999999999999999999987544433334
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCCCCCCCCHHHHHHHHHh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ip~~ip~ELkdLI~rc 989 (1044)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+... ......+..++.++.++|.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 4567899999999999988999999999999999999999999887766655544221 112333456789999999999
Q ss_pred hhcCCCCCCCHHHHHHHhc
Q 045028 990 WQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~Lk 1008 (1044)
|..+|.+||++.+++++-.
T Consensus 255 l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 255 LTREPQERATAQELLDHPF 273 (297)
T ss_pred hcCCcccCcCHHHHhhChh
Confidence 9999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.44 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=210.3
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
....|++.+.||+|+||+||++.. +++.|++|++..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 446799999999999999999986 588999998865432 23445678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999996 5777777655567999999999999999999999999 999999999999999999999999998654322
Q ss_pred ccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
....+++.|+|||++. ...++.++||||||+++|+|++|+.||...+.......+.........+..++.++++
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 2456889999999984 3557889999999999999999999998877666555443222222223457889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+|.+||..+|++||++.+++.+..
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChh
Confidence 999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.18 Aligned_cols=249 Identities=26% Similarity=0.346 Sum_probs=204.9
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|++.+.||.|++|.||++.+ +|+.|++|++............+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999976 6889999988755433344456888999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 833 PRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 833 ~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+ ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68999887633 46899999999999999999999999 99999999999999999999999999875443322223
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc----------------------
Q 045028 912 STAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---------------------- 968 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~---------------------- 968 (1044)
...+++.|+|||++.+. .++.++||||||+++|+|++|++||...+.......+...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34578899999988764 4688999999999999999999999876654332221110
Q ss_pred -----cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 969 -----HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 969 -----~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.........++.++.++|.+||+.+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011234677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.50 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=201.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++.++||+|+||.||++.. +++.||||.+............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46899999999999999999987 5789999988654333333345678999999999999999999886654
Q ss_pred --CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 824 --NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 824 --~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..++||||+. ++|.+++.+....+++..++.++.||+.||.|||++| |+|+||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3599999996 4888888765567999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCcc----cccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc------
Q 045028 902 MKHNTFL----SSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------ 970 (1044)
Q Consensus 902 ~~~~~~~----~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------ 970 (1044)
....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 5433211 112345788999999987654 68899999999999999999999987765543322211000
Q ss_pred -----------cCCCC-------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 -----------RLDIP-------------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 -----------~~~ip-------------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...++ ...+..+.+||.+||..||.+|||+.++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00011 1235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.59 Aligned_cols=242 Identities=22% Similarity=0.332 Sum_probs=186.6
Q ss_pred EeEecccCcEEEEEEEEC----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CCCceEEEEe
Q 045028 758 GERIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PPNLSIVAEF 831 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~~l~LVmEy 831 (1044)
+++||+|+||+||+|+.. +..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 46799998765432 2357789999999999999999998853 4568999999
Q ss_pred cCCCcHHHHhcC--------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE----cCCCeEEEEeccc
Q 045028 832 LPRGSLYRLLHR--------PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGL 899 (1044)
Q Consensus 832 ~~GGsL~dlLkr--------~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL----d~dg~VKLiDFGL 899 (1044)
+.+ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 864 78777642 1235889999999999999999999999 9999999999999 4667999999999
Q ss_pred cccccCCcc---cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------HHhhhc
Q 045028 900 SRMKHNTFL---SSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ---------VVGAVG 966 (1044)
Q Consensus 900 A~~~~~~~~---~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e---------il~~I~ 966 (1044)
++....... ......||+.|+|||++.+. .++.++|||||||+||||++|++||....... ....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 986543221 12345689999999999774 47899999999999999999999997543210 000000
Q ss_pred c---------------c-----------ccc----------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 967 F---------------Q-----------HRR----------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 967 ~---------------~-----------~~~----------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. . ... .......+..+.+||.+||..||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0 000 00011245678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=360.26 Aligned_cols=259 Identities=23% Similarity=0.308 Sum_probs=211.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|+++++||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999987 5789999998653222 234567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC----------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 830 EFLPRGSLYRLLHRP----------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~----------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
||++|++|.+++... ...++...++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999988641 133566778899999999999999999 99999999999999999999999999
Q ss_pred cccccCC------------------cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 045028 900 SRMKHNT------------------FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV 961 (1044)
Q Consensus 900 A~~~~~~------------------~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~ei 961 (1044)
++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9754110 0011234699999999999999999999999999999999999999987655443
Q ss_pred Hhhhcccc-ccCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHHHhccccCC
Q 045028 962 VGAVGFQH-RRLDIPDNLDPAVADIIRKCWQTDPKMRP-TFTEIMAALKPLQKP 1013 (1044)
Q Consensus 962 l~~I~~~~-~~~~ip~~ip~ELkdLI~rcL~kDPekRP-Ta~ELLe~Lk~L~k~ 1013 (1044)
........ ........+++.+.+++.+||..||++|+ +++++++.|+.+...
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 32211111 11111246889999999999999999996 677888888877653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=316.32 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=210.4
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
.|...+.||+|+||.||++.+ .++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455667999999999999976 57889999875433 23345688999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+.|++|.+++.. ..+++..++.++.||+.+|.|||++| |+||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999876 56899999999999999999999999 99999999999999999999999998875443333334
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHHHHHHHHHhh
Q 045028 912 STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~ELkdLI~rcL 990 (1044)
...|++.|++||.+.+..++.++||||||+++|+|++|+.||...+..+....+.... .....+..++..+.++|.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 4568999999999999889999999999999999999999998877766665553221 122223448899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 045028 991 QTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~ 1006 (1044)
..+|++||++.+++++
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=329.92 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=208.7
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-----Cce
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-----NLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-----~l~ 826 (1044)
.|.-.+++|.|+||.||.|.. +++.||||++..... .-.+|+.+|+.+.|||||+++.+|.... ++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 588899999999999999976 578899998764432 2236999999999999999998885432 467
Q ss_pred EEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEecccccc
Q 045028 827 IVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRM 902 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA~~ 902 (1044)
+||||++. +|.+.++. .+.+++...++-+..||++||.|||..| |+||||||.|||+|.+ |.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999965 89988874 3678999999999999999999999999 9999999999999976 9999999999987
Q ss_pred ccCCcccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR----------- 970 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~----------- 970 (1044)
...... ..+...|..|+|||.+.|.. |+.+.||||.||++.||+-|++.|.+.+..+.+..|...-+
T Consensus 176 L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 654433 24566799999999998865 89999999999999999999999999876655444321100
Q ss_pred ----cC------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccCCCCCCCCCCCCC
Q 045028 971 ----RL------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPITSSQVPRPVP 1024 (1044)
Q Consensus 971 ----~~------------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k~l~~~~~p~~~p 1024 (1044)
.. -+...+++++.+|+.++|..+|.+|.++.|++.| ++.++.+-...+..++.|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp 326 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLP 326 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCC
Confidence 00 1234578999999999999999999999999976 445555433333333333
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=342.72 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=214.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCce
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~ 826 (1044)
.+....|+++++||+||-+.||++... .+.||+|.+.........+.-+++|+.+|.+|+ |.+||.+|+|-..++++|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 456678999999999999999999874 567899888777777788899999999999996 999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC-
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN- 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~- 905 (1044)
|||||- ..+|..+|++....++.-.++.+..|++.++.++|++| |||.||||.|+|+-. |.+||+|||+|.....
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 999987 56999999987666666688999999999999999999 999999999999954 7999999999986543
Q ss_pred -CcccccCCCCCCCccCcccccCCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccC
Q 045028 906 -TFLSSRSTAGTAEWMAPEVLRNEP-----------SDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRL 972 (1044)
Q Consensus 906 -~~~~~~s~~GTp~Y~APEvL~g~~-----------~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~ 972 (1044)
+.....+-+||+-||+||.+.... .+.++||||||||||+|+.|+.||.... ...-+..|..-+..+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 344556778999999999985432 3568999999999999999999998754 233344444333455
Q ss_pred CCCCCCCHH-HHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 973 DIPDNLDPA-VADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 973 ~ip~~ip~E-LkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++|..-+.. +.++++.||.+||.+||++.++|+|-
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 666554444 99999999999999999999999873
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=350.43 Aligned_cols=247 Identities=30% Similarity=0.508 Sum_probs=218.9
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC--ceEE
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN--LSIV 828 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~--l~LV 828 (1044)
.+...+||+|+|-+||+|.+ +|-.||.-.++..++. ...+++|..|+.+|+.|+||||++||++|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 45678899999999999976 5777887655544333 4556899999999999999999999999987765 8899
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~~~~~~ 907 (1044)
+|.+..|+|..++++ -+.++.+.+..|+.||+.||.|||++.++|||||||-+||||+. .|.|||+|+|+|+......
T Consensus 122 TEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999999988 46789999999999999999999999999999999999999985 5899999999999876654
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWG-GMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~-~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
. ...+|||.|||||+.. ..|++.+||||||++|+||+|+..||. ..++.++++++.....+-.+...-+++++++|
T Consensus 201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 3 3478999999999998 779999999999999999999999995 57899999999877777677777799999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 045028 987 RKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+||.. ...|+|+.|||++
T Consensus 278 ekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhcC-chhccCHHHHhhC
Confidence 999998 9999999999976
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.85 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=218.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEE--ECCcEEEEEEeeccCcchhhH-HHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGD--WHGTEVAVKRFLDQDFFGESL-EEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak--~~g~~VAVK~l~~~~~~~~~~-~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.+..+.|+.-++||+|+||.||-+. .+|+.||+|.+.+..+....- ...++|..||.+++.++||.+-..|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 3456789999999999999999764 589999999887665543332 3467899999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++||..|+||+|.-+|... +..|++..++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+|+|+|+|+|....
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999998774 467999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhccccccCCCCCCCCH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----QVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~----eil~~I~~~~~~~~ip~~ip~ 980 (1044)
... .....+||..|||||++++..|+...|||+|||+||||+.|+.||...... ++-+.+ ......+++.+++
T Consensus 339 ~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 EGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFSE 415 (591)
T ss_pred CCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccCH
Confidence 443 344569999999999999999999999999999999999999999875432 333333 4556778899999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 045028 981 AVADIIRKCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
++++|+..+|++||.+|. .+.++.+|
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 999999999999999996 45577776
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=343.82 Aligned_cols=253 Identities=17% Similarity=0.229 Sum_probs=189.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC---CcEEEEEE--------------ee-ccCcchhhHHHHHHHHHHHHhCCCCCe
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH---GTEVAVKR--------------FL-DQDFFGESLEEFRSEVLIMKRVRHPNV 812 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~---g~~VAVK~--------------l~-~~~~~~~~~~~~~~EI~ILk~LrHPNI 812 (1044)
..++|+++++||+|+||+||++... +...++|. +. ...........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998652 11222221 11 111112234568899999999999999
Q ss_pred eEEEeeeecCCCceEEEEecCCCcHHHHhcCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC
Q 045028 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRP----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888 (1044)
Q Consensus 813 Vkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~ 888 (1044)
+++++++...+..|+|++++. ++|..++... ........++.++.||+.||.|||++| ||||||||+||||+.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 999999999999999999995 5777776432 223446677889999999999999999 999999999999999
Q ss_pred CCeEEEEeccccccccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCC--hH-HHHh
Q 045028 889 NWVVKVCDFGLSRMKHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQP-WGGMN--PM-QVVG 963 (1044)
Q Consensus 889 dg~VKLiDFGLA~~~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~P-F~~~~--~~-eil~ 963 (1044)
++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+||||++|..+ |.... +. ++..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999997654322 223346799999999999999999999999999999999998764 43221 11 1111
Q ss_pred hhcccc-ccC-----------------------CC-----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 964 AVGFQH-RRL-----------------------DI-----PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 964 ~I~~~~-~~~-----------------------~i-----p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+.... ... .+ ...++.++.++|.+||..||.+|||+.|+|+|
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 110000 000 00 11356778889999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.94 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=214.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
...|+..+.||+|+||.||++++ ++..+|+|.+..... .......+.+|+.+++.++|||++++++++......++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 34588999999999999999986 578899998865432 234456788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.| +|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 999975 788877665677999999999999999999999999 99999999999999999999999999865432
Q ss_pred cccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
.....|++.|+|||.+. +..++.++|||||||++|+|++|+.||...+.......+............+++.++++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 22356889999999984 45678899999999999999999999988776666655543333333445688999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
|.+||..+|.+||++.++++++..+..
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhcc
Confidence 999999999999999999998776543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.15 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=208.4
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|++.+.||.|++|.||++.. +++.+++|.+............+.+|+.++++++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67789999999999999987 5788999998765544344567888999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccC
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s 912 (1044)
.+ +|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 75 888888775678999999999999999999999999 999999999999999999999999998765544322333
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--------------------
Q 045028 913 TAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR-------------------- 971 (1044)
Q Consensus 913 ~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~-------------------- 971 (1044)
..++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5688899999999877 6899999999999999999999999887765443332111000
Q ss_pred --------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 --------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 --------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......++.++.++|.+||.+||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 01123468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=312.19 Aligned_cols=241 Identities=25% Similarity=0.366 Sum_probs=202.7
Q ss_pred ecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 761 IGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 761 LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
||+|+||+||++.+ +|+.|++|.+....... .....+..|+++++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999976 58899999886543222 2344567899999999999999999999999999999999999999
Q ss_pred HHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCC
Q 045028 838 YRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916 (1044)
Q Consensus 838 ~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GT 916 (1044)
.+++.+.. ..+++..++.++.|++.||.|||++| |+||||+|+|||++.++.++|+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99987633 46899999999999999999999999 999999999999999999999999998754332 222345678
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhc
Q 045028 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP----MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992 (1044)
Q Consensus 917 p~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~----~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~k 992 (1044)
..|++||++.+..++.++|||||||++|+|++|+.||..... .++...+ ......++..+++.+.++|.+||..
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--LEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--ccccccCCccCCHHHHHHHHHHccC
Confidence 899999999888899999999999999999999999977543 2222222 2334566778899999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 045028 993 DPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 993 DPekRP-----Ta~ELLe~ 1006 (1044)
||.+|| ++.++++|
T Consensus 236 ~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 236 DPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ChhHccCCCcccHHHHHhC
Confidence 999999 88888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.41 Aligned_cols=240 Identities=29% Similarity=0.474 Sum_probs=205.5
Q ss_pred ecccCcEEEEEEEEC--CcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 761 IGLGSYGEVYRGDWH--GTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 761 LGkG~FGtVykak~~--g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
||.|+||.||++++. ++.+++|.+...... ......+.+|+.++++++||||+++++.+......+++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999884 889999988654332 24456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc--------c
Q 045028 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL--------S 909 (1044)
Q Consensus 838 ~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~--------~ 909 (1044)
.+++.+. ..+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 9999874 37899999999999999999999999 99999999999999999999999999875433211 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCC--CHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNL--DPAVADIIR 987 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~i--p~ELkdLI~ 987 (1044)
.....++..|++||.+.+..++.++||||||+++|+|++|..||......+....+.. .....+..+ +.++.++|.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHH
Confidence 2345688899999999988899999999999999999999999998888877766643 333444444 899999999
Q ss_pred HhhhcCCCCCCCH---HHHHH
Q 045028 988 KCWQTDPKMRPTF---TEIMA 1005 (1044)
Q Consensus 988 rcL~kDPekRPTa---~ELLe 1005 (1044)
+||+.+|.+|||+ .++++
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhc
Confidence 9999999999999 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=314.72 Aligned_cols=253 Identities=24% Similarity=0.312 Sum_probs=205.4
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-----
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP----- 823 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~----- 823 (1044)
..++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999987 5788999998765433344456788999999999999999999887654
Q ss_pred -----CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 824 -----NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 824 -----~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
.+++||||+++ +|..++......+++..++.++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999976 777777765567999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCcc-cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-----
Q 045028 899 LSRMKHNTFL-SSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----- 971 (1044)
Q Consensus 899 LA~~~~~~~~-~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~----- 971 (1044)
++........ ......++..|++||.+.+. .++.++|||||||++|+|++|++||...+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9876543221 11223467889999988654 4788999999999999999999999876655444332211000
Q ss_pred -----------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 -----------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 -----------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......++..+.++|.+||..+|.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01123478999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=315.81 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=198.6
Q ss_pred CeeEEeEecccCcEEEEEEEE----CCcEEEEEEeeccC-cchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCce
Q 045028 754 EITLGERIGLGSYGEVYRGDW----HGTEVAVKRFLDQD-FFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~----~g~~VAVK~l~~~~-~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~ 826 (1044)
+|++.++||+|+||.||+|.+ .++.||+|.+.... ........+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 489999999999999999987 56889999987632 1122345678899999999999999999999988 7899
Q ss_pred EEEEecCCCcHHHHhcCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC----CCeEEEEecc
Q 045028 827 IVAEFLPRGSLYRLLHRP----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK----NWVVKVCDFG 898 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~----dg~VKLiDFG 898 (1044)
+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999965 677766432 236899999999999999999999999 999999999999999 9999999999
Q ss_pred ccccccCCcc---cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------HHhhh
Q 045028 899 LSRMKHNTFL---SSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ---------VVGAV 965 (1044)
Q Consensus 899 LA~~~~~~~~---~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e---------il~~I 965 (1044)
++........ ......+++.|+|||++.+. .++.++|||||||+||+|++|++||.+..... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9876433221 22345688999999988764 57899999999999999999999997654322 00000
Q ss_pred c------------------------cccccCCCC-----------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 966 G------------------------FQHRRLDIP-----------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 966 ~------------------------~~~~~~~ip-----------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. .......++ ...+.++.++|.+||+.||++|||+.|+++|
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000001111 1567789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.79 Aligned_cols=257 Identities=26% Similarity=0.380 Sum_probs=207.6
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-----CCc
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-----PNL 825 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-----~~l 825 (1044)
.+|++.+.||+|+||+||++++ +++.||||.+............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999986 578999998865433334455678899999999999999999987654 348
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999995 689888876 467999999999999999999999999 99999999999999999999999999986544
Q ss_pred CcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc----------------
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---------------- 968 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~---------------- 968 (1044)
.........++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3223344568899999998865 45889999999999999999999999776533222111000
Q ss_pred ----------ccc---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccCC
Q 045028 969 ----------HRR---LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKP 1013 (1044)
Q Consensus 969 ----------~~~---~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k~ 1013 (1044)
... ......+++++.++|.+||..+|.+|||+.++++| +..+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000 11224678999999999999999999999999998 6655444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.77 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=205.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~LV 828 (1044)
++|++.++||.|+||.||++.+ +++.+|+|.+..... ......+.+|++++++++||||+++++++... +.+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4799999999999999999987 578899998865432 24456789999999999999999999988654 468999
Q ss_pred EEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 829 AEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|||+++++|.+++.. ....+++..+..++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999888653 3456899999999999999999999999 99999999999999999999999999865433
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHhhhccccccCCCC-----
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM-----NPMQVVGAVGFQHRRLDIP----- 975 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~-----~~~eil~~I~~~~~~~~ip----- 975 (1044)
.. .....++..|++||.+.+..++.++|||||||++|+|++|..||... ...+....+... ....++
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPGN 234 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCCC
Confidence 22 12346788999999999999999999999999999999999999765 223344333211 111111
Q ss_pred -CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 976 -DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 976 -~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
...++++.++|.+||.++|.+|||+.|++++-.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 234678999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.11 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=195.7
Q ss_pred EecccCcEEEEEEEE--CCcEEEEEEeeccCcchhh-HHHHHHHHHHHH---hCCCCCeeEEEeeeecCCCceEEEEecC
Q 045028 760 RIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGES-LEEFRSEVLIMK---RVRHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 760 ~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~-~~~~~~EI~ILk---~LrHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
.||+|+||.||++.+ +++.+|+|.+......... ...+.+|..+++ ..+||||+.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 5789999988654332221 222344444443 3479999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCC
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~ 913 (1044)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 9999998876 356999999999999999999999999 999999999999999999999999998654322 22335
Q ss_pred CCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHhhhccccccCCCCCCCCHHHHHHHHHhh
Q 045028 914 AGTAEWMAPEVLR-NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM--QVVGAVGFQHRRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 914 ~GTp~Y~APEvL~-g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~--eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL 990 (1044)
.||..|+|||.+. +..++.++|||||||++|+|++|..||...... ...... .......++..++.+++++|.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHh
Confidence 6899999999986 456889999999999999999999999764322 112221 123345677889999999999999
Q ss_pred hcCCCCCC-----CHHHHHHHh
Q 045028 991 QTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 991 ~kDPekRP-----Ta~ELLe~L 1007 (1044)
..||.+|| ++.++++|.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCc
Confidence 99999999 699999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.00 Aligned_cols=249 Identities=27% Similarity=0.491 Sum_probs=225.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+-|.++++||+|+||.||++.+ .|+.+|||.+.. +..++++..||.|++++..|++|++|+.+.....+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4588999999999999999855 799999998643 3467889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
||.-|++.++++.+++.+++..+..++...+.||+|||... -||||||..|||++.+|+.||+|||.+-...++....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 99999999999988999999999999999999999999998 8999999999999999999999999998887777777
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHHHHHHHHHh
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~ELkdLI~rc 989 (1044)
.+..|||.|||||++..-.|+.++||||||++..||..|++||.+..+...+..|..+. ..+..|...+.++.++|+.|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 88999999999999999999999999999999999999999999887766555553222 24455677788999999999
Q ss_pred hhcCCCCCCCHHHHHHHh
Q 045028 990 WQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~L 1007 (1044)
|.+.|++|-|+.++++|-
T Consensus 267 LiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHT 284 (502)
T ss_pred hcCCHHHHHHHHHHhhhh
Confidence 999999999999999884
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=313.29 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=200.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|+..+.||+|+||.||++.+ +++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..++..+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 45788889999999999999987 5788999988654332 34567888999999996 99999999999999999999
Q ss_pred EEecCCCcHHHHhc---C-CCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 829 AEFLPRGSLYRLLH---R-PNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 829 mEy~~GGsL~dlLk---r-~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
|||+.+ +|.++.. . ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.++|+|||++...
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999854 5544432 2 246799999999999999999999974 8 999999999999999999999999998754
Q ss_pred cCCcccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhccccc---cCCCCC
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNE---PSDEKCDVYSFGVILWELCTMQQPWGGMNP-MQVVGAVGFQHR---RLDIPD 976 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~---~~s~kSDIWSLG~LLyELLTGk~PF~~~~~-~eil~~I~~~~~---~~~ip~ 976 (1044)
.... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... .+....+..... ....+.
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 3322 12334688999999999876 688999999999999999999999976542 122222211111 112223
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.++.++.+||.+||.++|.+|||+.+|+++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 588999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.18 Aligned_cols=246 Identities=23% Similarity=0.400 Sum_probs=195.6
Q ss_pred eEecccCcEEEEEEEE-CCc---EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW-HGT---EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~-~g~---~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
++||+|+||.||+++. ++. .+++|.+.... .....+.+.+|+.+++.++||||+++++.+......++||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999975 332 35566554332 123456789999999999999999999999999999999999999
Q ss_pred CcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--ccc
Q 045028 835 GSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLS 909 (1044)
Q Consensus 835 GsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~~~ 909 (1044)
++|.+++.+. ...++...++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999998753 234677788899999999999999999 999999999999999999999999998642211 112
Q ss_pred ccCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhcccc----ccCCCCCC
Q 045028 910 SRSTAGTAEWMAPEVLRN-------EPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQH----RRLDIPDN 977 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g-------~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~----~~~~ip~~ 977 (1044)
....+++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+.... .+..++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 234568899999999853 235678999999999999997 577898777766665543222 12334456
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+++.+.+++..|| .+|++||++.+|++.|.
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 7889999999999 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.77 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=205.0
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCceEEEE
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNLSIVAE 830 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l~LVmE 830 (1044)
|++.+.||.|+||.||++.+ +++.+|+|.+............+.+|+.+++.++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 68899999999999999987 468899999876643334456688899999999999999999999888 78999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-c
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-S 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~ 909 (1044)
|+.+ +|.+++.+....+++..++.++.||+.||.|||+.| ++|+||||+|||++.++.++|+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 899998775568999999999999999999999999 99999999999999999999999999976544321 1
Q ss_pred ccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-----------------
Q 045028 910 SRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----------------- 971 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~----------------- 971 (1044)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 2234578899999987654 5789999999999999999999999887765444333210000
Q ss_pred ------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 ------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+...++.++.++|.+||..+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111238899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=319.44 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=202.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-----Cc
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-----NL 825 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-----~l 825 (1044)
++|++.++||+|+||.||++.+ +|+.||||++.... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6899999999999999999976 67899999885422 1233456788999999999999999998765443 47
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++++||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999964 88888864 57999999999999999999999999 99999999999999999999999999875432
Q ss_pred Ccc---cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc--------------
Q 045028 906 TFL---SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-------------- 967 (1044)
Q Consensus 906 ~~~---~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-------------- 967 (1044)
... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 211 1223568999999998755 4688999999999999999999999977654322211100
Q ss_pred -c---------cccC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccC
Q 045028 968 -Q---------HRRL-----DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQK 1012 (1044)
Q Consensus 968 -~---------~~~~-----~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k 1012 (1044)
. .... .....+++++.++|.+||+.+|++|||+.++++| ++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 0000 0113467889999999999999999999999998 665554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.63 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=201.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++.++||.|+||.||++.+ +++.++||++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999987 5788999988655433333345778999999999999999998875433
Q ss_pred --CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 824 --NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 824 --~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
.+++||||+.+ +|...+......+++..++.++.||+.||.|||++| |+|+||||+|||++.++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 46999999965 677777665668999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCccc-----------ccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc
Q 045028 902 MKHNTFLS-----------SRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH 969 (1044)
Q Consensus 902 ~~~~~~~~-----------~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~ 969 (1044)
........ .....+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 1223578889999988654 47899999999999999999999998877655444322110
Q ss_pred cc---------------------CCC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 RR---------------------LDI-------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 ~~---------------------~~i-------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.. ... ...+.+++.++|.+||..||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00 000 12345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.63 Aligned_cols=241 Identities=26% Similarity=0.394 Sum_probs=199.1
Q ss_pred eEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHH-HhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIM-KRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~IL-k~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.||.|+||.||+|.. .++.||+|.+...... ......+..|..++ ...+|+||+++++++...+.+|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999987 5789999998654332 22233445555544 455899999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 999999976 356899999999999999999999999 99999999999999999999999999875432 23456
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc--cCCCCCCCCHHHHHHHHHhhhc
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR--RLDIPDNLDPAVADIIRKCWQT 992 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~--~~~ip~~ip~ELkdLI~rcL~k 992 (1044)
|+..|++||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .......+++++.++|.+||..
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88999999999988889999999999999999999999998887776655532221 2233456899999999999999
Q ss_pred CCCCCCCH---HHHHHH
Q 045028 993 DPKMRPTF---TEIMAA 1006 (1044)
Q Consensus 993 DPekRPTa---~ELLe~ 1006 (1044)
+|++||++ .|++.|
T Consensus 235 ~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 235 DPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHccCCCcHHHHHcC
Confidence 99999965 566554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.28 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=208.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-----Cce
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-----NLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-----~l~ 826 (1044)
+|++.+.||.|+||.||++++ .++.|+||.+..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999987 4788999988764433445567889999999999999999999988775 789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
++|||+. ++|.+++.+ ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 589998876 348999999999999999999999999 999999999999999999999999999865443
Q ss_pred c---ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-----------
Q 045028 907 F---LSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----------- 971 (1044)
Q Consensus 907 ~---~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~----------- 971 (1044)
. .......+++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+.+..+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 122345689999999999888 7899999999999999999999999887765544433211000
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 ------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......++.++.++|.+||.++|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01123478899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.15 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=206.4
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPP 823 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~ 823 (1044)
.+.+..++|++.+.||+|+||.||++.+. ++.||||.+...... .....+..|+.++..+. ||||+++++++....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 45667789999999999999999999885 889999998755432 23345666777666665 999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.++++|||+. ++|.+++......+++..+..++.||+.||.|||+ ++ |+||||+|+||+++.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999985 47887776655678999999999999999999997 58 99999999999999999999999999875
Q ss_pred ccCCcccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhcccc-ccCCCCC
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEP----SDEKCDVYSFGVILWELCTMQQPWGGMNP-MQVVGAVGFQH-RRLDIPD 976 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~----~s~kSDIWSLG~LLyELLTGk~PF~~~~~-~eil~~I~~~~-~~~~ip~ 976 (1044)
...... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+.+..+.... .......
T Consensus 165 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 165 LVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred ccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 443221 22345788999999997654 78899999999999999999999976433 23333332121 1122223
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.++.++.+||.+||..||.+||++.+++++..
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 47899999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=370.08 Aligned_cols=250 Identities=30% Similarity=0.468 Sum_probs=218.5
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+++-+..||.|.||.||.+.+ +|...|+|.++.+.........+.+|..++..|+|||+|++|++-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 355577899999999999976 788899999887776666677899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc----
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF---- 907 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~---- 907 (1044)
|.||+|.++++. ++-.++.....+..|++.|+.|||++| ||||||||+|||++.+|.+|++|||.|.......
T Consensus 1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999999999976 566778888889999999999999999 9999999999999999999999999998765442
Q ss_pred ccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccccCCCCCCCCHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNE---PSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~---~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.......||+.|||||++.+. +...+.|||||||++.||+||+.||...+.. .+..++ .....+.+|..++++-+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-AAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-hccCCCCCchhhhHhHH
Confidence 123456799999999999754 4567899999999999999999999886554 444444 35677889999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++|.+||..||++|.++.||+++=
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhh
Confidence 999999999999999999999873
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=318.10 Aligned_cols=255 Identities=20% Similarity=0.343 Sum_probs=204.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCC--Cce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPP--NLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~--~l~ 826 (1044)
.++|++.+.||+|+||.||+|.+ +++.+|||++............+.+|+.+++++ +||||+++++++...+ .++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 46899999999999999999976 578899998865433334455677899999999 9999999999886543 589
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+. ++|..++... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999998763 7889999999999999999999999 999999999999999999999999998754332
Q ss_pred c-----ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-----------
Q 045028 907 F-----LSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH----------- 969 (1044)
Q Consensus 907 ~-----~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~----------- 969 (1044)
. .......|++.|++||++.+ ..++.++||||||+++|+|++|+.||.+....+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 1 12233468999999998865 457889999999999999999999998765544332221110
Q ss_pred ------------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hcccc
Q 045028 970 ------------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQ 1011 (1044)
Q Consensus 970 ------------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~ 1011 (1044)
........++.++.++|.+||+.||.+|||+.+++++ +.++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0011123478999999999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.42 Aligned_cols=248 Identities=26% Similarity=0.332 Sum_probs=201.9
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC---CCCCeeEEEeeeecCCC-----
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV---RHPNVVLFMGAVTRPPN----- 824 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L---rHPNIVkl~~~~~~~~~----- 824 (1044)
|++.+.||+|+||.||++++ +++.||+|.+............+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 68899999999999999987 478999999875433333334566788877766 59999999999988776
Q ss_pred ceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++++|||+.+ +|.+++.+. ...+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999975 798888763 346899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc---c---------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR---R--------- 971 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~---~--------- 971 (1044)
..... .....++..|++||++.+..++.++|||||||++|+|++|++||......+.+..+..... .
T Consensus 158 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 43321 2234578899999999998899999999999999999999999988776655544321100 0
Q ss_pred -------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 -------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 -------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......+++.+.++|.+||..||.+||++.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00012356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=300.26 Aligned_cols=241 Identities=29% Similarity=0.446 Sum_probs=210.6
Q ss_pred ecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 761 IGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 761 LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
||.|+||.||++.. .++.+++|++...... ......+..|+.+++.++||||+++++.+.....+++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999987 4789999998765433 23566789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCC
Q 045028 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA 917 (1044)
Q Consensus 838 ~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp 917 (1044)
.+++.+. ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 9999763 46899999999999999999999999 99999999999999999999999999876544323344567899
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 045028 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR 997 (1044)
Q Consensus 918 ~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekR 997 (1044)
.|++||.+.+...+.++|+|+||+++|+|++|..||...+..+....+.. ....++..++.++.++|.+||..||++|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999988889999999999999999999999988777666666643 5567888889999999999999999999
Q ss_pred CCH---HHHHHH
Q 045028 998 PTF---TEIMAA 1006 (1044)
Q Consensus 998 PTa---~ELLe~ 1006 (1044)
|++ .++++|
T Consensus 236 ~~~~~~~~l~~~ 247 (250)
T cd05123 236 LGSGGAEEIKAH 247 (250)
T ss_pred CCcccHHHHHhC
Confidence 999 676654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.54 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=205.5
Q ss_pred CeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCc
Q 045028 754 EITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l 825 (1044)
+|++.+.||.|+||.||+++. +|+.||+|++...... ....+.+.+|+.+++++ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999875 5788999998654321 22346688899999999 599999999999998999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999999876 356889999999999999999999999 99999999999999999999999999875433
Q ss_pred Cc-ccccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhccccccCCCCCCC
Q 045028 906 TF-LSSRSTAGTAEWMAPEVLRNE--PSDEKCDVYSFGVILWELCTMQQPWGGMNP----MQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 906 ~~-~~~~s~~GTp~Y~APEvL~g~--~~s~kSDIWSLG~LLyELLTGk~PF~~~~~----~eil~~I~~~~~~~~ip~~i 978 (1044)
.. .......|+..|++||.+.+. .++.++||||||+++|+|++|..||..... .++...+ ......++..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccC
Confidence 21 122345689999999998753 467899999999999999999999964322 2233332 22334567789
Q ss_pred CHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 045028 979 DPAVADIIRKCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
++.+.+++.+||..||.+|| ++.+++++
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999999997 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=312.43 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=207.3
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
-|...++||+|+||+||+|++ +++.|++|++..... .......+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 377788899999999999986 678899998865433 23344568889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+. ++|.+++......+++..++.++.||+.+|.|||++| |+|+||||+||+++.++.+||+|||++..... .
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~ 174 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----A 174 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----C
Confidence 995 5788887765677999999999999999999999999 99999999999999999999999999864322 2
Q ss_pred cCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 911 RSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+............++..++++|.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 3456899999999984 4557889999999999999999999998877666555553333333334567788999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||+++|.+||++.+++.+
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.99 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=203.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec----CCCce
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PPNLS 826 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~----~~~l~ 826 (1044)
++|++.+.||+|+||.||++.. +++.||+|++............+.+|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999976 58899999987654333455678889999999999999999988753 34689
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 589999876 355999999999999999999999999 999999999999999999999999998754322
Q ss_pred cc----cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-------------
Q 045028 907 FL----SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ------------- 968 (1044)
Q Consensus 907 ~~----~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~------------- 968 (1044)
.. ......|+..|++||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 1123468999999999866 45789999999999999999999999876543322211100
Q ss_pred -----------cccCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 969 -----------HRRLD-----IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 969 -----------~~~~~-----ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..... +...++.+++++|.+||+.+|.+||++.+++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00011 12456899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=306.85 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=196.7
Q ss_pred EecccCcEEEEEEEE--CCcEEEEEEeeccCcchhh-HHHHHHHH---HHHHhCCCCCeeEEEeeeecCCCceEEEEecC
Q 045028 760 RIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGES-LEEFRSEV---LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 760 ~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~-~~~~~~EI---~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
.||+|+||.||++.+ +++.||+|.+......... ...+..|. .+++...||+|+++++++...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999876 5789999988765432211 11233333 34445579999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCC
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~ 913 (1044)
|++|..++.+ ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 9999998875 457999999999999999999999999 999999999999999999999999998754322 22345
Q ss_pred CCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 914 AGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMN---PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 914 ~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~---~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.|+..|+|||++.+. .++.++||||||+++|+|++|+.||.... ........ ......++..++.++.++|.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHH
Confidence 799999999999754 58899999999999999999999998762 22222222 2334567778899999999999
Q ss_pred hhcCCCCCC-----CHHHHHHHh
Q 045028 990 WQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 990 L~kDPekRP-----Ta~ELLe~L 1007 (1044)
|..+|.+|| ++.+++++-
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCc
Confidence 999999999 999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=333.03 Aligned_cols=262 Identities=32% Similarity=0.567 Sum_probs=230.0
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC----Cc--EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeee
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH----GT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~----g~--~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~ 819 (1044)
...++..+.+.+.++||.|.||.||.|.++ |. .||||.-+... .....+.|..|..+|+.++||||++++|++
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 345667778888999999999999999763 33 48888765543 344578899999999999999999999998
Q ss_pred ecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 820 TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 820 ~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
.. ...|||||.++-|.|..+++++...++......++.||+.+|.|||+.. +|||||...|||+....-|||+|||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 65 5689999999999999999998999999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 900 SRMKHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 900 A~~~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
++...+.. +......-..-|||||.++-..++.++|||-||++|||++. |..||.+....+++..+. +..+++.|+.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCCC
Confidence 99766543 33333344568999999999999999999999999999885 899999998888887774 6778999999
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
||+.+..|+.+||+.+|.+||++.+|...|.++..
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999998877654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=310.02 Aligned_cols=256 Identities=16% Similarity=0.189 Sum_probs=189.0
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECC-----cEEEEEEeeccCcch-hhH--------HHHHHHHHHHHhCCCCCeeE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFG-ESL--------EEFRSEVLIMKRVRHPNVVL 814 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g-----~~VAVK~l~~~~~~~-~~~--------~~~~~EI~ILk~LrHPNIVk 814 (1044)
++..++|++.++||+|+||+||+|.+.+ ..+++|+........ ... .....+...+..+.|++|++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3455789999999999999999998743 356666533221110 000 01122334455678999999
Q ss_pred EEeeeecCC----CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC
Q 045028 815 FMGAVTRPP----NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 815 l~~~~~~~~----~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg 890 (1044)
+++++.... ..+++++++. .++.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998765543 3467788773 466666654 234678889999999999999999999 99999999999999999
Q ss_pred eEEEEeccccccccCCc-------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 045028 891 VVKVCDFGLSRMKHNTF-------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP-MQVV 962 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~~~~-------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~-~eil 962 (1044)
.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||+||||++|..||.+... ....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999997542211 112234699999999999999999999999999999999999999987632 2211
Q ss_pred hhh-----ccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 963 GAV-----GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 963 ~~I-----~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
... ............+++++.+++..||..+|++||++.+|++.|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 0001111123567899999999999999999999999998763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=317.04 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=198.0
Q ss_pred eEeccc--CcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 759 ERIGLG--SYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 759 r~LGkG--~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
..||+| +||+||++++ .|+.||+|++..........+.+.+|+.+++.++||||++++++|...+.+++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999987 789999999876554555667899999999999999999999999999999999999999
Q ss_pred CcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-----
Q 045028 835 GSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL----- 908 (1044)
Q Consensus 835 GsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~----- 908 (1044)
++|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999998763 345899999999999999999999999 99999999999999999999999986532211100
Q ss_pred --cccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc---------------
Q 045028 909 --SSRSTAGTAEWMAPEVLRNE--PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH--------------- 969 (1044)
Q Consensus 909 --~~~s~~GTp~Y~APEvL~g~--~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~--------------- 969 (1044)
......++..|++||++.+. .++.++|||||||++|+|++|..||......+.........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 01112356679999999764 47899999999999999999999998765443332211000
Q ss_pred ------------------------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 970 ------------------------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 970 ------------------------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.....+..+++++.+||.+||..||++|||+.++++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 00111234677899999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.34 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=203.7
Q ss_pred eeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCC
Q 045028 755 ITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+.+++.+|.|+++.|+++..+++.||||++............+.+|+.+++.++|+||+++++++...+..+++|||+.+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45667777888888888888899999999877655556778899999999999999999999999999999999999999
Q ss_pred CcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc------
Q 045028 835 GSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF------ 907 (1044)
Q Consensus 835 GsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~------ 907 (1044)
++|.+++.+. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999999763 456899999999999999999999999 9999999999999999999999999886432211
Q ss_pred -ccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh-hhccc---------------
Q 045028 908 -LSSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVG-AVGFQ--------------- 968 (1044)
Q Consensus 908 -~~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~-~I~~~--------------- 968 (1044)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 11223457788999999976 357889999999999999999999998765443221 11100
Q ss_pred ----------------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 969 ----------------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 969 ----------------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.........++.++.++|.+||..||++|||+.+++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000011123456789999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.64 Aligned_cols=249 Identities=26% Similarity=0.467 Sum_probs=208.2
Q ss_pred CeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccC---cchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 754 EITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQD---FFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~---~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+|.+.++||+|+||.||++++. +..+++|.++... ........+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5899999999999999999774 3456666654322 2223334577799999999999999999999998999999
Q ss_pred EEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 829 AEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|||+.+++|.+++.+ ....+++..++.++.|++.||.|||+.| |+|+||||+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998863 3467999999999999999999999999 999999999999975 5799999999876544
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
.........|++.|++||.+.+..++.++|+||||+++|+|++|..||...........+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333445568899999999988888999999999999999999999998776665555543 233445567889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||..+|++||++.+++++
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=316.15 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=203.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++.+.||+|+||.||++.+ ++..||||++............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 46799999999999999999976 5788999988654333344556889999999999999999999987654
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999999 7799988865 56899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------ 970 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------ 970 (1044)
... .....+++.|++||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+.....
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 332 223467899999999876 4578999999999999999999999987665433322211000
Q ss_pred -----------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 -----------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 -----------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...+...+++++.++|.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011224678889999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=312.55 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=210.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
...|...+.||+|+||.||++++ ++..+++|.+..... .......+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 45688899999999999999987 577899998864322 233455688899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+. ++|.+++......+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 99996 5788877655567899999999999999999999999 999999999999999999999999998754322
Q ss_pred cccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+.........+..++.++++|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 2356889999999985 34578899999999999999999999988766555544432222222345688999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
|.+||..+|.+||++.+++++...+.
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCccccc
Confidence 99999999999999999998855443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=310.56 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=207.1
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|....+||+|+||.||++.. +++.||||.+.... ......+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33456799999999999977 67889999875332 234456889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccC
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s 912 (1044)
++++|.+++.. ..+++..++.++.|++.+|.|||+.| |+|+||+|+||+++.++.++|+|||++............
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 99999998864 46899999999999999999999999 999999999999999999999999988754433223344
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCCCCCCCCHHHHHHHHHhhh
Q 045028 913 TAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLDIPDNLDPAVADIIRKCWQ 991 (1044)
Q Consensus 913 ~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ip~~ip~ELkdLI~rcL~ 991 (1044)
..|++.|++||.+.+..++.++|+||||+++|+|++|..||......+....+... .........+++.+.++|.+||.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 56899999999998888899999999999999999999999887666554443211 12223345678999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 045028 992 TDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 992 kDPekRPTa~ELLe~ 1006 (1044)
.+|.+||++.+++++
T Consensus 256 ~~P~~R~~~~~ll~~ 270 (292)
T cd06657 256 RDPAQRATAAELLKH 270 (292)
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.79 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=202.2
Q ss_pred CCee-EEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchh------------hHHHHHHHHHHHHhCCCCCeeEEEe
Q 045028 753 EEIT-LGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGE------------SLEEFRSEVLIMKRVRHPNVVLFMG 817 (1044)
Q Consensus 753 e~y~-I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~------------~~~~~~~EI~ILk~LrHPNIVkl~~ 817 (1044)
++|. +.+.||.|+||+||++.+ .++.||||++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 567899999999999976 578899998865432210 0124678999999999999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
++...+..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||++| |+|+||||+|||++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 589998865 456899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCC--------------cccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 045028 898 GLSRMKHNT--------------FLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV 962 (1044)
Q Consensus 898 GLA~~~~~~--------------~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil 962 (1044)
|++...... ........+++.|+|||.+.+.. ++.++|||||||++|+|++|++||...+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998754411 11112334688999999997654 688999999999999999999999887766554
Q ss_pred hhhccccc---c-----------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 963 GAVGFQHR---R-----------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 963 ~~I~~~~~---~-----------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..+..... . ......++.++.++|.+||.++|.+||++.+++.+-.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 43321000 0 0012345788999999999999999999999997543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.37 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=206.7
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|++.+.||+|+||.||+++. +++.|++|.+............+..|+.+++.++|+||+++++++...+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67788999999999999987 4789999998765433344566788999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccC
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s 912 (1044)
. ++|.+++.+....+++..++.++.|++.+|.|||+.| |+||||+|+||+++.++.++|+|||++............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 7 5899999875567999999999999999999999999 999999999999999999999999998765443333334
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc----------------ccC---
Q 045028 913 TAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH----------------RRL--- 972 (1044)
Q Consensus 913 ~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~----------------~~~--- 972 (1044)
..++..|+|||.+.+. .++.++|||||||++|||++|.+||...+..+.+..+.... ...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999999776 78899999999999999999999998776554433321100 000
Q ss_pred --------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 --------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 --------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.....++..+.++|.+||..+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 1112357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=305.64 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=205.8
Q ss_pred CeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCc
Q 045028 754 EITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l 825 (1044)
+|++.+.||+|+||.||+++. +++.||||.+++.... ......+.+|+.++.++ +||||+++++++.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 489999999999999999864 4678999998754322 22345688899999999 599999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+.+++|.+++.+ ...+++..++.++.|++.+|.|||+.+ ++||||||.||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999999876 356889999999999999999999999 99999999999999999999999999875432
Q ss_pred Ccc-cccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhccccccCCCCCCC
Q 045028 906 TFL-SSRSTAGTAEWMAPEVLRNEP--SDEKCDVYSFGVILWELCTMQQPWGGMN----PMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 906 ~~~-~~~s~~GTp~Y~APEvL~g~~--~s~kSDIWSLG~LLyELLTGk~PF~~~~----~~eil~~I~~~~~~~~ip~~i 978 (1044)
... ......|+..|++||.+.+.. .+.++||||||+++|+|++|..||.... ..++...+ .......+..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 221 122346899999999997765 6789999999999999999999996432 22222222 22345667788
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
+.++.++|.+||+.||++|||+.++.+.|+.
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 9999999999999999999997766555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.98 Aligned_cols=240 Identities=21% Similarity=0.382 Sum_probs=195.8
Q ss_pred CCeeEEeEe--cccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceE
Q 045028 753 EEITLGERI--GLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 753 e~y~I~r~L--GkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~L 827 (1044)
++|++.+.+ |+|+||.||++.. ++..+++|.+....... .|+.+...+ +||||+++++++...+.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 456666665 9999999999976 57889999876543221 122222222 69999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~~~~~ 906 (1044)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 99999999999999774 48999999999999999999999999 99999999999999988 9999999998755432
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HhhhccccccCCCCCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV--VGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~ei--l~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
....|+..|+|||++.+..++.++||||||+++|+|++|..||........ .............+..+++.+++
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 234689999999999999999999999999999999999999986543321 11111123344566689999999
Q ss_pred HHHHhhhcCCCCCCC-HHHHHHH
Q 045028 985 IIRKCWQTDPKMRPT-FTEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPT-a~ELLe~ 1006 (1044)
+|.+||+.+|.+||+ ++++++|
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcC
Confidence 999999999999996 6999865
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.12 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=202.6
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------C
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------N 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------~ 824 (1044)
++|.+.+.||+|+||.||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5799999999999999999976 5889999988754333334456889999999999999999999886543 3
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+++||||+. .+|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 699999995 47777653 46899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-------------
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------- 970 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------- 970 (1044)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 AE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 22 223467889999999876 4588999999999999999999999988765444333211000
Q ss_pred -------------cC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccC
Q 045028 971 -------------RL---DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQK 1012 (1044)
Q Consensus 971 -------------~~---~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k 1012 (1044)
.. .....++.++.++|.+||+.||.+||++.+++.| ++.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 0112467889999999999999999999999977 555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=335.51 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=215.8
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
..|.-++.||.|+||.||-+++ +...||||.+...... .+.-..+..|+..|++++|||++.+-++|-.+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3578889999999999999876 5778999998755321 223356888999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|||-| +-.|++.-+.+++-+..+..|..+.+.||.|||+++ .||||||..|||+++.|.|||+|||.+.....
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 99954 777887777788999999999999999999999999 99999999999999999999999999876543
Q ss_pred ccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
..+++|||+|||||++. .+.|+-++|||||||+..||.-.++|+..++....+..|..+..+..-....+..|+++|
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 45789999999999985 345889999999999999999999999999998888887544433333456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhc
Q 045028 987 RKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..||++-|..|||.+++|+|-.
T Consensus 259 d~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcch
Confidence 9999999999999999998753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.40 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=204.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC-----
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN----- 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~----- 824 (1044)
.++|++.+.||+|+||.||++++ +++.||||++............+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 56899999999999999999987 57889999886543333445667889999999999999999988766554
Q ss_pred -ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 -LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 -l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799999875 56899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-----------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----------- 971 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~----------- 971 (1044)
... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 332 2345688999999998653 5788999999999999999999999877665544433211100
Q ss_pred ---------------C---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 ---------------L---DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ---------------~---~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. .....+++++.++|.+||..+|.+|||+.+|++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 1112468899999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.50 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=201.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------C
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------P 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~ 823 (1044)
.++|++.+.||+|+||.||++.+ +++.||+|++..........+.+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 47899999999999999999975 688899998875433333456688899999999999999999987543 3
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.++++++++ |++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 467888887 7899888865 46899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------ 970 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------ 970 (1044)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 171 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 332 234568899999999876 4678899999999999999999999987665443332211000
Q ss_pred --------------c---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 971 --------------R---LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 971 --------------~---~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
. .......++++.++|.+||.+||.+||++.+++.|-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0 001124678899999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=327.10 Aligned_cols=263 Identities=36% Similarity=0.653 Sum_probs=233.8
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
...+|+....++.+..+||-|.||.||.|.|+ .-.||||.++... -.+++|+.|..+|+.++|||+|+++++|..
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 45678888999999999999999999999985 4569999886543 357889999999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
+..+|||+|||..|+|.+++++++ ..++....++|+.||..|++||..++ +|||||...|+|+.++..||++|||++
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999998864 45677788899999999999999999 999999999999999999999999999
Q ss_pred ccccCC-cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 901 RMKHNT-FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 901 ~~~~~~-~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
+++... +..+....-..-|.|||.|.-..++.++|||+||++|||+.| |..||.+.+..+++..+. +..+..-|..|
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGC 491 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGC 491 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCC
Confidence 976544 333333345668999999999999999999999999999997 788999999888887764 66788999999
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
++.+..|+..||.++|.+||++.||-+.|+.++.
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 9999999999999999999999999999988764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=311.62 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=199.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--------
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-------- 822 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-------- 822 (1044)
.+|++.+.||.|+||.||++.. +++.|++|.+..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 5899999999999999999977 578899998865543 3456788999999999999999999776543
Q ss_pred ------CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEE
Q 045028 823 ------PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVC 895 (1044)
Q Consensus 823 ------~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLi 895 (1044)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEEC
Confidence 34789999996 589888864 46899999999999999999999999 999999999999974 5688999
Q ss_pred eccccccccCCcc---cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc--
Q 045028 896 DFGLSRMKHNTFL---SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-- 969 (1044)
Q Consensus 896 DFGLA~~~~~~~~---~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-- 969 (1044)
|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875432211 1122357889999998754 557889999999999999999999998776554433321100
Q ss_pred ---------------------ccC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 ---------------------RRL-----DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 ---------------------~~~-----~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
... .+...++.++.++|.+||..||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 1123578899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=337.95 Aligned_cols=261 Identities=33% Similarity=0.571 Sum_probs=234.3
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC--C---cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH--G---TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~--g---~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+|.....+|.++||.|-||.|++|+.+ | ..||||.++.. ..+++...|+.|+.||-++.||||+++.++.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 456678999999999999999999873 3 45999998754 45677788999999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+.||+|||++|+|..||+++..+|...+..-|++.|+.|+.||-+++ +|||||...||||+.+..+|++|||+++..
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999999999999999999999999999999999999 999999999999999999999999999976
Q ss_pred cCCcccccCC---CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 904 HNTFLSSRST---AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 904 ~~~~~~~~s~---~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
.+......+. .-..+|.|||.+....++.++||||+|++|||.++ |..||+++...+.+..|. ...+++-|..||
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP 860 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCP 860 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCc
Confidence 5443222222 23468999999999999999999999999999775 999999999999999885 566778888999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
..+.+|+..||++|-.+||++.+|+..|++|.+.
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999998763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=308.84 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=201.6
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec-CCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-PPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-~~~l~L 827 (1044)
..++|++.+.||.|+||.||++.. +++.||||++............+..|+.+++.++||||+++++++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 346799999999999999999976 57889999886544333445678889999999999999999998865 457899
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
+|||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||+|.|||++.++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99998 5689988864 45788889999999999999999999 999999999999999999999999998754322
Q ss_pred ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-------------------
Q 045028 908 LSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF------------------- 967 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~------------------- 967 (1044)
.....++..|++||.+.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 233467889999999866 5689999999999999999999999987654322111100
Q ss_pred -----ccccCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 968 -----QHRRLD-----IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 968 -----~~~~~~-----ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...... ....++++++++|.+||..+|++|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000001 123578899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=331.28 Aligned_cols=259 Identities=34% Similarity=0.607 Sum_probs=229.2
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEEC---Cc--EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEee
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWH---GT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~---g~--~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~ 818 (1044)
....+-|..+++++.++||+|.||.|++|.|+ |+ .||||++....... ....|.+|+.+|.+|+|||++++|++
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeee
Confidence 34457788899999999999999999999984 33 59999997765443 67889999999999999999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
..+ ..+.||||.++.|+|.+.+.+ ....|.......|+.||+.|+.||..++ +|||||...||||-....|||+||
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecc
Confidence 887 779999999999999999987 5677888999999999999999999999 999999999999999999999999
Q ss_pred cccccccCC---cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCC
Q 045028 898 GLSRMKHNT---FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLD 973 (1044)
Q Consensus 898 GLA~~~~~~---~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ 973 (1044)
|+.+-.... |.......-...|+|||.|+...++.++|+|++|++||||++ |+.||.+....++++.|. ...++.
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLp 335 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLP 335 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCC
Confidence 999854432 222223335668999999999999999999999999999998 689999999999999997 778899
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
-|..|++.+.++++.||..+|.+|||+..|.+.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999999999999999999999999997554
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=308.41 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=197.5
Q ss_pred CeeEEeEecccCcEEEEEEEEC----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeec----CCC
Q 045028 754 EITLGERIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTR----PPN 824 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~----~~~ 824 (1044)
+|++.+.||+|+||.||++++. +..||+|++............+.+|+.++++++ ||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4899999999999999999874 568999987643322233456788999999994 9999999986432 245
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+++++||+. ++|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788899885 689888865 467899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCcc----cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-----------
Q 045028 905 NTFL----SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ----------- 968 (1044)
Q Consensus 905 ~~~~----~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~----------- 968 (1044)
.... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 2211 1233468999999998866 46889999999999999999999999876644333221100
Q ss_pred ---------------cccC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 969 ---------------HRRL---DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 969 ---------------~~~~---~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.... .....++.++.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 1123467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=337.56 Aligned_cols=147 Identities=29% Similarity=0.466 Sum_probs=133.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|+++++||+|+||+||+|.+. ++.||||++...... ......+..|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999885 889999998754332 34456788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
|||+.|++|.+++.. ...+++..++.++.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976 356889999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=298.77 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=199.9
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEe
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
|++.+.||+|+||+||+|.. +++.|+||++...... .......+|+..+++++ |+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 68899999999999999987 5678999987654322 22233456899999999 99999999999999999999999
Q ss_pred cCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 832 LPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
+ +++|.+++.... ..+++..++.++.|++.+|.|||+++ |+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence 9 789998887643 57899999999999999999999999 9999999999999999999999999997654322 22
Q ss_pred cCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------------cC
Q 045028 911 RSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-----------------RL 972 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-----------------~~ 972 (1044)
....++..|+|||++.+ ..++.++|+||||+++|+|++|++||......+.+..+..... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 33568899999998854 4578899999999999999999999987665443332211000 00
Q ss_pred -----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 -----------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 -----------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......+.++.++|.+||..+|.+|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0112236889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=319.74 Aligned_cols=266 Identities=28% Similarity=0.504 Sum_probs=225.4
Q ss_pred CCccccCcCCCCeeEEeEecccCcEEEEEEEECC-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 743 DDVAECEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 743 ~~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
....-.+++.....++++||+|-||.|.+|...+ ..||||.++.... ......|.+||++|.+|+||||++++++|..
T Consensus 528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred cCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 3445567888999999999999999999998866 8999999876543 2335789999999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCC-CcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~-Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
++.++||+||++.|+|..++.++.-. .......+|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||++
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999999886333 355667789999999999999999 999999999999999999999999999
Q ss_pred ccccC--CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHhhhccc------cc
Q 045028 901 RMKHN--TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT--MQQPWGGMNPMQVVGAVGFQ------HR 970 (1044)
Q Consensus 901 ~~~~~--~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT--Gk~PF~~~~~~eil~~I~~~------~~ 970 (1044)
+.... .+......+-..+|||+|.+....++.++|+|+||++|||+++ ...||.....+++.+..... ..
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce
Confidence 84332 2222233445679999999999999999999999999999764 68899998888877654321 11
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 971 RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 971 ~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
-+..|..|+.++.++|.+||..+-.+||+++++-.+|.+..
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 24567889999999999999999999999999999887643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.04 Aligned_cols=245 Identities=28% Similarity=0.422 Sum_probs=206.4
Q ss_pred CCCeeEE-eEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeec----CC
Q 045028 752 WEEITLG-ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTR----PP 823 (1044)
Q Consensus 752 ~e~y~I~-r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~----~~ 823 (1044)
.++|.|- ++||-|-.|.|..|.+ +++.+|+|++.+. ...++|+++.-.. .|||||.++++|.. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4567764 6799999999998865 7889999987654 3467888887666 49999999998754 34
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEeccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGL 899 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGL 899 (1044)
.+.||||+++||.|+..|+.+ ...|+++++..|+.||..|+.|||+.+ |.||||||+|+|.+. +..+||+|||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence 689999999999999999874 457999999999999999999999999 999999999999974 45799999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhccccccCCCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----QVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~----eil~~I~~~~~~~~ip 975 (1044)
|+..... ....+.|-||+|.|||++....|+...|+||+|++||-||+|++||+...-. .+..+|. ...+.||
T Consensus 211 AK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~--~gqy~FP 287 (400)
T KOG0604|consen 211 AKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR--TGQYEFP 287 (400)
T ss_pred ccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh--ccCccCC
Confidence 9876543 3456778999999999999999999999999999999999999999865432 3445553 3445555
Q ss_pred ----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 976 ----DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 976 ----~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..++...+++|+.+|..+|++|.|+.+++.|-.
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 458999999999999999999999999987744
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=324.67 Aligned_cols=245 Identities=28% Similarity=0.420 Sum_probs=212.3
Q ss_pred EeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCC
Q 045028 758 GERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
.+.||.|.||+||-|++ +|+.||||++.+..+..++...+++|+.||+.+.||.||.+-..|+..+.+++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999998865 7999999999988888888889999999999999999999999999999999999999776
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC---CeEEEEeccccccccCCcccccC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN---WVVKVCDFGLSRMKHNTFLSSRS 912 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d---g~VKLiDFGLA~~~~~~~~~~~s 912 (1044)
-|.-++.....+++++....++.||+.||.|||.++ |+|+||||+|||+... .++||||||+|+..+... ...+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhh
Confidence 666666666789999999999999999999999999 9999999999999643 589999999999887653 4567
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc--ccCCCCCCCCHHHHHHHHHhh
Q 045028 913 TAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH--RRLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 913 ~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~--~~~~ip~~ip~ELkdLI~rcL 990 (1044)
.+|||.|+|||+++++.|+..-|+||.|+|+|--|.|..||.... ++-.+|.... ....-+.++++++.+||+.+|
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999997543 2333332111 122334579999999999999
Q ss_pred hcCCCCCCCHHHHHHHh
Q 045028 991 QTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~L 1007 (1044)
+..-.+|.++...+.|.
T Consensus 804 qVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHP 820 (888)
T ss_pred HHHHHHhcchHhhccch
Confidence 99999999999887763
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.54 Aligned_cols=255 Identities=24% Similarity=0.425 Sum_probs=210.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~ 824 (1044)
.....++++++..||.|+-|+||+++. +|...|||.+..... .+..+++++.+.++...+ +|+||+.+++|..+..
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 344556788889999999999999977 568999999987654 344566777777665554 9999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++|.||.+ +..+..++++-...+++..+-.+...++.||.||.++. .|+|||+||+|||+|..|+|||||||++-...
T Consensus 166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceee
Confidence 99999998 55677888777788999999999999999999997553 29999999999999999999999999997665
Q ss_pred CCcccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccCCCC--CCC
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRN---EPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIP--DNL 978 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g---~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~~ip--~~i 978 (1044)
+... .....|.+.|||||.+.- ..|+.++||||||+.|+||.||+.||.+.+ +.+.+.++.. ...+.++ ..+
T Consensus 244 dSkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gF 321 (391)
T KOG0983|consen 244 DSKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGF 321 (391)
T ss_pred cccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCc
Confidence 4433 344579999999999953 358899999999999999999999999843 4455655543 3333333 348
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++.+++++..||++|+.+||.+.++|+|-
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 99999999999999999999999999873
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.07 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=208.4
Q ss_pred CeeE-EeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEE
Q 045028 754 EITL-GERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 754 ~y~I-~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVm 829 (1044)
-|++ .+.||+|+|+.|-.+.. +|..||||++.++. .....++.+|++++.+.+ |+||+.++++|+++..+|+||
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 3555 46799999999998865 89999999988774 455678999999999996 999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC---CeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN---WVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d---g~VKLiDFGLA~~~~~~ 906 (1044)
|.+.||.|..+|++ ...|++..+.++.++|+.||.|||.+| |.||||||+|||-... .-||||||.+.......
T Consensus 156 EKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred ecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 99999999999987 577999999999999999999999999 9999999999998654 46899999987643221
Q ss_pred -------cccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------------hH
Q 045028 907 -------FLSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMN---------------PM 959 (1044)
Q Consensus 907 -------~~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---------------~~ 959 (1044)
.....+.+|+..|||||+.. ...|+++.|.||||+|||-||+|++||.+.- ..
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 22335667999999999872 3458999999999999999999999997632 12
Q ss_pred HHHhhhccccccCCCCC----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 960 QVVGAVGFQHRRLDIPD----NLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 960 eil~~I~~~~~~~~ip~----~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+++.| +...+++|+ +++.+.+++|..+|..|+.+|.++.+++.|-
T Consensus 313 ~LFesI--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 313 KLFESI--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHH--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 355555 455666764 6999999999999999999999999998753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=319.62 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=209.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
-|..++.||-|+||.|.+++. +...||+|.+.+.++ ...++..++.|..||.....+-||++|..|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 477889999999999999865 455699999877654 35677889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc---CC-
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH---NT- 906 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~---~~- 906 (1044)
|++||++..+|-+ -.-|++..++.++.++.+|+++.|..| +|||||||+|||||.+|+|||+||||++-.. +.
T Consensus 710 YIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999999999877 567899999999999999999999999 9999999999999999999999999996210 00
Q ss_pred --------------------------------------cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh
Q 045028 907 --------------------------------------FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT 948 (1044)
Q Consensus 907 --------------------------------------~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT 948 (1044)
.......+||+.|+|||++....|+..+|||+.|+|||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 001124569999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHhhhccccccCCC--CCCCCHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 045028 949 MQQPWGGMNPMQVVGAVGFQHRRLDI--PDNLDPAVADIIRKCWQTDPKMRP---TFTEIMAA 1006 (1044)
Q Consensus 949 Gk~PF~~~~~~eil~~I~~~~~~~~i--p~~ip~ELkdLI~rcL~kDPekRP---Ta~ELLe~ 1006 (1044)
|++||....+.+...+++.-...+.+ ...+++++.++|.+++ .+++.|. .++++..|
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAH 928 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcC
Confidence 99999998888776666433333333 4679999999999866 4678885 34445544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=287.94 Aligned_cols=224 Identities=22% Similarity=0.264 Sum_probs=186.4
Q ss_pred cCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcHHHHh
Q 045028 764 GSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL 841 (1044)
Q Consensus 764 G~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL~dlL 841 (1044)
|.||.||++++ +++.||+|.+.... .+.+|...+....||||+++++++...+..++||||+.|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 68889999986543 2334555555667999999999999999999999999999999998
Q ss_pred cCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccC
Q 045028 842 HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMA 921 (1044)
Q Consensus 842 kr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~A 921 (1044)
.+ ...+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SK-FLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HH-hcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 76 346899999999999999999999999 999999999999999999999999987654332 223456778999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-
Q 045028 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTF- 1000 (1044)
Q Consensus 922 PEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa- 1000 (1044)
||.+.+..++.++|+||+|+++|+|++|+.||...... . .......+|..+++.++++|.+||+.||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 99998888999999999999999999999887643211 1 1122345778899999999999999999999985
Q ss_pred ----HHHHHH
Q 045028 1001 ----TEIMAA 1006 (1044)
Q Consensus 1001 ----~ELLe~ 1006 (1044)
.++++|
T Consensus 225 ~~~~~~~~~h 234 (237)
T cd05576 225 VAGVEDIKSH 234 (237)
T ss_pred ccchHHHHcC
Confidence 666643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=304.09 Aligned_cols=270 Identities=34% Similarity=0.576 Sum_probs=216.4
Q ss_pred CCCCCCCCCccccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHh--CCCCCee
Q 045028 736 SSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR--VRHPNVV 813 (1044)
Q Consensus 736 ss~S~~~~~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~--LrHPNIV 813 (1044)
++.|+.+.+.-..+....++.+.+.||+|.||.||+|+|.|..||||+|...+ ...+.+|.+|++. |+|+||+
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhh
Confidence 44555666665666667889999999999999999999999999999986543 2456778887775 4999999
Q ss_pred EEEeeeecCC----CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-----CC-CcEEEecCCCCc
Q 045028 814 LFMGAVTRPP----NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-----CT-PVIVHRDLKSPN 883 (1044)
Q Consensus 814 kl~~~~~~~~----~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-----~G-~~IVHRDIKPeN 883 (1044)
.|++.-..++ ++|||++|.+.|+|+|++.+ ..++....++++..++.||+|||. +| ++|.|||||..|
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 9998765443 49999999999999999987 789999999999999999999994 23 559999999999
Q ss_pred EEEcCCCeEEEEeccccccccCC----cccccCCCCCCCccCcccccCCCC------CchhHHHHHHHHHHHHHh-----
Q 045028 884 LLVDKNWVVKVCDFGLSRMKHNT----FLSSRSTAGTAEWMAPEVLRNEPS------DEKCDVYSFGVILWELCT----- 948 (1044)
Q Consensus 884 ILLd~dg~VKLiDFGLA~~~~~~----~~~~~s~~GTp~Y~APEvL~g~~~------s~kSDIWSLG~LLyELLT----- 948 (1044)
|||..+|...|+|+|+|...... .......+||.+|||||+|...-. -..+||||||.+|||+..
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 99999999999999999754322 223455789999999999965432 247899999999999985
Q ss_pred -----CCCCCCCC-----ChHHHHhhhccccccCCCCCC--CC---HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 949 -----MQQPWGGM-----NPMQVVGAVGFQHRRLDIPDN--LD---PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 949 -----Gk~PF~~~-----~~~eil~~I~~~~~~~~ip~~--ip---~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
-++||.+. +.+++..-+.....++.+|.. -+ ..+..+|+.||..||.-|.|+-.|.+.|.++.+
T Consensus 427 gi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 26788764 334555555555556666532 22 335678999999999999999999999988774
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=334.99 Aligned_cols=246 Identities=29% Similarity=0.458 Sum_probs=193.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-------- 821 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-------- 821 (1044)
..+|+.++.||+||||.||++++ +|+.||||++.... .......+.+|+.+|.+|+|||||++|..|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 45788999999999999999987 79999999987665 55666789999999999999999998743200
Q ss_pred --------------------------------------------------------------------------------
Q 045028 822 -------------------------------------------------------------------------------- 821 (1044)
Q Consensus 822 -------------------------------------------------------------------------------- 821 (1044)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC
Q 045028 822 -----------------------P--------PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870 (1044)
Q Consensus 822 -----------------------~--------~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~ 870 (1044)
+ -.+||-||||+...|.+++.++...-.....|+++.||++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 116788999999888888877322225788899999999999999999
Q ss_pred CCcEEEecCCCCcEEEcCCCeEEEEecccccccc------------------CCcccccCCCCCCCccCcccccCCC---
Q 045028 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH------------------NTFLSSRSTAGTAEWMAPEVLRNEP--- 929 (1044)
Q Consensus 871 G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~------------------~~~~~~~s~~GTp~Y~APEvL~g~~--- 929 (1044)
| ||||||||.|||++.++.|||+|||+++... .......+.+||..|+|||++.+..
T Consensus 717 g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred c--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 9999999999999999999999999997510 1111334567999999999997765
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhccccccCCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 045028 930 SDEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIP----DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004 (1044)
Q Consensus 930 ~s~kSDIWSLG~LLyELLTGk~PF~~~-~~~eil~~I~~~~~~~~ip----~~ip~ELkdLI~rcL~kDPekRPTa~ELL 1004 (1044)
|+.|+||||||+||+||+. ||... ....++..+. ...++.+ ..--+.-..+|.+||+.||.+|||+.|+|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 9999999999999999986 56653 3333444442 2222222 11223456799999999999999999998
Q ss_pred H
Q 045028 1005 A 1005 (1044)
Q Consensus 1005 e 1005 (1044)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 6
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=318.91 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=206.4
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~L 827 (1044)
..+.|.+...+|.|+|+.|-.+.+ +++.+++|++.+.. ....+|+.++... .||||+++.+.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 357899999999999999999876 67889999987652 2234577666655 59999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE-cCCCeEEEEeccccccccCC
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV-DKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL-d~dg~VKLiDFGLA~~~~~~ 906 (1044)
|||++.|+.|.+.+.. .+.+. ..+..|+.+|+.++.|||.+| ||||||||+|||+ +..|+++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999999999888865 23333 777789999999999999999 9999999999999 68899999999999876544
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccccCCCCCCCCHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
..+.+-|..|.|||++....|++++||||||++||+||+|+.||...... ++...+ ....+...++.++++|
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdL 542 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDL 542 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHH
Confidence 33456788999999999999999999999999999999999999876544 454444 2334448999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
|.+||+.||.+|+++.+++.|-.-+.+
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred HHHhccCChhhCcChhhhccCcchhcC
Confidence 999999999999999999988665333
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=318.29 Aligned_cols=253 Identities=31% Similarity=0.479 Sum_probs=219.4
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeec----
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTR---- 821 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~---- 821 (1044)
..+.+-|+|.+.||+|.+|.||+++. +++..|+|++.... ..-+++..|.+||+.+. |||++.+|++|..
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34567899999999999999998865 78999999876543 23356788999999885 9999999998853
Q ss_pred -CCCceEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 822 -PPNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 822 -~~~l~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
++.+|||||||.||+.-|+++. .+.++.|..+..|+..++.||.|||... ++|||||-.|||++.++.|||+|||.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeee
Confidence 4579999999999999999986 3678999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC-C
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL-D 973 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~-~ 973 (1044)
+.....+.....+.+|||.|||||++.. ..|+.++|+||||++-.||--|.+|+-++-+...+..|....... .
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 9888877777888999999999999953 346789999999999999999999999998887777765443322 2
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
-|..-+.++.++|..||.+|-.+||++.++++|
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 356677899999999999999999999999876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=319.27 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=204.2
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------Cc
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------NL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------~l 825 (1044)
-+...+.||+|+||.||++++ +|+.||||.+.... ....++...+|+++|++++|+|||+++++-.... ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 466778899999999999986 79999999887654 3455678889999999999999999998865543 47
Q ss_pred eEEEEecCCCcHHHHhcCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc--CCC--eEEEEeccc
Q 045028 826 SIVAEFLPRGSLYRLLHRP--NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD--KNW--VVKVCDFGL 899 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~--~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd--~dg--~VKLiDFGL 899 (1044)
.+|||||.||+|...+++. ...+++..++.++..++.||.|||++| |+||||||.||++- .+| ..||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 8999999999999999984 467999999999999999999999999 99999999999984 333 579999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhccc------
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----QVVGAVGFQ------ 968 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~----eil~~I~~~------ 968 (1044)
|+...+.. ...+.+||+.|++||.+.. ..|+..+|.|||||++|++.||..||...... ++...+...
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 99776654 5677899999999999985 77899999999999999999999999654322 222222111
Q ss_pred -------cc------cCCCCCCCCHH----HHHHHHHhhhcCCCCCC--CHHHHHHHhccccC
Q 045028 969 -------HR------RLDIPDNLDPA----VADIIRKCWQTDPKMRP--TFTEIMAALKPLQK 1012 (1044)
Q Consensus 969 -------~~------~~~ip~~ip~E----LkdLI~rcL~kDPekRP--Ta~ELLe~Lk~L~k 1012 (1044)
+. .+++|.++++. +-..+..+|..+|.+|. ...++...+.++.+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11 12334444444 34577788899999998 77777777666543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=305.52 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=209.1
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-----hhHHHHHHHHHHHHhCCCCCeeEEEeeeec-C
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-----ESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-P 822 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-----~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-~ 822 (1044)
..++|-++.+||+|+|+.||++-+ ..+.||||+-.....+. ...+...+|..|.+.|.||.||++|++|.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 346788999999999999999865 57789999764333222 234557789999999999999999999964 4
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc---CCCeEEEEeccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD---KNWVVKVCDFGL 899 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd---~dg~VKLiDFGL 899 (1044)
+.++-|+|||+|.+|..++++ .+.+++..++.|+.||+.||.||.+..++|||-||||.|||+- ..|.|||+|||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 569999999999999999987 5789999999999999999999999999999999999999994 468999999999
Q ss_pred cccccCCccc-------ccCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhh-c
Q 045028 900 SRMKHNTFLS-------SRSTAGTAEWMAPEVLRNE----PSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAV-G 966 (1044)
Q Consensus 900 A~~~~~~~~~-------~~s~~GTp~Y~APEvL~g~----~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I-~ 966 (1044)
++.+....+. .....||.+|++||.+.-. ..+.++||||+|+|+|.++.|+.||...... ++++.. .
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9976654332 3456799999999998533 3578999999999999999999999875433 333322 2
Q ss_pred cccccCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 967 FQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 967 ~~~~~~~ip--~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+.....|| +.++.+++++|++||++--+.|.++.+|..+
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 233344444 6799999999999999999999999988754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=320.80 Aligned_cols=261 Identities=33% Similarity=0.628 Sum_probs=226.4
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEE
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFM 816 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~ 816 (1044)
.+++..++..+.+.||.|.||+||+|... ...||||.++..... .+.+.+..|+++|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 78888899999999999999999998642 346999988766544 67788999999999995 99999999
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
+++...+.+++|+||+..|+|..+++..+ ..++....+.++.||+.|++||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998755 34888999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCC-cccccCCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNT-FLSSRSTAG--TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~-~~~~~s~~G--Tp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~ 957 (1044)
.|||++.+..+||+|||+++..... ++......| ...|||||.+....|+.++||||+|++|||+++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999854332 222222233 345999999999999999999999999999998 688999865
Q ss_pred -hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 958 -PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 958 -~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
..+++. ......+...|..++.++.++++.||+.+|++||++.++.+.|..+.
T Consensus 527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 555555 34467788999999999999999999999999999999999998854
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=276.32 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=211.3
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
.|.-.++||+|+||+||++++ +++.||+|.+...+..+.......+||-+|+.++|.|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466778999999999999976 577899999876655555556788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
|. .+|..++...+..++...++.++.|++.||.|+|+++ ++|||+||.|+||+.+|.+||+|||+++-.+.+..-..
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 94 5899999888899999999999999999999999999 99999999999999999999999999987766654444
Q ss_pred CCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccC---------------CC
Q 045028 912 STAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRL---------------DI 974 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~---------------~i 974 (1044)
..+-|.+|++|.++.|.. |+...|+||.|||+.|+.. |.+.|.+.+..+.+.+|-..-..+ .+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 556799999999998876 7889999999999999986 677788888777666653221110 00
Q ss_pred ---C---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 975 ---P---------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 975 ---p---------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
| +.+...-++|++++|.-+|.+|.++++.++|
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1 1123346899999999999999999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=270.16 Aligned_cols=237 Identities=33% Similarity=0.512 Sum_probs=199.3
Q ss_pred CcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcHHHHhc
Q 045028 765 SYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH 842 (1044)
Q Consensus 765 ~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL~dlLk 842 (1044)
+||.||++.+. ++.+++|++........ .+.+.+|+.++++++|+||+++++++......+++|||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999884 68899999876543221 5789999999999999999999999998899999999999999999987
Q ss_pred CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCc
Q 045028 843 RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922 (1044)
Q Consensus 843 r~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~AP 922 (1044)
... .++...++.++.+++.+|.+||+.+ |+|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 633 3899999999999999999999999 9999999999999999999999999998655432 23445688999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhccccccCCCCCC-CCHHHHHHHHHhhhcCCCCCCCH
Q 045028 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG-MNPMQVVGAVGFQHRRLDIPDN-LDPAVADIIRKCWQTDPKMRPTF 1000 (1044)
Q Consensus 923 EvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~-~~~~eil~~I~~~~~~~~ip~~-ip~ELkdLI~rcL~kDPekRPTa 1000 (1044)
|.+.+..++.++|||+||+++|+|++|..||.. .+...+...+............ ++.++.+++.+||..+|++||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988889999999999999999999999987 5555555444322222111111 88999999999999999999999
Q ss_pred HHHHHH
Q 045028 1001 TEIMAA 1006 (1044)
Q Consensus 1001 ~ELLe~ 1006 (1044)
.+++++
T Consensus 236 ~~~~~~ 241 (244)
T smart00220 236 EEALQH 241 (244)
T ss_pred HHHhhC
Confidence 999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=295.91 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=200.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec-CCC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-PPN 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-~~~ 824 (1044)
...|+++..||+|+||.||++... ...+|||.++...-....-....+|+.+++.++||||+.+..+|-. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357999999999999999999442 2369999887552211112345689999999999999999998876 778
Q ss_pred ceEEEEecCCCcHHHHhcCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC----CeEEEEe
Q 045028 825 LSIVAEFLPRGSLYRLLHRP----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN----WVVKVCD 896 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d----g~VKLiD 896 (1044)
+++++||.+. +|+.+|+-+ .+.++...+..++.||+.|+.|||++- |+||||||.||||..+ |.|||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999966 899888642 467899999999999999999999999 9999999999999877 8999999
Q ss_pred ccccccccCCcc---cccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHh
Q 045028 897 FGLSRMKHNTFL---SSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPM---------QVVG 963 (1044)
Q Consensus 897 FGLA~~~~~~~~---~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---------eil~ 963 (1044)
||+++...++.. .....+-|.+|+|||.+.|.. |+.+.|||+.|||+.||++-++.|.+.... +.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998765432 334456799999999999876 899999999999999999998888663321 1111
Q ss_pred hhccccc------c---CCCC--------------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 964 AVGFQHR------R---LDIP--------------------------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 964 ~I~~~~~------~---~~ip--------------------------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.|...-. + ..+| ..-++...+|+.+||..||.+|.|+++.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 1100000 0 0011 112455789999999999999999999998865
Q ss_pred cccC
Q 045028 1009 PLQK 1012 (1044)
Q Consensus 1009 ~L~k 1012 (1044)
-...
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 3333
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=299.93 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=205.3
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC--CC----CeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR--HP----NVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr--HP----NIVkl~~ 817 (1044)
...++...+|.|+..||+|+||.|-.+.+ .+..||||+++... ...+..+-|+++|+++. .| -+|.+.+
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 34455678999999999999999999866 46789999886543 44566788999999994 23 3788889
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC--------
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-------- 888 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-------- 888 (1044)
||...++.+||+|.+ |-++++++..+ -..++..+++.|+.||+++++|||+.+ ++|.||||+|||+..
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEec
Confidence 999999999999999 77999999884 467999999999999999999999999 999999999999841
Q ss_pred ------------CCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 045028 889 ------------NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM 956 (1044)
Q Consensus 889 ------------dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~ 956 (1044)
+..|+|+|||.|+..+.. ....+.|..|+|||++.+.+++.++||||+||||+|+++|...|++.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 346999999999876544 35677899999999999999999999999999999999999999987
Q ss_pred ChHHH---Hhhhcc----------------ccccCCCCCC-------------------------CCHHHHHHHHHhhhc
Q 045028 957 NPMQV---VGAVGF----------------QHRRLDIPDN-------------------------LDPAVADIIRKCWQT 992 (1044)
Q Consensus 957 ~~~ei---l~~I~~----------------~~~~~~ip~~-------------------------ip~ELkdLI~rcL~k 992 (1044)
+..+. .+.|.- ...+++.+.. -..++.+||.+||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 75552 222210 0011221111 113488999999999
Q ss_pred CCCCCCCHHHHHHH
Q 045028 993 DPKMRPTFTEIMAA 1006 (1044)
Q Consensus 993 DPekRPTa~ELLe~ 1006 (1044)
||.+|+|+.|+|.|
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=333.17 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=193.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
..|...+.||+|+||.||+|++ ++..||||.+..... ....|++++++++|||||++++++.+.+..++|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3466778899999999999986 688999998764331 12346889999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHH---hCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH---NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLH---s~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|+++|+|.++++. +++..+..++.||+.||.||| +.+ |+||||||+|||++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 9999999999963 789999999999999999999 556 9999999999999998887765 665433211
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhhcc--cc--------cc----
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP--MQVVGAVGF--QH--------RR---- 971 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~--~eil~~I~~--~~--------~~---- 971 (1044)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...... .. ..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1234688999999999999999999999999999999999999854211 111111100 00 00
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 972 ~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
...+.....++.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 01111122357789999999999999999999999998877433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=289.80 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=207.5
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeee
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVT 820 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~ 820 (1044)
+..-+.+..++.+-+..||.|+||+|++-.+ .|+..|||++...+. .....+++.|.+...+- ++||||+||+...
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 3445667778888899999999999998765 689999999987765 34456677787765554 6999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcC----CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEe
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHR----PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCD 896 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr----~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiD 896 (1044)
.++..||-||.| ..+|..+.+. ....+++..+-.+....+.||.||-..- .|||||+||+|||++..|.|||||
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeec
Confidence 999999999999 5577666543 3567899999999999999999997543 299999999999999999999999
Q ss_pred ccccccccCCcccccCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhccccc-cC
Q 045028 897 FGLSRMKHNTFLSSRSTAGTAEWMAPEVLR--NEPSDEKCDVYSFGVILWELCTMQQPWGGMNP-MQVVGAVGFQHR-RL 972 (1044)
Q Consensus 897 FGLA~~~~~~~~~~~s~~GTp~Y~APEvL~--g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~-~eil~~I~~~~~-~~ 972 (1044)
||++-...+... .....|...|||||.+. +..|+.++|+||||++|||+.||..||++.+. .+.+..+..... .+
T Consensus 212 FGIcGqLv~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 212 FGICGQLVDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL 290 (361)
T ss_pred ccchHhHHHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence 999976554432 33467899999999995 34589999999999999999999999988654 233333322222 22
Q ss_pred CCCC---CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 DIPD---NLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ~ip~---~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+. +++..+..+|..||.+|-..||.+.+++++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2333 378899999999999999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=289.82 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=201.7
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-----CceE
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-----NLSI 827 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-----~l~L 827 (1044)
++-.+.||.|+||.||-+.+ +|+.||+|++......-...+.+.+|+++|...+|.|++..+++.+-.. .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34456899999999998876 7899999988655433445677899999999999999999988876543 4788
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
++|.+ ..+|..+|-. ...++...+.-+++||+.||.|||+.+ |+||||||.|+|++.+..+||||||+++......
T Consensus 135 ~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88988 4578888766 567899999999999999999999999 9999999999999999999999999998654322
Q ss_pred c-cccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--------------
Q 045028 908 L-SSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR-------------- 971 (1044)
Q Consensus 908 ~-~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~-------------- 971 (1044)
. .....+-|.+|+|||++.|.. |+.++||||.|||+.||+..+..|+..++.+.++.|...-..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 1 122234688999999999876 899999999999999999999999988887766554321111
Q ss_pred ----------CC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 972 ----------LD--------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 972 ----------~~--------ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
.. -+..-.-+...++.++|..||.+|.+..+.+.++..
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 01 112233467789999999999999999999988643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=287.94 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=203.7
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------ 822 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------ 822 (1044)
....|+-..++|+|+||.||+++. +|+.||+|++.-.+-.........+|+.+|..|+|+|++.+++++...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345677888999999999998865 678899987644322222234467899999999999999998876432
Q ss_pred --CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 823 --PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 823 --~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
..+|+||++|+. +|..++.....+|+..++..++.++..||.|+|... |+|||+|++|+||+.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence 249999999965 899999887789999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC----cccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc--cCC
Q 045028 901 RMKHNT----FLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR--RLD 973 (1044)
Q Consensus 901 ~~~~~~----~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~--~~~ 973 (1044)
+..... .......+-|.+|++||.+.|.. |+++.|||+.||||.||+++.+.|.+..+.+.+..|..... ..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 643211 11123345699999999998875 89999999999999999999999998877765555422111 011
Q ss_pred ------------------C-------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 974 ------------------I-------------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 974 ------------------i-------------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+ |-.-+++..+|+.++|..||.+|+++.+++.|-.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 1 1123567889999999999999999999998754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=290.91 Aligned_cols=258 Identities=31% Similarity=0.498 Sum_probs=210.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC--CCCCeeEEEeeeecCC----Cc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV--RHPNVVLFMGAVTRPP----NL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L--rHPNIVkl~~~~~~~~----~l 825 (1044)
...+++.+.||+|.||.||+|..+++.||||++.. .+...+..|.+|+... +|+||++|++.-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 46688899999999999999999999999999753 4456788888888754 7999999999876555 79
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC-------CcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT-------PVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G-------~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
+||++|.+.|+|.++++. ...++....+++..+++||+|||+.- ++|+|||||..||||..++...|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999986 67899999999999999999999632 569999999999999999999999999
Q ss_pred ccccccCCcc--cccCCCCCCCccCcccccCCCC-C-----chhHHHHHHHHHHHHHhC------------CCCCCC---
Q 045028 899 LSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPS-D-----EKCDVYSFGVILWELCTM------------QQPWGG--- 955 (1044)
Q Consensus 899 LA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~-s-----~kSDIWSLG~LLyELLTG------------k~PF~~--- 955 (1044)
+|........ ....-+||.+|||||+|.|... . .+.||||+|.+||||++. ++||+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 9986543221 1233679999999999977542 2 478999999999999973 234431
Q ss_pred --CChHHHHhhhccccccCCCCCC-----CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 956 --MNPMQVVGAVGFQHRRLDIPDN-----LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 956 --~~~~eil~~I~~~~~~~~ip~~-----ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
...+++...+..+..++.+|.. -..-+++.+..||..|++-|.|+.=+.+.+..+...+..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 2344555566666677777643 235588999999999999999998888888888776544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=303.16 Aligned_cols=249 Identities=16% Similarity=0.231 Sum_probs=170.7
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--C----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEee----
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--H----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA---- 818 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~---- 818 (1044)
.+..++|++.++||+|+||.||+|.+ + +..||+|++..... .+....+ .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 34567899999999999999999987 3 67899998754321 1111111 1111122222222211
Q ss_pred --eecCCCceEEEEecCCCcHHHHhcCCCCC-------------------CcHHHHHHHHHHHHHHHHHHHhCCCcEEEe
Q 045028 819 --VTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-------------------LDERRRLRMALDAARGMNYLHNCTPVIVHR 877 (1044)
Q Consensus 819 --~~~~~~l~LVmEy~~GGsL~dlLkr~~~~-------------------Lse~~il~Ia~QIa~AL~yLHs~G~~IVHR 877 (1044)
......+++||||+.+++|.+++...... .....+..++.||+.||.|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 23456799999999999999998753211 123446679999999999999999 9999
Q ss_pred cCCCCcEEEcC-CCeEEEEeccccccccC-CcccccCCCCCCCccCcccccCC----------------------CCCch
Q 045028 878 DLKSPNLLVDK-NWVVKVCDFGLSRMKHN-TFLSSRSTAGTAEWMAPEVLRNE----------------------PSDEK 933 (1044)
Q Consensus 878 DIKPeNILLd~-dg~VKLiDFGLA~~~~~-~~~~~~s~~GTp~Y~APEvL~g~----------------------~~s~k 933 (1044)
||||+||||+. ++.+||+|||+++.... .........+|+.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 58999999999975432 12233456799999999976432 23446
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-------------------ccCCCCCCCCHHHHHHHHHhhhcCC
Q 045028 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-------------------RRLDIPDNLDPAVADIIRKCWQTDP 994 (1044)
Q Consensus 934 SDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-------------------~~~~ip~~ip~ELkdLI~rcL~kDP 994 (1044)
+|||||||+||||+++..++... .......+.... ..+.+.+..+...++||.+||++||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 79999999999999977665421 111111110000 0011112234456699999999999
Q ss_pred CCCCCHHHHHHH
Q 045028 995 KMRPTFTEIMAA 1006 (1044)
Q Consensus 995 ekRPTa~ELLe~ 1006 (1044)
.+|||+.++|+|
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=293.30 Aligned_cols=258 Identities=20% Similarity=0.224 Sum_probs=186.7
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE------------------CCcEEEEEEeeccCcch------------hhHHHHH
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW------------------HGTEVAVKRFLDQDFFG------------ESLEEFR 798 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~------------------~g~~VAVK~l~~~~~~~------------~~~~~~~ 798 (1044)
++..++|++.++||+|+||+||+|.+ .++.||||++....... ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34567999999999999999999853 34679999986432110 0112234
Q ss_pred HHHHHHHhCCCCCe-----eEEEeeeec--------CCCceEEEEecCCCcHHHHhcCCC--------------------
Q 045028 799 SEVLIMKRVRHPNV-----VLFMGAVTR--------PPNLSIVAEFLPRGSLYRLLHRPN-------------------- 845 (1044)
Q Consensus 799 ~EI~ILk~LrHPNI-----Vkl~~~~~~--------~~~l~LVmEy~~GGsL~dlLkr~~-------------------- 845 (1044)
.|+.++.+++|.++ +++++++.. .+..++||||+.+++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777777766554 566666543 356899999999999999886421
Q ss_pred ---CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc-ccccCCCCCCCccC
Q 045028 846 ---NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-LSSRSTAGTAEWMA 921 (1044)
Q Consensus 846 ---~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-~~~~s~~GTp~Y~A 921 (1044)
..+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++....... .......+|+.|++
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12456778899999999999999999 9999999999999999999999999996543221 11122345899999
Q ss_pred cccccCCC--------------------C--CchhHHHHHHHHHHHHHhCCC-CCCCCChH-----------HHHhhhcc
Q 045028 922 PEVLRNEP--------------------S--DEKCDVYSFGVILWELCTMQQ-PWGGMNPM-----------QVVGAVGF 967 (1044)
Q Consensus 922 PEvL~g~~--------------------~--s~kSDIWSLG~LLyELLTGk~-PF~~~~~~-----------eil~~I~~ 967 (1044)
||++.... + ..+.||||+||+||+|++|.. ||...... .....+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99985432 1 124799999999999999976 77542111 11111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHhhhcCC---CCCCCHHHHHHHhc
Q 045028 968 QHRRLDIPDNLDPAVADIIRKCWQTDP---KMRPTFTEIMAALK 1008 (1044)
Q Consensus 968 ~~~~~~ip~~ip~ELkdLI~rcL~kDP---ekRPTa~ELLe~Lk 1008 (1044)
....+...+.+++..++||.+||.++| .+|+|+.|+|+|-.
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 222344456788999999999999876 68999999998754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=299.64 Aligned_cols=255 Identities=30% Similarity=0.558 Sum_probs=221.7
Q ss_pred CeeEEeEecccCcEEEEEEEE--CC----cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HG----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g----~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..+..++||.|+||+||+|.| .| -+||+|++.... ..+.-.++..|+.+|.+++|||++++++++.... +.|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 455678899999999999987 33 468889876443 2344577999999999999999999999998765 889
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|++|+++|.|.++++.++..+-.+..+.|..||++||.|||.+. +|||||-..||||..-.+|||.|||+++......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999999998899999999999999999999999999 9999999999999999999999999998754332
Q ss_pred --ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 908 --LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 908 --~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
+......-.+-|||-|.+....|+.++||||||+++||++| |..||.+....++-..+. ...++..|+.++.++.-
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHH
Confidence 22223334567999999999999999999999999999998 899999998888777664 55669999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
++.+||..|+..||+++++...+..+.+.
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 99999999999999999999999887664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=243.66 Aligned_cols=211 Identities=41% Similarity=0.655 Sum_probs=186.6
Q ss_pred ecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcHH
Q 045028 761 IGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY 838 (1044)
Q Consensus 761 LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL~ 838 (1044)
||.|.+|.||++... ++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 8899999987554321 3467899999999999999999999999989999999999999999
Q ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEeccccccccCCcccccCCCCCC
Q 045028 839 RLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRMKHNTFLSSRSTAGTA 917 (1044)
Q Consensus 839 dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~~~~~~~~~~s~~GTp 917 (1044)
+++......++...++.++.+++.+|.+||+.| ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999874457899999999999999999999999 999999999999999 89999999999976554322233456788
Q ss_pred CccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCC
Q 045028 918 EWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKM 996 (1044)
Q Consensus 918 ~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPek 996 (1044)
.|++||.+... .++.+.|+|+||+++++| ..+.+++.+|+..+|.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence 99999999887 788999999999999999 67899999999999999
Q ss_pred CCCHHHHHHHh
Q 045028 997 RPTFTEIMAAL 1007 (1044)
Q Consensus 997 RPTa~ELLe~L 1007 (1044)
||++.++++++
T Consensus 205 R~~~~~l~~~~ 215 (215)
T cd00180 205 RPSAKEILEHL 215 (215)
T ss_pred CcCHHHHhhCC
Confidence 99999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=263.65 Aligned_cols=244 Identities=21% Similarity=0.387 Sum_probs=198.0
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCC--Cc
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPP--NL 825 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~--~l 825 (1044)
..++|++.+++|+|.|+.||.|.. +.+.++||+++... .+.+++|+.||+.|. ||||++++++..+.. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 347899999999999999999974 77889999886543 467999999999997 999999999998764 47
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA~~~~ 904 (1044)
.+||||+++.+...+.. .++...+..++.||+.||.|||++| |+|||+||.|+|||.. -.++|+|||+|...+
T Consensus 111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 89999999998888764 4888899999999999999999999 9999999999999965 589999999998766
Q ss_pred CCcccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHhhhccc-----------ccc
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWG-GMNPMQVVGAVGFQ-----------HRR 971 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~-~~~~~eil~~I~~~-----------~~~ 971 (1044)
... .....+.+..|.-||.+...+ |+..-|+|||||+|..|+..+-||. +.+..+.+-+|... ...
T Consensus 185 p~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 185 PGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 442 334566788999999997755 7889999999999999999988864 43333222221100 000
Q ss_pred CCC------------------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 LDI------------------------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ~~i------------------------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+.+ ..-.++++.+|+.++|..|-.+|+|+.|.+.|
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 11246899999999999999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=272.04 Aligned_cols=130 Identities=23% Similarity=0.363 Sum_probs=110.3
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-----C---CCeeEEEeeee
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-----H---PNVVLFMGAVT 820 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-----H---PNIVkl~~~~~ 820 (1044)
...+|.+.++||.|.|++||++.+ ..+.||+|+.+... ...+....||++|++++ | .+||++++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 348999999999999999999987 45779999987543 23355778999999983 2 36999999997
Q ss_pred cC----CCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEE
Q 045028 821 RP----PNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLV 886 (1044)
Q Consensus 821 ~~----~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILL 886 (1044)
.. .+++||||++ |.+|..+|++. -+.++...++.|+.||+.||.|||. +| |||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 54 4699999999 77888888874 4569999999999999999999996 56 9999999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=295.84 Aligned_cols=242 Identities=30% Similarity=0.507 Sum_probs=192.5
Q ss_pred eeEEeEecccCcEE-EEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGE-VYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGt-Vykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|.-.+.+|.|+-|+ ||+|...|+.||||++.. +..+...+||..|+.-. |||||++|+.-++...+||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 33446789999987 799999999999998643 33456788999998884 999999999999999999999999
Q ss_pred CCCcHHHHhcCC--CCCC-cHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---C--CeEEEEecccccccc
Q 045028 833 PRGSLYRLLHRP--NNQL-DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---N--WVVKVCDFGLSRMKH 904 (1044)
Q Consensus 833 ~GGsL~dlLkr~--~~~L-se~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---d--g~VKLiDFGLA~~~~ 904 (1044)
..+|.++++.. ...+ .....+.++.|++.||+|||+.+ ||||||||.||||+. + ..++|+|||+++...
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999873 1111 11445778999999999999999 999999999999975 2 579999999998754
Q ss_pred CC---cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhccccccC-CCCCCCC
Q 045028 905 NT---FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRL-DIPDNLD 979 (1044)
Q Consensus 905 ~~---~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~~~~~~-~ip~~ip 979 (1044)
.. .....+..||-.|+|||++.....+.++|||||||++|+.++| .+||...-..+. .|......+ .+-...+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPD 740 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCch
Confidence 32 2234556799999999999999888999999999999999987 999987544432 121111111 1112222
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.++.+||.+|+.++|..||++.++|.|
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 389999999999999999999999977
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=285.41 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=205.6
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC------CCeeEEEee
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH------PNVVLFMGA 818 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH------PNIVkl~~~ 818 (1044)
-.++...+|.+....|+|-|++|.+|++ .|+.||||++....+. .+.=+.|++||++|+. -|+++++..
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3455667899999999999999999987 5789999999766532 3445779999999952 379999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEE
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRP--NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVC 895 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~--~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLi 895 (1044)
|.+.+++|||||-+ ..+|.+++++. +-.|....+..|+.|++.||..|-.+| |+|.||||.||||++. ..+|||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeec
Confidence 99999999999998 66899999874 456888999999999999999999999 9999999999999975 578999
Q ss_pred eccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCC--
Q 045028 896 DFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD-- 973 (1044)
Q Consensus 896 DFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~-- 973 (1044)
|||.|......... -+.-...|.|||++.|.+|+...|+||+||+||||+||+..|.+....+++.........++
T Consensus 580 DfGSA~~~~eneit--PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 580 DFGSASFASENEIT--PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cCcccccccccccc--HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 99999765544321 12245679999999999999999999999999999999999999877776654321111100
Q ss_pred --------------------------------------CC-----------CCCC-------HHHHHHHHHhhhcCCCCC
Q 045028 974 --------------------------------------IP-----------DNLD-------PAVADIIRKCWQTDPKMR 997 (1044)
Q Consensus 974 --------------------------------------ip-----------~~ip-------~ELkdLI~rcL~kDPekR 997 (1044)
.| ..++ ..|++|+.+||.+||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 00 0011 348899999999999999
Q ss_pred CCHHHHHHHh
Q 045028 998 PTFTEIMAAL 1007 (1044)
Q Consensus 998 PTa~ELLe~L 1007 (1044)
.|+.+.|+|-
T Consensus 738 it~nqAL~Hp 747 (752)
T KOG0670|consen 738 ITVNQALKHP 747 (752)
T ss_pred CCHHHHhcCC
Confidence 9999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=264.43 Aligned_cols=268 Identities=25% Similarity=0.429 Sum_probs=224.3
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEE
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~ 816 (1044)
...+..+..+++++...+-+|+||.||.|.|. .+.|.+|.++... ..-++..+..|.-++..+.|||++.+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 34455667788999999999999999999653 2446677665443 345677889999999999999999999
Q ss_pred eeeecC-CCceEEEEecCCCcHHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC
Q 045028 817 GAVTRP-PNLSIVAEFLPRGSLYRLLHR-------PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888 (1044)
Q Consensus 817 ~~~~~~-~~l~LVmEy~~GGsL~dlLkr-------~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~ 888 (1044)
++...+ ...++++.+..-|+|..++.. ..+.++..+...++.|++.|++|||+++ |||.||...|++|++
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD 431 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence 976544 467888899999999999982 2355777888999999999999999999 999999999999999
Q ss_pred CCeEEEEeccccccccCCcccc--cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 045028 889 NWVVKVCDFGLSRMKHNTFLSS--RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAV 965 (1044)
Q Consensus 889 dg~VKLiDFGLA~~~~~~~~~~--~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I 965 (1044)
..+|||+|=.+++......+.. ........||+||.+.+..|+.++|+||||++||||+| |+.||...++.++...+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 9999999999998543332221 11123457999999999999999999999999999998 89999999999998877
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 966 GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 966 ~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
. ...++..|-+||+++..++..||+..|++||+++++..-|.++..+++
T Consensus 512 k-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 512 K-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred h-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 5 667889999999999999999999999999999999999988765543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=287.09 Aligned_cols=251 Identities=29% Similarity=0.506 Sum_probs=216.8
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
+.++|++++++|.|+||.||++++ ++...|+|+++... .....-+.+|+-+++..+||||+.+++.+-..+.+||.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 457899999999999999999987 68889999987554 23445677899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
||||.||+|.+..+- ...+++.++..+.++.++||+|||+.| =+|||||-.|||++..|.+||+|||.+-.....-.
T Consensus 91 MEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999999999998765 578999999999999999999999999 89999999999999999999999999988877777
Q ss_pred cccCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc---ccCCCCCCCCHHH
Q 045028 909 SSRSTAGTAEWMAPEVL---RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH---RRLDIPDNLDPAV 982 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL---~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~---~~~~ip~~ip~EL 982 (1044)
...++.||++|||||+- +...|...+|||++|+...|+-.-++|....-+...+....... ....-+..-++.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 78889999999999986 45668999999999999999998888877666665554432222 2223334567889
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+|++.+|.++|.+||+++.+|.|
T Consensus 248 h~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheec
Confidence 999999999999999999998874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=250.98 Aligned_cols=215 Identities=27% Similarity=0.461 Sum_probs=176.7
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~ 824 (1044)
.++..++..-+..||+|+||.|-+-++ +|+..|+|.+..... .+...++.+|+.+..+. .+|++|+||+.+..+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 566777888899999999999865554 899999999876543 34456677888876655 69999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+||.||.+ ..+|..+.++ .+..+++..+-+|+..++.||.|||++- .|||||+||+||||+.+|+||+||||++-
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999 4577766543 5788999999999999999999999874 39999999999999999999999999987
Q ss_pred cccCCcccccCCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhc
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRN----EPSDEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVG 966 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g----~~~s~kSDIWSLG~LLyELLTGk~PF~~~-~~~eil~~I~ 966 (1044)
...+.-. .....|...|||||.+.. ..|+-++||||||+++.||.+++.||... .+.+.+.++.
T Consensus 198 ~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 198 YLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred eehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 6544321 222568899999999853 36889999999999999999999999764 5666666653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=279.81 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=173.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcch------hhHHHHHHHHHHHHhCC---CCCeeEEEeeee
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFG------ESLEEFRSEVLIMKRVR---HPNVVLFMGAVT 820 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~------~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~ 820 (1044)
..+|..++.||.|+||.|++|.++ ...|+||.+.+..... ..+-.+-.||.||.+++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 457999999999999999999874 4568899776654321 22334667999999997 999999999999
Q ss_pred cCCCceEEEEec-CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 821 RPPNLSIVAEFL-PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 821 ~~~~l~LVmEy~-~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
+++++||+||-. +|.+|+++|.. ...+++..+..|++|++-|+++||+.| |||||||-+||.++.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 999999999975 56799999987 578999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGG 955 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~ 955 (1044)
+...... ...+++||..|.|||++.|..| +..-|||+||++||.++....||+.
T Consensus 717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8765433 2356889999999999999987 6788999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=236.17 Aligned_cols=208 Identities=34% Similarity=0.557 Sum_probs=177.7
Q ss_pred eeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|.+.+.||.|+||.||++... ++.+++|.+...... .....+.+|+..++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 678899999999999999884 588999998765432 24678899999999999999999999999889999999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc-cccc
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-LSSR 911 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-~~~~ 911 (1044)
.+++|.+++......+++..++.++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999874333899999999999999999999999 9999999999999999999999999987654432 1223
Q ss_pred CCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChH-HHHhhh
Q 045028 912 STAGTAEWMAPEVL-RNEPSDEKCDVYSFGVILWELCTMQQPWGG-MNPM-QVVGAV 965 (1044)
Q Consensus 912 s~~GTp~Y~APEvL-~g~~~s~kSDIWSLG~LLyELLTGk~PF~~-~~~~-eil~~I 965 (1044)
...++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+.. ++.+.+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 45678899999999 666778899999999999999999999977 4444 555555
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=254.72 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=197.8
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------C
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------N 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------~ 824 (1044)
.+|.-++.+|.|.- .|-.+-+ .++.||+|.+...........+..+|..++..++|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46888889999998 5554443 6899999988665433445567788999999999999999999986543 5
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.|+|||++. .+|...+. -.++-..+..++.|++.|+.|||+.| |+||||||+||++..++.+||.|||+++...
T Consensus 96 ~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccC
Confidence 999999994 57887776 35677888999999999999999999 9999999999999999999999999998665
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-------------
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------- 971 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------- 971 (1044)
.. ......+.|..|.|||++.+..|...+||||+||++.||++|+..|.+.+..+.+.++...-+.
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 44 3344567899999999999999999999999999999999999999886655433332111000
Q ss_pred ------------CC----CCC-----------CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 ------------LD----IPD-----------NLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 ------------~~----ip~-----------~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.. +|+ .-...+++++.+||..||++|.+++++|+|-
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 01 111 1123478999999999999999999999873
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=241.89 Aligned_cols=253 Identities=19% Similarity=0.291 Sum_probs=216.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVm 829 (1044)
-.|+++++||+|.||.++.|++ +++.||||.-... ...-.++.|...++.|. .+.|..+|.+.+...+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 3699999999999999999976 8999999964322 23346888999999885 799999999988888899999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-----CeEEEEeccccccc-
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-----WVVKVCDFGLSRMK- 903 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-----g~VKLiDFGLA~~~- 903 (1044)
|.+ |-+|.|++.-++++|+..++..++.|++.-++|+|++. +|+|||||+|+||..- ..|.|+|||+|+..
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 999 88999999989999999999999999999999999999 9999999999999743 47999999999853
Q ss_pred ------cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhcccccc---
Q 045028 904 ------HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN---PMQVVGAVGFQHRR--- 971 (1044)
Q Consensus 904 ------~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---~~eil~~I~~~~~~--- 971 (1044)
+.++....+..||.+||+-..+.|...+.+.|+-|||.+++++|-|.+||++.. ..+-+++|....+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 445666788899999999999999999999999999999999999999999854 44556666443332
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 972 ~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
..+..++|.++...+...-..+..+-|+++-+...+.++++
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 23557899999999999999999999999887777766553
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=241.78 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=205.3
Q ss_pred CeeEEeEecccCcEEEEEEEECC---cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC----CCeeEEEeee-ecCCCc
Q 045028 754 EITLGERIGLGSYGEVYRGDWHG---TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH----PNVVLFMGAV-TRPPNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g---~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH----PNIVkl~~~~-~~~~~l 825 (1044)
+|++.++||+|+||.||++.... ..+|+|.......... ..++.|+.++..+.. .++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 79999999999999999998744 3688887655422111 157889999988862 6899999999 477789
Q ss_pred eEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-----CeEEEEeccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-----WVVKVCDFGL 899 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-----g~VKLiDFGL 899 (1044)
||||+.+ |.+|.++..... +.|+..++..++.|++.+|.+||+.| ++||||||.|+++... ..+.|+|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999998 889999986644 88999999999999999999999999 9999999999999865 4699999999
Q ss_pred cc--cccCC-------ccc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc
Q 045028 900 SR--MKHNT-------FLS-SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH 969 (1044)
Q Consensus 900 A~--~~~~~-------~~~-~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~ 969 (1044)
++ ..... ... ...+.||..|.++.++.+...+.+.|+|||+.++.+|+.|..||...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 32111 111 234569999999999999999999999999999999999999998766432232222111
Q ss_pred ccCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 970 RRLD---IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 970 ~~~~---ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.... .....+.++..+...+-..+...+|.+..+...|+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111 34556788999998888899999999999999988776653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-23 Score=218.17 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=204.8
Q ss_pred eeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchh-hHHHHHHHHHHHHhCCCC-CeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGE-SLEEFRSEVLIMKRVRHP-NVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~-~~~~~~~EI~ILk~LrHP-NIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 789999999999999999888 7899998876654432 567899999999999988 7999999997777789999999
Q ss_pred CCCcHHHHhcCCC--CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEeccccccccCCcc-
Q 045028 833 PRGSLYRLLHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKHNTFL- 908 (1044)
Q Consensus 833 ~GGsL~dlLkr~~--~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~~~~~~~- 908 (1044)
.+++|.+++.... ..+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999997777643 27999999999999999999999999 99999999999999988 799999999875443321
Q ss_pred -----cccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhcccccc-CC--
Q 045028 909 -----SSRSTAGTAEWMAPEVLRN---EPSDEKCDVYSFGVILWELCTMQQPWGGMNP----MQVVGAVGFQHRR-LD-- 973 (1044)
Q Consensus 909 -----~~~s~~GTp~Y~APEvL~g---~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~----~eil~~I~~~~~~-~~-- 973 (1044)
......||..|++||.+.+ ..+....|+|++|++++++++|..||..... .+....+...... ..
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2456789999999999988 5788899999999999999999999877663 3444444322222 11
Q ss_pred CCCCC----CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 974 IPDNL----DPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 974 ip~~i----p~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..... ...+.+++.+++..+|..|.+..+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2578999999999999999998887765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=250.56 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=195.9
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~ 823 (1044)
...+.|.++++||.|+|++||++.. .+..||+|.+.... ....+.+|+++|..+. +.||+++.+++..++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3456799999999999999998854 45679999876543 4466899999999996 899999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~ 902 (1044)
...+||||++.....+++.. ++...+..++..++.||.++|..| ||||||||+|+|++. .++-.|+|||++..
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999998888754 778999999999999999999999 999999999999984 57899999999961
Q ss_pred c---------------cCC--------------------c---------ccccCCCCCCCccCcccccCCC-CCchhHHH
Q 045028 903 K---------------HNT--------------------F---------LSSRSTAGTAEWMAPEVLRNEP-SDEKCDVY 937 (1044)
Q Consensus 903 ~---------------~~~--------------------~---------~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIW 937 (1044)
. +.. + .......||+.|+|||++...+ .+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 0 000 0 0012345999999999997765 68899999
Q ss_pred HHHHHHHHHHhCCCCCCCCC-hHHHHhh------------hccc------------------------------------
Q 045028 938 SFGVILWELCTMQQPWGGMN-PMQVVGA------------VGFQ------------------------------------ 968 (1044)
Q Consensus 938 SLG~LLyELLTGk~PF~~~~-~~eil~~------------I~~~------------------------------------ 968 (1044)
|.|+|+..++++..||.... ..+.+.. ....
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999984321 1100000 0000
Q ss_pred -cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 969 -HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 969 -~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.......+.++..+.+|+.+||..||.+|.|+++.|+|-
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 001111234566889999999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=277.62 Aligned_cols=195 Identities=18% Similarity=0.194 Sum_probs=143.4
Q ss_pred CCC-CCeeEEEeee-------ecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEec
Q 045028 807 VRH-PNVVLFMGAV-------TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRD 878 (1044)
Q Consensus 807 LrH-PNIVkl~~~~-------~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRD 878 (1044)
++| +||+.++++| .....++++|||+ +++|.+++......+++..++.++.||+.||.|||++| |+|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 345 5777777776 2334578888987 66999999876677999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCe-------------------EEEEeccccccccCC----------------cccccCCCCCCCccCcc
Q 045028 879 LKSPNLLVDKNWV-------------------VKVCDFGLSRMKHNT----------------FLSSRSTAGTAEWMAPE 923 (1044)
Q Consensus 879 IKPeNILLd~dg~-------------------VKLiDFGLA~~~~~~----------------~~~~~s~~GTp~Y~APE 923 (1044)
|||+||||+..|. +||+|||+++..... ........||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999965444 555555555421100 00011245899999999
Q ss_pred cccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 045028 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEI 1003 (1044)
Q Consensus 924 vL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~EL 1003 (1044)
++.+..++.++|||||||+||||++|.+||..... ....+......... ....+...+++.+||.++|.+||++.|+
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 99999999999999999999999999988764321 11111111111111 1124567789999999999999999999
Q ss_pred HHHh
Q 045028 1004 MAAL 1007 (1044)
Q Consensus 1004 Le~L 1007 (1044)
++|-
T Consensus 263 l~h~ 266 (793)
T PLN00181 263 LQSE 266 (793)
T ss_pred hhch
Confidence 9874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=220.32 Aligned_cols=162 Identities=23% Similarity=0.338 Sum_probs=131.3
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
|+|.+++...+..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876677999999999999999999999987 999999999999999 9998765432 236
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccccC-----CCCCCCCH--HHHHHH
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRL-----DIPDNLDP--AVADII 986 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~~~-----~ip~~ip~--ELkdLI 986 (1044)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+....... ..+..++. +++++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221111111 11223333 699999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 987 RKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.+||..+|.+||++.++++++..+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=236.21 Aligned_cols=234 Identities=22% Similarity=0.376 Sum_probs=182.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEe-eeecCCCceE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMG-AVTRPPNLSI 827 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~-~~~~~~~l~L 827 (1044)
.+.|.|.+.||+|.||.+.++++. .+.+++|.+.... .....|.+|..---.|. |.||+.-|+ .|+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 467999999999999999999985 5679999876654 23456777776655564 889998776 5788889999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc--CCCeEEEEeccccccccC
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD--KNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd--~dg~VKLiDFGLA~~~~~ 905 (1044)
++||++.|+|..-+.. ..+-+.....++.|++.||.|||+++ +||||||.+||||- +..+|||||||+++..+.
T Consensus 100 ~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999988865 56888999999999999999999999 99999999999994 345999999999986654
Q ss_pred CcccccCCCCCCCccCcccccCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHhhhccccccCCCC
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEP-----SDEKCDVYSFGVILWELCTMQQPWGGMNPM-----QVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~-----~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-----eil~~I~~~~~~~~ip 975 (1044)
.-.. .--+..|.+||.+.... ..+.+|+|.||+++|.+|||.+||+..... +...+. .......|
T Consensus 176 tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~--~rk~~~~P 250 (378)
T KOG1345|consen 176 TVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL--KRKNPALP 250 (378)
T ss_pred eehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh--cccCccCc
Confidence 3211 12355688999874332 356799999999999999999999853222 222222 12222334
Q ss_pred ---CCCCHHHHHHHHHhhhcCCCCC
Q 045028 976 ---DNLDPAVADIIRKCWQTDPKMR 997 (1044)
Q Consensus 976 ---~~ip~ELkdLI~rcL~kDPekR 997 (1044)
.-+++.+..++++-|..++++|
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCccccc
Confidence 4578889999999999999999
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=221.82 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=211.2
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~ 826 (1044)
+-...|+++++||.|+||.+|++.. .|..||||.-...... ..+..|..+++.|+ ...|..+..++....+-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4457899999999999999999976 7899999975443321 24677899999987 467778888888888999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc---CCCeEEEEeccccccc
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD---KNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd---~dg~VKLiDFGLA~~~ 903 (1044)
+||+.+ |.+|.+++.-+.+.|+..+++.++-|++.-++|+|.++ +|||||||+|+|.. ...++.|+|||+++..
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhh
Confidence 999999 88999999988899999999999999999999999999 99999999999996 3468999999999853
Q ss_pred -------cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhccccc---
Q 045028 904 -------HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGFQHR--- 970 (1044)
Q Consensus 904 -------~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~~~~--- 970 (1044)
+-++.......||.+|.+--.+.+...+.+.|+-|+|.+|.++.-|.+||++.... +-+++|.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 34455667788999999999988888899999999999999999999999986544 33444432221
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 971 RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 971 ~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
...+...+|.|+.-.+..|-..-.++-|+..-|.+.+.-|+
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 22345789999999999999999999999776666554443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-23 Score=243.51 Aligned_cols=225 Identities=27% Similarity=0.405 Sum_probs=193.0
Q ss_pred EecccCcEEEEEEE-----ECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEecC
Q 045028 760 RIGLGSYGEVYRGD-----WHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 760 ~LGkG~FGtVykak-----~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
.+|+|+||.|++++ +.|..+|+|+.++...........+.|..++..++ ||++|++...|+.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 35777999988765443333336777889999997 9999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCC
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~ 913 (1044)
||+|+..+.+ ...+.+.....+..+++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-.... .
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----A 153 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----c
Confidence 9999999877 456777777888899999999999999 99999999999999999999999999986544322 2
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcC
Q 045028 914 AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993 (1044)
Q Consensus 914 ~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kD 993 (1044)
|||..|||||+++ .+..++|+||||+++|+|++|..||.. ++...| ....+.+|..++.++++++.+++.++
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhC
Confidence 9999999999999 567789999999999999999999998 445454 34467889999999999999999999
Q ss_pred CCCCCC
Q 045028 994 PKMRPT 999 (1044)
Q Consensus 994 PekRPT 999 (1044)
|.+|.-
T Consensus 226 p~nrLg 231 (612)
T KOG0603|consen 226 PENRLG 231 (612)
T ss_pred HHHHhc
Confidence 999953
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=221.55 Aligned_cols=167 Identities=21% Similarity=0.161 Sum_probs=129.5
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE---CCcEEEEEEeeccCc---chhhHHHHHHHHHHHHhCCCCCeeE-EEeeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW---HGTEVAVKRFLDQDF---FGESLEEFRSEVLIMKRVRHPNVVL-FMGAVT 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~---~g~~VAVK~l~~~~~---~~~~~~~~~~EI~ILk~LrHPNIVk-l~~~~~ 820 (1044)
.....++|.+.+.||+|+||+||+|.+ +++.+|||++..... .......+.+|+++|+.++|+||++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 344567899999999999999999976 467789998653311 2234566999999999999999985 4432
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecC-CCCcEEEcCCCeEEEEeccc
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDL-KSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDI-KPeNILLd~dg~VKLiDFGL 899 (1044)
+..||||||++|++|... .. . . ...++.|++.+|.|||++| |+|||| ||+|||++.++.+||+|||+
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~-~---~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP-H---G---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc-c---c---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 468999999999999732 21 1 1 1467889999999999999 999999 99999999999999999999
Q ss_pred cccccCCccc--------ccCCCCCCCccCcccccCC
Q 045028 900 SRMKHNTFLS--------SRSTAGTAEWMAPEVLRNE 928 (1044)
Q Consensus 900 A~~~~~~~~~--------~~s~~GTp~Y~APEvL~g~ 928 (1044)
++........ -....+++.|++||.+...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9854332211 1245688889999998543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=244.42 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=190.7
Q ss_pred eEEeEecccCcEEEEEEEE--CCcEEEEEEee----ccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 756 TLGERIGLGSYGEVYRGDW--HGTEVAVKRFL----DQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 756 ~I~r~LGkG~FGtVykak~--~g~~VAVK~l~----~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
...+.+|.|+||.|+.... ....++.|.+. ...........+..|..+-..+.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4577899999998876644 33445555433 11111111222666777788889999998888777766666669
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-- 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-- 907 (1044)
|||++ +|+.++.+ ..++....+..++.||+.||.|||.+| |.|||||++|++++..|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 99999987 357899999999999999999999999 9999999999999999999999999987654433
Q ss_pred --ccccCCCCCCCccCcccccCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCChHHHH--hhh-----ccccccCCCCCC
Q 045028 908 --LSSRSTAGTAEWMAPEVLRNEPSDE-KCDVYSFGVILWELCTMQQPWGGMNPMQVV--GAV-----GFQHRRLDIPDN 977 (1044)
Q Consensus 908 --~~~~s~~GTp~Y~APEvL~g~~~s~-kSDIWSLG~LLyELLTGk~PF~~~~~~eil--~~I-----~~~~~~~~ip~~ 977 (1044)
......+|...|+|||++.+..|.+ ..||||.|++++.|++|+.||......+.. ... ........+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 2345678999999999999998875 689999999999999999999764433221 111 111112223356
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++.+.+.+|.+||+.||.+|.|+++|++.
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhC
Confidence 78889999999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=208.59 Aligned_cols=255 Identities=30% Similarity=0.619 Sum_probs=216.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
+...+..++.+|.+...|..|+|+|.|..++.|++.........-..|..|.-.|+-+.||||+.+++.+....++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 34556778889999999999999999999999998776666555567888888898889999999999999999999999
Q ss_pred EecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEE--eccccccccCC
Q 045028 830 EFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC--DFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLi--DFGLA~~~~~~ 906 (1044)
.|++.|+|+..++.. .-..+..++.+++.+++.|++|||+..+-|.---|....++||++.+.+|. |--++-
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence 999999999999874 334677889999999999999999998656566788999999998765543 322221
Q ss_pred cccccCCCCCCCccCcccccCCCCC---chhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSD---EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s---~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
......-.|.||+||.++..+-+ .++|+|||.++||||.|...||....+.+.--++.....+..+|+.+++-+.
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 11223347889999999877643 5789999999999999999999999999988888888889999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.|++-|+..||.+||.+..|+-.|+++.
T Consensus 420 klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999988887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-20 Score=227.39 Aligned_cols=204 Identities=29% Similarity=0.438 Sum_probs=158.0
Q ss_pred CCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.+|..++.+-.|+||.||.++++ .+.+|+|+ .++++. +++ |+.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li------lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI------LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh------hhc---cccccCCccee-----------------
Confidence 57999999999999999999774 88899964 333211 111 34444455554
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC-----
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN----- 905 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~----- 905 (1044)
|+-..+++.. +.++... +.+++|||+.| |+|||+||+|++|+.-|++|++|||+++....
T Consensus 136 ----gDc~tllk~~-g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-GPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccC-CCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 4555555442 2333222 78999999999 99999999999999999999999999874211
Q ss_pred ----------CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-cCCC
Q 045028 906 ----------TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDI 974 (1044)
Q Consensus 906 ----------~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-~~~i 974 (1044)
........+|||.|+|||++..+.|++.+|||++|+|+||++.|..||.+..+++++..+..... +.+-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 11124567899999999999999999999999999999999999999999999999987743222 2233
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCC
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRP 998 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRP 998 (1044)
-+.+++|++++|.++|+.+|..|-
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhc
Confidence 456889999999999999999994
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-20 Score=226.60 Aligned_cols=239 Identities=20% Similarity=0.258 Sum_probs=184.7
Q ss_pred CeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+|...+.||.+.|=+|.++++....|+||++.++.-. -....+...|++ ...++|||++++..+...+...|||.+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6889999999999999999997777999999776521 122233334444 5556899999999988888889999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--ccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLS 909 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~~~ 909 (1044)
+ ..+|+|.+.. +..+...+.+.|+.||+.||..+|..| |+|||||.+||||+.-+-+.|+||..-+...-+ ...
T Consensus 103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 9 4589999876 567888889999999999999999999 999999999999999999999999876532111 111
Q ss_pred c-----cCCCCCCCccCcccccCC----------C-CCchhHHHHHHHHHHHHHh-CCCCCCC-----------CChHHH
Q 045028 910 S-----RSTAGTAEWMAPEVLRNE----------P-SDEKCDVYSFGVILWELCT-MQQPWGG-----------MNPMQV 961 (1044)
Q Consensus 910 ~-----~s~~GTp~Y~APEvL~g~----------~-~s~kSDIWSLG~LLyELLT-Gk~PF~~-----------~~~~ei 961 (1044)
. .+.....+|+|||.+... + .+++-||||+||++.||++ |++||.- .++...
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 1 112234579999998542 2 4678999999999999997 5777731 122222
Q ss_pred HhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 962 VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 962 l~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
+++| -+..++++|..|++.||.+|.++++.|+.-..
T Consensus 259 Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 259 LEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHhC------------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 2222 23468999999999999999999999988433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.9e-20 Score=195.55 Aligned_cols=175 Identities=15% Similarity=0.095 Sum_probs=135.7
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchh-hHHH------HHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGE-SLEE------FRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~-~~~~------~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+...+|++.+.||.|+||.||+...+++.+|||++.......+ .... +.+|+..+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 4567899999999999999999877888999999865432222 2222 67899999999999999998886533
Q ss_pred --------CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEE
Q 045028 823 --------PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKV 894 (1044)
Q Consensus 823 --------~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKL 894 (1044)
+..+|+|||++|.+|.++.. +++ ....+++.+|..||..| |+||||||+||+++.+| ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEE
Confidence 35889999999999988742 222 24569999999999999 99999999999999988 999
Q ss_pred EeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh
Q 045028 895 CDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT 948 (1044)
Q Consensus 895 iDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT 948 (1044)
+|||........... ..++....+..+.|+|+||++|..+..
T Consensus 176 iDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999987643221110 113344456678999999999876643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=188.27 Aligned_cols=140 Identities=21% Similarity=0.226 Sum_probs=108.5
Q ss_pred EeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhh------------------------HHHHHHHHHHHHhCCCCCe
Q 045028 758 GERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGES------------------------LEEFRSEVLIMKRVRHPNV 812 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~------------------------~~~~~~EI~ILk~LrHPNI 812 (1044)
...||+|+||.||+|.. +|+.||||+++........ ......|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 6899999998754221111 1223459999999987776
Q ss_pred eEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHH-HhCCCcEEEecCCCCcEEEcCCCe
Q 045028 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL-HNCTPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 813 Vkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yL-Hs~G~~IVHRDIKPeNILLd~dg~ 891 (1044)
.....+.. ...+|||||++|++|...+.. ...++...+..++.|++.+|.+| |+.| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 43332222 234899999999877655333 35789999999999999999999 7999 99999999999998 578
Q ss_pred EEEEeccccccc
Q 045028 892 VKVCDFGLSRMK 903 (1044)
Q Consensus 892 VKLiDFGLA~~~ 903 (1044)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=195.86 Aligned_cols=232 Identities=22% Similarity=0.283 Sum_probs=152.7
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCC----------CCeeEEEeeee
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRH----------PNVVLFMGAVT 820 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrH----------PNIVkl~~~~~ 820 (1044)
.+..++.||.|+|+.||.+.+ +++.+|||++...... ....+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 467789999999999999998 5699999988655422 3456677777655544322 12222222221
Q ss_pred c---------C---C-----CceEEEEecCCCcHHHHhcC---CC---CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEe
Q 045028 821 R---------P---P-----NLSIVAEFLPRGSLYRLLHR---PN---NQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877 (1044)
Q Consensus 821 ~---------~---~-----~l~LVmEy~~GGsL~dlLkr---~~---~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHR 877 (1044)
- . . +.+++|+-+ .++|.+++.- .. ..+.....+.+..|+++.+++||..| |||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 1 1 1 346778877 5588877542 11 12334445566799999999999999 9999
Q ss_pred cCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHhC
Q 045028 878 DLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN--------EPSDEKCDVYSFGVILWELCTM 949 (1044)
Q Consensus 878 DIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g--------~~~s~kSDIWSLG~LLyELLTG 949 (1044)
||||+|+|++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|+||
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999987655443321 234577999997743 2468899999999999999999
Q ss_pred CCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 045028 950 QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR 997 (1044)
Q Consensus 950 k~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekR 997 (1044)
..||........... .+..+..+|..++.||..+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999987654432221 233344889999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=185.57 Aligned_cols=188 Identities=16% Similarity=0.175 Sum_probs=145.5
Q ss_pred eEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchh--hHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEec
Q 045028 756 TLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGE--SLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 756 ~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~--~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
.+...|++|+||+||.+...+.+++.+.+........ ....+.+|+++|++|. |++|++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 4678899999999999888889998887654433211 1225789999999996 5889999886 3579999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecC-CCCcEEEcCCCeEEEEeccccccccCCccc--
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDL-KSPNLLVDKNWVVKVCDFGLSRMKHNTFLS-- 909 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDI-KPeNILLd~dg~VKLiDFGLA~~~~~~~~~-- 909 (1044)
.|.+|...+.. ....++.|++.+|.+||.+| |+|||| ||+|||++.+|.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999765422 11357789999999999999 999999 799999999999999999999854433210
Q ss_pred -----------ccCCCCCCCccCcccccCC-CCC-chhHHHHHHHHHHHHHhCCCCCCCCC
Q 045028 910 -----------SRSTAGTAEWMAPEVLRNE-PSD-EKCDVYSFGVILWELCTMQQPWGGMN 957 (1044)
Q Consensus 910 -----------~~s~~GTp~Y~APEvL~g~-~~s-~kSDIWSLG~LLyELLTGk~PF~~~~ 957 (1044)
..-...++.|+.|+...-. ..+ .+.++++.|+-+|.++|+..++.+.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0112268889999876543 223 57899999999999999999876654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=180.86 Aligned_cols=141 Identities=20% Similarity=0.183 Sum_probs=110.6
Q ss_pred EEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcch------------------------hhHHHHHHHHHHHHhCCCCC
Q 045028 757 LGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFG------------------------ESLEEFRSEVLIMKRVRHPN 811 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~------------------------~~~~~~~~EI~ILk~LrHPN 811 (1044)
+.+.||+|+||+||+|.+ +|+.||||++....... .....+..|...+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999987 59999999987542110 00223467899999999988
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHH-hcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCC
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRL-LHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKN 889 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dl-Lkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~d 889 (1044)
|.....+... ..+|||||++|+++... +. ...++...+..++.|++.+|.+||. .| |+||||||+|||++ +
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence 7544333322 34899999998855433 33 3567888999999999999999999 99 99999999999999 8
Q ss_pred CeEEEEecccccccc
Q 045028 890 WVVKVCDFGLSRMKH 904 (1044)
Q Consensus 890 g~VKLiDFGLA~~~~ 904 (1044)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.1e-19 Score=195.46 Aligned_cols=193 Identities=23% Similarity=0.325 Sum_probs=146.8
Q ss_pred CCCCeeEEEeeeecC---------------------------CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHH
Q 045028 808 RHPNVVLFMGAVTRP---------------------------PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDA 860 (1044)
Q Consensus 808 rHPNIVkl~~~~~~~---------------------------~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QI 860 (1044)
+|||||+++..|.+. ..+|+||.... .+|..++.. ...+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHH
Confidence 699999998877542 23788998774 488888865 556778888899999
Q ss_pred HHHHHHHHhCCCcEEEecCCCCcEEEc--CC--CeEEEEecccccccc-----CCcccc-cCCCCCCCccCcccccCCCC
Q 045028 861 ARGMNYLHNCTPVIVHRDLKSPNLLVD--KN--WVVKVCDFGLSRMKH-----NTFLSS-RSTAGTAEWMAPEVLRNEPS 930 (1044)
Q Consensus 861 a~AL~yLHs~G~~IVHRDIKPeNILLd--~d--g~VKLiDFGLA~~~~-----~~~~~~-~s~~GTp~Y~APEvL~g~~~ 930 (1044)
++|+.|||++| |.|||+|.+||||. ++ ..+.|+|||.+--.. -++... ...-|+...||||+....+-
T Consensus 351 LEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 351 LEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 99999999999994 33 478999999874211 122222 23447888999999865432
Q ss_pred ------CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 045028 931 ------DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004 (1044)
Q Consensus 931 ------s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELL 1004 (1044)
-.+.|.|+.|.+-||++....||+......+-..-......+.+|+.+++.+++|+..+|+.||.+|++..-..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 35799999999999999999999884433222222223445678899999999999999999999998755433
Q ss_pred H
Q 045028 1005 A 1005 (1044)
Q Consensus 1005 e 1005 (1044)
.
T Consensus 509 N 509 (598)
T KOG4158|consen 509 N 509 (598)
T ss_pred h
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.6e-18 Score=207.29 Aligned_cols=248 Identities=21% Similarity=0.254 Sum_probs=184.0
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC---CCCeeEEEeee
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR---HPNVVLFMGAV 819 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~ 819 (1044)
....+++..+.|.|.+.||+|+||+||+|.. +|+.||||+-+....++-.+ =.+++.+|+ -+-|..+...+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHH
Confidence 3456677889999999999999999999976 68899999866555433211 122333333 23455666666
Q ss_pred ecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-------CCeE
Q 045028 820 TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-------NWVV 892 (1044)
Q Consensus 820 ~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-------dg~V 892 (1044)
...+.-++|+||.+.|+|.+++. ..+.+++..+..+..|++..+++||.++ |||+||||+|+||.. ..-+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccce
Confidence 66778899999999999999998 4788999999999999999999999999 999999999999953 3469
Q ss_pred EEEecccccccc--CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc
Q 045028 893 KVCDFGLSRMKH--NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR 970 (1044)
Q Consensus 893 KLiDFGLA~~~~--~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~ 970 (1044)
+|||||.+..+. .........++|-.+-.+|++.|.+++...|.|.|+.+++-||.|+.- + . ....
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q----~-~~g~ 908 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E----V-KNGS 908 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H----h-cCCc
Confidence 999999886432 111233456789999999999999999999999999999999998542 1 1 1111
Q ss_pred cCCCCCCCC----HH-HHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 971 RLDIPDNLD----PA-VADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 971 ~~~ip~~ip----~E-LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.......++ .+ +.+++..+|..|-..=|...+|...|+..+
T Consensus 909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 122222222 22 456888888733333477888877776644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=172.20 Aligned_cols=136 Identities=26% Similarity=0.419 Sum_probs=115.2
Q ss_pred eEecccCcEEEEEEEECCcEEEEEEeeccCcchh------hHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 759 ERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGE------SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~------~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
+.||+|++|.||+|.+.|..+++|+......... ....+.+|+.++..+.|++|.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998654332111 2245788999999999998877766776778899999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+|++|.+++.... . .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986522 1 77889999999999999999 99999999999999 78999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=173.16 Aligned_cols=134 Identities=19% Similarity=0.274 Sum_probs=104.6
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-----CCCCeeEEEeeeecCC---Cce-EE
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-----RHPNVVLFMGAVTRPP---NLS-IV 828 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-----rHPNIVkl~~~~~~~~---~l~-LV 828 (1044)
.+.||+|+||.||....++.. +||++..... ...+.+.+|+.+++.+ .||||+++++++.++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 467999999999974334444 6888765322 2346789999999999 5799999999998874 333 78
Q ss_pred EEe--cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHH-HHHHhCCCcEEEecCCCCcEEEcC----CCeEEEEecccc
Q 045028 829 AEF--LPRGSLYRLLHRPNNQLDERRRLRMALDAARGM-NYLHNCTPVIVHRDLKSPNLLVDK----NWVVKVCDFGLS 900 (1044)
Q Consensus 829 mEy--~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL-~yLHs~G~~IVHRDIKPeNILLd~----dg~VKLiDFGLA 900 (1044)
||| +.+++|.+++++. .+++. ..++.|++.++ .|||+++ |+||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999763 46555 35677888777 9999999 999999999999974 348999995433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-17 Score=166.00 Aligned_cols=132 Identities=26% Similarity=0.391 Sum_probs=108.9
Q ss_pred EecccCcEEEEEEEECCcEEEEEEeeccCcch------hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecC
Q 045028 760 RIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFG------ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 760 ~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~------~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
.||+|+||.||++.+.+..+++|......... .....+.+|++++..+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999865433211 123567889999999988876554445556677899999999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
|++|.+++..... .++.+++.+|.+||+.| |+|+|++|.|||++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998765211 78999999999999999 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.3e-16 Score=168.13 Aligned_cols=144 Identities=22% Similarity=0.137 Sum_probs=112.3
Q ss_pred CeeEEeEecccCcEEEEEEE---ECCcEEEEEEeeccCcch----------------------hhHHHHHHHHHHHHhCC
Q 045028 754 EITLGERIGLGSYGEVYRGD---WHGTEVAVKRFLDQDFFG----------------------ESLEEFRSEVLIMKRVR 808 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak---~~g~~VAVK~l~~~~~~~----------------------~~~~~~~~EI~ILk~Lr 808 (1044)
.|.+.+.||+|+||.||+|. .+|+.||||++....... .....+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 378999999987543110 01123578999999997
Q ss_pred C--CCeeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE
Q 045028 809 H--PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV 886 (1044)
Q Consensus 809 H--PNIVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL 886 (1044)
+ ..+.+++.+ ...++||||+.|++|...+.. ...+....+..++.||+.+|.+||..| .|+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 5 334445543 245899999999888766533 245666777889999999999999987 49999999999999
Q ss_pred cCCCeEEEEecccccccc
Q 045028 887 DKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 887 d~dg~VKLiDFGLA~~~~ 904 (1044)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999986443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=185.67 Aligned_cols=137 Identities=22% Similarity=0.342 Sum_probs=115.1
Q ss_pred CeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcch------hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFG------ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~------~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
.|...+.||+|+||+||++.+.+..+++|+........ ...+.+.+|+++++.++|++|+..+.++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 45678899999999999999988877777643322111 123568899999999999999887777777778899
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
||||++|++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999885 35678999999999999999 9999999999999 678999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.7e-16 Score=181.00 Aligned_cols=210 Identities=31% Similarity=0.547 Sum_probs=168.0
Q ss_pred HHhCCCCCeeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCc
Q 045028 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPN 883 (1044)
Q Consensus 804 Lk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeN 883 (1044)
|+.+.|.|+.+|++.+.+...+++|.+||..|+|.+.+......++..-...++++|+.||.|||..-. ..|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecccc
Confidence 356789999999999999999999999999999999999878889999999999999999999998872 2999999999
Q ss_pred EEEcCCCeEEEEeccccccccC--CcccccCCCCCCCccCcccccCCC-------CCchhHHHHHHHHHHHHHhCCCCCC
Q 045028 884 LLVDKNWVVKVCDFGLSRMKHN--TFLSSRSTAGTAEWMAPEVLRNEP-------SDEKCDVYSFGVILWELCTMQQPWG 954 (1044)
Q Consensus 884 ILLd~dg~VKLiDFGLA~~~~~--~~~~~~s~~GTp~Y~APEvL~g~~-------~s~kSDIWSLG~LLyELLTGk~PF~ 954 (1044)
++++....+||+|||+...... .........-..-|.|||.+.+.. .+.+.||||+|++++|+++.+.||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 9999999999999999876532 111111112344689999997742 3567899999999999999999997
Q ss_pred CC----ChHHHHhhhccccc---cCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 955 GM----NPMQVVGAVGFQHR---RLDIP--DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 955 ~~----~~~eil~~I~~~~~---~~~ip--~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.. .+.++...+..... ++.+. ..+++++..++..||..+|.+||++.++...++.+.+..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 62 33455555433111 22222 245668999999999999999999999999998887753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=159.13 Aligned_cols=136 Identities=21% Similarity=0.170 Sum_probs=107.5
Q ss_pred eeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcch--------------------hhHHHHHHHHHHHHhCCCC--C
Q 045028 755 ITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFG--------------------ESLEEFRSEVLIMKRVRHP--N 811 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~--------------------~~~~~~~~EI~ILk~LrHP--N 811 (1044)
|.+.+.||+|+||.||++.. +|+.||||++....... .....+..|+.++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 78889999999999999987 68999999865432100 0112367788899988776 4
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~ 891 (1044)
++.+++. ...++||||+.|++|..+... .....++.+++.++.++|+.| |+||||||+||+++.++.
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCc
Confidence 4444432 456999999999998776431 345678899999999999999 999999999999999999
Q ss_pred EEEEeccccccc
Q 045028 892 VKVCDFGLSRMK 903 (1044)
Q Consensus 892 VKLiDFGLA~~~ 903 (1044)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-16 Score=182.31 Aligned_cols=172 Identities=23% Similarity=0.377 Sum_probs=130.8
Q ss_pred CCceEEEEecCCCcHHHHhcC--CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHR--PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr--~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
.++||.|++|...+|.++|.+ .....+....+.++.|++.++.| ++ .+|+|+||.||++..+..+||.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 358999999999999999975 34567778889999999999999 77 999999999999999999999999998
Q ss_pred ccccCC------cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCC
Q 045028 901 RMKHNT------FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLD 973 (1044)
Q Consensus 901 ~~~~~~------~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ 973 (1044)
...... ........||..||+||++.+..|+.++|||+||+||+|+++ -...|....... .+........
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~---d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT---DIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh---hhhcCCCChH
Confidence 754332 234456789999999999999999999999999999999998 222222211111 1111111111
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEI 1003 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~EL 1003 (1044)
+.... ++-..|+.+||.+.|.+||++.+.
T Consensus 481 ~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 481 FLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 22233 344579999999999999955444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-17 Score=196.95 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=203.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE---CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW---HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~---~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~L 827 (1044)
...|.+.+.||+|+|+.|-+... ....+|+|.+...............|..+-+.+. |.|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45688888999999999987755 2344667765544333344556667888888887 9999999999999999999
Q ss_pred EEEecCCCcHHHHh-cCCCCCCcHHHHHHHHHHHHHHHHHHH-hCCCcEEEecCCCCcEEEcCCC-eEEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLL-HRPNNQLDERRRLRMALDAARGMNYLH-NCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlL-kr~~~~Lse~~il~Ia~QIa~AL~yLH-s~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~~~ 904 (1044)
+++|..|+++++.+ .......+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||++....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999999 544436777888889999999999999 888 99999999999999999 99999999998654
Q ss_pred C---CcccccCCCC-CCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh--hhccccc-cCCCCC
Q 045028 905 N---TFLSSRSTAG-TAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVG--AVGFQHR-RLDIPD 976 (1044)
Q Consensus 905 ~---~~~~~~s~~G-Tp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~--~I~~~~~-~~~ip~ 976 (1044)
. ........+| ++.|+|||.+.+. ...+..|+||+|+++.-+++|..||.......... ....... ....+.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 4 2233445678 9999999999885 45778999999999999999999997755443221 1111111 244557
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.++....+++.+++..+|..|.+.+++-..-
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~ 287 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDN 287 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccc
Confidence 7889999999999999999999999887553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.2e-15 Score=140.62 Aligned_cols=134 Identities=18% Similarity=0.173 Sum_probs=113.2
Q ss_pred EEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC--CCeeEEEeeeecCCCceEEEEecCC
Q 045028 757 LGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH--PNVVLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH--PNIVkl~~~~~~~~~l~LVmEy~~G 834 (1044)
+++.||.|.++.||++...+..+++|.+..... ...+..|+.+++.++| .++++++.++...+..+++|||+.|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 467899999999999999888999998765432 4568889999999976 5899999988888889999999998
Q ss_pred CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC-CcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT-PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 835 GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G-~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+..+ +......++.+++.+|.+||... ..++|+||+|+|||++..+.++++|||.+..
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877544 45566778999999999999852 1299999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=9e-15 Score=149.28 Aligned_cols=137 Identities=23% Similarity=0.180 Sum_probs=98.3
Q ss_pred EeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHH----------------------HHHHHHHHHhCCCC--Ce
Q 045028 758 GERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEE----------------------FRSEVLIMKRVRHP--NV 812 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~----------------------~~~EI~ILk~LrHP--NI 812 (1044)
++.||+|+||+||++... ++.||||++............ ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 567999999999999875 899999987654322111111 13566666666443 24
Q ss_pred eEEEeeeecCCCceEEEEecCCCcHHH-HhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCC
Q 045028 813 VLFMGAVTRPPNLSIVAEFLPRGSLYR-LLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 813 Vkl~~~~~~~~~l~LVmEy~~GGsL~d-lLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg 890 (1044)
.+++++ ...++||||++|+.+.. .+... .. ...+..++.+++.++.+||. .+ |+|+||||+|||++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RL-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh--hh-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 445543 24699999999854321 11110 01 15677899999999999999 99 99999999999999 89
Q ss_pred eEEEEecccccccc
Q 045028 891 VVKVCDFGLSRMKH 904 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~ 904 (1044)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-14 Score=153.13 Aligned_cols=137 Identities=16% Similarity=0.211 Sum_probs=106.3
Q ss_pred EeEec-ccCcEEEEEEEECCcEEEEEEeeccCcc-----------hhhHHHHHHHHHHHHhCCCCCe--eEEEeeeecCC
Q 045028 758 GERIG-LGSYGEVYRGDWHGTEVAVKRFLDQDFF-----------GESLEEFRSEVLIMKRVRHPNV--VLFMGAVTRPP 823 (1044)
Q Consensus 758 ~r~LG-kG~FGtVykak~~g~~VAVK~l~~~~~~-----------~~~~~~~~~EI~ILk~LrHPNI--Vkl~~~~~~~~ 823 (1044)
...|| .|+.|+||.++..+..++||.+....+. ......+.+|+.++..|.|++| +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34577 8888889988888999999988643221 1223567889999999998775 56666543322
Q ss_pred -C---ceEEEEecCC-CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 824 -N---LSIVAEFLPR-GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 824 -~---l~LVmEy~~G-GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
. .++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||+.| |+||||||+|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 3599999997 699998865 3445443 568999999999999 9999999999999999999999999
Q ss_pred cccc
Q 045028 899 LSRM 902 (1044)
Q Consensus 899 LA~~ 902 (1044)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.6e-13 Score=159.37 Aligned_cols=252 Identities=22% Similarity=0.196 Sum_probs=193.8
Q ss_pred cCCCCeeEEeEecc--cCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecC
Q 045028 750 IPWEEITLGERIGL--GSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRP 822 (1044)
Q Consensus 750 i~~e~y~I~r~LGk--G~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~ 822 (1044)
+....+.+.+.+|. |.+|.||.++. .+..+|+|.-+...........=.+|+...+.++ |++.++.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34456778899999 99999997654 6778999874333222222223345666666775 99999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHH----HHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEec
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR----GMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDF 897 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~----AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDF 897 (1044)
+..|+-+|++ +.+|..+.......++...++.++.+... ||.++|..+ |+|-|+||.||++..+ ...+++||
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCc
Confidence 9999999999 57999998887777999999999999999 999999999 9999999999999999 89999999
Q ss_pred cccccccCCccccc-----CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC
Q 045028 898 GLSRMKHNTFLSSR-----STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL 972 (1044)
Q Consensus 898 GLA~~~~~~~~~~~-----s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~ 972 (1044)
|+....+....... ...|...|++||.+++. ++...|||+||.++.+..+|...........+.+ +.......
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cccccCch
Confidence 99987665543222 22688999999999876 6788999999999999998865543331111111 11112344
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++....+.++..++..|+..+|..|++...++.+
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 5556677888889999999999999998877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.9e-13 Score=165.73 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=195.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.+...+.+.+.+.+-+|.|+.++.++- .|-..+.|........ ....+....+-.++-..++|.++.....+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 556778999999999999999998754 2333444443322211 1223444555555555667888887777667778
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.+++++|++|++|...++.. ...+......++..+++++++||... ++|+|++|.|+|+..+|+.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999999999873 35667777788889999999999998 9999999999999999999999998432100
Q ss_pred C-------------------------------CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 045028 905 N-------------------------------TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW 953 (1044)
Q Consensus 905 ~-------------------------------~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF 953 (1044)
. .........||+.|.+||.+.+......+|||++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 001123456999999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcccc-ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q 045028 954 GGMNPMQVVGAVGFQH-RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFT 1001 (1044)
Q Consensus 954 ~~~~~~eil~~I~~~~-~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ 1001 (1044)
....+.++++.+.... .+...+...+.++++++.+++..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999988774322 23445567899999999999999999997765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.6e-12 Score=124.84 Aligned_cols=129 Identities=17% Similarity=0.086 Sum_probs=97.0
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCee-EEEeeeecCCCceEEEEecCCCc
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV-LFMGAVTRPPNLSIVAEFLPRGS 836 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIV-kl~~~~~~~~~l~LVmEy~~GGs 836 (1044)
++.|+.|.++.||+++..+..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 46789999999999999999999998654321 122457899999988654444 455443 234689999999987
Q ss_pred HHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCC---cEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 837 LYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP---VIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 837 L~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~---~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+.... .....++.+++.+|..||..+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 78 l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 75430 1112456799999999999871 149999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.1e-11 Score=142.88 Aligned_cols=141 Identities=22% Similarity=0.220 Sum_probs=95.7
Q ss_pred eEecccCcEEEEEEEE-CCcEEEEEEeeccCcch--h--------------------------hHH----------HHHH
Q 045028 759 ERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFG--E--------------------------SLE----------EFRS 799 (1044)
Q Consensus 759 r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~--~--------------------------~~~----------~~~~ 799 (1044)
+.||.|++|+||+|+. +|+.||||+........ . .++ .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 78999999875321000 0 000 1344
Q ss_pred HHHHHHhC----CCCCeeEEEeee-ecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHH-HHHHHHhCCCc
Q 045028 800 EVLIMKRV----RHPNVVLFMGAV-TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR-GMNYLHNCTPV 873 (1044)
Q Consensus 800 EI~ILk~L----rHPNIVkl~~~~-~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~-AL~yLHs~G~~ 873 (1044)
|...+.++ +|.+-+.+-.++ ......+|||||++|++|.++......... ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--
Confidence 55555544 232223322222 223457999999999999887643211222 3345556655 468889999
Q ss_pred EEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 874 IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++|+|+||.||+++.+|.++|+|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.8e-11 Score=139.68 Aligned_cols=164 Identities=19% Similarity=0.263 Sum_probs=127.2
Q ss_pred ECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHH
Q 045028 774 WHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR 853 (1044)
Q Consensus 774 ~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~i 853 (1044)
.++.+|.|+.++.... ......++.++.|+.++||||+++++.+..++.+|||+|.+. .|..++++ +....+
T Consensus 35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHH
Confidence 3677888887765543 445668889999999999999999999999999999999984 46666655 336667
Q ss_pred HHHHHHHHHHHHHHH-hCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCc
Q 045028 854 LRMALDAARGMNYLH-NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932 (1044)
Q Consensus 854 l~Ia~QIa~AL~yLH-s~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~ 932 (1044)
..-+.||+.||.||| +++ ++|++|.-.-|+|+..|+.||++|.++..............---.|..|+.+.... .
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence 778999999999997 566 99999999999999999999999998865433322122222233456666554332 3
Q ss_pred hhHHHHHHHHHHHHHhC
Q 045028 933 KCDVYSFGVILWELCTM 949 (1044)
Q Consensus 933 kSDIWSLG~LLyELLTG 949 (1044)
..|.|.|||+++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 47999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.3e-12 Score=138.21 Aligned_cols=200 Identities=20% Similarity=0.359 Sum_probs=144.3
Q ss_pred HHHhCCCCCeeEEEeeeecCC-----CceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcE
Q 045028 803 IMKRVRHPNVVLFMGAVTRPP-----NLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVI 874 (1044)
Q Consensus 803 ILk~LrHPNIVkl~~~~~~~~-----~l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~I 874 (1044)
-|-++-|.|||+++.|+.+.. ...++.||+..|+|..+|++ ....+....-.+|+.||+.||.|||++.++|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 445567999999999986644 48899999999999999986 3567888888899999999999999999999
Q ss_pred EEecCCCCcEEEcCCCeEEEEeccccccccCC-----cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC
Q 045028 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT-----FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM 949 (1044)
Q Consensus 875 VHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~-----~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG 949 (1044)
+|+++...-|++..+|-|||.---... .+.. ........+-+.|.+||.=.....+-++|||+||...++|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999988875321111 1100 1112334567899999987777777889999999999999887
Q ss_pred CCC-CCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 950 QQP-WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 950 k~P-F~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..- -......+.-..+ .+..+.....+ =+.+|.+||...|..||++++++.|.-
T Consensus 279 Eiq~tnseS~~~~ee~i--a~~i~~len~l---qr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENI--ANVIIGLENGL---QRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred eeccCCCcceeehhhhh--hhheeeccCcc---ccCcCcccccCCCCCCcchhhhhcCce
Confidence 543 1111111111111 01111111111 246899999999999999999987753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-10 Score=138.27 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=93.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE-C-CcEEEEEEeeccCcc----------------------------h----hhHHH-
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW-H-GTEVAVKRFLDQDFF----------------------------G----ESLEE- 796 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~-~-g~~VAVK~l~~~~~~----------------------------~----~~~~~- 796 (1044)
+.+|+. +.||.|++|+||+|+. + |+.||||+....... . +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455776 7899999999999987 3 899999998643100 0 01111
Q ss_pred -----HHHHHHHHHhC----CCCCeeEEEeeeec-CCCceEEEEecCCCcHHHH--hcCCCC---CCcHHHHHHHHHHHH
Q 045028 797 -----FRSEVLIMKRV----RHPNVVLFMGAVTR-PPNLSIVAEFLPRGSLYRL--LHRPNN---QLDERRRLRMALDAA 861 (1044)
Q Consensus 797 -----~~~EI~ILk~L----rHPNIVkl~~~~~~-~~~l~LVmEy~~GGsL~dl--Lkr~~~---~Lse~~il~Ia~QIa 861 (1044)
+.+|+..+.++ .+...+.+-.++.+ ....+|||||+.|+.|.++ +...+. .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 33344444443 23333443333322 3467899999999999875 322211 244444444555554
Q ss_pred HHHHHHHhCCCcEEEecCCCCcEEEcCCC----eEEEEeccccccc
Q 045028 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNW----VVKVCDFGLSRMK 903 (1044)
Q Consensus 862 ~AL~yLHs~G~~IVHRDIKPeNILLd~dg----~VKLiDFGLA~~~ 903 (1044)
..| ++|+|+||+||+++.+| +++++|||++...
T Consensus 278 -------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 -------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 578 99999999999999888 9999999998543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-11 Score=142.95 Aligned_cols=250 Identities=21% Similarity=0.163 Sum_probs=183.6
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE---CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCc
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW---HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~---~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l 825 (1044)
....+|..+..||.|.|+.|+.+.. ++..|++|.+.........-..-..|+.+...+. |.+++.++..|....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3457899999999999999998643 5778999977654433322223345666666664 88999988888777888
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA~~~~ 904 (1044)
||-.|||.++++...+. ....+.+...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||..+...
T Consensus 342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccc
Confidence 89999999998877663 2456788889999999999999999999 9999999999999876 788999999886421
Q ss_pred CCcccccCCCCCCCcc--CcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 905 NTFLSSRSTAGTAEWM--APEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~--APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
. .......+-++. ++..+....+..+.|+++||..+++.++|...-+..+.. ................++
T Consensus 419 ~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 419 F---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----LTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred e---ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----eeeecccccCCCchHHhh
Confidence 1 112222333444 555556667888999999999999999986532221111 111223233334444889
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+.+.+.++.+++..||.+.++..+.+.+
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999999887765543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.3e-10 Score=117.62 Aligned_cols=139 Identities=20% Similarity=0.174 Sum_probs=99.8
Q ss_pred EeEecccCcEEEEEEEEC--------CcEEEEEEeeccC--cc------------------hhhHHH----HHHHHHHHH
Q 045028 758 GERIGLGSYGEVYRGDWH--------GTEVAVKRFLDQD--FF------------------GESLEE----FRSEVLIMK 805 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~--------g~~VAVK~l~~~~--~~------------------~~~~~~----~~~EI~ILk 805 (1044)
...||.|--+.||.|... +..+|||+++... +. ...... .++|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 346899999999999653 3689999864211 00 011222 348999999
Q ss_pred hCCC--CCeeEEEeeeecCCCceEEEEecCCCcHHH-HhcCCCCCCcHHHHHHHHHHHHHHHHHH-HhCCCcEEEecCCC
Q 045028 806 RVRH--PNVVLFMGAVTRPPNLSIVAEFLPRGSLYR-LLHRPNNQLDERRRLRMALDAARGMNYL-HNCTPVIVHRDLKS 881 (1044)
Q Consensus 806 ~LrH--PNIVkl~~~~~~~~~l~LVmEy~~GGsL~d-lLkr~~~~Lse~~il~Ia~QIa~AL~yL-Hs~G~~IVHRDIKP 881 (1044)
++.. -++..++++ ...+|||||+.+..+.. .++. ..++......+..+++.+|..| |..| |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 8853 456666654 46799999997754422 2222 2345566677889999999999 8999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccC
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
.|||++ ++.+.|+|||.+.....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCCC
Confidence 999997 46899999998875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.6e-10 Score=115.33 Aligned_cols=133 Identities=26% Similarity=0.354 Sum_probs=105.5
Q ss_pred eEecccCcEEEEEEEECCcEEEEEEeeccCcchhh------HHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 759 ERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGES------LEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~------~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
..+++|+-+.+|.+.+.|..+.+|.-..+...... .....+|..++.+++--.|...+-++.+.+...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999988888888865444333222 345778999999887555555555666778899999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+|..|.+.+... ...++..+-.-+.-||..| |+|+||.++||++..++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998763 2456677777888999999 99999999999998765 99999999863
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-09 Score=113.03 Aligned_cols=140 Identities=21% Similarity=0.238 Sum_probs=107.8
Q ss_pred eEecccCcEEEEEEEECC-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC--CCeeEEEeeeecC---CCceEEEEec
Q 045028 759 ERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH--PNVVLFMGAVTRP---PNLSIVAEFL 832 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH--PNIVkl~~~~~~~---~~l~LVmEy~ 832 (1044)
+.||.|.++.||++...+ +.+++|........ .....+..|+.+++.+.+ ..+.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998765 88999986543321 134568899999999975 3456677666543 3678999999
Q ss_pred CCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 045028 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT----------------------------------------- 871 (1044)
Q Consensus 833 ~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G----------------------------------------- 871 (1044)
+|.+|.+.+.. ..++......++.+++.+|.+||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99988776542 35677777788888888888888421
Q ss_pred -------------CcEEEecCCCCcEEEcC--CCeEEEEeccccc
Q 045028 872 -------------PVIVHRDLKSPNLLVDK--NWVVKVCDFGLSR 901 (1044)
Q Consensus 872 -------------~~IVHRDIKPeNILLd~--dg~VKLiDFGLA~ 901 (1044)
..++|+|+++.|||++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23899999999999998 6778999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-09 Score=110.23 Aligned_cols=145 Identities=19% Similarity=0.255 Sum_probs=110.1
Q ss_pred EEeEecccCcEEEEEEEECCcEEEEEEeeccCcchh------hHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 757 LGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGE------SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~------~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.+..|-+|+-+.|+++.+.|+...||.-..+...-. ...+.++|+++|.+++--.|.-..-+|.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 567888999999999999999999986433322211 23567889999998865455544446667778899999
Q ss_pred ecCC-CcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---eEEEEeccccccc
Q 045028 831 FLPR-GSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW---VVKVCDFGLSRMK 903 (1044)
Q Consensus 831 y~~G-GsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg---~VKLiDFGLA~~~ 903 (1044)
|++| .++.+++.... ..........++..|-..|.-||..+ |||+||..+||++..++ .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 47778776532 23333333678889999999999999 99999999999997554 4589999998643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=5e-08 Score=111.37 Aligned_cols=252 Identities=18% Similarity=0.249 Sum_probs=164.0
Q ss_pred CCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEee------eecCCC-
Q 045028 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGA------VTRPPN- 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~------~~~~~~- 824 (1044)
+-+..++.||+|+-+.+|-...-+.. +-|++...-.... - +.+..|... .||-+-.-+.| .-+...
T Consensus 11 e~i~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~----a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 11 EPIPPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQ----A-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred cccCCCccccCCccceeeecchhhch-hheeecCCCchHH----H-HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 34566789999999999964332222 3455544321111 1 122223322 46654432222 122222
Q ss_pred ceEEEEecCCCc-HHHHhc-----CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 825 LSIVAEFLPRGS-LYRLLH-----RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 825 l~LVmEy~~GGs-L~dlLk-----r~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
+.++|..+.|.. +..++. +......+.-.++.+..|+.+.+.||..| .+-+|+.++|+|+.+++.|.|+|-.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEccc
Confidence 778888887763 222222 12345788999999999999999999999 9999999999999999999999855
Q ss_pred ccccccCCcccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCCCC-------hHH-HHhh
Q 045028 899 LSRMKHNTFLSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTM-QQPWGGMN-------PMQ-VVGA 964 (1044)
Q Consensus 899 LA~~~~~~~~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~-------~~e-il~~ 964 (1044)
.-... .........+|..+|.+||.-+ +...+...|.|.||+++|++|.| ++||.+.. +.+ .+..
T Consensus 163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 43322 2223344567999999999764 44456789999999999999987 99997632 222 1111
Q ss_pred h----cccccc------CCCC-CCCCHHHHHHHHHhhhcC--CCCCCCHHHHHHHhccccCC
Q 045028 965 V----GFQHRR------LDIP-DNLDPAVADIIRKCWQTD--PKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 965 I----~~~~~~------~~ip-~~ip~ELkdLI~rcL~kD--PekRPTa~ELLe~Lk~L~k~ 1013 (1044)
. ....++ ..+| ..+++.++.|+.+|+... +.-|||++.++..|..+..+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0 001111 1112 347899999999999643 56899999998888766543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.6e-07 Score=109.64 Aligned_cols=210 Identities=16% Similarity=0.240 Sum_probs=152.6
Q ss_pred EEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec----CCCceEEEEecCCC-cHHH
Q 045028 767 GEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PPNLSIVAEFLPRG-SLYR 839 (1044)
Q Consensus 767 GtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~----~~~l~LVmEy~~GG-sL~d 839 (1044)
.+.|++.. +|..|++|++.-... ........-+++++++.|+|||+|.++|.. +..+++|++|.++. +|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 46788855 799999999832111 111123345788999999999999998873 34589999998754 7777
Q ss_pred HhcC--------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 840 LLHR--------------PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 840 lLkr--------------~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+.-. .+...++..+|.++.||..||.++|+.| +.-+-|.|.+||++.+.+|+|.-.|+......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6432 1345788999999999999999999999 88899999999999999999988887654432
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChHHH-HhhhccccccCCCCCCCCHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQV-VGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~-PF~~~~~~ei-l~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.. . |-+.+ -.+-|.-.||.+++.|.||.. -|......+. +.. +-..++.+++
T Consensus 446 d~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D~r 499 (655)
T KOG3741|consen 446 DP------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTDLR 499 (655)
T ss_pred CC------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHHHH
Confidence 21 0 11221 135799999999999999843 3444333333 222 2356788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++|..+...++++ -++.+++.++
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHHH
Confidence 9999999998886 5788887765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.1e-08 Score=107.17 Aligned_cols=133 Identities=18% Similarity=0.105 Sum_probs=96.1
Q ss_pred EEEEEEEECCcEEEEEEeeccCcch---------hhHHHHHHHHHHHHhCCCCCe--eEEEeeeec-----CCCceEEEE
Q 045028 767 GEVYRGDWHGTEVAVKRFLDQDFFG---------ESLEEFRSEVLIMKRVRHPNV--VLFMGAVTR-----PPNLSIVAE 830 (1044)
Q Consensus 767 GtVykak~~g~~VAVK~l~~~~~~~---------~~~~~~~~EI~ILk~LrHPNI--Vkl~~~~~~-----~~~l~LVmE 830 (1044)
..|++....|+.|.||......... .....+.+|...+.+|..-+| +..+.++.. ....+||||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 4466788889999999764333110 111246788888887743222 233333332 234789999
Q ss_pred ecCCC-cHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-------CCeEEEEeccccc
Q 045028 831 FLPRG-SLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-------NWVVKVCDFGLSR 901 (1044)
Q Consensus 831 y~~GG-sL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-------dg~VKLiDFGLA~ 901 (1044)
++++. +|.+++... ....+......++.+++..+..||..| |+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99886 899888531 234566777789999999999999999 999999999999975 4689999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-07 Score=98.48 Aligned_cols=127 Identities=28% Similarity=0.260 Sum_probs=83.7
Q ss_pred EEEEEEE-CCcEEEEEEeeccC--cc----------------------hhhHHHHHHHHHHHHhCCCC--CeeEEEeeee
Q 045028 768 EVYRGDW-HGTEVAVKRFLDQD--FF----------------------GESLEEFRSEVLIMKRVRHP--NVVLFMGAVT 820 (1044)
Q Consensus 768 tVykak~-~g~~VAVK~l~~~~--~~----------------------~~~~~~~~~EI~ILk~LrHP--NIVkl~~~~~ 820 (1044)
-||.|.. +|..+|||+.+... +. .......++|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3888876 68889999864321 00 01134578899999999755 456666553
Q ss_pred cCCCceEEEEecC--CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHH-HHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 821 RPPNLSIVAEFLP--RGSLYRLLHRPNNQLDERRRLRMALDAARGMNY-LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 821 ~~~~l~LVmEy~~--GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~y-LHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
..+|||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||.+.|||++.+ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 5689999998 7666555433 12234456677788885555 57999 9999999999999987 9999999
Q ss_pred ccccccc
Q 045028 898 GLSRMKH 904 (1044)
Q Consensus 898 GLA~~~~ 904 (1044)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.5e-07 Score=97.97 Aligned_cols=127 Identities=24% Similarity=0.247 Sum_probs=90.6
Q ss_pred EECCcEEEEEEeeccCcch-----hhHHHHHHHHHHHHhCCCC--CeeEEEeeeecCC----CceEEEEecCCC-cHHHH
Q 045028 773 DWHGTEVAVKRFLDQDFFG-----ESLEEFRSEVLIMKRVRHP--NVVLFMGAVTRPP----NLSIVAEFLPRG-SLYRL 840 (1044)
Q Consensus 773 k~~g~~VAVK~l~~~~~~~-----~~~~~~~~EI~ILk~LrHP--NIVkl~~~~~~~~----~l~LVmEy~~GG-sL~dl 840 (1044)
...++.+.+|.+....... .......+|...+..|..- ...+.+.+..... ..+||+|++++. +|.++
T Consensus 29 ~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 29 DLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred cccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHH
Confidence 3455666666543221111 1234577788887777432 2334444444322 358999999884 89999
Q ss_pred hcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---eEEEEecccccc
Q 045028 841 LHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW---VVKVCDFGLSRM 902 (1044)
Q Consensus 841 Lkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg---~VKLiDFGLA~~ 902 (1044)
+..... ++......++.+++..+.-||..| |+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 109 ~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQ-LDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcc-cchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 876222 667778889999999999999999 99999999999999887 999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=8.1e-08 Score=115.33 Aligned_cols=148 Identities=18% Similarity=0.304 Sum_probs=110.2
Q ss_pred HHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-c--------ccCCCCCCCccCcccccC
Q 045028 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-S--------SRSTAGTAEWMAPEVLRN 927 (1044)
Q Consensus 857 a~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~--------~~s~~GTp~Y~APEvL~g 927 (1044)
+.+.+.|+.|+|..- .+||+.|.|++|.++.+|.+||+.|+++........ . .....-...|.|||++.+
T Consensus 105 l~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445569999999774 399999999999999999999999998864332110 0 011113457999999999
Q ss_pred CCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHh--hhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 045028 928 EPSDEKCDVYSFGVILWELC-TMQQPWGGMNPMQVVG--AVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004 (1044)
Q Consensus 928 ~~~s~kSDIWSLG~LLyELL-TGk~PF~~~~~~eil~--~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELL 1004 (1044)
...+.++|+||||+++|.+. .|+.-+...+....+. .........-+...+|.|+++-+.+++..+...||++.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 88899999999999999999 5666665543332222 11222334455678999999999999999999999777665
Q ss_pred H
Q 045028 1005 A 1005 (1044)
Q Consensus 1005 e 1005 (1044)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=95.41 Aligned_cols=138 Identities=23% Similarity=0.181 Sum_probs=101.1
Q ss_pred eeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCc-------c-------------hhhHHHHHHHHHHHHhCCCC--C
Q 045028 755 ITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDF-------F-------------GESLEEFRSEVLIMKRVRHP--N 811 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~-------~-------------~~~~~~~~~EI~ILk~LrHP--N 811 (1044)
+.++.+||-|.-+.||.|.. .|.++|||.-..... . .-......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45788999999999999988 599999995321110 0 01233467899999998644 6
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~ 891 (1044)
+.+.+++ +...+||||++|..|...-- .....-.++..|++-+..+-..| |||+|+.+-|||++.+|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 6666655 56799999999977765531 23344455566666666666888 999999999999999999
Q ss_pred EEEEecccccccc
Q 045028 892 VKVCDFGLSRMKH 904 (1044)
Q Consensus 892 VKLiDFGLA~~~~ 904 (1044)
+.++||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999997665433
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.8e-06 Score=85.89 Aligned_cols=140 Identities=19% Similarity=0.218 Sum_probs=83.2
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC--CeeEEEeeee---cCCCceEEEEec
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP--NVVLFMGAVT---RPPNLSIVAEFL 832 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP--NIVkl~~~~~---~~~~l~LVmEy~ 832 (1044)
++.|+.|..+.||+....+..+++|..... .....+..|..+++.+... -+.+++.+.. .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 578999999999999998889999985433 3445677888888887522 2445555332 223478999999
Q ss_pred CCCcHHH----------------Hhc---CC---CCCCcHHH---------HHHH------------HHHHHH-HHHHHH
Q 045028 833 PRGSLYR----------------LLH---RP---NNQLDERR---------RLRM------------ALDAAR-GMNYLH 868 (1044)
Q Consensus 833 ~GGsL~d----------------lLk---r~---~~~Lse~~---------il~I------------a~QIa~-AL~yLH 868 (1044)
+|..+.. .+. +. ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9998887 111 10 01111000 0000 111222 233333
Q ss_pred h-----CCCcEEEecCCCCcEEEc-CCCeEEEEeccccc
Q 045028 869 N-----CTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSR 901 (1044)
Q Consensus 869 s-----~G~~IVHRDIKPeNILLd-~dg~VKLiDFGLA~ 901 (1044)
. ....++|+|+.|.|||++ .++.|.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 223399999999999999 67778999999774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.9e-06 Score=88.60 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=95.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhh-H------HHHHHHHHHHHhCC---CCCeeEEEeee
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGES-L------EEFRSEVLIMKRVR---HPNVVLFMGAV 819 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~-~------~~~~~EI~ILk~Lr---HPNIVkl~~~~ 819 (1044)
+...+|++.+.+-......|.+-..+|+.+.+|.........+. . ....+++..+..++ .-.+..++-..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34568999999999999999999999999999987654322111 1 11233444444442 22222222222
Q ss_pred -----ecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEE
Q 045028 820 -----TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKV 894 (1044)
Q Consensus 820 -----~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKL 894 (1044)
.-....+|+|||++|..|.++.. +++ .+...|.+++..||+.| ++|+|+.|.|++++.++ +++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEE
Confidence 11234678999999988866542 122 24456778899999999 99999999999999654 999
Q ss_pred Eeccccc
Q 045028 895 CDFGLSR 901 (1044)
Q Consensus 895 iDFGLA~ 901 (1044)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=86.53 Aligned_cols=139 Identities=16% Similarity=0.074 Sum_probs=102.6
Q ss_pred cccCcEEEEEEEECCcEEEEEEeeccCcc----hhhHHHHHHHHHHHHhCCC--CCeeEEEeeee--cC--CCceEEEEe
Q 045028 762 GLGSYGEVYRGDWHGTEVAVKRFLDQDFF----GESLEEFRSEVLIMKRVRH--PNVVLFMGAVT--RP--PNLSIVAEF 831 (1044)
Q Consensus 762 GkG~FGtVykak~~g~~VAVK~l~~~~~~----~~~~~~~~~EI~ILk~LrH--PNIVkl~~~~~--~~--~~l~LVmEy 831 (1044)
|+||-+-|++....|+.+-+|.-...... +.-...|.+|+..|++|.. -.+.++..... .. -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 67899999999988888999975421110 2234578999999988852 22444442211 11 237899998
Q ss_pred cCC-CcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe--EEEEecccccc
Q 045028 832 LPR-GSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV--VKVCDFGLSRM 902 (1044)
Q Consensus 832 ~~G-GsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~--VKLiDFGLA~~ 902 (1044)
+.| .+|.+++... -.+.+......++.+++..|..||+.| +.|+|+.+.|||++.+|. |+++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 754 5898887653 235677778889999999999999999 999999999999986666 99999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.3e-05 Score=86.41 Aligned_cols=131 Identities=19% Similarity=0.164 Sum_probs=84.4
Q ss_pred eEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC--eeEEEeeeecCCCceEEEEecCCCc
Q 045028 759 ERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--VVLFMGAVTRPPNLSIVAEFLPRGS 836 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN--IVkl~~~~~~~~~l~LVmEy~~GGs 836 (1044)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+++.+....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 36678889765422 2345788999998886333 4567777777777889999999963
Q ss_pred -HHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHH-----------------------------------------hCCCcE
Q 045028 837 -LYRLLHRPNNQLDERRRLRMALDAARGMNYLH-----------------------------------------NCTPVI 874 (1044)
Q Consensus 837 -L~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLH-----------------------------------------s~G~~I 874 (1044)
+...+.. +......++.+++..+.-|| .....+
T Consensus 81 ~~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 81 SFSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred chhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 2111110 00111111111112111122 122348
Q ss_pred EEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 875 VHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 875 VHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+|+|+.|.||+++.++ +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999999988 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.6e-06 Score=73.89 Aligned_cols=54 Identities=30% Similarity=0.287 Sum_probs=46.7
Q ss_pred ccceecchhHHHHHHHHHHhCCceEEeeccccc---------CCCCceeEEEEeCCCceEEEec
Q 045028 295 LTIGLARHRALLFKVLADIVGIPCRLVKGQQYT---------GCDDVAMNFVRIDDGREYIVDL 349 (1044)
Q Consensus 295 l~~g~c~~~Allfk~lad~~gl~~~lv~G~~~~---------~~~~~~~~~v~~~~~~~y~vDl 349 (1044)
-+.|.|.++|.||..|+..+||||++|.|..-. ....++|+.|.+ +++||.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~-~~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYL-EGGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEE-CCCeEEEeC
Confidence 468999999999999999999999999993322 357778999999 699999995
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.2e-05 Score=94.19 Aligned_cols=140 Identities=21% Similarity=0.207 Sum_probs=88.3
Q ss_pred eEecccCcEEEEEEEEC-CcEEEEEEeeccCcc----------------------------hhhHH----H------HHH
Q 045028 759 ERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFF----------------------------GESLE----E------FRS 799 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~----------------------------~~~~~----~------~~~ 799 (1044)
+.|+.++-|+||+|+.. |+.||||+....-.. ...++ . +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999985 999999985321100 00011 1 233
Q ss_pred HHHHHHhC----C-CCCeeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcE
Q 045028 800 EVLIMKRV----R-HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874 (1044)
Q Consensus 800 EI~ILk~L----r-HPNIVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~I 874 (1044)
|..-+.++ + .++|.-.--++.-.+.-.|+|||++|..+.+........++...+.....++. +..+-..| +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg--f 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG--F 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC--c
Confidence 44444444 2 33332222223334567899999999999888433224444333332222222 22333467 9
Q ss_pred EEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 875 VHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+|.|..|.||+++.+|++.+.|||+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceec
Confidence 9999999999999999999999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.4e-05 Score=82.87 Aligned_cols=137 Identities=21% Similarity=0.175 Sum_probs=84.4
Q ss_pred EecccCc-EEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEecCCCcH
Q 045028 760 RIGLGSY-GEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 760 ~LGkG~F-GtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
.|-.|.. ..||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 7899987777788889764432 234677898888874 43455777777766778999999999877
Q ss_pred HHHhc-------------------CC---CCCCcHH--HHHHHHH--------------------HHHHHHHHHHh----
Q 045028 838 YRLLH-------------------RP---NNQLDER--RRLRMAL--------------------DAARGMNYLHN---- 869 (1044)
Q Consensus 838 ~dlLk-------------------r~---~~~Lse~--~il~Ia~--------------------QIa~AL~yLHs---- 869 (1044)
..... .. ...+... ....... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64321 10 0011100 0000000 01111122211
Q ss_pred -CCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 870 -CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 870 -~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 11339999999999999998888999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.5e-06 Score=98.21 Aligned_cols=54 Identities=33% Similarity=0.565 Sum_probs=47.3
Q ss_pred cceecchhHHHHHHHHHHhCCceEEeecccccCC---------CCceeEEEEeCCCceEEEeccCC
Q 045028 296 TIGLARHRALLFKVLADIVGIPCRLVKGQQYTGC---------DDVAMNFVRIDDGREYIVDLMAD 352 (1044)
Q Consensus 296 ~~g~c~~~Allfk~lad~~gl~~~lv~G~~~~~~---------~~~~~~~v~~~~~~~y~vDl~~~ 352 (1044)
-.++|..||.|||.||..+||||-+|+| |-++ .+++||.||+ |+.||+||.--.
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIeg--f~k~~~~~~~~~~iNHaWN~Vki-D~~yy~VDtTwg 270 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEG--FLKSPIYYTRDININHAWNIVKI-DNEYYLVDTTWG 270 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEee--cccccccccCCccccceeeEEEE-CCeEEEEeeecC
Confidence 4689999999999999999999999999 6444 4788999999 559999998653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.2e-05 Score=82.09 Aligned_cols=132 Identities=20% Similarity=0.232 Sum_probs=96.9
Q ss_pred eeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeE-EEeeeecCCCceEEEEecC
Q 045028 755 ITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL-FMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVk-l~~~~~~~~~l~LVmEy~~ 833 (1044)
.+..+.||+|++|.||++.+.|..+|+|+-... .....+..|+++|+.+.--++.+ +|.+. ..++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence 455678999999999999999999999975433 44567899999999998666554 44443 3355699999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC-CCcEEEcCCCeEEEEecccccccc
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK-SPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK-PeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
|..|.++.... +.. -+..+++.---|-..| |-|+.|. |..++|..++.+.|+||..|+...
T Consensus 96 G~~L~~~~~~~----~rk----~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 96 GRPLGKLEIGG----DRK----HLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred Ccchhhhhhcc----cHH----HHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 98888776431 222 3345555555677788 9999986 666666666699999999987443
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.9e-06 Score=77.70 Aligned_cols=53 Identities=32% Similarity=0.341 Sum_probs=43.9
Q ss_pred cceecchhHHHHHHHHHHhCCceEEeeccccc----------CCCCceeEEEEeCCCceEEEe
Q 045028 296 TIGLARHRALLFKVLADIVGIPCRLVKGQQYT----------GCDDVAMNFVRIDDGREYIVD 348 (1044)
Q Consensus 296 ~~g~c~~~Allfk~lad~~gl~~~lv~G~~~~----------~~~~~~~~~v~~~~~~~y~vD 348 (1044)
++|.|.++|.||..|+..+||||++|.|.... ....++|+.|.+.+++||.+|
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 56999999999999999999999999993331 234577999999999999998
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.7e-05 Score=81.71 Aligned_cols=140 Identities=23% Similarity=0.162 Sum_probs=96.5
Q ss_pred EeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchh----------------------hHHHHHHHHHHHHhCC--CCCe
Q 045028 758 GERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGE----------------------SLEEFRSEVLIMKRVR--HPNV 812 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~----------------------~~~~~~~EI~ILk~Lr--HPNI 812 (1044)
...|..|.-+.||+|.. ++..+|+|+++..-..-. ......+|..-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 33566777788999876 588999998753321110 1224566777888774 4445
Q ss_pred eEEEeeeecCCCceEEEEecCCCcH-HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCC
Q 045028 813 VLFMGAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 813 Vkl~~~~~~~~~l~LVmEy~~GGsL-~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg 890 (1044)
.+.+.+. .-.|||||+....+ .-.|+ .-.+.......+..++++.+.-|-. .+ +||+||..-|||+. ++
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 5556554 35899999955411 01111 1233344677788899999998877 78 99999999999999 88
Q ss_pred eEEEEeccccccccCC
Q 045028 891 VVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~~~ 906 (1044)
.+.|||||-+....++
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 9999999988755443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.4e-06 Score=102.02 Aligned_cols=185 Identities=21% Similarity=0.194 Sum_probs=136.8
Q ss_pred CeeEEeEecccCcEEEEEEEECCcE-EEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC-eeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTE-VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN-VVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~-VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN-IVkl~~~~~~~~~l~LVmEy 831 (1044)
.+.....+++|+++++++.+...+. ...+.+... ....-++++|.+++||| .+..++-++.+.+.++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 4666677899999999998765443 223332211 34566899999999999 77778888888899999999
Q ss_pred cCCC-cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 832 LPRG-SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 832 ~~GG-sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
+.++ +-...+....-.+...+...+...-+.++++||+.- =+|+| ||+... +..++.||+......... ..
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 9877 332222222233445555666777788899999875 58888 776655 688999999886555443 45
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 045028 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW 953 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF 953 (1044)
.+..+|+.+++||+.....+....|.|++|.--.+|--|.+|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 6778999999999999999999999999998766777666553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00031 Score=89.19 Aligned_cols=79 Identities=11% Similarity=0.160 Sum_probs=56.3
Q ss_pred EeEecccCcEEEEEEEECC----cEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCe--eEEEeeeecC---CCceE
Q 045028 758 GERIGLGSYGEVYRGDWHG----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNV--VLFMGAVTRP---PNLSI 827 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g----~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNI--Vkl~~~~~~~---~~l~L 827 (1044)
++.|+.|.+..+|+....+ ..+++|+....... .....+.+|+.+|+.+. |.+| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 5778999999999987654 46778865432211 12346889999999995 6665 6777776654 46889
Q ss_pred EEEecCCCcH
Q 045028 828 VAEFLPRGSL 837 (1044)
Q Consensus 828 VmEy~~GGsL 837 (1044)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00083 Score=71.93 Aligned_cols=129 Identities=29% Similarity=0.385 Sum_probs=91.5
Q ss_pred CCCCeeEEeEecccCc-EEEEEEEECCcEEEEEEeeccCcc----------h---------hhHHHHHHHHHHHHhC---
Q 045028 751 PWEEITLGERIGLGSY-GEVYRGDWHGTEVAVKRFLDQDFF----------G---------ESLEEFRSEVLIMKRV--- 807 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~F-GtVykak~~g~~VAVK~l~~~~~~----------~---------~~~~~~~~EI~ILk~L--- 807 (1044)
...+++.++.||.|.- |.||+++..|+.||+|.+..-... . ...+-|..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 3478999999999999 999999999999999994321110 0 1122356677766666
Q ss_pred CCCCe--eEEEeeeecC------------------CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHH
Q 045028 808 RHPNV--VLFMGAVTRP------------------PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867 (1044)
Q Consensus 808 rHPNI--Vkl~~~~~~~------------------~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yL 867 (1044)
.+.++ |++++|+.-. ....||.||+.... .+... -+.+|..-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHH
Confidence 45566 8999987321 12467888876532 22222 345777778889
Q ss_pred HhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 868 Hs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
|..| |+-+|+++.|.. + =+|+|||.+
T Consensus 181 ~k~g--I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG--IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHCC--eeeccCcccccc---C--CEEEecccC
Confidence 9999 999999999987 2 378999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00058 Score=72.03 Aligned_cols=99 Identities=20% Similarity=0.235 Sum_probs=79.3
Q ss_pred HHHHHHHhCCC-CCeeEEEeeeecCCCceEEEEecCCCcHHHH---hcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC-Cc
Q 045028 799 SEVLIMKRVRH-PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRL---LHRPNNQLDERRRLRMALDAARGMNYLHNCT-PV 873 (1044)
Q Consensus 799 ~EI~ILk~LrH-PNIVkl~~~~~~~~~l~LVmEy~~GGsL~dl---Lkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G-~~ 873 (1044)
.|.-+++.+.+ +++++++|++. .++++||+..+++... +.+ -...++..+.+++.++++.+.+|+..- ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888875 69999999984 3789999987766432 111 134689999999999999999998732 23
Q ss_pred EEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 874 IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+...|++++|+-++.+|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00038 Score=74.80 Aligned_cols=74 Identities=18% Similarity=0.112 Sum_probs=46.4
Q ss_pred EeEecccCcE-EEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC---CeeEEEeeeecC---CCceEEEE
Q 045028 758 GERIGLGSYG-EVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP---NVVLFMGAVTRP---PNLSIVAE 830 (1044)
Q Consensus 758 ~r~LGkG~FG-tVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP---NIVkl~~~~~~~---~~l~LVmE 830 (1044)
++.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... -+..++...... ...+++|+
T Consensus 2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 2 IEPVDSGGTDNATFRL---GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred ceeccCCCcccceEEc---CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 3567777776 48875 345778864432 1234688899999887531 233444443332 23588999
Q ss_pred ecCCCcHH
Q 045028 831 FLPRGSLY 838 (1044)
Q Consensus 831 y~~GGsL~ 838 (1044)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00077 Score=75.70 Aligned_cols=80 Identities=13% Similarity=0.013 Sum_probs=58.2
Q ss_pred CeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC---CCeeEEEeeeec---CCCceE
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH---PNVVLFMGAVTR---PPNLSI 827 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH---PNIVkl~~~~~~---~~~l~L 827 (1044)
...-.+.||.|..+.||+....+..+.+|..+.. .....+..|...|+.|.. -.+.++++++.. .+..+|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3445678999999999998776666778874321 122468889999988853 356777876654 366899
Q ss_pred EEEecCCCcH
Q 045028 828 VAEFLPRGSL 837 (1044)
Q Consensus 828 VmEy~~GGsL 837 (1044)
|||+++|.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00076 Score=71.97 Aligned_cols=129 Identities=21% Similarity=0.245 Sum_probs=91.7
Q ss_pred eEecccCcEEEEEEEECCcEEEEEEeeccC--------------cchhhHHHHHHHHHHHHhCC------CCCeeEEEee
Q 045028 759 ERIGLGSYGEVYRGDWHGTEVAVKRFLDQD--------------FFGESLEEFRSEVLIMKRVR------HPNVVLFMGA 818 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~g~~VAVK~l~~~~--------------~~~~~~~~~~~EI~ILk~Lr------HPNIVkl~~~ 818 (1044)
..||+|+.-.||..-. +...+||++.... .......+..+|+.-+..+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 4689999999997543 3446788776554 01112455667777666665 7889999999
Q ss_pred eecCCCceEEEEecCC------CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC---
Q 045028 819 VTRPPNLSIVAEFLPR------GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN--- 889 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~G------GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d--- 889 (1044)
.+++-...+|+|.+.. .+|.++++. ..++. .....+. .-..||-+.+ |+.+||+|.||++...
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEecCCC
Confidence 9999999999998642 378888865 34555 4443444 4456777777 9999999999999643
Q ss_pred C-eEEEEe
Q 045028 890 W-VVKVCD 896 (1044)
Q Consensus 890 g-~VKLiD 896 (1044)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 2 688888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00035 Score=84.10 Aligned_cols=140 Identities=19% Similarity=0.143 Sum_probs=85.3
Q ss_pred eEecccCcEEEEEEEE-CCcEEEEEEeeccCcch-----------------------------hhHHH------HHHHHH
Q 045028 759 ERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFG-----------------------------ESLEE------FRSEVL 802 (1044)
Q Consensus 759 r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~-----------------------------~~~~~------~~~EI~ 802 (1044)
+.||.-+.|+||+++. +|+.||||+-+..-... +-.+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999987 68889999753221000 00011 222332
Q ss_pred H----HHhCCCCC------eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCC
Q 045028 803 I----MKRVRHPN------VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872 (1044)
Q Consensus 803 I----Lk~LrHPN------IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~ 872 (1044)
- .+.+.|-+ |.++|-.+ ...-.|+|||++|..+.++-.-....++...+...+.+... ..|=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC-
Confidence 2 22334444 33333222 23578999999999766553222244555544443333332 2223457
Q ss_pred cEEEecCCCCcEEEcC----CCeEEEEecccccccc
Q 045028 873 VIVHRDLKSPNLLVDK----NWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 873 ~IVHRDIKPeNILLd~----dg~VKLiDFGLA~~~~ 904 (1044)
++|+|=.|.||+++. ++.+.+.|||+.....
T Consensus 322 -ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 -FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999986543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00093 Score=71.23 Aligned_cols=73 Identities=16% Similarity=0.180 Sum_probs=47.7
Q ss_pred EeEecccCcEEEEEEEEC---CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC-CeeEEEeeeecCCCceEEEEecC
Q 045028 758 GERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP-NVVLFMGAVTRPPNLSIVAEFLP 833 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~---g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP-NIVkl~~~~~~~~~l~LVmEy~~ 833 (1044)
++.|..|-...+|+.... ++.|++|+..... ...-...+|+.+++.+... -..+++..+. -.++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence 467888888899998765 5789999764321 1112235688888888533 3344554432 248999999
Q ss_pred CCcH
Q 045028 834 RGSL 837 (1044)
Q Consensus 834 GGsL 837 (1044)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00049 Score=74.83 Aligned_cols=135 Identities=16% Similarity=0.125 Sum_probs=77.8
Q ss_pred EecccCcEEEEEEEECCcEEEEEEeeccCcchhhH-HHHHHHHHHHHhCCCCCe-eEEEeeeecCCCceEEEEecCCCcH
Q 045028 760 RIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESL-EEFRSEVLIMKRVRHPNV-VLFMGAVTRPPNLSIVAEFLPRGSL 837 (1044)
Q Consensus 760 ~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~-~~~~~EI~ILk~LrHPNI-Vkl~~~~~~~~~l~LVmEy~~GGsL 837 (1044)
.+..|-...+|+...+++.+++|...... ... -...+|..+++.+..-.+ .+++.... -++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 35567778899988888889998754321 111 124678888888864333 33443322 3799999998765
Q ss_pred HHH--------------h---cCC---CCCCcHH-HHHHHHHHH---------HHHHHHHHhC------CCcEEEecCCC
Q 045028 838 YRL--------------L---HRP---NNQLDER-RRLRMALDA---------ARGMNYLHNC------TPVIVHRDLKS 881 (1044)
Q Consensus 838 ~dl--------------L---kr~---~~~Lse~-~il~Ia~QI---------a~AL~yLHs~------G~~IVHRDIKP 881 (1044)
... + +.. ...++.. .+..+..++ ...+..+-.. ...++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 321 1 110 1112211 111221111 1112222111 12399999999
Q ss_pred CcEEEcCCCeEEEEecccccc
Q 045028 882 PNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~ 902 (1044)
.||+++.++ +.|+||..+..
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC-CEEEeccccCc
Confidence 999999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00091 Score=74.85 Aligned_cols=144 Identities=19% Similarity=0.167 Sum_probs=84.2
Q ss_pred CeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC--eeEEEee------eecCCCc
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--VVLFMGA------VTRPPNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN--IVkl~~~------~~~~~~l 825 (1044)
....++.++.|....+|+.+.++..+++|+..... ....+..|+.++..|.... +.+++.. ....+..
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 34556778888888999988767788899765421 1234556777777764222 3344332 1223567
Q ss_pred eEEEEecCCCcHH-----------HH---hcCCCCC----------Cc-HHHHH------------HHHHHHHHHHHHHH
Q 045028 826 SIVAEFLPRGSLY-----------RL---LHRPNNQ----------LD-ERRRL------------RMALDAARGMNYLH 868 (1044)
Q Consensus 826 ~LVmEy~~GGsL~-----------dl---Lkr~~~~----------Ls-e~~il------------~Ia~QIa~AL~yLH 868 (1044)
+++|+|++|..+. .. +++.... .. +.... .....+...+.++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999886431 00 1110000 00 00000 00112233455553
Q ss_pred h-----CCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 869 N-----CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 869 s-----~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
. ....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 11239999999999999998877999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0024 Score=81.59 Aligned_cols=233 Identities=16% Similarity=0.162 Sum_probs=155.7
Q ss_pred ecccCcEEEEEEEECC------cEEEEEEee-ccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC----CceEEE
Q 045028 761 IGLGSYGEVYRGDWHG------TEVAVKRFL-DQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP----NLSIVA 829 (1044)
Q Consensus 761 LGkG~FGtVykak~~g------~~VAVK~l~-~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~----~l~LVm 829 (1044)
|..-++|++++.++.- +++-++.-. .............-|+..+..+.|+|++.++.|.-... ...+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 6677888888887632 222222110 11111234455666778888899999999998865433 244556
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCC---cEEEcCCCeEEEE--ecccccccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSP---NLLVDKNWVVKVC--DFGLSRMKH 904 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPe---NILLd~dg~VKLi--DFGLA~~~~ 904 (1044)
+++.+.++..+++. -...+....+.+..++.+||.|+|... ..|.-+..+ +.-++..+.+.+. ||+......
T Consensus 266 ~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 266 EICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred hhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCC
Confidence 88888888888876 466788888899999999999999886 555444444 3444556677777 898887654
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCc--hhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDE--KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~--kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
..... .+..-+..|.++|......+.. ..|+|.+|.++..+..|..+-.-.... ....+.....+.
T Consensus 343 d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~-----------~~~l~~~~~~~~ 410 (1351)
T KOG1035|consen 343 DNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP-----------VSLLDVLSTSEL 410 (1351)
T ss_pred Ccccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch-----------hhhhccccchhh
Confidence 43322 2233455677888887766654 479999999999998875542111000 011112222377
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.+.+.+|+..+.++|+.+.+++.+..
T Consensus 411 ~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhhhcchhhhhccchhhhhhchh
Confidence 88999999999999999999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=4.4e-05 Score=97.99 Aligned_cols=177 Identities=13% Similarity=0.060 Sum_probs=127.8
Q ss_pred EEEEEeeccCcc---hhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CCCceEEEEecCCCcHHHHhcCCCC---CCcH
Q 045028 779 VAVKRFLDQDFF---GESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PPNLSIVAEFLPRGSLYRLLHRPNN---QLDE 850 (1044)
Q Consensus 779 VAVK~l~~~~~~---~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~~l~LVmEy~~GGsL~dlLkr~~~---~Lse 850 (1044)
+.+|+.+...+. +...+.+..|...++...|+++...+.-... ....+++++|+.+|.+++.|-+.-. .+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 556665543321 2223334445556666789988876654432 3458899999999999999876422 2333
Q ss_pred HHHHHHHHHHHHHHHHHHhC---CCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccC
Q 045028 851 RRRLRMALDAARGMNYLHNC---TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927 (1044)
Q Consensus 851 ~~il~Ia~QIa~AL~yLHs~---G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g 927 (1044)
.-+.....+.+....-+|.. |...+|+++|+-|.+|..+.++|+.++|+.+.........+...+++.|+.+++.+.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence 33333334436666665543 234899999999999999999999999999966655555667789999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 045028 928 EPSDEKCDVYSFGVILWELCTMQQPWGG 955 (1044)
Q Consensus 928 ~~~s~kSDIWSLG~LLyELLTGk~PF~~ 955 (1044)
-.++.++|+|..|+.+|....|..+|..
T Consensus 1415 ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1415 IKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred HhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 9999999999999999999988877754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0054 Score=71.98 Aligned_cols=77 Identities=22% Similarity=0.114 Sum_probs=54.1
Q ss_pred EeEecccCcEEEEEEEECC--cEEEEEEeecc-----CcchhhHHHHHHHHHHHHhCC---CCCeeEEEeeeecCCCceE
Q 045028 758 GERIGLGSYGEVYRGDWHG--TEVAVKRFLDQ-----DFFGESLEEFRSEVLIMKRVR---HPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g--~~VAVK~l~~~-----~~~~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~~~~~l~L 827 (1044)
.+.||.|.+..||++...+ +.++||.-... ....-..++...|.+.|+.+. ..++.+++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999998854 38999974311 111234567778888888763 2456677766 4466899
Q ss_pred EEEecCCCc
Q 045028 828 VAEFLPRGS 836 (1044)
Q Consensus 828 VmEy~~GGs 836 (1044)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0015 Score=72.30 Aligned_cols=139 Identities=20% Similarity=0.130 Sum_probs=83.8
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC--CeeEEEee------eecCCCceEEE
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP--NVVLFMGA------VTRPPNLSIVA 829 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP--NIVkl~~~------~~~~~~l~LVm 829 (1044)
++.|..|....+|+....+..+++|+... .....+..|+.++..+.+- .+.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 56788888889999887777899998654 1234566788888777432 24444432 23345678999
Q ss_pred EecCCCcHHH----H-------h---cC--CC--C------CCcHHHH--H--------HHHHHHHHHHHHHHh-----C
Q 045028 830 EFLPRGSLYR----L-------L---HR--PN--N------QLDERRR--L--------RMALDAARGMNYLHN-----C 870 (1044)
Q Consensus 830 Ey~~GGsL~d----l-------L---kr--~~--~------~Lse~~i--l--------~Ia~QIa~AL~yLHs-----~ 870 (1044)
+|++|..+.. . + +. .. . ...+... . .....+..++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876422 0 0 10 00 0 0010000 0 011112233444443 1
Q ss_pred CCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 871 G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 1239999999999999998778999999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0057 Score=68.56 Aligned_cols=139 Identities=16% Similarity=0.110 Sum_probs=75.9
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC--CeeEEEe------eeecCCCceEEE
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP--NVVLFMG------AVTRPPNLSIVA 829 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP--NIVkl~~------~~~~~~~l~LVm 829 (1044)
.+.|+.|....+|+.+..+..+++|++. ... ...+..|+.+++.|... .+.+++. +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4567778888999988777789999865 111 23344455555555211 1233332 122345678999
Q ss_pred EecCCCcHH-----------HHh---cCCCC----------CCcH-HHHH------------HHHHH-HHHHHHHHHh--
Q 045028 830 EFLPRGSLY-----------RLL---HRPNN----------QLDE-RRRL------------RMALD-AARGMNYLHN-- 869 (1044)
Q Consensus 830 Ey~~GGsL~-----------dlL---kr~~~----------~Lse-~~il------------~Ia~Q-Ia~AL~yLHs-- 869 (1044)
+|++|..+. ..+ +.... .+.+ .... ..+.+ +...+..+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999987431 111 11000 0001 0100 01111 1112222221
Q ss_pred ---CCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 870 ---CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 870 ---~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
.-..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11239999999999999976666899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0063 Score=67.65 Aligned_cols=74 Identities=20% Similarity=0.297 Sum_probs=46.5
Q ss_pred EeEecccCcEEEEEEEEC--------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCe-eEEEeeeecCCCceEE
Q 045028 758 GERIGLGSYGEVYRGDWH--------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV-VLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~--------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNI-Vkl~~~~~~~~~l~LV 828 (1044)
++.|..|--..||+.... ++.+++|+..... .......+|..+++.+....+ .+++.++. -.+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC----CCch
Confidence 345666666788988764 4789999865432 122346678888888753233 34555543 2468
Q ss_pred EEecCCCcHH
Q 045028 829 AEFLPRGSLY 838 (1044)
Q Consensus 829 mEy~~GGsL~ 838 (1044)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.014 Score=66.58 Aligned_cols=142 Identities=20% Similarity=0.197 Sum_probs=87.1
Q ss_pred eeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC--eeEEEeeeecCC--CceEEEE
Q 045028 755 ITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--VVLFMGAVTRPP--NLSIVAE 830 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN--IVkl~~~~~~~~--~l~LVmE 830 (1044)
..+++..-.|.--.+|....+++.+.+. ...............+|..+++.+.--. +...++++..+. ..|.||+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred CceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3444444333334456655568888888 3322223345566778888888775322 223444544443 6799999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHH-HHHHHHHHHHHhCC--------------------------------------
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMA-LDAARGMNYLHNCT-------------------------------------- 871 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia-~QIa~AL~yLHs~G-------------------------------------- 871 (1044)
|+.|..+.+.+... +.. .+++ ..+...|.-||+-.
T Consensus 106 ~veGe~~~~~~~~~----~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 106 WVEGEVVWSALPPE----SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred EecceeccCcCCcc----cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 99986443333211 001 1222 25556666666321
Q ss_pred ------------------CcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 872 ------------------PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 872 ------------------~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..++|+|+.+.||+|+.++.+-|+||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 24999999999999999999999999998653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.016 Score=65.23 Aligned_cols=76 Identities=25% Similarity=0.203 Sum_probs=49.7
Q ss_pred eeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC---CCCeeEEEeeeecCCCceEEEEe
Q 045028 755 ITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR---HPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
.+-.+.|+-|....+|+.+.+++.+.||+-.. .....+..|..-|+.|. --.+.+++.+....+.-+|||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 45567899999999999998899999997552 22245778888888873 34577888888877788999999
Q ss_pred cCCC
Q 045028 832 LPRG 835 (1044)
Q Consensus 832 ~~GG 835 (1044)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF04473 DUF553: Transglutaminase-like domain; InterPro: IPR007562 This entry represents a transglutaminase-like domain found in a family of uncharacterised archaeal proteins that had previously been called DUF553 and UPF0252 | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0046 Score=63.50 Aligned_cols=107 Identities=13% Similarity=0.092 Sum_probs=68.0
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCcchh---hhhHHHHHHHHHHhhCC---ceeecc--cccceecchhHHHHHHHHHHh
Q 045028 243 FVGIDLVRNLAVLVADYMGGPVGDPENM---SRASRSLSYSLKATLGS---MVLPLG--SLTIGLARHRALLFKVLADIV 314 (1044)
Q Consensus 243 ~~~~~~v~~la~~V~~~mgg~~~~~~~~---~~~~~~~~~~l~~~~~~---~v~plG--~l~~g~c~~~Allfk~lad~~ 314 (1044)
-+..+-+..|...+.+.|.=....+... .--|...........+. .--|.. ..++|+|+.||+|...|--..
T Consensus 13 ~~~~e~~~nIl~W~~~NI~Yd~~Ka~~~~~~i~~~~~~~~~~~~~~~~~~~i~tp~etl~~k~GiC~DYA~Lta~lLl~~ 92 (153)
T PF04473_consen 13 NDIKETIWNILEWEDENIEYDYEKAESPEPFIYIWSTYRTEVYEDYKNSTYIQTPYETLKYKKGICGDYAILTAALLLNM 92 (153)
T ss_pred CCHHHHHHHHHHHHHhccccchhhccCCCceeEeeeccceeeeccccccccccCHHHHHHcCCeeeHHHHHHHHHHHHHC
Confidence 3456678888888888765543332211 11121111110000000 112332 457899999999999999999
Q ss_pred CCceEEeecccccCCCCceeEEEEeCCCceEEEecc
Q 045028 315 GIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLM 350 (1044)
Q Consensus 315 gl~~~lv~G~~~~~~~~~~~~~v~~~~~~~y~vDl~ 350 (1044)
|+.-.-|-+..+.+..+++|+.|++ ||++|++|--
T Consensus 93 g~~~~yi~~~~~~~~~~Haa~aV~i-ng~~yvlDq~ 127 (153)
T PF04473_consen 93 GYSPVYILHIEFDNDPGHAAVAVKI-NGKYYVLDQH 127 (153)
T ss_pred CCCceEEEEEecCCCCCeEEEEEEE-CCEEEEEeCC
Confidence 9877555566666666999999999 9999999954
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.014 Score=67.38 Aligned_cols=142 Identities=22% Similarity=0.257 Sum_probs=94.6
Q ss_pred EEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcc--h---------------------hh-HHHHHHHHHHHHhCCCCC
Q 045028 757 LGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFF--G---------------------ES-LEEFRSEVLIMKRVRHPN 811 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~--~---------------------~~-~~~~~~EI~ILk~LrHPN 811 (1044)
|-..|..|.-..||.+.. +|..+|||+++..-+. . .. .-+...|+.-|++|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445677888889999866 7888999987532110 0 11 123566888888886544
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHH-HhCCCcEEEecCCCCcEEEcCCC
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL-HNCTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yL-Hs~G~~IVHRDIKPeNILLd~dg 890 (1044)
|...--+.- ....|||+|+.+. =+-.=.-..-.++...+..+-.+++.-+.-| |.++ +||.||.--|+|+. +|
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrd-gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRD-GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCCCceee--ecceEeeeeccCC-CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-CC
Confidence 332111111 2468999999533 2221111235677777888888888888777 5677 99999999999985 57
Q ss_pred eEEEEecccccccc
Q 045028 891 VVKVCDFGLSRMKH 904 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~ 904 (1044)
.+.|||.+-+....
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 99999998776443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.046 Score=64.50 Aligned_cols=76 Identities=14% Similarity=-0.004 Sum_probs=53.0
Q ss_pred EEeEecccCcEEEEEEEECCcEEEEEEeeccCc-----chhhHHHHHHHHHHHHhCC---CCCeeEEEeeeecCCCceEE
Q 045028 757 LGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDF-----FGESLEEFRSEVLIMKRVR---HPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~-----~~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~~~~~l~LV 828 (1044)
..+.||.|....||+....++.++||.-..... ..-...+-..|...|+.+. ..++.+++.+.. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467889999999999988777899997542111 1113445556677777664 246777887765 457889
Q ss_pred EEecCC
Q 045028 829 AEFLPR 834 (1044)
Q Consensus 829 mEy~~G 834 (1044)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.045 Score=60.80 Aligned_cols=27 Identities=30% Similarity=0.409 Sum_probs=24.5
Q ss_pred EEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 874 IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 999999999999988 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.02 Score=67.25 Aligned_cols=75 Identities=25% Similarity=0.138 Sum_probs=52.8
Q ss_pred EeEecccCcEEEEEEEEC--CcEEEEEEeec----cCcchhhHHHHHHHHHHHHhCC--CCC-eeEEEeeeecCCCceEE
Q 045028 758 GERIGLGSYGEVYRGDWH--GTEVAVKRFLD----QDFFGESLEEFRSEVLIMKRVR--HPN-VVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~--g~~VAVK~l~~----~~~~~~~~~~~~~EI~ILk~Lr--HPN-IVkl~~~~~~~~~l~LV 828 (1044)
.+.||.|.-.-||++.+. ++.++||.-.. ....+-..++...|.++|+... .|. +.++|. .++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 678999999999999874 66799996432 1222345677788888888774 454 445554 355677889
Q ss_pred EEecCC
Q 045028 829 AEFLPR 834 (1044)
Q Consensus 829 mEy~~G 834 (1044)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.004 Score=70.81 Aligned_cols=134 Identities=20% Similarity=0.155 Sum_probs=93.0
Q ss_pred eeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcc-------h----------h---hHHHHHHHHHHHHhCC-CCC-
Q 045028 755 ITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFF-------G----------E---SLEEFRSEVLIMKRVR-HPN- 811 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~-------~----------~---~~~~~~~EI~ILk~Lr-HPN- 811 (1044)
+.+++.||-|.-+-||.+-+ .|++.++|.-...... . + ..-...+|...|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56788999999999999877 5999999853211100 0 0 0112355777777774 333
Q ss_pred eeEEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe
Q 045028 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 812 IVkl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~ 891 (1044)
+.+.++ .+..++|||++.|-.|...-+- .+ .-.+...+..-+.-|..+| +||+|..-=||+|+.++.
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d---~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHV----ED---PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeec----CC---hHHHHHHHHHHHHHHHHcC--ceecccchheeEEecCCC
Confidence 333443 3567999999999877655322 12 2334555666677888999 999999999999999999
Q ss_pred EEEEeccccc
Q 045028 892 VKVCDFGLSR 901 (1044)
Q Consensus 892 VKLiDFGLA~ 901 (1044)
+++|||--..
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.04 Score=61.92 Aligned_cols=29 Identities=21% Similarity=0.279 Sum_probs=26.8
Q ss_pred EEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 874 IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
++|+|+.+.|||++.++.+.|+||..++.
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 99999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.06 Score=60.11 Aligned_cols=30 Identities=27% Similarity=0.509 Sum_probs=25.2
Q ss_pred cEEEecCCCCcEEEcCCCe-EEEEecccccc
Q 045028 873 VIVHRDLKSPNLLVDKNWV-VKVCDFGLSRM 902 (1044)
Q Consensus 873 ~IVHRDIKPeNILLd~dg~-VKLiDFGLA~~ 902 (1044)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.071 Score=62.00 Aligned_cols=74 Identities=20% Similarity=0.145 Sum_probs=49.7
Q ss_pred EecccCcEEEEEEEECC--cEEEEEEeecc-----CcchhhHHHHHHHHHHHHhCC--CCC-eeEEEeeeecCCCceEEE
Q 045028 760 RIGLGSYGEVYRGDWHG--TEVAVKRFLDQ-----DFFGESLEEFRSEVLIMKRVR--HPN-VVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 760 ~LGkG~FGtVykak~~g--~~VAVK~l~~~-----~~~~~~~~~~~~EI~ILk~Lr--HPN-IVkl~~~~~~~~~l~LVm 829 (1044)
.||.|....||++...+ +.++||.-... ...+-..++...|...|+... .|. +.++|. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57999999999998754 57999975321 112344566677888887764 453 444543 3556677999
Q ss_pred EecCCC
Q 045028 830 EFLPRG 835 (1044)
Q Consensus 830 Ey~~GG 835 (1044)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG1305 Transglutaminase-like enzymes, putative cysteine proteases [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.012 Score=64.66 Aligned_cols=50 Identities=34% Similarity=0.436 Sum_probs=42.4
Q ss_pred ceecchhHHHHHHHHHHhCCceEEeecccccCCC--------------CceeEEEEeCCC-ceEEEec
Q 045028 297 IGLARHRALLFKVLADIVGIPCRLVKGQQYTGCD--------------DVAMNFVRIDDG-REYIVDL 349 (1044)
Q Consensus 297 ~g~c~~~Allfk~lad~~gl~~~lv~G~~~~~~~--------------~~~~~~v~~~~~-~~y~vDl 349 (1044)
.|+|+|.|-||=.|+-..|||||+|.| |.... .++|..+.+ .| .|+-||-
T Consensus 194 ~G~C~d~a~l~val~Ra~GIpAR~V~G--y~~~~~~~~~~~~~~~~~~~Haw~ev~~-~~~gW~~~Dp 258 (319)
T COG1305 194 RGVCRDFAHLLVALLRAAGIPARYVSG--YLGAEVEPLSGRPLVRNDDAHAWAEVYL-PGRGWVPLDP 258 (319)
T ss_pred CcccccHHHHHHHHHHHcCCcceeeec--cccCCCCcccccccccCcccceeeeeec-CCCccEeecC
Confidence 899999999999999999999999999 54443 366999988 55 5888874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.09 Score=60.49 Aligned_cols=140 Identities=17% Similarity=0.241 Sum_probs=77.7
Q ss_pred CeeEEeEecccCcEEEEEEEEC------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCee-EEEeeeecCCCce
Q 045028 754 EITLGERIGLGSYGEVYRGDWH------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV-LFMGAVTRPPNLS 826 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIV-kl~~~~~~~~~l~ 826 (1044)
.+.+. .|-.|-.-.+|+.... ++.|.+|+..... ...+ ...+|..+++.+..-++- ++++.+.. .
T Consensus 38 ~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~----g 109 (344)
T PLN02236 38 ALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN----G 109 (344)
T ss_pred cEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECC----c
Confidence 34444 4544777789998652 3578888765432 1112 236688888888533333 45555532 2
Q ss_pred EEEEecCCCcHHHH-----------------hcCCC----C-CCcHHHHHHHHHHH-----------------HHHHHHH
Q 045028 827 IVAEFLPRGSLYRL-----------------LHRPN----N-QLDERRRLRMALDA-----------------ARGMNYL 867 (1044)
Q Consensus 827 LVmEy~~GGsL~dl-----------------Lkr~~----~-~Lse~~il~Ia~QI-----------------a~AL~yL 867 (1044)
.|.+|++|.+|... +++.. . ......+..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 68999987765311 11100 1 11112222232211 1111112
Q ss_pred ----Hh--CCCcEEEecCCCCcEEEcC-CCeEEEEeccccc
Q 045028 868 ----HN--CTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSR 901 (1044)
Q Consensus 868 ----Hs--~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~ 901 (1044)
.. ....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11 1123999999999999986 4789999999875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.18 Score=57.64 Aligned_cols=142 Identities=15% Similarity=0.199 Sum_probs=77.5
Q ss_pred CCeeEEeEecccCcEEEEEEEECC-----cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCe-eEEEeeeecCCCce
Q 045028 753 EEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV-VLFMGAVTRPPNLS 826 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~g-----~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNI-Vkl~~~~~~~~~l~ 826 (1044)
+.+++....| |=--.+|+....+ ..|.+|+..... . ..-...+|..+++.+..-++ .++++++. .+
T Consensus 15 ~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 15 SDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred CceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3455555444 6667789886543 378888764321 1 11223568888888854333 34555542 22
Q ss_pred EEEEecCCCcHHH--------------Hh---cCCC----CCC-cHHHHHHHHHHH------------------------
Q 045028 827 IVAEFLPRGSLYR--------------LL---HRPN----NQL-DERRRLRMALDA------------------------ 860 (1044)
Q Consensus 827 LVmEy~~GGsL~d--------------lL---kr~~----~~L-se~~il~Ia~QI------------------------ 860 (1044)
+|.+|++|..|.. .+ +... ..+ ....+..+..++
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5889987775421 01 1100 111 112222222221
Q ss_pred -HHHHHHHH-hCC--CcEEEecCCCCcEEEcC-CCeEEEEecccccc
Q 045028 861 -ARGMNYLH-NCT--PVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRM 902 (1044)
Q Consensus 861 -a~AL~yLH-s~G--~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~ 902 (1044)
+..+..+. ..+ ..++|.|+.+.|||++. ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111111 111 23899999999999975 57899999998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.052 Score=65.03 Aligned_cols=155 Identities=19% Similarity=0.254 Sum_probs=94.7
Q ss_pred HHHHHHHHHHhCCCCCeeEEEeeeecC-CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcE
Q 045028 796 EFRSEVLIMKRVRHPNVVLFMGAVTRP-PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874 (1044)
Q Consensus 796 ~~~~EI~ILk~LrHPNIVkl~~~~~~~-~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~I 874 (1044)
.+.-...+++.+.|+|+..++++-... ....+|||++ +.+|++.+..+. +-... +. .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~~-------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------LL-------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------hc-------ccc--c
Confidence 455677889999999999999876543 3488899999 779999987632 11111 10 122 3
Q ss_pred EEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 045028 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWG 954 (1044)
Q Consensus 875 VHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~ 954 (1044)
.|-. .++++| -+.... .+ +.++++|||++|.++.++.-|..-|.
T Consensus 89 ~~~~------------~~~~td-~~~t~~-------~~----------------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 89 LHLN------------IIYITD-HFLTKY-------PS----------------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ceeh------------hhhccc-cccccC-------CC----------------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2221 123333 111000 00 11248999999999999999877776
Q ss_pred CCChHHHHhhhccc---ccc-------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 045028 955 GMNPMQVVGAVGFQ---HRR-------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005 (1044)
Q Consensus 955 ~~~~~eil~~I~~~---~~~-------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe 1005 (1044)
.....+....+... ... ..+-..++..+.++..+|+...|..||...++.+
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 65544443332110 000 0122346777889999999999999987666554
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.11 Score=54.94 Aligned_cols=29 Identities=38% Similarity=0.606 Sum_probs=21.0
Q ss_pred cEEEecCCCCcEEE-cCCCeEEEEeccccc
Q 045028 873 VIVHRDLKSPNLLV-DKNWVVKVCDFGLSR 901 (1044)
Q Consensus 873 ~IVHRDIKPeNILL-d~dg~VKLiDFGLA~ 901 (1044)
.+.|.|+.+.|||+ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 39999999999999 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.14 Score=56.36 Aligned_cols=80 Identities=24% Similarity=0.203 Sum_probs=59.2
Q ss_pred CeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC---CCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR---HPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+++-.+.+.-|.--..|+..+...++.||+=. .+....|..|+.-|..|. --.+.+++.+....++.|+|||
T Consensus 17 ~i~er~~v~gG~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred hhhcccccCCccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 34445566677777788888888899999622 234566788887777664 3567788999999999999999
Q ss_pred ecCCCcHH
Q 045028 831 FLPRGSLY 838 (1044)
Q Consensus 831 y~~GGsL~ 838 (1044)
|++-+.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99876443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.27 Score=56.59 Aligned_cols=136 Identities=19% Similarity=0.253 Sum_probs=78.4
Q ss_pred ecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC---CC---eeEE----EeeeecCCCceEEEE
Q 045028 761 IGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH---PN---VVLF----MGAVTRPPNLSIVAE 830 (1044)
Q Consensus 761 LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH---PN---IVkl----~~~~~~~~~l~LVmE 830 (1044)
|.. .-..||+....+..+++|+.... . ...++..|+..+..|.- += +... +..+....+.+-+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-W---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-C---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 44568888887777799987654 2 23456677888877732 11 1111 122222237788999
Q ss_pred ecCCCcHHH-H----h----------cC--CC---------CCCcHH----H---------HHHHHHHHHHHHHHHHhCC
Q 045028 831 FLPRGSLYR-L----L----------HR--PN---------NQLDER----R---------RLRMALDAARGMNYLHNCT 871 (1044)
Q Consensus 831 y~~GGsL~d-l----L----------kr--~~---------~~Lse~----~---------il~Ia~QIa~AL~yLHs~G 871 (1044)
|++|..+.. . + +. .+ ....+. . -.....++...+..+...-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999987772 1 0 00 00 011111 0 0012233333444443221
Q ss_pred --------CcEEEecCCCCcEEEcCCCe-EEEEeccccc
Q 045028 872 --------PVIVHRDLKSPNLLVDKNWV-VKVCDFGLSR 901 (1044)
Q Consensus 872 --------~~IVHRDIKPeNILLd~dg~-VKLiDFGLA~ 901 (1044)
..|||+|+.|.|||++.+.. +.++|||.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12899999999999998875 8999999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1044 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-98 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-97 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-42 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-40 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-40 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-40 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-40 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-39 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-39 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-39 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-39 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-39 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-39 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-39 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-39 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-38 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-38 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-37 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-37 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-37 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-37 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-37 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-37 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-37 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-37 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-37 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-37 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-37 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-37 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-37 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-37 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-37 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-37 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-37 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-36 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-36 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-33 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-33 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-32 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-32 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-32 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-32 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-32 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-32 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-32 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-32 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-32 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-32 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-32 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-32 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-31 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-31 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-31 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-31 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-31 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-31 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-31 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-31 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-30 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-30 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-30 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-30 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-30 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-30 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-30 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-30 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-30 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-30 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-30 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-30 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-30 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-30 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-30 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-30 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-29 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-29 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-29 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-29 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-29 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-29 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-29 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-29 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-29 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-29 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-29 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-29 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-29 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-29 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-29 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-29 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-29 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-29 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-29 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-29 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-29 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-29 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-29 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-28 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-28 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-28 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-28 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-28 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-28 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-28 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-28 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-28 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-28 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-28 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-28 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-28 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-28 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-28 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-28 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-28 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-28 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-28 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-28 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-28 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-28 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-28 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-28 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-28 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-28 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-27 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-27 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-27 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-27 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-27 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-27 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-27 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-27 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-27 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-27 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-27 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-27 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-27 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-27 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-27 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-26 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-26 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-26 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-26 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-26 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-26 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-26 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-26 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-26 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-26 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-25 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-25 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-24 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-24 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-24 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-24 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-24 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-24 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-24 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-24 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-24 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-24 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-24 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-24 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-23 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-23 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-23 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-23 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-23 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-23 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-23 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-23 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-23 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-23 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-23 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-22 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-21 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-21 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-21 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-21 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-21 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-21 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-20 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-20 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-19 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 490 bits (1264), Expect = e-166
Identities = 179/298 (60%), Positives = 219/298 (73%), Gaps = 2/298 (0%)
Query: 721 NSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVA 780
+ + ++ D + +IPW ++ + E+IG GS+G V+R +WHG++VA
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVA 64
Query: 781 VKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRL 840
VK ++QDF E + EF EV IMKR+RHPN+VLFMGAVT+PPNLSIV E+L RGSLYRL
Sbjct: 65 VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL 124
Query: 841 LHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898
LH+ QLDERRRL MA D A+GMNYLHN P IVHR+LKSPNLLVDK + VKVCDFG
Sbjct: 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184
Query: 899 LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP 958
LSR+K +TFLSS+S AGT EWMAPEVLR+EPS+EK DVYSFGVILWEL T+QQPWG +NP
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244
Query: 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016
QVV AVGF+ +RL+IP NL+P VA II CW +P RP+F IM L+PL K
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 445 bits (1148), Expect = e-150
Identities = 75/270 (27%), Positives = 138/270 (51%), Gaps = 11/270 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
I ++++ ++ GE+++G W G ++ VK +D+ +F E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 809 HPNVVLFMGAVTRPP--NLSIVAEFLPRGSLYRLLHRPNN-QLDERRRLRMALDAARGMN 865
HPNV+ +GA PP + +++ ++P GSLY +LH N +D+ + ++ ALD ARGM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
+LH P+I L S ++++D++ ++ + + W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEAL 180
Query: 926 RNEPSD---EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982
+ +P D D++SF V+LWEL T + P+ ++ M++ V + R IP + P V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ +++ C DP RP F I+ L+ +Q
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 444 bits (1145), Expect = e-149
Identities = 95/316 (30%), Positives = 154/316 (48%), Gaps = 20/316 (6%)
Query: 719 GANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTE 778
G +S RS +S++ + E +IP+E++ +GE IG G +G+VY G WHG E
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQ--EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-E 57
Query: 779 VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY 838
VA++ + + L+ F+ EV+ ++ RH NVVLFMGA PP+L+I+ +LY
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 839 RLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898
++ LD + ++A + +GM YLH I+H+DLKS N+ D N V + DFG
Sbjct: 118 SVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFG 174
Query: 899 LSRMKHNTFLSSRST-----AGTAEWMAPEVLRN---------EPSDEKCDVYSFGVILW 944
L + R G +APE++R P + DV++ G I +
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 945 ELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
EL + P+ ++ +G + + ++DI+ CW + + RPTFT++M
Sbjct: 235 ELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294
Query: 1005 AALKPLQKPITSSQVP 1020
L+ L K P
Sbjct: 295 DMLEKLPKRNRRLSHP 310
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 442 bits (1138), Expect = e-148
Identities = 103/273 (37%), Positives = 149/273 (54%), Gaps = 15/273 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFL--DQDFFGESLEEFRSEVLIMKR 806
EI + E+TL E IG+G +G+VYR W G EVAVK + +++E R E +
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
++HPN++ G + PNL +V EF G L R+L ++ + A+ ARGMNY
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNY 120
Query: 867 LHNCTPV-IVHRDLKSPNLLVDK--------NWVVKVCDFGLSRMKHNTFLSSRSTAGTA 917
LH+ V I+HRDLKS N+L+ + N ++K+ DFGL+R H T + S AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977
WMAPEV+R + DV+S+GV+LWEL T + P+ G++ + V V L IP
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
A ++ CW DP RP+FT I+ L +
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 437 bits (1127), Expect = e-146
Identities = 101/279 (36%), Positives = 160/279 (57%), Gaps = 13/279 (4%)
Query: 743 DDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVL 802
D + EIP +IT+G+RIG GS+G VY+G WHG +VAVK + L+ F++EV
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR 862
++++ RH N++LFMG T P L+IV ++ SLY LH + + ++ + +A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWM 920
GM+YLH + I+HRDLKS N+ + ++ VK+ DFGL+ K S + G+ WM
Sbjct: 132 GMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 921 APEVLRNE---PSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLD--- 973
APEV+R + P + DVY+FG++L+EL T Q P+ +N Q++ VG D
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ N + ++ +C + RP+F I+A ++ L +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 424 bits (1092), Expect = e-141
Identities = 93/278 (33%), Positives = 142/278 (51%), Gaps = 21/278 (7%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGES-----LEEFRSEV 801
+ EI ++IG G +G V++G + VA+K + D GE+ +EF+ EV
Sbjct: 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
IM + HPN+V G + PP +V EF+P G LY L + + +LR+ LD A
Sbjct: 75 FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDK-----NWVVKVCDFGLSRMKHNTFLSSRSTAGT 916
G+ Y+ N P IVHRDL+SPN+ + KV DFGLS+ ++ G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGN 189
Query: 917 AEWMAPEVL--RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP--MQVVGAVGFQHRRL 972
+WMAPE + E EK D YSF +IL+ + T + P+ + ++ + + + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
IP++ P + ++I CW DPK RP F+ I+ L L
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 421 bits (1085), Expect = e-140
Identities = 90/285 (31%), Positives = 142/285 (49%), Gaps = 14/285 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
I ++EI + E +G G++G V + W +VA+K+ + + F E+ + RV
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE----RKAFIVELRQLSRVN 59
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH--RPNNQLDERRRLRMALDAARGMNY 866
HPN+V GA P + +V E+ GSLY +LH P + L ++G+ Y
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 867 LHNCTPV-IVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV 924
LH+ P ++HRDLK PNLL+ V+K+CDFG + ++ G+A WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN---KGSAAWMAPEV 174
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIPDNLDPAVA 983
EKCDV+S+G+ILWE+ T ++P+ + P + R + NL +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVSS 1028
++ +CW DP RP+ EI+ + L + + P P S
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-139
Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 17/293 (5%)
Query: 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ ++ GE +G G +G+ + T + F E+ F EV +M
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVM 61
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGM 864
+ + HPNV+ F+G + + L+ + E++ G+L ++ ++Q +R+ A D A GM
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--------------MKHNTFLSS 910
YLH+ I+HRDL S N LV +N V V DFGL+R +K
Sbjct: 122 AYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QH 969
+ G WMAPE++ DEK DV+SFG++L E+ P + +
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRP 1022
P N P+ I +C DP+ RP+F ++ L+ L+ + P
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-126
Identities = 89/331 (26%), Positives = 141/331 (42%), Gaps = 45/331 (13%)
Query: 722 SEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAV 781
GE + D + SS S G + ++I + ++IG G YGEV+ G W G +VAV
Sbjct: 6 PPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAV 65
Query: 782 KRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP----PNLSIVAEFLPRGSL 837
K F + E+ +E+ +RH N++ F+ A + L ++ ++ GSL
Sbjct: 66 KVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL 122
Query: 838 YRLLHRPNNQLDERRRLRMALDAARGMNYLH------NCTPVIVHRDLKSPNLLVDKNWV 891
Y L LD + L++A + G+ +LH P I HRDLKS N+LV KN
Sbjct: 123 YDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180
Query: 892 VKVCDFGLSRM----KHNTFLSSRSTAGTAEWMAPEVL------RNEPSDEKCDVYSFGV 941
+ D GL+ + + + GT +M PEVL + S D+YSFG+
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240
Query: 942 ILWELCT----------MQQPWGGMNPMQ-----VVGAVGFQHRRLDIP-----DNLDPA 981
ILWE+ Q P+ + P + V + R P D
Sbjct: 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ 300
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ ++ +CW +P R T + L + +
Sbjct: 301 MGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-119
Identities = 94/332 (28%), Positives = 146/332 (43%), Gaps = 45/332 (13%)
Query: 721 NSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVA 780
SEG + D +S S G + I L E IG G +GEV+RG W G EVA
Sbjct: 10 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVA 69
Query: 781 VKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PPNLSIVAEFLPRGS 836
VK F ++ E +E+ +RH N++ F+ A + L +V+++ GS
Sbjct: 70 VKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS 126
Query: 837 LYRLLHRPNNQLDERRRLRMALDAARGMNYLH------NCTPVIVHRDLKSPNLLVDKNW 890
L+ L+R + +++AL A G+ +LH P I HRDLKS N+LV KN
Sbjct: 127 LFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184
Query: 891 VVKVCDFGLSRMKHNT----FLSSRSTAGTAEWMAPEVLRNE------PSDEKCDVYSFG 940
+ D GL+ + ++ GT +MAPEVL + S ++ D+Y+ G
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
Query: 941 VILWELCT----------MQQPWGGMNPM-----QVVGAVGFQHRRLDIPDNL-----DP 980
++ WE+ Q P+ + P ++ V Q R +IP+
Sbjct: 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 304
Query: 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+A I+R+CW + R T I L L +
Sbjct: 305 VMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-119
Identities = 87/298 (29%), Positives = 134/298 (44%), Gaps = 45/298 (15%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+ITL E +G G YGEV+RG W G VAVK F +D E +E+ +RH N+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENI 64
Query: 813 VLFMGAVTR----PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+ F+ + L ++ + GSLY L LD LR+ L A G+ +LH
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLH 122
Query: 869 ------NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF----LSSRSTAGTAE 918
P I HRDLKS N+LV KN + D GL+ M + + + GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 919 WMAPEVLRNEP------SDEKCDVYSFGVILWELCT----------MQQPWGGMNP---- 958
+MAPEVL S ++ D+++FG++LWE+ + P+ + P
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 959 -MQVVGAVGFQHRRLDIPDNLD-----PAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ V +R +IP+ ++A ++++CW +P R T I L +
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-112
Identities = 75/319 (23%), Positives = 123/319 (38%), Gaps = 45/319 (14%)
Query: 734 NDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGES 793
+ S V + L E G +G V++ VAVK F QD +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQ 61
Query: 794 LEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN----LSIVAEFLPRGSLYRLLHRPNNQLD 849
+ EV + ++H N++ F+GA R + L ++ F +GSL L N +
Sbjct: 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVS 119
Query: 850 ERRRLRMALDAARGMNYLHN--------CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
+A ARG+ YLH P I HRD+KS N+L+ N + DFGL+
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 902 MKH--NTFLSSRSTAGTAEWMAPEVLRNEP-----SDEKCDVYSFGVILWELCTMQQPWG 954
+ + GT +MAPEVL + + D+Y+ G++LWEL +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 955 GMNP----------------MQVVGAVGFQHRRLDIPDNLDP-----AVADIIRKCWQTD 993
G + V + +R + D + + I +CW D
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299
Query: 994 PKMRPTFTEIMAALKPLQK 1012
+ R + + + +Q+
Sbjct: 300 AEARLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-106
Identities = 85/335 (25%), Positives = 128/335 (38%), Gaps = 60/335 (17%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLI 803
+E + + + L E IG G YG VY+G VAVK F + + F +E I
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNI 58
Query: 804 MK--RVRHPNVVLFMGAVTRPP-----NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRM 856
+ + H N+ F+ R +V E+ P GSL + L + D R+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRL 116
Query: 857 ALDAARGMNYLHN-------CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL- 908
A RG+ YLH P I HRDL S N+LV + + DFGLS L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 909 -------SSRSTAGTAEWMAPEVLRN-------EPSDEKCDVYSFGVILWEL---CTMQQ 951
++ S GT +MAPEVL E + ++ D+Y+ G+I WE+ CT
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 952 PWGGMNPMQV---------------VGAVGFQHRRLDIPDNLDP------AVADIIRKCW 990
P + Q+ V + +R P+ ++ + I CW
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 991 QTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPS 1025
D + R T + L ++ P
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-73
Identities = 87/275 (31%), Positives = 138/275 (50%), Gaps = 17/275 (6%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ + E++ LGE+IG G++GEV+ G T VAVK + + +F E I+
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARIL 166
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGM 864
K+ HPN+V +G T+ + IV E + G L +L + L+M DAA GM
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 865 NYLH--NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA--EWM 920
YL C +HRDL + N LV + V+K+ DFG+SR + + ++ +W
Sbjct: 227 EYLESKCC----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDN 977
APE L + DV+SFG++LWE ++ P+ ++ Q V G RL P+
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPCPEL 339
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
AV ++ +CW +P RP+F+ I L+ ++K
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 8e-73
Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 12/284 (4%)
Query: 729 DRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRG-DW-HGTEVAVKRFLD 786
+ ++ + IG GS+ VY+G D EVA D
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 787 QDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA----VTRPPNLSIVAEFLPRGSLYRLLH 842
+ + F+ E ++K ++HPN+V F + V + +V E + G+L L
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121
Query: 843 RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSR 901
R + + +G+ +LH TP I+HRDLK N+ + VK+ D GL+
Sbjct: 122 R-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV 961
+K +F +++ GT E+MAPE+ + DE DVY+FG+ + E+ T + P+
Sbjct: 181 LKRASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237
Query: 962 V-GAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ V + P V +II C + + R + +++
Sbjct: 238 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-72
Identities = 82/295 (27%), Positives = 141/295 (47%), Gaps = 21/295 (7%)
Query: 739 SDVGDDVAECEIP--WEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFG 791
S + +V + IP IG G +G VY G++ + A+K L +
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEM 63
Query: 792 ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-PNLSIVAEFLPRGSLYRLLHRPNNQLDE 850
+ +E F E L+M+ + HPNV+ +G + P ++ ++ G L + + P
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 851 RRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTF 907
+ + L ARGM YL VHRDL + N ++D+++ VKV DFGL+R + +
Sbjct: 124 KDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREY 179
Query: 908 LSSRSTAGTA---EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVG 963
S + +W A E L+ K DV+SFGV+LWEL T P+ ++P +
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
Query: 964 AVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018
+ Q RRL P+ ++ ++++CW+ DP +RPTF ++ ++ + +
Sbjct: 240 FLA-QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 9e-72
Identities = 88/272 (32%), Positives = 142/272 (52%), Gaps = 27/272 (9%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+ +E+ L + IG G +G+V GD+ G +VAVK + + + F +E +M ++R
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLR 72
Query: 809 HPNVVLFMGAVTR-PPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNY 866
H N+V +G + L IV E++ +GSL L R + L L+ +LD M Y
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 867 L--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA---EWMA 921
L +N VHRDL + N+LV ++ V KV DFGL++ + +W A
Sbjct: 133 LEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTA 182
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNL 978
PE LR + K DV+SFG++LWE+ + + P+ + VV V G+ ++D PD
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGC 239
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
PAV ++++ CW D MRP+F ++ L+ +
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 4e-71
Identities = 89/271 (32%), Positives = 142/271 (52%), Gaps = 17/271 (6%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
E+ EEITL + +G G +G V G W G +VAVK + + S +EF E M ++
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGS--MSEDEFFQEAQTMMKL 60
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
HP +V F G ++ + IV E++ G L L L+ + L M D GM +L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 868 --HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEV 924
H +HRDL + N LVD++ VKV DFG++R + + ++SS T +W APEV
Sbjct: 121 ESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPA 981
K DV++FG+++WE+ ++ + P+ +VV V G RL P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYRPHLASDT 233
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ I+ CW P+ RPTF +++++++PL++
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 5e-71
Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 32/278 (11%)
Query: 748 CEIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEV 801
+ E + +G G++G VY+G W VA+K L + ++ +E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
+M V +P+V +G + ++ + +P G L + + + + L + A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 862 RGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE- 918
+GMNYL VHRDL + N+LV VK+ DFGL++ L + AE
Sbjct: 128 KGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAK-----LLGAEEKEYHAEG 178
Query: 919 ------WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQH 969
WMA E + + + DV+S+GV +WEL T +P+ G+ ++ + G
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-- 236
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
RL P V I+RKCW D RP F E++
Sbjct: 237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-71
Identities = 86/307 (28%), Positives = 137/307 (44%), Gaps = 28/307 (9%)
Query: 739 SDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGES 793
++ + + + IP ++ TLG +G G +G V +VAVK L D S
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM-LKADIIASS 67
Query: 794 -LEEFRSEVLIMKRVRHPNVVLFMGAVTR------PPNLSIVAEFLPRGSLYRLL--HRP 844
+EEF E MK HP+V +G R P ++ F+ G L+ L R
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 845 NNQ---LDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899
L + +R +D A GM YL N +HRDL + N ++ ++ V V DFGL
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGL 183
Query: 900 SRMKHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGM 956
SR ++ + A +W+A E L + DV++FGV +WE+ T Q P+ G+
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243
Query: 957 NPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016
++ + RL P V D++ +CW DPK RP+FT + L+ + ++
Sbjct: 244 ENAEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
Query: 1017 SQVPRPV 1023
+
Sbjct: 303 LSTSQDP 309
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-70
Identities = 84/271 (30%), Positives = 129/271 (47%), Gaps = 17/271 (6%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
I E+T + IG G +G V+ G W +VA+K + + S E+F E +M ++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGA--MSEEDFIEEAEVMMKL 60
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
HP +V G + +V EF+ G L L L M LD GM YL
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 868 --HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEV 924
+HRDL + N LV +N V+KV DFG++R + + + SS T +W +PEV
Sbjct: 121 EEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPA 981
K DV+SFGV++WE+ + + P+ + +VV + GF RL P
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKPRLASTH 233
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
V I+ CW+ P+ RP F+ ++ L + +
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-70
Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 27/298 (9%)
Query: 734 NDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQD 788
++ + + + I + LG+ +G G +G V G+ +VAVK + D
Sbjct: 15 VPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKT-MKLD 73
Query: 789 FFGES-LEEFRSEVLIMKRVRHPNVVLFMGAVTR-----PPNLSIVAEFLPRGSLYRLL- 841
+ +EEF SE MK HPNV+ +G P ++ F+ G L+ L
Sbjct: 74 NSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL 133
Query: 842 -HRPNN---QLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVC 895
R + + L+ +D A GM YL N +HRDL + N ++ + V V
Sbjct: 134 YSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVA 189
Query: 896 DFGLSRMKHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQP 952
DFGLS+ ++ + +W+A E L + K DV++FGV +WE+ T P
Sbjct: 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
Query: 953 WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ G+ ++ + RL P++ + +I+ CW+TDP RPTF+ + L+ L
Sbjct: 250 YPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-70
Identities = 88/275 (32%), Positives = 135/275 (49%), Gaps = 20/275 (7%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEV 801
+ I E++ L +G G +GEVY G + VAVK +D ++ E+F SE
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKFMSEA 64
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
+IMK + HP++V +G + P I+ E P G L L R N L + +L
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 862 RGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAE 918
+ M YL NC VHRD+ N+LV VK+ DFGLSR ++ + + T +
Sbjct: 124 KAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIP 975
WM+PE + DV+ F V +WE+ + +QP+ + V+G + G RL P
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD---RLPKP 236
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
D P + ++ +CW DP RP FTE++ +L +
Sbjct: 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 8e-70
Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 17/269 (6%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EI +++T + +G G +G V G W G +VA+K + + S +EF E +M +
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGS--MSEDEFIEEAKVMMNL 76
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
H +V G T+ + I+ E++ G L L ++ ++ L M D M YL
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 868 --HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEV 924
+HRDL + N LV+ VVKV DFGLSR + + + SS + W PEV
Sbjct: 137 ESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPA 981
L K D+++FGV++WE+ ++ + P+ + + G RL P
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEK 249
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
V I+ CW RPTF +++ + +
Sbjct: 250 VYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 9e-70
Identities = 84/300 (28%), Positives = 136/300 (45%), Gaps = 21/300 (7%)
Query: 733 SNDSSKSDVGDDVAECEIPWEE--ITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFL 785
+ ++ V I + E IG G +G VY G AVK L
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-L 61
Query: 786 DQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-PNLSIVAEFLPRGSLYRLLHRP 844
++ + +F +E +IMK HPNV+ +G R + +V ++ G L +
Sbjct: 62 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
Query: 845 NNQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR- 901
+ + + L A+GM YL VHRDL + N ++D+ + VKV DFGL+R
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 902 MKHNTFLSSRSTAGTA---EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMN 957
M + S + G +WMA E L+ + K DV+SFGV+LWEL T P+ +N
Sbjct: 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237
Query: 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSS 1017
+ + Q RRL P+ + +++ KCW +MRP+F+E+++ + +
Sbjct: 238 TFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-69
Identities = 88/275 (32%), Positives = 130/275 (47%), Gaps = 20/275 (7%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEV 801
+ EI E I LG IG G +G+V++G + VA+K E+F E
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 67
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
L M++ HP++V +G +T P I+ E G L L LD + A +
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 862 RGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAE 918
+ YL VHRD+ + N+LV N VK+ DFGLSR M+ +T+ + +
Sbjct: 127 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIP 975
WMAPE + DV+ FGV +WE+ +P+ G+ V+G + G RL +P
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMP 239
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
N P + ++ KCW DP RP FTE+ A L +
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-69
Identities = 87/274 (31%), Positives = 128/274 (46%), Gaps = 19/274 (6%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFF--GESLEEFRS 799
C I +++ L E++G GS+G V RG+W VAVK L D E++++F
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC-LKPDVLSQPEAMDDFIR 70
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
EV M + H N++ G V PP + +V E P GSL L + R A+
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 860 AARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT- 916
A GM YL +HRDL + NLL+ +VK+ DFGL R
Sbjct: 130 VAEGMGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 917 --AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLD 973
W APE L+ D + FGV LWE+ T Q+PW G+N Q++ + + RL
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
P++ + +++ +CW P+ RPTF + L
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 5e-69
Identities = 84/308 (27%), Positives = 133/308 (43%), Gaps = 27/308 (8%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+P + ITL +G G++GEVY G G +VAVK L + + +F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 84
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN----QLDERRRLR 855
LI+ + H N+V +G + I+ E + G L L RP L L
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 856 MALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGLSRMKHNTFLSS 910
+A D A G YL ++ +HRD+ + N L+ V K+ DFG++R +
Sbjct: 145 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 911 RSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGF 967
+ +WM PE K D +SFGV+LWE+ ++ P+ + +V+ V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT- 259
Query: 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVS 1027
R+D P N V I+ +CWQ P+ RP F I+ ++ + P+
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGP 319
Query: 1028 SGRETGQI 1035
E ++
Sbjct: 320 LVEEEEKV 327
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 6e-69
Identities = 89/337 (26%), Positives = 142/337 (42%), Gaps = 23/337 (6%)
Query: 694 SDGDADSAGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWE 753
DG G E+ Y V ++ + V
Sbjct: 34 LDGICSIEELSTSLYKKAGSENLYF---QGANTVHIDLSALNPELVQAVQHVVI-GPSSL 89
Query: 754 EITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+ E IG G +G VY G AVK L++ + +F +E +IMK
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQFLTEGIIMKDFS 148
Query: 809 HPNVVLFMGAVTRP-PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
HPNV+ +G R + +V ++ G L + + + + L A+GM +L
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 868 --HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTA---EWMA 921
VHRDL + N ++D+ + VKV DFGL+R M F S + G +WMA
Sbjct: 209 ASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980
E L+ + K DV+SFGV+LWEL T P+ +N + + Q RRL P+
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 323
Query: 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSS 1017
+ +++ KCW +MRP+F+E+++ + +
Sbjct: 324 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-68
Identities = 89/272 (32%), Positives = 144/272 (52%), Gaps = 19/272 (6%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMK 805
E E+P E + L ER+G G +GEV+ G ++G T+VAVK S + F +E +MK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMK 63
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGM 864
+++H +V VT+ P I+ E++ GSL L P+ +L + L MA A GM
Sbjct: 64 QLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 865 NYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
++ N +HRDL++ N+LV K+ DFGL+R ++ N + + +W A
Sbjct: 123 AFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNL 978
PE + K DV+SFG++L E+ T + P+ GM +V+ + G+ R+ PDN
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVRPDNC 235
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ ++R CW+ P+ RPTF + + L+
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-68
Identities = 94/286 (32%), Positives = 150/286 (52%), Gaps = 27/286 (9%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+ E+IT+ +G GS+G VY G G T VA+K +++ EF +E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 79
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPN-------NQLDERR 852
+MK +VV +G V++ ++ E + RG L L RP +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 853 RLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910
++MA + A GM YL + VHRDL + N +V +++ VK+ DFG++R + T
Sbjct: 140 MIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 911 RSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGF 967
+ G WM+PE L++ DV+SFGV+LWE+ T+ +QP+ G++ QV+ V
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013
LD PDN + +++R CWQ +PKMRP+F EI++++K +P
Sbjct: 256 GGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-68
Identities = 88/276 (31%), Positives = 140/276 (50%), Gaps = 27/276 (9%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
+ +E+ L + IG G +G+V GD+ G +VAVK + + + F +E +M +
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQ 242
Query: 807 VRHPNVVLFMGAVTR-PPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGM 864
+RH N+V +G + L IV E++ +GSL L L L+ +LD M
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 865 NYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT---AEW 919
YL +N VHRDL + N+LV ++ V KV DFGL++ + +W
Sbjct: 303 EYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKW 352
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPD 976
APE LR + K DV+SFG++LWE+ + + P+ + VV V G+ ++D PD
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPD 409
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
PAV D+++ CW D RPTF ++ L+ ++
Sbjct: 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-68
Identities = 95/292 (32%), Positives = 135/292 (46%), Gaps = 24/292 (8%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLI 803
EI I + + IG G GEV G VA+K L + +F SE I
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEASI 103
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
M + HPN++ G VTR IV E++ GSL L + Q + + M G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 864 MNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT---AE 918
M YL VHRDL + N+LVD N V KV DFGLSR+ + ++ +T G
Sbjct: 164 MRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIP 975
W APE + DV+SFGV++WE+ ++P+ M V+ +V G+ RL P
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPAP 276
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVS 1027
A+ ++ CW D RP F++I++ L L I S + R +VS
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL---IRSPESLRATATVS 325
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-68
Identities = 86/306 (28%), Positives = 131/306 (42%), Gaps = 31/306 (10%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+P + ITL +G G++GEVY G G +VAVK L + + +F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 125
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN----QLDERRRLR 855
LI+ + H N+V +G + I+ E + G L L RP L L
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 856 MALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGLSRMKHNTFLSS 910
+A D A G YL ++ +HRD+ + N L+ V K+ DFG++R +
Sbjct: 186 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--GY 239
Query: 911 RSTAGTAE----WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV 965
G A WM PE K D +SFGV+LWE+ ++ P+ + +V+ V
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
Query: 966 GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPS 1025
R+D P N V I+ +CWQ P+ RP F I+ ++ + P+
Sbjct: 300 T-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 358
Query: 1026 VSSGRE 1031
E
Sbjct: 359 GPLVEE 364
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-68
Identities = 88/298 (29%), Positives = 136/298 (45%), Gaps = 48/298 (16%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
I +I L +G G++G+V+ + + VAVK D + ++F+ E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREA 68
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN------------- 846
++ ++H ++V F G L +V E++ G L + L H P+
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 847 QLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--- 901
+L + L +A A GM YL + VHRDL + N LV N +VK+ DFG+SR
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 902 ------MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWG 954
+ +T L R WM PE + + DV+SFGVILWE+ T +QPW
Sbjct: 185 STDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 955 GMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
++ +V+ + Q R L+ P V D++ CWQ +P+ R EI L L K
Sbjct: 238 QLSNTEVIECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 8e-68
Identities = 87/301 (28%), Positives = 144/301 (47%), Gaps = 32/301 (10%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEVL 802
EI +T + IG G +GEVY+G VA+K L + + +F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 98
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR 862
IM + H N++ G +++ + I+ E++ G+L + L + + + + M A
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 863 GMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT---A 917
GM YL N VHRDL + N+LV+ N V KV DFGLSR+ + ++ +T+G
Sbjct: 159 GMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDI 974
W APE + DV+SFG+++WE+ T ++P+ ++ +V+ A+ GF RL
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPT 271
Query: 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL----------KPLQKPITSSQVPRPVP 1024
P + A+ ++ +CWQ + RP F +I++ L K L + P
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPST 331
Query: 1025 S 1025
S
Sbjct: 332 S 332
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 9e-68
Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 34/286 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG---------TEVAVKRFLDQDFFGESLEEFRS 799
+I E++ E +G G++ ++++G TEV +K LD+ S E F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-LDKAHRNYS-ESFFE 61
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
+M ++ H ++VL G +V EF+ GSL L + N ++ +L +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 860 AARGMNYL--HNCTPVIVHRDLKSPNLLVDK--------NWVVKVCDFGLSRMKHNTFLS 909
A M++L + +H ++ + N+L+ + +K+ D G+S T L
Sbjct: 122 LAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----TVLP 173
Query: 910 SRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGF 967
W+ PE + N + + D +SFG LWE+C+ +P ++ + +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE- 232
Query: 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013
+L P +A++I C +P RP+F I+ L L P
Sbjct: 233 DRHQLPAPKA--AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-67
Identities = 99/273 (36%), Positives = 144/273 (52%), Gaps = 19/273 (6%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ E+ +IT+ ++G G YGEVY G W VAVK L +D +EEF E +M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM--EVEEFLKEAAVM 63
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARG 863
K ++HPN+V +G TR P I+ EF+ G+L L N Q + L MA +
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 864 MNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWM 920
M YL N +HRDL + N LV +N +VKV DFGLSR M +T+ + +W
Sbjct: 124 MEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDN 977
APE L K DV++FGV+LWE+ T P+ G++ QV + + R++ P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEG 236
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
V +++R CWQ +P RP+F EI A + +
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-67
Identities = 93/272 (34%), Positives = 141/272 (51%), Gaps = 19/272 (6%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMK 805
EIP E + L ++G G +GEV+ G W+G T VA+K S E F E +MK
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMK 234
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRL-RMALDAARGM 864
++RH +V V+ P IV E++ +GSL L + +L MA A GM
Sbjct: 235 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 865 NYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
Y+ N VHRDL++ N+LV +N V KV DFGL+R ++ N + + + +W A
Sbjct: 294 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNL 978
PE K DV+SFG++L EL T + P+ GM +V+ V G+ R+ P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPEC 406
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
++ D++ +CW+ +P+ RPTF + A L+
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-67
Identities = 88/295 (29%), Positives = 137/295 (46%), Gaps = 47/295 (15%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
I +I L +G G++G+V+ + H VAVK + + ++F+ E
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREA 94
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN------------Q 847
++ ++H ++V F G T L +V E++ G L R L H P+
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 848 LDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR---- 901
L + L +A A GM YL + VHRDL + N LV + VVK+ DFG+SR
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 902 -----MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGG 955
+ T L R WM PE + + DV+SFGV+LWE+ T +QPW
Sbjct: 211 TDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263
Query: 956 MNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
++ + + + Q R L+ P P V I+R CWQ +P+ R + ++ A L+ L
Sbjct: 264 LSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-67
Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 32/304 (10%)
Query: 748 CEIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEV 801
E+ + +G G +G V++G W V +K ++ +S + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
L + + H ++V +G L +V ++LP GSL + + L + L + A
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 862 RGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT--A 917
+GM YL H VHR+L + N+L+ V+V DFG++ + +
Sbjct: 126 KGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDI 974
+WMA E + + DV+S+GV +WEL T +P+ G+ +V + G RL
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLAQ 238
Query: 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL----------KPLQKPITSSQVPRPVP 1024
P V ++ KCW D +RPTF E+ +++ P P P
Sbjct: 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEP 298
Query: 1025 SVSS 1028
+
Sbjct: 299 HGLT 302
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-67
Identities = 86/297 (28%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
EI + E +G +G+VY+G G VA+K L G EEFR E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHEA 63
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN------------- 846
++ R++HPNVV +G VT+ LS++ + G L+ L P++
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 847 QLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--- 901
L+ + + A GM YL H+ VH+DL + N+LV VK+ D GL R
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 902 ------MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWG 954
+ N+ L R WMAPE + D++S+GV+LWE+ + QP+
Sbjct: 180 AADYYKLLGNSLLPIR-------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 955 GMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
G + VV + + L PD+ V ++ +CW P RP F +I + L+
Sbjct: 233 GYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-67
Identities = 101/285 (35%), Positives = 150/285 (52%), Gaps = 20/285 (7%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ E+ +IT+ ++G G YGEVY G W VAVK L +D +EEF E +M
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDT--MEVEEFLKEAAVM 270
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARG 863
K ++HPN+V +G TR P I+ EF+ G+L L N Q + L MA +
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 864 MNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWM 920
M YL N +HR+L + N LV +N +VKV DFGLSR M +T+ + +W
Sbjct: 331 MEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDN 977
APE L K DV++FGV+LWE+ T P+ G++ QV + + R++ P+
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEG 443
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL-QKPITSSQVPR 1021
V +++R CWQ +P RP+F EI A + + Q+ S +V +
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 488
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-67
Identities = 87/309 (28%), Positives = 143/309 (46%), Gaps = 22/309 (7%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLI 803
E+ I++ + +G G +GEV G VA+K L + + +F E I
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEASI 99
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
M + HPN++ G VT+ + IV E++ GSL L + + Q + + M A G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 864 MNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT---AE 918
M YL VHRDL + N+L++ N V KV DFGL R+ + ++ +T G
Sbjct: 160 MKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIP 975
W +PE + DV+S+G++LWE+ + ++P+ M+ V+ AV G+ RL P
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPP 272
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL-KPLQKPITSSQVPRPVPSVSSGRETGQ 1034
+ A+ ++ CWQ D RP F +I++ L K ++ P + + S+
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQS 332
Query: 1035 ISKFLADST 1043
T
Sbjct: 333 NVDITTFRT 341
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-67
Identities = 84/309 (27%), Positives = 129/309 (41%), Gaps = 55/309 (17%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEE 796
+ E P I IG G++G V++ G T VAVK L ++ + +
Sbjct: 38 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQAD 96
Query: 797 FRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN-------- 846
F+ E +M +PN+V +G + ++ E++ G L L P+
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 847 -------------QLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWV 891
L +L +A A GM YL VHRDL + N LV +N V
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMV 212
Query: 892 VKVCDFGLSR---------MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVI 942
VK+ DFGLSR N + R WM PE + + DV+++GV+
Sbjct: 213 VKIADFGLSRNIYSADYYKADGNDAIPIR-------WMPPESIFYNRYTTESDVWAYGVV 265
Query: 943 LWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFT 1001
LWE+ + QP+ GM +V+ V L P+N + +++R CW P RP+F
Sbjct: 266 LWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 1002 EIMAALKPL 1010
I L+ +
Sbjct: 325 SIHRILQRM 333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 9e-67
Identities = 81/290 (27%), Positives = 140/290 (48%), Gaps = 40/290 (13%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG----TEVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ W +I + IG G++G+V + + A+KR + + + +F E+ ++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 79
Query: 805 KRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSL---------------YRLLHRPNNQL 848
++ HPN++ +GA L + E+ P G+L + + + + L
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 849 DERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906
++ L A D ARGM+YL +HRDL + N+LV +N+V K+ DFGLSR +
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEVY 195
Query: 907 FLSSRSTAGTA---EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVV 962
WMA E L DV+S+GV+LWE+ ++ P+ GM ++
Sbjct: 196 ----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 963 GAV--GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ G+ RL+ P N D V D++R+CW+ P RP+F +I+ +L +
Sbjct: 252 EKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-66
Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 32/278 (11%)
Query: 748 CEIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEV 801
+ E + +G G++G VY+G W VA+K L + ++ +E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
+M V +P+V +G + ++ + +P G L + + + + L + A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 862 RGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE- 918
+GMNYL VHRDL + N+LV VK+ DFGL++ L + AE
Sbjct: 128 KGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAK-----LLGAEEKEYHAEG 178
Query: 919 ------WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQH 969
WMA E + + + DV+S+GV +WEL T +P+ G+ ++ + G
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-- 236
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007
RL P V I+ KCW D RP F E++
Sbjct: 237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 1e-66
Identities = 91/304 (29%), Positives = 152/304 (50%), Gaps = 42/304 (13%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG---------TEVAVKRFLDQDFFGESLEEFRS 799
E+P + + LG+ +G G++G+V + G T+VAVK L D + L + S
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 123
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSL---------------YRLLHR 843
E+ +MK + +H N++ +GA T+ L ++ E+ +G+L Y H
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 844 PNNQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
P QL + + A ARGM YL C +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 902 MKHNTFLSSRSTAGTA---EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMN 957
H+ + T +WMAPE L + + DV+SFGV+LWE+ T+ P+ G+
Sbjct: 240 DIHHI-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298
Query: 958 PMQVVGAV--GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015
++ + G R+D P N + ++R CW P RPTF +++ L + +
Sbjct: 299 VEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355
Query: 1016 SSQV 1019
+ ++
Sbjct: 356 NQEM 359
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-66
Identities = 84/272 (30%), Positives = 143/272 (52%), Gaps = 19/272 (6%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMK 805
EIP E + L +++G G +GEV+ ++ T+VAVK S+E F +E +MK
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMK 238
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL-HRPNNQLDERRRLRMALDAARGM 864
++H +V VT+ P I+ EF+ +GSL L ++ + + + A GM
Sbjct: 239 TLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 865 NYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
++ N +HRDL++ N+LV + V K+ DFGL+R ++ N + + +W A
Sbjct: 298 AFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNL 978
PE + K DV+SFG++L E+ T + P+ GM+ +V+ A+ G+ R+ P+N
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENC 410
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ +I+ +CW+ P+ RPTF I + L
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-66
Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 22/283 (7%)
Query: 749 EIPWEEITLGE-RIGLGSYGEVYRGDWHG----TEVAVKRFLDQDFFGESLEEFRSEVLI 803
+ + + + + +G G++G V +G + +VA+K L Q EE E I
Sbjct: 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQI 63
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
M ++ +P +V +G + +V E G L++ L ++ + + G
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 864 MNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA---E 918
M YL N VHRDL + N+L+ K+ DFGLS+ + + +
Sbjct: 123 MKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIP 975
W APE + + DV+S+GV +WE + Q+P+ M +V+ + G R++ P
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECP 235
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018
P + ++ CW + RP F + ++ + S
Sbjct: 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-66
Identities = 94/325 (28%), Positives = 141/325 (43%), Gaps = 27/325 (8%)
Query: 702 GYEPRDSGSGGREHNYLGANSEGERVSDRS-----ASNDSSKSDVGDDVAECEIPWEEIT 756
G S + G S VS+ + + + + EI E I
Sbjct: 336 GERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTR--DYEIQRERIE 393
Query: 757 LGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
LG IG G +G+V++G + VA+K E+F E L M++ HP+
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL--HN 869
+V +G +T P I+ E G L L LD + A + + YL
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNE 928
VHRD+ + N+LV N VK+ DFGLSR M+ +T+ + +WMAPE +
Sbjct: 512 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 929 PSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVADI 985
DV+ FGV +WE+ +P+ G+ V+G + G RL +P N P + +
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSL 624
Query: 986 IRKCWQTDPKMRPTFTEIMAALKPL 1010
+ KCW DP RP FTE+ A L +
Sbjct: 625 MTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 6e-66
Identities = 71/275 (25%), Positives = 126/275 (45%), Gaps = 22/275 (8%)
Query: 747 ECEIPWEEITLGER-IGLGSYGEVYRGDWHG----TEVAVKRFLDQDFFGESLEEFRSEV 801
E + + +TL ++ +G G++G V +G + VAVK ++ +E +E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
+M+++ +P +V +G + +V E G L + L + N + ++ + + +
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVS 127
Query: 862 RGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA-- 917
GM YL N VHRDL + N+L+ K+ DFGLS+ ++
Sbjct: 128 MGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 918 -EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLD 973
+W APE + K DV+SFGV++WE + Q+P+ GM +V + G R+
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMG 240
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
P + D++ CW D + RP F + L+
Sbjct: 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 6e-66
Identities = 83/297 (27%), Positives = 137/297 (46%), Gaps = 41/297 (13%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E P + + LG+ +G G +G+V + T VAVK L ++ L + SE
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSEF 77
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL-----------------------Y 838
++K+V HP+V+ GA ++ L ++ E+ GSL
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 839 RLLHRPNNQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCD 896
L H L + A ++GM YL VHRDL + N+LV + +K+ D
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISD 193
Query: 897 FGLSRMKHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPW 953
FGLSR + + + G +WMA E L + + DV+SFGV+LWE+ T+ P+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 954 GGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
G+ P ++ + R++ PDN + ++ +CW+ +P RP F +I L+ +
Sbjct: 254 PGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 7e-66
Identities = 90/298 (30%), Positives = 150/298 (50%), Gaps = 36/298 (12%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG---------TEVAVKRFLDQDFFGESLEEFRS 799
E P +++TLG+ +G G++G+V + G VAVK L D + L + S
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVS 89
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPN----------- 845
E+ +MK + +H N++ +GA T+ L ++ E+ +G+L L RP
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 846 --NQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
Q+ + + ARGM YL C +HRDL + N+LV +N V+K+ DFGL+R
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 902 MKHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNP 958
+N ++T G +WMAPE L + + DV+SFGV++WE+ T+ P+ G+
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016
++ + + R+D P N + ++R CW P RPTF +++ L + T+
Sbjct: 266 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-65
Identities = 74/321 (23%), Positives = 132/321 (41%), Gaps = 36/321 (11%)
Query: 721 NSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHG---- 776
+ + + + + + +D + + +++G G++G V +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68
Query: 777 --TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN--LSIVAEFL 832
VAVK+ Q E L +F E+ I+K ++H N+V + G L ++ E+L
Sbjct: 69 TGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126
Query: 833 PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNW 890
P GSL L + ++D + L+ +GM YL +HRDL + N+LV+
Sbjct: 127 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENEN 182
Query: 891 VVKVCDFGLSRMKHNTFLSSRSTAGTA---EWMAPEVLRNEPSDEKCDVYSFGVILWELC 947
VK+ DFGL+++ + W APE L DV+SFGV+L+EL
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
Query: 948 TM----------------QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQ 991
T G M ++ + + RL PD + I+ +CW
Sbjct: 243 TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWN 301
Query: 992 TDPKMRPTFTEIMAALKPLQK 1012
+ RP+F ++ + ++
Sbjct: 302 NNVNQRPSFRDLALRVDQIRD 322
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-65
Identities = 88/293 (30%), Positives = 145/293 (49%), Gaps = 38/293 (12%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG---------TEVAVKRFLDQDFFGESLEEFRS 799
E P +++TLG+ +G G +G+V + G VAVK L D + L + S
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVS 135
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPNN---------- 846
E+ +MK + +H N++ +GA T+ L ++ E+ +G+L L RP
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 847 ---QLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
Q+ + + ARGM YL C +HRDL + N+LV +N V+K+ DFGL+R
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 902 MKHNTFLSSRSTAGTA---EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMN 957
+N + T +WMAPE L + + DV+SFGV++WE+ T+ P+ G+
Sbjct: 252 DINNI-DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
++ + + R+D P N + ++R CW P RPTF +++ L +
Sbjct: 311 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 5e-65
Identities = 93/272 (34%), Positives = 141/272 (51%), Gaps = 19/272 (6%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMK 805
EIP E + L ++G G +GEV+ G W+G T VA+K S E F E +MK
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMK 317
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRL-RMALDAARGM 864
++RH +V V+ P IV E++ +GSL L + +L MA A GM
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 865 NYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
Y+ N VHRDL++ N+LV +N V KV DFGL+R ++ N + + + +W A
Sbjct: 377 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLDIPDNL 978
PE K DV+SFG++L EL T + P+ GM +V+ V G+ R+ P
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPEC 489
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
++ D++ +CW+ +P+ RPTF + A L+
Sbjct: 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 5e-65
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 34/290 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH------GTEVAVKRFLDQDFFGESLEEFRSEVL 802
+ +G G +G+V + G +VAVK L + G + + + E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIE 75
Query: 803 IMKRVRHPNVVLFMGAVTRPPN--LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDA 860
I++ + H N+V + G T + ++ EFLP GSL L + N+++ +++L+ A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 861 ARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA- 917
+GM+YL VHRDL + N+LV+ VK+ DFGL++
Sbjct: 136 CKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 918 --EWMAPEVLRNEPSDEKCDVYSFGVILWELCT---------------MQQPWGGMNPMQ 960
W APE L DV+SFGV L EL T + G M +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+V + + +RL P N V ++RKCW+ P R +F ++ + L
Sbjct: 252 LVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-64
Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 37/291 (12%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E P + G+ +G G++G+V G +VAVK L + E SE+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSEL 100
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRP-----------NNQ 847
IM + +H N+V +GA T + ++ E+ G L L N+
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 848 LDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MK 903
R L + A+GM +L NC +HRD+ + N+L+ V K+ DFGL+R M
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPW-GGMNPMQV 961
+ ++ + +WMAPE + + + DV+S+G++LWE+ ++ P+ G + +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 962 VGAV--GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
V G+ ++ P + I++ CW +P RPTF +I + L+
Sbjct: 277 YKLVKDGY---QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-64
Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 41/301 (13%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E P ++ G+ +G G++G+V +G VAVK L E SE+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPN------------- 845
++ + H N+V +GA T ++ E+ G L L R +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 846 --NQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
LD L + A+GM +L NC +HRDL + N+L+ + K+CDFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR 193
Query: 902 MKHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNP 958
N +WMAPE + N + DV+S+G+ LWEL ++ P+ GM
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 959 -MQVVGAV--GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015
+ + GF R+ P++ + DI++ CW DP RPTF +I+ ++ T
Sbjct: 254 DSKFYKMIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
Query: 1016 S 1016
+
Sbjct: 311 N 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 5e-64
Identities = 72/295 (24%), Positives = 124/295 (42%), Gaps = 36/295 (12%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSE 800
+ + +++G G++G V + VAVK+ L E L +F E
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHST-EEHLRDFERE 61
Query: 801 VLIMKRVRHPNVVLFMGAVTRPPNLS--IVAEFLPRGSLYRLLHRPNNQLDERRRLRMAL 858
+ I+K ++H N+V + G + ++ E+LP GSL L + ++D + L+
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 859 DAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916
+GM YL +HRDL + N+LV+ VK+ DFGL+++ +
Sbjct: 122 QICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 917 A---EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM----------------QQPWGGMN 957
W APE L DV+SFGV+L+EL T G M
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
++ + + RL PD + I+ +CW + RP+F ++ + ++
Sbjct: 238 VFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 5e-64
Identities = 77/302 (25%), Positives = 128/302 (42%), Gaps = 37/302 (12%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSE 800
+ +G G +G+V + VAVK L D + ++ E
Sbjct: 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQE 83
Query: 801 VLIMKRVRHPNVVLFMGAVTRP--PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMAL 858
+ I++ + H +++ + G +L +V E++P GSL L R + + + L A
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQ 141
Query: 859 DAARGMNYLH--NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916
GM YLH + +HRDL + N+L+D + +VK+ DFGL++ R
Sbjct: 142 QICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197
Query: 917 A---EWMAPEVLRNEPSDEKCDVYSFGVILWELCT---------------MQQPWGGMNP 958
W APE L+ DV+SFGV L+EL T + G M
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018
+++ + + RL PD V +++ CW+T+ RPTF ++ LK + + Q
Sbjct: 258 LRLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK-YQGQ 315
Query: 1019 VP 1020
P
Sbjct: 316 AP 317
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-63
Identities = 86/301 (28%), Positives = 136/301 (45%), Gaps = 40/301 (13%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E P + + LG+ +G G++G+V D G VAVK L + SE+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSEL 81
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPN-LSIVAEFLPRGSLYRLL--HRPN------------ 845
I+ + H NVV +GA T+P L ++ EF G+L L R
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 846 -NQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902
+ L + + A+GM +L C +HRDL + N+L+ + VVK+CDFGL+R
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 903 KHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGM-NP 958
+ R +WMAPE + + + DV+SFGV+LWE+ ++ P+ G+
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 959 MQVVGAV--GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016
+ + G R+ PD P + + CW +P RPTF+E++ L L +
Sbjct: 258 EEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314
Query: 1017 S 1017
Sbjct: 315 Q 315
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 9e-63
Identities = 81/297 (27%), Positives = 128/297 (43%), Gaps = 40/297 (13%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEV 801
E P E + G+ +G G++G+V +G +VAVK L + E SE+
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSEL 99
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL--HRPN------------- 845
+M ++ H N+V +GA T + ++ E+ G L L R
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 846 -------NQLDERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCD 896
N L L A A+GM +L +C VHRDL + N+LV VVK+CD
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICD 215
Query: 897 FGLSRMKHNTFLSSRSTAGT--AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPW 953
FGL+R + +WMAPE L K DV+S+G++LWE+ ++ P+
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 954 GGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
G+ + ++D P + I++ CW D + RP+F + + L
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-62
Identities = 76/312 (24%), Positives = 126/312 (40%), Gaps = 41/312 (13%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSE 800
+ ++G G++G V + VAVK+ Q + +F+ E
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQRE 74
Query: 801 VLIMKRVRHPNVVLFMGAVTRP--PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMAL 858
+ I+K + +V + G P +L +V E+LP G L L R +LD R L +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 859 DAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916
+GM YL C VHRDL + N+LV+ VK+ DFGL+++
Sbjct: 135 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 917 A---EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPW--------------GGMNP 958
W APE L + + DV+SFGV+L+EL T +
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL------QK 1012
+++ + + +RL P V ++++ CW P+ RP+F+ + L L +
Sbjct: 251 SRLLELLE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309
Query: 1013 PITSSQVPRPVP 1024
+ P
Sbjct: 310 THAFTAHPEGKH 321
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-59
Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 22/285 (7%)
Query: 747 ECEIPWEEITLGE-RIGLGSYGEVYRGDWHG----TEVAVKRFLDQDFFGESLEEFRSEV 801
+ + + + + + +G G++G V +G + +VA+K L Q EE E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 387
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
IM ++ +P +V +G + +V E G L++ L ++ + +
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 862 RGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTA-- 917
GM YL N VHR+L + N+L+ K+ DFGLS+ + +
Sbjct: 447 MGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 918 -EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAV--GFQHRRLD 973
+W APE + + DV+S+GV +WE + Q+P+ M +V+ + G R++
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RME 559
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018
P P + ++ CW + RP F + ++ + S
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 83/316 (26%), Positives = 133/316 (42%), Gaps = 28/316 (8%)
Query: 694 SDGDADSAGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWE 753
S G A S + SG + LG +E + + ++V
Sbjct: 6 SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEV-------H 58
Query: 754 EITLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS-EVLIMKRVRHP 810
+T R+G GS+GEV+R D G + AVK+ LE FR E++ + P
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLSSP 110
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
+V GAV P ++I E L GSL +L+ + L E R L A G+ YLH
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 871 TPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSR-----MKHNTFLSSRSTAGTAEWMAPEV 924
I+H D+K+ N+L+ + +CDFG + + L+ GT MAPEV
Sbjct: 170 R--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAVA 983
+ +P D K D++S ++ + PW + + + +IP + P A
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 984 DIIRKCWQTDPKMRPT 999
I++ + +P R +
Sbjct: 288 QAIQEGLRKEPVHRAS 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-55
Identities = 58/252 (23%), Positives = 128/252 (50%), Gaps = 6/252 (2%)
Query: 756 TLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
++IG GS+G+ G + +K + EE R EV ++ ++HPN+V
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMNYLHNCTP 872
+ + +L IV ++ G L++ ++ E + L + + ++H+
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK- 145
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932
I+HRD+KS N+ + K+ V++ DFG++R+ ++T +R+ GT +++PE+ N+P +
Sbjct: 146 -ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
K D+++ G +L+ELCT++ + + +V + + + + ++ + ++
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKR 263
Query: 993 DPKMRPTFTEIM 1004
+P+ RP+ I+
Sbjct: 264 NPRDRPSVNSIL 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-55
Identities = 67/282 (23%), Positives = 128/282 (45%), Gaps = 19/282 (6%)
Query: 756 TLGERIGLGSYGEVYRG-DWH-GTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+ ++IG G + EVYR G VA+K+ + ++ + E+ ++K++ HPNV
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLL---HRPNNQLDERRRLRMALDAARGMNYLHN 869
+ + + L+IV E G L R++ + + ER + + + ++H+
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
++HRD+K N+ + VVK+ D GL R + ++ S GT +M+PE +
Sbjct: 155 RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGG--MNPMQVVGAVGFQHRRLDIP----DNLDPAVA 983
+ K D++S G +L+E+ +Q P+ G MN + + + D P D+ +
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EQCDYPPLPSDHYSEELR 268
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPS 1025
++ C DP+ RP T + + T+S +
Sbjct: 269 QLVNMCINPDPEKRPDVTYVY-DVAKRMHACTASSLEHHHHH 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-55
Identities = 76/284 (26%), Positives = 133/284 (46%), Gaps = 24/284 (8%)
Query: 728 SDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRG-DWH-GTEVAVKRFL 785
S RS +SD+ + E + + +G G+YG VY G D +A+K
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYD-ENGD---RVVLGKGTYGIVYAGRDLSNQVRIAIKEIP 56
Query: 786 DQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN 845
++D + E+ + K ++H N+V ++G+ + + I E +P GSL LL
Sbjct: 57 ERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW 114
Query: 846 NQLDERRRL-----RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGL 899
L + + + L G+ YLH+ IVHRD+K N+L++ + V+K+ DFG
Sbjct: 115 GPLKDNEQTIGFYTKQIL---EGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT 169
Query: 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS--DEKCDVYSFG-VILWELCTMQQPWGGM 956
S+ + + GT ++MAPE++ P + D++S G I+ E+ T + P+ +
Sbjct: 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYEL 228
Query: 957 -NPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT 999
P + VG +IP+++ I KC++ DP R
Sbjct: 229 GEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-53
Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 11/260 (4%)
Query: 756 TLGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ IG GSYG R G + K + SEV +++ ++HPN+V
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 814 LFMGAVTRPPN--LSIVAEFLPRGSLYRLL---HRPNNQLDERRRLRMALDAARGMNYLH 868
+ + N L IV E+ G L ++ + LDE LR+ + H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 869 ---NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
+ ++HRDLK N+ +D VK+ DFGL+R+ ++ +++ GT +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
+EK D++S G +L+ELC + P+ + ++ G + + + IP + +I
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEI 247
Query: 986 IRKCWQTDPKMRPTFTEIMA 1005
I + RP+ EI+
Sbjct: 248 ITRMLNLKDYHRPSVEEILE 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-53
Identities = 72/297 (24%), Positives = 115/297 (38%), Gaps = 24/297 (8%)
Query: 726 RVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRG-DWH-GTEVAVKR 783
RVS R ++++ +S D + R+G GSYGEV++ G AVKR
Sbjct: 30 RVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89
Query: 784 FLDQDFFGES-LEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL 841
F G +EV ++V +HP V A L + E SL +
Sbjct: 90 -SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC 147
Query: 842 HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
L E + D + +LH+ +VH D+K N+ + K+ DFGL
Sbjct: 148 EAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 902 MKHNTFLSSRSTA----GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN 957
L + G +MAPE+L DV+S G+ + E+ + G
Sbjct: 206 E-----LGTAGAGEVQEGDPRYMAPELL-QGSYGTAADVFSLGLTILEVACNMELPHGGE 259
Query: 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP-LQKP 1013
Q + G+ L + ++ + DPK+R T ++A P L++P
Sbjct: 260 GWQQLRQ-GYLPPE--FTAGLSSELRSVLVMMLEPDPKLRATAEALLA--LPVLRQP 311
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 64/271 (23%), Positives = 121/271 (44%), Gaps = 40/271 (14%)
Query: 756 TLGERIGLGSYGEVYRG----DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
E IG G +G+V++ D G +KR + + E+ EV + ++ H N
Sbjct: 14 KEIELIGSGGFGQVFKAKHRID--GKTYVIKR-VKYN-----NEKAEREVKALAKLDHVN 65
Query: 812 VVLFMGA----------------VTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRL 854
+V + G ++ L I EF +G+L + + R +LD+ L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 855 RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRST 913
+ +G++Y+H+ +++RDLK N+ + VK+ DFGL +K++ + +
Sbjct: 126 ELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR--S 181
Query: 914 AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD 973
GT +M+PE + ++ ++ D+Y+ G+IL EL + + + R
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDL----RDGI 235
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
I D D +++K P+ RP +EI+
Sbjct: 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 86/318 (27%), Positives = 147/318 (46%), Gaps = 41/318 (12%)
Query: 724 GERVSDRSAS-NDSSKSDVGDDVAECEIPWEEITL-------GERIGLGSYGEVYRGDWH 775
G + S + S ND+ S +P ++ IG G +G+VY+G
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 776 -GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834
G +VA+KR + G EEF +E+ + RHP++V +G + ++ +++
Sbjct: 62 DGAKVALKRRTPESSQGI--EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 835 GSLYRLLHRPNNQ---LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV 891
G+L R L+ + + +RL + + AARG++YLH T I+HRD+KS N+L+D+N+V
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFV 177
Query: 892 VKVCDFGLSRMKHNTFLSSRST--AGTAEWMAPE-VLRNEPSDEKCDVYSFGVILWELCT 948
K+ DFG+S+ + ST GT ++ PE ++ + EK DVYSFGV+L+E+
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLC 236
Query: 949 MQQPWGGMNPMQVVGAV------GFQHRRLDIPDNLDPA------------VADIIRKCW 990
+ + V H + +DP D KC
Sbjct: 237 ARSA---IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 991 QTDPKMRPTFTEIMAALK 1008
+ RP+ +++ L+
Sbjct: 294 ALSSEDRPSMGDVLWKLE 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 70/316 (22%), Positives = 117/316 (37%), Gaps = 35/316 (11%)
Query: 731 SASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQD 788
+S + G V I + +++G G + V G G A+KR L +
Sbjct: 10 HSSGRENLYFQGHMV---IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE 66
Query: 789 FFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN----LSIVAEFLPRGSLYRLL--- 841
+ EE + E + + HPN++ + R ++ F RG+L+ +
Sbjct: 67 Q--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL 124
Query: 842 HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
N L E + L + L RG+ +H HRDLK N+L+ + D G
Sbjct: 125 KDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
Query: 902 MKHNTFLSSRSTA---------GTAEWMAPEVL---RNEPSDEKCDVYSFGVILWELCTM 949
SR T + APE+ + DE+ DV+S G +L+ +
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 950 QQP--WGGMNPMQVVGAVGFQHRRLDIPDNLD--PAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ P V AV +L IP + A+ ++ DP RP +++
Sbjct: 243 EGPYDMVFQKGDSVALAV---QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
Query: 1006 ALKPLQKPITSSQVPR 1021
L+ LQ P +
Sbjct: 300 QLEALQPPAPGQHTTQ 315
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 57/284 (20%), Positives = 127/284 (44%), Gaps = 24/284 (8%)
Query: 756 TLGERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--V 812
++ ++IG G +V++ + A+K ++ ++L+ +R+E+ + +++ + +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ + +V E L L + +D R + ++ +H
Sbjct: 91 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRST-AGTAEWMAPEVLRNEPS 930
IVH DLK N L+ ++K+ DFG++ M+ +T + + GT +M PE +++ S
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 931 -----------DEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIPDNL 978
K DV+S G IL+ + + P+ + N + + A+ + ++ PD
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPITSSQVP 1020
+ + D+++ C + DPK R + E++A ++ P+
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-52
Identities = 55/266 (20%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 756 TLGERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--V 812
++ ++IG G +V++ + A+K ++ ++L+ +R+E+ + +++ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ + +V E L L + +D R + ++ +H
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG- 128
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRST-AGTAEWMAPEVLRNEPS 930
IVH DLK N L+ ++K+ DFG++ M+ +T + + GT +M PE +++ S
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 931 -----------DEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIPDNL 978
K DV+S G IL+ + + P+ + N + + A+ + ++ PD
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ + D+++ C + DPK R + E++
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELL 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-51
Identities = 65/323 (20%), Positives = 139/323 (43%), Gaps = 26/323 (8%)
Query: 699 DSAGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLG 758
S+G PR GSG +E + D +D S ++ + ++
Sbjct: 6 HSSGLVPR--GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECIS--VKGRIYSIL 61
Query: 759 ERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--VVLF 815
++IG G +V++ + A+K ++ ++L+ +R+E+ + +++ + ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
+ +V E L L + +D R + ++ +H IV
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG--IV 177
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRST-AGTAEWMAPEVLRNEPS--- 930
H DLK N L+ ++K+ DFG++ M+ +T + + G +M PE +++ S
Sbjct: 178 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 931 --------DEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIPDNLDPA 981
K DV+S G IL+ + + P+ + N + + A+ + ++ PD +
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 982 VADIIRKCWQTDPKMRPTFTEIM 1004
+ D+++ C + DPK R + E++
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELL 319
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-51
Identities = 68/282 (24%), Positives = 114/282 (40%), Gaps = 41/282 (14%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+G G++G+V + + A+K+ + E L SEV+++ + H V
Sbjct: 9 EEIAVLGQGAFGQVVKA-RNALDSRYYAIKK-IRHT--EEKLSTILSEVMLLASLNHQYV 64
Query: 813 VLFMGAVTRPPNLS-------------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
V + A N I E+ G+LY L+H N R+
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA----- 914
++Y+H+ I+HRDLK N+ +D++ VK+ DFGL++ H + + +
Sbjct: 125 ILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 915 ---------GTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGA 964
GTA ++A EVL +EK D+YS G+I +E+ GM + ++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKK 240
Query: 965 VGFQHRRLD--IPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ DN IIR DP RP ++
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-51
Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 26/282 (9%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESL---EEFRSEVLIMKRV 807
G ++G G +G VY+G + T VAVK+ L + ++F E+ +M +
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK-LAAMVDITTEELKQQFDQEIKVMAKC 87
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ--LDERRRLRMALDAARGMN 865
+H N+V +G + +L +V ++P GSL L + L R ++A AA G+N
Sbjct: 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN 147
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWMAP 922
+LH +HRD+KS N+L+D+ + K+ DFGL+R T ++SR GT +MAP
Sbjct: 148 FLHE--NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYMAP 204
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ--VVGAVGFQHRRLDIPDNLDP 980
E LR E + K D+YSFGV+L E+ T Q + + I D +D
Sbjct: 205 EALRGEIT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263
Query: 981 A-----------VADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
+ + +C RP ++ L+ +
Sbjct: 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-50
Identities = 78/327 (23%), Positives = 128/327 (39%), Gaps = 41/327 (12%)
Query: 731 SASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQD 788
AS VG V E+ + + + G + VY + G E A+KR L +
Sbjct: 9 GASGRDQSDFVGQTV---ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65
Query: 789 FFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLS-------IVAEFLPRGSLYRL 840
E EV MK++ HPN+V F A + S ++ L +G L
Sbjct: 66 E--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123
Query: 841 L--HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898
L L L++ R + ++H P I+HRDLK NLL+ +K+CDFG
Sbjct: 124 LKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183
Query: 899 LSRMKHNTFLSSRSTA------------GTAEWMAPEVL---RNEPSDEKCDVYSFGVIL 943
+ + S S T + PE++ N P EK D+++ G IL
Sbjct: 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
Query: 944 WELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD--PAVADIIRKCWQTDPKMRPTFT 1001
+ LC Q P+ +++V + IP + +IR Q +P+ R +
Sbjct: 244 YLLCFRQHPFEDGAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA 297
Query: 1002 EIMAALKPLQKPITSSQVPRPVPSVSS 1028
E++ L+ + + P+ +
Sbjct: 298 EVVHQLQEIA-AARNVNPKSPITELLE 323
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-49
Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 38/278 (13%)
Query: 761 IGLGSYGEVYRGD-WHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819
+G G +G+VY+G GT VAVKR L ++ +F++EV ++ H N++ G
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 820 TRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAARGMNYLHN-CTPVIV 875
P +V ++ GS+ L LD +R R+AL +ARG+ YLH+ C P I+
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSRM--KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
HRD+K+ N+L+D+ + V DFGL+++ +T +++ GT +APE L S EK
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 215
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL-----------DIPDNLDPA- 981
DV+ +GV+L EL T G + L + +D
Sbjct: 216 TDVFGYGVMLLELIT------GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269
Query: 982 -----------VADIIRKCWQTDPKMRPTFTEIMAALK 1008
+ + C Q+ P RP +E++ L+
Sbjct: 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-49
Identities = 68/291 (23%), Positives = 115/291 (39%), Gaps = 28/291 (9%)
Query: 733 SNDSSKSDVGDDVAECE-IPWEEITLGERIGLGSYGE-VYRGDWHGTEVAVKRFLDQDFF 790
S+ S + D GD+ + + +G G+ G VYRG + +VAVKR L + F
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF- 61
Query: 791 GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLD 849
EV +++ HPNV+ + I E +L + + +
Sbjct: 62 ----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 850 ERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV-----DKNWVVKVCDFGLSRM-- 902
+ + G+ +LH+ IVHRDLK N+L+ + DFGL +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 903 -KHNTFLSSRSTAGTAEWMAPEVLRNEPS---DEKCDVYSFGVILWE-LCTMQQPWGGMN 957
++F GT W+APE+L + D++S G + + + P+G
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 958 PMQV---VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
Q +GA L + D ++I K DP+ RP+ ++
Sbjct: 235 QRQANILLGACSLDC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 45/282 (15%)
Query: 752 WEEITLGERIGLGSYGEVYRG----DWHGTEVAVKRFLDQDFFGES-LEEFRSEVLIMKR 806
+ E E+IG G +G V++ D G A+KR + G + EV
Sbjct: 13 FHE---LEKIGSGEFGSVFKCVKRLD--GCIYAIKR-SKKPLAGSVDEQNALREVYAHAV 66
Query: 807 V-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL---HRPNNQLDERRRLRMALDAAR 862
+ +H +VV + A ++ I E+ GSL + +R + E + L R
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKN-------------------WVVKVCDFGLSRMK 903
G+ Y+H+ + +VH D+K N+ + + + K+ D G
Sbjct: 127 GLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 904 HNTFLSSRSTAGTAEWMAPEVLR-NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV 962
+ + G + ++A EVL+ N K D+++ + + + + +
Sbjct: 185 SSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240
Query: 963 GAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
Q R IP L ++++ DP+ RP+ ++
Sbjct: 241 ----RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 36/268 (13%)
Query: 751 PWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P E T E+IG GS+GEV++G + VA+K +D + + +E+ + E+ ++ +
Sbjct: 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCD 78
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
P V + G+ + L I+ E+L GS LL LDE + + + +G++YLH
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH 136
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------RMKHNTFLSSRSTAGTAEWMAP 922
+ +HRD+K+ N+L+ ++ VK+ DFG++ ++K NTF GT WMAP
Sbjct: 137 SEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAP 188
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP------- 975
EV++ D K D++S G+ EL + P ++PM+V+ IP
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTL 239
Query: 976 -DNLDPAVADIIRKCWQTDPKMRPTFTE 1002
N + + + C +P RPT E
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-48
Identities = 62/312 (19%), Positives = 108/312 (34%), Gaps = 51/312 (16%)
Query: 753 EEITLGERIGLGSYGEVY----RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+ + +G G +G V+ + D A+KR + + E+ EV + ++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVD--DCNYAIKR-IRLPNRELAREKVMREVKALAKLE 61
Query: 809 HPNVVLFMGA------------VTRPPNLSIVAEFLPRGSLYRLLH--RPNNQLDERRRL 854
HP +V + A + L I + + +L ++ + + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 855 RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914
+ L A + +LH+ ++HRDLK N+ + VVKV DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 915 ------------GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV 962
GT +M+PE + K D++S G+IL+EL M ++ +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTL 237
Query: 963 GAVGFQHRRLDIPDNLD---PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP-ITSSQ 1018
V R L P P +++ P RP I ++
Sbjct: 238 TDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI------IENAVFEDLD 287
Query: 1019 VPRPVPSVSSGR 1030
P R
Sbjct: 288 FPGKTVLRQRSR 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-47
Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 34/273 (12%)
Query: 751 PWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRV 807
P E + +G G++G+VY+ G A K + E LE++ E+ I+
Sbjct: 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATC 73
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
HP +V +GA L I+ EF P G++ ++ + L E + + +N+L
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------RMKHNTFLSSRSTAGTAEWMA 921
H+ I+HRDLK+ N+L+ +++ DFG+S K ++F+ GT WMA
Sbjct: 134 HSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMA 185
Query: 922 PEVLRNEPS-----DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----- 971
PEV+ E D K D++S G+ L E+ ++ P +NPM+V+ + +
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LKIAKSDPPT 241
Query: 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
L P D ++ +P+ RP+ +++
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-46
Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 23/283 (8%)
Query: 730 RSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGD--WHGTEVAVKRF-LD 786
+ + + D+ + + P E + E++G GSYG VY+ G VA+K+ ++
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE 65
Query: 787 QDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNN 846
D L+E E+ IM++ P+VV + G+ + +L IV E+ GS+ ++ N
Sbjct: 66 SD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120
Query: 847 QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------ 900
L E + +G+ YLH +HRD+K+ N+L++ K+ DFG++
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178
Query: 901 RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ 960
K NT + GT WMAPEV++ + D++S G+ E+ + P+ ++PM+
Sbjct: 179 MAKRNTVI------GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232
Query: 961 VVGAVGFQHR-RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTE 1002
+ + P+ D +++C P+ R T T+
Sbjct: 233 AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 71/262 (27%), Positives = 128/262 (48%), Gaps = 23/262 (8%)
Query: 751 PWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRV 807
P ++ T E+IG G+ G VY G EVA+++ L Q E +E+L+M+
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN 74
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
++PN+V ++ + L +V E+L GSL ++ +DE + + + + + +L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFL 132
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------RMKHNTFLSSRSTAGTAEWMA 921
H+ ++HRD+KS N+L+ + VK+ DFG + K +T GT WMA
Sbjct: 133 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMA 184
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDP 980
PEV+ + K D++S G++ E+ + P+ NP++ + + L P+ L
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 981 AVADIIRKCWQTDPKMRPTFTE 1002
D + +C + D + R + E
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKE 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 31/266 (11%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWHGT--EVAVKRF-LDQDFFGESLEEFRSEVLIMKRV 807
P + +IG GS G V + +VAVK L + + E +EV+IM+
Sbjct: 43 PRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY 99
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
+H NVV + L ++ EFL G+L ++ +L+E + + + + YL
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYL 157
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------RMKHNTFLSSRSTAGTAEWMA 921
H ++HRD+KS ++L+ + VK+ DFG K + GT WMA
Sbjct: 158 HAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL------VGTPYWMA 209
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-----RLDIPD 976
PEV+ + D++S G+++ E+ + P+ +P+Q + + R +L
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----KRLRDSPPPKLKNSH 265
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTE 1002
+ P + D + + DP+ R T E
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQE 291
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 57/299 (19%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
L + +G G+ V+RG H G A+K + F ++ E ++K++ H N+
Sbjct: 12 LLSDILGQGATANVFRG-RHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 813 V-LFMGAV---TRPPNLSIVAEFLPRGSLYRLLHRPNNQ--LDERRRLRMALDAARGMNY 866
V LF A+ T + ++ EF P GSLY +L P+N L E L + D GMN+
Sbjct: 70 VKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 867 LHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
L IVHR++K N++ D V K+ DFG +R ++ + S GT E++
Sbjct: 128 LRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLH 183
Query: 922 PEVLR--------NEPSDEKCDVYSFGVILWELCT-----------------MQQPWGGM 956
P++ + D++S GV + T M + G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 957 NPMQVVGAVGFQHRRLD----------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ G ++ +D + L + ++ + D + F + A
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 75/273 (27%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 750 IPWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
I ++ L E IG G+ V +VA+KR ++ + S++E E+ M +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQC 70
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL-------HRPNNQLDERRRLRMALDA 860
HPN+V + + L +V + L GS+ ++ + LDE + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG----LSRMKHNTFLSSRST-AG 915
G+ YLH +HRD+K+ N+L+ ++ V++ DFG L+ T R T G
Sbjct: 131 LEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 916 TAEWMAPEVL-RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVV------GAVGFQ 968
T WMAPEV+ + D K D++SFG+ EL T P+ PM+V+ +
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 969 HRRLDIPD--NLDPAVADIIRKCWQTDPKMRPT 999
D + +I C Q DP+ RPT
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 12/253 (4%)
Query: 757 LGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEE-FRSEVLIMKRVRHPNVV 813
+G +G G +G VY R +A+K +E R EV I +RHPN++
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
G + ++ E+ P G++YR L + ++ DE+R + A ++Y H+
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA-GTAEWMAPEVLRNEPSDE 932
++HRD+K NLL+ +K+ DFG S ++ R+ GT +++ PE++ DE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDE 186
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT 992
K D++S GV+ +E + P+ + + PD + D+I + +
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKH 244
Query: 993 DPKMRPTFTEIMA 1005
+P RP E++
Sbjct: 245 NPSQRPMLREVLE 257
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-44
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 28/297 (9%)
Query: 721 NSEGERVSDRSASNDSSKSDVGDDVAECEI---PWEEITLGERIGLGSYGEVYRG--DWH 775
N + D + + S DVAE P + + IG GS+G VY +
Sbjct: 19 NLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRN 78
Query: 776 GTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPR 834
VA+K+ E ++ EV ++++RHPN + + G R +V E+
Sbjct: 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137
Query: 835 GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKV 894
GS LL L E + A +G+ YLH+ ++HRD+K+ N+L+ + +VK+
Sbjct: 138 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKL 195
Query: 895 CDFGLS--RMKHNTFLSSRSTAGTAEWMAPEVLRNEPS---DEKCDVYSFGVILWELCTM 949
DFG + N+F GT WMAPEV+ D K DV+S G+ EL
Sbjct: 196 GDFGSASIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
Query: 950 QQPWGGMNPMQVVGAVGFQHRRLDIP----DNLDPAVADIIRKCWQTDPKMRPTFTE 1002
+ P MN M + + + + P + + + C Q P+ RPT
Sbjct: 250 KPPLFNMNAMSAL----YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 9e-44
Identities = 70/317 (22%), Positives = 124/317 (39%), Gaps = 59/317 (18%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
L + +G G+ V+RG H G A+K + F ++ E ++K++ H N+
Sbjct: 12 LLSDILGQGATANVFRG-RHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 813 V-LFMGAV---TRPPNLSIVAEFLPRGSLYRLLHRPNNQ--LDERRRLRMALDAARGMNY 866
V LF A+ T + ++ EF P GSLY +L P+N L E L + D GMN+
Sbjct: 70 VKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 867 LHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
L IVHR++K N++ D V K+ DFG +R ++ + S GT E++
Sbjct: 128 LRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLH 183
Query: 922 PEVLR--------NEPSDEKCDVYSFGVILWELCTMQQPW----GGMNPMQVV------- 962
P++ + D++S GV + T P+ G +V+
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 963 -------------GAVGFQHRRL---DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006
G + + + L + ++ + D + F + A
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 1007 LKPL--QKPITSSQVPR 1021
+ + I + +
Sbjct: 304 TSDILHRMVIHVFSLQQ 320
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 1e-43
Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+ ER+G G +G V R H G +VA+K Q+ ++ E + E+ IMK++ HPNV
Sbjct: 17 EMKERLGTGGFGYVLRW-IHQDTGEQVAIK-QCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 813 V-LF-----MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ--LDERRRLRMALDAARGM 864
V + + + E+ G L + L++ N L E + D + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKN---WVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWM 920
YLH I+HRDLK N+++ + K+ D G ++ + + GT +++
Sbjct: 135 RYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQYL 190
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTMQQPW-GGMNPMQ------------------V 961
APE+L + D +SFG + +E T +P+ P+Q +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 962 VGAVGFQHRRLDIPDNLDPAVADIIRKCW-----QTDPKMRPTFTEIM 1004
GAV F L P++L +A + + W + R T +
Sbjct: 251 TGAVKF-SSVLPTPNHLSGILAGKLER-WLQCMLMWHQRQRGTDPQNP 296
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 83/300 (27%), Positives = 132/300 (44%), Gaps = 41/300 (13%)
Query: 731 SASNDSSKSDVGD-DVAECEIPWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQ 787
S ++DS + + D++ P L E +G G+YG+VY+G G A+K
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV---M 57
Query: 788 DFFGESLEEFRSEVLIMKRV-RHPNVVLFMGA------VTRPPNLSIVAEFLPRGSLYRL 840
D G+ EE + E+ ++K+ H N+ + GA L +V EF GS+ L
Sbjct: 58 DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 841 LH-RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899
+ N L E + + RG+++LH ++HRD+K N+L+ +N VK+ DFG+
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 900 S------RMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-----DEKCDVYSFGVILWELCT 948
S + NTF GT WMAPEV+ + + D K D++S G+ E+
Sbjct: 176 SAQLDRTVGRRNTF------IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 949 MQQPWGGMNPMQVVGAVGFQHRRLDIP----DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
P M+PM+ + F R P I C + RP ++M
Sbjct: 230 GAPPLCDMHPMRAL----FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 66/252 (26%), Positives = 114/252 (45%), Gaps = 10/252 (3%)
Query: 757 LGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEE-FRSEVLIMKRVRHPNVV 813
+G +G G +G VY R + +A+K E +E R E+ I +RHPN++
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ ++ EF PRG LY+ L + + + DE+R + A ++Y H
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEK 933
++HRD+K NLL+ +K+ DFG S + R+ GT +++ PE++ + DEK
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLPPEMIEGKTHDEK 192
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTD 993
D++ GV+ +E P+ + + + + L P L D+I K +
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLISKLLRYH 250
Query: 994 PKMRPTFTEIMA 1005
P R +M
Sbjct: 251 PPQRLPLKGVME 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 75/349 (21%), Positives = 127/349 (36%), Gaps = 90/349 (25%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEE 796
D ++ E P + + LG+ +G G++G+V D G VAVK L +
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRA 71
Query: 797 FRSEV---------------------------LIMKRVRHPNVVLF-MGAVTRPPNLSIV 828
SE+ +I++ + N+ +
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 829 AEFLPRGSLY---------------------------------------RLLHRPNNQLD 849
+G Y + L
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 850 ERRRLRMALDAARGMNYL--HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHN 905
+ + A+GM +L C +HRDL + N+L+ + VVK+CDFGL+R K
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
Query: 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGM-NPMQVVG 963
++ +WMAPE + + + DV+SFGV+LWE+ ++ P+ G+ +
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
Query: 964 AV--GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ G R+ PD P + + CW +P RPTF+E++ L L
Sbjct: 308 RLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 71/273 (26%), Positives = 124/273 (45%), Gaps = 27/273 (9%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLI-MK 805
E+ +++ +G G+YG V + G +AVKR + + + ++ I M+
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSL---YRLLHRPNNQLDERRRLRMALDAAR 862
V P V F GA+ R ++ I E + SL Y+ + + E ++A+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----MKHNTFLSSRSTAGTA 917
+ +LH+ VI HRD+K N+L++ VK+CDFG+S + + AG
Sbjct: 121 ALEHLHSKLSVI-HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCK 173
Query: 918 EWMAPEVLRNEPS----DEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGA-VGFQHRR 971
+MAPE + E + K D++S G+ + EL ++ P+ P Q + V +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233
Query: 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
L D D +C + + K RPT+ E+M
Sbjct: 234 LP-ADKFSAEFVDFTSQCLKKNSKERPTYPELM 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-41
Identities = 64/325 (19%), Positives = 124/325 (38%), Gaps = 51/325 (15%)
Query: 725 ERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRG--DWHGTEVAVK 782
E + ++ + E+ ++ +G G+ G V++ G +A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 783 RF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL 841
L+ + E+ ++ P +V F GA +SI E + GSL ++L
Sbjct: 65 LIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 842 HRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901
+ ++ E+ ++++ +G+ YL I+HRD+K N+LV+ +K+CDFG+S
Sbjct: 123 KKAG-RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV 961
++ + S GT +M+PE L+ + D++S G+ L E+ + P + ++
Sbjct: 181 QLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 962 VGAVGFQHRRLD---------------------------------IPDNLDPAVA----- 983
G Q I + P +
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298
Query: 984 ----DIIRKCWQTDPKMRPTFTEIM 1004
D + KC +P R ++M
Sbjct: 299 LEFQDFVNKCLIKNPAERADLKQLM 323
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 16/285 (5%)
Query: 732 ASNDSSKSDVGDDVAE--CEIPWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQ 787
+S S K + + ++ +G G+ G+V++ G +AVK+ + +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRR 60
Query: 788 DFFGESLEEFRSEVLI-MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNN 846
E + ++ + +K P +V G ++ I E + +L R
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG 119
Query: 847 QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906
+ ER +M + + + YL VI HRD+K N+L+D+ +K+CDFG+S +
Sbjct: 120 PIPERILGKMTVAIVKALYYLKEKHGVI-HRDVKPSNILLDERGQIKLCDFGISGRLVDD 178
Query: 907 FLSSRSTAGTAEWMAPEVLRNEPS-----DEKCDVYSFGVILWELCTMQQPWGGMNP-MQ 960
+ +AG A +MAPE + D + DV+S G+ L EL T Q P+ +
Sbjct: 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237
Query: 961 VVGA-VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
V+ + + L ++ C D + RP + +++
Sbjct: 238 VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-40
Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 46/287 (16%)
Query: 756 TLGERIGLGSYGEV-YRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
+ +G GS G V ++G + G VAVKR L + E+ ++ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVI 72
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR-------GMNY 866
+ + T L I E +L L+ N DE +L+ + G+ +
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNV-SDENLKLQKEYNPISLLRQIASGVAH 130
Query: 867 LHNCTPVIVHRDLKSPNLLVD-------------KNWVVKVCDFGLSRM---KHNTFLSS 910
LH+ I+HRDLK N+LV +N + + DFGL + ++F ++
Sbjct: 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 911 RSTA-GTAEWMAPEVLRN-------EPSDEKCDVYSFGVILWE-LCTMQQPWGGMNPMQ- 960
+ GT+ W APE+L D++S G + + L + P+G +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 961 --VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ G + +L D+I + DP RPT +++
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 52/291 (17%), Positives = 110/291 (37%), Gaps = 47/291 (16%)
Query: 757 LGERIGLGSYGEVYRGDWHGTEVAVK---------------RFLDQDFFGESLEEFRSEV 801
+ + G + ++ + A+K D+ ++F++E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
I+ +++ + G +T + I+ E++ S+ + LD+ + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVI 153
Query: 862 R--------GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST 913
+ +Y+HN I HRD+K N+L+DKN VK+ DFG S + + + +
Sbjct: 154 KCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGS 210
Query: 914 AGTAEWMAPEVLRNEP--SDEKCDVYSFGVILWELCTMQQP-WGGMNPMQ---------- 960
GT E+M PE NE + K D++S G+ L+ + P ++ ++
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 961 -------VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ + L D ++ + +P R T + +
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 76/295 (25%), Positives = 120/295 (40%), Gaps = 58/295 (19%)
Query: 757 LGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGES--LEEFRSEVLIMKRVRHPN 811
G +G G + + + A K + + + E+ E+ I + + H +
Sbjct: 19 RGRFLGKGGFAKCFEIS-DADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------G 863
VV F G + +V E R SL L +RR + AR G
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLG 127
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923
YLH ++HRDLK NL ++++ VK+ DFGL+ + GT ++APE
Sbjct: 128 CQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD---------- 973
VL + + DV+S G I++ L +VG F+ L
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTL--------------LVGKPPFETSCLKETYLRIKKNE 231
Query: 974 --IPDNLDPAVADIIRKCWQTDPKMRPTFTEIM------AALKPLQKPITSSQVP 1020
IP +++P A +I+K QTDP RPT E++ + P + PIT +P
Sbjct: 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIP 286
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 76/259 (29%), Positives = 125/259 (48%), Gaps = 23/259 (8%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPN 811
L + IG G++ +V H G EVA+K +D+ + L++ EV IMK + HPN
Sbjct: 18 RLLKTIGKGNFAKVKLA-RHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 812 VV-LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYL 867
+V LF T L ++ E+ G ++ L + ++ E R + R + A + Y
Sbjct: 76 IVKLFEVIET-EKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSA---VQYC 130
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLR 926
H IVHRDLK+ NLL+D + +K+ DFG S L + G + APE+ +
Sbjct: 131 HQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQ 186
Query: 927 NEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
+ D + DV+S GVIL+ L + P+ G N ++ V + IP + ++
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENL 244
Query: 986 IRKCWQTDPKMRPTFTEIM 1004
+++ +P R T +IM
Sbjct: 245 LKRFLVLNPIKRGTLEQIM 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-39
Identities = 60/265 (22%), Positives = 108/265 (40%), Gaps = 35/265 (13%)
Query: 757 LGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEE-FRSEVLIMKRVRHPNVV 813
+G +G GS+ VY G EVA+K + + + + ++EV I +++HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ +V E G + R L E GM YLH+
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTA-GTAEWMAPEVLRNEPSD 931
I+HRDL NLL+ +N +K+ DFGL+ ++K T GT +++PE+
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHG 190
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------RLDIPDNLD 979
+ DV+S G + + L ++G F ++P L
Sbjct: 191 LESDVWSLGCMFYTL--------------LIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIM 1004
D+I + + +P R + + ++
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVL 261
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 67/271 (24%), Positives = 126/271 (46%), Gaps = 19/271 (7%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRSEVLI-MK 805
+ E++ IG G+YG V + G +AVKR + + ++ ++ + M+
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMR 76
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR----PNNQLDERRRLRMALDAA 861
P +V F GA+ R + I E + S + ++ + E ++ L
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMA 921
+ +N+L +I HRD+K N+L+D++ +K+CDFG+S ++ ++ AG +MA
Sbjct: 136 KALNHLKENLKII-HRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMA 193
Query: 922 PEVLRNEPS----DEKCDVYSFGVILWELCTMQQPWGGMNPM--QVVGAVGFQHRRLDIP 975
PE + S D + DV+S G+ L+EL T + P+ N + Q+ V +L
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253
Query: 976 DNLD--PAVADIIRKCWQTDPKMRPTFTEIM 1004
+ + P+ + + C D RP + E++
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-39
Identities = 52/311 (16%), Positives = 97/311 (31%), Gaps = 25/311 (8%)
Query: 744 DVAECEIPWEEITLGERIGLG--SYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS 799
++ L IG G V G V V+R + E + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLL-HRPNNQLDERRRLRMAL 858
E+ + K HPN+V + L +V F+ GS L+ + ++E +
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 859 DAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS------RMKHNTFLSSRS 912
+ ++Y+H+ VHR +K+ ++L+ + V + + +
Sbjct: 136 GVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 913 T-AGTAEWMAPEVLRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH 969
W++PEVL+ D K D+YS G+ EL P+ M Q++
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML------- 246
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVSSG 1029
L+ + P + D + L
Sbjct: 247 --LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304
Query: 1030 RETGQISKFLA 1040
+ F+
Sbjct: 305 TFSPHFHHFVE 315
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 29/266 (10%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ E +G G++ V R T E A K + ++ E I ++++HPN+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GMN 865
++ +V + + G L+ ++ R E DA+ +
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEA-------DASHCIQQILESIA 119
Query: 866 YLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
Y H+ IVHR+LK NLL+ K VK+ DFGL+ + + AGT +++
Sbjct: 120 YCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLS 175
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLD 979
PEVL+ +P + D+++ GVIL+ L P+ + ++ + P D +
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMA 1005
P +I +PK R T + +
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALK 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 76/295 (25%), Positives = 120/295 (40%), Gaps = 58/295 (19%)
Query: 757 LGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGES--LEEFRSEVLIMKRVRHPN 811
G +G G + + + A K + + + E+ E+ I + + H +
Sbjct: 45 RGRFLGKGGFAKCFEIS-DADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------G 863
VV F G + +V E R SL L +RR + AR G
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLG 153
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923
YLH ++HRDLK NL ++++ VK+ DFGL+ + GT ++APE
Sbjct: 154 CQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD---------- 973
VL + + DV+S G I++ L +VG F+ L
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTL--------------LVGKPPFETSCLKETYLRIKKNE 257
Query: 974 --IPDNLDPAVADIIRKCWQTDPKMRPTFTEIM------AALKPLQKPITSSQVP 1020
IP +++P A +I+K QTDP RPT E++ + P + PIT +P
Sbjct: 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIP 312
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 82/259 (31%), Positives = 124/259 (47%), Gaps = 16/259 (6%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ +G GS+GEV + T E AVK + EV ++K++ HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ + IV E G L+ ++ R + E R+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 873 VIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNE 928
IVHRDLK N+L+ +K+ +K+ DFGLS + NT + R GTA ++APEVLR
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-G 197
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADII 986
DEKCDV+S GVIL+ L + P+ G N ++ V D+P + D+I
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 987 RKCWQTDPKMRPTFTEIMA 1005
RK P +R T T+ +
Sbjct: 258 RKMLTFHPSLRITATQCLE 276
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-38
Identities = 85/284 (29%), Positives = 139/284 (48%), Gaps = 21/284 (7%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+++G G+YGEV T E A+K S + EV ++K + HPN++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
N +V E G L+ ++HR + +E + G+ YLH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 873 VIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNE 928
IVHRDLK NLL+ +K+ ++K+ DFGLS ++ + R GTA ++APEVLR +
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER--LGTAYYIAPEVLR-K 212
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADII 986
DEKCDV+S GVIL+ L P+GG +++ V D P N+ D+I
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272
Query: 987 RKCWQTDPKMRPTFTEIMAALK-P-LQKPITSSQVPRPVPSVSS 1028
++ Q D + R + + AL+ P +++ + + +PS+++
Sbjct: 273 KQMLQFDSQRRISAQQ---ALEHPWIKEMCSKKESGIELPSLAN 313
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-38
Identities = 58/271 (21%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRF------LDQDFFGESLEEFRSEVLIMKR 806
+ + +G G+ GEV + +VA++ + + +E+ I+K+
Sbjct: 138 IMSKTLGSGACGEVKLA-FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMN 865
+ HP ++ + IV E + G L+ +++ +L E +
Sbjct: 197 LNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQ 253
Query: 866 YLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
YLH I+HRDLK N+L+ +++ ++K+ DFG S+ + + + R+ GT ++A
Sbjct: 254 YLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLA 309
Query: 922 PEVLRNEPS---DEKCDVYSFGVILWELCTMQQP-WGGMNPMQVVGAVGFQHRRLDIP-- 975
PEVL + + + D +S GVIL+ + P + + + + +
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYNFIPE 367
Query: 976 --DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ D+++K DPK R T E +
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 25/252 (9%)
Query: 770 YRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829
++ + + + ++ ++ M N V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 830 EFLPRGSLYRLLHR--PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD 887
+ + +L ++R + L + + A + +LH+ ++HRDLK N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 888 KNWVVKVCDFGLSRMKHNTFLSSRSTA------------GTAEWMAPEVLRNEPSDEKCD 935
+ VVKV DFGL GT +M+PE + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 936 VYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD---PAVADIIRKCWQT 992
++S G+IL+EL M ++++ V R L P P +++
Sbjct: 259 IFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSP 312
Query: 993 DPKMRPTFTEIM 1004
P RP T+I+
Sbjct: 313 SPTERPEATDII 324
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 39/273 (14%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
W+ L + +G G+YGEV + VAVK +D + E + E+ I K +
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAV-NRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML 62
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR----- 862
H NVV F G + E+ G L+ ++++ + A+
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF-------DRIEPDIGMPE--PDAQRFFHQ 113
Query: 863 ---GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTA-GTA 917
G+ YLH I HRD+K NLL+D+ +K+ DFGL+ ++N + GT
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 918 EWMAPEVLRNEPSD-EKCDVYSFGVILWELCTMQQPW-GGMNPMQV---VGAVGFQHRRL 972
++APE+L+ E DV+S G++L + + PW + Q
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 228
Query: 973 DIP-DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
P +D A ++ K +P R T +I
Sbjct: 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIK 260
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-37
Identities = 83/261 (31%), Positives = 122/261 (46%), Gaps = 32/261 (12%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+ +G GS+GEV + E AVK + EV ++K++ HPN+
Sbjct: 25 NIVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GM 864
+ + + IV E G L+ ++ R + E DAAR G+
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEH-------DAARIIKQVFSGI 134
Query: 865 NYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWM 920
Y+H IVHRDLK N+L+ +K+ +K+ DFGLS + NT + R GTA ++
Sbjct: 135 TYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYI 190
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNL 978
APEVLR DEKCDV+S GVIL+ L + P+ G N ++ V D+P +
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 979 DPAVADIIRKCWQTDPKMRPT 999
D+IRK P +R T
Sbjct: 250 SDDAKDLIRKMLTFHPSLRIT 270
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 60/270 (22%), Positives = 123/270 (45%), Gaps = 21/270 (7%)
Query: 757 LGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFG--ESLEEFRSEVLIMKRVRHPNV 812
+ +++G G VY + +VA+K + E+L+ F EV ++ H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
V + +V E++ +L + + L + G+ + H+
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA-GTAEWMAPEVLRNEPSD 931
IVHRD+K N+L+D N +K+ DFG+++ T L+ + GT ++ +PE + E +D
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD-------NLDPAVAD 984
E D+YS G++L+E+ + P+ G + + +H + +P+ ++ ++++
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----IKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 985 IIRKCWQTDPKMRP-TFTEIMAALKPLQKP 1013
+I + + D R T E+ L +
Sbjct: 247 VILRATEKDKANRYKTIQEMKDDLSSVLHE 276
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 29/266 (10%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ E +G G++ V R T E A K + ++ E I ++++HPN+V
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GMN 865
++ +V + + G L+ ++ R E DA+ +
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEA-------DASHCIQQILESIA 142
Query: 866 YLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
Y H+ IVHR+LK NLL+ K VK+ DFGL+ + + AGT +++
Sbjct: 143 YCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLS 198
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLD 979
PEVL+ +P + D+++ GVIL+ L P+ + ++ + P D +
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMA 1005
P +I +PK R T + +
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALK 284
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 74/310 (23%), Positives = 120/310 (38%), Gaps = 47/310 (15%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRVR 808
+GE +G G + V + G E A K R G S EE EV I+++V
Sbjct: 15 DIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR----- 862
H NV+ ++ ++ E + G L+ L + L E +A
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEE-------EATSFIKQI 124
Query: 863 --GMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-MKHNTFLSSRSTAG 915
G+NYLH I H DLK N+++ +K+ DFGL+ ++ ++ G
Sbjct: 125 LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975
T E++APE++ EP + D++S GVI + L + P+ G + + + D
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TSVSYDFD 238
Query: 976 ----DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP-ITSSQVPRPVPSVSSGR 1030
+ D IRK + + R T E L+ P IT + + S
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEA------LRHPWITPVDNQQAMVRRESVV 292
Query: 1031 ETGQISKFLA 1040
K
Sbjct: 293 NLENFRKQYV 302
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 41/359 (11%), Positives = 98/359 (27%), Gaps = 64/359 (17%)
Query: 693 RSDGDADSAGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPW 752
+ GD R + R + ++ VS + +E
Sbjct: 17 QGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE----SELGERP 72
Query: 753 EEITLGERIGLGSYGEVYRGDWH---GTEVAVK-RFLDQDFFGESLEEFRSEVLIMKRVR 808
+ G +G G V + + ++++ + EVL ++ +R
Sbjct: 73 RTLVRGTVLGQEDPYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 809 -------------------------HPNVVLFMGAVTRPPNLSIVAEF-LPRGSLYRLLH 842
++ LS + + +L
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 843 ------RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCD 896
+ L RL++ L R + LH+ +VH L+ ++++D+ V +
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTG 249
Query: 897 FGLSRMKHNTFLSSRSTAGTAEWMAPEVL-----------RNEPSDEKCDVYSFGVILWE 945
F + ++ + + PE+ R D ++ G++++
Sbjct: 250 FEHLVRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 946 LCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ P + N+ V ++ + + R + M
Sbjct: 306 IWCADLPITKDAALGG------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 35/294 (11%), Positives = 71/294 (24%), Gaps = 48/294 (16%)
Query: 755 ITLGERIGLGSYGEVYRG-DWH-GTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPN 811
+ L E + +G V+ D + A+K F + + LE R+ +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 812 VVLFMG--------AVTRPPNLSIVAEF-----------------LPRGSLYRLLHR--- 843
+ A+ L L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 844 ---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900
+ R L + +VH NL + + + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 901 RMKHNTFLSSRSTAGTAEWMAPEVL--RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP 958
+++ + E L + + G+ ++ + + P+G + P
Sbjct: 242 WKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 959 -------MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ G L V +I + D + R E M
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 66/269 (24%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
++G G++G+V+ + + E +K +++D +E+ +E+ ++K + HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQ--LDERRRLRMALDAARGM------ 864
N+ IV E G L R++ L E A M
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG-------YVAELMKQMMNA 136
Query: 865 -NYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEW 919
Y H+ +VH+DLK N+L + +K+ DFGL+ K + ++ AGTA +
Sbjct: 137 LAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA--AGTALY 192
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD---IPD 976
MAPEV + KCD++S GV+++ L T P+ G + +V ++ +
Sbjct: 193 MAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECR 249
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
L P D++++ DP+ RP+ +++
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 759 ERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVL 814
+ +GLG G+V H G + A+K D + R EV + P++V
Sbjct: 35 QVLGLGVNGKVLECF-HRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVC 86
Query: 815 FMGA----VTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
+ L I+ E + G L+ R+ R + ER + D + +LH+
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 870 CTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
I HRD+K NLL +K+ V+K+ DFG ++ L ++ T ++APEVL
Sbjct: 147 HN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPEVLG 202
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR--LDIP----DNLDP 980
E D+ CD++S GVI++ L P+ + + + R P +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262
Query: 981 AVADIIRKCWQTDPKMRPTFTEIMA------ALKPLQKPITSSQVPR 1021
+IR +TDP R T T+ M ++ Q P+ +++V +
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ 309
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 72/264 (27%), Positives = 128/264 (48%), Gaps = 32/264 (12%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGES--LEEFRSEVLIMKRVRHP 810
LG+ +G+G++G+V G+ H G +VAVK L++ + + + E+ +K RHP
Sbjct: 14 VLGDTLGVGTFGKVKIGE-HQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR-------- 862
+++ ++ P + +V E++ G L+ + + + R+ AR
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELF-------DYICKHGRVEE--MEARRLFQQILS 122
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
++Y H +VHRDLK N+L+D + K+ DFGLS M FL R++ G+ + A
Sbjct: 123 AVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAA 178
Query: 922 PEVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980
PEV+ + D++S GVIL+ L P+ + + + + IP+ L+
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNR 236
Query: 981 AVADIIRKCWQTDPKMRPTFTEIM 1004
+VA ++ Q DP R T +I
Sbjct: 237 SVATLLMHMLQVDPLKRATIKDIR 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-36
Identities = 79/262 (30%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPN 811
+G GS+GEV G E AVK + E EV ++K++ HPN
Sbjct: 29 KGQRVLGKGSFGEVILC-KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------G 863
++ +V E G L+ ++ R + E DAAR G
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEV-------DAARIIRQVLSG 138
Query: 864 MNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEW 919
+ Y+H IVHRDLK NLL+ K+ +++ DFGLS + + + + GTA +
Sbjct: 139 ITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYY 194
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DN 977
+APEVL DEKCDV+S GVIL+ L + P+ G N ++ V ++P
Sbjct: 195 IAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 978 LDPAVADIIRKCWQTDPKMRPT 999
+ + D+IRK P MR +
Sbjct: 254 VSESAKDLIRKMLTYVPSMRIS 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 24/262 (9%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
TL IG GS+GEV GT A K+ E ++ F+ E+ IMK + HPN++
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNII 69
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPN-NQLDERRRLRMALDAARGMNYLHNCT 871
++ +V E G L+ R++H+ + D R ++ L A + Y H
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYCHKLN 126
Query: 872 PVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRN 927
+ HRDLK N L + +K+ DFGL+ K + ++ GT +++P+VL
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLEG 182
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP----DNLDPAVA 983
+CD +S GV+++ L P+ +V+ + + P N+ P
Sbjct: 183 -LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLNVSPQAE 239
Query: 984 DIIRKCWQTDPKMRPTFTEIMA 1005
+IR+ PK R T + +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALE 261
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-36
Identities = 76/310 (24%), Positives = 124/310 (40%), Gaps = 47/310 (15%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRVR 808
GE +G G + V + G + A K R G S E+ EV I+K ++
Sbjct: 14 DTGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR----- 862
HPNV+ ++ ++ E + G L+ L + L E +A
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEE-------EATEFLKQI 123
Query: 863 --GMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-MKHNTFLSSRSTAG 915
G+ YLH+ I H DLK N+++ +K+ DFGL+ + ++ G
Sbjct: 124 LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFG 179
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975
T E++APE++ EP + D++S GVI + L + P+ G + + V +
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--SAVNYEFE 237
Query: 976 DNLDPAVA----DIIRKCWQTDPKMRPTFTEIMAALKPLQKP-ITSSQVPRPVPSVSSGR 1030
D + D IR+ DPK R T + LQ P I + + +S
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS------LQHPWIKPKDTQQALSRKASAV 291
Query: 1031 ETGQISKFLA 1040
+ KF A
Sbjct: 292 NMEKFKKFAA 301
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-36
Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 45/273 (16%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVK-----------RFLDQDFFGESLEEFRSEVL 802
++G G+YGEV E A+K D + EE +E+
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAA 861
++K + HPN++ +V EF G L+ ++++R ++ DE DAA
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDEC-------DAA 149
Query: 862 R-------GMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSS 910
G+ YLH IVHRD+K N+L+ + +K+ DFGLS + L
Sbjct: 150 NIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 911 RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR 970
R GTA ++APEVL+ + +EKCDV+S GVI++ L P+GG N ++ V +
Sbjct: 208 R--LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--EKG 262
Query: 971 RLDIP----DNLDPAVADIIRKCWQTDPKMRPT 999
+ N+ ++I+ D R T
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 42/278 (15%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK-------RFLDQDFFGESLEEFRSEVLIMK 805
E +G G V R H E AVK + E E EV I++
Sbjct: 20 EPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 806 RV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR- 862
+V HPN++ +V + + +G L+ L + L E+ + +
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEK-------ETRKI 129
Query: 863 ------GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAG 915
+ LH IVHRDLK N+L+D + +K+ DFG S + L R G
Sbjct: 130 MRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCG 185
Query: 916 TAEWMAPEVLRNEPS------DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH 969
T ++APE++ + ++ D++S GVI++ L P+ M ++ + +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 970 RRLDIP--DNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ P D+ V D++ + P+ R T E +A
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-36
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 58/304 (19%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK---RFLDQDFFGESLEEFRSEVLIMKRVRH 809
L IG GSYG V A+K + + + +E ++EV +MK++ H
Sbjct: 29 HLKGAIGQGSYGVVRVA-IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMAL---------- 858
PN+ + +V E G L +L ++ + +
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 859 ---------------------DAAR-------GMNYLHNCTPVIVHRDLKSPNLLV--DK 888
+ ++YLHN I HRD+K N L +K
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNK 205
Query: 889 NWVVKVCDFGLSRM----KHNTFLSSRSTAGTAEWMAPEVLR--NEPSDEKCDVYSFGVI 942
++ +K+ DFGLS+ + + + AGT ++APEVL NE KCD +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 943 LWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRPTF 1000
L L P+ G+N + V + + P + L P D++ + R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 1001 TEIM 1004
+
Sbjct: 326 MRAL 329
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 39/273 (14%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
W+ L + +G G+YGEV + VAVK +D + E + E+ I K +
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAV-NRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML 62
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR----- 862
H NVV F G + E+ G L+ ++++ + A+
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF-------DRIEPDIGMPE--PDAQRFFHQ 113
Query: 863 ---GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTA-GTA 917
G+ YLH I HRD+K NLL+D+ +K+ DFGL+ ++N + GT
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 918 EWMAPEVLRNEPSD-EKCDVYSFGVILWELCTMQQPW-GGMNPMQV---VGAVGFQHRRL 972
++APE+L+ E DV+S G++L + + PW + Q
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 228
Query: 973 DIP-DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
P +D A ++ K +P R T +I
Sbjct: 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIK 260
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-36
Identities = 62/265 (23%), Positives = 110/265 (41%), Gaps = 26/265 (9%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
L E +G G++ V R E A + ++ E I + ++HPN+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGM-------N 865
+++ + ++ + + G L+ ++ R E DA+ +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEA-------DASHCIQQILEAVL 124
Query: 866 YLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922
+ H +VHR+LK NLL+ K VK+ DFGL+ + AGT +++P
Sbjct: 125 HCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDP 980
EVLR +P + D+++ GVIL+ L P+ + ++ + P D + P
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 981 AVADIIRKCWQTDPKMRPTFTEIMA 1005
D+I K +P R T E +
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALK 267
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 73/308 (23%), Positives = 119/308 (38%), Gaps = 43/308 (13%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRVR 808
+GE +G G + V + G E A K R G EE EV I+++V
Sbjct: 15 DIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR----- 862
HPN++ ++ ++ E + G L+ L + L E +A
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEE-------EATSFIKQI 124
Query: 863 --GMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-MKHNTFLSSRSTAG 915
G+NYLH I H DLK N+++ +K+ DFGL+ ++ ++ G
Sbjct: 125 LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975
T E++APE++ EP + D++S GVI + L + P+ G + + + D
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240
Query: 976 --DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP-ITSSQVPRPVPSVSSGRET 1032
D IRK + + R T E L+ P IT + + S
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEA------LRHPWITPVDTQQAMVRRESVVNL 294
Query: 1033 GQISKFLA 1040
K
Sbjct: 295 ENFKKQYV 302
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 36/266 (13%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRVR 808
+GE +G G + V + G E A K R L G S EE EV I++ +R
Sbjct: 8 EMGEELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR----- 862
HPN++ ++ ++ E + G L+ L + L E +A +
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTED-------EATQFLKQI 117
Query: 863 --GMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-MKHNTFLSSRSTAG 915
G++YLH+ I H DLK N+++ N +K+ DFG++ ++ ++ G
Sbjct: 118 LDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFG 173
Query: 916 TAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975
T E++APE++ EP + D++S GVI + L + P+ G + + + + D
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 233
Query: 976 --DNLDPAVADIIRKCWQTDPKMRPT 999
N D IR+ DPK R T
Sbjct: 234 YFSNTSELAKDFIRRLLVKDPKRRMT 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 35/295 (11%)
Query: 757 LGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFG--ESLEEFRSEVLIMKRVRHPNV 812
LGE +G G EV+ +VAVK L D FR E + HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 813 VLFMGAV--------TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGM 864
V AV P IV E++ +L ++H + +R + + DA + +
Sbjct: 75 V----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA---GTAEWMA 921
N+ H I+HRD+K N+++ VKV DFG++R ++ S TA GTA++++
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP------ 975
PE R + D + DVYS G +L+E+ T + P+ G +P+ V +QH R D
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVREDPIPPSARH 243
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVSSGR 1030
+ L + ++ K +P+ R M A L + P + R
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRAD--LVRVHNGEPPEAPKVLTDAER 296
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 47/286 (16%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK-----RFLDQDFFGES-------------- 793
TL + IG GSYG V + T A+K + + Q F
Sbjct: 16 TLKDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 794 -----LEEFRSEVLIMKRVRHPNVV-LF--MGAVTRPPNLSIVAEFLPRGSLYRLLHRPN 845
+E+ E+ I+K++ HPNVV L + +L +V E + +G + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTL-- 131
Query: 846 NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM--K 903
L E + D +G+ YLH I+HRD+K NLLV ++ +K+ DFG+S
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSD---EKCDVYSFGVILWELCTMQQPWGGMNPMQ 960
+ LS +T GT +MAPE L + DV++ GV L+ Q P+ M
Sbjct: 190 SDALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 961 VVGAVGFQHRRLDIPD--NLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ + + + L+ PD ++ + D+I + +P+ R EI
Sbjct: 248 LHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 66/316 (20%), Positives = 128/316 (40%), Gaps = 54/316 (17%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRF------LDQDFFGESLEEFRSEVLIMKR 806
+ + +G G+ GEV + +VA+K + + +E+ I+K+
Sbjct: 13 IMSKTLGSGACGEVKLA-FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR--- 862
+ HP ++ + IV E + G L+ +++ +L E
Sbjct: 72 LNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEA-------TCKLYFY 121
Query: 863 ----GMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRSTA 914
+ YLH I+HRDLK N+L+ +++ ++K+ DFG S+ + + + R+
Sbjct: 122 QMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC 177
Query: 915 GTAEWMAPEVLRNEPS---DEKCDVYSFGVILWELCTMQQP-WGGMNPMQVVGAVGFQHR 970
GT ++APEVL + + + D +S GVIL+ + P + + +
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSG 235
Query: 971 RLDIP----DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP-ITSSQVPRPVPS 1025
+ + + D+++K DPK R T E L+ P + + R
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA------LRHPWLQDEDMKRKFQD 289
Query: 1026 VSSG-RETGQISKFLA 1040
+ S E+ + + LA
Sbjct: 290 LLSEENESTALPQVLA 305
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 76/344 (22%), Positives = 125/344 (36%), Gaps = 53/344 (15%)
Query: 709 GSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGE 768
GS H++ ++K G + E ++ +G +G G +G
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQ---VGPLLGSGGFGS 58
Query: 769 VYRGDWH---GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRVRH--PNVVLFMGAV 819
VY G VA+K + + EV+++K+V V+ +
Sbjct: 59 VYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 820 TRPPNLSIVAEF-LPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNCTPVIV 875
RP + ++ E P L+ + L E R L+A R + HNC ++
Sbjct: 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVR---HCHNCG--VL 171
Query: 876 HRDLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSD-EK 933
HRD+K N+L+D N +K+ DFG + +T GT + PE +R
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRS 229
Query: 934 CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------LDIPDNLDPAVADIIR 987
V+S G++L+++ V G + F+H + + +IR
Sbjct: 230 AAVWSLGILLYDM--------------VCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR 275
Query: 988 KCWQTDPKMRPTFTEIMA------ALKPLQKPITSSQVPRPVPS 1025
C P RPTF EI L P + P PS
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 43/291 (14%), Positives = 96/291 (32%), Gaps = 44/291 (15%)
Query: 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGT-------EVAVKRFLDQDFFGESLEEFRS 799
E ++ + + + +G G++ +VY + +K E
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK-VQKPANPWE-FYIGTQ 116
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR----PNNQLDERRRLR 855
+ +K + F A +V E G+L ++ P + + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 856 MALDAARGMNYLHNCTPVIVHRDLKSPNLLV-----------DKNWVVKVCDFGLSR--- 901
A+ + +H+C I+H D+K N ++ D + + + D G S
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 902 -MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ 960
T +++ T+ + E+L N+P + + D + ++ + +
Sbjct: 235 LFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 961 VVGAVGFQ------------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPT 999
F+ H L+IPD D++R+ + + T
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
E +G G++ EV+ T A+K F + +E+ ++K+++H N+V
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GMN 865
+ +V + + G L+ R+L R E+ DA+ +
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEK-------DASLVIQQVLSAVK 120
Query: 866 YLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922
YLH IVHRDLK NLL ++N + + DFGLS+M+ N + + GT ++AP
Sbjct: 121 YLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAP 176
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP----DNL 978
EVL +P + D +S GVI + L P+ ++ + + + D++
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI--KEGYYEFESPFWDDI 234
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ D I + DP R T + ++
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALS 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 68/306 (22%), Positives = 115/306 (37%), Gaps = 44/306 (14%)
Query: 757 LGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-PNV 812
+ +G G + V + G E A K + + E E+ +++ + P V
Sbjct: 33 TSKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GM 864
+ + ++ E+ G ++ L + E D R G+
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN-------DVIRLIKQILEGV 144
Query: 865 NYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRM-KHNTFLSSRSTAGTAEWM 920
YLH IVH DLK N+L+ +K+ DFG+SR H L R GT E++
Sbjct: 145 YYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYL 200
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980
APE+L +P D+++ G+I + L T P+ G + + + +D +
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--SQVNVDYSEETFS 258
Query: 981 AVA----DIIRKCWQTDPKMRPTFTEIMAALK-P-LQKPITSSQVPRPVPSVSSGRETGQ 1034
+V+ D I+ +P+ RPT L LQ+ + S SS Q
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEI---CLSHSWLQQWDFENLFHPEETSSSS-----Q 310
Query: 1035 ISKFLA 1040
Sbjct: 311 TQDHSV 316
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 9e-35
Identities = 41/325 (12%), Positives = 94/325 (28%), Gaps = 54/325 (16%)
Query: 755 ITLGERIGLGSYGEVYRG-DWH-GTEVAVKRF-LDQDFFGESLEEFRSEVLIMKR----- 806
+ G +G D G V + ++++ + EVL ++
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 807 -----------------VRHPNVVLFMGAVTRPPNLSIVAEFL----PRGSLYRLLH--- 842
V+ P + ++ +++ F + +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 843 ---RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899
+ L RL++ L R + LH+ +VH L+ ++++D+ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 900 SRMKHNTFLSSRSTA-GTAEWMAPEVLRNEPSDEK-----CDVYSFGVILWELCTMQQPW 953
+ +S E A +L D ++ G+ ++ + P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 954 GGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA-----LK 1008
+ + F+ + +IP V ++ + + R + M L+
Sbjct: 318 TDDAALGGSEWI-FRSCK-NIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
Query: 1009 PLQKPITSSQVPRPVPSVSSGRETG 1033
P+ G
Sbjct: 372 TELSAALPLYQTDGEPTREGGAPPS 396
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 60/271 (22%), Positives = 110/271 (40%), Gaps = 40/271 (14%)
Query: 757 LGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFF---GESLEEFRSEVLIMKRVRHP 810
+G+ +G GSYG+V AVK L + + E+ +++R+RH
Sbjct: 9 MGDLLGEGSYGKVKEV-LDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 811 NVV-LF--MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR----- 862
NV+ L + + +V E+ G L P + A
Sbjct: 67 NVIQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPV--------CQAHGYFCQ 117
Query: 863 ---GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM----KHNTFLSSRSTAG 915
G+ YLH+ IVH+D+K NLL+ +K+ G++ + R++ G
Sbjct: 118 LIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQG 173
Query: 916 TAEWMAPEVLRNEP--SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD 973
+ + PE+ S K D++S GV L+ + T P+ G N ++ +
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKGSYA 231
Query: 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
IP + P ++D+++ + +P R + +I
Sbjct: 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 61/272 (22%), Positives = 104/272 (38%), Gaps = 46/272 (16%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRVR 808
LG +G G +G V+ G +VA+K + EV ++ +V
Sbjct: 34 RLGPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 809 ----HPNVVLFMGAVTRPPNLSIVAEF-LPRGSLYRLLHRPNNQLDE---RRRLRMALDA 860
HP V+ + +V E LP L+ + L E R + A
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAA 151
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
+ + H+ +VHRD+K N+L+D + K+ DFG + H+ GT +
Sbjct: 152 IQ---HCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVY 204
Query: 920 MAPEVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------L 972
PE + V+S G++L+++ V G + F+ + L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDM--------------VCGDIPFERDQEILEAEL 250
Query: 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
P ++ P +IR+C P RP+ EI+
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 74/329 (22%), Positives = 132/329 (40%), Gaps = 41/329 (12%)
Query: 704 EPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGL 763
S S N + ++ D D A + +++ + IG
Sbjct: 45 RDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGR 104
Query: 764 GSYGEVYRGDWH---GTEVAVKRF------LDQDFFGESLEEFRSEVLIMKRVR-HPNVV 813
G V R H G E AVK L + E E R E I+++V HP+++
Sbjct: 105 GVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GMN 865
+ + + +V + + +G L+ L + L E+ + ++
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEK-------ETRSIMRSLLEAVS 214
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEV 924
+LH IVHRDLK N+L+D N +++ DFG S ++ L R GT ++APE+
Sbjct: 215 FLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEI 270
Query: 925 LRNEPS------DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--D 976
L+ ++ D+++ GVIL+ L P+ + ++ + + P D
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ V D+I + Q DP+ R T + +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQ 359
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 61/267 (22%), Positives = 103/267 (38%), Gaps = 27/267 (10%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPN 811
+ +G GS+ + H AVK + + E+ +K HPN
Sbjct: 14 LKDKPLGEGSFSICRKC-VHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPN 67
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
+V + +V E L G L+ R+ + E + ++++H+
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV 125
Query: 871 TPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
+VHRDLK NLL + N +K+ DFG +R+K ++ T + APE+L
Sbjct: 126 G--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 928 EPSDEKCDVYSFGVILWELCTMQQP-WGGMNPMQVVGAVGFQHR----RLDIP----DNL 978
DE CD++S GVIL+ + + Q P + AV + N+
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMA 1005
D+I+ DP R + +
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 56/271 (20%), Positives = 103/271 (38%), Gaps = 44/271 (16%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLD-------QDFFGESLEEFRSEVLIMK 805
+ +G G++G V+ EV VK F+ L + E+ I+
Sbjct: 27 STMSPLGSGAFGFVWTAV-DKEKNKEVVVK-FIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 806 RVRHPNVVLFMGAVTRPPNLSIVAEFLPRGS-LY-RLLHRPNNQLDERRRL-RMALDAAR 862
RV H N++ + +V E G L+ + P + R + A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA-- 142
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMA 921
+ YL I+HRD+K N+++ +++ +K+ DFG + ++ + GT E+ A
Sbjct: 143 -VGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TFCGTIEYCA 197
Query: 922 PEVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------LDI 974
PEVL P + +++S GV L+ L V F +
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTL--------------VFEENPFCELEETVEAAIHP 243
Query: 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
P + + ++ Q P+ R T +++
Sbjct: 244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 39/290 (13%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKR-VRHPN 811
+ E IG+GSY R H E AVK S + E+ I+ R +HPN
Sbjct: 25 EVKEDIGVGSYSVCKRC-IHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPN 77
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
++ + +V E + G L ++L + ER + + + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ 135
Query: 871 TPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSRM--KHNTFLSSRSTAGTAEWMAPEV 924
+VHRDLK N+L +++CDFG ++ N L + TA ++APEV
Sbjct: 136 G--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYTANFVAPEV 191
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQP-WGG--MNPMQVVGAVGFQHRRLDIP--DNLD 979
L + D CD++S GV+L+ + T P G P +++ +G L +++
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIM----------AALKPLQKPITSSQV 1019
D++ K DP R T ++ L + V
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV 301
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 34/261 (13%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ +G G+ VYR GT A+K + R+E+ ++ R+ HPN++
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNII 111
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GMN 865
P +S+V E + G L+ R++ + ER DAA +
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEK--GYYSER-------DAADAVKQILEAVA 162
Query: 866 YLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRM-KHNTFLSSRSTAGTAEWMA 921
YLH IVHRDLK NLL + +K+ DFGLS++ +H + ++ GT + A
Sbjct: 163 YLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCA 218
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQP-WGGMNPMQVVGAVGFQHRRLDIP--DNL 978
PE+LR + D++S G+I + L +P + + + P D +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278
Query: 979 DPAVADIIRKCWQTDPKMRPT 999
D++RK DPK R T
Sbjct: 279 SLNAKDLVRKLIVLDPKKRLT 299
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 44/272 (16%)
Query: 756 TLGERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ IG G++G R VAVK ++++ + E + E++ + +RHPN+V
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVK-YIERGAAID--ENVQREIINHRSLRHPNIV 79
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GMN 865
F + P +L+I+ E+ G LY + R + D AR G++
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI---------CNAGRFSEDEARFFFQQLLSGVS 130
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWV--VKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAP 922
Y H+ I HRDLK N L+D + +K+CDFG S+ ++ +ST GT ++AP
Sbjct: 131 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAP 186
Query: 923 EVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPM-------QVVGAVGFQHRRLDI 974
EVL + D + DV+S GV L+ + P+ Q + +V + I
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-----I 241
Query: 975 PDN--LDPAVADIIRKCWQTDPKMRPTFTEIM 1004
PD+ + P +I + + DP R + EI
Sbjct: 242 PDDIRISPECCHLISRIFVADPATRISIPEIK 273
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 75/263 (28%), Positives = 123/263 (46%), Gaps = 33/263 (12%)
Query: 757 LGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGES--LEEFRSEVLIMKRVRHPN 811
+ E +G GS+G+V H +VA+K F+ + +S E+ +K +RHP+
Sbjct: 13 IRETLGEGSFGKVKLAT-HYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------G 863
++ +T P ++ +V E+ G L+ + + E++R+ D R
Sbjct: 71 IIKLYDVITTPTDIVMVIEYAG-GELF-------DYIVEKKRMTE--DEGRRFFQQIICA 120
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAP 922
+ Y H IVHRDLK NLL+D N VK+ DFGLS M FL +++ G+ + AP
Sbjct: 121 IEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAP 176
Query: 923 EVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981
EV+ + + DV+S G++L+ + + P+ + V +PD L P
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPG 234
Query: 982 VADIIRKCWQTDPKMRPTFTEIM 1004
+IR+ DP R T EI
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIR 257
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 75/300 (25%), Positives = 117/300 (39%), Gaps = 52/300 (17%)
Query: 759 ERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVL 814
+ +G G++ V + E AVK Q G EV ++ + + H NV+
Sbjct: 19 DVLGEGAHARVQTCI-NLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ +V E + GS+ + R +E + D A +++LHN
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG-- 131
Query: 874 IVHRDLKSPNLLV---DKNWVVKVCDFGLSR-MKHNTFLSSRST------AGTAEWMAPE 923
I HRDLK N+L ++ VK+CDF L +K N S ST G+AE+MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 924 VLRNEPS-----DEKCDVYSFGVIL----------WELCTMQQPWGGMNPMQVVGAVGF- 967
V+ D++CD++S GVIL C W + F
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 968 --QHRRLDIP----DNLDPAVADIIRKCWQTDPKMRPTFTEIM--------AALKPLQKP 1013
Q + + P ++ A D+I K D K R + +++ A L P
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTP 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-33
Identities = 70/379 (18%), Positives = 144/379 (37%), Gaps = 53/379 (13%)
Query: 694 SDGDADSAGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWE 753
+ + HN +++R S + D+ P++
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 754 ---------------EITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLE 795
++ E +G G +G+V++ + G ++A K + + E
Sbjct: 75 HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE-ETATGLKLAAK-IIKTRGM-KDKE 131
Query: 796 EFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRL 854
E ++E+ +M ++ H N++ A ++ +V E++ G L+ R++ + L E
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTEL--- 187
Query: 855 RMALDAAR-------GMNYLHNCTPVIVHRDLKSPNLLV--DKNWVVKVCDFGLSR-MKH 904
D G+ ++H I+H DLK N+L +K+ DFGL+R K
Sbjct: 188 ----DTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGA 964
L + GT E++APEV+ + D++S GVI + L + P+ G N + +
Sbjct: 242 REKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
Query: 965 VGFQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP-ITSSQVPR 1021
+ L+ ++ + I K + R + +E L+ P ++ ++
Sbjct: 300 ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA------LKHPWLSDHKLHS 353
Query: 1022 PVPSVSSGRETGQISKFLA 1040
+ + F+
Sbjct: 354 RLSAQKKKNRGSDAQDFVT 372
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-33
Identities = 73/263 (27%), Positives = 127/263 (48%), Gaps = 32/263 (12%)
Query: 757 LGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGES--LEEFRSEVLIMKRVRHPN 811
LG+ +G+G++G+V G H G +VAVK L++ + + R E+ +K RHP+
Sbjct: 20 LGDTLGVGTFGKVKVGK-HELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------G 863
++ ++ P ++ +V E++ G L+ + + + RL +R G
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELF-------DYICKNGRLDE--KESRRLFQQILSG 128
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAP 922
++Y H +VHRDLK N+L+D + K+ DFGLS M FL R++ G+ + AP
Sbjct: 129 VDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAP 184
Query: 923 EVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981
EV+ + D++S GVIL+ L P+ + + + P L+P+
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPS 242
Query: 982 VADIIRKCWQTDPKMRPTFTEIM 1004
V +++ Q DP R T +I
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIR 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 57/285 (20%), Positives = 102/285 (35%), Gaps = 29/285 (10%)
Query: 756 TLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFG--ESLEEFRSEVLIMKRVRHPN 811
L +G G G+VY D VA+K + + + E R++ P+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 812 VVLFMGAV----TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
VV + L + + L +L R L R + + ++
Sbjct: 96 VV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAA 150
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA-GTAEWMAPEVLR 926
H HRD+K N+LV + + DFG++ + L+ GT +MAPE
Sbjct: 151 HAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP------DNLDP 980
+ + D+Y+ +L+E T P+ G + + V+ H IP +
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVM----GAHINQAIPRPSTVRPGIPV 263
Query: 981 AVADIIRKCWQTDPKMR-PTFTEIMAALKPLQKPITSSQVPRPVP 1024
A +I + +P+ R T ++ AA + +
Sbjct: 264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILR 308
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-33
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 39/292 (13%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPN 811
+ +GLG G+V + ++ + A+K D + R EV + R + P+
Sbjct: 65 VTSQVLGLGINGKVLQI-FNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPH 116
Query: 812 VVLFMGA----VTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGMNY 866
+V + L IV E L G L+ R+ R + ER + + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 867 LHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRM--KHNTFLSSRSTAGTAEWMA 921
LH+ I HRD+K NLL N ++K+ DFG ++ HN+ + T ++A
Sbjct: 177 LHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVA 231
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----QVVGAVGFQHRRLDIP-- 975
PEVL E D+ CD++S GVI++ L P+ + + + + P
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMA------ALKPLQKPITSSQVPR 1021
+ V +IR +T+P R T TE M + K Q P+ +S+V +
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 343
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 53/300 (17%)
Query: 732 ASNDSSKSDVGDDVAECEIPWEEI-TLGERIGLGSYGEVYRGDWHGT--EVAVK-----R 783
+ S D+A+ ++ +E++ L E IG G + V R T + AVK +
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 784 FLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLY-RLLH 842
F G S E+ + E I ++HP++V + + L +V EF+ L ++
Sbjct: 62 FTSSP--GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK 119
Query: 843 R--PNNQLDERRRLRMALDAARGM-------NYLHNCTPVIVHRDLKSPNLLV---DKNW 890
R E A+ M Y H+ I+HRD+K +L+ + +
Sbjct: 120 RADAGFVYSEA-------VASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSA 170
Query: 891 VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILW-ELCTM 949
VK+ FG++ + L + GT +MAPEV++ EP + DV+ GVIL+ L
Sbjct: 171 PVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS-- 228
Query: 950 QQPWGGMNP--------MQVVGAVGFQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRPT 999
G P + + ++ ++ ++ + D++R+ DP R T
Sbjct: 229 -----GCLPFYGTKERLFEGIIKGKYK---MNPRQWSHISESAKDLVRRMLMLDPAERIT 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 49/259 (18%), Positives = 101/259 (38%), Gaps = 30/259 (11%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ E +G G +G V+R + K F+ G + E+ I+ RH N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVK--GTDQVLVKKEISILNIARHRNIL 64
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GMN 865
+ L ++ EF+ ++ R+ +L+ER + +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTS-AFELNER-------EIVSYVHQVCEALQ 116
Query: 866 YLHNCTPVIVHRDLKSPNLLV--DKNWVVKVCDFGLSRM-KHNTFLSSRSTAGTAEWMAP 922
+LH+ I H D++ N++ ++ +K+ +FG +R K R E+ AP
Sbjct: 117 FLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAP 172
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDP 980
EV +++ D++S G +++ L + P+ Q++ + D +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 981 AVADIIRKCWQTDPKMRPT 999
D + + + K R T
Sbjct: 233 EAMDFVDRLLVKERKSRMT 251
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 68/311 (21%), Positives = 132/311 (42%), Gaps = 37/311 (11%)
Query: 711 GGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAE--CEIPWEEI----TLGERIGLG 764
G H++ G+ G+ + D D+ E+ + + E +G G
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62
Query: 765 SYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821
++G V+R G K F++ + ++E+ IM ++ HP ++ A
Sbjct: 63 AFGVVHRCV-EKATGRVFVAK-FINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 822 PPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAAR-------GMNYLHNCTPV 873
+ ++ EFL G L+ R+ + ++ E + G+ ++H +
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAE-DYKMSEA-------EVINYMRQACEGLKHMHEHS-- 169
Query: 874 IVHRDLKSPNLLV--DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
IVH D+K N++ K VK+ DFGL+ + + + + T TAE+ APE++ EP
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPV 227
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRK 988
D+++ GV+ + L + P+ G + ++ + V D ++ P D I+
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 989 CWQTDPKMRPT 999
Q +P+ R T
Sbjct: 288 LLQKEPRKRLT 298
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 57/257 (22%), Positives = 108/257 (42%), Gaps = 32/257 (12%)
Query: 757 LGERIGLGSYGEVY--RGDWHGTEVAVKRF-------LDQDFFGESLEEFRSEVLIMKRV 807
G+ +G GS+ V R E A+K ++ + E +M R+
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK------VPYVTRERDVMSRL 87
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMA--LDAARGMN 865
HP V L + G L + + + + + R A + A +
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA---LE 144
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWMAPE 923
YLH I+HRDLK N+L++++ +++ DFG +++ +R+ + GTA++++PE
Sbjct: 145 YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDP 980
+L + + + D+++ G I+++L P+ N + FQ D P+ P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKFFP 257
Query: 981 AVADIIRKCWQTDPKMR 997
D++ K D R
Sbjct: 258 KARDLVEKLLVLDATKR 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-31
Identities = 60/284 (21%), Positives = 106/284 (37%), Gaps = 35/284 (12%)
Query: 757 LGERIGLGSYGEVYRGD---WHGTEVAVKRFL---DQDFFGESLEEFRSEVLIMKRVRHP 810
+ I G G +Y +G V +K + D + +E + V HP
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA----QAMAMAERQFLAEVVHP 139
Query: 811 NVVL-----FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMN 865
++V P IV E++ SL R + L + L+ ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALS 196
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
YLH+ +V+ DLK N+++ + + K+ D G S GT + APE++
Sbjct: 197 YLHSIG--LVYNDLKPENIMLTEEQL-KLIDLGAVS----RINSFGYLYGTPGFQAPEIV 249
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
R P+ D+Y+ G L L G + V + L + +
Sbjct: 250 RTGPTV-ATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTY----DSYGRL 300
Query: 986 IRKCWQTDPKMRP-TFTEIMAALKPLQKPITSSQVPRPVPSVSS 1028
+R+ DP+ R T E+ A L + + + + P P +S+
Sbjct: 301 LRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLST 344
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 21/280 (7%)
Query: 756 TLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ E +G G++G V+R T A K F+ E R E+ M +RHP +V
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAK-FVMTPH-ESDKETVRKEIQTMSVLRHPTLV 217
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
A + ++ EF+ G L+ + +N++ E + +G+ ++H
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 275
Query: 874 IVHRDLKSPNLLV--DKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
VH DLK N++ ++ +K+ DFGL+ + + + T GTAE+ APEV +P
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPV 333
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA----DII 986
D++S GV+ + L + P+GG N + + V + ++ D+ ++ D I
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNMDDSAFSGISEDGKDFI 391
Query: 987 RKCWQTDPKMRPTFTEIMAALK-PLQKPITSSQVPRPVPS 1025
RK DP R T + AL+ P P + +PS
Sbjct: 392 RKLLLADPNTRMTIHQ---ALEHPWLTPGNAPGRDSQIPS 428
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 68/312 (21%), Positives = 120/312 (38%), Gaps = 66/312 (21%)
Query: 759 ERIGLGSYGEVYRGDWH---GTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+IG GSYG V++ + G VA+K+F +D R E+ ++K+++HPN+V
Sbjct: 9 GKIGEGSYGVVFKC-RNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVN 66
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNCT 871
+ R L +V E+ ++ L R + E + L + +N+ H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKHN 122
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-APEVLR 926
+HRD+K N+L+ K+ V+K+CDFG +R+ L+ S E W +PE+L
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPELLV 175
Query: 927 NEPS-DEKCDVYSFGVILWELCTMQ------------------------QPWGGMNPMQV 961
+ DV++ G + EL + + + Q
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 962 VGAVGF------QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT---------FTEIMAA 1006
V + L P N+ +++ C DP R T F I
Sbjct: 236 FSGVKIPDPEDMEPLELKFP-NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294
Query: 1007 LKPLQKPITSSQ 1018
++ ++
Sbjct: 295 EDLAKEHDKPAE 306
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 66/274 (24%), Positives = 103/274 (37%), Gaps = 64/274 (23%)
Query: 756 TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPN 811
+ +GLG G+V + + + A+K D + R EV + R + P+
Sbjct: 21 VTSQVLGLGINGKVLQIF-NKRTQEKFALKMLQDC-------PKARREVELHWRASQCPH 72
Query: 812 VVLFMGA----VTRPPNLSIVAEFLPRGSLY-RLLHRPNNQLDERRRLRMALDAARGM-- 864
+V + L IV E L G L+ R+ R + ER +A+ M
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------EASEIMKS 125
Query: 865 -----NYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916
YLH+ I HRD+K NLL N ++K+ DFG
Sbjct: 126 IGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166
Query: 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----QVVGAVGFQHRRL 972
A E E D+ CD++S GVI++ L P+ + + + +
Sbjct: 167 ----AKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 973 DIP--DNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
P + V +IR +T+P R T TE M
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 56/257 (21%), Positives = 106/257 (41%), Gaps = 34/257 (13%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVK-----RFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
IG G++GEV + A+K L + FR E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA----ETACFREERDVLVNGDSKWIT 137
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMNYL 867
A NL +V ++ G L LL + ++L E + +A+D +
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SV 191
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLR 926
H VHRD+K N+L+D N +++ DFG ++ + + S GT ++++PE+L+
Sbjct: 192 HQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 927 NEPSDEK-----CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP---DNL 978
+ CD +S GV ++E+ + P+ + ++ G + R P ++
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 979 DPAVADIIRKCWQTDPK 995
D+IR+ +
Sbjct: 310 SENAKDLIRRLICSREH 326
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 61/260 (23%), Positives = 112/260 (43%), Gaps = 51/260 (19%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRF-------LDQDFFGESLEEFRSEVLIMKRVRHPN 811
+G GS+G V + A+K L Q +E +E I++ V P
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ------IEHTLNEKRILQAVNFPF 102
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------G 863
+V + NL +V E++ G ++ L RR R + AR
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---------RRIGRFSEPHARFYAAQIVLT 153
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWM 920
YLH+ +++RDLK NLL+D+ ++V DFG ++ + T GT E +
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPEAL 205
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDN 977
APE++ ++ ++ D ++ GV+++E+ P+ P+Q+ ++ ++ P +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSH 260
Query: 978 LDPAVADIIRKCWQTDPKMR 997
+ D++R Q D R
Sbjct: 261 FSSDLKDLLRNLLQVDLTKR 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 69/284 (24%), Positives = 114/284 (40%), Gaps = 57/284 (20%)
Query: 759 ERIGLGSYGEVYRGDWH---GTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G GSYG V + + G VA+K+F D R E+ ++K++RH N+V
Sbjct: 31 GLVGEGSYGMVMKC-RNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVN 88
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNCT 871
+ + +V EF+ ++ L N LD ++ L + G+ + H+
Sbjct: 89 LLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHSHN 144
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-APEVLR 926
I+HRD+K N+LV ++ VVK+CDFG +R L++ E W APE+L
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVATRWYRAPELLV 197
Query: 927 NEPS-DEKCDVYSFGVILWELCTMQ------------------------QPWGGMNPMQV 961
+ + DV++ G ++ E+ + + N V
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 962 VGAVGF------QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT 999
V + P L V D+ +KC DP RP
Sbjct: 258 FAGVRLPEIKEREPLERRYP-KLSEVVIDLAKKCLHIDPDKRPF 300
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 55/257 (21%), Positives = 102/257 (39%), Gaps = 29/257 (11%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNVVLFMG 817
IG G++ EV T A+K D + FR E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMNYLHNCT 871
A L +V E+ G L LL + ++ + MA+D +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID------SVHRLG 182
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
VHRD+K N+L+D+ +++ DFG +++ + + S GT ++++PE+L+
Sbjct: 183 --YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 931 DEK-------CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP---DNLDP 980
CD ++ GV +E+ Q P+ + + G + L +P + +
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 981 AVADIIRKCWQTDPKMR 997
D I++ P+ R
Sbjct: 301 EARDFIQR-LLCPPETR 316
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-27
Identities = 72/325 (22%), Positives = 123/325 (37%), Gaps = 85/325 (26%)
Query: 759 ERIGLGSYGEVYRG-DWHGTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
+ IG GS+G V++ EVA+K+ D+ F + R E+ IM+ V+HPNVV
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNR-ELQIMRIVKHPNVVDLK 98
Query: 817 GAVTRPPN------LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA--------- 861
+ L++V E++P ++YR +L+ +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS-------RHYAKLKQTMPMLLIKLYMYQL 150
Query: 862 -RGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRM----KHNT-FLSSRSTA 914
R + Y+H+ I HRD+K NLL+D V+K+ DFG +++ + N ++ SR
Sbjct: 151 LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR--- 205
Query: 915 GTAEWM-APEVLRNEPS-DEKCDVYSFGVILWELCTMQ---------------------- 950
+ APE++ + D++S G ++ EL Q
Sbjct: 206 ----YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 951 --QPWGGMNPMQV------VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTE 1002
+ MNP + + F P D+I + + P R T E
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKV---FRPRTPPDAIDLISRLLEYTPSARLTAIE 318
Query: 1003 IMA--ALKPLQKPITSSQVPRPVPS 1025
+ L+ R +P
Sbjct: 319 ALCHPFFDELRTGEARMPNGRELPP 343
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 51/280 (18%)
Query: 759 ERIGLGSYGEVYRG-DWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
E++G G+YG VY+ D G VA+KR LD + G R E+ ++K + HPN+V +
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLI 85
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNCTPV 873
+ L++V EF+ + L ++L L + + L L RG+ + H
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHR-- 139
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-APEVLRNE 928
I+HRDLK NLL++ + +K+ DFGL+R + T E W AP+VL
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 929 PS-DEKCDVYSFGVILWELCTMQ------------------------QPWGGMNPMQVVG 963
D++S G I E+ T + + W + + +
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 964 AVGF-QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPT 999
F + D++ DP R +
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 69/284 (24%), Positives = 114/284 (40%), Gaps = 50/284 (17%)
Query: 759 ERIGLGSYGEVYRG-DWHGTEVAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFM 816
E+IG G+YG VY+ + +G A+K+ L+++ G R E+ I+K ++H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLY 66
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNCTPV 873
+ L +V E L + L +LL L+ + L L G+ Y H+
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDRR-- 120
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-APEVLRNE 928
++HRDLK NLL+++ +K+ DFGL+R T E W AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 929 PS-DEKCDVYSFGVILWELCTMQ------------------------QPWGGMNPMQVVG 963
D++S G I E+ + W + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 964 AVGFQHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
+ L LD + D++ K + DP R T + +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 64/255 (25%), Positives = 107/255 (41%), Gaps = 31/255 (12%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNVVLFMG 817
IG G++GEV T A+K + S F E IM P VV
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GMNYLHN 869
A L +V E++P G L L+ + AR ++ +H+
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALDAIHS 186
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
+HRD+K N+L+DK+ +K+ DFG +M + + GT ++++PEVL+++
Sbjct: 187 MG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 929 PSDEK----CDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD--PAV 982
D CD +S GV L+E+ P+ + + + L PD+ D
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304
Query: 983 ADIIRKCWQTDPKMR 997
++I + TD ++R
Sbjct: 305 KNLICA-FLTDREVR 318
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 64/260 (24%), Positives = 115/260 (44%), Gaps = 51/260 (19%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRF-------LDQDFFGESLEEFRSEVLIMKRVRHPN 811
+G GS+G V+ R +G A+K L Q +E E L++ V HP
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ------VEHTNDERLMLSIVTHPF 67
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------G 863
++ G + ++ +++ G L+ LL R+ R A+
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLL---------RKSQRFPNPVAKFYAAEVCLA 118
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWM 920
+ YLH+ I++RDLK N+L+DKN +K+ DFG ++ T GT +++
Sbjct: 119 LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL------CGTPDYI 170
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDN 977
APEV+ +P ++ D +SFG++++E+ P+ N M+ ++ + L P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRFPPF 225
Query: 978 LDPAVADIIRKCWQTDPKMR 997
+ V D++ + D R
Sbjct: 226 FNEDVKDLLSRLITRDLSQR 245
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 67/282 (23%), Positives = 111/282 (39%), Gaps = 54/282 (19%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
E+IG G+YG V++ T VA+KR LD D G R E+ ++K ++H N+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL 66
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLH-NCT 871
+ L++V EF + L + N LD + L L +G+ + H
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSRN- 121
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-APEVLR 926
++HRDLK NLL+++N +K+ +FGL+R +AE W P+VL
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 927 NEPS-DEKCDVYSFGVILWELCTMQQP-------------------------WGGMNPMQ 960
D++S G I EL +P W M +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 961 VVGAVGFQHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPT 999
+ + L+ D+++ + +P R +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 65/325 (20%), Positives = 116/325 (35%), Gaps = 77/325 (23%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRVRHPNVV-- 813
G G++G V G + G VA+K+ D F L+ + + + HPN+V
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLHHPNIVQL 84
Query: 814 --LFMGAVTRPPN---LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD--------A 860
F R L++V E++P +L+R RR++
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPPPILIKVFLFQL 138
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRM----KHNT-FLSSRSTA 914
R + LH + + HRD+K N+LV++ + +K+CDFG ++ + N ++ SR
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR--- 195
Query: 915 GTAEWM-APEVLRNEPS-DEKCDVYSFGVILWELCTMQQP-------------------- 952
+ APE++ D++S G I E+ +P
Sbjct: 196 ----YYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLGC 250
Query: 953 -----WGGMNP------MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFT 1001
+NP + + + + D D++ Q P+ R
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 1002 EIMA--ALKPLQKPITSSQVPRPVP 1024
E + L P T + +P
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDLP 335
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 76/325 (23%), Positives = 131/325 (40%), Gaps = 73/325 (22%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRF-LDQDFFGESLEEFRS----EVLIMKRVRHPN 811
+ +G G + VY+ D + VA+K+ L E+ + E+ +++ + HPN
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR--SEAKDGINRTALREIKLLQELSHPN 73
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNYLH 868
++ + A N+S+V +F+ L ++ + L + + M L +G+ YLH
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLH 129
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK---HNTFLSSRSTAGTAE----WM- 920
I+HRDLK NLL+D+N V+K+ DFGL++ + + T + W
Sbjct: 130 QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQVVTRWYR 179
Query: 921 APEVLRNEPS-DEKCDVYSFGVILWELCTMQ------------------------QPWGG 955
APE+L D+++ G IL EL + W
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 956 MNPMQVVGAVGF-QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPTFTEIMAALK--- 1008
M + V F + + + D+I+ + +P R T T+ ALK
Sbjct: 240 MCSLP--DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ---ALKMKY 294
Query: 1009 --PLQKPITSSQVPRPVPSVSSGRE 1031
P Q+PRP V + +E
Sbjct: 295 FSNRPGPTPGCQLPRPNCPVETLKE 319
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 15/246 (6%)
Query: 761 IGLGSYGEVYRGDWHGTEV--AVKRFLDQDFFGESLEEF--RSEVLIMKRVRHPNVVLFM 816
+G G +GEV T A K+ L++ + E +E I+++V VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 817 GAVTRPPNLSIVAEFLPRGSL-YRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875
A L +V + G L + + H E R + A + G+ LH IV
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IV 308
Query: 876 HRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
+RDLK N+L+D + +++ D GL+ + + R GT +MAPEV++NE
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVVKNERYTFSP 366
Query: 935 DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVADIIRKCWQ 991
D ++ G +L+E+ Q P+ V + + + P + +
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 992 TDPKMR 997
DP R
Sbjct: 426 KDPAER 431
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 73/319 (22%), Positives = 129/319 (40%), Gaps = 76/319 (23%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEE------FRSEVLIMKRVRH 809
+++G G+Y VY+G T+ VA+K L+ EE R EV ++K ++H
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-------EEGAPCTAIR-EVSLLKDLKH 59
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDE---RRRLRMALDAARGMNY 866
N+V + +L++V E+L + L + L N ++ + L L RG+ Y
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAY 115
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-A 921
H ++HRDLK NLL+++ +K+ DFGL+R K S + E W
Sbjct: 116 CHRQK--VLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVTLWYRP 168
Query: 922 PEVLRNEPS-DEKCDVYSFGVILWELCTMQ------------------------QPWGGM 956
P++L + D++ G I +E+ T + + W G+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 957 NPMQVVGAVGF-QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPT---------FTEI 1003
+ + ++R + LD AD++ K Q + + R + F +
Sbjct: 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288
Query: 1004 MAALKPLQKPITSSQVPRP 1022
+ L P T+S
Sbjct: 289 GERIHKL--PDTTSIFALK 305
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 61/259 (23%), Positives = 112/259 (43%), Gaps = 24/259 (9%)
Query: 761 IGLGSYGEVYRGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G G++G+V T + K + + + +E +++ RHP +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTA 212
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
+ L V E+ G L+ L R ++R R A + ++YLH+ +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN-V 270
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKC 934
V+RDLK NL++DK+ +K+ DFGL + + ++ GT E++APEVL +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330
Query: 935 DVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVADIIRKCWQ 991
D + GV+++E+ + P+ + ++ F+ + P L P ++ +
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLGPEAKSLLSGLLK 385
Query: 992 TDPKMR----PT-FTEIMA 1005
DPK R EIM
Sbjct: 386 KDPKQRLGGGSEDAKEIMQ 404
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 54/259 (20%), Positives = 114/259 (44%), Gaps = 41/259 (15%)
Query: 761 IGLGSYGEVYRGDWHGTEV--AVK-----RFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
IG GS+G+V + T+ A+K + ++++ + E+ IM+ + HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN----EVRNVFKELQIMQGLEHPFLV 78
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GMN 865
+ ++ +V + L G L L ++ + + + ++
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYHL---------QQNVHFKEETVKLFICELVMALD 129
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPEV 924
YL N I+HRD+K N+L+D++ V + DF ++ + T +++ + GT +MAPE+
Sbjct: 130 YLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEM 185
Query: 925 LRNEPS---DEKCDVYSFGVILWELCTMQQPW---GGMNPMQVVGAVGFQHRRLDIPDNL 978
+ D +S GV +EL ++P+ + ++V F+ + P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTYPSAW 243
Query: 979 DPAVADIIRKCWQTDPKMR 997
+ +++K + +P R
Sbjct: 244 SQEMVSLLKKLLEPNPDQR 262
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 38/256 (14%)
Query: 761 IGLGSYGEVY---RGDWHGTEV--AVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+G GS+G+V+ + A+K + E I+ V HP +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR-----LRMALDAARGMNYLHNC 870
A L ++ +FL G L+ L + +E + L +ALD +LH+
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------HLHSL 145
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAEWMAPEV 924
I++RDLK N+L+D+ +K+ DFGLS+ + H +F GT E+MAPEV
Sbjct: 146 G--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 197
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPA 981
+ + D +SFGV+++E+ T P+ G + + +L +P L P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAKLGMPQFLSPE 252
Query: 982 VADIIRKCWQTDPKMR 997
++R ++ +P R
Sbjct: 253 AQSLLRMLFKRNPANR 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 62/265 (23%), Positives = 110/265 (41%), Gaps = 37/265 (13%)
Query: 761 IGLGSYGEVYRGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+G G++G+V T + K + + + +E +++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK---DEVAHTVTESRVLQNTRHPFLTA 69
Query: 815 FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVI 874
A L V E+ G L+ L R E R + + YLH+ +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD--V 126
Query: 875 VHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAEWMAPEVLRNE 928
V+RD+K NL++DK+ +K+ DFGL + + TF GT E++APEVL +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDN 180
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVADI 985
D + GV+++E+ + P+ + ++ F+ + P L P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSL 235
Query: 986 IRKCWQTDPKMR----PT-FTEIMA 1005
+ + DPK R P+ E+M
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 72/324 (22%), Positives = 122/324 (37%), Gaps = 82/324 (25%)
Query: 759 ERIGLGSYGEVYRGDWH--GTEVAVKR-FLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+ IG GS+G VY+ G VA+K+ D+ F + R E+ IM+++ H N+V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNR-ELQIMRKLDHCNIVRL 112
Query: 816 MGAVTRPPN------LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD--------AA 861
L++V +++P ++YR+ + R + + +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS-----RAKQTLPVIYVKLYMYQLF 166
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRM----KHNT-FLSSRSTAG 915
R + Y+H+ I HRD+K NLL+D + V+K+CDFG ++ + N ++ SR
Sbjct: 167 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 916 TAEWM-APEVLRNEPS-DEKCDVYSFGVILWELCTMQ----------------------- 950
+ APE++ DV+S G +L EL Q
Sbjct: 221 ---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277
Query: 951 -QPWGGMNPMQV------VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEI 1003
+ MNP + A + P + + + P R T E
Sbjct: 278 REQIREMNPNYTEFKFPQIKAHPWTKV---FRPRTPPEAIALCSRLLEYTPTARLTPLEA 334
Query: 1004 MAA--LKPLQKPITSSQVPRPVPS 1025
A L+ P R P+
Sbjct: 335 CAHSFFDELRDPNVKLPNGRDTPA 358
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 46/261 (17%)
Query: 761 IGLGSYGEVY---RGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
+G G YG+V+ + T V K + ++ + ++E I++ V+HP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPF 82
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMN 865
+V + A L ++ E+L G L+ L R E + MAL
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALG------ 135
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAEW 919
+LH I++RDLK N++++ VK+ DFGL + + +TF GT E+
Sbjct: 136 HLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------GTIEY 187
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPD 976
MAPE+L + D +S G +++++ T P+ G N + +L++P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKILKCKLNLPP 242
Query: 977 NLDPAVADIIRKCWQTDPKMR 997
L D+++K + + R
Sbjct: 243 YLTQEARDLLKKLLKRNAASR 263
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 61/249 (24%), Positives = 101/249 (40%), Gaps = 18/249 (7%)
Query: 761 IGLGSYGEVYRGDWHGTEV--AVKRFLDQDFFGESLEEF--RSEVLIMKRVRHPNVVLFM 816
+G G +GEV+ T A K+ L++ + E I+ +V +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKK-LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAARGMNYLHNCTPV 873
A +L +V + G + ++ + E R + G+ +LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKHNTFLSSRSTAGTAEWMAPEVLRNEPSD 931
I++RDLK N+L+D + V++ D GL+ T AGT +MAPE+L E D
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYD 367
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVADIIRK 988
D ++ GV L+E+ + P+ + Q + + PD PA D
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 989 CWQTDPKMR 997
Q DP+ R
Sbjct: 427 LLQKDPEKR 435
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 38/286 (13%), Positives = 79/286 (27%), Gaps = 46/286 (16%)
Query: 757 LGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFG--ESLEEFRSEVLIMKRVRHPNV 812
L G + ++ D +VA+ F+D + L+E S L + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ V +VAE++ GSL + +R A + H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDE 932
+ + V + V + ++
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANP 181
Query: 933 KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD------NLDPAVADII 986
+ D+ G L+ L + P + + + ++ ++ +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-ERDTAGQPIEPADIDRDIPFQISAVA 240
Query: 987 RKCWQTDPKMRP--TFTEIMAALKPLQKPITSSQVPRPVPSVSSGR 1030
+ Q D +R T +M + P ++ R
Sbjct: 241 ARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 759 ERIGLGSYGEVYRG--DWHGTEVAVKRF-LDQDFFGESLEEFRS----EVLIMKRVRHPN 811
+IG G++GEV++ G +VA+K+ ++ + G F E+ I++ ++H N
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-----FPITALREIKILQLLKHEN 77
Query: 812 VVLFMGAVT--------RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR---LRMALDA 860
VV + ++ +V +F L LL + ++M L
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL-- 134
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE-- 918
G+ Y+H I+HRD+K+ N+L+ ++ V+K+ DFGL+R + +S+ T
Sbjct: 135 -NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYTNRVV 190
Query: 919 --WM-APEVLRNEPS-DEKCDVYSFGVILWELCTMQ 950
W PE+L E D++ G I+ E+ T
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 28/208 (13%)
Query: 759 ERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRS---------EVLIMKRVR 808
I GSYG V G D G VA+KR + G ++ E+ ++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 809 HPNVVLFMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQL-DERRRLRM--ALD 859
HPN++ + +V E + L +++H + + + M L
Sbjct: 88 HPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL- 144
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW 919
G++ LH +VHRDL N+L+ N + +CDF L+R + +
Sbjct: 145 --LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRWY 199
Query: 920 MAPEVLRNEPS-DEKCDVYSFGVILWEL 946
APE++ + D++S G ++ E+
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEM 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 55/274 (20%)
Query: 761 IGLGSYGEVYRGDWHGTEV--AVK----RFLDQDFFGESLEEFRSE--VLIMKRVRHPNV 812
IG GS+G+V EV AVK + + + + + SE VL+ K V+HP +
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK---KEEKHIMSERNVLL-KNVKHPFL 101
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GM 864
V + L V +++ G L+ L R E R AR +
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPR--------ARFYAAEIASAL 152
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAE 918
YLH+ IV+RDLK N+L+D + + DFGL + ++H +TF GT E
Sbjct: 153 GYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF------CGTPE 204
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIP 975
++APEVL +P D D + G +L+E+ P+ N ++ + ++ L +
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLK 259
Query: 976 DNLDPAVADIIRKCWQTDPKMR----PTFTEIMA 1005
N+ + ++ Q D R F EI +
Sbjct: 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 67/325 (20%), Positives = 114/325 (35%), Gaps = 59/325 (18%)
Query: 720 ANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTE- 778
A+ + A S + ++G G+YGEVY+ T
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSI-DRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 779 -VAVKRF-LDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGS 836
VA+KR L+ + G R EV ++K ++H N++ + L ++ E+
Sbjct: 61 TVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118
Query: 837 LYRLLHRPNNQLDE---RRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW--- 890
L + + + N + + L + G+N+ H+ +HRDLK NLL+ +
Sbjct: 119 LKKYMDK-NPDVSMRVIKSFLYQLI---NGVNFCHSRR--CLHRDLKPQNLLLSVSDASE 172
Query: 891 --VVKVCDFGLSRMKHNTFLSSRSTAGTAE----WM-APEVLRNEPS-DEKCDVYSFGVI 942
V+K+ DFGL+R T E W PE+L D++S I
Sbjct: 173 TPVLKIGDFGLARAF-----GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 943 LWELCTMQ------------------------QPWGGMN--PMQVVGAVGFQHRRL--DI 974
E+ W G+ P F+ + L +
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 975 PDNLDPAVADIIRKCWQTDPKMRPT 999
LD D++ + DP R +
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRIS 312
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 38/213 (17%)
Query: 759 ERIGLGSYGEVYRGDWHGTE--VAVKRF-LDQDFFGESLEEFRS----EVLIMKRVRHPN 811
E++G G+Y VY+G T VA+K LD + E S E+ +MK ++H N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE------EGTPSTAIREISLMKELKHEN 64
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRR--------LRMALDAARG 863
+V + L++V EF+ L + + R L +G
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QG 120
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE----W 919
+ + H I+HRDLK NLL++K +K+ DFGL+R ++E W
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEVVTLW 173
Query: 920 M-APEVLRNEPS-DEKCDVYSFGVILWELCTMQ 950
AP+VL + D++S G IL E+ T +
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-22
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 33/253 (13%)
Query: 761 IGLGSYGEVYRGDWHGTE--VAVK----RFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
+G GS+G+V+ ++ T A+K + D + +E E ++ HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLT 81
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
NL V E+L G L + ++ D R A + G+ +LH+
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG-- 138
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAEWMAPEVLRN 927
IV+RDLK N+L+DK+ +K+ DFG+ + M NTF GT +++APE+L
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------CGTPDYIAPEILLG 192
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVAD 984
+ + D +SFGV+L+E+ Q P+ G + ++ F P L+ D
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEAKD 247
Query: 985 IIRKCWQTDPKMR 997
++ K + +P+ R
Sbjct: 248 LLVKLFVREPEKR 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 70/331 (21%), Positives = 119/331 (35%), Gaps = 83/331 (25%)
Query: 759 ERIGLGSYGEVYRG-DWHGTE--VAVKRF-LDQDFFGESLEEFRSEVLIMKRVR---HPN 811
IG G+YG+V++ D VA+KR + G L R EV +++ + HPN
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPN 75
Query: 812 VV-----LFMGAVTRPPNLSIVAEFLPRGSLYRLL-HRPNNQLDE---RRRLRMALDAAR 862
VV + R L++V E + + L L P + + + L R
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL---R 131
Query: 863 GMNYLH-NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN--TFLSSRSTAGTAE- 918
G+++LH + +VHRDLK N+LV + +K+ DFGL+R+ T+
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TSVV 180
Query: 919 ---WM-APEVLRNEPSDEKCDVYSFGVILWELCTMQ------------------------ 950
W APEVL D++S G I E+ +
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 951 QPWGGMNPMQVVGAVGFQHRRL-DIPDNLDPAVADIIRKCWQTDPKMRPT---------F 1000
+ W + + + ++D D++ KC +P R + F
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300
Query: 1001 TEIMAALKPLQKPITSSQVPRPVPSVSSGRE 1031
++ + +P + E
Sbjct: 301 QDL---------ERCKENLDSHLPPSQNTSE 322
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-21
Identities = 57/253 (22%), Positives = 110/253 (43%), Gaps = 33/253 (13%)
Query: 761 IGLGSYGEVYRGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
+G GS+G+V + GT+ + K + QD + +E E ++ + P +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD---DDVECTMVEKRVLALPGKPPFLT 405
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L V E++ G L + + + E + A + A G+ +L +
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG-- 462
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAEWMAPEVLRN 927
I++RDLK N+++D +K+ DFG+ + + TF GT +++APE++
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAY 516
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVAD 984
+P + D ++FGV+L+E+ Q P+ G + ++ FQ + P ++
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVA 571
Query: 985 IIRKCWQTDPKMR 997
I + P R
Sbjct: 572 ICKGLMTKHPGKR 584
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 70/315 (22%), Positives = 126/315 (40%), Gaps = 50/315 (15%)
Query: 720 ANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGER--------------IGLGS 765
+ E S +A + D G+ + + L +G G+
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66
Query: 766 YGEVY---RGDWHGTEV--AVKRFLDQDFFGESLEEF---RSEVLIMKRVRH-PNVVLFM 816
YG+V+ + H T A+K L + + + R+E +++ +R P +V
Sbjct: 67 YGKVFLVRKISGHDTGKLYAMK-VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERR------RLRMALDAARGMNYLHNC 870
A L ++ +++ G L+ L + + E + +AL+ +LH
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALE------HLHKL 178
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA---GTAEWMAPEVLRN 927
I++RD+K N+L+D N V + DFGLS K + GT E+MAP+++R
Sbjct: 179 G--IIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 928 EPS--DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAV 982
S D+ D +S GV+++EL T P+ + + P +
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEMSALA 293
Query: 983 ADIIRKCWQTDPKMR 997
D+I++ DPK R
Sbjct: 294 KDLIQRLLMKDPKKR 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 71/293 (24%), Positives = 110/293 (37%), Gaps = 69/293 (23%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRF-LDQDFFGESLEEFRS----EVLIMKRVR--- 808
IG+G+YG VY+ D H G VA+K + G EV +++R+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLRRLEAFE 72
Query: 809 HPNVV----LFMG-AVTRPPNLSIVAEFLPRGSLYRLL-HRPNNQLDE---RRRLRMALD 859
HPNVV + R +++V E + + L L P L + +R L
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL- 130
Query: 860 AARGMNYLH-NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH--NTFLSSRSTAGT 916
RG+++LH NC IVHRDLK N+LV VK+ DFGL+R+ T
Sbjct: 131 --RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------T 177
Query: 917 AE----WM-APEVLRNEPSDEKCDVYSFGVILWELCTMQ--------------------- 950
W APEVL D++S G I E+ +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237
Query: 951 ---QPWGGMNPMQVVGAVGFQHRRL-DIPDNLDPAVADIIRKCWQTDPKMRPT 999
W + R + + ++ + A ++ + +P R +
Sbjct: 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-21
Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 761 IGLGSYGEVYRGDWHGTEV--AVK-----RFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
IG G +GEVY T A+K R + +L E R + ++ P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 255
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
A P LS + + + G L+ L + + E A + G+ ++HN
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL-RNEPSDE 932
+V+RDLK N+L+D++ V++ D GL+ + ++ GT +MAPEVL + D
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 933 KCDVYSFGVILWELCTMQQPW---GGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
D +S G +L++L P+ + ++ +++PD+ P + ++
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 428
Query: 990 WQTDPKMR 997
Q D R
Sbjct: 429 LQRDVNRR 436
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-20
Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 761 IGLGSYGEVYRGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
+G GS+G+V T V K + QD + +E +E I+ HP +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPFLT 87
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
P L V EF+ G L + + + + DE R A + + +LH+
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKG-- 144
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWMAPEVLRNEPSD 931
I++RDLK N+L+D K+ DFG+ K + GT +++APE+L+
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVADIIRK 988
D ++ GV+L+E+ P+ N + F+ + + P L I++
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGILKS 257
Query: 989 CWQTDPKMR 997
+P MR
Sbjct: 258 FMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-20
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 25/249 (10%)
Query: 761 IGLGSYGEVYRGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
+G GS+G+V + GT+ + K + QD + +E E ++ + P +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD---DDVECTMVEKRVLALPGKPPFLT 84
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L V E++ G L + + + E + A + A G+ +L +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG-- 141
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA--GTAEWMAPEVLRNEPSD 931
I++RDLK N+++D +K+ DFG+ K N + + GT +++APE++ +P
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 199
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ---HRRLDIPDNLDPAVADIIRK 988
+ D ++FGV+L+E+ Q P+ G + ++ FQ + P ++ I +
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVAICKG 254
Query: 989 CWQTDPKMR 997
P R
Sbjct: 255 LMTKHPGKR 263
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVL 814
+G G+YG V G VA+K+ + F + L R+ E+ I+K +H N++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 815 FMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQL-DERRRLRM--ALDAARGMN 865
+ RP + I+ E + L+R++ L D+ + + L R +
Sbjct: 74 IF-NIQRPDSFENFNEVYIIQELMQT-DLHRVIS--TQMLSDDHIQYFIYQTL---RAVK 126
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWM----- 920
LH ++HRDLK NLL++ N +KVCDFGL+R+ + + G M
Sbjct: 127 VLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 921 -----APEVLRNEPS-DEKCDVYSFGVILWEL 946
APEV+ DV+S G IL EL
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 46/219 (21%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 757 LGERIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
G ++G G+YG VY+ + A+K+ + G S+ R E+ +++ ++HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACR-EIALLRELKHPNV 80
Query: 813 VLFMGAVTRPPNLSI--VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA--------R 862
+ + + + ++ L+ ++ ++ +++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGLSRMKHNTFLSSRS-TAGTA 917
G++YLH ++HRDLK N+LV + VK+ D G +R+ ++ +
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS---PLKPLADLDP 194
Query: 918 E----WM-APEVLRNEPS-DEKCDVYSFGVILWELCTMQ 950
W APE+L + D+++ G I EL T +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 65/265 (24%), Positives = 113/265 (42%), Gaps = 48/265 (18%)
Query: 761 IGLGSYGEVYRGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
IG GSY +V T+ V K ++ D E ++ ++E + ++ HP +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 73
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR--------GMN 865
L V E++ G L + R +L E AR +N
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEH--------ARFYSAEISLALN 124
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAEW 919
YLH I++RDLK N+L+D +K+ D+G+ + ++ +TF GT +
Sbjct: 125 YLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNY 176
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG----FQ---HRRL 972
+APE+LR E D ++ GV+++E+ + P+ + FQ +++
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236
Query: 973 DIPDNLDPAVADIIRKCWQTDPKMR 997
IP +L A +++ DPK R
Sbjct: 237 RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 61/333 (18%), Positives = 120/333 (36%), Gaps = 110/333 (33%)
Query: 759 ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV--- 813
+ +G GS+G V G A+K+ L + + R E+ IMK + H N++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNR-ELDIMKVLDHVNIIKLV 66
Query: 814 -----------------------------LFMGAVTRPPN------LSIVAEFLPRGSLY 838
+ + N L+++ E++P +L+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH 125
Query: 839 RLLHRPNNQLDERRRLRMALD--------AARGMNYLHNCTPVIVHRDLKSPNLLVD-KN 889
++L R + ++ R + ++H+ I HRD+K NLLV+ K+
Sbjct: 126 KVLKSFI-----RSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKD 178
Query: 890 WVVKVCDFGLSRM----KHNT-FLSSRSTAGTAEWM-APEVLRNEPS-DEKCDVYSFGVI 942
+K+CDFG ++ + + ++ SR + APE++ D++S G +
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 943 LWELCTMQ------------------------QPWGGMNP------MQVVGAVGFQHRRL 972
EL + + MNP + A ++
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI-- 289
Query: 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+P+ D++ + + +P +R E MA
Sbjct: 290 -LPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVL 814
+ IG G+ G V D VA+K+ F R+ E+++MK V H N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 815 FMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+ T +L IV E + +L +++ LD R + G+ +LH
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH 144
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
+ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 145 SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 201
Query: 929 PSDEKCDVYSFGVILWEL 946
E D++S G I+ E+
Sbjct: 202 GYKENVDIWSVGCIMGEM 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 32/257 (12%)
Query: 761 IGLGSYGEVYRGDWHGTE------VAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
IG GSY +V T+ V K ++ D E ++ ++E + ++ HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 116
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
L V E++ G L + R +L E + + + +NYLH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG-- 173
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSR--MKH----NTFLSSRSTAGTAEWMAPEVLRN 927
I++RDLK N+L+D +K+ D+G+ + ++ +TF GT ++APE+LR
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 227
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG----FQ---HRRLDIPDNLDP 980
E D ++ GV+++E+ + P+ + FQ +++ IP +L
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 287
Query: 981 AVADIIRKCWQTDPKMR 997
A +++ DPK R
Sbjct: 288 KAASVLKSFLNKDPKER 304
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 22/249 (8%)
Query: 708 SGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGERIGLGSYG 767
G + + ++ +S N +VGD ++ + + IG G+ G
Sbjct: 20 FCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNL---KPIGSGAQG 76
Query: 768 EVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVLFMGAVTRPP 823
V VA+K+ F R+ E+++MK V H N++ + T
Sbjct: 77 IVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134
Query: 824 NLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHR 877
L +V E + +L +++ LD R + G+ +LH+ I+HR
Sbjct: 135 TLEEFQDVYLVMELMD-ANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAG--IIHR 188
Query: 878 DLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVY 937
DLK N++V + +K+ DFGL+R +F+ + T + APEV+ E D++
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
Query: 938 SFGVILWEL 946
S G I+ E+
Sbjct: 248 SVGCIMGEM 256
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 44/230 (19%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVL 814
IG GSYG VY D + VA+K+ F + ++ R E+ I+ R++ ++
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIR 89
Query: 815 FMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRM--ALDAARGMNY 866
+ P +L IV E L +L P +E + + L G N+
Sbjct: 90 LY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL---LGENF 144
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR------------MKHNTFLSSRSTA 914
+H I+HRDLK N L++++ VKVCDFGL+R
Sbjct: 145 IHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 915 GTAEWM----------APEVLRNEPS-DEKCDVYSFGVILWELCTMQQPW 953
+ + APE++ + + + D++S G I EL M Q
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 69/296 (23%), Positives = 126/296 (42%), Gaps = 63/296 (21%)
Query: 756 TLGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPN 811
+G G+YG V D G +VA+K+ F + R+ E+L++K ++H N
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 812 VVLFMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRM--ALDAARG 863
V+ + T +L +V F+ L +++ +E+ + + L +G
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQML---KG 138
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT---FLSSRSTAGTAEW- 919
+ Y+H+ +VHRDLK NL V+++ +K+ DFGL+R ++ +R W
Sbjct: 139 LKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-------WY 189
Query: 920 MAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVG-------- 963
APEV+ + ++ D++S G I+ E+ T + + G + ++V G
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 964 ------AVGF-----QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
A + Q R D P AD++ K + D R T + +
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 47/221 (21%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 750 IPWEEI---TLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLI 803
+ W L ++G G Y EV+ + +V VK ++ + E+ I
Sbjct: 30 VEWGNQDDYQLVRKLGRGKYSEVFEA-INITNNEKVVVKILKP-----VKKKKIKREIKI 83
Query: 804 MKRVR-HPNVVLFMGAVTRPP---NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
++ +R PN++ + + P ++V E + +L + D R + L
Sbjct: 84 LENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-DIRFYMYEIL- 140
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKH-----NTFLSSRST 913
+ ++Y H+ I+HRD+K N+++D ++ +++ D+GL+ H N ++SR
Sbjct: 141 --KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR-- 194
Query: 914 AGTAEWM-APEVLRNEPS-DEKCDVYSFGVILWELCTMQQP 952
+ PE+L + D D++S G +L + ++P
Sbjct: 195 -----YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-18
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 50/292 (17%)
Query: 701 AGYEPRDSGSGGREHNYLGANSEGERVSDRSASNDSSKSDVGDDVAECEIPWEEITLGER 760
+ +E + + + S+ E + + + + ++ +IP + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHL 60
Query: 761 IGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVLFM 816
IG GSYG V D VA+K+ F + ++ R E+ I+ R+ H +VV +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 817 GAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRM--ALDAARGMNYLH 868
+ P ++ +V E +L P + + + L G+ Y+H
Sbjct: 119 -DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLL---VGVKYVH 173
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----------------MKHNTFLSSR 911
+ I+HRDLK N LV+++ VKVCDFGL+R ++
Sbjct: 174 SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 912 STAGTAEWM----------APEVLRNEPS-DEKCDVYSFGVILWELCTMQQP 952
T + APE++ + + E DV+S G I EL M +
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 58/291 (19%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVL 814
+ +G G+YG V D G +VA+K+ F L R+ E+ ++K +RH NV+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 815 FMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+ T L +V F+ L +L+ + +L E R + +G+ Y+H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT---FLSSRSTAGTAEWM-APEV 924
I+HRDLK NL V+++ +K+ DFGL+R + ++ +R W APEV
Sbjct: 146 AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-------WYRAPEV 196
Query: 925 LRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVG------------- 963
+ N + D++S G I+ E+ T + + G + M+V G
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 964 -AVGF-----QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
A + + + D N P +++ K D + R T E +A
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 52/288 (18%)
Query: 759 ERIGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVRHPNVVL 814
+G G+YG V G VAVK+ F + R+ E+ ++K ++H NV+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 815 FMGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+ T +L +V + L ++ +L + + RG+ Y+H
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIH 149
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEW-MAPEVLRN 927
+ I+HRDLK NL V+++ +K+ DFGL+R + +T W APE++ N
Sbjct: 150 SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT----RWYRAPEIMLN 203
Query: 928 EPS-DEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVG--------------AV 965
++ D++S G I+ EL T + + G + +++VG A
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 966 GF-----QHRRLDIPD---NLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ Q +++ + +P D++ K D R T + +A
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 58/311 (18%), Positives = 106/311 (34%), Gaps = 83/311 (26%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKR--FLDQDFFGESLEEFRSEVLIMKRVRHPNVVL 814
+ +G G G V+ D VA+K+ D R E+ I++R+ H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS---VKHALR-EIKIIRRLDHDNIVK 72
Query: 815 FMGAVTRPPNLSIVAEFLPRGS--------------LYRLLHRPNNQL-DERRRLRM--A 857
+ P + + L +L L +E RL M
Sbjct: 73 VF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQL 129
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKHNTFLSSRSTAGT 916
L RG+ Y+H+ ++HRDLK NL ++ ++ V+K+ DFGL+R
Sbjct: 130 L---RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHYSH 177
Query: 917 AEWM----------APEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNP------- 958
+ +P +L + + + D+++ G I E+ T + + G +
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 959 MQVVG--------AVGFQHRR--LDIPD-----------NLDPAVADIIRKCWQTDPKMR 997
++ + + + + D + + P R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 998 PTFTEIMAALK 1008
T E AL
Sbjct: 298 LTAEE---ALS 305
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 45/211 (21%)
Query: 761 IGLGSYGEVYRG-DWH-GTEVAVKR---FLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
IG G+YG V D VA+K+ F Q + R E+ I+ R RH N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY---CQRTLR-EIKILLRFRHENIIGI 90
Query: 816 MGAVTRPPNLS------IVAEFLPRGSLYRLLHRPNNQL-DERRRLRM--ALDAARGMNY 866
+ R P + IV + + LY+LL L ++ + L RG+ Y
Sbjct: 91 N-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLK--TQHLSNDHICYFLYQIL---RGLKY 143
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWM------ 920
+H+ ++HRDLK NLL++ +K+CDFGL+R + ++
Sbjct: 144 IHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVAT 194
Query: 921 ----APEVLRNEPS-DEKCDVYSFGVILWEL 946
APE++ N + D++S G IL E+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 44/221 (19%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS--EVLIMKRVR-HPNVV 813
+++G G+YG V++ D G VAVK+ D F S + R+ E++I+ + H N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 814 LFMGAVTRPPNLS---IVAEFLPRGSLYRLLHRPNNQL-DERRRLRM--ALDAARGMNYL 867
+ V R N +V +++ L+ ++ N L ++ + + + + YL
Sbjct: 73 NLL-NVLRADNDRDVYLVFDYME-TDLHAVIR--ANILEPVHKQYVVYQLI---KVIKYL 125
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----------MKHNTFLSSRSTAGT 916
H+ ++HRD+K N+L++ VKV DFGLSR + + ++ +
Sbjct: 126 HSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 917 AEWM----------APEVLRNEPS-DEKCDVYSFGVILWEL 946
+ APE+L + D++S G IL E+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 55/210 (26%), Positives = 85/210 (40%), Gaps = 36/210 (17%)
Query: 759 ERIGLGSYGEVYRGDWHGT--EVAVK------RFLDQDFFGESLEEFRSEVLIMKRVRHP 810
IG GS+G+V + VA+K FL+Q + EV +++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA---------QIEVRLLELMNKH 110
Query: 811 ------NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLR-MALDAARG 863
+V +L +V E L +LY LL N + R A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 864 MNYLHNCTPVIVHRDLKSPNLLV--DKNWVVKVCDFGLS---RMKHNTFLSSRSTAGTAE 918
+ +L I+H DLK N+L+ K +K+ DFG S + ++ SR
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 223
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCT 948
+ +PEVL P D D++S G IL E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 1e-14
Identities = 42/249 (16%), Positives = 70/249 (28%), Gaps = 62/249 (24%)
Query: 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVK--RFLDQDFFG----ESLEEFRSEVLI 803
+P E++ E+IG G +GEV++ T VA+K D ++ EE E++I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 804 MKRV---------RHPNVVLFMGA------------------------------VTRPPN 824
K + R + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNL 884
L IV EF G L + + + HRDL N+
Sbjct: 137 LFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNV 193
Query: 885 LVDKNWVVKVCDFGLSR----------MKHNTFLSSRSTAGT----AEWMAPEVLRNEPS 930
L+ K + K+ + + + SR + E L
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG 253
Query: 931 DEKCDVYSF 939
D + D+Y
Sbjct: 254 DYQFDIYRL 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 42/212 (19%)
Query: 759 ERIGLGSYGEVYRGDWHGT--EVAVK------RFLDQDFFGESLEEFRSEVLIMKRVRH- 809
+ IG GS+G+V + H VA+K RF Q E+ I++ +R
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---------AAEEIRILEHLRKQ 153
Query: 810 -----PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAA 861
NV+ + T ++ + E L +LY L+ + Q L R+ A
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSIL 210
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLV--DKNWVVKVCDFGLS---RMKHNTFLSSRSTAGT 916
+ ++ LH I+H DLK N+L+ +KV DFG S + T++ SR
Sbjct: 211 QCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF---- 264
Query: 917 AEWMAPEVLRNEPSDEKCDVYSFGVILWELCT 948
+ APEV+ D++S G IL EL T
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 46/225 (20%), Positives = 92/225 (40%), Gaps = 54/225 (24%)
Query: 759 ERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-------- 808
++G G + V+ D T VA+K + E+ E+ E+ +++RV
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKED 81
Query: 809 ---HPNVVLFMGAVT-RPPNLS---IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
+++ + + PN +V E L +L L+ + ++ + L
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYV 133
Query: 862 R--------GMNYLH-NCTPVIVHRDLKSPNLLVD------KNWVVKVCDFGLSRMKHNT 906
+ G++Y+H C I+H D+K N+L++ +K+ D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 907 F---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT 948
+ + +R E+ +PEVL P D++S +++EL T
Sbjct: 192 YTNSIQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 77/346 (22%), Positives = 117/346 (33%), Gaps = 116/346 (33%)
Query: 759 ERIGLGSYGEVYRG---DWHGTEVAVK------RFLDQDFFGESLEEFRSEVLIMKRVRH 809
+ +G G++G+V G VAVK R+ + RSE+ +++ +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---------RSEIQVLEHLNT 70
Query: 810 P------NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRL------RMA 857
V + ++ IV E L S Y + + N +MA
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFI-KENG----FLPFRLDHIRKMA 124
Query: 858 LDAARGMNYLHNCTPVIVHRDLKSPN-LLVDKNWV------------------VKVCDFG 898
+ +N+LH+ + H DLK N L V ++ +KV DFG
Sbjct: 125 YQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 899 ---LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT------- 948
H+T +S+R APEV+ + CDV+S G IL E
Sbjct: 183 SATYDDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 949 --------MQQPWGGMNPMQVVGAVG----FQHRRLDIP--------------------- 975
M + G P ++ F H RLD
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 976 --DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK-----PLQKPI 1014
D + D+I+K + DP R T E ALK L+K I
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLRE---ALKHPFFDLLKKSI 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 60/230 (26%)
Query: 759 ERIGLGSYGEVYRGDWHGT---EVAVK------RFLDQDFFGESLEEFRSEVLIMKRVRH 809
+G G++G+V H +VA+K ++ + R E+ ++K+++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---------RLEINVLKKIKE 75
Query: 810 P------NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDA 860
VL ++ I E L + + L N Q L R MA
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAYQL 132
Query: 861 ARGMNYLHNCTPVIVHRDLKSPN-LLVD------------------KNWVVKVCDFG--- 898
+ +LH + H DLK N L V+ KN ++V DFG
Sbjct: 133 CHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 899 LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT 948
H T +++R PEV+ + CDV+S G IL+E
Sbjct: 191 FDHEHHTTIVATRHY------RPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 52/234 (22%), Positives = 94/234 (40%), Gaps = 64/234 (27%)
Query: 759 ERIGLGSYGEVYRGDWHGT--EVAVK------RFLDQDFFGESLEEFRSEVLIMKRVRH- 809
++G G++G V AVK ++ + E I+K++++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---------KIEADILKKIQND 91
Query: 810 ----PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAAR 862
N+V + G ++ ++ E L SLY ++ R N +++ + ++ +
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL--YCIEILK 148
Query: 863 GMNYLHNCTPVIVHRDLKSPN-LLVD------------------------KNWVVKVCDF 897
+NYL + + H DLK N LL D K+ +K+ DF
Sbjct: 149 ALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 898 G---LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT 948
G H + +++R + APEV+ N D D++SFG +L EL T
Sbjct: 207 GCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 42/226 (18%)
Query: 757 LGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEE----FRSEVLIMKRVRH- 809
+G RIG GS+G ++ G + +VA+K E R E K +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 810 ---PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
PNV F N+ +V + L SL LL + + A +
Sbjct: 66 TGIPNVYYF--GQEGLHNV-LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNW-----VVKVCDFGLSRM-------KHNTFLSSRSTA 914
+H + +V+RD+K N L+ + ++ V DFG+ + +H + ++ +
Sbjct: 122 IHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 915 GTAEWMAPEV-LRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMN 957
GTA +M+ L E S D D+ + G + PW G+
Sbjct: 180 GTARYMSINTHLGREQSRRD---DLEALGHVFMYFLRGSLPWQGLK 222
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 40/223 (17%)
Query: 757 LGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRS----EVLIMKRVRH- 809
LG +IG GS+G++Y G D G EVA+K E ++ E I K ++
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 810 ---PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
P + N+ +V E L SL L + + + + L +A + Y
Sbjct: 65 VGIPTIRWC--GAEGDYNV-MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNW---VVKVCDFGLSRM-------KHNTFLSSRSTAGT 916
+H+ +HRD+K N L+ +V + DFGL++ +H + +++ GT
Sbjct: 121 IHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 917 AEWMAPEV-LRNEPS--DEKCDVYSFGVILWELCTMQQPWGGM 956
A + + L E S D D+ S G +L PW G+
Sbjct: 179 ARYASINTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGL 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 757 LGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH----P 810
+G++IG G++GE+ G + + VA+K L E K++ P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHL---EYRFYKQLGSGDGIP 68
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRG-SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
V F N +V E L G SL L + + L +A+ M Y+H+
Sbjct: 69 QVYYF--GPCGKYNA-MVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 870 CTPVIVHRDLKSPNLLVDKNW-----VVKVCDFGLSRM-------KHNTFLSSRSTAGTA 917
+++RD+K N L+ + V+ + DF L++ KH + +S GTA
Sbjct: 124 KN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 918 EWMAPEV-LRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMN 957
+M+ L E S D D+ + G + PW G+
Sbjct: 182 RYMSINTHLGKEQSRRD---DLEALGHMFMYFLRGSLPWQGLK 221
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 33/193 (17%), Positives = 62/193 (32%), Gaps = 32/193 (16%)
Query: 757 LGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLF 815
+G IG G +G +Y D + V +E+ +R P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 816 MGAVTRPPNLSI-------------------VAEFLPRGSLYRLLHRPNNQLDERRRLRM 856
+ L + + + L ++ + + L++
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQL 157
Query: 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKV--CDFGLSR-------MKHNTF 907
+L + Y+H VH D+K+ NLL++ +V D+GL+ K
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 908 LSSRSTAGTAEWM 920
R GT E+
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 5e-08
Identities = 89/667 (13%), Positives = 178/667 (26%), Gaps = 240/667 (35%)
Query: 101 LDSESNNSR--DPDVEEEYQIQMALELSAKEDPEAVQI----EAVKQISLGSCDPEN--- 151
+D E+ + D+ ++ K+ + + E + I + S D +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHI-IMSKDAVSGTL 65
Query: 152 --------TPAEVVA--------YRY-WNYNSLSYDDKIMDGFYDLYGIPSESTSDRM-- 192
E+V Y + + + + + +Y DR+
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY----IEQRDRLYN 121
Query: 193 --PSLVDLQGTPVSGSVMWEAVLVNRAADSNLLKLEQKVLEVAVKSRSHSQAFV-GIDLV 249
V+R LKL Q +LE+ R + G
Sbjct: 122 DNQVFAKYN--------------VSRL--QPYLKLRQALLEL----RPAKNVLIDG---- 157
Query: 250 RNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVL---------PLGS--LTIG 298
+ G G K + V L +
Sbjct: 158 ----------VLG-SG----------------KTWVALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 299 LARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDDGREYIVDLMAD---PGT 355
+ ++L + + + D + +RI + + L+
Sbjct: 191 NCNSPETVLEMLQKL----LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 356 LIPSDAVGSHVECDDSF-YSASPL--SRDIDSSHAASSSSGVGSSFEEHSE-FGTCDKRS 411
L+ V + + ++F S L +R + S+++ S + HS + +S
Sbjct: 247 LLVLLNV-QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 412 RFRNSAAVAGQS--NETGKSNAFFNLTRTTEGEEELKMLPEN-----------KHPSDRE 458
Q E +N L ++ E+ KH + +
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRR-----------LSIIAESIRDGLATWDNWKHVNCDK 354
Query: 459 -----KAFVREL-PN--KPNY------PHAHARSPS------WTEGVS------------ 486
++ + L P + + P A P+ W + +
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 487 -SPAAHRMKVKDVSQYMI--DAAKENPQLAQKLHDVLLES----------GVVAPP---- 529
S + K +S I + + LH +++ ++ P
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYA-LHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 530 ------------------NLFTEIYAEQLDASTVEVRSPTETQDKNKQG----TGSQERK 567
LF ++ LD +E + ++ N G T Q +
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVF---LDFRFLEQKIRHDSTAWNASGSILNTLQQLKF 529
Query: 568 -----NQDDPSPAR-------FLPPLPRPRAPSKATSFDQPEEDLGLSRQSDVMAAAGQP 615
+DP R FLP + EE+L S+ +D++ A
Sbjct: 530 YKPYICDNDPKYERLVNAILDFLP---------------KIEENLICSKYTDLLRIA--- 571
Query: 616 LSPQSEA 622
L + EA
Sbjct: 572 LMAEDEA 578
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 44/333 (13%), Positives = 102/333 (30%), Gaps = 85/333 (25%)
Query: 778 EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH----PNVV-----LFMGAVTRPPNLSIV 828
V F+ +F + +++ +L + + H + V LF +++ +V
Sbjct: 23 SVFEDAFV-DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE--MV 79
Query: 829 AEFLPRGSL---YR-LLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNL 884
+F+ L Y+ L+ + + + R + L+N V ++
Sbjct: 80 QKFV-EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR--DRLYNDNQVFAKYNVSRLQP 136
Query: 885 LVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAE-WMAPEVLRNEPSDEKCD--VY--SF 939
++ L ++ + G+ + W+A +V + K D ++ +
Sbjct: 137 Y----LKLRQA---LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL 189
Query: 940 G---------VILWELCT------MQQPWGGMNPMQVVGAVG------FQHRR----LDI 974
+L +L + N + ++ + + L +
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 975 PDNL--------------------DPAVADIIRKCWQTDPKM---RPTFT--EIMAAL-K 1008
N+ V D + T + T T E+ + L K
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 1009 PLQKPITSSQVPRPVPSVSSGRETGQISKFLAD 1041
L +PR V + + R I++ + D
Sbjct: 310 YLDCRP--QDLPREVLTTNP-RRLSIIAESIRD 339
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 37/197 (18%), Positives = 64/197 (32%), Gaps = 43/197 (21%)
Query: 757 LGERIGLGSYGEVYRG--DWHGTEVAVKRFLDQDFFGESLEEFRS-----EVLIMKRVRH 809
LG++IG G +G +Y + A +E + E+ +RV
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARH--------VVKVEYQENGPLFSELKFYQRVAK 92
Query: 810 PNVVLFMGAVTRPPNLSI-----VAEFLPRGSLYRL------------LHRPNNQLDERR 852
+ + + L I +G YR + N +
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 853 RLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKV--CDFGLSRM-------K 903
L++ + + Y+H VH D+K+ NLL+ +V D+GLS K
Sbjct: 153 VLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 904 HNTFLSSRSTAGTAEWM 920
+ GT E+
Sbjct: 211 QYQENPRKGHNGTIEFT 227
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 757 LGERIGLGSYGEVYRG-DWH-GTEVAVKRFLDQDFFGESLEE----FRSEVLIMKRVRH- 809
LG +IG GS+GE+Y G + EVA+K E+++ E I + ++
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGG 62
Query: 810 ---PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
PNV F V N+ +V + L SL L + + +L + L +A + +
Sbjct: 63 TGIPNVRWF--GVEGDYNV-LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNW---VVKVCDFGLSRM-------KHNTFLSSRSTAGT 916
+H+ +HRD+K N L+ V + DFGL++ +H + +++ GT
Sbjct: 119 VHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 917 AEWMAPEV-LRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMN 957
A + + L E S D D+ S G +L PW G+
Sbjct: 177 ARYASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLK 217
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 47/254 (18%), Positives = 85/254 (33%), Gaps = 72/254 (28%)
Query: 761 IGLGSYGEVY--RGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-----HPN-- 811
+G G + V+ VA+K + + E+ + E+ ++K VR PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 812 -VVLFMGAVT-RPPN---LSIVAEFLPRGSLYRLLHRPNNQLDERRRLR-MALDAARGMN 865
VV + N + +V E L L + + + N Q ++ + +G++
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 866 YLHNCTPVIVHRDLKSPNLLV--------------------------------------- 886
YLH I+H D+K N+L+
Sbjct: 161 YLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 887 ----------DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDV 936
+ VK+ D G + H F T ++ + EVL + D+
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR---QYRSLEVLIGSGYNTPADI 276
Query: 937 YSFGVILWELCTMQ 950
+S + +EL T
Sbjct: 277 WSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 38/193 (19%), Positives = 61/193 (31%), Gaps = 32/193 (16%)
Query: 757 LGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDF---FGESLEEFRSEVLIMKRVRHPNVV 813
L + G +Y T Q F +E +R P V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 814 LFMGAVTRPPNLSI----------------VAEFLPRGSLYRLLHR-PNNQLDERRRLRM 856
+ P L+I V L R SL L P + L ER L++
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQV 164
Query: 857 ALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKV--CDFGLSRM-----KHNTFLS 909
A + +LH VH ++ + N+ VD +V +G + KH ++
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 910 SRSTA--GTAEWM 920
+ G E++
Sbjct: 223 GSRSPHEGDLEFI 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1044 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.68 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 97.79 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.39 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.07 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 96.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.16 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 95.55 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.71 | |
| 2q3z_A | 687 | Transglutaminase 2; transglutaminase 2, tissue tra | 94.58 | |
| 1vjj_A | 692 | Protein-glutamine glutamyltransferase E; transglut | 93.81 | |
| 1g0d_A | 695 | Protein-glutamine gamma-glutamyltransferase; tissu | 92.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.06 | |
| 1ex0_A | 731 | Coagulation factor XIII A chain; transglutaminase, | 89.9 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=480.07 Aligned_cols=252 Identities=23% Similarity=0.442 Sum_probs=223.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|+++++||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 47899999999999999999987 5889999999877766777888999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 830 EFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+||+|.++|... ...+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999999999753 456899999999999999999999999 99999999999999999999999999987654433
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
...+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..+... ....++..+++++++||.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHH
Confidence 345568999999999999999999999999999999999999999999998888887533 3345678899999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||++||++|||+.|+|+|
T Consensus 260 ~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HTCSSGGGSCCHHHHHTS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=462.24 Aligned_cols=266 Identities=35% Similarity=0.604 Sum_probs=227.3
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
..|++..++|+++++||+|+||+||+|++.+ .||||+++.........+.|.+|+.+|++++|||||++++++. ++.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeE
Confidence 4578999999999999999999999999866 5999998876666677788999999999999999999999875 4679
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+||||||+||+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999986543
Q ss_pred C--cccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-ccc---CCCCC
Q 045028 906 T--FLSSRSTAGTAEWMAPEVLRNE---PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRR---LDIPD 976 (1044)
Q Consensus 906 ~--~~~~~s~~GTp~Y~APEvL~g~---~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~---~~ip~ 976 (1044)
. .......+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..+... ... ..++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 2234456899999999999643 5899999999999999999999999987665444333222 222 24567
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
.+++++.+||.+||++||++|||+.||+++|+.|.+++.
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 899999999999999999999999999999999987653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=471.49 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=225.3
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++++.||+|+||+||+|++ +|+.||||++.+.... ....+.+.+|+.+|++++|||||+++++|++++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346899999999999999999987 6889999999765432 3456789999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC-
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT- 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~- 906 (1044)
|||||+||+|.+++++ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999865432
Q ss_pred -cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 907 -FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 907 -~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
.....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++..+. ...+.+|..+++++++|
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDL 264 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTCCHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCcccCHHHHHH
Confidence 233456799999999999999999999999999999999999999999999999888884 45567889999999999
Q ss_pred HHHhhhcCCCCCCCHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIM 1004 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELL 1004 (1044)
|.+||++||++|||+.|++
T Consensus 265 i~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGT
T ss_pred HHHHccCCHhHCcChHHHc
Confidence 9999999999999998864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=470.37 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=224.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+.|+++++||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999988 588999999875432 23356889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|||+||+|.+++.+ ..+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+|+........
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999999976 56999999999999999999999999 999999999999999999999999999876655555
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~ELkdLI~r 988 (1044)
..+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.... .....+..+++++++||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 667899999999999999999999999999999999999999999999888887774322 2344556799999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||.+||++|||+.|+++|-
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCG
T ss_pred HcCCChhHCcCHHHHhcCH
Confidence 9999999999999999873
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=464.80 Aligned_cols=270 Identities=26% Similarity=0.358 Sum_probs=229.2
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..+.|++.++||+|+||+||+|++ +|+.||||++..... ..+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456799999999999999999987 588999999876543 24699999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~~~~~~ 907 (1044)
||||+||+|.+++++ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+| ++||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999986 457999999999999999999999999 99999999999999987 69999999998654321
Q ss_pred -----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-CCCCCCCCHH
Q 045028 908 -----LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR-LDIPDNLDPA 981 (1044)
Q Consensus 908 -----~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~-~~ip~~ip~E 981 (1044)
......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..+...... ..+|..++++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1234468999999999999999999999999999999999999999988877777776544332 3578899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCCCCCCCCCCCCCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPSVSSGRE 1031 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~~p~~~ps~s~~~~ 1031 (1044)
+++||.+||++||.+|||+.||+++|.......... ..|+......|+.
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l-~hPw~~~~~~Pr~ 334 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL-KSPWKGEYKEPRG 334 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS-CSCSSSSCCCCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc-cCCCcCCCCCCCC
Confidence 999999999999999999999999988766544432 2345554444443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=458.61 Aligned_cols=260 Identities=33% Similarity=0.573 Sum_probs=225.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
..+..++|.+.++||+|+||+||+|++. ++.||||+++... ....+.|.+|+.+|++++|||||++++++.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3466789999999999999999999863 6789999987543 455678999999999999999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCC--------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPN--------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV 886 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~--------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL 886 (1044)
+.+.+|||||||++|+|.+++++.. ..+++..++.|+.||+.||.|||+++ ||||||||+||||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence 9999999999999999999997632 45899999999999999999999999 9999999999999
Q ss_pred cCCCeEEEEeccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHh
Q 045028 887 DKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVG 963 (1044)
Q Consensus 887 d~dg~VKLiDFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~ 963 (1044)
+.++.+||+|||+++..... .......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999865332 222345679999999999999999999999999999999999 899999999888887
Q ss_pred hhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 964 AVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 964 ~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.+. ...++..|..+++++.+||.+||++||++|||+.||+++|+.+.+
T Consensus 272 ~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 775 345678899999999999999999999999999999999998875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=465.07 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=218.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
.++|++++.||+|+||+||+|++ +++.||||++.+..........+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46899999999999999999976 4678999999765544444456889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
||||||+||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999986 467999999999999999999999999 999999999999999999999999999865554
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..+. ...+.+|..+++++++||
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCcCCHHHHHHH
Confidence 445567899999999999999999999999999999999999999999999999888874 455678899999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 045028 987 RKCWQTDPKMRPT-----FTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRPT-----a~ELLe~ 1006 (1044)
.+||++||++||| ++|+++|
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999999999998 5788876
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=456.09 Aligned_cols=259 Identities=32% Similarity=0.545 Sum_probs=229.0
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
.+..++|.+.++||+|+||+||+|++ +++.||||+++... ....+.|.+|+.+|++++|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 56778999999999999999999986 36789999987543 4556789999999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCC------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRP------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN 889 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d 889 (1044)
.+.++||||||++|+|.+++++. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 99999999999999999999753 357999999999999999999999999 9999999999999999
Q ss_pred CeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhc
Q 045028 890 WVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVG 966 (1044)
Q Consensus 890 g~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~ 966 (1044)
+.+||+|||+++...... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999998643322 22234569999999999999999999999999999999998 899999999988888775
Q ss_pred cccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 967 FQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 967 ~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
...+...|..+++++.+||.+||+.||++|||+.+|++.|+++.+
T Consensus 245 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 345567889999999999999999999999999999999998865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=473.02 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=225.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+.|+++++||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 45799999999999999999988 588999999875542 23456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
|||+||+|.++++. ..+++..+..|+.||+.||.|||++| ||||||||+||||+.+|.|||+|||+|+........
T Consensus 228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999999975 56999999999999999999999999 999999999999999999999999999876655555
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~ELkdLI~r 988 (1044)
..+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.... .....+..+++++++||.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 667899999999999999999999999999999999999999999999888887775332 2445567899999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||.+||++|||+.|+|+|-
T Consensus 384 ~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCG
T ss_pred HcCCChhHCcCHHHHhcCH
Confidence 9999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=448.19 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=208.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++.+.... ......+.+|+.+|++++|||||++++++.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999987 5899999998765433 33456799999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+ +|+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999 6799999876 467999999999999999999999999 9999999999999999999999999998654332
Q ss_pred cccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
...+.+||+.|||||++.+..| +.++|||||||+||+|++|++||.+.+..+++..+. ...+.+|..+++++++||.
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 3346789999999999999886 589999999999999999999999998888888774 4556788999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHh
Q 045028 988 KCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~L 1007 (1044)
+||++||++|||+.|+++|-
T Consensus 245 ~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCH
T ss_pred HHccCChhHCcCHHHHHcCc
Confidence 99999999999999999873
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=451.92 Aligned_cols=259 Identities=31% Similarity=0.551 Sum_probs=228.7
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
.++...+++++++||+|+||+||+|++ +++.||||+++... .....+.|.+|+.++++++|||||++++++.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 356778899999999999999999986 35789999986543 2345678999999999999999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEE
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLL 885 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNIL 885 (1044)
.++.++||||||++|+|.++|... ...+++..++.++.||+.||.|||+++ ||||||||+|||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL 177 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence 999999999999999999999653 245899999999999999999999999 999999999999
Q ss_pred EcCCCeEEEEeccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 045028 886 VDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVV 962 (1044)
Q Consensus 886 Ld~dg~VKLiDFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil 962 (1044)
|+.++.+||+|||+++..... .......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999865332 223445679999999999999999999999999999999998 89999999998888
Q ss_pred hhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 963 GAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 963 ~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
..+. ...+...|..+++++.+||.+||+.||.+|||+.||+++|+.+
T Consensus 258 ~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8775 3455678899999999999999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=449.28 Aligned_cols=249 Identities=27% Similarity=0.471 Sum_probs=217.6
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec----CCCceEE
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PPNLSIV 828 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~----~~~l~LV 828 (1044)
|++.++||+|+||+||+|.+ ++..||+|++..........+.+.+|+.+|++++|||||+++++|.. ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 48889999999999999987 47889999998776666677889999999999999999999999865 3458999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+||+|.+++.+ ...+++..++.++.||+.||.|||+++++||||||||+||||+. +|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999986 46799999999999999999999998877999999999999984 799999999999865433
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
...+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.. ...+...+........++..+++++++||
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 3456789999999999976 59999999999999999999999997654 45555566544445566778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHh
Q 045028 987 RKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+||++||++|||+.|+++|-
T Consensus 264 ~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHccCChhHCcCHHHHhcCc
Confidence 999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=453.44 Aligned_cols=265 Identities=31% Similarity=0.558 Sum_probs=229.8
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEECC-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC-CCeeEEE
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-PNVVLFM 816 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH-PNIVkl~ 816 (1044)
..+|+++.++|+++++||+|+||+||+|++.+ +.||||.+.... .....+.+.+|+.+|.+++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34678999999999999999999999998743 579999986543 23456779999999999975 9999999
Q ss_pred eeeecC-CCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC
Q 045028 817 GAVTRP-PNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK 880 (1044)
Q Consensus 817 ~~~~~~-~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK 880 (1044)
+++... +.++||||||++|+|.++|++. ...+++..++.++.||+.||.|||+++ |||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK 212 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA 212 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccC
Confidence 998664 5699999999999999999642 245899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 045028 881 SPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957 (1044)
Q Consensus 881 PeNILLd~dg~VKLiDFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~ 957 (1044)
|+||||+.++.+||+|||+|+..... .......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865332 223345679999999999999999999999999999999998 999999877
Q ss_pred hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 958 ~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
..+.+..+.....++..|..+++++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 5555544444566788899999999999999999999999999999999998765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=440.05 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=214.8
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec------CCC
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR------PPN 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~------~~~ 824 (1044)
++|++++.||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999987 58999999997766555667788999999999999999999998764 357
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|||||||+ |+|.+++.+ ...+++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+++...
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999995 689999976 567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CC----cccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC-------
Q 045028 905 NT----FLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL------- 972 (1044)
Q Consensus 905 ~~----~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~------- 972 (1044)
.. .....+.+||+.|||||++.+.. ++.++|||||||+||||++|++||.+.+..+.+..+......+
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 22345678999999999998864 6999999999999999999999999998887776653221110
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 ----------------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ----------------------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+...+++++++||.+||.+||.+|||+.|+|+|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0123578999999999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=425.97 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=193.6
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-------
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------- 823 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------- 823 (1044)
++|++++.||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999987 58899999987544 2344567899999999999999999999987544
Q ss_pred -----CceEEEEecCCCcHHHHhcCCC--CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEe
Q 045028 824 -----NLSIVAEFLPRGSLYRLLHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCD 896 (1044)
Q Consensus 824 -----~l~LVmEy~~GGsL~dlLkr~~--~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiD 896 (1044)
.+|||||||.||+|.+++.... ...++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 3799999999999999998643 23456778899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCc------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHh
Q 045028 897 FGLSRMKHNTF------------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVG 963 (1044)
Q Consensus 897 FGLA~~~~~~~------------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~ 963 (1044)
||+|+...... ....+.+||+.|||||++.+..|+.++|||||||+||||++ ||...... ..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 99998643321 11234679999999999999999999999999999999996 77653221 2222
Q ss_pred hhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 964 AVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 964 ~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+. .......+...++++.+||.+||++||.+|||+.|+++|
T Consensus 239 ~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 221 111111223456778899999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=423.96 Aligned_cols=254 Identities=33% Similarity=0.527 Sum_probs=202.7
Q ss_pred CCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC----CceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP----NLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~----~l~LV 828 (1044)
.+|.+.++||+|+||+||+|+++|+.||||++.... ........|+.++.+++|||||++++++..++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468999999999999999999999999999986542 11122344666667889999999999987654 47999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC--------CCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC--------TPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~--------G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
|||++||+|.+++++ ..+++..++.++.|++.||.|||++ + ||||||||+||||+.++++||+|||++
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--EeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999986 5689999999999999999999987 6 999999999999999999999999999
Q ss_pred ccccCCcc----cccCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhCCCCCCCCC-------------
Q 045028 901 RMKHNTFL----SSRSTAGTAEWMAPEVLRNE------PSDEKCDVYSFGVILWELCTMQQPWGGMN------------- 957 (1044)
Q Consensus 901 ~~~~~~~~----~~~s~~GTp~Y~APEvL~g~------~~s~kSDIWSLG~LLyELLTGk~PF~~~~------------- 957 (1044)
+....... .....+||+.|||||++.+. .++.++|||||||+||||+||.+||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543221 22345799999999999765 35679999999999999999977653221
Q ss_pred --hHHHHhhhccccccCCCCCC-----CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 958 --PMQVVGAVGFQHRRLDIPDN-----LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 958 --~~eil~~I~~~~~~~~ip~~-----ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
..++...+.....++.+|.. +++.+.+||.+||+.||++|||+.||++.|+++.++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 22333333333344455533 335789999999999999999999999999988754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=409.26 Aligned_cols=270 Identities=66% Similarity=1.152 Sum_probs=233.2
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
....++..++|++.+.||+|+||+||+++++++.||||++............+.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34567788999999999999999999999999999999998777666777889999999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCC--CCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNN--QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~--~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+++||||+.+++|.+++.+... .+++..++.++.||+.||.|||++|++|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999987432 38999999999999999999999987799999999999999999999999999986
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+........++..+++++
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 55544445567899999999999999999999999999999999999999999998888887766777888899999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.+||.+||..||.+|||+.++++.|+.+.+..
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=446.57 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=223.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 68899999987654 334567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC--CeEEEEeccccccccCCc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN--WVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d--g~VKLiDFGLA~~~~~~~ 907 (1044)
|||.||+|+++|.+....+++..+..++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+++......
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999999999876678999999999999999999999999 9999999999999854 899999999998764432
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip~ELkdL 985 (1044)
...+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+......+ ..+..+++++++|
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999999999888875443322 2336799999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||++||.+|||+.|+|+|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=451.18 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=215.8
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHH---HHHHHHHhCCCCCeeEEEeeeecC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFR---SEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~---~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
.+..++|+++++||+|+||+||+|++ +|+.||||++.+..... .....+. .++.+++.++|||||+++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 34568999999999999999999987 68899999997654322 2222333 345667778999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+|||||||+||+|.++|.+ ...+++..++.|+.||+.||.|||++| ||||||||+||||+.+|+|||+|||+|+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999999986 467999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhccccccCCCCCCC
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLR-NEPSDEKCDVYSFGVILWELCTMQQPWGGMN---PMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~-g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---~~eil~~I~~~~~~~~ip~~i 978 (1044)
.... ...+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.+ ..++...+ ......+|..+
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~ 417 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSF 417 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTS
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccC
Confidence 5443 345679999999999996 5679999999999999999999999997643 33344444 34566788999
Q ss_pred CHHHHHHHHHhhhcCCCCCCC-----HHHHHHHh
Q 045028 979 DPAVADIIRKCWQTDPKMRPT-----FTEIMAAL 1007 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPT-----a~ELLe~L 1007 (1044)
++++++||.+||.+||.+|++ +.||++|-
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 999999999999999999998 79999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=418.91 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=201.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l 825 (1044)
.++|+++++||+|+||+||+|++ +++.||||.+.... ....+.+|+++|+.+ +||||++++++|.+.+++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 36799999999999999999975 35789999886543 235678899999998 599999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA~~~~ 904 (1044)
||||||++||+|.++++ .+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999994 4899999999999999999999999 9999999999999876 899999999997543
Q ss_pred CCc----------------------------ccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCC
Q 045028 905 NTF----------------------------LSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGG 955 (1044)
Q Consensus 905 ~~~----------------------------~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~ 955 (1044)
... ....+.+||+.|+|||++.+.. |+.++||||+||+||||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 221 1123457999999999998764 89999999999999999999999965
Q ss_pred C-ChHHHHhhhccc----------------------------------------------------cccCCCCCCCCHHH
Q 045028 956 M-NPMQVVGAVGFQ----------------------------------------------------HRRLDIPDNLDPAV 982 (1044)
Q Consensus 956 ~-~~~eil~~I~~~----------------------------------------------------~~~~~ip~~ip~EL 982 (1044)
. +..+.+..+... .........+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 4 333332222100 00112235688999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++||.+||++||.+|+|+.|+|+|
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=400.60 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=226.6
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+..++|++++.||+|+||+||++++ +|+.||||++.+... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4467899999999999999999987 588999999876432 2345667889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999999976 457899999999999999999999999 999999999999999999999999999864444
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..++...+. .....+|..+++++++||
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHH
Confidence 444566789999999999999999999999999999999999999999988888877774 345667889999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHHh
Q 045028 987 RKCWQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 987 ~rcL~kDPekRP-----Ta~ELLe~L 1007 (1044)
.+||++||.+|| ++.+|++|-
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 999999999999 899999884
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=394.39 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=227.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
...++|++++.||+|+||.||+|++ +|+.||||++..........+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999987 68999999998776666677889999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+.|++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999976 356999999999999999999999999 9999999999999999999999999997654332
Q ss_pred ccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSD-EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s-~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.....+||+.|+|||++.+..+. .++|||||||+||+|++|+.||.+.+..++...+. .....+|..+++++.+||
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHH
Confidence 34557899999999999988865 89999999999999999999999999888887774 445677888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHh
Q 045028 987 RKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+||..||.+|||+.|+++|-
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCT
T ss_pred HHHCCCChhHCcCHHHHhcCH
Confidence 999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=376.29 Aligned_cols=260 Identities=29% Similarity=0.619 Sum_probs=233.1
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--CCc
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--PNL 825 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~~l 825 (1044)
..+..++|++.+.||+|+||+||+++++++.||||++..........+.+.+|+.++++++||||+++++++... +.+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456678999999999999999999999999999999987766666677899999999999999999999999887 789
Q ss_pred eEEEEecCCCcHHHHhcCCCC-CCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNN-QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~-~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++||||+++++|.+++.+... .+++..++.++.||+.||.|||+++..|+||||||+|||++.++.++|+|||+.....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987433 5899999999999999999999988779999999999999999999999999875422
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCc---hhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDE---KCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~---kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+....+........++..++++
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 23457899999999998765544 8999999999999999999999998888877776666677888999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+.++|.+||+.||.+|||+.++++.|+.+.+
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999998865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=400.51 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=219.9
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~ 824 (1044)
.+..++|++++.||+|+||+||++++ +++.||||++.+... .......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999987 578999999876432 234566788999999988 69999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+||||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999999976 467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+++..+. .....+|..+++++++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLHEDATG 253 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHH
Confidence 44445566789999999999999999999999999999999999999999999998888874 4556778899999999
Q ss_pred HHHHhhhcCCCCCCCH------HHHHHHh
Q 045028 985 IIRKCWQTDPKMRPTF------TEIMAAL 1007 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa------~ELLe~L 1007 (1044)
||.+||.+||.+||++ .+|++|-
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 9999999999999998 8888863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=375.33 Aligned_cols=261 Identities=31% Similarity=0.555 Sum_probs=231.0
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.+.+..++|++++.||+|+||+||++++ +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4567778999999999999999999988 6778999998765432 35688999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+++++|.+++......+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999999887778999999999999999999999999 99999999999999999999999999975543
Q ss_pred Cc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 906 TF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 906 ~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 237 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHHH
Confidence 22 22334557889999999999999999999999999999999 999999988888777764 3345566778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
++|.+||+.||.+|||+.+++++|+.+.+.
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 999999999999999999999999988653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.82 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=221.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||++.+ +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999976 688999999865442 23466889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.|++|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999976 46899999999999999999999999 999999999999999999999999999876655445
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc-ccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF-QHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~-~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.. .......+..+++++++||.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 5667899999999999999999999999999999999999999998887766554432 223455677899999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||+.||.+|||+.|+++|-
T Consensus 253 ~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp HSCSSTTTSCCHHHHTTCG
T ss_pred HccCChhHCcCHHHHhhCh
Confidence 9999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=394.31 Aligned_cols=262 Identities=31% Similarity=0.573 Sum_probs=228.8
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEE
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFM 816 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~ 816 (1044)
.+++..++|++++.||+|+||+||+|++. +..||||++.... .......+.+|+.+++.+ +||||++++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 35667789999999999999999999862 3469999986543 345567899999999999 899999999
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
+++...+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 99999999999999999999999997632 35889999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~ 958 (1044)
+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999998554322 22334567889999999999999999999999999999999 9999999888
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.++...+. ...+...+..++.++.+||.+||..||.+|||+.|++++|+.+..
T Consensus 312 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 312 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 77776654 344567788999999999999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=396.29 Aligned_cols=255 Identities=20% Similarity=0.344 Sum_probs=224.2
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~ 823 (1044)
..+..++|++++.||+|+||+||++++. ++.||||++.+... .......+..|+.++..+ +||||+++++++++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 3456789999999999999999999984 57899999876432 224456788999999988 7999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999999976 356999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..+. .....+|..++++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAV 249 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHH
Confidence 444444566789999999999999999999999999999999999999999999888888774 345678889999999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHHHh
Q 045028 984 DIIRKCWQTDPKMRPT-----FTEIMAAL 1007 (1044)
Q Consensus 984 dLI~rcL~kDPekRPT-----a~ELLe~L 1007 (1044)
+||.+||.+||.+||+ +.+|++|-
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 9999999999999994 68888873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=372.30 Aligned_cols=260 Identities=34% Similarity=0.611 Sum_probs=228.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEECC-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
.++..++|++++.||+|+||+||++++.+ ..||+|++..... ..+.+.+|+.++++++||||+++++++...+.++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 45667899999999999999999998854 5799999876543 2356889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999876667999999999999999999999999 999999999999999999999999999765433
Q ss_pred c-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 F-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHH
Confidence 2 22334457788999999999889999999999999999999 999999988887776664 33455667788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+|.+||+.||.+|||+.+++++|+.+.++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999999998765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=387.13 Aligned_cols=265 Identities=33% Similarity=0.517 Sum_probs=229.8
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
.++..++|++.+.||+|+||+||++++. +..||||++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3566789999999999999999999872 3459999986543 345567799999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+++||||+.|++|.+++......+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999999877778999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 903 KHNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 903 ~~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
...... ......+|+.|+|||++.+..++.++|||||||+||+|++ |..||.+....+....+. .......+..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 279 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCc
Confidence 543221 2233456788999999999999999999999999999999 999999998888877764 33456677889
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
++++.+||.+||..||.+|||+.+|++.|+.+.+....
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 99999999999999999999999999999999875443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=371.17 Aligned_cols=258 Identities=40% Similarity=0.709 Sum_probs=217.4
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
++..++|++.+.||+|+||+||++.+.++.||||++...... ....+.+.+|+.+++.++||||+++++++...+.++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 456789999999999999999999999999999998654322 234567899999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCc-EEEecCCCCcEEEcC--------CCeEEEEec
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV-IVHRDLKSPNLLVDK--------NWVVKVCDF 897 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~-IVHRDIKPeNILLd~--------dg~VKLiDF 897 (1044)
+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++|.. |+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999964 5799999999999999999999999833 889999999999986 778999999
Q ss_pred cccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 898 GLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 898 GLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
|++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.........+..
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 9997654332 23457999999999999999999999999999999999999999998888777777666667778899
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+++++.++|.+||+.||.+|||+.|++++|+.+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=375.71 Aligned_cols=262 Identities=29% Similarity=0.512 Sum_probs=227.7
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
...+++..++|++++.||+|+||+||++++. +..||||++...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 3456778889999999999999999999885 457999998765432 356889999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999999999876677999999999999999999999999 999999999999999999999999999755
Q ss_pred cCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 904 HNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 904 ~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+. .......+..++++
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEK 249 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHH
Confidence 3322 22234457889999999999999999999999999999998 999999988887777664 33455667788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+.++|.+||+.||.+|||+.+++++|+++.+
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=378.24 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=213.8
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch------------------------hhHHHHHHHHHH
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG------------------------ESLEEFRSEVLI 803 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~------------------------~~~~~~~~EI~I 803 (1044)
+..++|++.+.||+|+||+||+|++ +++.||||++....... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457899999999999999999987 57889999987553221 123568899999
Q ss_pred HHhCCCCCeeEEEeeeec--CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 804 MKRVRHPNVVLFMGAVTR--PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 804 Lk~LrHPNIVkl~~~~~~--~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
+++++||||+++++++.. .+.+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp 165 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKP 165 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence 999999999999999986 4579999999999999887654 57999999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP---SDEKCDVYSFGVILWELCTMQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~---~s~kSDIWSLG~LLyELLTGk~PF~~~~~ 958 (1044)
+|||++.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||+||+|++|+.||.....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999987654443345568999999999998765 37889999999999999999999998887
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......+............+++++++||.+||..||.+|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 777666644444444456789999999999999999999999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=386.93 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=214.1
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
..+..++|++++.||+|+||+||+++. +++.||||++...... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 345668999999999999999999986 5789999998765432 234456888999999999999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
..+.+|+||||+.|++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999999976 456899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
+............+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+....+. .....+|..+++
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~ 246 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KCKLNLPPYLTQ 246 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCCCCCTTSCH
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCH
Confidence 764433334456789999999999999999999999999999999999999999988888777763 345667889999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 045028 981 AVADIIRKCWQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRP-----Ta~ELLe~L 1007 (1044)
++++||.+||..||.+|| ++.++++|-
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 999999999999999999 889999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=381.16 Aligned_cols=256 Identities=25% Similarity=0.322 Sum_probs=214.3
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
.+...++|+++++||+|+||+||++++ +++.||||++............+.+|+.++++++||||+++++++...+.++
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 344568999999999999999999988 6788999998765544445577889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.+ +|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99999975 888888876777999999999999999999999999 999999999999999999999999999876544
Q ss_pred cccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--------------
Q 045028 907 FLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR-------------- 971 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~-------------- 971 (1044)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 444455679999999999987 45899999999999999999999999887666554443211000
Q ss_pred --------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 --------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 --------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+...+++++.+||.+||++||.+|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01124578899999999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=388.82 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=220.2
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCc
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l 825 (1044)
+..++|++++.||+|+||+||++++ +++.||||++.+.... ......+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567899999999999999999987 4788999999765433 34567788999999988 899999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999999976 357999999999999999999999999 99999999999999999999999999986444
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChHHHHhhhccccccCCCCC
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM---------NPMQVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~---------~~~eil~~I~~~~~~~~ip~ 976 (1044)
........+||+.|+|||++.+..++.++|||||||+||||++|+.||... ....+...+ ......+|.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 240 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 240 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCC
Confidence 434456678999999999999999999999999999999999999999752 223334444 234567888
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCH------HHHHHHh
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTF------TEIMAAL 1007 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa------~ELLe~L 1007 (1044)
.+++++++||.+||.+||.+||++ .++++|-
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 999999999999999999999985 7888763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=391.18 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=224.7
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
...++|++++.||+|+||+||++++ +|+.||||++.+.... ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3457899999999999999999987 5889999998754322 245677889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999999976 356999999999999999999999999 999999999999999999999999999865432
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+++..+. .....+|..+++++++||
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHH
Confidence 345689999999999999999999999999999999999999999999888888774 345677889999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHHh
Q 045028 987 RKCWQTDPKMRPT-----FTEIMAAL 1007 (1044)
Q Consensus 987 ~rcL~kDPekRPT-----a~ELLe~L 1007 (1044)
.+||+.||.+||+ +.+|++|-
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCc
Confidence 9999999999998 99999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=398.98 Aligned_cols=281 Identities=22% Similarity=0.353 Sum_probs=230.9
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~ 824 (1044)
.+..++|+++++||+|+||+||++++ +++.||||++.+.... ......+..|+.++.++ +||||++++++|.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45567999999999999999999987 5778999999765433 23345688899999887 79999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+||||||+.||+|..++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999999976 467999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHhhhccccccCCCC
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN---------PMQVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---------~~eil~~I~~~~~~~~ip 975 (1044)
.........+||+.|+|||++.+..++.++|||||||+||||++|++||.... ...+...+ ......+|
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIP 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCC
Confidence 44445667889999999999999999999999999999999999999996432 22233333 34567788
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCH------HHHHHHhccccCCC------CCCCCCCCCCCCCCCCCccchh
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTF------TEIMAALKPLQKPI------TSSQVPRPVPSVSSGRETGQIS 1036 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa------~ELLe~Lk~L~k~l------~~~~~p~~~ps~s~~~~~~~i~ 1036 (1044)
..+++++++||.+||++||.+||++ .||++|-. ++.+ ...-.||..|..........++
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf--f~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd 353 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF--FRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 353 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT--TTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSC
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc--ccCCCHHHHHcCCCCCCCcCCCCCccchhhcC
Confidence 9999999999999999999999984 78887732 1111 1123455566666555555554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=386.46 Aligned_cols=250 Identities=23% Similarity=0.427 Sum_probs=224.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+..++|++++.||+|+||+||+++. +|+.||||++.+.... ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3457899999999999999999987 5889999998754322 234667889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999999976 457999999999999999999999999 999999999999999999999999999865432
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+. .....+|..+++++++||
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLL 234 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHH
Confidence 345689999999999999999999999999999999999999999988888887774 345677889999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHHh
Q 045028 987 RKCWQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 987 ~rcL~kDPekRP-----Ta~ELLe~L 1007 (1044)
.+||.+||.+|| ++.++++|-
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 999999999999 899999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=383.95 Aligned_cols=265 Identities=31% Similarity=0.513 Sum_probs=229.4
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEECC-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeee
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~ 819 (1044)
...+..++|++++.||+|+||.||++++.+ +.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456777899999999999999999998754 789999987543 344567799999999999999999999999
Q ss_pred ecCCCceEEEEecCCCcHHHHhcCCC-----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEE
Q 045028 820 TRPPNLSIVAEFLPRGSLYRLLHRPN-----------------------NQLDERRRLRMALDAARGMNYLHNCTPVIVH 876 (1044)
Q Consensus 820 ~~~~~l~LVmEy~~GGsL~dlLkr~~-----------------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVH 876 (1044)
...+.+++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++| |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 99999999999999999999997632 57899999999999999999999999 999
Q ss_pred ecCCCCcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 045028 877 RDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPW 953 (1044)
Q Consensus 877 RDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF 953 (1044)
|||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999997543221 22334568899999999999999999999999999999999 99999
Q ss_pred CCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 954 GGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 954 ~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
.+....+....+. .......+..+++++.+||.+||..||.+|||+.+++++|+++.+.+.
T Consensus 278 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 9988887777664 334456788999999999999999999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=383.99 Aligned_cols=262 Identities=30% Similarity=0.492 Sum_probs=222.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
+..++|+++++||+|+||+||++.+ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4567899999999999999999987 4888999987543 34566789999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999887788999999999999999999999999 9999999999999999999999999997643322
Q ss_pred cc--------------ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-ccccccC
Q 045028 908 LS--------------SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV-GFQHRRL 972 (1044)
Q Consensus 908 ~~--------------~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I-~~~~~~~ 972 (1044)
.. .....||+.|+|||++.+..++.++|||||||+||+|++|..||............ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 12567999999999999999999999999999999999999998764332211110 0011123
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
..+..+++++.+||.+||+.||++|||+.++++.|+.+...+.
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 3567889999999999999999999999999999999886544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=388.29 Aligned_cols=266 Identities=31% Similarity=0.556 Sum_probs=227.8
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEE
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLF 815 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl 815 (1044)
....+++..++|++++.||+|+||.||++++ +++.||||++.... .....+.+.+|+.+++++ +||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3456778889999999999999999999984 34789999987543 334456799999999999 79999999
Q ss_pred EeeeecCCC-ceEEEEecCCCcHHHHhcCCCC------------------------------------------------
Q 045028 816 MGAVTRPPN-LSIVAEFLPRGSLYRLLHRPNN------------------------------------------------ 846 (1044)
Q Consensus 816 ~~~~~~~~~-l~LVmEy~~GGsL~dlLkr~~~------------------------------------------------ 846 (1044)
++++...+. +++||||+.||+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887654 9999999999999999986432
Q ss_pred -----------------CCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--c
Q 045028 847 -----------------QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--F 907 (1044)
Q Consensus 847 -----------------~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~ 907 (1044)
.+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1899999999999999999999999 999999999999999999999999999754322 2
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.......||+.|+|||++.+..++.++|||||||+||+|++ |..||.+....+..............+..+++++.++|
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 329 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 22344568899999999999999999999999999999998 99999987765555544445566778889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 987 RKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.+||+.||.+|||+.+++++|+.+..
T Consensus 330 ~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=395.55 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=223.3
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~ 824 (1044)
.+..++|++++.||+|+||+||++++ +++.||||++.+... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999987 578899999876432 123456788899999877 89999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999999976 357999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..+. .....+|..+++++++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKD 247 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCCCCCcccCHHHHH
Confidence 33344566789999999999999999999999999999999999999999999888888774 3456678889999999
Q ss_pred HHHHhhhcCCCCCCCHH-HHHHH
Q 045028 985 IIRKCWQTDPKMRPTFT-EIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~-ELLe~ 1006 (1044)
||.+||..||.+||++. +|++|
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHhcCCHhHcCCChHHHHcC
Confidence 99999999999999997 78765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=375.80 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=211.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 753 EEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
++|++++.||+|+||+||++++ .++.||+|++............+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999988 488999999876554444456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+.+ +|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 975 999999876778999999999999999999999999 99999999999999999999999999986544333344
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc--------------------
Q 045028 912 STAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-------------------- 970 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-------------------- 970 (1044)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 56789999999999765 589999999999999999999999998877665544321100
Q ss_pred -------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 971 -------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 971 -------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
...+...+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0012346899999999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=375.24 Aligned_cols=264 Identities=30% Similarity=0.549 Sum_probs=230.2
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEee
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~ 818 (1044)
..+++..++|++++.||+|+||.||++.+ +++.||||++.... .....+.+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 35667788999999999999999999976 24789999986543 34556789999999999999999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCCC-----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEE
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRPN-----------------------NQLDERRRLRMALDAARGMNYLHNCTPVIV 875 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~~-----------------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IV 875 (1044)
+...+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 999999999999999999999997632 34899999999999999999999999 99
Q ss_pred EecCCCCcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 045028 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQP 952 (1044)
Q Consensus 876 HRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~P 952 (1044)
||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999997653322 22334567889999999999989999999999999999999 9999
Q ss_pred CCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 953 WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 953 F~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
|.+....++...+. .......+..+++++.++|.+||+.||.+|||+.+++++|+.+..+
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99988877766654 3345667788999999999999999999999999999999988764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.74 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=213.8
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|+++++||+|+||+||++++ +++.||||++............+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5899999999999999999988 57889999998766555566788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.+ +|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9976 666666555678999999999999999999999999 9999999999999999999999999998765554455
Q ss_pred cCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHhhhcccc-------------------
Q 045028 911 RSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQP-WGGMNPMQVVGAVGFQH------------------- 969 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~P-F~~~~~~eil~~I~~~~------------------- 969 (1044)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5678999999999998776 79999999999999999988777 55555555444432110
Q ss_pred --------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 --------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 --------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
........+++++++||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0112234588999999999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=388.82 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=221.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.+.|++++.||+|+||+||++++ +|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46799999999999999999987 58899999987654322 2356799999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC----eEEEEeccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 901 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg----~VKLiDFGLA~ 901 (1044)
++||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 999999999999999976 467999999999999999999999999 99999999999998776 89999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip 979 (1044)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+ .++..++
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 168 EIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp ECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred EcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 654432 2345679999999999999999999999999999999999999999998888887774332221 1236789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+++++||.+||.+||.+|||+.|+++|-
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 9999999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=394.94 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=214.9
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHH-HHhCCCCCeeEEEeeeecCCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLI-MKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~I-Lk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.+..++|++++.||+|+||+||++++ +++.||||++.+.... ......+..|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 34567899999999999999999988 4778999999765443 2344556777776 567899999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999999976 457899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+. .....++..++.++++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ 268 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARH 268 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--HSCCCCCSSSCHHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcccCCCCCCCHHHHH
Confidence 44445567789999999999999999999999999999999999999999999888888774 3456678899999999
Q ss_pred HHHHhhhcCCCCCCCH----HHHHHH
Q 045028 985 IIRKCWQTDPKMRPTF----TEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa----~ELLe~ 1006 (1044)
||.+||++||.+||++ .+|++|
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 9999999999999987 456555
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.81 Aligned_cols=263 Identities=37% Similarity=0.664 Sum_probs=213.7
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
...++..++|+++++||+|+||+||++++.+ .||+|++..........+.+.+|+.+++.++||||++++++. ....+
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 4567888999999999999999999998765 599999987666666778899999999999999999999965 55679
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999999877788999999999999999999999999 99999999999999999999999999975432
Q ss_pred C--cccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhh-hcccc---ccCCCCC
Q 045028 906 T--FLSSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGA-VGFQH---RRLDIPD 976 (1044)
Q Consensus 906 ~--~~~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~-I~~~~---~~~~ip~ 976 (1044)
. ........||+.|+|||++. +..++.++|||||||++|+|++|+.||......+.... +.... ....++.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 1 12223456999999999997 66688899999999999999999999988655443333 22111 1223446
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.+++++.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 789999999999999999999999999999998875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=383.10 Aligned_cols=267 Identities=28% Similarity=0.459 Sum_probs=225.3
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~ 817 (1044)
..+++..++|++++.||+|+||+||+|++ .+..||||++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35677889999999999999999999986 34579999987442 233456789999999999 8999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCCC----------------------CCcHHHHHHHHHHHHHHHHHHHhCCCcEE
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNN----------------------QLDERRRLRMALDAARGMNYLHNCTPVIV 875 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~~----------------------~Lse~~il~Ia~QIa~AL~yLHs~G~~IV 875 (1044)
++...+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 99999999999999999999999987432 3789999999999999999999999 99
Q ss_pred EecCCCCcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 045028 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQP 952 (1044)
Q Consensus 876 HRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~P 952 (1044)
||||||+||||+.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||+||+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999997543322 12234457889999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 953 WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 953 F~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
|.+.........+.........+..+++++.+||.+||..||.+|||+.+++++|+.+.....
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 988776555555444555667788899999999999999999999999999999999887644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=401.67 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=224.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||+|.+ +|+.||+|++............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46799999999999999999987 6889999999877766666778999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc---CCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD---KNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd---~dg~VKLiDFGLA~~~~~~ 906 (1044)
||+.||+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999876 456999999999999999999999999 99999999999998 4688999999999876655
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC--CCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI--PDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i--p~~ip~ELkd 984 (1044)
........||+.|+|||++.+..++.++|||||||+||+|++|.+||.+.+..++...+......... ...+++++++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 44455678999999999999999999999999999999999999999999988888877544333322 2478999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
||.+||+.||.+|||+.|+++|-
T Consensus 247 li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSC
T ss_pred HHHHHcCCChhHCCCHHHHhcCc
Confidence 99999999999999999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=403.69 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=215.6
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+..++|+++++||+|+||.||++++ +|+.||||++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 345667899999999999999999987 578999999875432 22345567889999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++|||||++|++|.+++.+ ...+++..++.++.||+.||.|||+ +| |+||||||+||||+.++.+||+|||+++..
T Consensus 223 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999999976 4578999999999999999999998 99 999999999999999999999999999865
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
..........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..++...+. .....+|..++++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~ 377 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLGPEAK 377 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHH
Confidence 444444556789999999999999999999999999999999999999999998888887774 345667889999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHHh
Q 045028 984 DIIRKCWQTDPKMRP-----TFTEIMAAL 1007 (1044)
Q Consensus 984 dLI~rcL~kDPekRP-----Ta~ELLe~L 1007 (1044)
+||.+||.+||.+|| ++.|+++|-
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 999999999999999 999999873
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=389.44 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=221.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||.||++.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45799999999999999999987 5889999999877666667788999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC---CeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN---WVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d---g~VKLiDFGLA~~~~~~ 906 (1044)
||+.|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999999999976 457899999999999999999999999 9999999999999865 46999999999865533
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ELkd 984 (1044)
. ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++...+.........+ ..+++++++
T Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 185 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp C-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred c-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 2345689999999999999999999999999999999999999999988888877764433322222 468999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
||.+||.+||.+|||+.++++|
T Consensus 264 li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=388.90 Aligned_cols=271 Identities=31% Similarity=0.560 Sum_probs=234.3
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEE
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLF 815 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl 815 (1044)
..+++..++|+++++||+|+||+||+|++. +..||||++.... .......+.+|+.+++++ +||||+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 345777889999999999999999999863 2569999986543 345567899999999999 89999999
Q ss_pred EeeeecCCCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC
Q 045028 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK 880 (1044)
Q Consensus 816 ~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK 880 (1044)
++++...+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.| |+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 999999999999999999999999997643 45999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 045028 881 SPNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957 (1044)
Q Consensus 881 PeNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~ 957 (1044)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||+||+|++ |..||.+..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654322 22334567889999999999999999999999999999999 999999988
Q ss_pred hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCCCC
Q 045028 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVP 1020 (1044)
Q Consensus 958 ~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~~p 1020 (1044)
..++...+. .......+..+++++.+||.+||+.||.+|||+.+++++|+.+..........
T Consensus 299 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 299 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred HHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 888777664 44466678899999999999999999999999999999999988655444433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.70 Aligned_cols=261 Identities=32% Similarity=0.559 Sum_probs=216.7
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
.+++..++|++++.||+|+||+||+|.+. +..||+|.+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 45677889999999999999999999873 3469999876532 2445677899999999999999999999984
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
++..++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence 56789999999999999999876667999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 902 MKHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. ......++..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 243 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 654322 12233457889999999999999999999999999999996 999999988877776664 334556788999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+++.++|.+||..||.+|||+.+++++|+.+.+
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=403.50 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=223.8
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.++..++|+++++||+|+||+||++++ +++.||||++.+.... ......+.+|+.++..++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 345678999999999999999999988 4688999998753321 1223348889999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+||||||+.||+|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 99999999999999999886678999999999999999999999999 9999999999999999999999999997654
Q ss_pred CCc-ccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC--
Q 045028 905 NTF-LSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD-- 976 (1044)
Q Consensus 905 ~~~-~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~-- 976 (1044)
... ......+||+.|+|||++. +..++.++|||||||+||||++|+.||.+.+..+.+..+......+.+|.
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence 332 2334568999999999997 55689999999999999999999999999998888888755444455554
Q ss_pred -CCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 045028 977 -NLDPAVADIIRKCWQTDPKM--RPTFTEIMAAL 1007 (1044)
Q Consensus 977 -~ip~ELkdLI~rcL~kDPek--RPTa~ELLe~L 1007 (1044)
.+++++++||.+||..+|++ |+++.|+++|-
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 48999999999999988888 99999999973
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=400.05 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=223.3
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+..++|+++++||+|+||+||++++ +++.||||++.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 445678999999999999999999988 5788999998653221 1223457889999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+||||||++||+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999999999999975 46899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCc-ccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CC
Q 045028 905 NTF-LSSRSTAGTAEWMAPEVLRNEP----SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DN 977 (1044)
Q Consensus 905 ~~~-~~~~s~~GTp~Y~APEvL~g~~----~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ 977 (1044)
... ....+.+||+.|+|||++.+.. ++.++|||||||+||||++|++||.+.+..+.+..+........+| ..
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 299 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence 332 2344678999999999998766 7889999999999999999999999999888888876544344444 47
Q ss_pred CCHHHHHHHHHhhhcCCCC--CCCHHHHHHHhc
Q 045028 978 LDPAVADIIRKCWQTDPKM--RPTFTEIMAALK 1008 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPek--RPTa~ELLe~Lk 1008 (1044)
+++++++||.+||..+|.+ ||++.||++|-.
T Consensus 300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 9999999999999999988 999999999843
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.11 Aligned_cols=259 Identities=32% Similarity=0.565 Sum_probs=229.0
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+.+..++|++.+.||+|+||.||++.+ +++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+.++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 556778999999999999999999988 567899999876543 2357889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999876677999999999999999999999999 999999999999999999999999999765332
Q ss_pred c-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 907 F-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.. ......+..+++++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcHHHHH
Confidence 1 22234567889999999999999999999999999999999 8999999888877776643 3345567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+|.+||..||.+|||+.+++++|+.+.+
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=381.18 Aligned_cols=251 Identities=19% Similarity=0.294 Sum_probs=220.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||++.+ +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 46899999999999999999987 57889999886443 34466889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC--CCeEEEEeccccccccCCc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK--NWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~--dg~VKLiDFGLA~~~~~~~ 907 (1044)
||+.|++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999876678999999999999999999999999 999999999999987 7899999999998654332
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCC--CCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD--IPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~--ip~~ip~ELkdL 985 (1044)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ .+..+++++++|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 23345799999999999999899999999999999999999999999888888777643322221 125789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
|.+||..||.+|||+.|+++|-.
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHcCCChhHCcCHHHHhcChh
Confidence 99999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=393.70 Aligned_cols=263 Identities=32% Similarity=0.567 Sum_probs=229.8
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.+.+..++|++++.||+|+||.||+|++ +++.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4567778999999999999999999998 5889999988644 233445678899999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+++||||+++|+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999876667999999999999999999999999 9999999999999999999999999997644
Q ss_pred CCcccc--cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 905 NTFLSS--RSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 905 ~~~~~~--~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
...... ....+++.|+|||++.+..++.++|||||||+||||++ |..||.+....+....+. ...+...|..++++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 322111 12235678999999998889999999999999999998 999999988877766654 34566778889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999988653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=374.35 Aligned_cols=262 Identities=27% Similarity=0.499 Sum_probs=218.2
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
.++..++|+++++||+|+||+||++++ +++.||||++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345668999999999999999999984 57889999986543 4556779999999999999999999998854
Q ss_pred --CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 822 --PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 822 --~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
...+++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 35699999999999999999876667999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 045028 900 SRMKHNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----------------Q 960 (1044)
Q Consensus 900 A~~~~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~----------------e 960 (1044)
+....... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 98653321 1223345778899999999999999999999999999999999998653211 1
Q ss_pred HHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 961 il~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.... .....+...+..+++++.+||.+||+.||.+|||+.++++.|+.+.+.+
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHH-HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHH-HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111 1234456678899999999999999999999999999999999987764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.36 Aligned_cols=265 Identities=29% Similarity=0.498 Sum_probs=228.7
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~ 817 (1044)
..+++..++|++++.||+|+||+||++++ +++.||||++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 45677889999999999999999999985 35789999987543 234457799999999999 8999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCCC-----------------CCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNN-----------------QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK 880 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~~-----------------~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK 880 (1044)
++...+..++||||+.+++|.+++..... .+++..++.++.||+.||.|||++| |+|||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 99999999999999999999999976432 4899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 045028 881 SPNLLVDKNWVVKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957 (1044)
Q Consensus 881 PeNILLd~dg~VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~ 957 (1044)
|+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||+||+|++ |..||.+..
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999976543321 2234457889999999999999999999999999999999 999998876
Q ss_pred hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 958 ~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.................+..++.++.+||.+||..||.+|||+.+++++|+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 55554444334455566788999999999999999999999999999999987764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=367.46 Aligned_cols=257 Identities=36% Similarity=0.651 Sum_probs=219.7
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhh-----HHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGES-----LEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~-----~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
.+..++|++.+.||+|+||+||++++ +++.||||++......... .+.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 35568999999999999999999988 6889999998654432211 2678999999999999999999999866
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe-----EEEEe
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV-----VKVCD 896 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~-----VKLiD 896 (1044)
.. ++||||+.+++|.+++.+....+++..++.++.||+.||.|||++|.+|+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 44 799999999999999987777899999999999999999999999877999999999999988776 99999
Q ss_pred ccccccccCCcccccCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HhhhccccccC
Q 045028 897 FGLSRMKHNTFLSSRSTAGTAEWMAPEVLR--NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV--VGAVGFQHRRL 972 (1044)
Q Consensus 897 FGLA~~~~~~~~~~~s~~GTp~Y~APEvL~--g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~ei--l~~I~~~~~~~ 972 (1044)
||+++..... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||......+. ...+.......
T Consensus 173 fg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 173 FGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 9999754432 34567999999999994 45578999999999999999999999987654433 44444445566
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
.++..+++++.++|.+||+.||.+|||+.++++.|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 78889999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=371.72 Aligned_cols=265 Identities=23% Similarity=0.380 Sum_probs=222.4
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
++..++|++++.||+|+||+||++++ +++.||+|++..... .....+.+.+|+.++++++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34567899999999999999999987 578999999865433 344567899999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||++|++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999999976 357999999999999999999999999 99999999999999999999999999976543
Q ss_pred Cc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc---cCCCCCCCCHH
Q 045028 906 TF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR---RLDIPDNLDPA 981 (1044)
Q Consensus 906 ~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~---~~~ip~~ip~E 981 (1044)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.......... ....+..+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 32 223345799999999999999999999999999999999999999999887665544322221 12345778999
Q ss_pred HHHHHHHhhhcCCCCCC-CHHHHHHHhccccCCCCC
Q 045028 982 VADIIRKCWQTDPKMRP-TFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRP-Ta~ELLe~Lk~L~k~l~~ 1016 (1044)
+.++|.+||++||.+|| ++.++++.|..+...-..
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 99999999999999998 899999999988765443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=399.45 Aligned_cols=257 Identities=20% Similarity=0.317 Sum_probs=221.7
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+..++|++++.||+|+||+||++++ +|+.||||++.+.... ......+.+|+.++..++||||+++++++++.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 345668999999999999999999987 5889999998754321 2334558899999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+||||||++||+|.+++.+.+..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheecc
Confidence 99999999999999999875568999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc-cccCCCCCCCccCccccc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC-
Q 045028 905 NTFL-SSRSTAGTAEWMAPEVLR-------NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP- 975 (1044)
Q Consensus 905 ~~~~-~~~s~~GTp~Y~APEvL~-------g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip- 975 (1044)
.... .....+||+.|+|||++. +..++.++|||||||+||||++|+.||.+.+..+.+..+........+|
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 3322 234568999999999997 3568999999999999999999999999999888887775433333333
Q ss_pred --CCCCHHHHHHHHHhhhcCCCCC---CCHHHHHHHh
Q 045028 976 --DNLDPAVADIIRKCWQTDPKMR---PTFTEIMAAL 1007 (1044)
Q Consensus 976 --~~ip~ELkdLI~rcL~kDPekR---PTa~ELLe~L 1007 (1044)
..+++++++||.+||. +|.+| |++.||++|-
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 6799999999999999 99998 5999999873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.10 Aligned_cols=266 Identities=30% Similarity=0.499 Sum_probs=213.9
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEECC--c---EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeee
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHG--T---EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g--~---~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~ 819 (1044)
.....+..++|++++.||+|+||+||+|++.. + .||||++..........+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34556778899999999999999999998743 2 799999876655556678899999999999999999999999
Q ss_pred ecCCCc------eEEEEecCCCcHHHHhcCC-----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC
Q 045028 820 TRPPNL------SIVAEFLPRGSLYRLLHRP-----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888 (1044)
Q Consensus 820 ~~~~~l------~LVmEy~~GGsL~dlLkr~-----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~ 888 (1044)
...... ++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAE 172 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcC
Confidence 877655 9999999999999998642 236899999999999999999999999 999999999999999
Q ss_pred CCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 045028 889 NWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAV 965 (1044)
Q Consensus 889 dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I 965 (1044)
++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 9999999999997643322 12233457889999999999999999999999999999999 99999998888777766
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 966 GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 966 ~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
. .......+..+++++.+||.+||..||.+|||+.++++.|+++...
T Consensus 253 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 I-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred h-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 4 3345667788999999999999999999999999999999998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=369.40 Aligned_cols=263 Identities=29% Similarity=0.484 Sum_probs=219.7
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
...+....|++++.||+|+||.||++++ +++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3445567899999999999999999984 57889999987543 2345577899999999999999999999998
Q ss_pred cC--CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 821 RP--PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 821 ~~--~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
.. ..+++||||+.+++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccc
Confidence 76 6689999999999999999766677999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------------ChHHH
Q 045028 899 LSRMKHNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM--------------NPMQV 961 (1044)
Q Consensus 899 LA~~~~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~--------------~~~ei 961 (1044)
++....... .......||..|+|||++.+..++.++|||||||++|+|++|..||... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 997654332 2234556888999999999999999999999999999999999876432 11111
Q ss_pred HhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 962 VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 962 l~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.............+..+++++.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 222222445666788999999999999999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=384.58 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=213.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc---hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF---GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~---~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
.++|++++.||+|+||+||++.+ +++.||||++...... ....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999987 5889999998643221 124567999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe---EEEEecccc
Q 045028 827 IVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV---VKVCDFGLS 900 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~---VKLiDFGLA 900 (1044)
+||||++|++|.+++.+ ....+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888754 2346899999999999999999999999 999999999999986654 999999999
Q ss_pred ccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCC
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNL 978 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~i 978 (1044)
.............+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.. .+....+....... ..+..+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 876654444556789999999999999999999999999999999999999998754 34444442221111 112578
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++++++||.+||.+||.+|||+.++++|
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=365.76 Aligned_cols=264 Identities=32% Similarity=0.571 Sum_probs=227.6
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.++++..++|++++.||+|+||+||++++. ++.||||.+..... ..+.+.+|+.+++.++||||+++++++. .+.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 81 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP 81 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence 357788899999999999999999999885 45799999875442 3467899999999999999999999886 456
Q ss_pred ceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 899999999999999997632 36899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 904 HNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 904 ~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. .......+..++++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHH
Confidence 4332 22234457889999999998889999999999999999999 999999988877776664 23445667889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
+.++|.+||..||++|||+.++++.|+.+......
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999998875443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=377.81 Aligned_cols=253 Identities=27% Similarity=0.349 Sum_probs=211.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||++++ +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 588999999865432 223356889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--c
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--F 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~ 907 (1044)
||+.|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..... .
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999976 457999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred ccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccccCCCCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
......+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||...... ..................+++++.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22345679999999999988775 77999999999999999999999876543 22222222222333346789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
|.+||..||.+|||+.|++++-.
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHccCChhhCcCHHHHhhChh
Confidence 99999999999999999998743
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.86 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=222.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++.+.||+|+||.||++.+ +++.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999987 4789999999877666667788999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe---EEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV---VKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~---VKLiDFGLA~~~~~~ 906 (1044)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999998876 356999999999999999999999999 999999999999986654 999999999765443
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC--CCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI--PDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i--p~~ip~ELkd 984 (1044)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......... ...+++++.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred c-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2 234567999999999999999999999999999999999999999998888877776544333322 2578999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
||.+||+.||.+|||+.|+++|-
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSH
T ss_pred HHHHHcccChhhCCCHHHHhcCc
Confidence 99999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=390.15 Aligned_cols=263 Identities=30% Similarity=0.480 Sum_probs=227.1
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
.++..++|++++.||+|+||+||+|++ .++.||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 356678999999999999999999984 35679999986432 3444567889999999999999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCC------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---e
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPN------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW---V 891 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg---~ 891 (1044)
.....++||||+.||+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++ .
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999997532 45899999999999999999999999 99999999999999555 5
Q ss_pred EEEEeccccccccC--CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccc
Q 045028 892 VKVCDFGLSRMKHN--TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQ 968 (1044)
Q Consensus 892 VKLiDFGLA~~~~~--~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~ 968 (1044)
+||+|||+++.... .........||+.|+|||++.+..++.++|||||||+||||++ |..||......++...+. .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999975322 1222344568999999999999999999999999999999998 999999998888877764 3
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 969 ~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
......+..++.++.+||.+||+.||.+|||+.+|+++|+.+....
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 4456677889999999999999999999999999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=381.28 Aligned_cols=261 Identities=28% Similarity=0.411 Sum_probs=213.7
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.....+..++|+++++||+|+||+||+|++.++.||||++.... .......+|+.++++++||||+++++++.....
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 34456777899999999999999999999999999999986543 334456679999999999999999999987554
Q ss_pred ----ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC----------CCcEEEecCCCCcEEEcCCC
Q 045028 825 ----LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC----------TPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 825 ----l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~----------G~~IVHRDIKPeNILLd~dg 890 (1044)
+++||||+.+|+|.++++. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTC
T ss_pred CCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCC
Confidence 6999999999999999976 4599999999999999999999999 8 99999999999999999
Q ss_pred eEEEEeccccccccCCcc--cccCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----
Q 045028 891 VVKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNE-----PSDEKCDVYSFGVILWELCTMQQPWGGMNP----- 958 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~-----~~s~kSDIWSLG~LLyELLTGk~PF~~~~~----- 958 (1044)
.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+...
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999999999976443222 23346799999999999874 455688999999999999999999976432
Q ss_pred -----------HHHHhhhccccccCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 959 -----------MQVVGAVGFQHRRLDIPD-----NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 959 -----------~eil~~I~~~~~~~~ip~-----~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.++...+.....+..++. ..++++.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 122222222222222222 234569999999999999999999999999998865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=365.59 Aligned_cols=265 Identities=24% Similarity=0.453 Sum_probs=229.6
Q ss_pred cCcCCCCeeEEe-EecccCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 748 CEIPWEEITLGE-RIGLGSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 748 ~ei~~e~y~I~r-~LGkG~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+.+..++|.+.+ .||+|+||.||+|.+ ++..||||++.... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 456677899887 999999999999975 56789999987643 345567899999999999999999999999 45
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceee
Confidence 6799999999999999999876778999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 903 KHNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 903 ~~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+. ...+..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCc
Confidence 53321 12233457899999999998889999999999999999998 999999988777776654 34456778899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSS 1017 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~ 1017 (1044)
++++.++|.+||..||.+||++.+++++|+.+.......
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 999999999999999999999999999999987654433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=374.05 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=219.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.+.|++++.||+|+||+||++++ +++.||+|++....... ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35799999999999999999987 58899999987654322 2457799999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC----eEEEEeccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 901 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg----~VKLiDFGLA~ 901 (1044)
++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999976 467999999999999999999999999 99999999999999887 89999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip 979 (1044)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..++
T Consensus 167 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 167 KIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp ECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 654332 2345679999999999999999999999999999999999999999988877776654322211 1235789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+++++||.+||..||.+|||+.++++|-
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 9999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=394.33 Aligned_cols=257 Identities=34% Similarity=0.631 Sum_probs=226.1
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-Cc
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP-NL 825 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~-~l 825 (1044)
.+++..++|++++.||+|+||.||++++.++.||||+++... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 456778899999999999999999999999999999987543 3467899999999999999999999977655 79
Q ss_pred eEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|||||+.+|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999998643 34799999999999999999999999 9999999999999999999999999998543
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.. .....+++.|+|||++.+..++.++|||||||+||||++ |..||.+....+....+. ...+...|..+++++.
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 32 223467899999999999999999999999999999998 999999888777776664 3446778889999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+||.+||..||.+|||+.+|++.|+.+...
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999987653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.20 Aligned_cols=252 Identities=24% Similarity=0.431 Sum_probs=196.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|++.+.||+|+||.||++++ +++.||||++...... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999987 6889999998654322 22356789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999999886678999999999999999999999999 99999999999999999999999999986554433
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+. ......+..++.++++||.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999998876655555442 23456778899999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||..||.+|||+.++++|-
T Consensus 246 ~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp HSCSSGGGSCCHHHHTTST
T ss_pred HcccCHhhCCCHHHHhcCc
Confidence 9999999999999998763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=384.70 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=202.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCC--Cce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPP--NLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~--~l~ 826 (1044)
.++|++++.||+|+||+||+|.+ +|+.||||++............+.+|+.+++.+. ||||+++++++..++ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999987 5889999998765545566677889999999997 999999999997554 689
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+. ++|..++.. ..+++..+..++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999997 589999875 57899999999999999999999999 999999999999999999999999999754221
Q ss_pred ---------------------cccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhh
Q 045028 907 ---------------------FLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGA 964 (1044)
Q Consensus 907 ---------------------~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~ 964 (1044)
.......+||+.|+|||++.+ ..++.++|||||||+||||++|++||.+.+..+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 112234579999999999987 5689999999999999999999999999887766655
Q ss_pred hcccccc---------------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 045028 965 VGFQHRR---------------------------------------------LDIPDNLDPAVADIIRKCWQTDPKMRPT 999 (1044)
Q Consensus 965 I~~~~~~---------------------------------------------~~ip~~ip~ELkdLI~rcL~kDPekRPT 999 (1044)
+...... ...+..+++++.+||.+||..||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 4211100 0112367899999999999999999999
Q ss_pred HHHHHHH
Q 045028 1000 FTEIMAA 1006 (1044)
Q Consensus 1000 a~ELLe~ 1006 (1044)
+.|+++|
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=372.31 Aligned_cols=264 Identities=34% Similarity=0.563 Sum_probs=228.5
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEee
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~ 818 (1044)
..+++..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 356677889999999999999999999764 5779999986543 23445678999999999999999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCC---------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRP---------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN 889 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~---------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d 889 (1044)
+...+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 99999999999999999999998752 145789999999999999999999999 9999999999999999
Q ss_pred CeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhc
Q 045028 890 WVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVG 966 (1044)
Q Consensus 890 g~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~ 966 (1044)
+.+||+|||++....... .......||+.|+|||++.+..++.++|||||||+||+|++ |..||.+.+..+....+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999999997543322 12234457899999999999999999999999999999999 899999988887776664
Q ss_pred cccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 967 FQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 967 ~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.......+..++.++.+||.+||..||.+|||+.+++++|+.+..+
T Consensus 255 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 255 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 3344567788999999999999999999999999999999987663
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=366.39 Aligned_cols=262 Identities=35% Similarity=0.635 Sum_probs=230.6
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
...+++..++|++.+.||+|+||+||++.+. +..||+|++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3467788899999999999999999999884 7889999986543 3456789999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+.+++||||+.|++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999999763 456999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 902 MKHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .......+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence 654332 22233457889999999999999999999999999999999 999999988777766654 344566778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+++.+||.+||..||.+|||+.++++.|+.+..
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999988765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=365.22 Aligned_cols=253 Identities=25% Similarity=0.482 Sum_probs=219.8
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
++..++|++++.||+|+||+||++++ +++.||||++....... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45668999999999999999999987 46689999986543222 2346688999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+++++|.+++.+ ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999999876 356899999999999999999999999 99999999999999999999999999865433
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .....++..+++++++|
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999988887777663 34566788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
|.+||..||.+|||+.|+++|-.
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHH
T ss_pred HHHHhccChhhCCCHHHHhhCcc
Confidence 99999999999999999999854
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=382.51 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=216.5
Q ss_pred cCCCCeeEEeEeccc--CcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 750 IPWEEITLGERIGLG--SYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG--~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
...++|+++++||+| +||+||++++ +++.||||++............+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345689999999999 9999999998 488999999987766666778899999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999998763 366999999999999999999999999 9999999999999999999999999886432
Q ss_pred CC-------cccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----
Q 045028 905 NT-------FLSSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR----- 970 (1044)
Q Consensus 905 ~~-------~~~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~----- 970 (1044)
.. ........||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 112233579999999999988 5789999999999999999999999988665554433211100
Q ss_pred ---------------------------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hcc
Q 045028 971 ---------------------------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKP 1009 (1044)
Q Consensus 971 ---------------------------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~ 1009 (1044)
...++..+++++++||.+||+.||.+|||+.|+++| ++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 112456688999999999999999999999999988 454
Q ss_pred ccC
Q 045028 1010 LQK 1012 (1044)
Q Consensus 1010 L~k 1012 (1044)
+..
T Consensus 340 ~~~ 342 (389)
T 3gni_B 340 IKR 342 (389)
T ss_dssp C--
T ss_pred Hhh
Confidence 443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=368.29 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=209.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|+++++||+|+||+||++++ +|+.||||++..........+.+.+|+.++++++||||+++++++...+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999988 4889999998776655555677889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999998876 466999999999999999999999999 999999999999999999999999999876544444
Q ss_pred ccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-------------------
Q 045028 910 SRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH------------------- 969 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~------------------- 969 (1044)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 455679999999999986 568999999999999999999999999887766544332110
Q ss_pred ccCCC----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 RRLDI----------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 ~~~~i----------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..... ...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 14678899999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=370.62 Aligned_cols=273 Identities=29% Similarity=0.498 Sum_probs=222.2
Q ss_pred CCCCCCccccCcCCCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCee
Q 045028 739 SDVGDDVAECEIPWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813 (1044)
Q Consensus 739 S~~~~~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIV 813 (1044)
.+.........+..++|++++.||+|+||+||+|++. +..||||++..........+.+.+|+.++++++||||+
T Consensus 20 eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 99 (313)
T 3brb_A 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99 (313)
T ss_dssp ----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCee
Confidence 3344455666777889999999999999999999763 34799999877665566678899999999999999999
Q ss_pred EEEeeeecCC-----CceEEEEecCCCcHHHHhcC-----CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCc
Q 045028 814 LFMGAVTRPP-----NLSIVAEFLPRGSLYRLLHR-----PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPN 883 (1044)
Q Consensus 814 kl~~~~~~~~-----~l~LVmEy~~GGsL~dlLkr-----~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeN 883 (1044)
++++++.... ..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~N 177 (313)
T 3brb_A 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARN 177 (313)
T ss_dssp CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGG
T ss_pred eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcce
Confidence 9999987755 35999999999999999842 3467999999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 045028 884 LLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQ 960 (1044)
Q Consensus 884 ILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~e 960 (1044)
||++.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 999999999999999997643321 22234457889999999999999999999999999999999 899999888877
Q ss_pred HHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 961 il~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
....+. .......+..+++++.++|.+||..||.+|||+.+++++|+.+.+.+
T Consensus 258 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 258 MYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 776654 33456677889999999999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=374.98 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=213.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++++.||+|+||+||+|++ +++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 346899999999999999999985 688999999865432 23478899999999 89999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe-----EEEEecccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV-----VKVCDFGLSRM 902 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~-----VKLiDFGLA~~ 902 (1044)
||||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+++.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999 99999999876678999999999999999999999999 999999999999998887 99999999986
Q ss_pred ccCCcc-------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhccccccC
Q 045028 903 KHNTFL-------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGFQHRRL 972 (1044)
Q Consensus 903 ~~~~~~-------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~~~~~~ 972 (1044)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.. +.+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 433221 234678999999999999999999999999999999999999999885433 3333332111111
Q ss_pred ---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 973 ---DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 973 ---~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.....++ ++.++|.+||..||.+||++.+|++.|+++.+
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 1123455 99999999999999999999999999987764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=364.68 Aligned_cols=260 Identities=17% Similarity=0.249 Sum_probs=220.5
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l 825 (1044)
.+..++|++++.||+|+||+||+|++ +++.||||++..... ...+.+|+.+++.+ +|+||+++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34567899999999999999999985 788999998865432 23478899999999 799999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe-----EEEEecccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV-----VKVCDFGLS 900 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~-----VKLiDFGLA 900 (1044)
++||||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 99999999876677999999999999999999999999 999999999999987766 999999999
Q ss_pred ccccCCcc-------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhcccc-
Q 045028 901 RMKHNTFL-------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN---PMQVVGAVGFQH- 969 (1044)
Q Consensus 901 ~~~~~~~~-------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---~~eil~~I~~~~- 969 (1044)
+....... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.. ..+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 86543221 2345679999999999999999999999999999999999999998743 333333332111
Q ss_pred --ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 970 --RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 970 --~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
....+...+++++.++|.+||+.||.+|||+.+|++.|+++.+...
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 1122345789999999999999999999999999999999887554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=372.00 Aligned_cols=267 Identities=31% Similarity=0.547 Sum_probs=226.4
Q ss_pred CccccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEE
Q 045028 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLF 815 (1044)
Q Consensus 744 ~~~~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl 815 (1044)
....+++..++|++++.||+|+||+||++++ +++.||||++.... .......+.+|+.+++++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3445677788999999999999999999974 34789999987543 334556789999999999 69999999
Q ss_pred EeeeecCC-CceEEEEecCCCcHHHHhcCCCCC---------------CcHHHHHHHHHHHHHHHHHHHhCCCcEEEecC
Q 045028 816 MGAVTRPP-NLSIVAEFLPRGSLYRLLHRPNNQ---------------LDERRRLRMALDAARGMNYLHNCTPVIVHRDL 879 (1044)
Q Consensus 816 ~~~~~~~~-~l~LVmEy~~GGsL~dlLkr~~~~---------------Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDI 879 (1044)
++++...+ .+++||||+.+++|.+++...... +++..++.++.||+.||.|||++| |+||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccC
Confidence 99987655 499999999999999999874332 899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 045028 880 KSPNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGM 956 (1044)
Q Consensus 880 KPeNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~ 956 (1044)
||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999997543321 22234557889999999999999999999999999999998 99999887
Q ss_pred ChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 957 NPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 957 ~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
...+..............+..+++++.++|.+||+.||.+|||+.+++++|+.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 654444433334455677888999999999999999999999999999999988653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=364.33 Aligned_cols=288 Identities=22% Similarity=0.387 Sum_probs=224.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCCCCCeeEEEeeee--cCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRHPNVVLFMGAVT--RPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~--~~~~l 825 (1044)
.++|++++.||+|+||.||++.+ +++.||+|++...... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999987 5788999998754322 234567899999999999999999999984 44579
Q ss_pred eEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++||||+.++ |.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999999877 6666554 3567999999999999999999999999 9999999999999999999999999997653
Q ss_pred CC--cccccCCCCCCCccCcccccCCCC--CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 905 NT--FLSSRSTAGTAEWMAPEVLRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 905 ~~--~~~~~s~~GTp~Y~APEvL~g~~~--s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
.. ........||+.|+|||++.+... +.++|||||||++|+|++|+.||.+.+..+....+. .....++..+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~~ 238 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCGP 238 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSCH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccCH
Confidence 22 222345569999999999987543 789999999999999999999999988887777663 345567888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHh--ccccCCCCCCCCCCCCCCCCCCCCccchhhhhhcccC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAAL--KPLQKPITSSQVPRPVPSVSSGRETGQISKFLADSTG 1044 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~L--k~L~k~l~~~~~p~~~ps~s~~~~~~~i~~~~~~~~~ 1044 (1044)
++.+||.+||..||.+|||+.++++|- ...........+.++.+...+.+....+...+.|-.|
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 304 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLHG 304 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCCCCCCCC----CCC---CTTGGGC----
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCCCCCCCCcchHHHhhhceeehhhhhhcC
Confidence 999999999999999999999999873 3333333333334444444455556666666666444
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=387.84 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=219.2
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+..++|++++.||+|+||.||++++ +++.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 456678999999999999999999987 577899999875432 23456778999999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999999999987 467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhccccccCCCCCCC
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRN---EPSDEKCDVYSFGVILWELCTMQQPWGGMN---PMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g---~~~s~kSDIWSLG~LLyELLTGk~PF~~~~---~~eil~~I~~~~~~~~ip~~i 978 (1044)
.. ......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.... ..++...+ ......+|..+
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~ 243 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAW 243 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTS
T ss_pred CC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcC
Confidence 33 23456789999999999974 458899999999999999999999997543 33344443 34556778899
Q ss_pred CHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 045028 979 DPAVADIIRKCWQTDPKMRPT-FTEIMAA 1006 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPT-a~ELLe~ 1006 (1044)
++++.+||.+||.+||.+||+ +.++++|
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 999999999999999999998 8888765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.57 Aligned_cols=264 Identities=31% Similarity=0.570 Sum_probs=228.8
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE---------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEE
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW---------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLF 815 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~---------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl 815 (1044)
..+++..++|++++.||+|+||+||++++ ++..||||++.... .......+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 44677789999999999999999999986 35679999986543 345567799999999999 89999999
Q ss_pred EeeeecCCCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC
Q 045028 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK 880 (1044)
Q Consensus 816 ~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK 880 (1044)
++++...+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+|||||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 999999999999999999999999998643 24899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 045028 881 SPNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957 (1044)
Q Consensus 881 PeNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~ 957 (1044)
|+||||+.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||+||+|++ |..||.+..
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999997654332 12334457889999999998889999999999999999999 999999988
Q ss_pred hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 958 ~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
..++...+. .......+..++.++.++|.+||..||.+|||+.+++++|+.+...
T Consensus 265 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 265 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 877776654 3345667788999999999999999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=368.20 Aligned_cols=255 Identities=25% Similarity=0.464 Sum_probs=216.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC--C-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeee
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH--G-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~--g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~ 819 (1044)
++..++|++.+.||+|+||+||++++. + ..||+|++.... ....+.+.+|+.++++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 456689999999999999999999763 3 469999886543 34557799999999999999999999999
Q ss_pred ecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe--------
Q 045028 820 TRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV-------- 891 (1044)
Q Consensus 820 ~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~-------- 891 (1044)
...+..++||||+.|++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999886666999999999999999999999999 999999999999998876
Q ss_pred EEEEeccccccccCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhcccc
Q 045028 892 VKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQH 969 (1044)
Q Consensus 892 VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~~~ 969 (1044)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+........ .
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 999999998654332 23457889999999988 6689999999999999999995 5566655554444332 2
Q ss_pred ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 970 ~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
....++..+++++.+||.+||+.||.+|||+.+++++|+.+..+-
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 345667778899999999999999999999999999999988743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=371.43 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=219.1
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
.|+..++||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 488899999999999999987 58999999986543 23456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+.|++|.+++.+ ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999875 56999999999999999999999999 99999999999999999999999999986655444445
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-cCCCCCCCCHHHHHHHHHhh
Q 045028 912 STAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAVADIIRKCW 990 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-~~~ip~~ip~ELkdLI~rcL 990 (1044)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..... ....+..++++++++|.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 67899999999999999999999999999999999999999998888777666543222 22334568999999999999
Q ss_pred hcCCCCCCCHHHHHHHhc
Q 045028 991 QTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 991 ~kDPekRPTa~ELLe~Lk 1008 (1044)
..||.+|||+.++++|..
T Consensus 280 ~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 280 VRDPQERATAQELLDHPF 297 (321)
T ss_dssp CSSTTTSCCHHHHHTSGG
T ss_pred cCChhhCcCHHHHhcChh
Confidence 999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=362.28 Aligned_cols=261 Identities=30% Similarity=0.594 Sum_probs=222.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCc---EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc-eE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGT---EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL-SI 827 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~---~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l-~L 827 (1044)
.|++.++||+|+||+||+|++ +++ .||+|.+.... .....+.+.+|+.+++.++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 567789999999999999986 222 69999886533 344567889999999999999999999999876665 99
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC-
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT- 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~- 906 (1044)
||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999887788999999999999999999999999 999999999999999999999999999754332
Q ss_pred ---cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 907 ---FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 907 ---~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
........+|+.|+|||.+.+..++.++|||||||++|+|++| .+||...+..+....+. .......+..+++++
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 1223445688999999999999999999999999999999995 55666666666655553 444566778899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCC
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~ 1018 (1044)
.++|.+||..||.+|||+.++++.|+.+.+.+....
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 999999999999999999999999999988765544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=375.32 Aligned_cols=259 Identities=27% Similarity=0.501 Sum_probs=219.5
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcE----EEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTE----VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~----VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
.+..++|++++.||+|+||+||+|++ +++. ||+|.+.... .......+.+|+.+++.++||||+++++++. .
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 34567999999999999999999987 3444 7777764332 1223345778999999999999999999886 4
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+..++||||+.+|+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccc
Confidence 6799999999999999999886678999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 903 KHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 903 ~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICT 243 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCc
Confidence 54322 22344568889999999999999999999999999999999 999999888777666654 344666778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.++.++|.+||..||.+|||+.+++++|+.+.+
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999998875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=391.12 Aligned_cols=263 Identities=30% Similarity=0.558 Sum_probs=230.4
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+++..++|++.+.||+|+||+||+|.+. +..||||+++... ...+.+.+|+.+|++++||||+++++++. .+.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 456788899999999999999999999985 6789999987543 34577999999999999999999999986 567
Q ss_pred ceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++|||||+.+|+|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999999863 236889999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 904 HNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 904 ~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.... .......+|..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+. ...+...|..++++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4322 12233457889999999999999999999999999999999 999999998888877764 33456678899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
+.+||.+||..||++|||+.+|++.|+.+.....
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999887543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=386.86 Aligned_cols=261 Identities=31% Similarity=0.549 Sum_probs=217.4
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
++..++|++.+.||+|+||+||+|++. +..||||++.... .......+.+|+.++++++||||+++++++...+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 456678999999999999999999763 5679999986543 3455678999999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999887778999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 904 HNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 904 ~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
..... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||......++...+. ...+...+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 43221 1222345788999999999999999999999999999998 999999988887777664 333455677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.++.+||.+||+.||.+||++.++++.|+.+.+.
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=374.45 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=199.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||+|.+ +++.||||++.... .......+.+|+.++++++||||+++++++..++.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 35799999999999999999987 58899999987543 2233466889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC-----CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 830 EFLPRGSLYRLLHRP-----NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~-----~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
||+. ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9997 5899888642 246899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-------------
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR------------- 970 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~------------- 970 (1044)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 443444556799999999999874 589999999999999999999999998887765554421100
Q ss_pred -------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 -------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 -------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....+..++.++++||.+||+.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 011223678999999999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=383.94 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=218.8
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++++.||+|+||+||+|.+ +++.||||++....... .....+.+|+.+++.++||||+++++++...+.+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 347899999999999999999997 68899999986543221 223568899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 7789988865 357999999999999999999999999 9999999999999999999999999998654432
Q ss_pred ccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+....++...+ ......+|..+++++++||
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHH
Confidence 3345689999999999998876 78999999999999999999999887766655554 3345667888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhc
Q 045028 987 RKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.+||..||.+|||+.|+++|-.
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHH
T ss_pred HHHcCCChhHCcCHHHHHhChh
Confidence 9999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=376.65 Aligned_cols=259 Identities=27% Similarity=0.531 Sum_probs=217.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcE----EEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTE----VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~----VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+..++|+++++||+|+||+||+|++ +++. ||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 4557899999999999999999987 3443 5777664332 234557799999999999999999999999874
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..++|+||+.+|+|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 488999999999999999887788999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 904 HNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 904 ~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 43221 2233457889999999999999999999999999999999 999999888777666553 3445667788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
++.++|.+||+.||.+|||+.+++++|+.+.+.
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999987753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=373.72 Aligned_cols=266 Identities=27% Similarity=0.458 Sum_probs=219.2
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-- 821 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-- 821 (1044)
+..++|++++.||+|+||.||++++ +++.||||++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 4557899999999999999999984 57889999987543 3455679999999999999999999998864
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
...+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 45689999999999999999875567999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------------HHHhh
Q 045028 902 MKHNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM--------------QVVGA 964 (1044)
Q Consensus 902 ~~~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~--------------eil~~ 964 (1044)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 654322 1233456888999999999998999999999999999999999998654322 11112
Q ss_pred hccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCCC
Q 045028 965 VGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQV 1019 (1044)
Q Consensus 965 I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~~ 1019 (1044)
..........+..+++++.+||.+||+.||.+|||+.+++++|+.+.........
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 2223445667888999999999999999999999999999999998876554443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=362.95 Aligned_cols=260 Identities=32% Similarity=0.544 Sum_probs=221.5
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEECC-----cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~g-----~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
+.+..++|++.+.||+|+||+||+|.+.+ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 45667899999999999999999998632 359999886543 33456789999999999999999999999865
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+..++||||+.+++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 5679999999999999999876677999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 903 KHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 903 ~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+. .......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCH
Confidence 54322 12234557889999999999999999999999999999998 999998877776665553 3345567788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.+.++|.+||..||.+|||+.+++++|+.+..
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999988753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.60 Aligned_cols=262 Identities=26% Similarity=0.478 Sum_probs=223.3
Q ss_pred cCcCCCCeeEEe-EecccCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 748 CEIPWEEITLGE-RIGLGSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 748 ~ei~~e~y~I~r-~LGkG~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
..+..++|++.+ .||+|+||+||++.+ .++.||||++..........+.+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 345567899998 999999999999954 357899999876654445567899999999999999999999998 56
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 778999999999999999986 456999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 903 KHNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 903 ~~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+. ......++..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGC 245 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 543221 1223446789999999998889999999999999999999 999999988887776664 34456678899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
++++.++|.+||+.||.+||++.++++.|+.+....
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999987643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.88 Aligned_cols=264 Identities=28% Similarity=0.503 Sum_probs=226.6
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEECC-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~ 817 (1044)
..+++..++|++.+.||+|+||+||++.+.+ ..||+|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3567888999999999999999999998732 379999886543 234567799999999999 8999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcE
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRP-------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNL 884 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~-------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNI 884 (1044)
++...+.+++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NI 195 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNV 195 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGC
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceE
Confidence 999999999999999999999998752 345799999999999999999999999 99999999999
Q ss_pred EEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 045028 885 LVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQV 961 (1044)
Q Consensus 885 LLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~ei 961 (1044)
|++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 99999999999999997543321 12334457889999999999999999999999999999998 9999988766555
Q ss_pred HhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 962 VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 962 l~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
...+.........+..+++++.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 554444455566778899999999999999999999999999999988754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=412.23 Aligned_cols=254 Identities=20% Similarity=0.349 Sum_probs=225.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~ 823 (1044)
..+..++|+++++||+|+||+||++++ +++.||||++.+... .....+.+..|+.++..+ +||||+.+++++++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 446678999999999999999999987 567899999875432 233456788899999988 6999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+||||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999999986 357999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
..........+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+++..+. .....+|..++++++
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAV 570 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHH
Confidence 444445667889999999999999999999999999999999999999999999999988884 456778899999999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTF-----TEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa-----~ELLe~ 1006 (1044)
+||.+||++||.+||++ .||++|
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999999997 888876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=362.03 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=224.6
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++++.||+|+||+||++++ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 346899999999999999999988 477899999876543 23456778999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999999876 457899999999999999999999999 9999999999999999999999999998765444
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....++..+++++.++|.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHH
Confidence 44455679999999999999999999999999999999999999999988777766653 3456678899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhc
Q 045028 988 KCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+||..||.+|||+.+++++-.
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHH
T ss_pred HHcccChhhCcCHHHHhhChh
Confidence 999999999999999998744
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=374.10 Aligned_cols=270 Identities=33% Similarity=0.565 Sum_probs=224.9
Q ss_pred CCccccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 743 DDVAECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 743 ~~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
.....+++..++|++++.||+|+||.||++++.+ .+|+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3456778889999999999999999999999876 499999876544444455678899999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+++||||+.|++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+++.
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999999886678999999999999999999999999 99999999999998 68999999999865
Q ss_pred ccC-----CcccccCCCCCCCccCcccccC---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc
Q 045028 903 KHN-----TFLSSRSTAGTAEWMAPEVLRN---------EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ 968 (1044)
Q Consensus 903 ~~~-----~~~~~~s~~GTp~Y~APEvL~g---------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~ 968 (1044)
... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 321 1122234458999999999975 45788999999999999999999999998888777766544
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 969 ~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
......+..++.++.++|.+||..||.+|||+.++++.|+.+.+....
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 444444457889999999999999999999999999999999886433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.75 Aligned_cols=252 Identities=34% Similarity=0.589 Sum_probs=205.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHh--CCCCCeeEEEeeeec----CC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR--VRHPNVVLFMGAVTR----PP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~--LrHPNIVkl~~~~~~----~~ 823 (1044)
+..++|++++.||+|+||+||+|+++++.||||++... ....+..|.+++.. ++||||+++++++.. ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 44578999999999999999999999999999998543 23456667777776 789999999998654 24
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHH--------hCCCcEEEecCCCCcEEEcCCCeEEEE
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH--------NCTPVIVHRDLKSPNLLVDKNWVVKVC 895 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLH--------s~G~~IVHRDIKPeNILLd~dg~VKLi 895 (1044)
.+++||||+.+|+|.++++. ..+++..++.++.||+.||.||| +++ |+||||||+||||+.++.+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEe
Confidence 58999999999999999965 57999999999999999999999 888 9999999999999999999999
Q ss_pred eccccccccCCcc----cccCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhC----------CCCCCC
Q 045028 896 DFGLSRMKHNTFL----SSRSTAGTAEWMAPEVLRNE------PSDEKCDVYSFGVILWELCTM----------QQPWGG 955 (1044)
Q Consensus 896 DFGLA~~~~~~~~----~~~s~~GTp~Y~APEvL~g~------~~s~kSDIWSLG~LLyELLTG----------k~PF~~ 955 (1044)
|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999975433221 12345799999999999887 445799999999999999999 888865
Q ss_pred CCh-----HHHHhhhccccccCCCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 956 MNP-----MQVVGAVGFQHRRLDIP-----DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 956 ~~~-----~eil~~I~~~~~~~~ip-----~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
... ......+........++ ..+++++.+||.+||+.||.+|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322 22222222222333333 23567899999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=372.17 Aligned_cols=262 Identities=30% Similarity=0.530 Sum_probs=222.7
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEECC------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~g------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
.++..++|++.+.||+|+||+||+|.+.. ..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 35677899999999999999999997632 359999986543 34455678999999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
.+.+++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999999876678999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 902 MKHNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 902 ~~~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
....... ......+|+.|+|||++.+..++.++|||||||+||+|++ |..||......++...+. ...+...+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCccc
Confidence 6543211 1223446889999999999999999999999999999999 999999988887777664 3345566788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
++.++.++|.+||..||.+||++.+++++|+.+.+.
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999987653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=363.68 Aligned_cols=256 Identities=34% Similarity=0.636 Sum_probs=217.3
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-CCc
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-PNL 825 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-~~l 825 (1044)
.+.+..++|++++.||+|+||+||+++++|+.||||++.... ..+.+.+|+.++++++||||+++++++... +.+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 355677899999999999999999999999999999986543 346789999999999999999999986554 579
Q ss_pred eEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999999997632 23789999999999999999999999 9999999999999999999999999987544
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
.. .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+..+++++.
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHH
Confidence 32 223467899999999999999999999999999999998 999999888777766654 3345667788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
++|.+||+.||.+|||+.++++.|+.+..
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=376.06 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=203.2
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
...++|+++++||+|+||+||++++ +++.||||++............+.+|+.+++.++||||+++++++...+.+++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999976 68899999987665444455678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-----CCCeEEEEecccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-----KNWVVKVCDFGLSRM 902 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-----~dg~VKLiDFGLA~~ 902 (1044)
||||+.| +|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+ ..+.+||+|||+++.
T Consensus 111 v~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999975 99999976 456999999999999999999999999 99999999999994 556699999999986
Q ss_pred ccCCcccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC---------
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--------- 972 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--------- 972 (1044)
............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 654444445567899999999998754 8999999999999999999999999888776655542211100
Q ss_pred -------CC------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 973 -------DI------------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 973 -------~i------------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+ +..+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00 112789999999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=395.37 Aligned_cols=262 Identities=35% Similarity=0.632 Sum_probs=231.4
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
..+++..++|++.++||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+|++++||||+++++++...+
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 456778889999999999999999999885 7889999987543 23567999999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.++|||||+.+|+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999999763 456899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 903 KHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 903 ~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... .......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..++...+. ...+...|..+++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54322 22334457789999999999899999999999999999999 999999988877776653 3445677889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
++.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999988653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=362.67 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=220.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee--cCCCceE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT--RPPNLSI 827 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~--~~~~l~L 827 (1044)
.++|++++.||+|+||+||++++ +++.||+|++..........+.+.+|+.++++++||||+++++++. ....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999988 5889999999876666667788999999999999999999999874 4567999
Q ss_pred EEEecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCC---CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 828 VAEFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCT---PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G---~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998752 345999999999999999999999977 339999999999999999999999999997
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..++...+.. .....++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCHH
Confidence 654432223345689999999999999999999999999999999999999999888777666642 3344677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
+.++|.+||..||.+|||+.+|++++..
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 9999999999999999999999987754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.81 Aligned_cols=261 Identities=30% Similarity=0.516 Sum_probs=220.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEECC-----cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeee-ecCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV-TRPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~g-----~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~-~~~~~l 825 (1044)
..+|++.+.||+|+||+||+|.+.. ..+|+|.+.... .....+.+.+|+.++++++||||+++++++ ..++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3469999999999999999998632 248889876532 334567799999999999999999999985 556689
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+.+++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999887778999999999999999999999999 99999999999999999999999999975433
Q ss_pred Cc----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 906 TF----LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 906 ~~----~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
.. .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+. .......+..++.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCH
Confidence 22 12334557889999999999999999999999999999999 677787777666655553 3345556788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
++.++|.+||+.||.+|||+.++++.|+.+...+..
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999998876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=366.23 Aligned_cols=257 Identities=33% Similarity=0.661 Sum_probs=213.5
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
+..++|++.+.||+|+||+||++++.++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence 45678999999999999999999999999999988543 34567899999999999999999999887 4589999
Q ss_pred EecCCCcHHHHhcCCCC--CCcHHHHHHHHHHHHHHHHHHHh---CCCcEEEecCCCCcEEEcCCCe-EEEEeccccccc
Q 045028 830 EFLPRGSLYRLLHRPNN--QLDERRRLRMALDAARGMNYLHN---CTPVIVHRDLKSPNLLVDKNWV-VKVCDFGLSRMK 903 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~--~Lse~~il~Ia~QIa~AL~yLHs---~G~~IVHRDIKPeNILLd~dg~-VKLiDFGLA~~~ 903 (1044)
||++|++|.+++..... .++...++.++.||+.||.|||+ +| |+||||||+|||++.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999986432 47889999999999999999999 77 999999999999998876 799999999754
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHhhhccccccCCCCCCCCHH
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM--QVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~--eil~~I~~~~~~~~ip~~ip~E 981 (1044)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ........+..++++
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKP 232 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCHH
T ss_pred ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCHH
Confidence 332 22346999999999999999999999999999999999999999864322 222222 233455667789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~ 1018 (1044)
+.++|.+||..||.+|||+.++++.|+.+.+.+....
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 9999999999999999999999999999887665443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=394.28 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=225.0
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+..++|.+++.||+|+||+||+|++ +|+.||||++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 345568999999999999999999987 5889999998754322 2345678999999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+++||||+.|++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999999976 467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
... .....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.+..++...+. ......|..++++++
T Consensus 168 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 168 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVI 244 (476)
T ss_dssp TTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHH
T ss_pred ccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHH
Confidence 332 2345689999999999998875 789999999999999999999999988877777763 345567888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+||.+||..||.+|||+.++++|-
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred HHHHHHcCCCchhCcCHHHHHhCH
Confidence 999999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=373.06 Aligned_cols=255 Identities=21% Similarity=0.355 Sum_probs=214.4
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC--CCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH--PNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH--PNIVkl~~~~~~~~~l 825 (1044)
.+..++|++++.||+|+||+||++.+ +++.||||++..........+.+.+|+.+++.++| |||+++++++...+.+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34567899999999999999999987 57789999998766666677889999999999986 9999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+||||+ .+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+ ++.+||+|||+++....
T Consensus 85 ~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999994 58899999987 467899999999999999999999999 99999999999997 67899999999986543
Q ss_pred Ccc--cccCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhcccccc
Q 045028 906 TFL--SSRSTAGTAEWMAPEVLRN-----------EPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRR 971 (1044)
Q Consensus 906 ~~~--~~~s~~GTp~Y~APEvL~g-----------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~ 971 (1044)
... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.... ....+..+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 221 2345679999999999965 668899999999999999999999998743 33444444444556
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 972 LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 972 ~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..++...+.++.+||.+||..||.+|||+.++++|..
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 7788889999999999999999999999999998853
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=375.00 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=208.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|+++++||+|+||+||++++ +++.||||++...... .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999988 5788999988644311 111234579999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+. ++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 997 5899998877778999999999999999999999999 9999999999999999999999999998655444444
Q ss_pred cCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc------------------
Q 045028 911 RSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------------ 971 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------------ 971 (1044)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 55678999999999987 56899999999999999999999999998877665544221110
Q ss_pred ----------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccCCCC
Q 045028 972 ----------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPIT 1015 (1044)
Q Consensus 972 ----------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k~l~ 1015 (1044)
......+++++.+||.+||+.||.+|||+.|+++| +..+.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence 01123578999999999999999999999999997 444444433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=373.33 Aligned_cols=269 Identities=29% Similarity=0.427 Sum_probs=205.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHH--HHhCCCCCeeEEEeeee-----
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLI--MKRVRHPNVVLFMGAVT----- 820 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~I--Lk~LrHPNIVkl~~~~~----- 820 (1044)
..+..++|++++.||+|+||+||+|+++++.||||++.... ...+..|.++ +..++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 45677899999999999999999999999999999986432 2334444444 44589999999997543
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC---------CCcEEEecCCCCcEEEcCCCe
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC---------TPVIVHRDLKSPNLLVDKNWV 891 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~---------G~~IVHRDIKPeNILLd~dg~ 891 (1044)
....+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. | |+||||||+||||+.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 22357899999999999999976 4458899999999999999999999 8 999999999999999999
Q ss_pred EEEEeccccccccCC--------cccccCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 045028 892 VKVCDFGLSRMKHNT--------FLSSRSTAGTAEWMAPEVLRN-------EPSDEKCDVYSFGVILWELCTMQQPWGGM 956 (1044)
Q Consensus 892 VKLiDFGLA~~~~~~--------~~~~~s~~GTp~Y~APEvL~g-------~~~s~kSDIWSLG~LLyELLTGk~PF~~~ 956 (1044)
+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||+||||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999754322 112234579999999999987 34567899999999999999997765432
Q ss_pred Ch------------------HHHHhhhccccccCCCCCC------CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 957 NP------------------MQVVGAVGFQHRRLDIPDN------LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 957 ~~------------------~eil~~I~~~~~~~~ip~~------ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.. .+....+.....+..++.. +++++.+||.+||+.||++|||+.|+++.|+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21 1111112222333444443 44589999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCC
Q 045028 1013 PITSSQVPRPVPS 1025 (1044)
Q Consensus 1013 ~l~~~~~p~~~ps 1025 (1044)
.|.......+.+.
T Consensus 319 ~~~~~~~~~~~~~ 331 (336)
T 3g2f_A 319 IWERNKSVSPTAH 331 (336)
T ss_dssp CCCC---------
T ss_pred HHHhcccCCCccc
Confidence 8887776665543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=372.30 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=223.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|.+++.||+|+||.||++++ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46899999999999999999988 477899999876533 234567789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999999876 457899999999999999999999999 99999999999999999999999999987654444
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
......||+.|+|||++.+..++.++|||||||+||+|++|+.||......+.+..+. .....++..+++++.+||.+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHHHH
Confidence 4456779999999999999999999999999999999999999999888777766653 34556788999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHh
Q 045028 989 CWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~L 1007 (1044)
||+.||.+|||+.+++++-
T Consensus 275 ~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDE 293 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSH
T ss_pred HccCChhHCcCHHHHhcCc
Confidence 9999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=370.36 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=210.8
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc-
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL- 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l- 825 (1044)
...++|++++.||+|+||+||++++ +++.||||++...... ......+.+|+.++++++||||+++++++......
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 3457899999999999999999986 6889999998765332 34456789999999999999999999998876554
Q ss_pred ---eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 826 ---SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 826 ---~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999976 357999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCC
Q 045028 903 KHNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDN 977 (1044)
Q Consensus 903 ~~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ 977 (1044)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....... ..+..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 43321 12334569999999999999999999999999999999999999999988777665543222211 12356
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHH-HHhccccC
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIM-AALKPLQK 1012 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELL-e~Lk~L~k 1012 (1044)
+++++.+||.+||++||.+||+..+++ ..|..+..
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 899999999999999999999755555 44555544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=360.51 Aligned_cols=252 Identities=25% Similarity=0.467 Sum_probs=221.9
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.+..++|++++.||+|+||.||++++ +++.||||++....... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 45567899999999999999999988 46789999986543222 2346789999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999976 356899999999999999999999999 99999999999999999999999999875443
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .....++..++.+++++
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999888777766663 34556788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHh
Q 045028 986 IRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~L 1007 (1044)
|.+||..||.+|||+.++++|-
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCH
T ss_pred HHHHhhcCHhhCCCHHHHhhCH
Confidence 9999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=385.09 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=192.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-----CC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-----PN 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-----~~ 824 (1044)
.++|++++.||+|+||+||+|++ +++.||||++..........+.+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999976 588999999876554555667899999999999999999999998443 56
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999998 5799999976 467999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCc---------------------------ccccCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHh--------
Q 045028 905 NTF---------------------------LSSRSTAGTAEWMAPEVL-RNEPSDEKCDVYSFGVILWELCT-------- 948 (1044)
Q Consensus 905 ~~~---------------------------~~~~s~~GTp~Y~APEvL-~g~~~s~kSDIWSLG~LLyELLT-------- 948 (1044)
... ......+||+.|+|||++ .+..++.++||||||||||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 122345789999999986 56679999999999999999999
Q ss_pred ---CCCCCCCCCh--------------------HHHHhhhcc-----------------------------ccccCCCCC
Q 045028 949 ---MQQPWGGMNP--------------------MQVVGAVGF-----------------------------QHRRLDIPD 976 (1044)
Q Consensus 949 ---Gk~PF~~~~~--------------------~eil~~I~~-----------------------------~~~~~~ip~ 976 (1044)
|+++|.+.+. .+.+..+.. .........
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6777766431 111111000 000011234
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+++++.+||.+||..||.+|||+.|+|+|
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 568999999999999999999999999997
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=381.60 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=219.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999987 57889999986543 233457899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC--CCeEEEEeccccccccCCc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK--NWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~--dg~VKLiDFGLA~~~~~~~ 907 (1044)
||+.|++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. .+.+||+|||+++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999999999876678999999999999999999999999 999999999999974 5789999999998654332
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--CCCCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR--LDIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~--~~ip~~ip~ELkdL 985 (1044)
......||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+..+.+..+...... ...+..+++++++|
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 223457999999999999999999999999999999999999999998887777766433222 23345789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHh
Q 045028 986 IRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~L 1007 (1044)
|.+||..||.+|||+.++++|-
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHcCCChhHCcCHHHHhhCc
Confidence 9999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=365.16 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=219.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.++|++++.||+|+||.||++++ +|+.||||++....... ...+.+.+|+.+++.++||||+++++++...+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999987 58899999987654322 2357799999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC----eEEEEeccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 901 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg----~VKLiDFGLA~ 901 (1044)
++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999986 467999999999999999999999999 99999999999999887 89999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip 979 (1044)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... .++..++
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 168 EIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp ECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred ecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 654432 2345679999999999999999999999999999999999999999988887776664322211 1235789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.++++||.+||..||.+|||+.++++|-
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 9999999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=369.15 Aligned_cols=261 Identities=32% Similarity=0.624 Sum_probs=222.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcE--EEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTE--VAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~--VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~ 824 (1044)
+.+++|++.+.||+|+||.||++++ ++.. +|+|.+.... .......+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 5568999999999999999999976 4554 4899876432 233456788999999999 89999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC
Q 045028 825 LSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN 889 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d 889 (1044)
+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999998643 47999999999999999999999999 9999999999999999
Q ss_pred CeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccc
Q 045028 890 WVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQ 968 (1044)
Q Consensus 890 g~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~ 968 (1044)
+.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+. .
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~ 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-c
Confidence 99999999998743322 22234467889999999999889999999999999999998 999999988888777664 3
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 969 HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 969 ~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
......+..+++++.+||.+||..||.+|||+.+++++|+.+.....
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 34556778899999999999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=387.55 Aligned_cols=263 Identities=34% Similarity=0.587 Sum_probs=225.2
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEECC-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+++..++|++.++||+|+||+||+|.+.+ ..||||++..... ..+.+.+|+.+|++++||||+++++++.. +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 4567888999999999999999999999865 5799999875442 34678999999999999999999999876 77
Q ss_pred ceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++|||||+.+|+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999999999752 356899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 904 HNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 904 ~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+. ...+...|..++++
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4322 22233457889999999999999999999999999999999 999999998888877764 34456778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
+.+||.+||..||++|||+.+|++.|+.+.....
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 9999999999999999999999999999887543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.18 Aligned_cols=263 Identities=33% Similarity=0.575 Sum_probs=217.7
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC---Cc--EEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH---GT--EVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~---g~--~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
..+..++|++++.||+|+||+||++++. ++ .||||++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 3455678999999999999999999862 23 5899988654332 3456789999999999999999999999887
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
.. .++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccc
Confidence 54 89999999999999999875567999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 902 MKHNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 902 ~~~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.........+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 6543221 2234567889999999999889999999999999999999 99999999988888877666666777788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
++.++.++|.+||..||.+|||+.+++++|+.+...
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 999999999999999999999999999999987653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=379.37 Aligned_cols=248 Identities=26% Similarity=0.416 Sum_probs=212.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|++++.||+|+||+||++.+ +++.||||++..... ...+|++++.++ +||||+++++++.+.+.+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 46799999999999999999987 578899999876532 234688888888 799999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC----CeEEEEecccccccc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN----WVVKVCDFGLSRMKH 904 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d----g~VKLiDFGLA~~~~ 904 (1044)
|||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||+... +.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999999977 467999999999999999999999999 9999999999998543 359999999998765
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC---CChHHHHhhhccccccC--CCCCCCC
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG---MNPMQVVGAVGFQHRRL--DIPDNLD 979 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~---~~~~eil~~I~~~~~~~--~ip~~ip 979 (1044)
.........+||+.|+|||++.+..++.++|||||||+||+|++|..||.+ ....++...+....... ..+..++
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 544445567899999999999988899999999999999999999999986 34555666654322222 2346789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
+++++||.+||..||.+|||+.++++|-.
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 99999999999999999999999998743
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.82 Aligned_cols=258 Identities=28% Similarity=0.545 Sum_probs=217.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcE----EEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTE----VAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~----VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+..++|+++++||+|+||+||+|++ +++. |++|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 4567899999999999999999987 4554 4666654332 234567799999999999999999999999875
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
..++|+||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 488999999999999999887778999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 904 HNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 904 ~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
.... .......+|+.|+|||++.+..++.++|||||||+||+|++ |..||.+....++...+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 3322 22233457889999999999999999999999999999999 999999988777766553 4445667888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
++.+||.+||..||.+|||+.++++.|+.+.+
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=359.37 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=217.0
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec----CCC
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PPN 824 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~----~~~ 824 (1044)
....|++.+.||+|+||+||+|.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 445699999999999999999987 56789999998776666777889999999999999999999998865 345
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-CCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-~dg~VKLiDFGLA~~~ 903 (1044)
+++||||+++++|.+++.+ ...+++..++.++.||+.||.|||+.+.+|+||||||+|||++ .++.+||+|||++...
T Consensus 104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 8999999999999999976 3668999999999999999999999876699999999999998 7899999999999754
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccCCCCCCCCHHH
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+........++..+++++
T Consensus 183 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 183 RAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred ccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 433 2334679999999999875 48999999999999999999999998744 4445555544444555667788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+||.+||..||.+|||+.++++|-
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHccCChhhCCCHHHHhhCc
Confidence 9999999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=374.98 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=199.5
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
...++|++.+.||+|+||+||+|++ +++.||||++.... ..+.+.+|+.++++++||||+++++++...+.+++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3457899999999999999999998 46789999987543 23568889999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGLA~~~~ 904 (1044)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++...
T Consensus 126 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999976 456999999999999999999999999 999999999999975 8899999999998654
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhcccccc--CCCCCCCCHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ-VVGAVGFQHRR--LDIPDNLDPA 981 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e-il~~I~~~~~~--~~ip~~ip~E 981 (1044)
... ......||+.|+|||++.+..++.++|||||||+||+|++|..||......+ .+..+...... ......++.+
T Consensus 203 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 203 HQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred ccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 332 2345679999999999999999999999999999999999999998766544 44444322221 1233678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+++||.+||..||++|||+.++++|-
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCc
Confidence 99999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=361.97 Aligned_cols=263 Identities=24% Similarity=0.439 Sum_probs=210.6
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++.+.||+|+||.||++.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 456899999999999999999986 688999999875432 34556778999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999864 3567899999999999999999999999 9999999999999999999999999997655
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhccccccCCCCCCCCHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN--PMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~--~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+.........+..+++++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333445679999999999999999999999999999999999999997643 3344444432222223346789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
.+||.+||..||.+|||+.++++.|+++....+
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=366.63 Aligned_cols=260 Identities=24% Similarity=0.368 Sum_probs=212.8
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC--Cc
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP--NL 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~--~l 825 (1044)
+..++|+++++||+|+||+||+|++. ++.||||++..... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34568999999999999999999884 88999999875432 234567889999999999999999999988765 68
Q ss_pred eEEEEecCCCcHHHHhcCCC--CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE----cCCCeEEEEeccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGL 899 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~--~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL----d~dg~VKLiDFGL 899 (1044)
++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999998742 33999999999999999999999999 9999999999999 7888999999999
Q ss_pred cccccCCcccccCCCCCCCccCccccc--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhcc
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLR--------NEPSDEKCDVYSFGVILWELCTMQQPWGGMNP----MQVVGAVGF 967 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~--------g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~----~eil~~I~~ 967 (1044)
++...... ......||+.|+|||++. +..++.++|||||||+||||++|+.||..... .+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98654432 234567999999999986 56789999999999999999999999975432 222222211
Q ss_pred ccc-----------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 968 QHR-----------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 968 ~~~-----------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
... ...++..++..+.++|.+||+.||++|||+.|+++|..+-...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 110 0122234566889999999999999999999999999876553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=379.97 Aligned_cols=254 Identities=20% Similarity=0.355 Sum_probs=214.5
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC--CCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR--HPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr--HPNIVkl~~~~~~~~~l~ 826 (1044)
+...+|++++.||+|+||+||++.+ .++.||||++..........+.+.+|+.+|+.++ ||||+++++++...+.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3446799999999999999999987 4788999999876655667788999999999996 599999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
|||| +.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 568899999987 357899999999999999999999999 99999999999995 589999999999865432
Q ss_pred c--ccccCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccC
Q 045028 907 F--LSSRSTAGTAEWMAPEVLRN-----------EPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRL 972 (1044)
Q Consensus 907 ~--~~~~s~~GTp~Y~APEvL~g-----------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~ 972 (1044)
. ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ....+..+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 2 12345679999999999976 368899999999999999999999998753 334444554445566
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.++...+.++++||.+||..||.+|||+.|+++|..
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 778888999999999999999999999999998743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=365.64 Aligned_cols=251 Identities=24% Similarity=0.255 Sum_probs=206.9
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCc
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l 825 (1044)
.+..++|+++++||+|+||+||+|++ +++.||||++...............|+..+..+ +||||+++++++...+.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 34457899999999999999999988 588999999876544444445555666666555 899999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999999 67999988776678999999999999999999999999 99999999999999999999999999876543
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
.. ......||+.|+|||++.+ .++.++|||||||+||||++|..||......+ .+........++..+++++.+|
T Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 210 AG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSCHHHHHH
T ss_pred CC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCCHHHHHH
Confidence 32 2344569999999999987 68999999999999999999977665533322 2222222334556789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHh
Q 045028 986 IRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~L 1007 (1044)
|.+||++||++|||+.|++++-
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHcCCChhhCcCHHHHHhCc
Confidence 9999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=368.93 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=214.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc---chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF---FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~---~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
.++|++++.||+|+||+||++.+ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+.++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46799999999999999999987 577899999865422 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC---------------------------------------CCCCcHHHHHHHHHHHHHHHHHH
Q 045028 827 IVAEFLPRGSLYRLLHRP---------------------------------------NNQLDERRRLRMALDAARGMNYL 867 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~---------------------------------------~~~Lse~~il~Ia~QIa~AL~yL 867 (1044)
+||||++|++|.+++... ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998520 12346788899999999999999
Q ss_pred HhCCCcEEEecCCCCcEEEcCCC--eEEEEeccccccccCC----cccccCCCCCCCccCcccccC--CCCCchhHHHHH
Q 045028 868 HNCTPVIVHRDLKSPNLLVDKNW--VVKVCDFGLSRMKHNT----FLSSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSF 939 (1044)
Q Consensus 868 Hs~G~~IVHRDIKPeNILLd~dg--~VKLiDFGLA~~~~~~----~~~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSL 939 (1044)
|+.| |+||||||+||||+.++ .+||+|||++...... ........||+.|+|||++.+ ..++.++|||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9999 99999999999998776 8999999999754321 112345679999999999976 678899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccCC
Q 045028 940 GVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKP 1013 (1044)
Q Consensus 940 G~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k~ 1013 (1044)
||+||+|++|+.||.+.+..+....+.........+ ..+++++++||.+||..||.+|||+.++++| ++++...
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 999999999999999988888777765443333332 3489999999999999999999999999997 4444433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=376.62 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=202.1
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..++|++++.||+|+||+||++++ +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 457899999999999999999988 588999999875432 225678999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe--EEEEeccccccccCC
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV--VKVCDFGLSRMKHNT 906 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~--VKLiDFGLA~~~~~~ 906 (1044)
|||+.|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+++.....
T Consensus 95 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 95 MEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999876 456999999999999999999999999 999999999999987765 999999999743322
Q ss_pred cccccCCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhccccccCCCCCCCCHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEK-CDVYSFGVILWELCTMQQPWGGMNP----MQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~k-SDIWSLG~LLyELLTGk~PF~~~~~----~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.......||+.|+|||++.+..+..+ +|||||||+||+|++|+.||.+... ......+............++++
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence 22345679999999999988887655 8999999999999999999987544 23333333223333333468999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+++||.+||.+||.+|||+.|+++|-
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred HHHHHHHHccCChhHCcCHHHHHhCc
Confidence 99999999999999999999999984
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=359.77 Aligned_cols=251 Identities=29% Similarity=0.511 Sum_probs=223.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+.|++++.||+|+||+||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++.....+++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 46799999999999999999987 578999999875543 345678999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+++++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999975 57899999999999999999999999 999999999999999999999999999876554444
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHh
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rc 989 (1044)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+. ......++..++.++.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHH
Confidence 556779999999999999999999999999999999999999999888777666553 2344556778999999999999
Q ss_pred hhcCCCCCCCHHHHHHHhc
Q 045028 990 WQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 990 L~kDPekRPTa~ELLe~Lk 1008 (1044)
|..||.+|||+.+++++..
T Consensus 255 l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHH
T ss_pred cCCChhhCcCHHHHhhChh
Confidence 9999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=369.59 Aligned_cols=254 Identities=23% Similarity=0.273 Sum_probs=210.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch---hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG---ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~---~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
.++|++++.||+|+||.||++++ +|+.||||++....... .....+.+|+.+++.++||||+++++++...+.++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 46899999999999999999987 48899999986543221 11246788999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.+ +|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99999976 899999877778999999999999999999999999 999999999999999999999999999876554
Q ss_pred cccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC-------------
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL------------- 972 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~------------- 972 (1044)
........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 4445567899999999999765 48999999999999999999999999988776665543211100
Q ss_pred -------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 973 -------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 973 -------------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
.+...+++++++||.+||..||.+|||+.|+++|-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 011456789999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=377.71 Aligned_cols=262 Identities=17% Similarity=0.198 Sum_probs=208.9
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchh---------hHHHHHHHHHHHHhCCCCCee
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGE---------SLEEFRSEVLIMKRVRHPNVV 813 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~---------~~~~~~~EI~ILk~LrHPNIV 813 (1044)
+..++|+++++||+|+||+||+|.+. ++.||||++........ ....+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45568999999999999999999873 46799999865431100 011234456677788899999
Q ss_pred EEEeeeecC----CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc--
Q 045028 814 LFMGAVTRP----PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-- 887 (1044)
Q Consensus 814 kl~~~~~~~----~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-- 887 (1044)
++++++... ..++|||||+ |++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence 999998765 4489999999 99999999886678999999999999999999999999 99999999999999
Q ss_pred CCCeEEEEeccccccccCCcc-------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 045028 888 KNWVVKVCDFGLSRMKHNTFL-------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ 960 (1044)
Q Consensus 888 ~dg~VKLiDFGLA~~~~~~~~-------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e 960 (1044)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999975432211 1234559999999999999999999999999999999999999998643222
Q ss_pred HHhhhcccc---------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 961 VVGAVGFQH---------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 961 il~~I~~~~---------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
......... ........+++++.++|..||..||.+||++.+|++.|+.+.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 111110000 001123678999999999999999999999999999999887643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=358.75 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=201.3
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.++..++|++++.||+|+||+||++++ +++.||||++............+..+..+++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356678999999999999999999988 788999999876544444445556666668888999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 826 SIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
++||||++| +|.+++.. ....+++..++.++.||+.||.|||++ | |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999975 88777653 457899999999999999999999998 9 9999999999999999999999999997
Q ss_pred cccCCcccccCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhccccccCCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVL----RNEPSDEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL----~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~-~~~eil~~I~~~~~~~~ip~ 976 (1044)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||... ..................+.
T Consensus 159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 159 YLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 654332 23345799999999996 5667899999999999999999999999863 33344433333333333446
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+++++.++|.+||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 789999999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=370.94 Aligned_cols=261 Identities=29% Similarity=0.468 Sum_probs=216.5
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
....++|++.+.||+|+||+||++++ +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34567899999999999999999987 47899999876543 2446779999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCC---CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLLHRPN---NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~---~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999997632 35899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc------cc--------
Q 045028 905 NTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG------FQ-------- 968 (1044)
Q Consensus 905 ~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~------~~-------- 968 (1044)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+.+...... ..
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 221 12234458999999999999899999999999999999999999997754432211100 00
Q ss_pred -cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 969 -HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 969 -~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.....++..++.++.++|.+||+.||++|||+.+++++|+.+.+-
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 001112234557799999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=355.70 Aligned_cols=245 Identities=26% Similarity=0.416 Sum_probs=214.6
Q ss_pred CCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++.+.||+|+||+||++.+. +..+|+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999884 56899998875432 345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE---cCCCeEEEEeccccccccCCc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL---d~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999998876 456899999999999999999999999 9999999999999 788999999999997654332
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC----CCCCHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP----DNLDPAVA 983 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip----~~ip~ELk 983 (1044)
......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+... ...++ ..+++++.
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHH
T ss_pred -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHH
Confidence 33456799999999999765 899999999999999999999999998888777766433 23333 26899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||.+||+.||.+|||+.++++|
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=366.08 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=201.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC-------
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------- 823 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------- 823 (1044)
++|++++.||+|+||+||+|++ +++.||||++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999988 58899999987544 2345577999999999999999999999886543
Q ss_pred --------------------------------------------------CceEEEEecCCCcHHHHhcCCC--CCCcHH
Q 045028 824 --------------------------------------------------NLSIVAEFLPRGSLYRLLHRPN--NQLDER 851 (1044)
Q Consensus 824 --------------------------------------------------~l~LVmEy~~GGsL~dlLkr~~--~~Lse~ 851 (1044)
.+++||||+.|++|.+++.+.. ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2799999999999999998743 335666
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc------------ccccCCCCCCCc
Q 045028 852 RRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF------------LSSRSTAGTAEW 919 (1044)
Q Consensus 852 ~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~------------~~~~s~~GTp~Y 919 (1044)
.++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...... .......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78999999999999999999 9999999999999999999999999998654331 223446799999
Q ss_pred cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 045028 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPT 999 (1044)
Q Consensus 920 ~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPT 999 (1044)
+|||++.+..++.++|||||||++|+|++|..|+.. .......+. .......+...++++.+||.+||+.||.+|||
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 999999999999999999999999999998776532 112222221 11111122345688999999999999999999
Q ss_pred HHHHHHH
Q 045028 1000 FTEIMAA 1006 (1044)
Q Consensus 1000 a~ELLe~ 1006 (1044)
+.|+++|
T Consensus 320 ~~~~l~~ 326 (332)
T 3qd2_B 320 ATDIIEN 326 (332)
T ss_dssp HHHHHHS
T ss_pred HHHHhhc
Confidence 9999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=369.01 Aligned_cols=261 Identities=27% Similarity=0.448 Sum_probs=218.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC--C
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP--P 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~--~ 823 (1044)
...|+++++||+|+||+||++.+ +++.||||++.... .......+.+|+.++++++||||+++++++... .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 34459999999999999998865 57889999987543 345567799999999999999999999999874 5
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+++++|.+++.+ ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred eEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 68999999999999999986 35899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHhhhc
Q 045028 904 HNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ--------------VVGAVG 966 (1044)
Q Consensus 904 ~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e--------------il~~I~ 966 (1044)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 4332 12344568889999999999999999999999999999999999997532210 111122
Q ss_pred cccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCC
Q 045028 967 FQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSS 1017 (1044)
Q Consensus 967 ~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~ 1017 (1044)
........+..+++++.+||.+||+.||.+|||+.++++.|+.+.+.+...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 233456677889999999999999999999999999999999988765543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=370.80 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=212.9
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-----CCCeeEEEe
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-----HPNVVLFMG 817 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-----HPNIVkl~~ 817 (1044)
.....+..++|+++++||+|+||+||+|++ +++.||||++... ......+..|+.+++.+. ||||+++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344556678999999999999999999998 6888999998643 234556788999999996 999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC--------
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-------- 888 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-------- 888 (1044)
++...+.+++||||+ +++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcccccccccc
Confidence 999999999999999 899999997643 46999999999999999999999999 999999999999975
Q ss_pred -----------------CCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCC
Q 045028 889 -----------------NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ 951 (1044)
Q Consensus 889 -----------------dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~ 951 (1044)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||+|++|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999864432 345679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHhhhcccccc------------------------CCCC--------------------CCCCHHHHHHHH
Q 045028 952 PWGGMNPMQVVGAVGFQHRR------------------------LDIP--------------------DNLDPAVADIIR 987 (1044)
Q Consensus 952 PF~~~~~~eil~~I~~~~~~------------------------~~ip--------------------~~ip~ELkdLI~ 987 (1044)
||...+..+.+..+...... ..+| ...++++.+||.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 99988776655443211110 0111 122477889999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||+.||.+|||+.|+|+|
T Consensus 338 ~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCChhhCCCHHHHhcC
Confidence 9999999999999999876
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=363.17 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=208.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc---hhhHHHHHHHHHHHHhCC---CCCeeEEEeeeec
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF---GESLEEFRSEVLIMKRVR---HPNVVLFMGAVTR 821 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~---~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~~ 821 (1044)
+..++|+++++||+|+||+||++++ +++.||||++...... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4457899999999999999999985 6889999998644321 112245667887777664 9999999999877
Q ss_pred CC-----CceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEE
Q 045028 822 PP-----NLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC 895 (1044)
Q Consensus 822 ~~-----~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLi 895 (1044)
.. .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 65 4899999996 59999998743 34999999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC---
Q 045028 896 DFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--- 972 (1044)
Q Consensus 896 DFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--- 972 (1044)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.......
T Consensus 163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999997654332 2345679999999999999999999999999999999999999999988877665543211100
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 973 ----------------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 973 ----------------------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.....+++++.+||.+||++||.+|||+.|+++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 01246789999999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=364.10 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=210.5
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeec---
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTR--- 821 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~--- 821 (1044)
.....++|++++.||+|+||.||+|++ +++.||||++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344568899999999999999999998 68899999986543 2345788999999999 79999999999876
Q ss_pred ---CCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 822 ---PPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 822 ---~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
.+.+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeC
Confidence 45799999999999999999763 357899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCcccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC
Q 045028 898 GLSRMKHNTFLSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL 972 (1044)
Q Consensus 898 GLA~~~~~~~~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~ 972 (1044)
|++..............||+.|+|||++. +..++.++|||||||+||+|++|..||...+.......+.......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 99986554433345567999999999997 5668899999999999999999999999888776665554333333
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+..++.++++||.+||..||.+|||+.++++|
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 4456789999999999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.18 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=210.9
Q ss_pred CeeE--EeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 754 EITL--GERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 754 ~y~I--~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.|.+ .+.||+|+||+||+|++ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+.++|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3555 67899999999999987 588999999876542 34567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE--cCCCeEEEEeccccccccCCc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV--DKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL--d~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++......
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999999999998765667999999999999999999999999 9999999999999 567899999999998654332
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip~ELkdL 985 (1044)
.....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+..+.+..+....... .....+++++++|
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 2344579999999999999999999999999999999999999999988887777664332222 1235789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||.+||.+|||+.|+++|
T Consensus 323 i~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=369.53 Aligned_cols=261 Identities=30% Similarity=0.489 Sum_probs=221.6
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
++..++|++++.||+|+||.||++++ ++..||||++.... .......+.+|+.++++++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 45678999999999999999999974 45679999986432 34455678899999999999999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCC------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeE
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPN------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVV 892 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~V 892 (1044)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999997643 45899999999999999999999999 999999999999984 4569
Q ss_pred EEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhcccc
Q 045028 893 KVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQH 969 (1044)
Q Consensus 893 KLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~ 969 (1044)
||+|||++....... .......||+.|+|||++.+..++.++|||||||+||+|++ |..||......+....+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 999999987543221 22234568999999999999999999999999999999998 999999988877776664 33
Q ss_pred ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 970 ~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.....+..+++++.++|.+||..||.+|||+.+++++|+.+...
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 45567788999999999999999999999999999999988764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=355.39 Aligned_cols=253 Identities=27% Similarity=0.488 Sum_probs=213.4
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..+..++|++++.||+|+||.||++++ +++.||||++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 345668999999999999999999987 5889999998654322 2345678999999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+++||||+.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+|+||||+|||++.++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999999976 356899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCcccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......+....+. .....++..++.++.
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~ 239 (276)
T 2h6d_A 163 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVA 239 (276)
T ss_dssp C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred CCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHH
Confidence 332 2334578999999999998775 689999999999999999999999888777776663 344567788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++|.+||+.||.+|||+.++++|
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhhCCCHHHHHhC
Confidence 99999999999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=396.83 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=220.7
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+..++|++++.||+|+||+||++++ +|+.||||++.+.... ......+.+|+.+++.++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4457899999999999999999987 5889999998765332 234567889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 827 IVAEFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
+||||++||+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999998763 346999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhccccccCCCCCCCC
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN----PMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~----~~eil~~I~~~~~~~~ip~~ip 979 (1044)
..........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+ ..++...+. .....+|..++
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~s 417 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFS 417 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTSC
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcccC
Confidence 544444455689999999999999999999999999999999999999998753 344555542 34566788999
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 045028 980 PAVADIIRKCWQTDPKMRPT-----FTEIMAA 1006 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPT-----a~ELLe~ 1006 (1044)
+++++||.+||.+||.+||+ +.+|++|
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 99999999999999999996 4788876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=372.08 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=218.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
+.|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999986 688999999876533 2344567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||+. |+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 9997 5888888655678999999999999999999999999 99999999999999999999999999976543
Q ss_pred ccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.....||+.|+|||++. +..++.++|||||||+||||++|+.||.+.+..+....+.........+..+++++++||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 23467999999999985 566899999999999999999999999988877766665444444445667899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhcc
Q 045028 987 RKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
.+||+.||.+|||+.+++++..-
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHcccChhhCcCHHHHhhChhh
Confidence 99999999999999999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=364.47 Aligned_cols=260 Identities=26% Similarity=0.449 Sum_probs=198.3
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeee---
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVT--- 820 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~--- 820 (1044)
..++...+|++.++||+|+||.||++++ +++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3455667899999999999999999998 78899999886543 344567899999999996 999999999984
Q ss_pred -----cCCCceEEEEecCCCcHHHHhcC--CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEE
Q 045028 821 -----RPPNLSIVAEFLPRGSLYRLLHR--PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVK 893 (1044)
Q Consensus 821 -----~~~~l~LVmEy~~GGsL~dlLkr--~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VK 893 (1044)
....+++||||+. |+|.+++.+ ....+++..++.++.||+.||.|||++|.+|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 3334899999995 689888864 35679999999999999999999999876799999999999999999999
Q ss_pred EEeccccccccCCcc------------cccCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 045028 894 VCDFGLSRMKHNTFL------------SSRSTAGTAEWMAPEVL---RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP 958 (1044)
Q Consensus 894 LiDFGLA~~~~~~~~------------~~~s~~GTp~Y~APEvL---~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~ 958 (1044)
|+|||+++....... ......||+.|+|||++ .+..++.++|||||||+||+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999999976543211 11245699999999999 566789999999999999999999999987655
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
...... ......+..++..+.+||.+||+.||.+|||+.|++++|+.+...
T Consensus 259 ~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 259 LRIVNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcC----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 443322 223444567788899999999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=370.94 Aligned_cols=262 Identities=19% Similarity=0.255 Sum_probs=207.0
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcch---------hhHHHHHHHHHHHHhCCCCCeeE
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFFG---------ESLEEFRSEVLIMKRVRHPNVVL 814 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~~---------~~~~~~~~EI~ILk~LrHPNIVk 814 (1044)
++..++|++++.||+|+||+||+|.+ .+..+|||++....... .....+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 34557899999999999999999988 45789999887543211 01123667888999999999999
Q ss_pred EEeeeec----CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC
Q 045028 815 FMGAVTR----PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 815 l~~~~~~----~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg 890 (1044)
+++++.. ...+++||||+ |++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence 9999887 67899999999 99999999874 38999999999999999999999999 99999999999999887
Q ss_pred --eEEEEeccccccccCCc-------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChH
Q 045028 891 --VVKVCDFGLSRMKHNTF-------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM--NPM 959 (1044)
Q Consensus 891 --~VKLiDFGLA~~~~~~~-------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~--~~~ 959 (1044)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||... +..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999997543221 1124567999999999999999999999999999999999999999652 222
Q ss_pred HHHhhhccccccCCCC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 960 QVVGAVGFQHRRLDIP---------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 960 eil~~I~~~~~~~~ip---------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
...... ......++ ..++++++++|.+||..||.+|||+.+|++.|+.+..++..
T Consensus 269 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 332 (345)
T 2v62_A 269 AVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332 (345)
T ss_dssp HHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred HHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence 221111 11111122 27889999999999999999999999999999987764433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.33 Aligned_cols=252 Identities=27% Similarity=0.491 Sum_probs=214.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
...++|++++.||+|+||.||++.+. |+.||||++.... ....+.+|+.+++.++||||+++++++...+.+++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34578999999999999999999884 8899999987543 23568899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||+.+++|.+++......+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999755678999999999999999999999999 9999999999999999999999999998665544
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ip~~ip~ELkdLI 986 (1044)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ......+..++.++.+||
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 4445667999999999999999999999999999999999999999988776655443222 223344567899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHh
Q 045028 987 RKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+||..||.+|||+.++++|-
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTSH
T ss_pred HHHccCChhhCcCHHHHHhCH
Confidence 999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=352.72 Aligned_cols=245 Identities=21% Similarity=0.328 Sum_probs=210.4
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||+||++.+ +++.||||++............+.+|+.++..+ +||||+++++++...+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 588999999887655455667788999999999 8999999999999999999999
Q ss_pred EecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-----------------
Q 045028 830 EFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN----------------- 889 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d----------------- 889 (1044)
||++|++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999753 256899999999999999999999999 9999999999999844
Q ss_pred --CeEEEEeccccccccCCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc
Q 045028 890 --WVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG 966 (1044)
Q Consensus 890 --g~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~ 966 (1044)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++........+.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~--- 241 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR--- 241 (289)
T ss_dssp -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH---
T ss_pred CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH---
Confidence 47999999999865443 234699999999999876 56789999999999999999998876543322221
Q ss_pred cccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 967 FQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 967 ~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
......++..+++++.+||.+||..||.+|||+.++++|-
T Consensus 242 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 242 -QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp -TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred -cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 2344567788999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=389.10 Aligned_cols=251 Identities=31% Similarity=0.495 Sum_probs=218.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|+++++||+|+||+||++++ +++.||||++............+.+|+.++++++||||+++++++.....+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999987 5889999998765444445678999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc---CCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD---KNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd---~dg~VKLiDFGLA~~~~~~ 906 (1044)
||+.|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999998876 357999999999999999999999999 99999999999995 4568999999999765433
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ELkd 984 (1044)
. .....+||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..+++..+.........+ ..+++++++
T Consensus 178 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 178 T-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp -----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred C-ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 2 23456799999999999874 8999999999999999999999999999888888775444333333 468999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
||.+||..||.+|||+.++++|-
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCH
T ss_pred HHHHHcCCChhhCcCHHHHhcCH
Confidence 99999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=369.42 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=211.3
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..++|++++.||+|+||.||++++. ++.||||++............+.+|+.+++.++||||+++++++...+.+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4578999999999999999999884 88999999877665555567788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999999888765 456999999999999999999999999 99999999999999999999999999986554444
Q ss_pred cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-----------------
Q 045028 909 SSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR----------------- 970 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~----------------- 970 (1044)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 44556799999999999876 689999999999999999999999998877655443321100
Q ss_pred cCC------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 RLD------------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ~~~------------ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
... ....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 113578999999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=373.75 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=201.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-----CC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-----PN 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-----~~ 824 (1044)
.++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999987 578899999976544455667899999999999999999999999776 56
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999999985 599999986 467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc----------------------cccCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhC-----------C
Q 045028 905 NTFL----------------------SSRSTAGTAEWMAPEVL-RNEPSDEKCDVYSFGVILWELCTM-----------Q 950 (1044)
Q Consensus 905 ~~~~----------------------~~~s~~GTp~Y~APEvL-~g~~~s~kSDIWSLG~LLyELLTG-----------k 950 (1044)
.... .....+||+.|+|||++ .+..++.++|||||||+||||++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 3211 12556899999999986 556699999999999999999984 4
Q ss_pred CCCCCCCh-----------------HHHH------------------------hhhccccccCC-----CCCCCCHHHHH
Q 045028 951 QPWGGMNP-----------------MQVV------------------------GAVGFQHRRLD-----IPDNLDPAVAD 984 (1044)
Q Consensus 951 ~PF~~~~~-----------------~eil------------------------~~I~~~~~~~~-----ip~~ip~ELkd 984 (1044)
++|.+.+. .+.+ ..+........ ....+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44444321 0111 00100000111 11468999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
||.+||..||.+|||+.|+|+|
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=368.56 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=211.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------- 822 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------- 822 (1044)
.++|+++++||+|+||+||++++ +|+.||||++............+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999987 588999999876654444456788999999999999999999998763
Q ss_pred -CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 823 -PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 823 -~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+.+++||||+.+ +|.+.+......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 458999999975 788888776678999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCC----cccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CC
Q 045028 902 MKHNT----FLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DI 974 (1044)
Q Consensus 902 ~~~~~----~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~i 974 (1044)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 54321 1223446789999999999874 57999999999999999999999999988776655543211111 11
Q ss_pred CCC----------------------------CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 975 PDN----------------------------LDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 975 p~~----------------------------ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
... .++++.+||.+||+.||.+|||+.|+++|-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 111 2778999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.37 Aligned_cols=250 Identities=27% Similarity=0.365 Sum_probs=212.3
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|++++.||+|+||.||++.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999987 588999999865432 2345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--cc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FL 908 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~~ 908 (1044)
|+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999976 467999999999999999999999999 999999999999999999999999999754322 12
Q ss_pred cccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ..+..+.........+..+++++++||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2345679999999999988775 77999999999999999999999876543 222222222222333457899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 045028 987 RKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+||..||.+|||+.++++|
T Consensus 243 ~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHCCCCchhCCCHHHHhcC
Confidence 99999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=372.32 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=207.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++++.||+|+||+||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999987 5889999998665444555678899999999999999999999997663
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999976 56899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH------------- 969 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~------------- 969 (1044)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 432 345678999999999987 678999999999999999999999999887766554432110
Q ss_pred ----------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 ----------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 ----------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....+...+++++.+||.+||..||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0112345679999999999999999999999999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=364.86 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=213.0
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee----
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT---- 820 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~---- 820 (1044)
...+..++|++++.||+|+||.||++++ +++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 3445678899999999999999999986 68899999886543 345677899999999999999999999986
Q ss_pred cCCCceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
.....++||||+.+++|.+++.+ ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEec
Confidence 33468999999999999999875 4577999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCcc---------cccCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHh
Q 045028 898 GLSRMKHNTFL---------SSRSTAGTAEWMAPEVLRNEP---SDEKCDVYSFGVILWELCTMQQPWGGMNP--MQVVG 963 (1044)
Q Consensus 898 GLA~~~~~~~~---------~~~s~~GTp~Y~APEvL~g~~---~s~kSDIWSLG~LLyELLTGk~PF~~~~~--~eil~ 963 (1044)
|++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 99865332110 012235799999999998665 68899999999999999999999954211 11111
Q ss_pred hhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 964 AVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 964 ~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
.+. .......+..+++++.++|.+||..||.+|||+.+++++|+.+...
T Consensus 259 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AVQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHH-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hhh-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 121 2233444567899999999999999999999999999999988754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.34 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=214.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
++|++++.||+|+||.||++++ +++.||+|++....... ...+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5799999999999999999988 48899999987654332 23677999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC----eEEEEecccccc
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW----VVKVCDFGLSRM 902 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg----~VKLiDFGLA~~ 902 (1044)
+||||+.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999975 457899999999999999999999999 99999999999998877 899999999976
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCCH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLDP 980 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip~ 980 (1044)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+....... ..+..++.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 54332 2234569999999999999999999999999999999999999999988877766653322211 22357889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
++.+||.+||..||.+|||+.++++|
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 99999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=364.05 Aligned_cols=257 Identities=31% Similarity=0.557 Sum_probs=207.8
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC--CCCCeeEEEeeeecC----
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV--RHPNVVLFMGAVTRP---- 822 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L--rHPNIVkl~~~~~~~---- 822 (1044)
+...++|++++.||+|+||.||++++.++.||||++.... .....+|.+++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445789999999999999999999999999999985432 23445566666554 899999999998877
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC--------CCcEEEecCCCCcEEEcCCCeEEE
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC--------TPVIVHRDLKSPNLLVDKNWVVKV 894 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~--------G~~IVHRDIKPeNILLd~dg~VKL 894 (1044)
..+++||||+.+++|.++++. ..+++..++.++.|++.||.|||++ | |+||||||+||||+.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence 679999999999999999976 4699999999999999999999998 8 999999999999999999999
Q ss_pred EeccccccccCCcc----cccCCCCCCCccCcccccCCCCCch------hHHHHHHHHHHHHHhC----------CCCCC
Q 045028 895 CDFGLSRMKHNTFL----SSRSTAGTAEWMAPEVLRNEPSDEK------CDVYSFGVILWELCTM----------QQPWG 954 (1044)
Q Consensus 895 iDFGLA~~~~~~~~----~~~s~~GTp~Y~APEvL~g~~~s~k------SDIWSLG~LLyELLTG----------k~PF~ 954 (1044)
+|||++........ ......||+.|+|||++.+..+... +|||||||+||||++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999975433221 1235679999999999988776554 9999999999999999 77776
Q ss_pred CCCh-----HHHHhhhccccccCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 955 GMNP-----MQVVGAVGFQHRRLDIPD-----NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 955 ~~~~-----~eil~~I~~~~~~~~ip~-----~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.... ......+........++. .+++++.+||.+||+.||.+|||+.+++++|+.+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 5322 222222222233333432 56678999999999999999999999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=360.27 Aligned_cols=252 Identities=29% Similarity=0.507 Sum_probs=212.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
..++|++++.||+|+||.||++++. ++.||+|++.... ......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4578999999999999999999984 7889999886543 34457789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999998765677999999999999999999999999 99999999999999999999999998764332222
Q ss_pred cccCCCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-cCCCCCCCCHHH
Q 045028 909 SSRSTAGTAEWMAPEVL-----RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAV 982 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL-----~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-~~~ip~~ip~EL 982 (1044)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+..... ....+..++.++
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 23456799999999998 467789999999999999999999999999887776655533222 233456789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.++|.+||..||.+|||+.++++|
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHcccChhhCCCHHHHhcC
Confidence 999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=385.71 Aligned_cols=249 Identities=31% Similarity=0.454 Sum_probs=212.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|+++++||+|+||+||+|++ ++..||||++............+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999988 57889999998765544556778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEeccccccccCCc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGLA~~~~~~~ 907 (1044)
|+.||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999998876 356899999999999999999999999 999999999999976 4569999999998655432
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC--CCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI--PDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i--p~~ip~ELkdL 985 (1044)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+++..+......... ...+++++++|
T Consensus 194 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred -cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 2345679999999999874 5899999999999999999999999999988888877544433322 25789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||+.||.+|||+.++++|
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=368.66 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=189.9
Q ss_pred CCeeEE---eEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCce
Q 045028 753 EEITLG---ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 753 e~y~I~---r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~ 826 (1044)
++|++. +.||+|+||+||++.+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 456765 7899999999999988 4789999998643 3456788999999997 999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---eEEEEeccccccc
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW---VVKVCDFGLSRMK 903 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg---~VKLiDFGLA~~~ 903 (1044)
+||||++|++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999987 467999999999999999999999999 99999999999998765 8999999999866
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHhhhccccccCCCC-
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP-------MQVVGAVGFQHRRLDIP- 975 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~-------~eil~~I~~~~~~~~ip- 975 (1044)
..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. .++...+.. ....++
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~~~ 237 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSFEG 237 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCCCS
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCCCc
Confidence 5544445567799999999999999999999999999999999999999986443 344555432 222222
Q ss_pred ---CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 976 ---DNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 976 ---~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
..+++++++||.+||..||.+|||+.++++|-
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 36899999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=392.05 Aligned_cols=264 Identities=34% Similarity=0.582 Sum_probs=230.8
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEECC-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWHG-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
...+++..++|++.++||+|+||+||++++.+ ..||||+++.... ..+.+.+|+.+|++++||||+++++++.. +
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 34577888999999999999999999999865 6799999876542 34678999999999999999999999876 7
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.++|||||+.+|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 799999999999999999752 356899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCH
Q 045028 903 KHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980 (1044)
Q Consensus 903 ~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ 980 (1044)
..... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+++..+. ...+...+..++.
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 491 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54322 12233457889999999999999999999999999999999 999999998888877764 3445667889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
++.+||.+||+.||++|||+.+|++.|+.+.....
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 99999999999999999999999999999887543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.73 Aligned_cols=261 Identities=30% Similarity=0.475 Sum_probs=211.5
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
....+..++|++.+.||+|+||+||++++ +++.||||++...... .....+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 34556678999999999999999999987 5888999998654322 122358899999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCC---CCCCcHHHHHHHHHHHHHHHHHHHhC---CCcEEEecCCCCcEEEcCCCeEEEEecc
Q 045028 825 LSIVAEFLPRGSLYRLLHRP---NNQLDERRRLRMALDAARGMNYLHNC---TPVIVHRDLKSPNLLVDKNWVVKVCDFG 898 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~---~~~Lse~~il~Ia~QIa~AL~yLHs~---G~~IVHRDIKPeNILLd~dg~VKLiDFG 898 (1044)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ | |+||||||+|||++.++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999863 23499999999999999999999999 9 9999999999999999999999999
Q ss_pred ccccccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----Ch---HHHHhhhccc-
Q 045028 899 LSRMKHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM-----NP---MQVVGAVGFQ- 968 (1044)
Q Consensus 899 LA~~~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~-----~~---~eil~~I~~~- 968 (1044)
++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... .. .+........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 998654322 2233456999999999999888999999999999999999999999521 11 1111111000
Q ss_pred --------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 045028 969 --------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKP 1009 (1044)
Q Consensus 969 --------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~ 1009 (1044)
.....++...+.++.++|.+||+.||.+|||+.+++++|+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00112223344779999999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.47 Aligned_cols=263 Identities=20% Similarity=0.269 Sum_probs=212.1
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++.+.||+|+||.||++++ +++.||||++...... ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999987 5788999998755332 3345778999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||++|++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999976 356899999999999999999999999 9999999999999999999999999987654332
Q ss_pred -ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHHHHHH
Q 045028 908 -LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVADI 985 (1044)
Q Consensus 908 -~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~ELkdL 985 (1044)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...+...+.... .....+..+++++.++
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 22234579999999999999999999999999999999999999999877654444432221 1234567899999999
Q ss_pred HHHhhhcCCCCCC-CHHHHHHHhccccCCCCC
Q 045028 986 IRKCWQTDPKMRP-TFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 986 I~rcL~kDPekRP-Ta~ELLe~Lk~L~k~l~~ 1016 (1044)
|.+||..||++|| ++.++++.|+.+......
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 9999999999999 999999999988776543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.59 Aligned_cols=258 Identities=27% Similarity=0.478 Sum_probs=213.9
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
.....+..++|.....||+|+||.||+|.+ +++.||||.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 344556667777778999999999999987 57889999987553 23456789999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCC--CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEeccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGL 899 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~--~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGL 899 (1044)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999999999997642 35678999999999999999999999 999999999999987 89999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhccccccCCCCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEP--SDEKCDVYSFGVILWELCTMQQPWGGMNPMQ-VVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~--~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e-il~~I~~~~~~~~ip~ 976 (1044)
+..............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .............++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 986554433345567999999999997654 7899999999999999999999997644322 2222222334556788
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+++++.+||.+||..||++||++.+++++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 899999999999999999999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.95 Aligned_cols=249 Identities=25% Similarity=0.446 Sum_probs=209.8
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|.+.++||+|+||+||++++ ++..+|+|++..... ....+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999987 578899999876432 3345778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE---cCCCeEEEEecccccccc
Q 045028 831 FLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 831 y~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL---d~dg~VKLiDFGLA~~~~ 904 (1044)
|+.+++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998854 2467999999999999999999999999 9999999999999 456889999999997644
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC-CCCCCHHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI-PDNLDPAVA 983 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i-p~~ip~ELk 983 (1044)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......... ...+++++.
T Consensus 179 ~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SDE-HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Ccc-cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 332 2345679999999999864 5889999999999999999999999998887777665433333222 245789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||.+||+.||.+|||+.|+++|
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=353.34 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=212.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEee-eecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA-VTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~-~~~~~~l~LV 828 (1044)
.++|++++.||+|+||+||++++ +++.||||++...... ..+.+|+.+++.++|++++..+.+ +...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999985 6889999988654322 358899999999998776655554 4666778999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE---cCCCeEEEEeccccccccC
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL---d~dg~VKLiDFGLA~~~~~ 905 (1044)
|||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 99999999866678999999999999999999999999 9999999999999 4889999999999986543
Q ss_pred Ccc-------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhcccc---ccC
Q 045028 906 TFL-------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP---MQVVGAVGFQH---RRL 972 (1044)
Q Consensus 906 ~~~-------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~---~eil~~I~~~~---~~~ 972 (1044)
... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||..... .+.+..+.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 321 23456799999999999999999999999999999999999999987432 22222221111 111
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
.++..+++++.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 2346789999999999999999999999999999999887644
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.84 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=215.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||++++ +|+.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 35799999999999999999987 588999999875432 23356889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE---cCCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL---d~dg~VKLiDFGLA~~~~~~ 906 (1044)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999999875 356899999999999999999999999 9999999999999 78899999999998754332
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--CCCCCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR--LDIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~--~~ip~~ip~ELkd 984 (1044)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+...... ...+..+++++.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 223346899999999999999999999999999999999999999998888777766433322 2344678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
||.+||..||.+|||+.++++|-
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSH
T ss_pred HHHHHcCCChhHCcCHHHHhcCc
Confidence 99999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=387.41 Aligned_cols=252 Identities=30% Similarity=0.457 Sum_probs=220.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++.++||+|+||+||++++ +++.||||++...... ......+.+|+.++++++||||+++++++...+.+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 346899999999999999999987 5889999998765433 3456789999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE---cCCCeEEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL---d~dg~VKLiDFGLA~~~~ 904 (1044)
||||+.|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999876 467999999999999999999999999 9999999999999 567899999999997654
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAV 982 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~EL 982 (1044)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+.........+ ..+++++
T Consensus 181 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 181 ASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 332 2334579999999999987 58999999999999999999999999999888888775544443333 4689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
++||.+||.+||.+|||+.++++|-
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhCh
Confidence 9999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=385.34 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=215.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-----------hhHHHHHHHHHHHHhCCCCCeeEEEee
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-----------ESLEEFRSEVLIMKRVRHPNVVLFMGA 818 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-----------~~~~~~~~EI~ILk~LrHPNIVkl~~~ 818 (1044)
.++|+++++||+|+||+||+|++ +++.||||++....... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999987 57889999987654321 335678999999999999999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---eEEEE
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW---VVKVC 895 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg---~VKLi 895 (1044)
+.+...+++||||+.||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999876 356999999999999999999999999 99999999999998776 69999
Q ss_pred eccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC-
Q 045028 896 DFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI- 974 (1044)
Q Consensus 896 DFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i- 974 (1044)
|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+.........
T Consensus 192 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 999998654432 2345679999999999875 5899999999999999999999999999988888877543332221
Q ss_pred -CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 975 -PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 975 -p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+..+++++++||.+||.+||.+|||+.|+++|-
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 267899999999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=368.33 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=214.6
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.++..++|++++.||+|+||+||++++. ++.||+|++.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3456678999999999999999999984 8899999987543 345567799999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
++||||++|++|.+++.+ ...+++..++.++.||+.||.|||+. | |+||||||+||||+.++.+||+|||++....
T Consensus 107 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999976 35689999999999999999999985 8 9999999999999999999999999987543
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-------------------
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV------------------- 965 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I------------------- 965 (1044)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 22 233467999999999999999999999999999999999999999887655432221
Q ss_pred -----------------------ccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 966 -----------------------GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 966 -----------------------~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
............++.++++||.+||+.||.+|||+.++++|-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 111111122245789999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=375.68 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=199.3
Q ss_pred CCCeeEE-eEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHH-hCCCCCeeEEEeeeec----CC
Q 045028 752 WEEITLG-ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMK-RVRHPNVVLFMGAVTR----PP 823 (1044)
Q Consensus 752 ~e~y~I~-r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk-~LrHPNIVkl~~~~~~----~~ 823 (1044)
.++|.+. +.||+|+||+||++.+ +++.||||++... ..+.+|+.++. ..+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4578877 7899999999999987 5788999998642 34677888874 4579999999998865 56
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEeccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGL 899 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGL 899 (1044)
.+||||||+.||+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 799999999999999999874 346999999999999999999999999 999999999999997 78999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHhhhccccccCC--
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ----VVGAVGFQHRRLD-- 973 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e----il~~I~~~~~~~~-- 973 (1044)
++...... .....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+..... ....+........
T Consensus 211 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 211 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp CEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred ccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 98654322 2345689999999999999999999999999999999999999998765432 2233322222222
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
....+++++++||.+||..||.+|||+.++++|-.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 22578999999999999999999999999999854
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=394.72 Aligned_cols=264 Identities=24% Similarity=0.449 Sum_probs=225.2
Q ss_pred cCcCCCCeeEEe-EecccCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 748 CEIPWEEITLGE-RIGLGSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 748 ~ei~~e~y~I~r-~LGkG~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
..+..+++.+.+ +||+|+||+||+|.+ ++..||||+++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 445667788877 899999999999976 34569999987542 23456789999999999999999999999976
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.++|||||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 5699999999999999999876778999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 903 KHNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 903 ~~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
..... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+. ...+...|..+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 564 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 564 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 53221 11223346789999999999999999999999999999998 999999988888777764 34567788899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
++++.+||.+||..||.+||++.+|++.|+.+...+..
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999999998765443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=384.32 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=204.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|+++++||+|+||+||++.+ +++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 5889999999766545566778999999999999999999999997654
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+||||||+.+ +|.+.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46999999976 57677653 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------ 971 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------ 971 (1044)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+......
T Consensus 215 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 4432 234568999999999999999999999999999999999999999998876655544221110
Q ss_pred -------------CC----CCCC-----------CCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 -------------LD----IPDN-----------LDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 -------------~~----ip~~-----------ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.. ++.. .++++++||.+||..||.+|||+.|+|+|-
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 00 0111 156799999999999999999999999983
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=366.06 Aligned_cols=253 Identities=20% Similarity=0.358 Sum_probs=217.7
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchh---------------hHHHHHHHHHHHHhCCCCCe
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGE---------------SLEEFRSEVLIMKRVRHPNV 812 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~---------------~~~~~~~EI~ILk~LrHPNI 812 (1044)
..+..++|++++.||+|+||.||+++++++.||||++........ ..+.+.+|+.++++++||||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 345568999999999999999999999999999999865432211 12779999999999999999
Q ss_pred eEEEeeeecCCCceEEEEecCCCcHHHH------hcCC-CCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcE
Q 045028 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRL------LHRP-NNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNL 884 (1044)
Q Consensus 813 Vkl~~~~~~~~~l~LVmEy~~GGsL~dl------Lkr~-~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNI 884 (1044)
+++++++...+.+++||||+++++|.++ +.+. ...+++..++.++.||+.||.|||+ +| |+||||||+||
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni 183 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence 9999999999999999999999999998 5542 5779999999999999999999999 99 99999999999
Q ss_pred EEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 045028 885 LVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE-PSDE-KCDVYSFGVILWELCTMQQPWGGMNP-MQV 961 (1044)
Q Consensus 885 LLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~-kSDIWSLG~LLyELLTGk~PF~~~~~-~ei 961 (1044)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... .+.
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999999865433 33456799999999999887 5665 99999999999999999999988766 566
Q ss_pred HhhhccccccCCCC-------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 962 VGAVGFQHRRLDIP-------------------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 962 l~~I~~~~~~~~ip-------------------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
...+... ...++ ..+++++.+||.+||..||.+|||+.++++|
T Consensus 262 ~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 6665322 23333 6789999999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=375.04 Aligned_cols=261 Identities=30% Similarity=0.523 Sum_probs=214.2
Q ss_pred CCeeEEeEecccCcEEEEEEEEC---C--cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee-cCCCce
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH---G--TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT-RPPNLS 826 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~---g--~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~-~~~~l~ 826 (1044)
..|++.+.||+|+||+||+|++. + ..||+|.+.... .......+.+|+.++++++||||+++++++. .++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35889999999999999999762 2 358899876432 2345678999999999999999999999864 456789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999887778999999999999999999999999 999999999999999999999999999754322
Q ss_pred c----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 907 F----LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 907 ~----~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
. .......+|+.|+|||++.+..++.++|||||||+||||++ |.+||...+..+....+. ...+...|..++.+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 1 11233457889999999999999999999999999999999 788898877666655553 34455667889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSS 1017 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~ 1017 (1044)
+.++|.+||..||.+|||+.+++++|+.+...+...
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999998766543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=360.70 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=217.0
Q ss_pred CCCCeeEE-eEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCce
Q 045028 751 PWEEITLG-ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 751 ~~e~y~I~-r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~ 826 (1044)
..+.|.+. +.||+|+||+||++.+ +++.||||++............+.+|+.+++.+. ||||+++++++...+.++
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 34568887 8999999999999987 4889999998876554555678999999999995 699999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEecccccc
Q 045028 827 IVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGLSRM 902 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGLA~~ 902 (1044)
+||||+.|++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999999998653 467999999999999999999999999 999999999999987 78999999999986
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc--cCCCCCCCCH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR--RLDIPDNLDP 980 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~--~~~ip~~ip~ 980 (1044)
..... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+....+..... ....+..+++
T Consensus 184 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 184 IGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence 54332 23446799999999999999999999999999999999999999999888777666543322 2334467899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 981 AVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 981 ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
++++||.+||..||.+|||+.++++|-.
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 9999999999999999999999998743
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=374.80 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=213.9
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhC-CCCCeeEEEeeee
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRV-RHPNVVLFMGAVT 820 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~ 820 (1044)
.+..++|++++.||+|+||+||++++ +++.||||++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 34567999999999999999999987 6889999998654321 12334577899999999 6999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
..+.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999999976 356899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC-cccccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhccccccCC
Q 045028 901 RMKHNT-FLSSRSTAGTAEWMAPEVLRNE--PSDEKCDVYSFGVILWELCTMQQPWGGMN----PMQVVGAVGFQHRRLD 973 (1044)
Q Consensus 901 ~~~~~~-~~~~~s~~GTp~Y~APEvL~g~--~~s~kSDIWSLG~LLyELLTGk~PF~~~~----~~eil~~I~~~~~~~~ 973 (1044)
+..... .......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.... ...+...+ ......
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~ 284 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPP 284 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCC
Confidence 754322 2223446799999999999863 47899999999999999999999997543 22333333 234556
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHhc
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRP-----TFTEIMAALK 1008 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRP-----Ta~ELLe~Lk 1008 (1044)
++..++..+++||.+||.+||.+|| ++.++++|..
T Consensus 285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 7888999999999999999999999 9999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=369.98 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=211.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch------hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG------ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~------~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
.++|++++.||+|+||+||++++ +++.||||++....... .....+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35799999999999999999976 68889999987654322 13345778999999999999999999999999
Q ss_pred CceEEEEecCCC-cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRG-SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GG-sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.+++||||+.+| +|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999998766 99999987 456999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......+..++++
T Consensus 180 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 180 LERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKE 250 (335)
T ss_dssp CCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCSSCCCHH
T ss_pred CCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCCcccCHH
Confidence 54432 2344679999999999998886 88999999999999999999999763211 22334556778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+.+||.+||.+||.+|||+.+++++-
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCc
Confidence 99999999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.62 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=209.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEee-eecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA-VTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~-~~~~~~l~LV 828 (1044)
.++|++++.||+|+||+||++++ +++.||||++...... ..+.+|+.+++.++|++++..+.+ +...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 36899999999999999999985 6889999986544322 347889999999998776665554 4667778999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE---cCCCeEEEEeccccccccC
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL---d~dg~VKLiDFGLA~~~~~ 905 (1044)
|||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 99999999866678999999999999999999999999 9999999999999 7889999999999986543
Q ss_pred Cc-------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhcccc---ccC
Q 045028 906 TF-------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGFQH---RRL 972 (1044)
Q Consensus 906 ~~-------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~~~---~~~ 972 (1044)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +.+..+.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 22 1234567999999999999999999999999999999999999999875432 2222221111 111
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
.....+++++.+||.+||+.||.+|||+.++++.|+.+.+...
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 2236789999999999999999999999999999999886543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=394.56 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=219.5
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+..++|++++.||+|+||.||++++ +|+.||||++.+.... ......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4567899999999999999999987 5889999998764332 234566889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|||||++||+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998764 345999999999999999999999999 99999999999999999999999999986543
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhccccccCCCCCCCCHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN----PMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~----~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.. .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..++...+ ......++..++++
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSPQ 415 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCHH
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCHH
Confidence 32 2345689999999999999999999999999999999999999998753 23444444 23455677889999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
+++||.+||.+||.+|| ++.|+++|
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 99999999999999999 78999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.13 Aligned_cols=255 Identities=30% Similarity=0.483 Sum_probs=210.7
Q ss_pred eeEEeEecccCcEEEEEEEECCcEEEEEEeeccC--cchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEec
Q 045028 755 ITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQD--FFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~--~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
|..+++||+|+||+||+|.++++.||||++.... ......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4456899999999999999999999999986542 12344677999999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--c
Q 045028 833 PRGSLYRLLHRP--NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF--L 908 (1044)
Q Consensus 833 ~GGsL~dlLkr~--~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~--~ 908 (1044)
++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999998752 356899999999999999999999999 9999999999999999999999999997644321 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc----cc---------cccCCCC
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG----FQ---------HRRLDIP 975 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~----~~---------~~~~~ip 975 (1044)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||......+....+. .. ......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 23345799999999998764 7889999999999999999999998755433222111 00 0111223
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
..++..+.++|.+||..||.+|||+.+++++|+.+..
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 3456789999999999999999999999999998753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=366.91 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=201.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999987 5888999998765545566678899999999999999999999997665
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 57999999975 78888863 5899999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------ 971 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------ 971 (1044)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 178 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 4322 233467999999999999999999999999999999999999999998876665544321110
Q ss_pred --------CC--------------CCC------CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 --------LD--------------IPD------NLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 --------~~--------------ip~------~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.. +|. ..+.++++||.+||..||.+|||+.|+++|-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 010 1256899999999999999999999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.76 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=204.1
Q ss_pred CCCeeEE-eEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceE
Q 045028 752 WEEITLG-ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 752 ~e~y~I~-r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~L 827 (1044)
.+.|++. +.||+|+||+||++++ +++.||||++.... ......+.+|+.+++++ +||||+++++++...+.+++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3579985 7899999999999986 68899999987553 23456788999999985 79999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe---EEEEecccccccc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV---VKVCDFGLSRMKH 904 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~---VKLiDFGLA~~~~ 904 (1044)
||||+.|++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999976 357899999999999999999999999 999999999999998765 9999999987543
Q ss_pred CC-------cccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--------------
Q 045028 905 NT-------FLSSRSTAGTAEWMAPEVLRN-----EPSDEKCDVYSFGVILWELCTMQQPWGGMNP-------------- 958 (1044)
Q Consensus 905 ~~-------~~~~~s~~GTp~Y~APEvL~g-----~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~-------------- 958 (1044)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 21 111234569999999999975 4578899999999999999999999987542
Q ss_pred -HHHHhhhccccccCCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 959 -MQVVGAVGFQHRRLDIP----DNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 959 -~eil~~I~~~~~~~~ip----~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
..+...+. .....++ ..+++++++||.+||..||.+|||+.|+++|-
T Consensus 246 ~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 246 QNMLFESIQ--EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHh--ccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 22333332 2223333 46899999999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=360.86 Aligned_cols=261 Identities=28% Similarity=0.506 Sum_probs=218.8
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
..+..++|++++.||+|+||.||++++ +++.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 345567899999999999999999984 57889999986543 3456779999999999999999999998876
Q ss_pred CC--CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 822 PP--NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 822 ~~--~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
.+ .+++||||+++++|.+++.+....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcc
Confidence 54 789999999999999999876677999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 045028 900 SRMKHNTFL---SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----------------Q 960 (1044)
Q Consensus 900 A~~~~~~~~---~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~----------------e 960 (1044)
+........ ......++..|+|||++.+..++.++|||||||+||+|++|..||...... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 986543321 123345788899999999988999999999999999999999998642110 1
Q ss_pred HHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 961 il~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+...+ ....+...+..+++++.+||.+||..||.+|||+.++++.|+.+.+.
T Consensus 272 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111 22334567788999999999999999999999999999999988654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=350.48 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=216.6
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc---c----hhhHHHHHHHHHHHHhCC-CCCeeEEEeeee
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF---F----GESLEEFRSEVLIMKRVR-HPNVVLFMGAVT 820 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~---~----~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~ 820 (1044)
..++|++.+.||+|+||.||++.+ +++.||||++..... . ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999988 578999999875431 1 123456889999999996 999999999999
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
..+.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999976 457899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccccCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLR------NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI 974 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~------g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i 974 (1044)
....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||...+..+....+.........
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 172 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 7654332 234567999999999985 456789999999999999999999999998887777666443333322
Q ss_pred C--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 975 P--DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 975 p--~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+ ..++.++.+||.+||..||.+|||+.++++|
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2 4689999999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=361.94 Aligned_cols=256 Identities=33% Similarity=0.546 Sum_probs=213.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHh--CCCCCeeEEEeeeecCC----
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKR--VRHPNVVLFMGAVTRPP---- 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~--LrHPNIVkl~~~~~~~~---- 823 (1044)
...++|++.+.||+|+||+||+++++++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34578999999999999999999999999999998543 23567789999887 68999999999998876
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHH--------hCCCcEEEecCCCCcEEEcCCCeEEEE
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH--------NCTPVIVHRDLKSPNLLVDKNWVVKVC 895 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLH--------s~G~~IVHRDIKPeNILLd~dg~VKLi 895 (1044)
.+++||||+.+++|.+++.+ ..+++..++.++.||+.||.||| +.+ |+||||||+||||+.++.+||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEEC
T ss_pred eeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEE
Confidence 79999999999999999976 46899999999999999999999 888 9999999999999999999999
Q ss_pred eccccccccCCcc----cccCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhC----------CCCCCC
Q 045028 896 DFGLSRMKHNTFL----SSRSTAGTAEWMAPEVLRNEP------SDEKCDVYSFGVILWELCTM----------QQPWGG 955 (1044)
Q Consensus 896 DFGLA~~~~~~~~----~~~s~~GTp~Y~APEvL~g~~------~s~kSDIWSLG~LLyELLTG----------k~PF~~ 955 (1044)
|||++........ ......||+.|+|||++.+.. ++.++|||||||+||||++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 9999976543321 234557999999999998763 33689999999999999999 789876
Q ss_pred CC-----hHHHHhhhccccccCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 956 MN-----PMQVVGAVGFQHRRLDIPD-----NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 956 ~~-----~~eil~~I~~~~~~~~ip~-----~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
.. ...+...+.....+..++. .++..+.+||.+||..||.+|||+.+++++|+.+.++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 43 2333433333333333442 34468999999999999999999999999999987753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=355.91 Aligned_cols=256 Identities=24% Similarity=0.313 Sum_probs=211.9
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE---CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC------CeeEEEee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW---HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP------NVVLFMGA 818 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~---~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP------NIVkl~~~ 818 (1044)
.++..++|++++.||+|+||+||++.+ +++.||||++... ....+.+.+|+.+++.++|+ +|++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 445567999999999999999999976 5788999998643 24456788999999988655 59999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---------
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK--------- 888 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~--------- 888 (1044)
+...+.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCC
Confidence 99999999999999 889999987643 46899999999999999999999999 999999999999987
Q ss_pred ----------CCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 045028 889 ----------NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP 958 (1044)
Q Consensus 889 ----------dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~ 958 (1044)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999764432 3456799999999999999999999999999999999999999998776
Q ss_pred HHHHhhhccccc------------------------------------------cCCCCCCCCHHHHHHHHHhhhcCCCC
Q 045028 959 MQVVGAVGFQHR------------------------------------------RLDIPDNLDPAVADIIRKCWQTDPKM 996 (1044)
Q Consensus 959 ~eil~~I~~~~~------------------------------------------~~~ip~~ip~ELkdLI~rcL~kDPek 996 (1044)
.+....+..... ....+...++++.+||.+||..||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 654433211100 01112234678999999999999999
Q ss_pred CCCHHHHHHH--hccccC
Q 045028 997 RPTFTEIMAA--LKPLQK 1012 (1044)
Q Consensus 997 RPTa~ELLe~--Lk~L~k 1012 (1044)
|||+.|+++| ++.+.+
T Consensus 320 Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 320 RITLREALKHPFFDLLKK 337 (339)
T ss_dssp SCCHHHHTTSGGGGGGGC
T ss_pred ccCHHHHhcCHHHHHHhc
Confidence 9999999987 444443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=355.00 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=209.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE---CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC---CCCCeeEEEeeee-----
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW---HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV---RHPNVVLFMGAVT----- 820 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~---~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L---rHPNIVkl~~~~~----- 820 (1044)
.++|++++.||+|+||+||++++ +++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 36899999999999999999987 467899999875443322233466777777766 8999999999987
Q ss_pred cCCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567999999997 5999998763 345999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc----------
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH---------- 969 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~---------- 969 (1044)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 97654322 2345679999999999999999999999999999999999999999888766554442110
Q ss_pred ---------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 ---------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 ---------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....++..++.++++||.+||..||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112346789999999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=349.23 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=211.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-------- 821 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-------- 821 (1044)
..+|++++.||+|+||.||++++ +++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 35799999999999999999988 48899999987543 346789999999999999999998754
Q ss_pred --------CCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeE
Q 045028 822 --------PPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVV 892 (1044)
Q Consensus 822 --------~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~V 892 (1044)
...+++||||+++++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCE
Confidence 34589999999999999999753 457999999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC
Q 045028 893 KVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL 972 (1044)
Q Consensus 893 KLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~ 972 (1044)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+ ...
T Consensus 162 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~----~~~ 234 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL----RDG 234 (284)
T ss_dssp EECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----HTT
T ss_pred EECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----hcc
Confidence 999999997654432 233457999999999999999999999999999999999999887532 2222222 123
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCC
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITS 1016 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~ 1016 (1044)
.++..++.+++++|.+||..||.+|||+.+++++|+.+.+....
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 35678899999999999999999999999999999998876443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.96 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=196.2
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.+.+..++|++++.||+|+||.||++.+ +++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3567778999999999999999999976 688999998764432 2345678899999999999999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 825 LSIVAEFLPRGSLYRLLHR-------PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr-------~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
.++||||+.|++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999863 2456999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCc-----ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc-
Q 045028 898 GLSRMKHNTF-----LSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR- 970 (1044)
Q Consensus 898 GLA~~~~~~~-----~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~- 970 (1044)
|++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+..........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987543221 12234579999999999976 5689999999999999999999999998776655443321111
Q ss_pred -------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 -------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 -------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.......+++++.+||.+||..||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 122345788999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=392.51 Aligned_cols=260 Identities=26% Similarity=0.475 Sum_probs=221.1
Q ss_pred CcCCCCeeEE-eEecccCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 749 EIPWEEITLG-ERIGLGSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 749 ei~~e~y~I~-r~LGkG~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
.+....+.+. ++||+|+||+||+|.+ .++.||||+++.........+.+.+|+.+|++++|||||++++++.. +
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E 442 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 3444556654 4899999999999965 35779999997765555567889999999999999999999999864 5
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.++|||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred CEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 68999999999999999976 467999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 904 HNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 904 ~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
.... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+. ...+...+..++
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 598 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCP 598 (635)
T ss_dssp TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 3321 12233457889999999999999999999999999999998 999999999888777764 345667888999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+++.+||.+||+.||++|||+.+|++.|+++...
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=365.36 Aligned_cols=252 Identities=19% Similarity=0.230 Sum_probs=203.1
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC--------CCCeeEEE
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR--------HPNVVLFM 816 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr--------HPNIVkl~ 816 (1044)
..++..++|+++++||+|+||+||++++ +++.||||++... ....+.+.+|+.+++.++ |+||++++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 3345568899999999999999999987 5788999998643 244567889999999885 78899999
Q ss_pred eeee----cCCCceEEEEecCCCcHHHHh-cCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCC
Q 045028 817 GAVT----RPPNLSIVAEFLPRGSLYRLL-HRPNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 817 ~~~~----~~~~l~LVmEy~~GGsL~dlL-kr~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg 890 (1044)
+++. ....+++||||+.+ +|.+++ ......+++..++.++.||+.||.|||++ | |+||||||+||||+.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCH
T ss_pred cceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccc
Confidence 9987 55679999999954 555554 44446799999999999999999999998 9 99999999999999776
Q ss_pred -------------------------------------------------eEEEEeccccccccCCcccccCCCCCCCccC
Q 045028 891 -------------------------------------------------VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMA 921 (1044)
Q Consensus 891 -------------------------------------------------~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~A 921 (1044)
.+||+|||++...... .....||+.|+|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~a 261 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccC
Confidence 7999999999865433 334579999999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH------HHHhhhcccc--------------------------
Q 045028 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM------QVVGAVGFQH-------------------------- 969 (1044)
Q Consensus 922 PEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~------eil~~I~~~~-------------------------- 969 (1044)
||++.+..++.++|||||||+||+|++|+.||...+.. +.+..+....
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99999999999999999999999999999999865421 1111110000
Q ss_pred --------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 970 --------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 970 --------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
....++..+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 01122334457789999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=375.04 Aligned_cols=243 Identities=14% Similarity=0.144 Sum_probs=197.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHH---HHHhCCCCCeeEEE-------e
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVL---IMKRVRHPNVVLFM-------G 817 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~---ILk~LrHPNIVkl~-------~ 817 (1044)
..++|++++.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+. ++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356899999999999999999986 589999999875432 2345678899995 45555799999988 6
Q ss_pred eeecCC-----------------CceEEEEecCCCcHHHHhcCCC------CCCcHHHHHHHHHHHHHHHHHHHhCCCcE
Q 045028 818 AVTRPP-----------------NLSIVAEFLPRGSLYRLLHRPN------NQLDERRRLRMALDAARGMNYLHNCTPVI 874 (1044)
Q Consensus 818 ~~~~~~-----------------~l~LVmEy~~GGsL~dlLkr~~------~~Lse~~il~Ia~QIa~AL~yLHs~G~~I 874 (1044)
++...+ ..||||||+ +|+|.+++.+.. ..+++..++.++.||+.||.|||++| |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 665553 288999999 679999997521 23345888899999999999999999 9
Q ss_pred EEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCC-----------CCCchhHHHHHHHHH
Q 045028 875 VHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE-----------PSDEKCDVYSFGVIL 943 (1044)
Q Consensus 875 VHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~-----------~~s~kSDIWSLG~LL 943 (1044)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||+|
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999986433 2335567 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 944 WELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 944 yELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|||++|+.||.+.+..+....+. ..+..+++++++||.+||..||.+|||+.++++|
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999998766555444332 2346789999999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.47 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=208.7
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-----CCc
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-----PNL 825 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-----~~l 825 (1044)
++|++++.||+|+||.||++.+ +++.||||++.... .......+.+|+.++++++||||+++++++... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 5899999999999999999987 57889999986433 234456789999999999999999999998654 368
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999996 599999875 46999999999999999999999999 99999999999999999999999999986543
Q ss_pred Ccc---cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc----------
Q 045028 906 TFL---SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR---------- 971 (1044)
Q Consensus 906 ~~~---~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~---------- 971 (1044)
... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+.+..+......
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 221 1244579999999998754 45899999999999999999999999988776655544211000
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 -------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 -------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
..+...+++++.+||.+||..||.+|||+.|+++|-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 012256789999999999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=366.18 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=204.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec------
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR------ 821 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~------ 821 (1044)
...++|++++.||+|+||+||+|++ +|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4457899999999999999999987 688999998865431 23469999999999999999999843
Q ss_pred --------------------------------CCCceEEEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHH
Q 045028 822 --------------------------------PPNLSIVAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNY 866 (1044)
Q Consensus 822 --------------------------------~~~l~LVmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~y 866 (1044)
...+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3348899999975 77766652 35779999999999999999999
Q ss_pred HHhCCCcEEEecCCCCcEEEc-CCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHH
Q 045028 867 LHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILW 944 (1044)
Q Consensus 867 LHs~G~~IVHRDIKPeNILLd-~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLy 944 (1044)
||++| |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 157 LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99999 99999999999998 68999999999998654332 234567899999999998755 899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHhhhcccc---------------------------ccCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 045028 945 ELCTMQQPWGGMNPMQVVGAVGFQH---------------------------RRLDIPDNLDPAVADIIRKCWQTDPKMR 997 (1044)
Q Consensus 945 ELLTGk~PF~~~~~~eil~~I~~~~---------------------------~~~~ip~~ip~ELkdLI~rcL~kDPekR 997 (1044)
+|++|++||.+.+..+.+..+.... ....++..+++++.+||.+||..||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999988776655442110 0112456789999999999999999999
Q ss_pred CCHHHHHHH
Q 045028 998 PTFTEIMAA 1006 (1044)
Q Consensus 998 PTa~ELLe~ 1006 (1044)
||+.|+++|
T Consensus 314 ~t~~e~l~h 322 (383)
T 3eb0_A 314 INPYEAMAH 322 (383)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=361.94 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=208.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc----
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL---- 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l---- 825 (1044)
.++|.+.+.||+|+||+||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36899999999999999999987 588999999977655555667889999999999999999999999877655
Q ss_pred --eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 826 --SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 826 --~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 589888853 4999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-----------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----------- 971 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~----------- 971 (1044)
... .....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..+......
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 195 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 432 345678999999999987 67899999999999999999999999988776655544211100
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 ------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..++..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 11234678999999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.89 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=206.7
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-----CC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-----PN 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-----~~ 824 (1044)
.++|++.+.||+|+||+||++++. |+.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 478999999999999999999884 8899999986432 234456788999999999999999999987654 67
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 899999996 589999876 57999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCcc----------cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--
Q 045028 905 NTFL----------SSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR-- 971 (1044)
Q Consensus 905 ~~~~----------~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~-- 971 (1044)
.... ......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 2211 1223578999999998765 67899999999999999999999999988765544332110000
Q ss_pred ----------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 ----------------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 ----------------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
...+..+++++++||.+||..||.+|||+.++++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 011246899999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=369.05 Aligned_cols=248 Identities=15% Similarity=0.103 Sum_probs=189.7
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhC--CCCCeeEEE-------eeee
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRV--RHPNVVLFM-------GAVT 820 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~L--rHPNIVkl~-------~~~~ 820 (1044)
.+|++++.||+|+||+||+|++ +++.||||++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999987 578999999987654 334566788886555444 699988865 4443
Q ss_pred cC-----------------CCceEEEEecCCCcHHHHhcCCCCCCcHHHH------HHHHHHHHHHHHHHHhCCCcEEEe
Q 045028 821 RP-----------------PNLSIVAEFLPRGSLYRLLHRPNNQLDERRR------LRMALDAARGMNYLHNCTPVIVHR 877 (1044)
Q Consensus 821 ~~-----------------~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~i------l~Ia~QIa~AL~yLHs~G~~IVHR 877 (1044)
.. ..+||||||+. ++|.+++...+..+....+ +.++.||+.||.|||++| |+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence 32 23799999998 8999999864444555555 677899999999999999 9999
Q ss_pred cCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 045028 878 DLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWGG 955 (1044)
Q Consensus 878 DIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~~ 955 (1044)
||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998654322 13457799999999987 6799999999999999999999999987
Q ss_pred CChHHHH--hh---hccccc--cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 956 MNPMQVV--GA---VGFQHR--RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 956 ~~~~eil--~~---I~~~~~--~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....... .. ...... ....+..+++++++||.+||+.||++|||+.++++|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6443211 11 111111 223335889999999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=362.19 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=215.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc--ch----hhHHHHHHHHHHHHhC-CCCCeeEEEeeeecC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF--FG----ESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRP 822 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~--~~----~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~ 822 (1044)
.++|++.+.||+|+||+||+|.+ +|+.||||++..... .. ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 35799999999999999999987 488999999865431 11 2245688999999999 799999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
...++||||+.|++|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||++..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 999999999999999999975 457999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcccccCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCC--
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRN------EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI-- 974 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~i-- 974 (1044)
..... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||...+.......+.........
T Consensus 250 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 250 LEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred cCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 54332 2345689999999999863 35788999999999999999999999988877777666433322222
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+..++.++.+||.+||..||.+|||+.++++|-
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 257889999999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=349.81 Aligned_cols=250 Identities=31% Similarity=0.494 Sum_probs=216.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||.||++++ +++.||||++............+.+|+.++++++||||+++++++...+.+++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 46899999999999999999988 5889999998766554556678999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC---CeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN---WVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d---g~VKLiDFGLA~~~~~~ 906 (1044)
||+.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999998865 356899999999999999999999999 9999999999999754 47999999998765432
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC--CCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip--~~ip~ELkd 984 (1044)
. ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+++++.+
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 178 T-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp S-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred C-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 2 22334588999999999875 8899999999999999999999999988887777664433333332 578999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+|.+||..||.+|||+.+++++
T Consensus 256 li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHcccChhhCcCHHHHhcC
Confidence 9999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=368.95 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=193.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------C
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------P 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~ 823 (1044)
.++|++++.||+|+||.||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 37899999999999999999986 688999999876544455667888999999999999999999998654 5
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 7899999875 57999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-----------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR----------- 971 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~----------- 971 (1044)
... .....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..+......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 334679999999999987 67899999999999999999999999998876655443211000
Q ss_pred ----------C--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 972 ----------L--------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 972 ----------~--------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
. .....+++++.+||.+||..||.+|||+.++|+|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0 01235789999999999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.04 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=213.2
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC--CCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR--HPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr--HPNIVkl~~~~~~~~~ 824 (1044)
..+..++|++++.||+|+||.||++.+ +++.||||++..........+.+.+|+.++++++ ||||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 445567899999999999999999987 5788999999776655667788999999999997 5999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+++||| +.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||+|||++....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 568899999986 457899999999999999999999999 999999999999964 899999999997654
Q ss_pred CCc--ccccCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccc
Q 045028 905 NTF--LSSRSTAGTAEWMAPEVLRN-----------EPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHR 970 (1044)
Q Consensus 905 ~~~--~~~~s~~GTp~Y~APEvL~g-----------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~ 970 (1044)
... .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.... .......+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 322 12234579999999999976 468889999999999999999999998753 3333444444445
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 971 RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 971 ~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
...++..++.++.+||.+||..||.+||++.+++++..
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 56778888999999999999999999999999998753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=369.38 Aligned_cols=245 Identities=26% Similarity=0.339 Sum_probs=200.9
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------CC
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------PN 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~~ 824 (1044)
.+|++++.||+|+||+||+|++ +|+.||||++..... ...+|+.+|+.++||||++++++|... .+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4799999999999999999998 588999998865421 234699999999999999999988532 23
Q ss_pred ceEEEEecCCCcHHHHhc---CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEecccc
Q 045028 825 LSIVAEFLPRGSLYRLLH---RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLS 900 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLk---r~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA 900 (1044)
+++||||+.+ +|.+++. +....+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7799999976 5666554 24577999999999999999999999999 9999999999999955 67899999999
Q ss_pred ccccCCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-----------
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ----------- 968 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~----------- 968 (1044)
+...... ......||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+..+.+..+...
T Consensus 205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654322 23456799999999999775 6899999999999999999999999988766554443211
Q ss_pred ----cccCC------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 969 ----HRRLD------------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 969 ----~~~~~------------ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
...+. ++..+++++++||.+||.+||.+|||+.|+++|-
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 01111 3356789999999999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.54 Aligned_cols=243 Identities=20% Similarity=0.334 Sum_probs=202.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeec--CCCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTR--PPNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~--~~~l~ 826 (1044)
.++|+++++||+|+||+||++.+ +++.||||++.... .+.+.+|+.++++++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 46899999999999999999976 68899999986432 466889999999997 9999999999987 56789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~~~~ 905 (1044)
+||||+.+++|.+++.. +++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++....
T Consensus 110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999999853 889999999999999999999999 99999999999999776 999999999976543
Q ss_pred CcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhcc-------------cc-
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGF-------------QH- 969 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~-~~~eil~~I~~-------------~~- 969 (1044)
.. ......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||... ...+.+..+.. ..
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2345679999999999987 66899999999999999999999999543 22222111100 00
Q ss_pred ---------------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 ---------------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 ---------------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.....+..+++++++||.+||+.||.+|||+.|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011123379999999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=362.55 Aligned_cols=255 Identities=16% Similarity=0.177 Sum_probs=210.1
Q ss_pred CCCCeeEEeEecccCcEEEEEEEEC----------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeE------
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDWH----------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVL------ 814 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~~----------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVk------ 814 (1044)
..++|++.+.||+|+||.||+|++. ++.||||++... ..+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3578999999999999999999873 678999998654 34788999999999999887
Q ss_pred ---------EEeeeec-CCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCc
Q 045028 815 ---------FMGAVTR-PPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPN 883 (1044)
Q Consensus 815 ---------l~~~~~~-~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeN 883 (1044)
+++++.. ...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 5666655 67799999999 99999999864 367999999999999999999999999 9999999999
Q ss_pred EEEcCCC--eEEEEeccccccccCCcc-------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 045028 884 LLVDKNW--VVKVCDFGLSRMKHNTFL-------SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWG 954 (1044)
Q Consensus 884 ILLd~dg--~VKLiDFGLA~~~~~~~~-------~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~ 954 (1044)
||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999975432211 1234579999999999999999999999999999999999999998
Q ss_pred CCC--hHHHHhhhcc-ccccCCCC------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCC
Q 045028 955 GMN--PMQVVGAVGF-QHRRLDIP------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPIT 1015 (1044)
Q Consensus 955 ~~~--~~eil~~I~~-~~~~~~ip------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~ 1015 (1044)
... ...+...... ......++ ..+++++.+||.+||..||.+|||+.+|++.|+.+.+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 753 3222222210 11111111 3578999999999999999999999999999999887654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=364.28 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=204.1
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC-----
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN----- 824 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~----- 824 (1044)
...+|++++.||+|+||+||++++ .+..+|+|++..... ...+|+.+++.++||||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 345799999999999999999998 455699998765432 12369999999999999999999865433
Q ss_pred -ceEEEEecCCCcHHHHhc--CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-CCCeEEEEecccc
Q 045028 825 -LSIVAEFLPRGSLYRLLH--RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLS 900 (1044)
Q Consensus 825 -l~LVmEy~~GGsL~dlLk--r~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-~dg~VKLiDFGLA 900 (1044)
+++||||+.++.+..+.. .....+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 889999998754443332 23567999999999999999999999999 99999999999999 7999999999999
Q ss_pred ccccCCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc----------
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH---------- 969 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~---------- 969 (1044)
+...... ......||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+..+.+..+....
T Consensus 190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654332 23456789999999999775 48999999999999999999999999987765554432110
Q ss_pred -----cc------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccC
Q 045028 970 -----RR------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQK 1012 (1044)
Q Consensus 970 -----~~------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k 1012 (1044)
.. ..++..+++++.+||.+||++||.+|||+.|+++| ++.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 11334588999999999999999999999999987 444444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=370.10 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=212.8
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC--Cc
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP--NL 825 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~--~l 825 (1044)
+..++|++.++||+|+||+||+|++. ++.||||++..... ....+.+.+|+.++++++||||+++++++...+ ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34568999999999999999999884 88999999875432 234567889999999999999999999988765 68
Q ss_pred eEEEEecCCCcHHHHhcCCC--CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE----cCCCeEEEEeccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVKVCDFGL 899 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~--~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL----d~dg~VKLiDFGL 899 (1044)
++||||+.|++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999998632 33999999999999999999999999 9999999999999 7888999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhcc
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRN--------EPSDEKCDVYSFGVILWELCTMQQPWGGMN----PMQVVGAVGF 967 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g--------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~----~~eil~~I~~ 967 (1044)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98654432 2345679999999999875 456789999999999999999999997532 2233333321
Q ss_pred ccc-----------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 968 QHR-----------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 968 ~~~-----------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
... ...++..++..+.++|.+||..||++||++.++++.++.+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 110 0112233556789999999999999999999999999887764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.56 Aligned_cols=255 Identities=15% Similarity=0.173 Sum_probs=211.8
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEE-------ECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC---CCCeeEE
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGD-------WHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR---HPNVVLF 815 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak-------~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr---HPNIVkl 815 (1044)
...++..++|++.++||+|+||+||+|. ..++.||||++.... ...+..|+.+++.++ |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3455667899999999999999999993 367889999986542 346778888888887 9999999
Q ss_pred EeeeecCCCceEEEEecCCCcHHHHhcC----CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---
Q 045028 816 MGAVTRPPNLSIVAEFLPRGSLYRLLHR----PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK--- 888 (1044)
Q Consensus 816 ~~~~~~~~~l~LVmEy~~GGsL~dlLkr----~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~--- 888 (1044)
++++...+..+|||||++||+|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999974 3567999999999999999999999999 999999999999998
Q ss_pred --------CCeEEEEecccccccc--CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 045028 889 --------NWVVKVCDFGLSRMKH--NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP 958 (1044)
Q Consensus 889 --------dg~VKLiDFGLA~~~~--~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~ 958 (1044)
++.+||+|||+++... .........+||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997533 222234556799999999999999999999999999999999999999965433
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCC-CCHHHHHHHhccccCC
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMR-PTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekR-PTa~ELLe~Lk~L~k~ 1013 (1044)
.... + . . .......++.+.+++..||..+|.+| |++.++.+.|+.+...
T Consensus 291 ~~~~--~--~-~-~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 291 GECK--P--E-G-LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TEEE--E--C-S-CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Ccee--e--c-h-hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 2111 1 0 0 00111346789999999999999999 6788888888887653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.96 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=197.4
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
....+..++|++++.||+|+||.||++++ +|+.||||++............+..+..+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 34556778999999999999999999988 5889999999766544444455566666788889999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.+++||||+ ++.+..++......+++..++.++.||+.||.|||+. | |+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 6677777665457799999999999999999999995 9 99999999999999999999999999975
Q ss_pred ccCCcccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhcccc-ccCCCC
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQH-RRLDIP 975 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~-~~~eil~~I~~~~-~~~~ip 975 (1044)
..... ......||+.|+|||++. +..++.++|||||||+||+|++|+.||... ...+....+.... ......
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 44322 223457999999999994 456888999999999999999999999874 3444444442221 112223
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+++++.+||.+||..||.+|||+.++++|
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4689999999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=371.54 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=199.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch------hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG------ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~------~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
.++|.+.+.||+|+||+||+|.+ +++.||||++....... .....+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 47899999999999999999987 57899999987643221 122347899999999999999999999865 4
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC---eEEEEecccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW---VVKVCDFGLS 900 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg---~VKLiDFGLA 900 (1044)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 58999999999999999876 467999999999999999999999999 99999999999997544 5999999999
Q ss_pred ccccCCcccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhccccc--cCCC
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLRN---EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ-VVGAVGFQHR--RLDI 974 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~g---~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e-il~~I~~~~~--~~~i 974 (1044)
+...... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|++||....... ....+..... ....
T Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 8755432 2345679999999999864 567889999999999999999999998754332 2222221111 1112
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+..+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 356899999999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.51 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=202.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee---------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT--------- 820 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~--------- 820 (1044)
.++|++++.||+|+||.||++.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 468999999999999999999884 7899999887543 455678899999999999999999999874
Q ss_pred -----cCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-CCCeEEE
Q 045028 821 -----RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKV 894 (1044)
Q Consensus 821 -----~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-~dg~VKL 894 (1044)
....+++||||+. ++|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEE
Confidence 3356899999997 599999975 56899999999999999999999999 99999999999997 5679999
Q ss_pred EeccccccccCCc---ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc
Q 045028 895 CDFGLSRMKHNTF---LSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR 970 (1044)
Q Consensus 895 iDFGLA~~~~~~~---~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~ 970 (1044)
+|||+++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998654221 12233457999999999876 6789999999999999999999999998887665544421110
Q ss_pred ----------------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 971 ----------------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 971 ----------------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
....+..+++++++||.+||+.||.+|||+.++++|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 0112356899999999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.90 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=202.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc------hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF------GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~------~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
.++|++.+.||+|+||.||++.+ +++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35799999999999999999987 5788999998654321 122345889999999999999999999987654
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe---EEEEecccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV---VKVCDFGLS 900 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~---VKLiDFGLA 900 (1044)
+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 8999999999999999876 567999999999999999999999999 999999999999987654 999999999
Q ss_pred ccccCCcccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhccccc--cCCC
Q 045028 901 RMKHNTFLSSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHR--RLDI 974 (1044)
Q Consensus 901 ~~~~~~~~~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~--~~~i 974 (1044)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .+...+..... ....
T Consensus 165 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 165 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp EECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred eeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 7654332 123356899999999974 566889999999999999999999999865433 22222211111 1122
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 975 PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 975 p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+..++.++.+||.+||..||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 35689999999999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.72 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=207.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC-----
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN----- 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~----- 824 (1044)
.++|.+.+.||+|+||+||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36899999999999999999987 58899999987655445556788999999999999999999999987654
Q ss_pred -ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 -LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 -l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
+++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 588888753 5999999999999999999999999 999999999999999999999999999764
Q ss_pred cCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc--------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-------------- 968 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-------------- 968 (1044)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 177 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 177 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 432 234578999999999987 67899999999999999999999999988766554433210
Q ss_pred ---------------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 969 ---------------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 969 ---------------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
......+..+++++++||.+||..||.+|||+.++++|-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 001123457899999999999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.57 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=204.3
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcc---------hhhHHHHHHHHHHHHhCCCCCeeEEEee
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFF---------GESLEEFRSEVLIMKRVRHPNVVLFMGA 818 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~---------~~~~~~~~~EI~ILk~LrHPNIVkl~~~ 818 (1044)
....++|++++.||+|+||.||++.+ .++.||||++...... ....+.+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 34567899999999999999999976 6788999998653321 1234678999999999999999999999
Q ss_pred eec-----CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEE
Q 045028 819 VTR-----PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVK 893 (1044)
Q Consensus 819 ~~~-----~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VK 893 (1044)
+.. ...+++||||+. ++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEE
Confidence 844 235899999997 5888888876778999999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc--
Q 045028 894 VCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-- 970 (1044)
Q Consensus 894 LiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-- 970 (1044)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 175 l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999997543322 2344678999999999987 6689999999999999999999999998876665554421110
Q ss_pred ----------------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 ----------------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ----------------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 011234678999999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.89 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=200.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec---------
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--------- 821 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--------- 821 (1044)
++|++++.||+|+||+||++++ +++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4799999999999999999987 6889999998643 3456778999999999999999999998754
Q ss_pred ----CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 822 ----PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 822 ----~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
...+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeC
Confidence 34589999999999999999876677889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCC--------------cccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHH
Q 045028 898 GLSRMKHNT--------------FLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGM-NPMQV 961 (1044)
Q Consensus 898 GLA~~~~~~--------------~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~-~~~ei 961 (1044)
|++...... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||... +..+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999754321 1122345699999999999875 68999999999999999998 55432 23333
Q ss_pred Hhhhcccc--ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 962 VGAVGFQH--RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 962 l~~I~~~~--~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
...+.... ....++..+++.++++|.+||..||.+|||+.++++|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 33332211 12334566788899999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=366.84 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=208.7
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC------CCCCeeEEEeeeec
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV------RHPNVVLFMGAVTR 821 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L------rHPNIVkl~~~~~~ 821 (1044)
....+|+++++||+|+||+||+|.+ +++.||||++.... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3456899999999999999999987 47889999986532 3345677888888877 57799999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe--EEEEecc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV--VKVCDFG 898 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~--VKLiDFG 898 (1044)
.+.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999999995 58998887643 45999999999999999999999999 999999999999999887 9999999
Q ss_pred ccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-------
Q 045028 899 LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------- 971 (1044)
Q Consensus 899 LA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------- 971 (1044)
+++..... ....+||+.|+|||++.+..++.++|||||||+||||++|++||.+.+..+.+..+......
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 99765432 34568999999999999999999999999999999999999999988876655433211000
Q ss_pred --------------------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q 045028 972 --------------------------------------------------LDIPDNLDPAVADIIRKCWQTDPKMRPTFT 1001 (1044)
Q Consensus 972 --------------------------------------------------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ 1001 (1044)
..++...++++.+||.+||++||.+|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 001223478899999999999999999999
Q ss_pred HHHHHh
Q 045028 1002 EIMAAL 1007 (1044)
Q Consensus 1002 ELLe~L 1007 (1044)
|+|+|-
T Consensus 405 e~L~Hp 410 (429)
T 3kvw_A 405 QALRHP 410 (429)
T ss_dssp HHHTST
T ss_pred HHhCCh
Confidence 999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=351.59 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=205.0
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEEC--C-cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC------eeEEEee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWH--G-TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN------VVLFMGA 818 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~--g-~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN------IVkl~~~ 818 (1044)
.++..++|++++.||+|+||+||++.+. + +.||||++... ....+.+.+|+.+++.++|++ ++.++++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 3445689999999999999999999873 3 68999998643 244567888999999987655 8999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE-----------
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV----------- 886 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL----------- 886 (1044)
+...+.+++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||||
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccc
Confidence 99999999999999 5566666554 3457999999999999999999999999 9999999999999
Q ss_pred --------cCCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 045028 887 --------DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP 958 (1044)
Q Consensus 887 --------d~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~ 958 (1044)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|..||...+.
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999764432 3456799999999999999999999999999999999999999998776
Q ss_pred HHHHhhhcccccc------------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCC
Q 045028 959 MQVVGAVGFQHRR------------------------------------------LDIPDNLDPAVADIIRKCWQTDPKM 996 (1044)
Q Consensus 959 ~eil~~I~~~~~~------------------------------------------~~ip~~ip~ELkdLI~rcL~kDPek 996 (1044)
.+....+...... .......+.++.+||.+||..||.+
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 6544332111000 0011123468999999999999999
Q ss_pred CCCHHHHHHH
Q 045028 997 RPTFTEIMAA 1006 (1044)
Q Consensus 997 RPTa~ELLe~ 1006 (1044)
|||+.|+++|
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.85 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=189.1
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHH-HHHhCCCCCeeEEEeeeec
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVL-IMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~-ILk~LrHPNIVkl~~~~~~ 821 (1044)
...+.+..++|++++.||+|+||.||++.+. ++.||||++..... ......+..|+. +++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3456778899999999999999999999884 88999999876543 233344555655 6777899999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcC----CCCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEcCCCeEEEEe
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHR----PNNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVDKNWVVKVCD 896 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr----~~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd~dg~VKLiD 896 (1044)
.+..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. | |+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEcc
Confidence 9999999999976 77777652 356789999999999999999999998 9 99999999999999999999999
Q ss_pred ccccccccCCcccccCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhcccccc
Q 045028 897 FGLSRMKHNTFLSSRSTAGTAEWMAPEVL----RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRR 971 (1044)
Q Consensus 897 FGLA~~~~~~~~~~~s~~GTp~Y~APEvL----~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~~~~~ 971 (1044)
||+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... +....+. ....
T Consensus 170 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~ 247 (327)
T 3aln_A 170 FGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDP 247 (327)
T ss_dssp CSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCC
T ss_pred CCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCC
Confidence 99997654332 22334799999999999 4666899999999999999999999999875432 2222221 1122
Q ss_pred CCC----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 LDI----PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 ~~i----p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+ ...+++++.+||.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 222 24689999999999999999999999999886
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.17 Aligned_cols=256 Identities=20% Similarity=0.263 Sum_probs=196.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC---
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN--- 824 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~--- 824 (1044)
...++|++.+.||+|+||+||++++ +++.||||++..... ......+++..+..++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 4467899999999999999999987 488999998865432 22345677888888999999999999865433
Q ss_pred ----ceEEEEecCCCcHHHHhc---CCCCCCcHHHHHHHHHHHHHHHHHHH--hCCCcEEEecCCCCcEEEcC-CCeEEE
Q 045028 825 ----LSIVAEFLPRGSLYRLLH---RPNNQLDERRRLRMALDAARGMNYLH--NCTPVIVHRDLKSPNLLVDK-NWVVKV 894 (1044)
Q Consensus 825 ----l~LVmEy~~GGsL~dlLk---r~~~~Lse~~il~Ia~QIa~AL~yLH--s~G~~IVHRDIKPeNILLd~-dg~VKL 894 (1044)
+++||||+.++ |.+.+. .....+++..++.++.||+.||.||| ++| |+||||||+||||+. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 88999999875 443332 24577899999999999999999999 888 999999999999996 899999
Q ss_pred EeccccccccCCcccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc---
Q 045028 895 CDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR--- 970 (1044)
Q Consensus 895 iDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~--- 970 (1044)
+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 174 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 174 CDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999998654332 234567899999999997655 89999999999999999999999999887766554421100
Q ss_pred ---------------------------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccC
Q 045028 971 ---------------------------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQK 1012 (1044)
Q Consensus 971 ---------------------------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k 1012 (1044)
....+..+++++++||.+||+.||.+|||+.|+++| ++.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 011223367899999999999999999999999987 444443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=383.31 Aligned_cols=262 Identities=32% Similarity=0.555 Sum_probs=224.3
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT 820 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~ 820 (1044)
...++..++|++++.||+|+||+||+|.+. +..||||.+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 445677789999999999999999999873 3469999876432 3345577999999999999999999999985
Q ss_pred cCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 821 RPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 821 ~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
++.+++||||+.+|+|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCC
Confidence 46799999999999999999876667999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 901 RMKHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 901 ~~~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
+...... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+....+....+. ......++..+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccc
Confidence 8654332 22233457889999999999999999999999999999997 999999988888777764 33456678899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
++++.+||.+||..||.+|||+.+|++.|+.+.+
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999988753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=352.76 Aligned_cols=249 Identities=18% Similarity=0.284 Sum_probs=202.0
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-----------CCCeeEEE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-----------HPNVVLFM 816 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-----------HPNIVkl~ 816 (1044)
+..++|++++.||+|+||+||+|++ +++.||||++.... .....+.+|+.++++++ ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 4567899999999999999999986 68899999986432 34466888999998886 89999999
Q ss_pred eeeecCC----CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhC-CCcEEEecCCCCcEEEc---
Q 045028 817 GAVTRPP----NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNC-TPVIVHRDLKSPNLLVD--- 887 (1044)
Q Consensus 817 ~~~~~~~----~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~-G~~IVHRDIKPeNILLd--- 887 (1044)
+++...+ .+++||||+ +++|.+++.+. ...+++..++.++.||+.||.|||++ | |+||||||+||||+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9987654 689999999 88999998763 45699999999999999999999998 9 99999999999994
Q ss_pred ---CCCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----
Q 045028 888 ---KNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM----- 959 (1044)
Q Consensus 888 ---~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~----- 959 (1044)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||+|++|+.||...+..
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999765432 23457999999999999999999999999999999999999999865421
Q ss_pred -HHHhhhcc----------------------------------------ccccCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 045028 960 -QVVGAVGF----------------------------------------QHRRLDIPDNLDPAVADIIRKCWQTDPKMRP 998 (1044)
Q Consensus 960 -eil~~I~~----------------------------------------~~~~~~ip~~ip~ELkdLI~rcL~kDPekRP 998 (1044)
+.+..+.. ......++..+++++.+||.+||..||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111100 0011234445678899999999999999999
Q ss_pred CHHHHHHHh
Q 045028 999 TFTEIMAAL 1007 (1044)
Q Consensus 999 Ta~ELLe~L 1007 (1044)
|+.|+++|-
T Consensus 327 t~~ell~hp 335 (373)
T 1q8y_A 327 DAGGLVNHP 335 (373)
T ss_dssp CHHHHHTCG
T ss_pred CHHHHhhCh
Confidence 999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=347.53 Aligned_cols=246 Identities=24% Similarity=0.439 Sum_probs=200.8
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhC----CCCCeeEEEee
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRV----RHPNVVLFMGA 818 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~L----rHPNIVkl~~~ 818 (1044)
+...++|++++.||+|+||.||++++ +++.||||++....... .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999987 67889999986554322 1223456799999988 89999999999
Q ss_pred eecCCCceEEEEe-cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-CCCeEEEEe
Q 045028 819 VTRPPNLSIVAEF-LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCD 896 (1044)
Q Consensus 819 ~~~~~~l~LVmEy-~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-~dg~VKLiD 896 (1044)
+...+..++|||| +.+++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 789999999976 456999999999999999999999999 99999999999999 889999999
Q ss_pred ccccccccCCcccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCC
Q 045028 897 FGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975 (1044)
Q Consensus 897 FGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip 975 (1044)
||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... +.. .....++
T Consensus 184 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~------~~~~~~~ 253 (312)
T 2iwi_A 184 FGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EIL------EAELHFP 253 (312)
T ss_dssp CSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HTCCCCC
T ss_pred cchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HHh------hhccCCc
Confidence 99998655432 345679999999999987766 458999999999999999999997532 111 2345577
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 976 ~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
..++.++++||.+||..||++|||+.++++|-
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 88999999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=371.42 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=212.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC-CCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-PNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH-PNIVkl~~~~~~~~~l~LV 828 (1044)
.++|+++++||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++| ++|..+..++...+..+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 47899999999999999999987 5889999987654322 247789999999986 5666666677777889999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE---cCCCeEEEEeccccccccC
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL---d~dg~VKLiDFGLA~~~~~ 905 (1044)
|||+ +++|.+++......+++..++.++.||+.||.|||++| ||||||||+|||| +.++.+||+|||+++....
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 99999999876778999999999999999999999999 9999999999999 6889999999999986543
Q ss_pred Cc-------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhccc---cccC
Q 045028 906 TF-------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNP---MQVVGAVGFQ---HRRL 972 (1044)
Q Consensus 906 ~~-------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~---~eil~~I~~~---~~~~ 972 (1044)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+..+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 32 122366799999999999999999999999999999999999999987543 2333322111 1112
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.++..++.++.+||.+||..+|++||++.+|++.|+.+..
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2346789999999999999999999999999999988754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=352.04 Aligned_cols=247 Identities=23% Similarity=0.408 Sum_probs=209.1
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhCC--CCCeeEEEeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRVR--HPNVVLFMGAV 819 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~Lr--HPNIVkl~~~~ 819 (1044)
.+...++|++++.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999987 68899999987654322 12244677999999996 59999999999
Q ss_pred ecCCCceEEEEecCC-CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-CCCeEEEEec
Q 045028 820 TRPPNLSIVAEFLPR-GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDF 897 (1044)
Q Consensus 820 ~~~~~l~LVmEy~~G-GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-~dg~VKLiDF 897 (1044)
...+.+++|||++.+ ++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999976 899999876 467899999999999999999999999 99999999999999 7899999999
Q ss_pred cccccccCCcccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCC
Q 045028 898 GLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPD 976 (1044)
Q Consensus 898 GLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~ 976 (1044)
|++...... ......||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.... +.. .....++.
T Consensus 195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~------~~~~~~~~ 264 (320)
T 3a99_A 195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFFRQ 264 (320)
T ss_dssp TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCCSS
T ss_pred ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hhh------cccccccc
Confidence 999865543 2334679999999999987765 688999999999999999999997532 111 22345667
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
.+++++.+||.+||..||.+|||+.+++++-
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 8999999999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=358.20 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=185.9
Q ss_pred CCeeE-EeEecccCcEEEEEEEEC----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeee--cCCCc
Q 045028 753 EEITL-GERIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVT--RPPNL 825 (1044)
Q Consensus 753 e~y~I-~r~LGkG~FGtVykak~~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~--~~~~l 825 (1044)
+.|++ +++||+|+||+||+|++. ++.||||++...... ..+.+|+.+|+.++||||+++++++. ....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 35776 568999999999999863 678999998755432 35788999999999999999999995 46679
Q ss_pred eEEEEecCCCcHHHHhcC--------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEE----cCCCeEE
Q 045028 826 SIVAEFLPRGSLYRLLHR--------PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLV----DKNWVVK 893 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr--------~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILL----d~dg~VK 893 (1044)
++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+|
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 999999964 78887752 1235999999999999999999999999 9999999999999 6778999
Q ss_pred EEeccccccccCCc---ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------H
Q 045028 894 VCDFGLSRMKHNTF---LSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPM---------Q 960 (1044)
Q Consensus 894 LiDFGLA~~~~~~~---~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---------e 960 (1044)
|+|||+++...... ......+||+.|+|||++.+. .++.++|||||||+||+|++|++||.+.... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998654321 223456799999999999885 4899999999999999999999999765432 1
Q ss_pred HHhhhcccccc--------------------------C----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 045028 961 VVGAVGFQHRR--------------------------L----------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004 (1044)
Q Consensus 961 il~~I~~~~~~--------------------------~----------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELL 1004 (1044)
.+..+...... . ......++++.+||.+||..||.+|||+.|+|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111000000 0 01112367899999999999999999999999
Q ss_pred HHhcc
Q 045028 1005 AALKP 1009 (1044)
Q Consensus 1005 e~Lk~ 1009 (1044)
+|-.-
T Consensus 333 ~hp~f 337 (405)
T 3rgf_A 333 QDPYF 337 (405)
T ss_dssp TSGGG
T ss_pred cChhh
Confidence 98553
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=354.16 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=205.8
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CC-----CeeEEEeee
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HP-----NVVLFMGAV 819 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HP-----NIVkl~~~~ 819 (1044)
.+...++|++++.||+|+||+||+|.+ +++.||||++... ......+..|+.+++.++ |+ +|+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 344568999999999999999999987 5788999998643 234566788899988885 55 499999999
Q ss_pred ecCCCceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHh--CCCcEEEecCCCCcEEEc--CCCeEEE
Q 045028 820 TRPPNLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHN--CTPVIVHRDLKSPNLLVD--KNWVVKV 894 (1044)
Q Consensus 820 ~~~~~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs--~G~~IVHRDIKPeNILLd--~dg~VKL 894 (1044)
...+.+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||. .| |+||||||+||||+ .++.+||
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEE
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEE
Confidence 999999999999964 9999987643 569999999999999999999994 67 99999999999995 4788999
Q ss_pred EeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--
Q 045028 895 CDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL-- 972 (1044)
Q Consensus 895 iDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~-- 972 (1044)
+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+.......
T Consensus 203 ~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 203 VDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp CCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999999866432 345679999999999999999999999999999999999999999888776655442110000
Q ss_pred --------------CCC------------------CC----------------------------CCHHHHHHHHHhhhc
Q 045028 973 --------------DIP------------------DN----------------------------LDPAVADIIRKCWQT 992 (1044)
Q Consensus 973 --------------~ip------------------~~----------------------------ip~ELkdLI~rcL~k 992 (1044)
.++ .. ..+++++||.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 000 00 014789999999999
Q ss_pred CCCCCCCHHHHHHHh
Q 045028 993 DPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 993 DPekRPTa~ELLe~L 1007 (1044)
||.+|||+.|+|+|-
T Consensus 360 dP~~Rpta~e~L~hp 374 (382)
T 2vx3_A 360 DPKTRIQPYYALQHS 374 (382)
T ss_dssp CTTTSCCHHHHTTSG
T ss_pred ChhhCCCHHHHhcCc
Confidence 999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=348.22 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=178.2
Q ss_pred CCCCeeEEe-EecccCcEEEEEEEEC--CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec----CC
Q 045028 751 PWEEITLGE-RIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PP 823 (1044)
Q Consensus 751 ~~e~y~I~r-~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~----~~ 823 (1044)
..++|++.+ .||+|+||+||++.+. ++.||||++.... .........++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 356899965 6999999999999884 8899999986532 122223334567789999999999876 34
Q ss_pred CceEEEEecCCCcHHHHhcCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEeccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPN-NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGL 899 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~-~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGL 899 (1044)
.+++||||+.||+|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 5899999999999999998743 47999999999999999999999999 999999999999976 45699999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh----hhccccc--cCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVG----AVGFQHR--RLD 973 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~----~I~~~~~--~~~ 973 (1044)
++..... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.......... .+..... ...
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9765432 2335678999999999998889999999999999999999999998765543321 1111111 112
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
....+++++++||.+||..||.+|||+.++++|-.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 23578999999999999999999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.14 Aligned_cols=243 Identities=16% Similarity=0.137 Sum_probs=194.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+..++|++.+.||+|+||.||+|++. ++.||||++...... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45578999999999999999999984 889999998765433 345678999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
+||||++|++|.+++++. .....+..++.||+.||.|||++| |+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999999652 355678889999999999999999 9999999999999999999998543
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-cccccc----CCCCCCCCHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV-GFQHRR----LDIPDNLDPA 981 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I-~~~~~~----~~ip~~ip~E 981 (1044)
|++ .++.++|||||||+||+|++|+.||.+.+..+.+... ...... ..++..++++
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 333 3789999999999999999999999987654322111 001111 1234678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCCCCCCCCCC
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPS 1025 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~~~p~~~ps 1025 (1044)
+++||.+||++||.+| |+.|+++.|+.+..........++.++
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~p~~~ 278 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLGPIDE 278 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-------------
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCCCCCC
Confidence 9999999999999999 999999999998876554444444443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=359.19 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=197.4
Q ss_pred cCcCCCCeeEEeEecccCcEE-EEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCc
Q 045028 748 CEIPWEEITLGERIGLGSYGE-VYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGt-Vykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l 825 (1044)
..+...+|++.+.||+|+||+ ||++..+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+...+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 344556799999999999998 556677899999999865432 2256799999999 799999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-----CCeEEEEecccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-----NWVVKVCDFGLS 900 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-----dg~VKLiDFGLA 900 (1044)
||||||+. |+|.+++......+.+..++.++.||+.||.|||++| |+||||||+||||+. ...+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999996 5999999876666666677889999999999999999 999999999999953 236889999999
Q ss_pred ccccCCc---ccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccc-cC
Q 045028 901 RMKHNTF---LSSRSTAGTAEWMAPEVLR---NEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHR-RL 972 (1044)
Q Consensus 901 ~~~~~~~---~~~~s~~GTp~Y~APEvL~---g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~-~~ 972 (1044)
+...... ......+||+.|+|||++. +..++.++|||||||+||||++ |..||...........+..... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8654321 2234567999999999998 4567889999999999999999 9999976655444332211111 11
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+...+..+++||.+||+.||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1223456678999999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=347.38 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=188.6
Q ss_pred CCeeEEeEecccCcEEEEE-EEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYR-GDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVyk-ak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
+.|.+.+.||+|+||+||. +..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++...+.++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 4577789999999999964 4568999999988643 234578899999876 89999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCC------CcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-------------Ce
Q 045028 831 FLPRGSLYRLLHRPNNQ------LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-------------WV 891 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~------Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-------------g~ 891 (1044)
|+. |+|.+++...... ..+..++.++.||+.||.|||++| |+||||||+||||+.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 5999999864321 123345789999999999999999 9999999999999754 48
Q ss_pred EEEEeccccccccCCcc----cccCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 045028 892 VKVCDFGLSRMKHNTFL----SSRSTAGTAEWMAPEVLRN-------EPSDEKCDVYSFGVILWELCT-MQQPWGGMNPM 959 (1044)
Q Consensus 892 VKLiDFGLA~~~~~~~~----~~~s~~GTp~Y~APEvL~g-------~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~ 959 (1044)
+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999986543321 1234579999999999976 568999999999999999999 99999765443
Q ss_pred HHHhhhccccccCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 045028 960 QVVGAVGFQHRRLD-----IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAAL 1007 (1044)
Q Consensus 960 eil~~I~~~~~~~~-----ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~L 1007 (1044)
+.. +........ .+..+++++++||.+||+.||.+|||+.++++|-
T Consensus 247 ~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 247 ESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp HHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 311 111111111 1123568899999999999999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.80 Aligned_cols=226 Identities=26% Similarity=0.421 Sum_probs=184.7
Q ss_pred CCCeeEE-eEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHH-HhCCCCCeeEEEeeeec----CC
Q 045028 752 WEEITLG-ERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIM-KRVRHPNVVLFMGAVTR----PP 823 (1044)
Q Consensus 752 ~e~y~I~-r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~IL-k~LrHPNIVkl~~~~~~----~~ 823 (1044)
.++|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4568877 7899999999999987 6789999998643 3467788888 55689999999999876 66
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEeccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGL 899 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGL 899 (1044)
.+++||||+.|++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 799999999999999999864 347999999999999999999999999 999999999999998 78999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc--ccccCCCC--
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF--QHRRLDIP-- 975 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~--~~~~~~ip-- 975 (1044)
+.... +..++.++|||||||+||+|++|+.||.............. ......++
T Consensus 167 a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 167 AKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp CEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred ccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 86432 23467899999999999999999999987665543322211 11222333
Q ss_pred --CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 976 --DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 976 --~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
..+++++++||.+||..||.+|||+.|+++|-.
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 578999999999999999999999999998743
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.29 Aligned_cols=242 Identities=14% Similarity=0.146 Sum_probs=189.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--CcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCC-CCee--------------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRH-PNVV-------------- 813 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrH-PNIV-------------- 813 (1044)
...|.+.+.||+|+||+||+|++. |+.||||++..... .....+.+++|+.+++.++| .|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 446899999999999999999974 89999998873322 22345779999999999977 2211
Q ss_pred -------EEEeeeec-----CCCceEEEEecCCCcHHHHhc------CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEE
Q 045028 814 -------LFMGAVTR-----PPNLSIVAEFLPRGSLYRLLH------RPNNQLDERRRLRMALDAARGMNYLHNCTPVIV 875 (1044)
Q Consensus 814 -------kl~~~~~~-----~~~l~LVmEy~~GGsL~dlLk------r~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IV 875 (1044)
.++.++.. ...++++|+++ +++|.++++ .....+++..++.++.||+.||.|||++| |+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 11111111 12356677765 789999984 33456888899999999999999999999 99
Q ss_pred EecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCCCCCCccCcccc----------cCCCCCchhHHHHHHHHHHH
Q 045028 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL----------RNEPSDEKCDVYSFGVILWE 945 (1044)
Q Consensus 876 HRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL----------~g~~~s~kSDIWSLG~LLyE 945 (1044)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+|||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998765433 345678 999999999 55568889999999999999
Q ss_pred HHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 946 LCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 946 LLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|++|+.||...+..+....+ +.....+++++++||.+||++||.+||++.+++++
T Consensus 310 lltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999887665544443 22234678999999999999999999998777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=344.52 Aligned_cols=242 Identities=18% Similarity=0.215 Sum_probs=192.1
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCc------chhhHHHHHHHHHHHHhCC---------CCCeeE
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDF------FGESLEEFRSEVLIMKRVR---------HPNVVL 814 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~------~~~~~~~~~~EI~ILk~Lr---------HPNIVk 814 (1044)
+..++|+++++||+|+||+||+|+++|+.||||++..... .....+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999976532 2234577889999998885 666666
Q ss_pred EEeee-----------------ec-------------CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHH
Q 045028 815 FMGAV-----------------TR-------------PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGM 864 (1044)
Q Consensus 815 l~~~~-----------------~~-------------~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL 864 (1044)
+++.+ .. .+.+||||||+.+|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 66553 32 6789999999999977777654 5689999999999999999
Q ss_pred HHHH-hCCCcEEEecCCCCcEEEcCCC--------------------eEEEEeccccccccCCcccccCCCCCCCccCcc
Q 045028 865 NYLH-NCTPVIVHRDLKSPNLLVDKNW--------------------VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPE 923 (1044)
Q Consensus 865 ~yLH-s~G~~IVHRDIKPeNILLd~dg--------------------~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APE 923 (1044)
.||| ++| |+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 999 99999999999999887 9999999999865432 347999999999
Q ss_pred cccCCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCh-HHHHhhhc----ccc-ccCCCCCCCCHHHHHHHHHhhhcCCCC
Q 045028 924 VLRNEPSDEKCDVYSFGVI-LWELCTMQQPWGGMNP-MQVVGAVG----FQH-RRLDIPDNLDPAVADIIRKCWQTDPKM 996 (1044)
Q Consensus 924 vL~g~~~s~kSDIWSLG~L-LyELLTGk~PF~~~~~-~eil~~I~----~~~-~~~~ip~~ip~ELkdLI~rcL~kDPek 996 (1044)
++.+.. +.++||||||++ .+++++|..||..... ......+. ... .....+..+++++++||.+||++|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 999877 899999998777 7789999999854211 11111211 010 011122357889999999999977
Q ss_pred CCCHHHHH-HH
Q 045028 997 RPTFTEIM-AA 1006 (1044)
Q Consensus 997 RPTa~ELL-e~ 1006 (1044)
|+.|+| +|
T Consensus 324 --sa~e~l~~H 332 (336)
T 2vuw_A 324 --SATDLLCQH 332 (336)
T ss_dssp --SHHHHHHHC
T ss_pred --CHHHHHhcC
Confidence 999999 66
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=365.59 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=198.6
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEE---CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDW---HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~---~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.++..++|+++++||+|+||+||++.+ +++.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 345568999999999999999999987 47889999886532 23455678899999999999999999999987666
Q ss_pred -----ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccc
Q 045028 825 -----LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGL 899 (1044)
Q Consensus 825 -----l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGL 899 (1044)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++| ||||||||+||||+.+ .+||+|||+
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999988754 7999999999999999999999999 9999999999999985 999999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
++..... ....||+.|+|||++.+.. +.++|||||||+||+|++|.+||.+.....+. .......++
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------~~~~~~~~~ 294 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------EDDPVLKTY 294 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------TTCHHHHHC
T ss_pred chhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc--------ccccccccC
Confidence 9865433 4567999999999998764 88999999999999999999988752211000 000001245
Q ss_pred HHHHHHHHHhhhcCCCCCCC-HHHHHHHhcccc
Q 045028 980 PAVADIIRKCWQTDPKMRPT-FTEIMAALKPLQ 1011 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPT-a~ELLe~Lk~L~ 1011 (1044)
+.+.+||.+||++||.+||+ ++++...|..+.
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 78999999999999999995 666666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=357.68 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=203.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec------CC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR------PP 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~------~~ 823 (1044)
.++|+++++||+|+||+||++.+ +|+.||||++... ......+.+.+|+.++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47899999999999999999986 5889999987654 334556779999999999999999999998765 66
Q ss_pred CceEEEEecCCCcHHHHhcCCC--CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCe---EEEEecc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPN--NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWV---VKVCDFG 898 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~--~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~---VKLiDFG 898 (1044)
..++||||+.|++|.+++.... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999998743 36899999999999999999999999 999999999999997664 9999999
Q ss_pred ccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh-hh-----------c
Q 045028 899 LSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVG-AV-----------G 966 (1044)
Q Consensus 899 LA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~-~I-----------~ 966 (1044)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+ .
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998654432 2345679999999999999999999999999999999999999997643322110 00 0
Q ss_pred cccc----------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH-----HHHHhccccC
Q 045028 967 FQHR----------RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTE-----IMAALKPLQK 1012 (1044)
Q Consensus 967 ~~~~----------~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~E-----LLe~Lk~L~k 1012 (1044)
.... ...++..+++++.+||.+||..||.+|||+.+ +++.++.+..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000 01122346789999999999999999999988 4455555544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=301.47 Aligned_cols=186 Identities=15% Similarity=0.096 Sum_probs=133.5
Q ss_pred eEecccCcEEEEEEE--ECCcEEEEEEeeccCcc--------hhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCCCceE
Q 045028 759 ERIGLGSYGEVYRGD--WHGTEVAVKRFLDQDFF--------GESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 759 r~LGkG~FGtVykak--~~g~~VAVK~l~~~~~~--------~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~~l~L 827 (1044)
..++.|++|.+..++ +.|+.|+||++.+.... ....+++.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346778888777554 37999999998754321 23456799999999999 59999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||++|++|.++|.+ ...+++. .|+.||+.||.|||++| ||||||||+||||+.+|++||+|||+++......
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999987 4556654 47899999999999999 9999999999999999999999999998765554
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCC
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ 951 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~ 951 (1044)
....+.+||+.|||||++.+. +..++|+|++|+++++|+++..
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 455667899999999999875 5667999999999887765533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=267.34 Aligned_cols=186 Identities=16% Similarity=0.183 Sum_probs=148.6
Q ss_pred eEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchh------hHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 756 TLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGE------SLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 756 ~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~------~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
...++||+|+||+||++++.++.+++|+......... ..+.+.+|+.++++++||||+++..++...+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3467899999999999999999999998765433221 2345899999999999999995555555677889999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL- 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~- 908 (1044)
||++|++|.+++.+ ++.++.||+.+|.|||++| |+||||||+|||++. ++||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999975 5689999999999999999 999999999999999 999999999987654321
Q ss_pred ------cccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 045028 909 ------SSRSTAGTAEWMAPEVLRN--EPSDEKCDVYSFGVILWELCTMQQPWG 954 (1044)
Q Consensus 909 ------~~~s~~GTp~Y~APEvL~g--~~~s~kSDIWSLG~LLyELLTGk~PF~ 954 (1044)
.....+||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1235679999999999987 567888999999999888888776664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-22 Score=215.16 Aligned_cols=145 Identities=19% Similarity=0.130 Sum_probs=116.0
Q ss_pred CeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcch----------------hhHHHHHHHHHHHHhCCCCCeeEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFG----------------ESLEEFRSEVLIMKRVRHPNVVLFM 816 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~----------------~~~~~~~~EI~ILk~LrHPNIVkl~ 816 (1044)
.|.+++.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.++++++| ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 466779999999999999998 57899999986432111 135678999999999984 4555
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEe
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCD 896 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiD 896 (1044)
+++.. +..++||||++|++|.+ +.. .....++.||+.||.|||++| |+||||||+||||+ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEE
Confidence 54433 56799999999999998 432 224469999999999999999 99999999999999 99999999
Q ss_pred ccccccccCCcccccCCCCCCCccCccccc
Q 045028 897 FGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926 (1044)
Q Consensus 897 FGLA~~~~~~~~~~~s~~GTp~Y~APEvL~ 926 (1044)
||+++. +..|+|||.+.
T Consensus 236 FG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE-------------TTSTTHHHHHH
T ss_pred CCCCeE-------------CCCCCHHHHHH
Confidence 999863 34568899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=184.59 Aligned_cols=138 Identities=20% Similarity=0.186 Sum_probs=108.2
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcE--EEEEEeeccCcc----------------------hhhHHHHHHHHHHHHhC
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTE--VAVKRFLDQDFF----------------------GESLEEFRSEVLIMKRV 807 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~--VAVK~l~~~~~~----------------------~~~~~~~~~EI~ILk~L 807 (1044)
-|++.+.||+|+||.||+|.+ +|+. ||||++...... ......+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999987 7888 999987543211 01123678899999999
Q ss_pred CCCCe--eEEEeeeecCCCceEEEEecCC-C----cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHH-hCCCcEEEecC
Q 045028 808 RHPNV--VLFMGAVTRPPNLSIVAEFLPR-G----SLYRLLHRPNNQLDERRRLRMALDAARGMNYLH-NCTPVIVHRDL 879 (1044)
Q Consensus 808 rHPNI--Vkl~~~~~~~~~l~LVmEy~~G-G----sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLH-s~G~~IVHRDI 879 (1044)
.|++| ..++.+ ...+|||||+.+ | .|.++... .++..+..++.||+.+|.||| .+| |+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 87754 344432 367999999942 3 77776532 235567889999999999999 999 999999
Q ss_pred CCCcEEEcCCCeEEEEeccccccc
Q 045028 880 KSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 880 KPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.1e-16 Score=176.71 Aligned_cols=136 Identities=15% Similarity=0.115 Sum_probs=100.7
Q ss_pred eeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcc------------hhh--------HHHHHHHHHHHHhCCCCCee
Q 045028 755 ITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFF------------GES--------LEEFRSEVLIMKRVRHPNVV 813 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~------------~~~--------~~~~~~EI~ILk~LrHPNIV 813 (1044)
|++++.||.|+||.||+|.. +|+.||||+++..... ... .-...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999987 6889999987532110 000 01234567777777544432
Q ss_pred --EEEeeeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-
Q 045028 814 --LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW- 890 (1044)
Q Consensus 814 --kl~~~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg- 890 (1044)
..+++ ...+|||||++|++|..+... .....++.||+.+|.+||++| ||||||||.||||+.+|
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCC
Confidence 23322 245899999999998766432 124567899999999999999 99999999999998776
Q ss_pred ---------eEEEEeccccccc
Q 045028 891 ---------VVKVCDFGLSRMK 903 (1044)
Q Consensus 891 ---------~VKLiDFGLA~~~ 903 (1044)
.+.||||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 4899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=129.36 Aligned_cols=141 Identities=15% Similarity=0.026 Sum_probs=112.6
Q ss_pred CCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEe
Q 045028 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+.|++...+|.|+++.||++...++.+++|+...... .....+.+|+.+++.+. +..+.++++++...+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 5699999999999999999988889999998764211 11235888999999885 66788899998888889999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT---------------------------------------- 871 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G---------------------------------------- 871 (1044)
++|.+|.+.+.. ......++.++..+|..||+..
T Consensus 92 i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999887421 1223467889999999999810
Q ss_pred -----------------CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 872 -----------------PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 872 -----------------~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 239999999999999876667799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=3.6e-10 Score=117.56 Aligned_cols=136 Identities=19% Similarity=0.148 Sum_probs=100.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC--eeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--VVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN--IVkl~~~~~~~~~l~LV 828 (1044)
...|.+....+.|.++.||++... |+.+++|+..... ...+.+|+.+++.+.+.+ +.+++.++...+..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 345666554456667999998764 6779999865431 234778999999886434 45688888877889999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT------------------------------------- 871 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G------------------------------------- 871 (1044)
|||++|.+|. ... .. ...++.+++..|..||...
T Consensus 94 ~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9999999884 221 11 1256777888888888643
Q ss_pred -------------------CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 872 -------------------PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 872 -------------------~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999887677899999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=7.7e-10 Score=122.74 Aligned_cols=143 Identities=17% Similarity=0.167 Sum_probs=107.9
Q ss_pred eEEeEecccCcEEEEEEEECCcEEEEEEee--ccCcchhhHHHHHHHHHHHHhCC--CCCeeEEEeeeecC---CCceEE
Q 045028 756 TLGERIGLGSYGEVYRGDWHGTEVAVKRFL--DQDFFGESLEEFRSEVLIMKRVR--HPNVVLFMGAVTRP---PNLSIV 828 (1044)
Q Consensus 756 ~I~r~LGkG~FGtVykak~~g~~VAVK~l~--~~~~~~~~~~~~~~EI~ILk~Lr--HPNIVkl~~~~~~~---~~l~LV 828 (1044)
.-++.|+.|.++.||+....+..+++|+.. .... ......+.+|+.+++.+. +..+.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999999888889999765 2221 122346788999999997 44577888887765 458999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC-------------------------------------- 870 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~-------------------------------------- 870 (1044)
|||++|..+.+.. ...++......++.+++..|..||..
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998775422 13467888888999999999999973
Q ss_pred ------------------CCcEEEecCCCCcEEEcCCC--eEEEEecccccc
Q 045028 871 ------------------TPVIVHRDLKSPNLLVDKNW--VVKVCDFGLSRM 902 (1044)
Q Consensus 871 ------------------G~~IVHRDIKPeNILLd~dg--~VKLiDFGLA~~ 902 (1044)
...++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 13499999999999999775 369999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=4.2e-09 Score=114.30 Aligned_cols=186 Identities=20% Similarity=0.162 Sum_probs=122.9
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCC--eeEEEeeeecCC---CceEEEEe
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPN--VVLFMGAVTRPP---NLSIVAEF 831 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPN--IVkl~~~~~~~~---~l~LVmEy 831 (1044)
++.++.|.+..||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.+++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3458999999999863 56889975322 34567889999998874 322 334554443333 35899999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT---------------------------------------- 871 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G---------------------------------------- 871 (1044)
++|..|.+... ..++..+...++.+++..|..||...
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99998875432 24677777888888888888888611
Q ss_pred ----------------CcEEEecCCCCcEEEcC--CCeEEEEeccccccccCCcccccCCCCCCCccCccccc----CCC
Q 045028 872 ----------------PVIVHRDLKSPNLLVDK--NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR----NEP 929 (1044)
Q Consensus 872 ----------------~~IVHRDIKPeNILLd~--dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~----g~~ 929 (1044)
..++|+|++|.|||++. .+.+.|+||+.+................ .-..|+... ...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHcC
Confidence 23899999999999998 5678999999986533211110000000 002232211 111
Q ss_pred -C---------CchhHHHHHHHHHHHHHhCCCCCC
Q 045028 930 -S---------DEKCDVYSFGVILWELCTMQQPWG 954 (1044)
Q Consensus 930 -~---------s~kSDIWSLG~LLyELLTGk~PF~ 954 (1044)
. ....+.|++|.++|.+.+|..+|.
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 123689999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=5.2e-06 Score=90.74 Aligned_cols=135 Identities=18% Similarity=0.137 Sum_probs=95.8
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC---CeeEEEeeee-cCCCceEEEEecC
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP---NVVLFMGAVT-RPPNLSIVAEFLP 833 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP---NIVkl~~~~~-~~~~l~LVmEy~~ 833 (1044)
++.++.|....||+. +..+++|+-.. ......+.+|..+|+.+.+. .+.+++.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456889999999987 67899997421 23456789999999999742 2455666653 4556889999999
Q ss_pred CCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 045028 834 RGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT------------------------------------------ 871 (1044)
Q Consensus 834 GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G------------------------------------------ 871 (1044)
|..|.+..- ..++......++.++...|..||...
T Consensus 97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 998876322 12345555556666666666666432
Q ss_pred ----------------CcEEEecCCCCcEEEcC---CCe-EEEEecccccc
Q 045028 872 ----------------PVIVHRDLKSPNLLVDK---NWV-VKVCDFGLSRM 902 (1044)
Q Consensus 872 ----------------~~IVHRDIKPeNILLd~---dg~-VKLiDFGLA~~ 902 (1044)
..++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 13799999999999987 455 58999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.1e-06 Score=87.75 Aligned_cols=131 Identities=16% Similarity=0.221 Sum_probs=95.8
Q ss_pred ecccCcE-EEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEecCCCc
Q 045028 761 IGLGSYG-EVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEFLPRGS 836 (1044)
Q Consensus 761 LGkG~FG-tVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy~~GGs 836 (1044)
+..|..| .||+... .+..+++|+... .....+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445444 6898654 456799997542 23456888999998885 3236678888888888999999999998
Q ss_pred HHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 045028 837 LYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT--------------------------------------------- 871 (1044)
Q Consensus 837 L~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G--------------------------------------------- 871 (1044)
+.+..... ......+..++...|..||...
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 88765431 1223356677778888888532
Q ss_pred -----------CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 872 -----------PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 872 -----------~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 128999999999999988777899999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=5.6e-06 Score=91.36 Aligned_cols=84 Identities=7% Similarity=-0.088 Sum_probs=56.2
Q ss_pred eeEEeEe-cccCcEEEEEEEEC--------CcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCC-C--CCeeEEEeeeec
Q 045028 755 ITLGERI-GLGSYGEVYRGDWH--------GTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVR-H--PNVVLFMGAVTR 821 (1044)
Q Consensus 755 y~I~r~L-GkG~FGtVykak~~--------g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~Lr-H--PNIVkl~~~~~~ 821 (1044)
....+.| +.|....+|+.... ++.+++|+...... .......+.+|+.+++.+. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456788 89999999988765 67899997543210 0001134677888888774 2 346667776655
Q ss_pred C---CCceEEEEecCCCcHH
Q 045028 822 P---PNLSIVAEFLPRGSLY 838 (1044)
Q Consensus 822 ~---~~l~LVmEy~~GGsL~ 838 (1044)
. +..|+||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3578999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.6e-05 Score=87.72 Aligned_cols=77 Identities=18% Similarity=0.114 Sum_probs=50.2
Q ss_pred EEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-c----hhhHHHHHHHHHHHHhCCC--CC-eeEEEeeeecCCCce
Q 045028 757 LGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-F----GESLEEFRSEVLIMKRVRH--PN-VVLFMGAVTRPPNLS 826 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~----~~~~~~~~~EI~ILk~LrH--PN-IVkl~~~~~~~~~l~ 826 (1044)
-.+.||.|.++.||++.. .++.++||....... . ....+.+..|.++|+.+.. +. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999954 568899997643211 0 0123456778888887742 33 3355543 345678
Q ss_pred EEEEecCCC
Q 045028 827 IVAEFLPRG 835 (1044)
Q Consensus 827 LVmEy~~GG 835 (1044)
+||||+.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=4.2e-05 Score=82.81 Aligned_cols=138 Identities=15% Similarity=0.104 Sum_probs=78.8
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-----CCCeeEEE-e--eeecCCCceEEE
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-----HPNVVLFM-G--AVTRPPNLSIVA 829 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-----HPNIVkl~-~--~~~~~~~l~LVm 829 (1044)
++.|+.|..+.||+....+..+++|+.... ...+..|..+++.|. .|.++... + +....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456777788999999887777999987642 123444555555542 24443310 0 122456689999
Q ss_pred EecCCCcHH-----------H---HhcC--CCC--C---------CcHHH------------------------------
Q 045028 830 EFLPRGSLY-----------R---LLHR--PNN--Q---------LDERR------------------------------ 852 (1044)
Q Consensus 830 Ey~~GGsL~-----------d---lLkr--~~~--~---------Lse~~------------------------------ 852 (1044)
+|++|..+. . .+++ ... . ..+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986432 0 0111 000 0 01110
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 853 -RLRMALDAARGMNYLHN-----------CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 853 -il~Ia~QIa~AL~yLHs-----------~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
...+..++..++.+|+. ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 01111223345666653 12339999999999999888899999999774
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=97.79 E-value=4.3e-05 Score=84.29 Aligned_cols=88 Identities=20% Similarity=0.144 Sum_probs=63.9
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCcchhhhhHHHHHHHHHHhhCCceeecccccceecchhHHHHHHHHHHhCCceEEeec
Q 045028 244 VGIDLVRNLAVLVADYMGGPVGDPENMSRASRSLSYSLKATLGSMVLPLGSLTIGLARHRALLFKVLADIVGIPCRLVKG 323 (1044)
Q Consensus 244 ~~~~~v~~la~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~~~v~plG~l~~g~c~~~Allfk~lad~~gl~~~lv~G 323 (1044)
...+.++.|...|.+.+.=...... ......+ -| .-++|+|+++|.||-.|+..+|||||+|.|
T Consensus 141 ~~~~~~~ai~~~v~~~~~Y~~~~~~-~~~~a~~---~l------------~~~~G~C~d~A~l~val~Ra~GIPAR~VsG 204 (293)
T 3isr_A 141 NVYSKVLAITDWIYNNVEYISGSTN-SQTSAFD---TI------------TERAGVCRDFAHLGIALCRALSIPARYFTG 204 (293)
T ss_dssp SHHHHHHHHHHHHHHHSEECTTSCC-TTCCHHH---HH------------HHCEECHHHHHHHHHHHHHHTTCCEEEEEE
T ss_pred CHHHHHHHHHHHHHhhcEEeccCCC-CCCCHHH---hh------------cCCcEehHHHHHHHHHHHHHCCCCEEEEEE
Confidence 4567899999999987542222111 1111111 11 237899999999999999999999999999
Q ss_pred ccccC----CCCceeEEEEeCCCceEEEecc
Q 045028 324 QQYTG----CDDVAMNFVRIDDGREYIVDLM 350 (1044)
Q Consensus 324 ~~~~~----~~~~~~~~v~~~~~~~y~vDl~ 350 (1044)
|.. .+.++|+.|.+ +|.||.||--
T Consensus 205 --y~~~~~~~~~HAW~Evyl-~ggWv~~DpT 232 (293)
T 3isr_A 205 --YAFKLNPPDFHACFEAYI-GGNWIIFDAT 232 (293)
T ss_dssp --EETTCSSCCEEEEEEEEE-TTEEEEECTT
T ss_pred --ECCCCCCCCeEEEEEEEE-CCcEEEEECC
Confidence 543 35788999999 5699999965
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00025 Score=80.61 Aligned_cols=76 Identities=14% Similarity=0.049 Sum_probs=46.9
Q ss_pred EEeEecccCcEEEEEEEECCcEEEEEEeeccC--cchh-----hHHHHHHHHHHHHh-CCCCCeeEEEeeeecCCCceEE
Q 045028 757 LGERIGLGSYGEVYRGDWHGTEVAVKRFLDQD--FFGE-----SLEEFRSEVLIMKR-VRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~--~~~~-----~~~~~~~EI~ILk~-LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
-++.||.|..+.||++...++.++||...... .... ....+..|+..+.. .....+.+++.+. .+..++|
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 35778999999999998778889999532211 0110 22233334333322 2234556666654 5678999
Q ss_pred EEec-CC
Q 045028 829 AEFL-PR 834 (1044)
Q Consensus 829 mEy~-~G 834 (1044)
|||+ +|
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00037 Score=77.16 Aligned_cols=77 Identities=19% Similarity=0.099 Sum_probs=61.5
Q ss_pred eEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC---CCCeeEEEeeeecCCCceEEEEec
Q 045028 756 TLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR---HPNVVLFMGAVTRPPNLSIVAEFL 832 (1044)
Q Consensus 756 ~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr---HPNIVkl~~~~~~~~~l~LVmEy~ 832 (1044)
.-.+.|+.|.+..+|+....++.+++|+.... ....+..|...|+.|. ...+.+++.+....+..++||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 34678999999999999888889999976532 3456888999988874 356778888887778899999999
Q ss_pred CCCcH
Q 045028 833 PRGSL 837 (1044)
Q Consensus 833 ~GGsL 837 (1044)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00047 Score=74.11 Aligned_cols=78 Identities=21% Similarity=0.223 Sum_probs=55.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC---CCeeEEEeeeecCCCceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH---PNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH---PNIVkl~~~~~~~~~l~LV 828 (1044)
..+.-++.+|.|..+.||+.+. +|+.|.+|+..... ......+..|...|+.|.. --+.+++.+. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4567788999999999999987 68899999754332 1222457889999988842 1344555542 35899
Q ss_pred EEecCCCc
Q 045028 829 AEFLPRGS 836 (1044)
Q Consensus 829 mEy~~GGs 836 (1044)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998763
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00026 Score=77.93 Aligned_cols=53 Identities=21% Similarity=0.157 Sum_probs=47.9
Q ss_pred cccceecchhHHHHHHHHHHhCCceEEeecccccCCCCceeEEEEeCC-CceEEEeccC
Q 045028 294 SLTIGLARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDD-GREYIVDLMA 351 (1044)
Q Consensus 294 ~l~~g~c~~~Allfk~lad~~gl~~~lv~G~~~~~~~~~~~~~v~~~~-~~~y~vDl~~ 351 (1044)
.-++|+|+++|.||-.|+-.+|||||+|.| | ..++|+.|.+.. ..|+-||-..
T Consensus 137 ~~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g~~gWv~~Dpt~ 190 (295)
T 2f4m_A 137 ETRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDACE 190 (295)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEETTT
T ss_pred HcCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECCCCeEEEEeCCc
Confidence 458899999999999999999999999999 6 789999999965 5999999763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00041 Score=75.17 Aligned_cols=144 Identities=13% Similarity=0.090 Sum_probs=80.3
Q ss_pred CeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC--eeEEEee------eecCCCc
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN--VVLFMGA------VTRPPNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN--IVkl~~~------~~~~~~l 825 (1044)
...-++.|+.|....+|+....+..+++|+..... ....+..|+.+++.+.... +.+++.. ....+..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34456778889999999998776689999876421 1234556777777663211 2223321 1223457
Q ss_pred eEEEEecCCCcHHH-----------H---hcC---C-CCC----Cc---HHHHHH------------HHHHHHHHHHHHH
Q 045028 826 SIVAEFLPRGSLYR-----------L---LHR---P-NNQ----LD---ERRRLR------------MALDAARGMNYLH 868 (1044)
Q Consensus 826 ~LVmEy~~GGsL~d-----------l---Lkr---~-~~~----Ls---e~~il~------------Ia~QIa~AL~yLH 868 (1044)
+++|+|++|..+.. . ++. . ... .. +...+. +...+...+.+|+
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 89999998864311 0 111 0 000 01 111000 0011334455554
Q ss_pred hC-----CCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 869 NC-----TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 869 s~-----G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
.. ...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 21 1239999999999999987667899999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0011 Score=71.55 Aligned_cols=71 Identities=11% Similarity=0.105 Sum_probs=44.6
Q ss_pred EeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCe-eEEEeeeecCCCceEEEEec-CCC
Q 045028 758 GERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV-VLFMGAVTRPPNLSIVAEFL-PRG 835 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNI-Vkl~~~~~~~~~l~LVmEy~-~GG 835 (1044)
++.|+.|....+|+. ..+++|+..... .......+|+.+++.+..-.+ .+++.+ +.+.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 678999999999998 678899765321 011123457777776642222 345543 344568899999 665
Q ss_pred cH
Q 045028 836 SL 837 (1044)
Q Consensus 836 sL 837 (1044)
.|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0025 Score=67.71 Aligned_cols=140 Identities=15% Similarity=0.164 Sum_probs=96.7
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccccCCC
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA 914 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~s~~ 914 (1044)
+|.++++..+..+++.++|.++.|.+.+|.-+-. .. -..+=+.|..|+|..+|.|.+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------c
Confidence 8999999888999999999999999999887721 11 11223457899999999988764 1110 1
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhc--
Q 045028 915 GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQT-- 992 (1044)
Q Consensus 915 GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~k-- 992 (1044)
....+.+||... ...+.+.-|||||++||.-+--..| ...+..+++.+.+||..|..-
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~~ 158 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTVE 158 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhccc
Confidence 123466888764 3457889999999999999863222 122356889999999999865
Q ss_pred -----------------------CCCCCCCHHHHHHHhccc
Q 045028 993 -----------------------DPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 993 -----------------------DPekRPTa~ELLe~Lk~L 1010 (1044)
.+..|.++++|++.-..-
T Consensus 159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp --------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 245788999998876543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0016 Score=71.10 Aligned_cols=31 Identities=39% Similarity=0.468 Sum_probs=27.1
Q ss_pred cEEEecCCCCcEEEcCC----CeEEEEeccccccc
Q 045028 873 VIVHRDLKSPNLLVDKN----WVVKVCDFGLSRMK 903 (1044)
Q Consensus 873 ~IVHRDIKPeNILLd~d----g~VKLiDFGLA~~~ 903 (1044)
.++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999875 78999999988643
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0029 Score=74.63 Aligned_cols=90 Identities=14% Similarity=0.143 Sum_probs=61.9
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCcch--hhhhHHHHHHHHHHhhCCceeecccccceecchhHHHHHHHHHHhCCceEE
Q 045028 243 FVGIDLVRNLAVLVADYMGGPVGDPEN--MSRASRSLSYSLKATLGSMVLPLGSLTIGLARHRALLFKVLADIVGIPCRL 320 (1044)
Q Consensus 243 ~~~~~~v~~la~~V~~~mgg~~~~~~~--~~~~~~~~~~~l~~~~~~~v~plG~l~~g~c~~~Allfk~lad~~gl~~~l 320 (1044)
-+..+.++.|-.+|.+.+.-.....+. ..+. ...+.+. =+.|.|...|+||..|+..+||||++
T Consensus 242 ~~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~~------~a~~vl~--------~~~G~C~d~a~Ll~AllRa~GIpA~~ 307 (506)
T 3kd4_A 242 GNEQEKVNIIRDHILNNLSTCPIPMAMTGYTVR------DIDTVLR--------SAYGTPLEIAQLLNVMLNAAGIPSEV 307 (506)
T ss_dssp SSHHHHHHHHHHHHHHHCEECCCCGGGGTTCCC------CHHHHHH--------HTEECHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCHHHHHHHHHHHHHhccEecceecccCCCCCC------CHHHHHH--------hCCcchHHHHHHHHHHHHHCCCCcEE
Confidence 356678888888888876422111000 0000 0111111 13699999999999999999999999
Q ss_pred eecccccCCC----------CceeEEEEeCCCceEEEec
Q 045028 321 VKGQQYTGCD----------DVAMNFVRIDDGREYIVDL 349 (1044)
Q Consensus 321 v~G~~~~~~~----------~~~~~~v~~~~~~~y~vDl 349 (1044)
|-+ |++.+ +++|+.|++ ||+||++|-
T Consensus 308 v~~--~t~~~~~~~~~lp~~nh~i~~v~~-~g~~y~lDa 343 (506)
T 3kd4_A 308 LAV--YPGHLDTDACGLAAIQTLAVKATV-DGKDQYLSA 343 (506)
T ss_dssp EEE--EETTSCGGGCCSTTCCEEEEEEEE-TTEEEEESS
T ss_pred EEE--EcCCCCCccCCCCCCCEEEEEEEE-CCEEEEEec
Confidence 998 54432 678999998 999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0039 Score=69.31 Aligned_cols=73 Identities=16% Similarity=0.156 Sum_probs=43.5
Q ss_pred EeEecccCcEEEEEEEECC----------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC-eeEEEeeeecCCCce
Q 045028 758 GERIGLGSYGEVYRGDWHG----------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN-VVLFMGAVTRPPNLS 826 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g----------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN-IVkl~~~~~~~~~l~ 826 (1044)
++.|+.|..-.+|+....+ ..+++|+..... ........|..+++.+...+ +.++++.+ .-+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec----CCc
Confidence 4567888888999988754 678888764321 11112356888887774223 34566544 237
Q ss_pred EEEEecCCCcH
Q 045028 827 IVAEFLPRGSL 837 (1044)
Q Consensus 827 LVmEy~~GGsL 837 (1044)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0058 Score=70.22 Aligned_cols=72 Identities=14% Similarity=0.244 Sum_probs=48.5
Q ss_pred EeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC-eeEEEeeeecCCCceE
Q 045028 758 GERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN-VVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN-IVkl~~~~~~~~~l~L 827 (1044)
++.|+.|....||++... +..+.+|+..... ....+.+|..+++.+...+ ..++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 567888888999999864 4689999874321 1134557888888875323 3566665532 38
Q ss_pred EEEecCCCcH
Q 045028 828 VAEFLPRGSL 837 (1044)
Q Consensus 828 VmEy~~GGsL 837 (1044)
|+||++|..|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.011 Score=68.77 Aligned_cols=73 Identities=14% Similarity=0.037 Sum_probs=47.4
Q ss_pred EeEecccCcEEEEEEEECC--cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCe-eEEEeeeecCCCceEEEEecCC
Q 045028 758 GERIGLGSYGEVYRGDWHG--TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV-VLFMGAVTRPPNLSIVAEFLPR 834 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~~g--~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNI-Vkl~~~~~~~~~l~LVmEy~~G 834 (1044)
++.|+.|-...+|++...+ ..+++|+..... .. .-...+|..+++.|...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678888889999998876 789999864321 11 1112578888988864444 46776663 2 369999987
Q ss_pred CcH
Q 045028 835 GSL 837 (1044)
Q Consensus 835 GsL 837 (1044)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0078 Score=68.40 Aligned_cols=137 Identities=15% Similarity=0.167 Sum_probs=80.4
Q ss_pred eEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEE
Q 045028 759 ERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 759 r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LV 828 (1044)
+.|..|-...+|++... ++.+.+|+.-.. ......+.+|..+++.|. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45767777889988763 367999975321 123455668999998874 3223556666543 399
Q ss_pred EEecCCCcHHHH--------------h---cCC----CCCC--cHHHHHHHHHHHHH-------------------HHHH
Q 045028 829 AEFLPRGSLYRL--------------L---HRP----NNQL--DERRRLRMALDAAR-------------------GMNY 866 (1044)
Q Consensus 829 mEy~~GGsL~dl--------------L---kr~----~~~L--se~~il~Ia~QIa~-------------------AL~y 866 (1044)
|||++|..|... + +.. .+.. -..++.++..++-. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999988654311 1 111 1112 23445555544321 1233
Q ss_pred H----HhCC--CcEEEecCCCCcEEEcCC----CeEEEEecccccc
Q 045028 867 L----HNCT--PVIVHRDLKSPNLLVDKN----WVVKVCDFGLSRM 902 (1044)
Q Consensus 867 L----Hs~G--~~IVHRDIKPeNILLd~d----g~VKLiDFGLA~~ 902 (1044)
| ...+ ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3 2222 239999999999999876 7899999998853
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.014 Score=64.60 Aligned_cols=30 Identities=23% Similarity=0.437 Sum_probs=27.2
Q ss_pred cEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 873 ~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 399999999999999888999999988764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.16 E-value=0.027 Score=61.04 Aligned_cols=138 Identities=12% Similarity=0.086 Sum_probs=77.5
Q ss_pred eEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCC--CeeEEEee-----eecCCCceEEEE
Q 045028 759 ERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP--NVVLFMGA-----VTRPPNLSIVAE 830 (1044)
Q Consensus 759 r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHP--NIVkl~~~-----~~~~~~l~LVmE 830 (1044)
+.|+ |....||+... +|+.+++|....... ....+..|..+++.+... .+++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 77889998876 456799998753322 234566788887777421 23334432 122345678999
Q ss_pred ecCCCcHH-----H------H---hc----CC----CCCCcHHHH----------------------HHHHHHHHHHHHH
Q 045028 831 FLPRGSLY-----R------L---LH----RP----NNQLDERRR----------------------LRMALDAARGMNY 866 (1044)
Q Consensus 831 y~~GGsL~-----d------l---Lk----r~----~~~Lse~~i----------------------l~Ia~QIa~AL~y 866 (1044)
|++|..+. . . ++ .. ...++.... ...+.+++..+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99885431 0 0 11 00 011221110 0111122222222
Q ss_pred HHh--CCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 867 LHN--CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 867 LHs--~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.. ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 211 223389999999999999 4 899999998754
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=95.55 E-value=0.013 Score=65.46 Aligned_cols=52 Identities=19% Similarity=0.095 Sum_probs=46.1
Q ss_pred ccceecchhHHHHHHHHHHhCCceEEeecccccCCCCceeEEEEeCC-CceEEEeccC
Q 045028 295 LTIGLARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDD-GREYIVDLMA 351 (1044)
Q Consensus 295 l~~g~c~~~Allfk~lad~~gl~~~lv~G~~~~~~~~~~~~~v~~~~-~~~y~vDl~~ 351 (1044)
.++|.|.|+|.||-.|+-.+|||+|+|-| ...++|+.|.... ++|.=||-..
T Consensus 179 tr~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~~rWv~vDp~~ 231 (335)
T 1x3z_A 179 TRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVDSCE 231 (335)
T ss_dssp HCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEETTT
T ss_pred hCCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCCCCEEEECCCC
Confidence 46899999999999999999999999988 3589999999975 5899999664
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.058 Score=62.23 Aligned_cols=74 Identities=8% Similarity=0.060 Sum_probs=47.5
Q ss_pred EEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCce
Q 045028 757 LGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~ 826 (1044)
-++.|..|-...+|+.... ++.+.+++..... ...-...+|..+++.+. +.-..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3456777888899998875 6789999864321 11112356888888774 222345555432 38
Q ss_pred EEEEecCCCcH
Q 045028 827 IVAEFLPRGSL 837 (1044)
Q Consensus 827 LVmEy~~GGsL 837 (1044)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998753
|
| >2q3z_A Transglutaminase 2; transglutaminase 2, tissue transglutaminase, TG2, transferas; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1kv3_A 3ly6_A* | Back alignment and structure |
|---|
Probab=94.58 E-value=0.025 Score=68.55 Aligned_cols=54 Identities=17% Similarity=0.108 Sum_probs=44.4
Q ss_pred ccceecchhHHHHHHHHHHhCCceEEeeccc--------------cc--C----------CCCceeEEEEeC------C-
Q 045028 295 LTIGLARHRALLFKVLADIVGIPCRLVKGQQ--------------YT--G----------CDDVAMNFVRID------D- 341 (1044)
Q Consensus 295 l~~g~c~~~Allfk~lad~~gl~~~lv~G~~--------------~~--~----------~~~~~~~~v~~~------~- 341 (1044)
.+.|+|+++|-+|-+++-.+|||||+|.|-. |. + |+-++|+.|-+. .
T Consensus 272 ~k~G~C~dfA~~~~~llRalGIPAR~VsGy~~~~~~~~~l~~d~~~~~~g~~~~~~~d~~~~~HAW~Ev~~~rpDLp~g~ 351 (687)
T 2q3z_A 272 VKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGY 351 (687)
T ss_dssp EEEECHHHHHHHHHHHHHHHTCCEEEEEEEEEECC--CCHHHHHHHC---------CCCCBSEEEEEEEEECCTTSSTTC
T ss_pred cceeehHHHHHHHHHHHHhCCCCcEEEeecccccccccccccccccCCCCceeeecCCcccceeEEEEEEcccCCCCCCC
Confidence 7899999999999999999999999999932 11 1 235779999996 3
Q ss_pred CceEEEe
Q 045028 342 GREYIVD 348 (1044)
Q Consensus 342 ~~~y~vD 348 (1044)
+-|..||
T Consensus 352 ~GW~~~D 358 (687)
T 2q3z_A 352 EGWQALD 358 (687)
T ss_dssp CEEEEEC
T ss_pred CCEEEEC
Confidence 5798888
|
| >1vjj_A Protein-glutamine glutamyltransferase E; transglutaminase 3, X-RAY crystallography, metalloenzyme, calcium ION; HET: GDP; 1.90A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1sgx_A* 1l9m_A 1l9n_A* 1nud_A 1nuf_A 1nug_A 1rle_A* | Back alignment and structure |
|---|
Probab=93.81 E-value=0.036 Score=67.16 Aligned_cols=55 Identities=18% Similarity=0.131 Sum_probs=43.9
Q ss_pred ccceecchhHHHHHHHHHHhCCceEEeecc--------------cccC------------CCCceeEEEEeCC-------
Q 045028 295 LTIGLARHRALLFKVLADIVGIPCRLVKGQ--------------QYTG------------CDDVAMNFVRIDD------- 341 (1044)
Q Consensus 295 l~~g~c~~~Allfk~lad~~gl~~~lv~G~--------------~~~~------------~~~~~~~~v~~~~------- 341 (1044)
+|.|+|+|+|-+|-+|+-.+|||||+|.|. ||+. |+=++|+.+-+.-
T Consensus 267 V~~G~C~~fA~~~~~~lR~lGIPaR~Vtgy~s~~d~~~nL~~d~~~~~~g~~~~~~~dsIW~~HaW~E~w~~rpDLp~~~ 346 (692)
T 1vjj_A 267 VRYGQCWVFAGTLNTALRSLGIPSRVITNFNSAHDTDRNLSVDVYYDPMGNPLDKGSDSVWNFHVWNEGWFVRSDLGPSY 346 (692)
T ss_dssp EEEECHHHHHHHHHHHHHHHTCCEEEEEEEEEEECSSSSSEEEEEECTTSCBCCCCSCEEEEEEEEEEEEECCTTTCGGG
T ss_pred ccceeeHHHHHHHHHHHHhCCCCeeEEcccccccCCCCCcccceeeccCCcccccccccccceeEEEEEeccccCCCCCC
Confidence 678999999999999999999999999994 1221 1245689998853
Q ss_pred CceEEEec
Q 045028 342 GREYIVDL 349 (1044)
Q Consensus 342 ~~~y~vDl 349 (1044)
+.|+.||=
T Consensus 347 ~gW~~~Dp 354 (692)
T 1vjj_A 347 GGWQVLDA 354 (692)
T ss_dssp CEEEEECC
T ss_pred CCEEEECC
Confidence 67989883
|
| >1g0d_A Protein-glutamine gamma-glutamyltransferase; tissue transglutaminase,acyltransferase; 2.50A {Pagrus major} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 | Back alignment and structure |
|---|
Probab=92.28 E-value=0.098 Score=63.38 Aligned_cols=80 Identities=14% Similarity=0.049 Sum_probs=48.7
Q ss_pred ccchHHHHHHHHHHHHHh------cCCCCCC-cchhh-hhHHHHHHHHHHhhCCceeecccccceecchhHHHHHHHHHH
Q 045028 242 AFVGIDLVRNLAVLVADY------MGGPVGD-PENMS-RASRSLSYSLKATLGSMVLPLGSLTIGLARHRALLFKVLADI 313 (1044)
Q Consensus 242 ~~~~~~~v~~la~~V~~~------mgg~~~~-~~~~~-~~~~~~~~~l~~~~~~~v~plG~l~~g~c~~~Allfk~lad~ 313 (1044)
..+..+++..|...|-.. +|.-..+ ..-+. ..|--...-|++.+.+.+- .+|.|.|.|+|-+|-+++-.
T Consensus 209 r~dpv~v~r~lsa~vn~~dD~gvl~g~W~~~y~~g~~P~~w~gs~~il~~~~~~~~~---PV~~G~C~~fA~v~~t~lR~ 285 (695)
T 1g0d_A 209 RSDPVYVGRTITAMVNSNGDRGVLTGRWEEPYTDGVAPYRWTGSVPILQQWSKAGVR---PVKYGQCWVFAAVACTVLRC 285 (695)
T ss_dssp TTCHHHHHHHHHHHHTTCTTTCSEEECCSSCCTTSCCGGGCSBSHHHHHHHHHTTSC---CEEEECHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhhccCcCceeecccccccCCCcCCcccCChHHHHHHHHHcCCC---cccceeeHHHHHHHHHHHHh
Confidence 345667888888888554 2221111 00011 2222121223333333222 36889999999999999999
Q ss_pred hCCceEEeecc
Q 045028 314 VGIPCRLVKGQ 324 (1044)
Q Consensus 314 ~gl~~~lv~G~ 324 (1044)
+|||||+|.|.
T Consensus 286 lGIPaR~Vtgy 296 (695)
T 1g0d_A 286 LGIPTRPITNF 296 (695)
T ss_dssp HTCCEEEEEEE
T ss_pred CCCCeeEEccc
Confidence 99999999993
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.06 E-value=1.1 Score=50.72 Aligned_cols=29 Identities=24% Similarity=0.402 Sum_probs=25.0
Q ss_pred EEEecCCCCcEEE------cCCCeEEEEecccccc
Q 045028 874 IVHRDLKSPNLLV------DKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 874 IVHRDIKPeNILL------d~dg~VKLiDFGLA~~ 902 (1044)
++|+|+.+.|||+ +.++.++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3467899999998864
|
| >1ex0_A Coagulation factor XIII A chain; transglutaminase, blood coagulation, mutant, W279F, oxyanion, transferase; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1evu_A 1fie_A 1f13_A 1ggt_A 1ggu_A 1ggy_A 1qrk_A | Back alignment and structure |
|---|
Probab=89.90 E-value=0.28 Score=59.92 Aligned_cols=33 Identities=27% Similarity=0.455 Sum_probs=30.0
Q ss_pred cccceecchhHHHHHHHHHHhCCceEEeecccccC
Q 045028 294 SLTIGLARHRALLFKVLADIVGIPCRLVKGQQYTG 328 (1044)
Q Consensus 294 ~l~~g~c~~~Allfk~lad~~gl~~~lv~G~~~~~ 328 (1044)
.+|.|.|.|+|-+|-++.-.+|||||+|.| |.+
T Consensus 308 PV~~G~C~~fA~v~~~~lR~lGIPaRvVtg--y~s 340 (731)
T 1ex0_A 308 PVRYGQCWVFAGVFNTFLRCLGIPARIVTN--YFS 340 (731)
T ss_dssp CEEEECHHHHHHHHHHHHHHHTCCEEEEEE--EEE
T ss_pred ccceeeehhHHHHHHHHHHhCCCCeeEEcc--ccc
Confidence 367899999999999999999999999999 544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1044 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-86 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-81 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-76 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-75 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-74 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-74 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-74 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-73 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-73 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-73 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-73 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-73 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-73 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-73 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-72 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-72 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-72 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-71 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-71 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-70 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-70 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-69 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-67 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-67 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-66 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-64 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-62 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-62 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-61 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-52 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-51 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-43 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (706), Expect = 6e-86
Identities = 96/275 (34%), Positives = 157/275 (57%), Gaps = 13/275 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
EIP +IT+G+RIG GS+G VY+G WHG VAVK + L+ F++EV ++++ R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
H N++LFMG T P L+IV ++ SLY LH + + + + +A A+GM+YLH
Sbjct: 63 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST--AGTAEWMAPEVLR 926
I+HRDLKS N+ + ++ VK+ DFGL+ +K S + +G+ WMAPEV+R
Sbjct: 122 A--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 927 NE---PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL----DIPDNLD 979
+ P + DVY+FG++L+EL T Q P+ +N + + + + N
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014
A+ ++ +C + RP F +I+A+++ L + +
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (675), Expect = 1e-81
Identities = 87/267 (32%), Positives = 142/267 (53%), Gaps = 13/267 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
+ +E+ L + IG G +G+V GD+ G +VAVK + + + F +E +M ++R
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 809 HPNVVLFMGAVTRPPN-LSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNY 866
H N+V +G + L IV E++ +GSL L R + L L+ +LD M Y
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
L VHRDL + N+LV ++ V KV DFGL++ +T + +W APE LR
Sbjct: 119 LEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 927 NEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
+ K DV+SFG++LWE+ + + P+ + VV V + ++D PD PAV ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEV 232
Query: 986 IRKCWQTDPKMRPTFTEIMAALKPLQK 1012
++ CW D MRP+F ++ L+ ++
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 4e-76
Identities = 87/274 (31%), Positives = 146/274 (53%), Gaps = 14/274 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
E+P E + L ER+G G +GEV+ G ++ T+VAVK L Q + F +E +MK++
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSP--DAFLAEANLMKQL 65
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNN-QLDERRRLRMALDAARGMNY 866
+H +V VT+ P + I+ E++ GSL L P+ +L + L MA A GM +
Sbjct: 66 QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVL 925
+ +HRDL++ N+LV K+ DFGL+R ++ N + + +W APE +
Sbjct: 125 IEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 926 RNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
K DV+SFG++L E+ T + P+ GM +V+ + + R+ PDN +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQ 241
Query: 985 IIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018
++R CW+ P+ RPTF + + L+ T+++
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLED---FFTATE 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 9e-75
Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 9/262 (3%)
Query: 750 IPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
I +++T + +G G +G V G W +VA+K + + E +EF E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSE--DEFIEEAKVMMNLS 57
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
H +V G T+ + I+ E++ G L L ++ ++ L M D M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRN 927
+ +HRDL + N LV+ VVKV DFGLSR + + + SS + W PEVL
Sbjct: 118 SKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 928 EPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
K D+++FGV++WE+ ++ + P+ + + Q RL P V I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 987 RKCWQTDPKMRPTFTEIMAALK 1008
CW RPTF +++ +
Sbjct: 235 YSCWHEKADERPTFKILLSNIL 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 1e-74
Identities = 88/275 (32%), Positives = 133/275 (48%), Gaps = 15/275 (5%)
Query: 748 CEIPWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFG--ESLEEFRSE 800
C I +++ L E++G GS+G V RG+W VAVK L D E++++F E
Sbjct: 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC-LKPDVLSQPEAMDDFIRE 61
Query: 801 VLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDA 860
V M + H N++ G V PP + +V E P GSL L + R A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 861 ARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR---MKHNTFLSSRSTAGTA 917
A GM YL + +HRDL + NLL+ +VK+ DFGL R + ++
Sbjct: 121 AEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 918 EWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPD 976
W APE L+ D + FGV LWE+ T Q+PW G+N Q++ + + RL P+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
Query: 977 NLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011
+ + +++ +CW P+ RPTF + L Q
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 4e-74
Identities = 67/262 (25%), Positives = 121/262 (46%), Gaps = 11/262 (4%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP 810
E+ + IG GSYG + G + K + SEV +++ ++HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 811 NVVLFMGAVTRPPN--LSIVAEFLPRGSLYRLLHRPNNQ---LDERRRLRMALDAARGMN 865
N+V + + N L IV E+ G L ++ + + LDE LR+ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 866 YLH---NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAP 922
H + ++HRDLK N+ +D VK+ DFGL+R+ ++ +++ GT +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982
E + +EK D++S G +L+ELC + P+ + ++ G + + + IP +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 983 ADIIRKCWQTDPKMRPTFTEIM 1004
+II + RP+ EI+
Sbjct: 243 NEIITRMLNLKDYHRPSVEEIL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (620), Expect = 5e-74
Identities = 82/266 (30%), Positives = 129/266 (48%), Gaps = 9/266 (3%)
Query: 750 IPWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
I E+T + IG G +G V+ G W + +VA+K + + E E+F E +M ++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSE--EDFIEEAEVMMKLS 58
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HP +V G + +V EF+ G L L L M LD GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVLRN 927
++HRDL + N LV +N V+KV DFG++R + + + SS T +W +PEV
Sbjct: 119 EAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 928 EPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
K DV+SFGV++WE+ + + P+ + +VV + RL P V I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 987 RKCWQTDPKMRPTFTEIMAALKPLQK 1012
CW+ P+ RP F+ ++ L + +
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 2e-73
Identities = 69/269 (25%), Positives = 126/269 (46%), Gaps = 14/269 (5%)
Query: 750 IPWEEITLGER-IGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ + +TL ++ +G G++G V +G + VAVK ++ +E +E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 805 KRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGM 864
+++ +P +V +G + + +V E G L + L + N + ++ + + + GM
Sbjct: 63 QQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWMA 921
YL VHRDL + N+L+ K+ DFGLS+ N + + +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDP 980
PE + K DV+SFGV++WE + Q+P+ GM +V + + R+ P
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237
Query: 981 AVADIIRKCWQTDPKMRPTFTEIMAALKP 1009
+ D++ CW D + RP F + L+
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 2e-73
Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 36/293 (12%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT-------EVAVKRFLDQDFFGESLEEFRSEV 801
E P E + G+ +G G++G+V +G +VAVK L + E SE+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSEL 91
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ------------- 847
+M ++ H N+V +GA T + ++ E+ G L L +
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 848 ---------LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFG 898
L L A A+GM +L + VHRDL + N+LV VVK+CDFG
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFG 209
Query: 899 LSR--MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGG 955
L+R M + ++ + +WMAPE L K DV+S+G++LWE+ ++ P+ G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 956 MNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
+ + ++D P + I++ CW D + RP+F + + L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 242 bits (619), Expect = 2e-73
Identities = 87/275 (31%), Positives = 133/275 (48%), Gaps = 15/275 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT-----EVAVKRFLDQDFFGESLEEFRSEVLI 803
EI + + + IG G +GEV G VA+K L + + +F SE I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASI 80
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
M + HPNV+ G VT+ + I+ EF+ GSL L + + Q + + M A G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----MKHNTFLSSRSTAGTAE 918
M YL + VHRDL + N+LV+ N V KV DFGLSR T+ S+
Sbjct: 141 MKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDN 977
W APE ++ DV+S+G+++WE+ + ++P+ M V+ A+ Q RL P +
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
A+ ++ CWQ D RP F +I+ L + +
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 3e-73
Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 14/271 (5%)
Query: 747 ECEIPWEEITLGER-IGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEV 801
+ + + + + + +G G++G V +G + +VA+K L Q EE E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 60
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
IM ++ +P +V +G V + L +V E G L++ L ++ + +
Sbjct: 61 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAE 918
GM YL VHRDL + N+L+ K+ DFGLS+ + + + + +
Sbjct: 120 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 919 WMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDN 977
W APE + + DV+S+GV +WE + Q+P+ M +V+ + Q +R++ P
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
P + ++ CW + RP F + ++
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 3e-73
Identities = 94/281 (33%), Positives = 147/281 (52%), Gaps = 15/281 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT-EVAVKRFLDQDFFGESLEEFRSEVLIMKRV 807
EIP E + L ++G G +GEV+ G W+GT VA+K S E F E +MK++
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKL 69
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLD-ERRRLRMALDAARGMNY 866
RH +V V+ P + IV E++ +GSL L + + + MA A GM Y
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEVL 925
+ VHRDL++ N+LV +N V KV DFGL+R ++ N + + + +W APE
Sbjct: 129 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
K DV+SFG++L EL T + P+ GM +V+ V + R+ P ++ D
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 245
Query: 985 IIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQVPRPVPS 1025
++ +CW+ +P+ RPTF + A L+ TS++ P+ P
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDY---FTSTE-PQYQPG 282
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 4e-73
Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 19/279 (6%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P + + +G G++G+VY+ A K + E LE++ E+ I+
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCD 67
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HPN+V + A NL I+ EF G++ ++ L E + + +NYLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL--- 925
+ I+HRDLK+ N+L + +K+ DFG+S T S GT WMAPEV+
Sbjct: 128 DNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 926 --RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAV 982
++ P D K DV+S G+ L E+ ++ P +NPM+V+ + L P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 983 ADIIRKCWQTDPKMRPTFTEIMA-------ALKPLQKPI 1014
D ++KC + + R T ++++ + KP+++ I
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 8e-73
Identities = 82/285 (28%), Positives = 140/285 (49%), Gaps = 26/285 (9%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT----EVAVKRFLDQDFFGESLEEFRSEVLIM 804
+ W +I + IG G++G+V + + A+KR + + + +F E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64
Query: 805 KRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHR---------------PNNQL 848
++ HPN++ +GA L + E+ P G+L L + + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 849 DERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908
++ L A D ARGM+YL +HRDL + N+LV +N+V K+ DFGLSR ++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQVVGAVGF 967
WMA E L DV+S+GV+LWE+ ++ P+ GM ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
Q RL+ P N D V D++R+CW+ P RP+F +I+ +L + +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 1e-72
Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 12/258 (4%)
Query: 755 ITLGERIGLGSYGEVYRGDWHGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
+ IG GS+ VY+G T EVA D+ + F+ E ++K ++HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 813 VLFMGA----VTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
V F + V + +V E + G+L L R + + +G+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 869 NCTPVIVHRDLKSPN-LLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
TP I+HRDLK N + VK+ D GL+ +K +F +++ GT E+MAPE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEE 187
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPW-GGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
DE DVY+FG+ + E+ T + P+ N Q+ V + P V +II
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 987 RKCWQTDPKMRPTFTEIM 1004
C + + R + +++
Sbjct: 247 EGCIRQNKDERYSIKDLL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 240 bits (612), Expect = 2e-72
Identities = 98/269 (36%), Positives = 143/269 (53%), Gaps = 11/269 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E+ +IT+ ++G G YGEVY G W VAVK L +D +EEF E +MK
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKED--TMEVEEFLKEAAVMKE 69
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ-LDERRRLRMALDAARGMN 865
++HPN+V +G TR P I+ EF+ G+L L N Q + L MA + M
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 866 YLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAPEV 924
YL +HRDL + N LV +N +VKV DFGLSR M +T+ + +W APE
Sbjct: 130 YLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
L K DV++FGV+LWE+ T P+ G++ QV + + R++ P+ V
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVY 246
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+++R CWQ +P RP+F EI A + + +
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 4e-72
Identities = 87/271 (32%), Positives = 131/271 (48%), Gaps = 12/271 (4%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGTE-----VAVKRFLDQDFFGESLEEFRSEVLI 803
EI E I LG IG G +G+V++G + E VA+K E+F E L
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALT 61
Query: 804 MKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARG 863
M++ HP++V +G +T + I+ E G L L LD + A +
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 864 MNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-MKHNTFLSSRSTAGTAEWMAP 922
+ YL + VHRD+ + N+LV N VK+ DFGLSR M+ +T+ + +WMAP
Sbjct: 121 LAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 923 EVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981
E + DV+ FGV +WE+ +P+ G+ V+G + RL +P N P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 237
Query: 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ ++ KCW DP RP FTE+ A L + +
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 2e-71
Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 10/255 (3%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEE-FRSEVLIMKRVRH 809
E+ +G +G G +G VY +A+K +E R EV I +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
PN++ G + ++ E+ P G++YR L + ++ DE+R + A ++Y H+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 124
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
++HRD+K NLL+ +K+ DFG S ++ + GT +++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
DEK D++S GV+ +E + P+ + + PD + D+I +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238
Query: 990 WQTDPKMRPTFTEIM 1004
+ +P RP E++
Sbjct: 239 LKHNPSQRPMLREVL 253
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 236 bits (602), Expect = 5e-71
Identities = 80/300 (26%), Positives = 126/300 (42%), Gaps = 37/300 (12%)
Query: 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFR 798
E P I IG G++G V++ T VAVK L ++ + +F+
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQ 64
Query: 799 SEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ----------- 847
E +M +PN+V +G + ++ E++ G L L +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 848 ------------LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVC 895
L +L +A A GM YL VHRDL + N LV +N VVK+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIA 182
Query: 896 DFGLSRMKHNTFLSSRST--AGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ-P 952
DFGLSR ++ A WM PE + + DV+++GV+LWE+ + P
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 953 WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ GM +V+ V L P+N + +++R CW P RP+F I L+ + +
Sbjct: 243 YYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (599), Expect = 2e-70
Identities = 80/297 (26%), Positives = 135/297 (45%), Gaps = 17/297 (5%)
Query: 735 DSSKSDVGDDVAECEIPWEEITL--GERIGLGSYGEVYRG-----DWHGTEVAVKRFLDQ 787
+ ++ V I + + E IG G +G VY G D AVK L++
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNR 65
Query: 788 DFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN-LSIVAEFLPRGSLYRLLHRPNN 846
+ +F +E +IMK HPNV+ +G R +V ++ G L + +
Sbjct: 66 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 125
Query: 847 QLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH-- 904
+ + L A+GM + VHRDL + N ++D+ + VKV DFGL+R +
Sbjct: 126 NPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 905 --NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQ-PWGGMNPMQV 961
++ + +WMA E L+ + K DV+SFGV+LWEL T P+ +N +
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243
Query: 962 VGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSSQ 1018
+ Q RRL P+ + +++ KCW +MRP+F+E+++ + +
Sbjct: 244 TVYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 4e-70
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 14/274 (5%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT------EVAVKRFLDQDFFGESLEEFRSEVL 802
EI +T + IG G +GEVY+G + VA+K L + + +F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 61
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR 862
IM + H N++ G +++ + I+ E++ G+L + L + + + + M A
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTA---GTAEW 919
GM YL N VHRDL + N+LV+ N V KV DFGLSR+ + ++ +T+ W
Sbjct: 122 GMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 920 MAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW-GGMNPMQVVGAVGFQHRRLDIPDNL 978
APE + DV+SFG+++WE+ T + ++ +V+ A+ RL P +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
A+ ++ +CWQ + RP F +I++ L L +
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-69
Identities = 90/284 (31%), Positives = 146/284 (51%), Gaps = 23/284 (8%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEV 801
E+ E+IT+ +G GS+G VY G T VA+K +++ EF +E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 74
Query: 802 LIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------NQLDERR 852
+MK +VV +G V++ ++ E + RG L L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 853 RLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRS 912
++MA + A GM YL+ VHRDL + N +V +++ VK+ DFG++R + T +
Sbjct: 135 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 913 TA--GTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQH 969
WM+PE L++ DV+SFGV+LWE+ T +QP+ G++ QV+ V +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 251
Query: 970 RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013
LD PDN + +++R CWQ +PKMRP+F EI++++K +P
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 8e-69
Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 31/288 (10%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEV 801
E P ++ G+ +G G++G+V + VAVK L E SE+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 802 LIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQ------------- 847
++ + H N+V +GA T ++ E+ G L L R +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 848 ----LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR-- 901
LD L + A+GM +L + +HRDL + N+L+ + K+CDFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPW-GGMNPMQ 960
+ ++ + +WMAPE + N + DV+S+G+ LWEL ++ GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
+ + R+ P++ + DI++ CW DP RPTF +I+ ++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 4e-68
Identities = 87/300 (29%), Positives = 135/300 (45%), Gaps = 45/300 (15%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV 812
I L E IG G +GEV+RG W G EVAVK F ++ E +E+ +RH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 59
Query: 813 VLFMGAVTRP----PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+ F+ A + L +V+++ GSL+ L+R + +++AL A G+ +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH 117
Query: 869 N------CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM----KHNTFLSSRSTAGTAE 918
P I HRDLKS N+LV KN + D GL+ ++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 919 WMAPEVLRNE------PSDEKCDVYSFGVILWELCT----------MQQPWGGMNPM--- 959
+MAPEVL + S ++ D+Y+ G++ WE+ Q P+ + P
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 960 --QVVGAVGFQHRRLDIPDNLDP-----AVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
++ V Q R +IP+ +A I+R+CW + R T I L L +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 226 bits (578), Expect = 2e-67
Identities = 68/260 (26%), Positives = 111/260 (42%), Gaps = 13/260 (5%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFG-ESLEEFRSEVLIMKRV 807
P + + IG GS+G VY VA+K+ E ++ EV ++++
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 808 RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
RHPN + + G R +V E+ + L L E + A +G+ YL
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYL 131
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR- 926
H+ ++HRD+K+ N+L+ + +VK+ DFG + + S GT WMAPEV+
Sbjct: 132 HSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILA 185
Query: 927 --NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984
D K DV+S G+ EL + P MN M + + + +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245
Query: 985 IIRKCWQTDPKMRPTFTEIM 1004
+ C Q P+ RPT ++
Sbjct: 246 FVDSCLQKIPQDRPTSEVLL 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 6e-67
Identities = 86/290 (29%), Positives = 147/290 (50%), Gaps = 32/290 (11%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWHGT---------EVAVKRFLDQDFFGESLEEFRS 799
E+P + + LG+ +G G++G+V + G +VAVK L D + L + S
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 67
Query: 800 EVLIMKRV-RHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLH---------------R 843
E+ +MK + +H N++ +GA T+ L ++ E+ +G+L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 844 PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903
P QL + + A ARGM YL + +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 904 H--NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQ 960
H + + + + +WMAPE L + + DV+SFGV+LWE+ T+ P+ G+ +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 961 VVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ + + R+D P N + ++R CW P RPTF +++ L +
Sbjct: 246 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 1e-66
Identities = 71/270 (26%), Positives = 124/270 (45%), Gaps = 14/270 (5%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGT------EVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E + +G G++G VY+G W VA+K L + ++ +E E +M
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYVMAS 67
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
V +P+V +G + ++ + +P G L + + + + L + A+GMNY
Sbjct: 68 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM--KHNTFLSSRSTAGTAEWMAPEV 924
L + +VHRDL + N+LV VK+ DFGL+++ + +WMA E
Sbjct: 127 LEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 925 LRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVA 983
+ + + DV+S+GV +WEL T +P+ G+ ++ + + RL P V
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 243
Query: 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013
I+ KCW D RP F E++ + +
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-66
Identities = 68/257 (26%), Positives = 125/257 (48%), Gaps = 9/257 (3%)
Query: 751 PWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR 808
P ++ T E+IG G+ G VY G EVA+++ Q E +E+L+M+ +
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENK 75
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
+PN+V ++ + L +V E+L GSL ++ +DE + + + + + +LH
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH 133
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
+ ++HRD+KS N+L+ + VK+ DFG + GT WMAPEV+ +
Sbjct: 134 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-RLDIPDNLDPAVADIIR 987
K D++S G++ E+ + P+ NP++ + + L P+ L D +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 988 KCWQTDPKMRPTFTEIM 1004
+C D + R + E++
Sbjct: 252 RCLDMDVEKRGSAKELL 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-66
Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 28/293 (9%)
Query: 744 DVAECEIPWEEITLGERIGLGSYGEVYRGDWHGT-------EVAVKRFLDQDFFGESLEE 796
D ++ E P + + LG+ +G G++G+V D G VAVK + E
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 63
Query: 797 FRSEVLIMKRVRHPNVVLFMGAVTRPPN-LSIVAEFLPRGSLYRLLHRPNNQ-------- 847
+++ H NVV +GA T+P L ++ EF G+L L N+
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 848 -------LDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900
L + + A+GM +L + +HRDL + N+L+ + VVK+CDFGL+
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 901 R--MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957
R K ++ +WMAPE + + + DV+SFGV+LWE+ + P+ G+
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010
+ + R+ PD P + + CW +P RPTF+E++ L L
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-65
Identities = 74/269 (27%), Positives = 116/269 (43%), Gaps = 13/269 (4%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP 810
E+ L + +G G+YGEV VAVK +D + E + E+ I K + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
NVV F G + E+ G L+ + + + E R G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM--KHNTFLSSRSTAGTAEWMAPEVLRNE 928
I HRD+K NLL+D+ +K+ DFGL+ + +N GT ++APE+L+
Sbjct: 123 G--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 929 P-SDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLDIPDNLDPAVADII 986
E DV+S G++L + + PW + Q + L+ +D A ++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 987 RKCWQTDPKMRPTFTEIMAA---LKPLQK 1012
K +P R T +I KPL+K
Sbjct: 241 HKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 1e-65
Identities = 60/301 (19%), Positives = 115/301 (38%), Gaps = 49/301 (16%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E+ ++ +G G+ G V++ G +A K + + + E+ ++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHE 60
Query: 807 VRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNY 866
P +V F GA +SI E + GSL ++L + ++ E+ ++++ +G+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 867 LHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
L I+HRD+K N+LV+ +K+CDFG+S ++ + S GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 176
Query: 927 NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI------------ 974
+ D++S G+ L E+ + P + ++ G Q
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 975 ------------------------------PDNLDPAVADIIRKCWQTDPKMRPTFTEIM 1004
D + KC +P R ++M
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 1005 A 1005
Sbjct: 297 V 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-65
Identities = 57/266 (21%), Positives = 108/266 (40%), Gaps = 10/266 (3%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRH 809
E+ G+ +G GS+ V E A+K + E+ + E +M R+ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P V L + G L + + + DE + + YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 126
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRST--AGTAEWMAPEVLRN 927
I+HRDLK N+L++++ +++ DFG +++ +R+ GTA++++PE+L
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987
+ + + D+++ G I+++L P+ N + + D P+ P D++
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 242
Query: 988 KCWQTDPKMRPTFTEIMAALKPLQKP 1013
K D R E+ P
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 220 bits (562), Expect = 1e-64
Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 17/289 (5%)
Query: 749 EIPWEEI----TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVL 802
EI + + + E +G G++G V+R G A K + E R E+
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQ 75
Query: 803 IMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAAR 862
M +RHP +V A + ++ EF+ G L+ + +N++ E + +
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 863 GMNYLHNCTPVIVHRDLKSPNLLV--DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWM 920
G+ ++H VH DLK N++ ++ +K+ DFGL+ + S + T GTAE+
Sbjct: 136 GLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFA 192
Query: 921 APEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD--IPDNL 978
APEV +P D++S GV+ + L + P+GG N + + V +D +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 979 DPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPITSSQVPRPVPS 1025
D IRK DP R T + + L P P SQ+P +
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (545), Expect = 2e-62
Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 17/294 (5%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ E +G G++G V+R G K + ++E+ IM ++ HP ++
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLI 89
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
A + ++ EFL G L+ + + ++ E + A G+ ++H +
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS-- 147
Query: 874 IVHRDLKSPNLLVD--KNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSD 931
IVH D+K N++ + K VK+ DFGL+ + + +T TAE+ APE++ EP
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPVG 206
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV--GFQHRRLDIPDNLDPAVADIIRKC 989
D+++ GV+ + L + P+ G + ++ + V D ++ P D I+
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 990 WQTDPKMRPTFTEIMA------ALKPLQKPITSSQVPRPVPSVSSGRETGQISK 1037
Q +P+ R T + + L I SS+ + + +
Sbjct: 267 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-62
Identities = 48/260 (18%), Positives = 104/260 (40%), Gaps = 12/260 (4%)
Query: 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH 809
+E+ + E +G G +G V+R K G + E+ I+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
N++ + L ++ EF+ ++ ++ +L+ER + + +LH+
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 870 CTPVIVHRDLKSPNLLVD--KNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
I H D++ N++ ++ +K+ +FG +R + R E+ APEV ++
Sbjct: 121 HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQH 177
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD--IPDNLDPAVADI 985
+ D++S G +++ L + P+ Q++ + D + D
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 986 IRKCWQTDPKMRPTFTEIMA 1005
+ + + K R T +E +
Sbjct: 238 VDRLLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (533), Expect = 3e-61
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 17/278 (6%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ +G G++ EV + VA+K + + +E+ ++ +++HPN+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+L ++ + + G L+ + ER R+ + YLH+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG-- 127
Query: 874 IVHRDLKSPNLLV---DKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS 930
IVHRDLK NLL D++ + + DFGLS+M+ + S + GT ++APEVL +P
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKPY 186
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP--DNLDPAVADIIRK 988
+ D +S GVI + L P+ N ++ + D P D++ + D IR
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 989 CWQTDPKMRPTFTEIM-----AALKPLQKPITSSQVPR 1021
+ DP+ R T + + A L K I S +
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 284
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 8e-60
Identities = 69/294 (23%), Positives = 132/294 (44%), Gaps = 14/294 (4%)
Query: 753 EEITLGERIGLGSYGEVYRGDWHGT--EVAVKRF-LDQDFFGESLEEFRSEVLIMKRV-R 808
E+ L + +G GS+G+V+ ++ T A+K D + +E E ++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 809 HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
HP + NL V E+L G L + ++ D R A + G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH 120
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNE 928
+ IV+RDLK N+L+DK+ +K+ DFG+ + + + GT +++APE+L +
Sbjct: 121 SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988
+ D +SFGV+L+E+ Q P+ G + ++ ++ + P L+ D++ K
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 989 CWQTDPKMRPTFTEIMAA---LKPLQ-KPITSSQVPRP-VPSVSSGRETGQISK 1037
+ +P+ R + + + + + ++ P P V S + K
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDK 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 202 bits (515), Expect = 3e-59
Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 22/272 (8%)
Query: 752 WEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRF-------LDQDFFGESLEEFRSEVL 802
+E E +G G V R E AVK + E E EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 803 IMKRVR-HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
I+++V HPN++ +V + + +G L+ L L E+ ++
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALL 120
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMA 921
+ LH IVHRDLK N+L+D + +K+ DFG S R GT ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLA 177
Query: 922 PEVLRNEPSD------EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIP 975
PE++ +D ++ D++S GVI++ L P+ M ++ + + + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 976 --DNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
D+ V D++ + P+ R T E +A
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-57
Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 20/281 (7%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVK----RFLDQDFFGESLEEFRSEVLIMKRVRH 809
GE +G G + V + G + A K R G S E+ EV I+K ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
PNV+ ++ ++ E + G L+ L L E G+ YLH+
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 131
Query: 870 CTPVIVHRDLKSPNLLVDKNWV----VKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
I H DLK N+++ V +K+ DFGL+ ++ GT E++APE++
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIV 188
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLDPAVA 983
EP + D++S GVI + L + P+ G + + V + + N
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 984 DIIRKCWQTDPKMRPTFTEIMA----ALKPLQKPITSSQVP 1020
D IR+ DPK R T + + K Q+ ++S+
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 197 bits (501), Expect = 7e-57
Identities = 57/257 (22%), Positives = 113/257 (43%), Gaps = 11/257 (4%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRH 809
++ + +G GS+G V+ G A+K + +E E L++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P ++ G + ++ +++ G L R + + A + + YLH+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
I++RDLK N+L+DKN +K+ DFG ++ + + GT +++APEV+ +P
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
++ D +SFG++++E+ P+ N M+ + + L P + V D++ +
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRL 235
Query: 990 WQTDPKMRPTFTEIMAA 1006
D R +
Sbjct: 236 ITRDLSQRLGNLQNGTE 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-56
Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 33/286 (11%)
Query: 757 LGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVV 813
+ +GLG G+V + + A+K + + R EV + R + P++V
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIV 68
Query: 814 ----LFMGAVTRPPNLSIVAEFLPRGSLYRLLH-RPNNQLDERRRLRMALDAARGMNYLH 868
++ L IV E L G L+ + R + ER + + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 869 NCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL 925
+ I HRD+K NLL N ++K+ DFG ++ + S + T ++APEVL
Sbjct: 129 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVL 185
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDI------PDNLD 979
E D+ CD++S GVI++ L P+ + + + + + R +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMA------ALKPLQKPITSSQV 1019
V +IR +T+P R T TE M + K Q P+ +S+V
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-56
Identities = 57/276 (20%), Positives = 105/276 (38%), Gaps = 24/276 (8%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRF----LDQDFFGESLEEFRSEVLIMKRVR- 808
+G +G G +G VY G VA+K + + EV+++K+V
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 809 -HPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
V+ + RP + ++ E L E + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 868 HNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLR 926
HNC ++HRD+K N+L+D N +K+ DFG + +T + GT + PE +R
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGTRVYSPPEWIR 182
Query: 927 NEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985
V+S G++L+++ P+ + ++ + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------RGQVFFRQRVSSECQHL 234
Query: 986 IRKCWQTDPKMRPTFTEIMAA--LKPLQKPITSSQV 1019
IR C P RPTF EI ++ + P ++++
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 190 bits (484), Expect = 4e-55
Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 16/269 (5%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRHPNV 812
LGE +G G EV+ +VAVK S FR E + HP +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 813 VLFMGAVTRPPNLS----IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLH 868
V IV E++ +L ++H + +R + + DA + +N+ H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSH 128
Query: 869 NCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWMAPEVL 925
I+HRD+K N+++ VKV DFG++R N+ + + GTA++++PE
Sbjct: 129 QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 926 RNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD--IPDNLDPAVA 983
R + D + DVYS G +L+E+ T + P+ G +P+ V + + L +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 984 DIIRKCWQTDPKMRP-TFTEIMAALKPLQ 1011
++ K +P+ R T E+ A L +
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-54
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 17/297 (5%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRH 809
+ + +G G++G+V G A+K + + + +E +++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P + A L V E+ G L+ L R E R + + YLH+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
+V+RD+K NL++DK+ +K+ DFGL + + + ++ GT E++APEVL +
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
D + GV+++E+ + P+ + ++ + + P L P ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGL 239
Query: 990 WQTDPKMRPTFTEIMA--ALK-------PLQKPITSSQVPRPVPSVSSGRETGQISK 1037
+ DPK R A ++ Q + +P P V+S +T
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 4e-53
Identities = 51/271 (18%), Positives = 100/271 (36%), Gaps = 24/271 (8%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
LG +IG GS+G++Y G G EVA+K + + E I K ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ + +++ L SL L + + + + L +A + Y+H+
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 874 IVHRDLKSPNLLV---DKNWVVKVCDFGLSR-------MKHNTFLSSRSTAGTAEWMAPE 923
+HRD+K N L+ K +V + DFGL++ +H + +++ GTA + +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 924 VLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------LDIPDN 977
+ D+ S G +L PW G+ + +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008
A + C +P ++ + +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 186 bits (474), Expect = 1e-52
Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 13/259 (5%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEF----RSEVLIMKRVRH 809
++ IG G +GEVY G A+K + + E R + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P +V A P LS + + + G L+ L + + E A + G+ ++HN
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVL-RNE 928
+V+RDLK N+L+D++ V++ D GL+ ++ GT +MAPEVL +
Sbjct: 126 RF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGV 181
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGFQHRRLDIPDNLDPAVADIIR 987
D D +S G +L++L P+ + +++PD+ P + ++
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 988 KCWQTDPKMRPTFTEIMAA 1006
Q D R A
Sbjct: 242 GLLQRDVNRRLGCLGRGAQ 260
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-52
Identities = 60/294 (20%), Positives = 109/294 (37%), Gaps = 34/294 (11%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHP 810
E E+IG G+YG VY+ G VA+K+ E+ ++K + HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 811 NVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC 870
N+V + + L +V EFL + + + +G+ + H+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 871 TPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP- 929
++HRDLK NLL++ +K+ DFGL+R + T + APE+L
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV------------------------ 965
D++S G I E+ T + + G + + + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 966 ---GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPI 1014
+ + LD ++ + DP R + +A + + KP+
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-52
Identities = 65/299 (21%), Positives = 116/299 (38%), Gaps = 39/299 (13%)
Query: 759 ERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGES----LEEFRSEVLIMKRVRHPNV 812
+ +G G + VY+ VA+K+ + E+ E+ +++ + HPN+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 813 VLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTP 872
+ + A N+S+V +F+ L ++ + L L +G+ YLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 873 VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-D 931
I+HRDLK NLL+D+N V+K+ DFGL++ + + T + APE+L
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 932 EKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV-------------------------- 965
D+++ G IL EL G + + + +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 966 GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPITSSQVPRP 1022
I + D+I+ + +P R T T+ + P Q+PRP
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 181 bits (459), Expect = 1e-51
Identities = 43/277 (15%), Positives = 91/277 (32%), Gaps = 26/277 (9%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+G RIG GS+G ++ G +VA+K + + R E K + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ + +++ L SL LL + + A + +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--S 121
Query: 874 IVHRDLKSPNLLVDK-----NWVVKVCDFGLSRM-------KHNTFLSSRSTAGTAEWMA 921
+V+RD+K N L+ + ++ V DFG+ + +H + ++ +GTA +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQV------VGAVGFQHRRLDIP 975
+ D+ + G + PW G+ +G ++
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 976 DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012
+ P + + + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 179 bits (454), Expect = 5e-51
Identities = 63/282 (22%), Positives = 107/282 (37%), Gaps = 32/282 (11%)
Query: 753 EEITLGERIGLGSYGEVYRG-DWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN 811
E+ E+IG G+YG VY+ + +G A+K+ + E+ I+K ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 812 VVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT 871
+V + L +V E L L +LL L+ L G+ Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 872 PVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS- 930
++HRDLK NLL+++ +K+ DFGL+R T + AP+VL
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 931 DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV------------------------- 965
D++S G I E+ + G++ + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 966 --GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
LD + D++ K + DP R T + +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 6e-51
Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 39/289 (13%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKR--- 806
++ IG G+YG+V++ G VA+KR Q EV +++
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 807 VRHPNVVLFMGAVTRPPN-----LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
HPNVV T L++V E + + L P + M
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMA 921
RG+++LH+ +VHRDLK N+LV + +K+ DFGL+R+ ++ ++ S T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV---------------- 965
PEVL D++S G I E+ + + G + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 966 ---------GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
++D D++ KC +P R + ++
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 2e-49
Identities = 59/261 (22%), Positives = 112/261 (42%), Gaps = 16/261 (6%)
Query: 753 EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGES-LEEFRSEVLIMKRVRH 809
++ + +G GS+G V G A+K Q +E +E I++ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 810 PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
P +V + NL +V E++ G ++ L R + E A YLH+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEP 929
+++RDLK NLL+D+ ++V DFG ++ + GT E +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKG 214
Query: 930 SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKC 989
++ D ++ GV+++E+ P+ P+Q+ + ++ P + + D++R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNL 272
Query: 990 WQTDPKMR-----PTFTEIMA 1005
Q D R +I
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKN 293
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-48
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 44/289 (15%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
T IG G+YG V + VA+K+ + + E+ I+ R RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 814 LFMGAVTRPP----NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
+ P + L LY+LL L RG+ Y+H+
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS 127
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM---KHNTFLSSRSTAGTAEWMAPEVLR 926
++HRDLK NLL++ +K+CDFGL+R+ H+ T + APE++
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 927 NE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV-------------------- 965
N + D++S G IL E+ + + + G + + + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 966 ---------GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ + N D D++ K +P R + +A
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-46
Identities = 67/298 (22%), Positives = 121/298 (40%), Gaps = 25/298 (8%)
Query: 753 EEITLGERIGLGSYGEVYRG-----DWHGTEVAVKRFLDQDFFG--ESLEEFRSEVLIMK 805
E L + +G G+YG+V+ G A+K ++ E R+E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 806 RVRH-PNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGM 864
+R P +V A L ++ +++ G L+ L + + E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 142
Query: 865 NYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS-RMKHNTFLSSRSTAGTAEWMAPE 923
+LH I++RD+K N+L+D N V + DFGLS + + GT E+MAP+
Sbjct: 143 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 924 VLRNEPS--DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV--GFQHRRLDIPDNLD 979
++R S D+ D +S GV+++EL T P+ + P +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 980 PAVADIIRKCWQTDPKMRPTFTEIMAA-------LKPLQ-KPITSSQVPRP-VPSVSS 1028
D+I++ DPK R A + + + + +VP P P +
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRD 318
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-45
Identities = 57/281 (20%), Positives = 105/281 (37%), Gaps = 34/281 (12%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
E+IG G+YG V++ VA+KR D E+ ++K ++H N+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 814 LFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPV 873
+ L++V EF + N LD +G+ + H+
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKK-YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 874 IVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPS-DE 932
++HRDLK NLL+++N +K+ +FGL+R + T + P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 933 KCDVYSFGVILWELCTMQQPW-GGMNPMQVVGAV-------------------------- 965
D++S G I EL +P G + + +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 966 -GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+++ L+ D+++ + +P R + E +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-45
Identities = 63/306 (20%), Positives = 117/306 (38%), Gaps = 52/306 (16%)
Query: 749 EIPW----EEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVL 802
E P+ + +IG G++GEV++ G +VA+K+ L ++ E+
Sbjct: 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 803 IMKRVRHPNVVLFMGAVTRPP--------NLSIVAEFLPRGSLYRLLHRPNNQLDERRRL 854
I++ ++H NVV + ++ +V +F LL +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIK 120
Query: 855 RMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM----KHNTFLSS 910
R+ G+ Y+H I+HRD+K+ N+L+ ++ V+K+ DFGL+R K++
Sbjct: 121 RVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 911 RSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV---- 965
+ T + PE+L E D++ G I+ E+ T G + +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 966 ---------------------GFQHRRLDIPDNL-----DPAVADIIRKCWQTDPKMRPT 999
+ ++ + D L DP D+I K DP R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 1000 FTEIMA 1005
+ +
Sbjct: 299 SDDALN 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-44
Identities = 64/313 (20%), Positives = 105/313 (33%), Gaps = 48/313 (15%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
T + IG GS+G VY+ G VA+K+ L E+ IM+++ H N+V
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIV 76
Query: 814 LFMGAVTRP------PNLSIVAEFLPRGSLYRLLH--RPNNQLDERRRLRMALDAARGMN 865
L++V +++P H R L R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 866 YLHNCTPVIVHRDLK-SPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEV 924
Y+H+ I HRD+K LL V+K+CDFG ++ + +
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 925 LRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM-------QVVGAVGFQHRRLDIPD- 976
DV+S G +L EL Q + G + + +V+G + R P+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 977 -------------------NLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPIT 1015
P + + + P R T E A L+ P
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314
Query: 1016 SSQVPRPVPSVSS 1028
R P++ +
Sbjct: 315 KLPNGRDTPALFN 327
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-43
Identities = 66/308 (21%), Positives = 116/308 (37%), Gaps = 44/308 (14%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ +G G+YG V G +VA+K+ + E+ ++K +RH NV+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 814 LFMGAVTRPPNLSIVAEFL----PRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN 869
+ T L +F G+ L + + +L E R + +G+ Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 870 CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN-E 928
+HRDLK NL V+++ +K+ DFGL+R + T + APEV+ N
Sbjct: 140 AGI--IHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWM 194
Query: 929 PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL---------------- 972
+ D++S G I+ E+ T + + G + + + +
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 973 -------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPITSS 1017
I N P +++ K D + R T E +A + L
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314
Query: 1018 QVPRPVPS 1025
QV + S
Sbjct: 315 QVQKYDDS 322
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-38
Identities = 59/293 (20%), Positives = 110/293 (37%), Gaps = 43/293 (14%)
Query: 749 EIPWEEITLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKR 806
E+P E +G G+YG V G VAVK+ + E+ ++K
Sbjct: 15 EVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 73
Query: 807 VRHPNVVLFMGAVTRPPNLS-----IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAA 861
++H NV+ + T +L + L L ++ +L + +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 131
Query: 862 RGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMA 921
RG+ Y+H+ I+HRDLK NL V+++ +K+ DFGL+R + +T
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT--RWYRAP 187
Query: 922 PEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV---------------- 965
+L ++ D++S G I+ EL T + + G + + + +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 966 -------------GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ ++ +P D++ K D R T + +A
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-38
Identities = 54/298 (18%), Positives = 100/298 (33%), Gaps = 55/298 (18%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
+ IG G+ G V VA+K+ + E+++MK V H N++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 814 LFMGAVTRPP------NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYL 867
+ T ++ +V E + + D R + G+ +L
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHL 135
Query: 868 HNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRN 927
H+ + HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 136 HSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILG 192
Query: 928 EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV---------------------- 965
E D++S G I+ E+ + + G + + V
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 966 ------------------GFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMA 1005
+ D++ K DP R + + +
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 143 bits (362), Expect = 3e-38
Identities = 53/308 (17%), Positives = 112/308 (36%), Gaps = 58/308 (18%)
Query: 744 DVAECEIPWEEI---TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFR 798
D + W L ++G G Y EV+ +V VK ++ +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIK 77
Query: 799 SEVLIMKRVR-HPNVVLFMGAVTRPPN--LSIVAEFLPRGSLYRLLHRPNNQLDERRRLR 855
E+ I++ +R PN++ V P + ++V E + +L L +
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 856 MALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKHNTFLSSRSTA 914
+ + ++Y H+ I+HRD+K N+++D ++ +++ D+GL+ H
Sbjct: 134 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRV 190
Query: 915 GTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNP-----MQVVGAVGFQ 968
+ + PE+L + D D++S G +L + ++P+ + +++ +G +
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 969 HR-------------------------------RLDIPDNLDPAVADIIRKCWQTDPKMR 997
+ + P D + K + D + R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 998 PTFTEIMA 1005
T E M
Sbjct: 311 LTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (310), Expect = 3e-31
Identities = 51/348 (14%), Positives = 110/348 (31%), Gaps = 80/348 (22%)
Query: 756 TLGERIGLGSYGEVYRGDWH--GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVV 813
L ++G G + V+ T VA+K + E E+ +++RV +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNT 72
Query: 814 L---------------FMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMAL 858
F ++ +V E L L + + + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 859 DAARGMNYLHNCTPVIVHRDLKSPNLLVDKN------WVVKVCDFGLSRMKHNTFLSSRS 912
G++Y+H I+H D+K N+L++ +K+ D G + + +
Sbjct: 133 QLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 188
Query: 913 TAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGG----------------- 955
+ T E+ +PEVL P D++S +++EL T +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 956 -----------------------------MNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986
++ ++ + + ++D +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 987 RKCWQTDPKMRPTFTEIMAALKP-LQKPITSSQVPRP-VPSVSSGRET 1032
Q DP+ R ++ P L+ + ++ P SG +
Sbjct: 309 SPMLQLDPRKRADAGGLVN--HPWLKDTLGMEEIRVPDRELYGSGSDI 354
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 1e-19
Identities = 24/166 (14%), Positives = 51/166 (30%), Gaps = 32/166 (19%)
Query: 757 LGERIGLGSYGEVYRG-DWHGTEVAVK----------------RFLDQDFFGESLEEFRS 799
+G+ +G G V+ E VK + D F ++ R+
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 800 EVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALD 859
E +++++ V +++ E + + ++ +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGN----AVLMELID--------AKELYRVRVENPDEVLDM 111
Query: 860 AARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905
+ ++ IVH DL N+LV + + DF S
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1044 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.29 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 96.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.12 | |
| d2q3za4 | 316 | Transglutaminase catalytic domain {Human (Homo sap | 90.89 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=443.69 Aligned_cols=264 Identities=36% Similarity=0.638 Sum_probs=224.8
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+|++..++|+++++||+|+||+||+|++.+ .||||++..........+.+.+|+.+|++++|||||++++++. .+.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 578889999999999999999999998765 5999999776666677888999999999999999999999865 46789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
|||||++||+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999876778999999999999999999999999 999999999999999999999999999765432
Q ss_pred --cccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-c---cCCCCCC
Q 045028 907 --FLSSRSTAGTAEWMAPEVLRNE---PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-R---RLDIPDN 977 (1044)
Q Consensus 907 --~~~~~s~~GTp~Y~APEvL~g~---~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~---~~~ip~~ 977 (1044)
........||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+.......+.... . ...++..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2233456799999999999753 47899999999999999999999999876654443332222 1 2345678
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
+++++++||.+||..||++|||+.||+++|+.+.+.+
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999999988654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=441.83 Aligned_cols=249 Identities=25% Similarity=0.501 Sum_probs=224.7
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.++++++|||||++++++.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 357899999999999999999987 5788999998754432 2345678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~ 907 (1044)
||||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 vmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999999976 457999999999999999999999999 999999999999999999999999999765433
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
.....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+++..+. ...+.+|..+++++++||.
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHH
Confidence 2345679999999999999999999999999999999999999999999888888773 4556788899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||++||++|||+.|+++|
T Consensus 237 ~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTC
T ss_pred HHccCCHhHCcCHHHHHcC
Confidence 9999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=441.49 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=213.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--CCCceE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR--PPNLSI 827 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~--~~~l~L 827 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|++++|||||++++++.+ ++.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999987 58899999998777666777889999999999999999999998865 456899
Q ss_pred EEEecCCCcHHHHhcC---CCCCCcHHHHHHHHHHHHHHHHHHHhCC---CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 828 VAEFLPRGSLYRLLHR---PNNQLDERRRLRMALDAARGMNYLHNCT---PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr---~~~~Lse~~il~Ia~QIa~AL~yLHs~G---~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
||||++||+|.+++.+ ....+++..++.++.||+.||.|||+++ ..||||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 2467999999999999999999999864 239999999999999999999999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
............+||+.|+|||++.+..++.++|||||||+||||++|++||.+.+..++...+.. .....+|..++++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHH
Confidence 765544445667899999999999999999999999999999999999999999998888877753 3334678889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+++||.+||+.||.+|||+.||++|
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999999999999999876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=445.25 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=220.8
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~L 827 (1044)
..++|++++.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+.+|++++||||++++++|.+++.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 346899999999999999999987 588999999875432 23456779999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC-
Q 045028 828 VAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT- 906 (1044)
Q Consensus 828 VmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~- 906 (1044)
||||++||+|.+++.. ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++.....
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999999876 467999999999999999999999999 999999999999999999999999999865432
Q ss_pred -cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 907 -FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 907 -~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
.....+.+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+++..+. ...+.+|..+++++++|
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDL 240 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHH
Confidence 223345689999999999999999999999999999999999999999999988888874 44567889999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMA 1005 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe 1005 (1044)
|.+||++||.+|||++|+++
T Consensus 241 i~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHccCCHhHCcCHHHHcC
Confidence 99999999999999998644
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=442.72 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=223.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|+++++||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 35799999999999999999986 589999999876543 23467899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||++||+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++........
T Consensus 97 Ey~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999999999875 46999999999999999999999999 999999999999999999999999999876555555
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-cccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-HRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-~~~~~ip~~ip~ELkdLI~r 988 (1044)
....+||+.|+|||++.+..++.++|||||||+||+|++|++||.+.+..+.+..+... ......+..+++++++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 56778999999999999999999999999999999999999999998877766655432 33456678899999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 045028 989 CWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~ 1006 (1044)
||++||.+|||+.|+++|
T Consensus 253 ~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HTCSSTTTSCCHHHHTTC
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999886
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=441.03 Aligned_cols=251 Identities=29% Similarity=0.477 Sum_probs=222.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+.|++++.||+|+||+||+|++ +++.||||++.... ....+.+.+|+++|++++|||||++++++.+++.++|||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 35799999999999999999987 57889999987543 344567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLS 909 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~ 909 (1044)
||++||+|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++........
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999999999998765677999999999999999999999999 999999999999999999999999999765443333
Q ss_pred ccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-ccCCCCCCCCHHHH
Q 045028 910 SRSTAGTAEWMAPEVLR-----NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-RRLDIPDNLDPAVA 983 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~-----g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-~~~~ip~~ip~ELk 983 (1044)
..+.+||+.|+|||++. +..|+.++|||||||+||||++|++||.+.+..+.+..+.... .....+..++++++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 45678999999999984 4567899999999999999999999999998888877765432 24455678999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||.+||++||.+|||+.|+++|
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=444.59 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=229.4
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
+..++|++++.||+|+||+||+|++ +|+.||||++.+.... ....+.+.+|+.+|++++||||++++++|++++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 5567899999999999999999987 6889999998765432 345677899999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
|||||++||+|.+++.+ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++.....
T Consensus 82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999999987 467899999999999999999999999 999999999999999999999999999876555
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
.......+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+++..+. ...+.+|..+++++++||
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHH
Confidence 455567889999999999999999999999999999999999999999999988888774 456788999999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 045028 987 RKCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
.+||++||.+|+ ++.|+++|
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhhccCCchhhcccccccHHHHHcC
Confidence 999999999999 48999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=427.97 Aligned_cols=256 Identities=32% Similarity=0.569 Sum_probs=218.0
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
..++|+++++||+|+||+||+|++ +++.||||++..... ..+.+.+|+.++++++|||||++++++..++.+++||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 346899999999999999999998 467899999876443 3357899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc-c
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-L 908 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-~ 908 (1044)
||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999999999887788999999999999999999999999 9999999999999999999999999998654332 2
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
......||+.|+|||++.+..++.++|||||||+||||+| |.+||...+..++...+. ...+...|..+++++.+||.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 236 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHH
Confidence 2334679999999999999999999999999999999999 577777777777777764 34566778899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccccC
Q 045028 988 KCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+||+.||++|||++||+++|+++.+
T Consensus 237 ~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=433.42 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=212.4
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++..... ....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 46899999999999999999987 588999999875532 233456899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC--c
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--F 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~ 907 (1044)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+|+..... .
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999976 568999999999999999999999999 999999999999999999999999999865322 2
Q ss_pred ccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhccccccCCCCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQ-VVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~e-il~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
......+||+.|||||++.+..+ +.++|||||||+||||++|++||....... .+..+.........+..+++++++|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23456789999999999998876 678999999999999999999998765433 2233322223333346789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||++||++|||+.|+++|
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-50 Score=434.09 Aligned_cols=263 Identities=35% Similarity=0.622 Sum_probs=229.3
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
...|++..++|+++++||+|+||+||+|.+ +++.||||++.... ...+.+.+|+.+|++++|||||++++++.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 346788899999999999999999999988 57889999986543 3356799999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHR-PNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr-~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
+.++|||||+++|+|.+++.+ ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999999865 4567999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHhhhccccccCCCCCCCC
Q 045028 902 MKHNTFL-SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQP-WGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~~-~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~P-F~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
....... ......||+.|+|||++.+..++.++|||||||+||||++|..| |.+.+..++...+ ....+..+|..++
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~ 242 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCP 242 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCC
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccch
Confidence 6544322 23334589999999999999999999999999999999997555 5555665555544 3455678889999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
+++++||.+||+.||++|||+.||++.|+.+.+.
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999887654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=426.62 Aligned_cols=248 Identities=27% Similarity=0.475 Sum_probs=216.1
Q ss_pred eeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec----CCCceEE
Q 045028 755 ITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR----PPNLSIV 828 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~----~~~l~LV 828 (1044)
|++.++||+|+||+||+|.+ +++.||+|.+..........+.+.+|+++|++++|||||++++++.. ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 58889999999999999988 47789999998776666667889999999999999999999999864 3458999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc-CCCeEEEEeccccccccCCc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD-KNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd-~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|||++||+|.+++.+ ...+++..++.++.||+.||.|||+++.+|+||||||+||||+ .++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999999976 4679999999999999999999999887799999999999997 5789999999999865433
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhccccccCCCCCCCCHHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMN-PMQVVGAVGFQHRRLDIPDNLDPAVADII 986 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~-~~eil~~I~~~~~~~~ip~~ip~ELkdLI 986 (1044)
...+.+||+.|+|||++.+ .++.++|||||||+||||++|+.||.+.. ..++...+........++..+++++++||
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 2345789999999999976 49999999999999999999999997754 44555666544455566778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 045028 987 RKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 987 ~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+||++||++|||+.|+++|
T Consensus 247 ~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHccCCHhHCcCHHHHhCC
Confidence 99999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=436.96 Aligned_cols=260 Identities=30% Similarity=0.487 Sum_probs=223.8
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEECC-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~ 817 (1044)
..|+++.++|+++++||+|+||+||+|++.+ ..||+|.+.... .......+.+|+.+|.++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 3567888999999999999999999998732 258999876543 233446788999999998 8999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCC----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEE
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPN----------------------NQLDERRRLRMALDAARGMNYLHNCTPVIV 875 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~----------------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IV 875 (1044)
++.+.+.++|||||++||+|.++++... ..+++..++.++.||+.||.|||+++ ||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--Ii 186 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999999999999999999999997643 24788999999999999999999999 99
Q ss_pred EecCCCCcEEEcCCCeEEEEeccccccccCCcc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 045028 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQP 952 (1044)
Q Consensus 876 HRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~P 952 (1044)
||||||+|||++.++++||+|||+|+....... ...+..||+.|||||++.+..++.++|||||||+||||++ |++|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999986443321 2334568999999999999999999999999999999997 8999
Q ss_pred CCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 953 WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 953 F~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
|.+.+..+.+..+.....++..|..+++++++||.+||+.||++|||+.||+++|.
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99877766666665566678889999999999999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-49 Score=431.12 Aligned_cols=260 Identities=33% Similarity=0.570 Sum_probs=219.2
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEEC--Cc---EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWH--GT---EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~--g~---~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
++..++|++.++||+|+||+||+|++. ++ .||||.+.... .....+.+.+|+.+|++++|||||++++++...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 355678999999999999999999873 32 48888765433 3455678999999999999999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.++|||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999887778999999999999999999999999 999999999999999999999999999864
Q ss_pred cCCcc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCC
Q 045028 904 HNTFL-----SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDN 977 (1044)
Q Consensus 904 ~~~~~-----~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ 977 (1044)
..... ......||+.|+|||++.+..++.++|||||||+||||+| |++||.+....++...+. ...+...|..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 43211 1223458999999999999999999999999999999998 899999999888887775 3456677889
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 978 LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 978 ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+++++.+||.+||+.||++|||+.||++.|+++.+
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=424.45 Aligned_cols=259 Identities=32% Similarity=0.584 Sum_probs=226.1
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
.+|+++.++|+++++||+|+||+||+|++. ++.||||++..... ..+.+.+|+.++++++|||||++++++. ++.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCC
Confidence 467888999999999999999999999985 56799999875442 3467999999999999999999999875 467
Q ss_pred ceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
++|||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 89999999999999988653 235899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 904 HNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 904 ~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.... .......||+.|+|||++.+..++.++|||||||+||||+|| ++||...+..++...+. ...+...|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 4332 233456799999999999999999999999999999999995 56677777777777664 44567788999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
+.+||.+||+.||++|||+.+|++.|++++
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 999999999999999999999999998865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=438.52 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=212.3
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCce
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLS 826 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~ 826 (1044)
++..++|+++++||+|+||+||+|++ +|+.||+|++.... .......+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45668999999999999999999987 58899999987543 3344577899999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|||||+.||+|.+++.+ ...+++..++.++.||+.||.|||+ +| |+||||||+||||+.+|++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999976 4579999999999999999999997 58 99999999999999999999999999986543
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhc-------------------
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVG------------------- 966 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~------------------- 966 (1044)
. ...+.+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+......
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2 2345789999999999999999999999999999999999999998765432211100
Q ss_pred ----------------------cccccCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 967 ----------------------FQHRRLDIP-DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 967 ----------------------~~~~~~~ip-~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
........+ ..++.++++||.+||..||++|||+.|+|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000011111 2468899999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.7e-49 Score=437.64 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=222.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999987 58899999987554 334567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC--CCeEEEEeccccccccCCc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK--NWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~--dg~VKLiDFGLA~~~~~~~ 907 (1044)
||++||+|.+++.+....+++..++.++.||+.||.|||++| ||||||||+||||+. ++.+||+|||+++......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999999776678999999999999999999999999 999999999999964 6899999999998654432
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip~ELkdL 985 (1044)
...+..||+.|||||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+....... ..+..+++++++|
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 3345789999999999999999999999999999999999999999999888888775443322 2235689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||++||++|||+.|+|+|
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999997
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=420.00 Aligned_cols=253 Identities=29% Similarity=0.525 Sum_probs=228.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.++|+++++||+|+||+||+|++. ++.||||+++..... .+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 468999999999999999999984 568999998865533 3578999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc-c
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL-S 909 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~-~ 909 (1044)
|+.+|+|..++......+++..+++++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....... .
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999998877788999999999999999999999999 99999999999999999999999999976543322 3
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 910 SRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 910 ~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. ...+...|..+++++++||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHHH
Confidence 334679999999999999999999999999999999998 899999999988888775 445677889999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHhccc
Q 045028 989 CWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 989 cL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
||+.||++|||+.+|+++|.++
T Consensus 237 cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCSSGGGSCCHHHHHHHHHCC
T ss_pred HccCCHhHCcCHHHHHHHhhCC
Confidence 9999999999999999999764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-48 Score=436.77 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=223.1
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.++|+++++||+|+||+||+|++ +|+.||||++.... ......+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999987 58899999987654 233467889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc--CCCeEEEEeccccccccCCc
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD--KNWVVKVCDFGLSRMKHNTF 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd--~dg~VKLiDFGLA~~~~~~~ 907 (1044)
|||+||+|.+++.+....+++..++.++.||+.||.|||++| ||||||||+||||+ .++.+||+|||+++......
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999999999998877778999999999999999999999999 99999999999998 57899999999998765432
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--CCCCCCCCHHHHHH
Q 045028 908 LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR--LDIPDNLDPAVADI 985 (1044)
Q Consensus 908 ~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~--~~ip~~ip~ELkdL 985 (1044)
......||+.|+|||++.+..++.++|||||||+||+|++|++||.+.+..+.+..+...... ...+..+++++++|
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 234567999999999999999999999999999999999999999999988888777543332 23446899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 045028 986 IRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~ 1006 (1044)
|.+||++||.+|||+.|+|+|
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-49 Score=432.42 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=205.3
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
.+.|++++.||+|+||+||+|++ +++.||||++...... .....+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999987 5888999998765433 23356889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEc---CCCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVD---KNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd---~dg~VKLiDFGLA~~~~~~ 906 (1044)
||++||+|.+++.+ ...+++..+..++.||+.||.|||++| |+||||||+|||+. .++.+||+|||+++.....
T Consensus 87 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999999976 567999999999999999999999999 99999999999995 5789999999999865433
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip~ELkd 984 (1044)
. ...+.+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+....+....... ..+..+++++++
T Consensus 164 ~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 164 S-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred C-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 2 2345789999999999999999999999999999999999999999998888887775444333 344679999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
||.+||++||++|||+.|+++|
T Consensus 243 li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCHhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=422.74 Aligned_cols=259 Identities=24% Similarity=0.451 Sum_probs=226.5
Q ss_pred CcCCCCeeEEeE-ecccCcEEEEEEEE----CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 749 EIPWEEITLGER-IGLGSYGEVYRGDW----HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 749 ei~~e~y~I~r~-LGkG~FGtVykak~----~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
-+..++|.+.+. ||+|+||+||+|.+ ++..||||+++... .....+.+.+|+.+|++++|||||++++++.. +
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 345678999885 99999999999976 24469999986543 34556789999999999999999999999875 5
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+||||||++||+|.+++...+..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcc
Confidence 689999999999999998776778999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 904 HNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 904 ~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
.... .......||+.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..++...+. ...++.+|..++
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 238 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 238 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 4321 22334568999999999999999999999999999999998 899999988888777764 445678889999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999887654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-48 Score=430.49 Aligned_cols=247 Identities=23% Similarity=0.435 Sum_probs=224.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++.+.... ....+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999987 5889999998754332 34567899999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.||+|..++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++.....
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999999876 567889999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
..+.+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+..+++..+. .....+|..++++++++|.+
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999988888874 34567888999999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHH
Q 045028 989 CWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRP-----Ta~ELLe~ 1006 (1044)
||.+||.+|+ |+++|++|
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhhCHHhccccchhhHHHHHcC
Confidence 9999999996 99999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=420.55 Aligned_cols=261 Identities=32% Similarity=0.569 Sum_probs=219.3
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC-----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH-----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~-----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
+++++.++|++++.||+|+||+||+|++. +..||||.+.... .....+.+.+|+.+|++++|||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 36788899999999999999999999873 2358888765432 3455677999999999999999999999985
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
++.+|+||||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence 57799999999999999998776778999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCC-cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 902 MKHNT-FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 902 ~~~~~-~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
..... ........||+.|+|||++.+..++.++|||||||+||||++ |.+||.+.+..+++..+. ...+..+|..++
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 65432 223344568999999999999999999999999999999998 899999999888888775 345567889999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+++++||.+||..||++|||+.||+++|+.+.+
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999988754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=429.95 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=218.4
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.|+++++||+|+||+||+|++ +++.||||++...... ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999987 5788999998765443 3456779999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
||.||+|..++.. ...+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.... .
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC----C
Confidence 9999999776654 467999999999999999999999999 99999999999999999999999999986543 2
Q ss_pred cCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHH
Q 045028 911 RSTAGTAEWMAPEVLRN---EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIR 987 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g---~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~ 987 (1044)
...+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..+.........+..+++++++||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 45689999999999965 358899999999999999999999999988888777775554444556679999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 045028 988 KCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 988 rcL~kDPekRPTa~ELLe~ 1006 (1044)
+||++||.+|||+.|+++|
T Consensus 249 ~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHCcCChhHCcCHHHHHhC
Confidence 9999999999999999886
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=421.91 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=221.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++.+..... ...+.+.+|+.+|++++|||||+++++|.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999987 58899999987654332 2467899999999999999999999999999999
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC----eEEEEeccccc
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 901 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg----~VKLiDFGLA~ 901 (1044)
||||||++||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999976 457999999999999999999999999 99999999999998776 59999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CCCCCCC
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DIPDNLD 979 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~ip~~ip 979 (1044)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+....... ..+..++
T Consensus 166 ~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 166 KIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp ECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 654432 2345689999999999999999999999999999999999999999999888887775433322 2346789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+++++||.+||++||++|||+.|+++|
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-48 Score=433.00 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=223.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999987 5889999998754322 34567789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+.||+|..++.+ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999999876 457999999999999999999999999 999999999999999999999999999876533
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
..+.+||+.|||||++.+..++.++|||||||+||||++|++||.+.+..+++..+. .....+|..+++++.+||.+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999888888874 44567788999999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHH
Q 045028 989 CWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRP-----Ta~ELLe~ 1006 (1044)
||.+||.+|+ |+.+|++|
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhhCHHhccccccccHHHHHcC
Confidence 9999999994 99999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=418.04 Aligned_cols=260 Identities=30% Similarity=0.542 Sum_probs=220.5
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEECC------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDWHG------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP 822 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~~g------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~ 822 (1044)
++..+.|++.++||+|+||+||+|.+.+ ..||||++.... .......+.+|+.++++++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4566789999999999999999998742 369999986543 344556789999999999999999999999999
Q ss_pred CCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccc
Q 045028 823 PNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRM 902 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~ 902 (1044)
+.+++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999998877788999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 903 KHNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 903 ~~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
..... .......||+.|+|||++.+..++.++|||||||+||||++| .+||...+..++...+. ...+...|..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhh
Confidence 43321 122345689999999999999999999999999999999995 55566667777766664 44567788899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
+.++++||.+||+.||++|||+.||++.|+.+.+
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999999999988765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=418.22 Aligned_cols=252 Identities=27% Similarity=0.503 Sum_probs=215.5
Q ss_pred eeEE-eEecccCcEEEEEEEEC----CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEE
Q 045028 755 ITLG-ERIGLGSYGEVYRGDWH----GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 755 y~I~-r~LGkG~FGtVykak~~----g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVm 829 (1044)
+.+. ++||+|+||+||+|.+. ++.||||++..........+.+.+|+.+|++++|||||++++++.. +.++|||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 4444 47999999999999762 3579999987655445566789999999999999999999999865 5678999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCc--
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTF-- 907 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~-- 907 (1044)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 87 E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp ECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999999976 467999999999999999999999999 9999999999999999999999999998643321
Q ss_pred -ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHH
Q 045028 908 -LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADI 985 (1044)
Q Consensus 908 -~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdL 985 (1044)
.......||+.|+|||++.+..++.++|||||||+||||++ |++||.+.+..++...+. ...++.+|..+++++++|
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDL 242 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHH
Confidence 12234569999999999999999999999999999999998 899999998888877764 445678889999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 986 IRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 986 I~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
|.+||+.||++|||+.+|++.|+.++
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 99999999999999999998887754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=427.12 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=223.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCc-chhhHHHHHHHHHHHH-hCCCCCeeEEEeeeecCCCceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDF-FGESLEEFRSEVLIMK-RVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~-~~~~~~~~~~EI~ILk-~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
++|++++.||+|+||+||+|++ +++.||||++.+... .....+.+..|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999988 688999999875432 2344566777777765 68999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999999999976 467899999999999999999999999 99999999999999999999999999987655555
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHH
Q 045028 909 SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRK 988 (1044)
Q Consensus 909 ~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~r 988 (1044)
......||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..++...+. ...+.+|..+++++++||.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 5566789999999999999999999999999999999999999999999998888874 45667888999999999999
Q ss_pred hhhcCCCCCCCHH-HHHHH
Q 045028 989 CWQTDPKMRPTFT-EIMAA 1006 (1044)
Q Consensus 989 cL~kDPekRPTa~-ELLe~ 1006 (1044)
||.+||.+|||+. ++++|
T Consensus 237 ~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGS
T ss_pred hcccCCCCCcCHHHHHHhC
Confidence 9999999999995 78775
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-47 Score=410.70 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=216.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCC----
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPN---- 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~---- 824 (1044)
.++|++.+.||+|+||+||+|++ +|+.||||++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999987 5889999998765443 3455679999999999999999999999876543
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+||||||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.++|+|||++....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhc
Confidence 8999999999999998876 457999999999999999999999999 9999999999999999999999999986533
Q ss_pred CC---cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc--CCCCCCCC
Q 045028 905 NT---FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR--LDIPDNLD 979 (1044)
Q Consensus 905 ~~---~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~--~~ip~~ip 979 (1044)
.. .......+||+.|+|||++.+..++.++|||||||+||||+||++||.+.+..+....+...... ......+|
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 22 22344567999999999999999999999999999999999999999998888877665433332 23456899
Q ss_pred HHHHHHHHHhhhcCCCCCC-CHHHHHHHhcccc
Q 045028 980 PAVADIIRKCWQTDPKMRP-TFTEIMAALKPLQ 1011 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRP-Ta~ELLe~Lk~L~ 1011 (1044)
+++++||.+||++||.+|| |++++++.|.++.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 9999999999999999999 8999999988765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=415.58 Aligned_cols=265 Identities=33% Similarity=0.567 Sum_probs=222.9
Q ss_pred CCccccCcCCCCeeEEeEecccCcEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec
Q 045028 743 DDVAECEIPWEEITLGERIGLGSYGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR 821 (1044)
Q Consensus 743 ~~~~~~ei~~e~y~I~r~LGkG~FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~ 821 (1044)
....+|+|..++|++++.||+|+||+||+|++. ++.||||++..... ..+.+.+|+.++++++|||||++++++.
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~- 82 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS- 82 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEe-
Confidence 344568888999999999999999999999885 45799999865543 3467999999999999999999999985
Q ss_pred CCCceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
++.+++||||+++|+|..++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchh
Confidence 46789999999999999888653 356999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhccccccCCCCCCC
Q 045028 901 RMKHNTF-LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGFQHRRLDIPDNL 978 (1044)
Q Consensus 901 ~~~~~~~-~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~~~~~~~ip~~i 978 (1044)
+...... .......||+.|+|||++.+..++.++|||||||+||||++| ++||......+++..+. ...+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~ 239 (285)
T d1fmka3 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPEC 239 (285)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTS
T ss_pred hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCccc
Confidence 8654332 223346799999999999999999999999999999999995 55566677777777664 34466788999
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 979 DPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 979 p~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
++++++||.+||+.||++||++.+|++.|+++....
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999999999998877643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=422.14 Aligned_cols=250 Identities=19% Similarity=0.299 Sum_probs=220.6
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEE
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LV 828 (1044)
.+++|++++.||+|+||+||+|.+ +++.||||++.... .....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 367899999999999999999987 57889999987654 2335688999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC--CeEEEEeccccccccCC
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN--WVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d--g~VKLiDFGLA~~~~~~ 906 (1044)
||||+||+|.+++.+.+..+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999886668999999999999999999999999 9999999999999854 58999999999865433
Q ss_pred cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCC--CCCCCCHHHHH
Q 045028 907 FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD--IPDNLDPAVAD 984 (1044)
Q Consensus 907 ~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~--ip~~ip~ELkd 984 (1044)
. .....+||+.|+|||.+.+..++.++|||||||+||+|++|++||.+.+..+.+..+......+. .+..+++++++
T Consensus 158 ~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred C-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 2 23456799999999999999999999999999999999999999999999888888753332221 22478999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
||.+||.+||.+|||+.|+++|
T Consensus 237 li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=413.53 Aligned_cols=247 Identities=23% Similarity=0.275 Sum_probs=206.9
Q ss_pred EEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch---hhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEEe
Q 045028 757 LGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG---ESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 757 I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~---~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
.+++||+|+||+||+|++ +|+.||||++....... .....+.+|+.+|++++|||||++++++..++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999987 58899999986543221 1234688999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCccccc
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSSR 911 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~~ 911 (1044)
+.|+++..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 988877766644 677999999999999999999999999 99999999999999999999999999987666555566
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccccc-------------------
Q 045028 912 STAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRR------------------- 971 (1044)
Q Consensus 912 s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~------------------- 971 (1044)
..+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+..+.+..+......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 67899999999998754 5799999999999999999999999998887766554211000
Q ss_pred -------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 972 -------LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 972 -------~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......+++++++||.+||++||++|||+.|+|+|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00113578999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=413.73 Aligned_cols=254 Identities=34% Similarity=0.641 Sum_probs=219.8
Q ss_pred cCcCCCCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec-CCCce
Q 045028 748 CEIPWEEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-PPNLS 826 (1044)
Q Consensus 748 ~ei~~e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-~~~l~ 826 (1044)
|++..++|+++++||+|+||.||+|+++|+.||||++++.. ..+.+.+|++++++++||||+++++++.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 67788999999999999999999999999999999986543 34678999999999999999999998854 46789
Q ss_pred EEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
|||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999999753 235899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHHHH
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAVAD 984 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~ELkd 984 (1044)
. .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..++...+. ...++.+|..+++++++
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHH
Confidence 3 334578999999999999999999999999999999998 799999988888888774 45677889999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 985 IIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 985 LI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
||.+||..||.+|||+.+|+++|+++.
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=417.13 Aligned_cols=265 Identities=30% Similarity=0.557 Sum_probs=216.6
Q ss_pred ccccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEE
Q 045028 745 VAECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFM 816 (1044)
Q Consensus 745 ~~~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~ 816 (1044)
..+|+++.++|+++++||+|+||+||+|++. ++.||||++..... ....+.+.+|+.++.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 4567888999999999999999999999862 35799999865432 34456677888888777 689999999
Q ss_pred eeeecC-CCceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC
Q 045028 817 GAVTRP-PNLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK 880 (1044)
Q Consensus 817 ~~~~~~-~~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK 880 (1044)
+++... ..+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlK 161 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA 161 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCC
Confidence 987654 4689999999999999998642 235899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCC
Q 045028 881 SPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMN 957 (1044)
Q Consensus 881 PeNILLd~dg~VKLiDFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~ 957 (1044)
|+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++| .+||.+..
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999754332 2233456799999999999999999999999999999999987 56888776
Q ss_pred hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 958 ~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
..+.+..+.....++.+|..+++++++||.+||+.||++|||+.||+++|+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 6555555444566778889999999999999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-47 Score=425.54 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=212.9
Q ss_pred CCCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchh-hHHHHH---HHHHHHHhCCCCCeeEEEeeeecCCC
Q 045028 751 PWEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGE-SLEEFR---SEVLIMKRVRHPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 751 ~~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~-~~~~~~---~EI~ILk~LrHPNIVkl~~~~~~~~~ 824 (1044)
..++|+++++||+|+||+||+|++ +|+.||||++.+...... ....+. .++.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 457899999999999999999987 588999999865433221 222333 34677778889999999999999999
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+||||||++||+|.+++.+ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999999976 467899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-ccccccCCCCCCCCHHH
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLR-NEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAV-GFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~-g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I-~~~~~~~~ip~~ip~EL 982 (1044)
.. .....+||+.|+|||++. +..|+.++|||||||+||||++|+.||.+.+..+..... ........+|..+++++
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 234568999999999996 456899999999999999999999999876544332211 12345667788999999
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHHH
Q 045028 983 ADIIRKCWQTDPKMRPT-----FTEIMAA 1006 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPT-----a~ELLe~ 1006 (1044)
++||.+||.+||.+||| ++||++|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999 7999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=416.18 Aligned_cols=263 Identities=31% Similarity=0.526 Sum_probs=229.0
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEECC-------cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEee
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDWHG-------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGA 818 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~~g-------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~ 818 (1044)
..++++.++|++++.||+|+||+||+|++.+ +.||||++.... .....+.+.+|+.+|++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3567888999999999999999999998743 679999886543 34456789999999999999999999999
Q ss_pred eecCCCceEEEEecCCCcHHHHhcCC-----------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEE
Q 045028 819 VTRPPNLSIVAEFLPRGSLYRLLHRP-----------------------NNQLDERRRLRMALDAARGMNYLHNCTPVIV 875 (1044)
Q Consensus 819 ~~~~~~l~LVmEy~~GGsL~dlLkr~-----------------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IV 875 (1044)
+...+.++++|||+.+|+|.+++... ...+++..++.++.||+.||.|||+++ ||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence 99999999999999999999998642 134888999999999999999999999 99
Q ss_pred EecCCCCcEEEcCCCeEEEEeccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CC
Q 045028 876 HRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQ-QP 952 (1044)
Q Consensus 876 HRDIKPeNILLd~dg~VKLiDFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk-~P 952 (1044)
||||||+||||+.++.+||+|||+++..... .....+..||+.|+|||++.+..++.++|||||||+||||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999999754322 22234567899999999999999999999999999999999995 68
Q ss_pred CCCCChHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 953 WGGMNPMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 953 F~~~~~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
|.+.+..++...+.. .....+|..+++++.+||.+||+.||++|||+.||++.|+++.+
T Consensus 243 ~~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 999999888888753 44667888999999999999999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=414.43 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=214.0
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
|+|+++++||+|+||+||+|++ +|+.||||++............+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 58899999997654444456788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.++.+..........+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99776555555555678999999999999999999999999 9999999999999999999999999998766655556
Q ss_pred cCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc----------------cCC
Q 045028 911 RSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR----------------RLD 973 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~----------------~~~ 973 (1044)
....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+..+..... ...
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 6678999999999987766 57899999999999999999999998877665544311000 000
Q ss_pred -----------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccc
Q 045028 974 -----------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPL 1010 (1044)
Q Consensus 974 -----------ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L 1010 (1044)
....+++++++||.+||.+||++|||+.|+++| |+++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 113567899999999999999999999999997 4444
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.3e-47 Score=410.01 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=220.0
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch-------hhHHHHHHHHHHHHhCC-CCCeeEEEeeeec
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG-------ESLEEFRSEVLIMKRVR-HPNVVLFMGAVTR 821 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~-------~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~ 821 (1044)
.++|++++.||+|+||+||+|++ +|+.||||++....... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999987 68899999987654322 22346889999999997 9999999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
++.+||||||++||+|.++++. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999976 457999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccccCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCC--
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRN------EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLD-- 973 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g------~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~-- 973 (1044)
...... ......||+.|+|||++.+ ..++.++||||+||+||+|++|+.||.+.+..+....+......+.
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 765432 3455789999999999853 3468899999999999999999999999998888777754443332
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.+..+++++++||.+||.+||++|||+.|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 234799999999999999999999999999887
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=416.15 Aligned_cols=256 Identities=28% Similarity=0.529 Sum_probs=218.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEEC--Cc----EEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCc
Q 045028 752 WEEITLGERIGLGSYGEVYRGDWH--GT----EVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNL 825 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~~--g~----~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l 825 (1044)
.++|+++++||+|+||+||+|++. |+ .||+|.+.... .....+.+.+|+.++++++|||||++++++.+ +..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCe
Confidence 467999999999999999999873 43 58888775432 23456789999999999999999999999976 567
Q ss_pred eEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccC
Q 045028 826 SIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~ 905 (1044)
+++|||+.+++|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 8889999999999998887888999999999999999999999999 99999999999999999999999999986543
Q ss_pred Ccc--cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCCHHH
Q 045028 906 TFL--SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPAV 982 (1044)
Q Consensus 906 ~~~--~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~EL 982 (1044)
... ......||+.|+|||++.+..++.++|||||||+||||+| |.+||.+.+..++...+. ...++..|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 222 2334568999999999999999999999999999999998 799999888877766653 445677889999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 983 ADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 983 kdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.+||.+||..||.+|||+.||+++|..+.+
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=411.33 Aligned_cols=258 Identities=33% Similarity=0.569 Sum_probs=217.3
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEEC---C--cEEEEEEeeccCcc-hhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDWH---G--TEVAVKRFLDQDFF-GESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~~---g--~~VAVK~l~~~~~~-~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~ 823 (1044)
+..++|++++.||+|+||+||+|++. + ..||||++...... ....+.+.+|+.+|++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 45678999999999999999999863 2 36899988655432 3445789999999999999999999999965 5
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhc
Confidence 789999999999999988776678999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhccccccCCCCCCCC
Q 045028 904 HNTF---LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNPMQVVGAVGFQHRRLDIPDNLD 979 (1044)
Q Consensus 904 ~~~~---~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~~eil~~I~~~~~~~~ip~~ip 979 (1044)
.... .......|+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.....++..+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 3322 12334457889999999999999999999999999999998 8999999999999888877777788889999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 045028 980 PAVADIIRKCWQTDPKMRPTFTEIMAALKPL 1010 (1044)
Q Consensus 980 ~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L 1010 (1044)
+++++||.+||..||++|||+.+|++.|++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999999999999999999999999988764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=408.02 Aligned_cols=261 Identities=32% Similarity=0.592 Sum_probs=225.3
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEECC---------cEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEE
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWHG---------TEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFM 816 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~g---------~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~ 816 (1044)
.|+++.++|++++.||+|+||.||+|+..+ ..||||++.... .......+.+|..++.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 478889999999999999999999997632 369999886543 345567788899999888 799999999
Q ss_pred eeeecCCCceEEEEecCCCcHHHHhcCCC---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCC
Q 045028 817 GAVTRPPNLSIVAEFLPRGSLYRLLHRPN---------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKS 881 (1044)
Q Consensus 817 ~~~~~~~~l~LVmEy~~GGsL~dlLkr~~---------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKP 881 (1044)
+++.+++.+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 99999999999999999999999997542 45899999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 045028 882 PNLLVDKNWVVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMNP 958 (1044)
Q Consensus 882 eNILLd~dg~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~~ 958 (1044)
+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..|+.++|||||||+||||++ |++||.+.+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999999998654332 22344678999999999999999999999999999999998 7999999888
Q ss_pred HHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 045028 959 MQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQ 1011 (1044)
Q Consensus 959 ~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~ 1011 (1044)
.+++..+. ...++..|..+++++++||.+||++||.+|||+.||++.|+++.
T Consensus 244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 88877664 45677889999999999999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=410.11 Aligned_cols=261 Identities=32% Similarity=0.629 Sum_probs=223.5
Q ss_pred CcCCCCeeEEeEecccCcEEEEEEEE--CCc--EEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeecCC
Q 045028 749 EIPWEEITLGERIGLGSYGEVYRGDW--HGT--EVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTRPP 823 (1044)
Q Consensus 749 ei~~e~y~I~r~LGkG~FGtVykak~--~g~--~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~~~ 823 (1044)
.+.+++|++.++||+|+||+||+|++ +|. .||||.+.... .....+.+.+|+++|+++ +|||||++++++..++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 35678999999999999999999987 344 46777765332 233456799999999999 7999999999999999
Q ss_pred CceEEEEecCCCcHHHHhcCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP---------------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK 888 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~---------------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~ 888 (1044)
.++|||||++||+|.+++++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 999999999999999999753 367999999999999999999999999 999999999999999
Q ss_pred CCeEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhcc
Q 045028 889 NWVVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGF 967 (1044)
Q Consensus 889 dg~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~ 967 (1044)
++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||+||||++| .+||.+.+..++...+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240 (309)
T ss_dssp GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 9999999999997544332 23455799999999999999999999999999999999996 56788888888888775
Q ss_pred ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 968 ~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
...++..|..+++++++||.+||+.||++|||+.||+++|+++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 34567888899999999999999999999999999999999988654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-46 Score=402.40 Aligned_cols=252 Identities=24% Similarity=0.304 Sum_probs=211.9
Q ss_pred CCCeeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
.++|+++++||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|++++||||+++++++..++..+++||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 36899999999999999999987 57899999997665545556789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
|+.++.+..+... ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||++..........
T Consensus 81 ~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9987766666554 678999999999999999999999999 9999999999999999999999999998766555555
Q ss_pred cCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc--------------------
Q 045028 911 RSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH-------------------- 969 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~-------------------- 969 (1044)
....|++.|+|||.+.+. .++.++|||||||+||||++|+.||.+.+..+.+..+....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 566799999999999765 46899999999999999999999999887766554432100
Q ss_pred -------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 -------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 -------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....++..+++++++||++||++||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0012345678999999999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=404.58 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=210.9
Q ss_pred CCeeEEeEecccCcEEEEEEEEC---CcEEEEEEeeccCcchhhHHHHHHHHHHHHhC---CCCCeeEEEeeeec-----
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH---GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV---RHPNVVLFMGAVTR----- 821 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~---g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L---rHPNIVkl~~~~~~----- 821 (1044)
++|+++++||+|+||+||+|++. ++.||||++............+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999873 55799999876543333334466788777665 79999999998853
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
...++++|||+.++.+..........+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 34689999999998887776666788999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc------------
Q 045028 902 MKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH------------ 969 (1044)
Q Consensus 902 ~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~------------ 969 (1044)
..... .......||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+....
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65433 23456789999999999999999999999999999999999999999988776655542110
Q ss_pred -------------ccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 -------------RRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 -------------~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
....++..+++++++||.+||++||++|||+.|+|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0112345789999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=407.37 Aligned_cols=263 Identities=35% Similarity=0.570 Sum_probs=231.8
Q ss_pred ccCcCCCCeeEEeEecccCcEEEEEEEEC-------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeee
Q 045028 747 ECEIPWEEITLGERIGLGSYGEVYRGDWH-------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAV 819 (1044)
Q Consensus 747 ~~ei~~e~y~I~r~LGkG~FGtVykak~~-------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~ 819 (1044)
+|++..++|+++++||+|+||+||+|.+. ++.||||++.... .......+.+|+.++++++||||+++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 57889999999999999999999999764 4679999987543 344556789999999999999999999999
Q ss_pred ecCCCceEEEEecCCCcHHHHhcCC---------CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC
Q 045028 820 TRPPNLSIVAEFLPRGSLYRLLHRP---------NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW 890 (1044)
Q Consensus 820 ~~~~~l~LVmEy~~GGsL~dlLkr~---------~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg 890 (1044)
..++..++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 9999999999999999999998632 245788999999999999999999999 99999999999999999
Q ss_pred eEEEEeccccccccCCc--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhcc
Q 045028 891 VVKVCDFGLSRMKHNTF--LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTM-QQPWGGMNPMQVVGAVGF 967 (1044)
Q Consensus 891 ~VKLiDFGLA~~~~~~~--~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTG-k~PF~~~~~~eil~~I~~ 967 (1044)
++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||+||||+|| .+||.+.+..+++..+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~- 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999998654322 223445689999999999999999999999999999999998 58899999888888775
Q ss_pred ccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCC
Q 045028 968 QHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKP 1013 (1044)
Q Consensus 968 ~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~ 1013 (1044)
...+...|..+++++.+||.+||+.||++|||+.+|+++|++..++
T Consensus 250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 4456778899999999999999999999999999999999987664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=406.29 Aligned_cols=264 Identities=29% Similarity=0.510 Sum_probs=229.9
Q ss_pred cccCcCCCCeeEEeEecccCcEEEEEEEE-------CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEe
Q 045028 746 AECEIPWEEITLGERIGLGSYGEVYRGDW-------HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMG 817 (1044)
Q Consensus 746 ~~~ei~~e~y~I~r~LGkG~FGtVykak~-------~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~ 817 (1044)
..|+++.++|+++++||+|+||.||+|++ .++.||||+++... .......+.+|+.+++++ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 36788899999999999999999999986 24579999987544 344556799999999999 6999999999
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCC-----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCC
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPN-----------------NQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLK 880 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~-----------------~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIK 880 (1044)
++...+.++|||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |||||||
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLK 172 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccc
Confidence 9999999999999999999999987532 35899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccCC--cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 045028 881 SPNLLVDKNWVVKVCDFGLSRMKHNT--FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCT-MQQPWGGMN 957 (1044)
Q Consensus 881 PeNILLd~dg~VKLiDFGLA~~~~~~--~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLT-Gk~PF~~~~ 957 (1044)
|+|||++.++.+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||+||||+| |.+||...+
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865432 223345679999999999999999999999999999999998 677777777
Q ss_pred hHHHHhhhccccccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 958 PMQVVGAVGFQHRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 958 ~~eil~~I~~~~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
..+.+..+.....+...+..+++++.+||.+||+.||.+|||+.+|++.|+++..
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 7666666555666778888999999999999999999999999999999986543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=411.05 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=204.5
Q ss_pred CCCeeEEe-EecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhC-CCCCeeEEEeeeec----CC
Q 045028 752 WEEITLGE-RIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRV-RHPNVVLFMGAVTR----PP 823 (1044)
Q Consensus 752 ~e~y~I~r-~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~L-rHPNIVkl~~~~~~----~~ 823 (1044)
.++|++.+ .||+|+||+||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46899875 599999999999987 5889999998643 3577899987654 79999999999875 45
Q ss_pred CceEEEEecCCCcHHHHhcCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEeccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRP-NNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGL 899 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~-~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGL 899 (1044)
.+|||||||+||+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++. .+.+||+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 699999999999999999864 457999999999999999999999999 999999999999985 56899999999
Q ss_pred cccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc--ccccCCCC--
Q 045028 900 SRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF--QHRRLDIP-- 975 (1044)
Q Consensus 900 A~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~--~~~~~~ip-- 975 (1044)
++...... .....+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+....+.. ......+|
T Consensus 161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 98654432 34557899999999999999999999999999999999999999987665444333211 22233333
Q ss_pred --CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 976 --DNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 976 --~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
..+++++++||.+||++||++|||+.|+++|
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3589999999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=402.06 Aligned_cols=241 Identities=23% Similarity=0.428 Sum_probs=206.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcch----hhHHHHHHHHHHHHhCC--CCCeeEEEeeeecCCC
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFG----ESLEEFRSEVLIMKRVR--HPNVVLFMGAVTRPPN 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~----~~~~~~~~EI~ILk~Lr--HPNIVkl~~~~~~~~~ 824 (1044)
++|+++++||+|+||+||+|++ +|+.||||++....... .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999987 58899999987543321 11234678999999986 8999999999999999
Q ss_pred ceEEEEecCC-CcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-CCeEEEEecccccc
Q 045028 825 LSIVAEFLPR-GSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-NWVVKVCDFGLSRM 902 (1044)
Q Consensus 825 l~LVmEy~~G-GsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-dg~VKLiDFGLA~~ 902 (1044)
+++||||+.+ +++.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 688888765 467999999999999999999999999 999999999999985 57999999999986
Q ss_pred ccCCcccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccCCCCCCCCHH
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRNEPS-DEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRLDIPDNLDPA 981 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g~~~-s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~~ip~~ip~E 981 (1044)
.... ...+..||+.|+|||++.+..+ +.++|||||||+||||++|+.||...+ ++. .....++..++++
T Consensus 161 ~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~------~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFFRQRVSSE 230 (273)
T ss_dssp CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCCSSCCCHH
T ss_pred cccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHh------hcccCCCCCCCHH
Confidence 5443 2345789999999999987765 678999999999999999999997632 221 2345677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 982 VADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 982 LkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
+++||.+||++||++|||+.|+++|
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcC
Confidence 9999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=400.02 Aligned_cols=259 Identities=30% Similarity=0.516 Sum_probs=218.2
Q ss_pred eeEEeEecccCcEEEEEEEECC-----cEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec-CCCceEE
Q 045028 755 ITLGERIGLGSYGEVYRGDWHG-----TEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-PPNLSIV 828 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~~g-----~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-~~~l~LV 828 (1044)
+++.++||+|+||+||+|++.. ..||||++.... .....+.+.+|+++|++++||||+++++++.. ++.+++|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 3447899999999999998732 258999886432 34566789999999999999999999998764 5679999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFL 908 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~ 908 (1044)
|||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999999987788899999999999999999999999 99999999999999999999999999986543221
Q ss_pred ----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhccccccCCCCCCCCHHHH
Q 045028 909 ----SSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGM-NPMQVVGAVGFQHRRLDIPDNLDPAVA 983 (1044)
Q Consensus 909 ----~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~-~~~eil~~I~~~~~~~~ip~~ip~ELk 983 (1044)
......||+.|+|||.+.+..++.++||||||++||||++|..||... +..++...+. ...++..|..+++++.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHH
Confidence 223356899999999999999999999999999999999977776553 4444444443 4456778899999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccccCCCCCC
Q 045028 984 DIIRKCWQTDPKMRPTFTEIMAALKPLQKPITSS 1017 (1044)
Q Consensus 984 dLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l~~~ 1017 (1044)
+||.+||+.||++||++.||+++|+.+.+.+...
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 9999999999999999999999999998765554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=396.77 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=209.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP------ 823 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~------ 823 (1044)
.++|+++++||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999987 5899999999766555666778999999999999999999999997655
Q ss_pred CceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccc
Q 045028 824 NLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMK 903 (1044)
Q Consensus 824 ~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~ 903 (1044)
.+||||||+ +.+|..+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 479999999 7788888865 57999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc--------------
Q 045028 904 HNTFLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ-------------- 968 (1044)
Q Consensus 904 ~~~~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~-------------- 968 (1044)
... .....||+.|+|||++.+. .++.++|||||||+||+|++|++||.+.+..+.+..+...
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 443 3456799999999999765 4689999999999999999999999987766544332110
Q ss_pred ---------------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hcccc
Q 045028 969 ---------------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQ 1011 (1044)
Q Consensus 969 ---------------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~ 1011 (1044)
.........+++++.+||.+||..||.+|||+.|+|+| |+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 01112345789999999999999999999999999998 55444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=383.11 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=216.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCCCceEEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPPNLSIVAE 830 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~~l~LVmE 830 (1044)
++|+++++||+|+||+||+|++ +++.||||+++...........+.+|+.+|+.++||||+++++++.+...+++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999987 57889999997766555667889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCCcccc
Q 045028 831 FLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNTFLSS 910 (1044)
Q Consensus 831 y~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~~~~~ 910 (1044)
++.|++|..++.. ...+++..++.++.|++.||+|||++| |+||||||+||||+.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9999999888765 577899999999999999999999999 9999999999999999999999999998776655555
Q ss_pred cCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHhhhccc--------------------
Q 045028 911 RSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWG-GMNPMQVVGAVGFQ-------------------- 968 (1044)
Q Consensus 911 ~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~-~~~~~eil~~I~~~-------------------- 968 (1044)
....+++.|+|||++.+.. ++.++|||||||++|||++|+.||. +.+..+....+...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 5667889999999998765 6899999999999999999998864 44444444432110
Q ss_pred -------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 969 -------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 969 -------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
......+..+++++.+||.+||++||.+|||++|+|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122345678999999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=388.61 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=205.8
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeec--------
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTR-------- 821 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~-------- 821 (1044)
.++|+++++||+|+||+||+|++ +|+.||||++............+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999987 58899999987665555556778899999999999999999998755
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
++.+++||||+.++.+..+ ......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 3468999999977665544 444678999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCC----cccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC--CC
Q 045028 902 MKHNT----FLSSRSTAGTAEWMAPEVLRNE-PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL--DI 974 (1044)
Q Consensus 902 ~~~~~----~~~~~s~~GTp~Y~APEvL~g~-~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~--~i 974 (1044)
..... .....+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 54322 1223446799999999999876 58999999999999999999999999887776655442211100 00
Q ss_pred C----------------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 045028 975 P----------------------------DNLDPAVADIIRKCWQTDPKMRPTFTEIMAALK 1008 (1044)
Q Consensus 975 p----------------------------~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk 1008 (1044)
. ...++++++||.+||++||++|||+.|+|+|-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 0 013678899999999999999999999998753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=394.26 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=205.6
Q ss_pred CeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------CCc
Q 045028 754 EITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------PNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~~l 825 (1044)
+|+.+++||+|+||+||+|++ +|+.||||++..... ...+|+.+|++++||||++++++|... .++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999998 588999999876432 234799999999999999999998543 347
Q ss_pred eEEEEecCCCcHHHHhc--CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCC-eEEEEecccccc
Q 045028 826 SIVAEFLPRGSLYRLLH--RPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNW-VVKVCDFGLSRM 902 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dlLk--r~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg-~VKLiDFGLA~~ 902 (1044)
+|||||++++.+..+.. +....+++..++.++.||+.||+|||++| |+||||||+||||+.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 89999997764444332 24567999999999999999999999999 99999999999999775 899999999986
Q ss_pred ccCCcccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccc-------------
Q 045028 903 KHNTFLSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQ------------- 968 (1044)
Q Consensus 903 ~~~~~~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~------------- 968 (1044)
..... ...+.+||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+..+.+..+...
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 54332 3345689999999999875 46899999999999999999999999988776655443210
Q ss_pred --cccC------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccCCCC
Q 045028 969 --HRRL------------DIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA--LKPLQKPIT 1015 (1044)
Q Consensus 969 --~~~~------------~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~--Lk~L~k~l~ 1015 (1044)
.... .....+++++.+||.+||.+||++|||+.|+|+| |+++..+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 314 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCC
Confidence 0000 1224578999999999999999999999999987 566655433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=391.01 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=203.1
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC----Cce
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP----NLS 826 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~----~l~ 826 (1044)
++|+++++||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4699999999999999999987 58999999986544 2445567899999999999999999999987653 245
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccccccCC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~~~ 906 (1044)
++++|+.||+|.+++.. ..+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 56667779999999975 46999999999999999999999999 999999999999999999999999999754332
Q ss_pred c---ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcccc-------------
Q 045028 907 F---LSSRSTAGTAEWMAPEVLRN-EPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQH------------- 969 (1044)
Q Consensus 907 ~---~~~~s~~GTp~Y~APEvL~g-~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~------------- 969 (1044)
. ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+.........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 1 22345679999999999854 567899999999999999999999998877654433321100
Q ss_pred -----------cc-----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 970 -----------RR-----LDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 970 -----------~~-----~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
.. ......+++++++||.+||.+||.+|||+.|+|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01234678899999999999999999999999997
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=390.04 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=207.6
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC-----CC
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP-----PN 824 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~-----~~ 824 (1044)
.++|+++++||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 36899999999999999999987 589999999987665556667899999999999999999999998643 34
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
.+++|+|+.||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccC
Confidence 5777888889999999965 57999999999999999999999999 9999999999999999999999999997554
Q ss_pred CCcccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccccC-----------
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHRRL----------- 972 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~~~----------- 972 (1044)
.. ..+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.......
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 32 34567999999999987765 6889999999999999999999999887665554442111100
Q ss_pred ----------C--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 973 ----------D--------IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 973 ----------~--------ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. ....+++++++||.+||..||.+|||+.|+|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0 124678999999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=393.21 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=213.9
Q ss_pred cCCCCeeEEeEecccCcEEEEEEEE-----CCcEEEEEEeeccCcc--hhhHHHHHHHHHHHHhCCC-CCeeEEEeeeec
Q 045028 750 IPWEEITLGERIGLGSYGEVYRGDW-----HGTEVAVKRFLDQDFF--GESLEEFRSEVLIMKRVRH-PNVVLFMGAVTR 821 (1044)
Q Consensus 750 i~~e~y~I~r~LGkG~FGtVykak~-----~g~~VAVK~l~~~~~~--~~~~~~~~~EI~ILk~LrH-PNIVkl~~~~~~ 821 (1044)
+..++|+++++||+|+||+||+|+. +|+.||||++...... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 4458899999999999999999975 4788999998654322 2234568889999999976 899999999999
Q ss_pred CCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 822 PPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 822 ~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
...++++|||+.||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999999976 456788999999999999999999999 9999999999999999999999999997
Q ss_pred cccC-CcccccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc--ccccCCCCC
Q 045028 902 MKHN-TFLSSRSTAGTAEWMAPEVLRNE--PSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF--QHRRLDIPD 976 (1044)
Q Consensus 902 ~~~~-~~~~~~s~~GTp~Y~APEvL~g~--~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~--~~~~~~ip~ 976 (1044)
.... ......+..|++.|++||.+.+. .++.++|||||||+||+|++|+.||.+.+..+....+.. ......+|.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 5432 22234556799999999999765 367899999999999999999999988665544333321 233566778
Q ss_pred CCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 045028 977 NLDPAVADIIRKCWQTDPKMRP-----TFTEIMAA 1006 (1044)
Q Consensus 977 ~ip~ELkdLI~rcL~kDPekRP-----Ta~ELLe~ 1006 (1044)
.+++++++||.+||.+||++|| |++|+++|
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 8999999999999999999999 58999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=385.63 Aligned_cols=253 Identities=33% Similarity=0.535 Sum_probs=199.4
Q ss_pred CCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecCC----CceEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRPP----NLSIV 828 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~~----~l~LV 828 (1044)
++|.+.++||+|+||+||+|+++|+.||||++.... ........|+..+..++||||+++++++.+++ .++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 478999999999999999999999999999885432 11122334555556789999999999987654 48999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhC--------CCcEEEecCCCCcEEEcCCCeEEEEecccc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNC--------TPVIVHRDLKSPNLLVDKNWVVKVCDFGLS 900 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~--------G~~IVHRDIKPeNILLd~dg~VKLiDFGLA 900 (1044)
|||+++|+|.+++++ ..+++..++.++.|++.||.|||.. | ||||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999986 4689999999999999999999974 6 999999999999999999999999999
Q ss_pred ccccCCc----ccccCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhCCCCCCCCC-------------
Q 045028 901 RMKHNTF----LSSRSTAGTAEWMAPEVLRNEP------SDEKCDVYSFGVILWELCTMQQPWGGMN------------- 957 (1044)
Q Consensus 901 ~~~~~~~----~~~~s~~GTp~Y~APEvL~g~~------~s~kSDIWSLG~LLyELLTGk~PF~~~~------------- 957 (1044)
+...... .......||+.|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 8654322 1234567999999999997653 4678999999999999999988764321
Q ss_pred --hHHHHhhhccccccCCCCCC-----CCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 958 --PMQVVGAVGFQHRRLDIPDN-----LDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 958 --~~eil~~I~~~~~~~~ip~~-----ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
...+...+.....++.++.. ...++.+|+.+||+.||.+|||+.||++.|+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11222222222223333332 23468999999999999999999999999998764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-43 Score=377.35 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=204.8
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCC-eeEEEeeeecCCCceEEE
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPN-VVLFMGAVTRPPNLSIVA 829 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPN-IVkl~~~~~~~~~l~LVm 829 (1044)
++|++++.||+|+||+||+|++ +|+.||||++..... ...+..|+++++.++|+| |+.+..++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999987 488999998765432 134788999999998665 556666777888899999
Q ss_pred EecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC---CCeEEEEeccccccccCC
Q 045028 830 EFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK---NWVVKVCDFGLSRMKHNT 906 (1044)
Q Consensus 830 Ey~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~---dg~VKLiDFGLA~~~~~~ 906 (1044)
||+ +++|.+.+......+++..++.++.|++.||+|||++| ||||||||+|||++. +..+||+|||+++.....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 55677776666778999999999999999999999999 999999999999864 457999999999865432
Q ss_pred c-------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhcc------ccccCC
Q 045028 907 F-------LSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGF------QHRRLD 973 (1044)
Q Consensus 907 ~-------~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~------~~~~~~ 973 (1044)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 1 223456799999999999999999999999999999999999999987655443322210 111122
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccC
Q 045028 974 IPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQK 1012 (1044)
Q Consensus 974 ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k 1012 (1044)
.+..+|+++.++|.+||+.+|++||++.+|.+.|+++..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 456899999999999999999999999999888887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-42 Score=374.11 Aligned_cols=256 Identities=17% Similarity=0.262 Sum_probs=214.5
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC-CCeeEEEeeeecCCCceEE
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-PNVVLFMGAVTRPPNLSIV 828 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH-PNIVkl~~~~~~~~~l~LV 828 (1044)
.++|+++++||+|+||+||+|++ +|+.||||++..... ...+.+|+++++.+.| +||+.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46899999999999999999987 578999998755432 2346788999999975 8999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcC-----CCeEEEEeccccccc
Q 045028 829 AEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDK-----NWVVKVCDFGLSRMK 903 (1044)
Q Consensus 829 mEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~-----dg~VKLiDFGLA~~~ 903 (1044)
|||+ +++|.+++......++...+..++.|++.||.|||++| |+||||||+||||+. ++.+||+|||+++..
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999 78999999877778999999999999999999999999 999999999999974 578999999999864
Q ss_pred cCC-------cccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhcccc---c
Q 045028 904 HNT-------FLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPM---QVVGAVGFQH---R 970 (1044)
Q Consensus 904 ~~~-------~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~---eil~~I~~~~---~ 970 (1044)
... .......+||+.|||||++.+..++.++|||||||++|||++|+.||.+.... +.+..+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 322 12234567999999999999999999999999999999999999999865432 2233322111 1
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccCCC
Q 045028 971 RLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAALKPLQKPI 1014 (1044)
Q Consensus 971 ~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~Lk~L~k~l 1014 (1044)
...++..+|+++.+++..|+..+|++||+++.+.+.|+++.++.
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 22344678999999999999999999999999999888876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-42 Score=378.41 Aligned_cols=243 Identities=21% Similarity=0.338 Sum_probs=200.2
Q ss_pred CCCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecC--CCce
Q 045028 752 WEEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRP--PNLS 826 (1044)
Q Consensus 752 ~e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~--~~l~ 826 (1044)
.++|+++++||+|+||+||+|++ +|+.||||+++... .+.+.+|+.+|+.++ ||||++++++|... ..++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36899999999999999999987 58899999986432 456889999999996 99999999998744 5699
Q ss_pred EEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCC-CeEEEEeccccccccC
Q 045028 827 IVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKN-WVVKVCDFGLSRMKHN 905 (1044)
Q Consensus 827 LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~d-g~VKLiDFGLA~~~~~ 905 (1044)
+||||+.+++|..+. +.+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+++....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999997765 45999999999999999999999999 9999999999999865 4799999999986543
Q ss_pred CcccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhcc----------------
Q 045028 906 TFLSSRSTAGTAEWMAPEVLRNEP-SDEKCDVYSFGVILWELCTMQQPWGGMNPM-QVVGAVGF---------------- 967 (1044)
Q Consensus 906 ~~~~~~s~~GTp~Y~APEvL~g~~-~s~kSDIWSLG~LLyELLTGk~PF~~~~~~-eil~~I~~---------------- 967 (1044)
.. .....+||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||...... +....+..
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 345567999999999988764 799999999999999999999999765432 11111000
Q ss_pred c-------------------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 968 Q-------------------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 968 ~-------------------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
. .........+++++++||.+||.+||.+|||++|+|+|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011123478999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=385.73 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=197.5
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCeeEEEeeeecC------CC
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNVVLFMGAVTRP------PN 824 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNIVkl~~~~~~~------~~ 824 (1044)
++|+++++||+|+||+||+|++ +|+.||||++............+.+|+.+|++++||||++++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999987 489999999987766666777899999999999999999999998643 56
Q ss_pred ceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEecccccccc
Q 045028 825 LSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKH 904 (1044)
Q Consensus 825 l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDFGLA~~~~ 904 (1044)
+|+||||+.++.+ +.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhccc
Confidence 8999999976544 4443 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhccccc--------------
Q 045028 905 NTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQVVGAVGFQHR-------------- 970 (1044)
Q Consensus 905 ~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~eil~~I~~~~~-------------- 970 (1044)
... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 171 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 432 33456799999999999999999999999999999999999999998776655443311000
Q ss_pred ------cCC--------------C------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 045028 971 ------RLD--------------I------PDNLDPAVADIIRKCWQTDPKMRPTFTEIMAA 1006 (1044)
Q Consensus 971 ------~~~--------------i------p~~ip~ELkdLI~rcL~kDPekRPTa~ELLe~ 1006 (1044)
... . +..+++++++||.+||..||++|||++|+|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 01245678999999999999999999999988
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-38 Score=346.77 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=191.2
Q ss_pred CCeeEEeEecccCcEEEEEEEE--CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-----------CCCeeEEEeee
Q 045028 753 EEITLGERIGLGSYGEVYRGDW--HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-----------HPNVVLFMGAV 819 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~--~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-----------HPNIVkl~~~~ 819 (1044)
.+|+++++||+|+||+||+|++ +|+.||||++.+.. ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 68999999987543 23456778998888774 57899999887
Q ss_pred ecC--CCceEEEEecCCCcH--HHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCcEEEecCCCCcEEEcCCC----
Q 045028 820 TRP--PNLSIVAEFLPRGSL--YRLLHRPNNQLDERRRLRMALDAARGMNYLHN-CTPVIVHRDLKSPNLLVDKNW---- 890 (1044)
Q Consensus 820 ~~~--~~l~LVmEy~~GGsL--~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs-~G~~IVHRDIKPeNILLd~dg---- 890 (1044)
... ...+++|+++..+.. ..........+++..++.++.||+.||.|||+ +| |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 643 456666666554432 22333446789999999999999999999997 88 99999999999998654
Q ss_pred --eEEEEeccccccccCCcccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH------HH
Q 045028 891 --VVKVCDFGLSRMKHNTFLSSRSTAGTAEWMAPEVLRNEPSDEKCDVYSFGVILWELCTMQQPWGGMNPMQ------VV 962 (1044)
Q Consensus 891 --~VKLiDFGLA~~~~~~~~~~~s~~GTp~Y~APEvL~g~~~s~kSDIWSLG~LLyELLTGk~PF~~~~~~e------il 962 (1044)
.++|+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||....... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 5999999999755432 345689999999999999999999999999999999999999997543211 00
Q ss_pred hh-hcc---------------------c------------------cccCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 045028 963 GA-VGF---------------------Q------------------HRRLDIPDNLDPAVADIIRKCWQTDPKMRPTFTE 1002 (1044)
Q Consensus 963 ~~-I~~---------------------~------------------~~~~~ip~~ip~ELkdLI~rcL~kDPekRPTa~E 1002 (1044)
.. +.. . .....++...++++++||.+||.+||.+|||+.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00 000 0 0011122335678999999999999999999999
Q ss_pred HHHH--hcccc
Q 045028 1003 IMAA--LKPLQ 1011 (1044)
Q Consensus 1003 LLe~--Lk~L~ 1011 (1044)
+|+| +++..
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 9987 44443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.9e-22 Score=202.43 Aligned_cols=166 Identities=17% Similarity=0.093 Sum_probs=120.5
Q ss_pred eeEEeEecccCcEEEEEEEE-CCcEEEEEEeeccCcc----------------hhhHHHHHHHHHHHHhCCCCCeeEEEe
Q 045028 755 ITLGERIGLGSYGEVYRGDW-HGTEVAVKRFLDQDFF----------------GESLEEFRSEVLIMKRVRHPNVVLFMG 817 (1044)
Q Consensus 755 y~I~r~LGkG~FGtVykak~-~g~~VAVK~l~~~~~~----------------~~~~~~~~~EI~ILk~LrHPNIVkl~~ 817 (1044)
+.++++||+|+||+||+|++ +|+.||||+++..... ........+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999986 6889999986532110 011234566888999999999998886
Q ss_pred eeecCCCceEEEEecCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCcEEEecCCCCcEEEcCCCeEEEEec
Q 045028 818 AVTRPPNLSIVAEFLPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCTPVIVHRDLKSPNLLVDKNWVVKVCDF 897 (1044)
Q Consensus 818 ~~~~~~~l~LVmEy~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G~~IVHRDIKPeNILLd~dg~VKLiDF 897 (1044)
+. ..+++|||+++..+.. ++......++.|++.+|.|||++| |+||||||+|||++.+ .++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 64 3489999998876543 333445678999999999999999 9999999999999965 5899999
Q ss_pred cccccccCCcccccCCCCCCCccCc--cc---ccCCCCCchhHHHHHHHHH
Q 045028 898 GLSRMKHNTFLSSRSTAGTAEWMAP--EV---LRNEPSDEKCDVYSFGVIL 943 (1044)
Q Consensus 898 GLA~~~~~~~~~~~s~~GTp~Y~AP--Ev---L~g~~~s~kSDIWSLG~LL 943 (1044)
|+++....+.. ..|... +. +....|..++|+||+.--+
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99976543311 111111 00 1124567788999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=4.1e-07 Score=93.14 Aligned_cols=141 Identities=14% Similarity=0.009 Sum_probs=101.3
Q ss_pred CCeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecCCCceEEEEe
Q 045028 753 EEITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRPPNLSIVAEF 831 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~~~l~LVmEy 831 (1044)
+.|++.+..+-++.+.||+...+++.+.||+...... .....+.+|..++..+. +--+.+++.++..++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 5678777766666689999988888899998654321 12234677888888774 33356677777788889999999
Q ss_pred cCCCcHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 045028 832 LPRGSLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT---------------------------------------- 871 (1044)
Q Consensus 832 ~~GGsL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G---------------------------------------- 871 (1044)
++|..+.+..... . ....++.++...+..||+..
T Consensus 92 l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccccc---c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9999887665321 1 12234556666677777432
Q ss_pred -----------------CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 872 -----------------PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 872 -----------------~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 128999999999999987777799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=4.5e-05 Score=77.20 Aligned_cols=128 Identities=20% Similarity=0.197 Sum_probs=84.6
Q ss_pred EecccC-cEEEEEEEEC-CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC--CCeeEEEeeeecCCCceEEEEecCCC
Q 045028 760 RIGLGS-YGEVYRGDWH-GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH--PNVVLFMGAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 760 ~LGkG~-FGtVykak~~-g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH--PNIVkl~~~~~~~~~l~LVmEy~~GG 835 (1044)
.+..|. -+.||+...+ +..+.+|...... ...+..|...++.+.. -.+.+++.+..+.+..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344454 3689998875 4568888754332 1236678888877642 23566787778888899999999987
Q ss_pred cHHHHhcCCCCCCcHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 045028 836 SLYRLLHRPNNQLDERRRLRMALDAARGMNYLHNCT-------------------------------------------- 871 (1044)
Q Consensus 836 sL~dlLkr~~~~Lse~~il~Ia~QIa~AL~yLHs~G-------------------------------------------- 871 (1044)
++.+.. +... ..+.++...|..||...
T Consensus 92 ~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 92 DLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp ETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 654321 1111 12234444555555321
Q ss_pred ------------CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 872 ------------PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 872 ------------~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 128999999999999987777899999774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.29 E-value=0.00024 Score=77.91 Aligned_cols=78 Identities=18% Similarity=0.132 Sum_probs=49.7
Q ss_pred EeEecccCcEEEEEEEE--CCcEEEEEEeecc-----CcchhhHHHHHHHHHHHHhCC--CC-CeeEEEeeeecCCCceE
Q 045028 758 GERIGLGSYGEVYRGDW--HGTEVAVKRFLDQ-----DFFGESLEEFRSEVLIMKRVR--HP-NVVLFMGAVTRPPNLSI 827 (1044)
Q Consensus 758 ~r~LGkG~FGtVykak~--~g~~VAVK~l~~~-----~~~~~~~~~~~~EI~ILk~Lr--HP-NIVkl~~~~~~~~~l~L 827 (1044)
.+.||.|....||+... +++.++||.-... .......++...|...|+.+. .| .+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999865 4668999965321 111123345667888887663 23 34555543 4556789
Q ss_pred EEEecCCCcH
Q 045028 828 VAEFLPRGSL 837 (1044)
Q Consensus 828 VmEy~~GGsL 837 (1044)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.18 E-value=0.0024 Score=67.61 Aligned_cols=54 Identities=22% Similarity=0.152 Sum_probs=47.2
Q ss_pred cccccceecchhHHHHHHHHHHhCCceEEeecccccCCCCceeEEEEeCC-CceEEEecc
Q 045028 292 LGSLTIGLARHRALLFKVLADIVGIPCRLVKGQQYTGCDDVAMNFVRIDD-GREYIVDLM 350 (1044)
Q Consensus 292 lG~l~~g~c~~~Allfk~lad~~gl~~~lv~G~~~~~~~~~~~~~v~~~~-~~~y~vDl~ 350 (1044)
|=.-|+|.|.|+|.+|-.++-.+|||+|+|.| | .+++|+.|...+ ++|.-||-.
T Consensus 135 ll~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~--~---~~H~W~Ev~~~~~~rWv~vDp~ 189 (287)
T d2f4ma1 135 LLETRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDAC 189 (287)
T ss_dssp HHHHCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEETT
T ss_pred HHHhcCccHHHHHHHHHHHHHHcCCCeEEEec--C---CcceeEEEEecCCCcEEEecCc
Confidence 33568999999999999999999999999999 4 379999999975 469999964
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.89 E-value=0.01 Score=62.55 Aligned_cols=66 Identities=11% Similarity=-0.001 Sum_probs=41.9
Q ss_pred EEEEEEEE-CCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCCCCe--eEEE-----eeeecCCCceEEEEecCCC
Q 045028 767 GEVYRGDW-HGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRHPNV--VLFM-----GAVTRPPNLSIVAEFLPRG 835 (1044)
Q Consensus 767 GtVykak~-~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrHPNI--Vkl~-----~~~~~~~~l~LVmEy~~GG 835 (1044)
-.||+++. +|+.|++|+..... ...+++..|...+..|....| +..+ ..+...+..+.+++++.|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 57999976 67889999875443 234567778888877742211 1111 1223455688899998765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.58 E-value=0.0082 Score=62.45 Aligned_cols=144 Identities=13% Similarity=0.028 Sum_probs=74.8
Q ss_pred CeeEEeEecccCcEEEEEEEECCcEEEEEEeeccCcchhhHHHHHHHHHHHHhCCC-----CCeeEEEe---eeecCCCc
Q 045028 754 EITLGERIGLGSYGEVYRGDWHGTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVRH-----PNVVLFMG---AVTRPPNL 825 (1044)
Q Consensus 754 ~y~I~r~LGkG~FGtVykak~~g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~LrH-----PNIVkl~~---~~~~~~~l 825 (1044)
.+.-.+.|..|---+.|+.+.++..+++|++.... ..+.+..|+.++..|.. |..+...+ +.......
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 44445566677778899998888889999875431 12345556767766632 22221100 11122345
Q ss_pred eEEEEecCCCcHHHH--------------hc----CC----CCCC------------------cHHHHHHHHHHHHHHHH
Q 045028 826 SIVAEFLPRGSLYRL--------------LH----RP----NNQL------------------DERRRLRMALDAARGMN 865 (1044)
Q Consensus 826 ~LVmEy~~GGsL~dl--------------Lk----r~----~~~L------------------se~~il~Ia~QIa~AL~ 865 (1044)
..++.++.|...... ++ .. .... ........+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 566666655422110 00 00 0000 00111122223333333
Q ss_pred HHHhCC--CcEEEecCCCCcEEEcCCCeEEEEeccccc
Q 045028 866 YLHNCT--PVIVHRDLKSPNLLVDKNWVVKVCDFGLSR 901 (1044)
Q Consensus 866 yLHs~G--~~IVHRDIKPeNILLd~dg~VKLiDFGLA~ 901 (1044)
..+..+ ..|||+|+.++||+++.+...-|+||+.+.
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 333211 239999999999999998878999999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.12 E-value=0.031 Score=60.29 Aligned_cols=76 Identities=14% Similarity=0.274 Sum_probs=49.7
Q ss_pred CCeeEEeEecccCcEEEEEEEEC---------CcEEEEEEeeccCcchhhHHHHHHHHHHHHhCC-CCCeeEEEeeeecC
Q 045028 753 EEITLGERIGLGSYGEVYRGDWH---------GTEVAVKRFLDQDFFGESLEEFRSEVLIMKRVR-HPNVVLFMGAVTRP 822 (1044)
Q Consensus 753 e~y~I~r~LGkG~FGtVykak~~---------g~~VAVK~l~~~~~~~~~~~~~~~EI~ILk~Lr-HPNIVkl~~~~~~~ 822 (1044)
+++++ +.|+.|--=.+|++... ...|.+++.-... ......+|..+++.+. +.-..++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34555 56888888889998753 2457777654222 2234567888988885 4334467777643
Q ss_pred CCceEEEEecCCCcH
Q 045028 823 PNLSIVAEFLPRGSL 837 (1044)
Q Consensus 823 ~~l~LVmEy~~GGsL 837 (1044)
++|+||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 789999987644
|
| >d2q3za4 d.3.1.4 (A:146-461) Transglutaminase catalytic domain {Human (Homo sapiens), tissue isozyme [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Transglutaminase catalytic domain species: Human (Homo sapiens), tissue isozyme [TaxId: 9606]
Probab=90.89 E-value=0.084 Score=55.55 Aligned_cols=79 Identities=15% Similarity=0.033 Sum_probs=51.4
Q ss_pred ccchHHHHHHHHHHHHHh------cCCCCCC-cchhhh-hHHHHHHHHHHhhCCceeecccccceecchhHHHHHHHHHH
Q 045028 242 AFVGIDLVRNLAVLVADY------MGGPVGD-PENMSR-ASRSLSYSLKATLGSMVLPLGSLTIGLARHRALLFKVLADI 313 (1044)
Q Consensus 242 ~~~~~~~v~~la~~V~~~------mgg~~~~-~~~~~~-~~~~~~~~l~~~~~~~v~plG~l~~g~c~~~Allfk~lad~ 313 (1044)
..+.-.|...|...|--. +|.-..+ .+-+.+ .|.-...-|++...+...| +|.|-|-++|-.+-+++-.
T Consensus 69 R~dPv~V~Rv~samvns~dd~GVL~G~Ws~~y~~G~~P~~W~GSv~IL~q~~~~~~~p---VkyGqCwvFA~v~~tvlR~ 145 (316)
T d2q3za4 69 RSSPVYVGRVGSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQR---VKYGQCWVFAAVACTVLRC 145 (316)
T ss_dssp TTCHHHHHHHHHHTTTCTTTTSSEEECCSSCCTTSCCTTTCCBSHHHHHHHHHTTTCC---EEEECHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhhhccCCCCceeecccccccCCCcCCCCCCCcHHHHHHHHHcCCcc---cccchhHHHHHHHHHHHHh
Confidence 445566777777766422 2222212 111233 2333333366666665544 7999999999999999999
Q ss_pred hCCceEEeec
Q 045028 314 VGIPCRLVKG 323 (1044)
Q Consensus 314 ~gl~~~lv~G 323 (1044)
+|||||+|.|
T Consensus 146 lGIPaRvVT~ 155 (316)
T d2q3za4 146 LGIPTRVVTN 155 (316)
T ss_dssp HTCCEEEEEE
T ss_pred cCCCceEecc
Confidence 9999999999
|